sequence,citation_id,target_id,dbaasp_id,citation,target
RKRIHIGPGRAFYTT,1,2,12,Antibacterial activity of peptides derived from envelope glycoproteins of HIV-1,Escherichiacoli
FLPKTLRKFFARIRGGRAAVLNALGKEEQIGRASNSGRKCARKKK,2,3,53,Peptide fragments of a beta-defensin derivative with potent bactericidal activity,Pseudomonasaeruginosa
DAACAAHCLFRGRSGGYCNGKRVCVCR,3,1,59,"Synthesis and structure-function study about tenecin 1, an antibacterial protein from larvae of Tenebrio molitor",None_target
ALWKTLLKKVLKAAAKAALKAVLVGANA,4,4,102,Antibacterial properties of dermaseptin S4 derivatives with in vivo activity,Staphylococcusaureus
GLRKRLRKFRNKIKEKLKKI,5,2,104,"Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes.",Escherichiacoli
GLRKRLRKPRNKPKEKLKKI,6,2,127,"Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes",Escherichiacoli
GLRKRKRKFRNKKKEKLKKI,6,2,128,"Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes",Escherichiacoli
GLRKALRKFRNKIKEALKKI,6,2,129,"Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes",Escherichiacoli
GLRKRLRKARNKIKEKLKKI,6,2,130,"Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes",Escherichiacoli
GLRKRLRKFRNKIKQKLKKI,6,2,131,"Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes",Escherichiacoli
LLGDLLRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,7,5,140,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV
LLGDLLRKSKEKIGKEFKRIVQR,7,5,141,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV
KRIVQRIKDFLRNLVPRTES,7,5,142,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV
SKEKIGKEFKRIVQRIKDFLR,7,5,143,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV
FKRIVQRIKDFLR,7,5,144,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV
RLFDKIRQVIRKF,7,5,145,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV
KRIVQRIKDFLR,7,5,146,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV
GFKRIVQRIKDFLRNLV,7,5,147,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV
GIKEFKRIVQRIKDFLRNLV,7,5,150,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV
GIKEWKRIVQRIKDFLRNLV,7,5,152,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV
GIKQFKRIVQRIKDFLRNLV,7,5,153,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV
GIKEFKREFQRIKDFLRNLV,7,5,154,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV
GRFKRFRKPFKKLFKKIS,7,5,156,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV
GRFKRIRKKLKKLFKKIS,7,5,158,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV
GRFKRFRKKFKKLFK,7,5,159,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV
RRRFPWVCWPFLRRR,8,6,161,Antimicrobial activity of a 13 amino acid tryptophan-rich peptide derived from a putative porcine precursor protein of a novel family of antibacterial peptides,Aspergillusfumigatus
RFPWWWPFLR,8,6,162,Antimicrobial activity of a 13 amino acid tryptophan-rich peptide derived from a putative porcine precursor protein of a novel family of antibacterial peptides,Aspergillusfumigatus
KWKSFIKKLTSAAKKVVTTAKPLISS,9,2,165,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli
KWKLFKKIGIGAVLKVLTTGLPALIS,9,2,166,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli
KWKLFKKIGIGAVLKVLTTGLPALKLTK,9,2,167,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli
KWKSFIKKLTTAVKKVLTTGLPALIS,9,2,168,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli
KWKSFIKKLTSAAKKVTTAAKPLTK,9,2,169,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli
KWKKFIKKIGIGAVLKVLTTGLPALKLTKK,9,2,170,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli
KKWKKFIKKIGIGAVLTTPGAKK,9,2,171,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli
KWKSFIKKLTSAAKKVVTTAKPLALIS,9,2,172,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli
KWKSFIKKLTKAAKKVVTTAKKPLIV,9,2,173,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli
KWKKFIKSLTKSAAKTVVKTAKKPLIV,9,2,174,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli
KWKLFKKIGIGAVLKVLTTGLPALKLTLK,9,2,175,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli
KLFKKIGIGAVLKVLTTGLPALKLTLK,9,2,176,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli
KWKFKKIGIGAVLKVLTTGLPALKLTLK,10,2,177,Biological properties of structurally related alpha-helical cationic antimicrobial peptide,Escherichiacoli
KLWKLFKKIGIGAVLKVLTTGLPALKLTLK,9,2,178,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli
KWKSFIKNLTKGGSKILTTGLPALIS,9,2,179,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli
KWKKFIKNLTKGGSKILTTGLPALIS,9,2,180,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli
KWKSFIKKLTSAAKKVLTTGLPALIS,9,2,181,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli
KKWWKAQKAVNSGPNALQTLAQ,9,2,182,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli
KKWWKAKKFANSGPNALQTLAQ,9,2,183,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli
KKWWKFIKKAVNSGTTGLQTLAS,9,2,184,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli
KWKSFIKKLTSVLKKVVTTAKPLISS,9,2,185,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli
KKKSFIKLLTSAKVSVLTTAKPLISS,9,2,186,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli
WKVFKSFIKKASSFAQSVLD,9,2,187,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli
KKWRKSFFKQVGSFDNSV,9,2,188,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli
YVLWKRKRFIFI,11,2,189,Designed beta-boomerang antiendotoxic and antimicrobial peptides: structures and activities in lipopolysaccharide,Escherichiacoli
YVLWKRKRWIFI,11,2,190,Designed beta-boomerang antiendotoxic and antimicrobial peptides: structures and activities in lipopolysaccharide,Escherichiacoli
YVLWKRKRYIFI,11,2,191,Designed beta-boomerang antiendotoxic and antimicrobial peptides: structures and activities in lipopolysaccharide,Escherichiacoli
YVLFKRKRFIFI,11,2,192,Designed beta-boomerang antiendotoxic and antimicrobial peptides: structures and activities in lipopolysaccharide,Escherichiacoli
YVLLKRKRLIFI,11,2,193,Designed beta-boomerang antiendotoxic and antimicrobial peptides: structures and activities in lipopolysaccharide,Escherichiacoli
YVLAKRKRAIFI,11,2,194,Designed beta-boomerang antiendotoxic and antimicrobial peptides: structures and activities in lipopolysaccharide,Escherichiacoli
GWKRKRFG,11,2,195,Designed beta-boomerang antiendotoxic and antimicrobial peptides: structures and activities in lipopolysaccharide,Escherichiacoli
FQWQRNMRKVRGPPVS,12,2,272,Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111,Escherichiacoli
FQWQRNMRKVR,12,2,273,Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111,Escherichiacoli
FQWQRNPRKVR,12,2,274,Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111,Escherichiacoli
SGSLSTFFRLFNRSFTQALGK,13,7,327,"Targeted killing of Streptococcus mutans by a pheromone-guided ""smart"" antimicrobial peptide",Streptococcusmutans
TFFRLFNRSFTQALGK,13,7,328,"Targeted killing of Streptococcus mutans by a pheromone-guided ""smart"" antimicrobial peptide",Streptococcusmutans
TFFRLFNR,13,7,331,"Targeted killing of Streptococcus mutans by a pheromone-guided ""smart"" antimicrobial peptide",Streptococcusmutans
FKKFWKWFRRF,13,7,333,"Targeted killing of Streptococcus mutans by a pheromone-guided ""smart"" antimicrobial peptide",Streptococcusmutans
TRRRLFNRSFTQALGKSGGGFKKFWKWFRRF,13,7,334,"Targeted killing of Streptococcus mutans by a pheromone-guided ""smart"" antimicrobial peptide",Streptococcusmutans
TFFRLFNRSGGGFKKFWKWFRRF,13,7,335,"Targeted killing of Streptococcus mutans by a pheromone-guided ""smart"" antimicrobial peptide",Streptococcusmutans
RHRHRHRH,14,8,339,Antimicrobial activity of a chelatable poly(arginyl-histidine) produced by the ergot fungus Verticillium kibiense,Bacillussubtilis
RHRHRHRHRHRH,14,8,341,Antimicrobial activity of a chelatable poly(arginyl-histidine) produced by the ergot fungus Verticillium kibiense,Bacillussubtilis
HRHRHRHRHR,14,8,342,Antimicrobial activity of a chelatable poly(arginyl-histidine) produced by the ergot fungus Verticillium kibiense,Bacillussubtilis
KHKHKHKHKH,14,8,343,Antimicrobial activity of a chelatable poly(arginyl-histidine) produced by the ergot fungus Verticillium kibiense,Bacillussubtilis
RGRGRGRGRG,14,8,344,Antimicrobial activity of a chelatable poly(arginyl-histidine) produced by the ergot fungus Verticillium kibiense,Bacillussubtilis
GHGHGHGHGH,14,8,345,Antimicrobial activity of a chelatable poly(arginyl-histidine) produced by the ergot fungus Verticillium kibiense,Bacillussubtilis
RCRCRCRCRC,14,8,346,Antimicrobial activity of a chelatable poly(arginyl-histidine) produced by the ergot fungus Verticillium kibiense,Bacillussubtilis
RLLRRLLRRLLRRLLRRLLR,15,8,354,Helix stability confers salt resistance upon helical antimicrobial peptides,Bacillussubtilis
APKAMRLLRRLLRRLLR,15,8,355,Helix stability confers salt resistance upon helical antimicrobial peptides,Bacillussubtilis
RLLRRLLRRLLRLQKKGI,15,8,356,Helix stability confers salt resistance upon helical antimicrobial peptides,Bacillussubtilis
APKAMRLLRRLLRLQKKGI,15,8,357,Helix stability confers salt resistance upon helical antimicrobial peptides,Bacillussubtilis
PKAMRLLRRLLRLQKKG,15,8,358,Helix stability confers salt resistance upon helical antimicrobial peptides,Bacillussubtilis
APKAMHSAKKFGKAFVGEIMLQKKGI,15,8,359,Helix stability confers salt resistance upon helical antimicrobial peptides,Bacillussubtilis
KLFKRWKHLFR,16,7,373,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans
RLLKRFKHLFK,16,7,374,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans
KLLQTFKQIFR,16,7,376,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans
RILKELKNLFK,16,7,377,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans
KLVEQLKEIFR,16,7,380,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans
RVLQEIKQILK,16,7,381,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans
KLAENVKEILR,16,7,384,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans
RALHEAKEALK,16,7,385,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans
YLFQTWQHLFR,16,7,388,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans
YLLTEFQHLFK,16,7,389,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans
KLLQTFNQIFR,16,7,392,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans
TILQSLKNIFK,16,7,393,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans
KLVQQLKNIFR,16,7,396,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans
RVLNQVKQILK,16,7,397,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans
KLAQKVKRVLR,16,7,400,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans
RALKRIKHVLK,16,7,402,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans
KLKKLLKKLKKLLK,16,7,404,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans
KLKKLLKRWRRWWR,16,7,408,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans
KRLFKKLLFSLRKY,17,9,488,"Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides",Candidapseudotropicalis
SSSKEENRIIPGGI,17,9,489,"Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides",Candidapseudotropicalis
ELDRICGYGTARCRKKCRSQEYRIGRCPNTYACCLRK,18,10,490,Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity.,Staphylococcuscarnosus
RRGWVLALVLRYGRR,20,2,520,Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity,Escherichiacoli
RRGWVLALYLRYGRR,20,2,522,Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity,Escherichiacoli
RRGWALRLVLAY,20,2,524,Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity,Escherichiacoli
WVLVLRLGY,20,2,526,Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity,Escherichiacoli
KSCCRNTWARNCYNVCRLPGTISREICAKKCRCKIISGTTCPSDYPK,22,12,596,Structural dissection of a highly knotted peptide reveals minimal motif with antimicrobial activity,Clavibactermichiganensis
CCRNTWARNCYNVCRLPGTISREICAKKCDCKIISGTTC,22,12,597,Structural dissection of a highly knotted peptide reveals minimal motif with antimicrobial activity,Clavibactermichiganensis
CCRNTWARNCYNVCRLPGTISREICAKKCRCKIISGTTC,22,12,598,Structural dissection of a highly knotted peptide reveals minimal motif with antimicrobial activity,Clavibactermichiganensis
TWARNCYNVCRLPGTISREICAKKCD,22,12,599,Structural dissection of a highly knotted peptide reveals minimal motif with antimicrobial activity,Clavibactermichiganensis
TWARNCYNVCRLPGTISREICAKKCR,22,12,600,Structural dissection of a highly knotted peptide reveals minimal motif with antimicrobial activity,Clavibactermichiganensis
REISAKKSD,22,12,602,Structural dissection of a highly knotted peptide reveals minimal motif with antimicrobial activity,Clavibactermichiganensis
REISAKKSR,22,12,603,Structural dissection of a highly knotted peptide reveals minimal motif with antimicrobial activity,Clavibactermichiganensis
VCRLPGTISREICA,22,12,604,Structural dissection of a highly knotted peptide reveals minimal motif with antimicrobial activity,Clavibactermichiganensis
TWARNSYNVSRLP,22,12,605,Structural dissection of a highly knotted peptide reveals minimal motif with antimicrobial activity,Clavibactermichiganensis
ALWMTLLKKVLKAAAKAALDAVLVGANA,23,2,607,Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity,Escherichiacoli
ALWDTLLKKVLKAAAKAALNAVLVGANA,23,2,608,Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity,Escherichiacoli
ALWDTLLKKVLKAAAKAALDAVLVGANA,23,2,609,Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity,Escherichiacoli
ALWMTLLKKVLKAAAKAALKAVLVGANA,23,2,610,Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity,Escherichiacoli
ALWKTLLKKVLKAAAKAALNAVLVGANA,23,2,611,Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity,Escherichiacoli
ALWMTLLKKVLKAAAKAALN,23,2,612,Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity,Escherichiacoli
ALWMTLLKKVLKAAAK,23,2,613,Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity,Escherichiacoli
ALWMTLLKKVLK,23,2,614,Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity,Escherichiacoli
TLLKKVLKAAAK,23,2,615,Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity,Escherichiacoli
TLLKKVLKAAAKAALNAVLVGANA,23,2,616,Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity,Escherichiacoli
KVLKAAAKAALNAVLVGANA,23,2,617,Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity,Escherichiacoli
AAAKAALNAVLVGANA,23,2,618,Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity,Escherichiacoli
ALWKTLLKKVLKAAAK,23,2,619,Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity,Escherichiacoli
FLGALFKVA,24,8,627,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis
FLGALFKVASK,24,8,632,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis
FLGALFKVASKV,24,8,633,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis
FLGALFKVASKVL,24,8,634,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis
GALFKVASKVL,24,8,635,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis
LGALFKVASKVLP,24,8,636,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis
GALFKVASKVLPS,24,8,637,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis
ALFKVASKVLPSV,24,8,638,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis
LFKVASKVLPSVK,24,8,639,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis
FLKALFKVASKVL,24,8,640,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis
FLKALFKVALKVL,24,8,641,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis
ALGALFKVASKVL,25,8,642,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5.,Bacillussubtilis
WLGALFKVASKVL,25,8,643,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5.,Bacillussubtilis
WLGALFKVASK,24,8,644,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis
FWGALFKVASK,24,8,645,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis
FLWALFKVASK,24,8,646,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis
FLGAWFKVASK,24,8,651,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis
FLGALWKVASK,24,8,653,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis
FLGALFWVASK,24,8,654,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis
FLGALFKWASK,24,8,655,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis
FLGALFKVWSK,24,8,656,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis
FLGALFKVAWK,24,8,663,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis
FLGALFKVASW,24,8,664,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis
FLGLLFKVASK,24,8,665,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis
FLGKLFKVASK,24,8,666,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis
FLGFLFKVASK,24,8,667,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis
FLGALFKLASK,24,8,668,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis
FLGALFKKASK,24,8,669,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis
FLGALFKFASK,24,8,670,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis
FLGWLFKWASK,24,8,671,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis
LCYCRRRFCVCVGR,26,2,675,Protegrin structure-activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity.,Escherichiacoli
RGGRLCYARRRFAVCVGR,26,13,682,Protegrin structure-activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity.,Neisseriagonorrhoeae
RGGRLAYCRRRFCVAVGR,26,2,683,Protegrin structure-activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity.,Escherichiacoli
KNLRRIIRKGIHIIKKYG,27,3,696,Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides.,Pseudomonasaeruginosa
KNLRRITRKIIHIIKKYG,27,3,697,Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides.,Pseudomonasaeruginosa
RRWQWRMKKLG,28,2,717,Solution structure of a novel tryptophan-rich peptide with bidirectional antimicrobial activity,Escherichiacoli
HPLKQYWWRPSI,28,2,718,Solution structure of a novel tryptophan-rich peptide with bidirectional antimicrobial activity,Escherichiacoli
VTCDILSVEAKGVKLNDAACAAHCLFRGRSGGYCNGKRVCVCR,3,4,719,"Synthesis and structure-function study about tenecin 1, an antibacterial protein from larvae of Tenebrio molitor",Staphylococcusaureus
GDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,31,2,765,"Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37",Escherichiacoli
RKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,31,2,766,"Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37",Escherichiacoli
KLFKRIVKRILKFLRKLV,31,2,767,"Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37",Escherichiacoli
RVKRVWPLVIRTVIA,32,4,773,"Structure-activity relationships of fowlicidin-1, a cathelicidin antimicrobial peptide in chicken",Staphylococcusaureus
RVKRVWPLVIRTVIAGYNLYRAI,32,4,774,"Structure-activity relationships of fowlicidin-1, a cathelicidin antimicrobial peptide in chicken",Staphylococcusaureus
LVIRTVIAGYNLYRAIKKK,32,4,775,"Structure-activity relationships of fowlicidin-1, a cathelicidin antimicrobial peptide in chicken",Staphylococcusaureus
VWPLVIRTVIAGYNLYRAIKKK,32,4,776,"Structure-activity relationships of fowlicidin-1, a cathelicidin antimicrobial peptide in chicken",Staphylococcusaureus
RVKRVWPLVIRTVIALYNLYRAIKKK,32,4,777,"Structure-activity relationships of fowlicidin-1, a cathelicidin antimicrobial peptide in chicken",Staphylococcusaureus
RVKRVWKLVIRLVKALYKLYRAIKKK,32,4,778,"Structure-activity relationships of fowlicidin-1, a cathelicidin antimicrobial peptide in chicken",Staphylococcusaureus
SLSRYAKLANRLA,33,2,819,Identification of the region that plays an important role in determining antibacterial activity of bovine seminalplasmin.,Escherichiacoli
PKLLETFLSKWIG,33,2,820,Identification of the region that plays an important role in determining antibacterial activity of bovine seminalplasmin.,Escherichiacoli
SLSRYAKLANRLANPKLLETFLSKWIG,33,2,821,Identification of the region that plays an important role in determining antibacterial activity of bovine seminalplasmin.,Escherichiacoli
GATAIKQVKKLFKKWGW,34,14,830,Structure and mode of action of the membrane-permeabilizing antimicrobial peptide pheromone plantaricin A.,Lactobacillussakei
KPVPIIYCNRRTGKCQRM,35,15,853,"Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.",Aerococcusviridans
VPIIYCNRRTGKCQRM,35,15,854,"Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.",Aerococcusviridans
IIYCNRRTGKCQRM,35,15,855,"Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.",Aerococcusviridans
YCNRRTGKCQRM,35,15,856,"Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.",Aerococcusviridans
GSKKPVPIIYCNRRTGKCQR,35,15,857,"Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.",Aerococcusviridans
GSKKPVPIIYCNRRTGKCQ,35,15,859,"Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.",Aerococcusviridans
GSKKPVPIIYCNRRTGKC,35,15,861,"Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.",Aerococcusviridans
GSKKPVPIIYCNRRGKCQRM,36,2,865,"Role of amino acid residues within the disulfide loop of thanatin, a potent antibiotic peptide.",Escherichiacoli
GSKKPVPIIYCNRRTKCQRM,36,2,866,"Role of amino acid residues within the disulfide loop of thanatin, a potent antibiotic peptide.",Escherichiacoli
GSKKPVPIIYCNRRKCQRM,36,2,867,"Role of amino acid residues within the disulfide loop of thanatin, a potent antibiotic peptide.",Escherichiacoli
GSKKPVPIIYCNRRATGKCQRM,36,2,868,"Role of amino acid residues within the disulfide loop of thanatin, a potent antibiotic peptide.",Escherichiacoli
GSKKPVPIIYCNRRAATGKCQRM,36,2,869,"Role of amino acid residues within the disulfide loop of thanatin, a potent antibiotic peptide.",Escherichiacoli
GSKKPVPIIYANRRTGKAQRM,36,2,870,"Role of amino acid residues within the disulfide loop of thanatin, a potent antibiotic peptide.",Escherichiacoli
RAGLQFPVGRVHRLLRK,37,8,873,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis
AGLQFPVGRVHRLLRK,37,8,874,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis
GLQFPVGRVHRLLRK,37,8,875,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis
LQFPVGRVHRLLRK,37,8,876,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis
QFPVGRVHRLLRK,37,8,877,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis
FPVGRVHRLLRK,37,8,878,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis
PVGRVHRLLRK,37,8,879,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis
TRSSRAGLQFPVGRVHR,37,8,880,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis
RAGLQFPVGRVHRLLR,37,8,881,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis
RAGLQFPVGRVHRLL,37,8,882,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis
RAGLQFPVGRVHRL,37,8,883,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis
RAGLQFLVGRVHRLLRK,37,8,884,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis
RKGLQKLVGRVHRLLRK,37,8,885,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis
RVHRLLRRVHRLLRRVHRLLR,37,8,886,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis
RAGLQFPVGRLLRRLLRRLLR,37,8,887,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis
RAGLQFPVGGIGKFLHSAKKFGK,37,8,888,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis
TRSSRAGLQWPVGRVHRLLRK,38,2,889,Interactions of the novel antimicrobial peptide buforin 2 with lipid bilayers: proline as a translocation promoting factor.,Escherichiacoli
TRSSRAGLQWAVGRVHRLLRK,38,2,890,Interactions of the novel antimicrobial peptide buforin 2 with lipid bilayers: proline as a translocation promoting factor.,Escherichiacoli
FLGWLFKVASK,25,8,926,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5.,Bacillussubtilis
VKKFPWWWPFLKK,39,2,951,Selective cytotoxicity following Arg-to-Lys substitution in tritrpticin adopting a unique amphipathic turn structure.,Escherichiacoli
RRFPWWWPFRR,39,2,952,Selective cytotoxicity following Arg-to-Lys substitution in tritrpticin adopting a unique amphipathic turn structure.,Escherichiacoli
KKFPWWWPFKK,39,2,953,Selective cytotoxicity following Arg-to-Lys substitution in tritrpticin adopting a unique amphipathic turn structure.,Escherichiacoli
GLFGKLQKKFGRKAISYAVKKARGKH,40,2,968,N-terminal amphipathic helix as a trigger of hemolytic activity in antimicrobial peptides: a case study in latarcins.,Escherichiacoli
GLFGKLIKKKGRKAISYAVKKARGKH,40,2,969,N-terminal amphipathic helix as a trigger of hemolytic activity in antimicrobial peptides: a case study in latarcins.,Escherichiacoli
GLFGKLIKKFLRKAISYAVKKARGKH,40,2,970,N-terminal amphipathic helix as a trigger of hemolytic activity in antimicrobial peptides: a case study in latarcins.,Escherichiacoli
GKLIKKFGRKAISYAVKKARGKH,40,2,971,N-terminal amphipathic helix as a trigger of hemolytic activity in antimicrobial peptides: a case study in latarcins.,Escherichiacoli
GIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK,41,2,974,Antimicrobial characterization of human beta-defensin 3 derivatives.,Escherichiacoli
KYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK,41,2,975,Antimicrobial characterization of human beta-defensin 3 derivatives.,Escherichiacoli
YCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK,41,2,976,Antimicrobial characterization of human beta-defensin 3 derivatives.,Escherichiacoli
KEEQIGKSSTRGRKSSRRKK,41,2,978,Antimicrobial characterization of human beta-defensin 3 derivatives.,Escherichiacoli
KSSTRGRKSSRRKK,41,2,979,Antimicrobial characterization of human beta-defensin 3 derivatives.,Escherichiacoli
RGRKSSRRKK,41,2,980,Antimicrobial characterization of human beta-defensin 3 derivatives.,Escherichiacoli
RGRKSSRRK,41,2,981,Antimicrobial characterization of human beta-defensin 3 derivatives.,Escherichiacoli
KYYSRVRGGRSAVLSSLPK,41,2,982,Antimicrobial characterization of human beta-defensin 3 derivatives.,Escherichiacoli
GIINTLQKYYSRVRGGR,41,2,983,Antimicrobial characterization of human beta-defensin 3 derivatives.,Escherichiacoli
GWKKWFTKGERLSQRHFA,42,16,1000,Novel antimicrobial peptides derived from flatfish genes.,Aeromonassalmonicida
GFLGILFHGVHHGRKKALHMNSERRS,42,16,1002,Novel antimicrobial peptides derived from flatfish genes.,Aeromonassalmonicida
RLCRIVVIRVCR,43,2,1060,Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane.,Escherichiacoli
RLSRIVVIRVSR,43,2,1061,Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane.,Escherichiacoli
RRLCRIVVIRVCRR,43,2,1063,Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane.,Escherichiacoli
RRCPIVVIRVCR,43,2,1065,Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane.,Escherichiacoli
KKCPIVVIRVCK,43,2,1067,Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane.,Escherichiacoli
KRLRKFRNKIKEKLKKIG,44,3,1068,Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis.,Pseudomonasaeruginosa
RKRLRKFRNKIKEKLKKIGQKI,44,3,1070,Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis.,Pseudomonasaeruginosa
KNLRRIIRKIIHIIKKYG,44,3,1074,Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis.,Pseudomonasaeruginosa
RRRCPIVVIRVCRR,45,2,1082,"Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.",Escherichiacoli
RRRLCPIVIRVCRR,45,2,1083,"Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.",Escherichiacoli
RLCRIVPVIRVCR,45,2,1086,"Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.",Escherichiacoli
RLCRIVWVIRVCR,45,2,1087,"Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.",Escherichiacoli
RRLCRIVWVIRVCRR,45,2,1088,"Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.",Escherichiacoli
FKCRRWQWRMKKLGAPSITCVRRAFA,46,17,1096,Antibacterial activity in bovine lactoferrin-derived peptides.,Listeriamonocytogenes
KKLGAPSITCVRRAFA,46,17,1097,Antibacterial activity in bovine lactoferrin-derived peptides.,Listeriamonocytogenes
GFIATLCTKVLDFGIDKLIQLIEDK,47,18,1105,"Cytolytic and antibacterial activity of synthetic peptides derived from amoebapore, the pore-forming peptide of Entamoeba histolytica.",Micrococcusluteus
GEILCNLCTGLINTLENLLTTKGADKVK,47,18,1107,"Cytolytic and antibacterial activity of synthetic peptides derived from amoebapore, the pore-forming peptide of Entamoeba histolytica.",Micrococcusluteus
GEILANLATGLINTLENLLTTKGADKVK,47,18,1108,"Cytolytic and antibacterial activity of synthetic peptides derived from amoebapore, the pore-forming peptide of Entamoeba histolytica.",Micrococcusluteus
IKHQGLPQE,48,19,1110,Altering the composition of caseicins A and B as a means of determining the contribution of specific residues to antimicrobial activity.,Cronobactersakazakii
VLNENLLR,48,19,1111,Altering the composition of caseicins A and B as a means of determining the contribution of specific residues to antimicrobial activity.,Cronobactersakazakii
IAHQGLPQE,48,19,1112,Altering the composition of caseicins A and B as a means of determining the contribution of specific residues to antimicrobial activity.,Cronobactersakazakii
IKAQGLPQE,48,19,1114,Altering the composition of caseicins A and B as a means of determining the contribution of specific residues to antimicrobial activity.,Cronobactersakazakii
IAAQGLPQE,48,19,1115,Altering the composition of caseicins A and B as a means of determining the contribution of specific residues to antimicrobial activity.,Cronobactersakazakii
KHQGLPQE,48,19,1116,Altering the composition of caseicins A and B as a means of determining the contribution of specific residues to antimicrobial activity.,Cronobactersakazakii
VLNENLLA,48,19,1117,Altering the composition of caseicins A and B as a means of determining the contribution of specific residues to antimicrobial activity.,Cronobactersakazakii
VLNENLAR,48,19,1119,Altering the composition of caseicins A and B as a means of determining the contribution of specific residues to antimicrobial activity.,Cronobactersakazakii
VLNENALR,48,19,1120,Altering the composition of caseicins A and B as a means of determining the contribution of specific residues to antimicrobial activity.,Cronobactersakazakii
CTRPNYNKRKRIHIG,49,2,1122,Antibacterial activity of peptides derived from envelope glycoproteins of HIV-1.,Escherichiacoli
RIVFAVLSIVNRVRQ,49,2,1123,Antibacterial activity of peptides derived from envelope glycoproteins of HIV-1.,Escherichiacoli
LGKEEQIGRASNSGRKCARKKK,50,3,1144,Peptide fragments of a beta-defensin derivative with potent bactericidal activity.,Pseudomonasaeruginosa
FLPKTLRKFF,50,3,1145,Peptide fragments of a beta-defensin derivative with potent bactericidal activity.,Pseudomonasaeruginosa
LRKFFARIRGGR,50,3,1146,Peptide fragments of a beta-defensin derivative with potent bactericidal activity.,Pseudomonasaeruginosa
RGGRAAVLNA,50,3,1147,Peptide fragments of a beta-defensin derivative with potent bactericidal activity.,Pseudomonasaeruginosa
IRGGRAAVLNALGKEEQIGRAS,50,3,1148,Peptide fragments of a beta-defensin derivative with potent bactericidal activity.,Pseudomonasaeruginosa
LPKTLRKFFARIRGGRAAVLNALGKEEQIGRASNSGRKCARKKK,50,1,1150,Peptide fragments of a beta-defensin derivative with potent bactericidal activity.,None_target
PKTLRKFFARIRGGRAAVLNALGKEEQIGRASNSGRKCARKKK,50,3,1152,Peptide fragments of a beta-defensin derivative with potent bactericidal activity.,Pseudomonasaeruginosa
LRKFFARIRGGRAAVLNALGKEEQIGRASNSGRKCARKKK,50,3,1153,Peptide fragments of a beta-defensin derivative with potent bactericidal activity.,Pseudomonasaeruginosa
FFARIRGGRAAVLNALGKEEQIGRASNSGRKCARKKK,50,3,1154,Peptide fragments of a beta-defensin derivative with potent bactericidal activity.,Pseudomonasaeruginosa
RIRGGRAAVLNALGKEEQIGRASNSGRKCARKKK,50,3,1155,Peptide fragments of a beta-defensin derivative with potent bactericidal activity.,Pseudomonasaeruginosa
GGRAAVLNALGKEEQIGRASNSGRKCARKKK,50,3,1157,Peptide fragments of a beta-defensin derivative with potent bactericidal activity.,Pseudomonasaeruginosa
AAVLNALGKEEQIGRASNSGRKCARKKK,50,3,1158,Peptide fragments of a beta-defensin derivative with potent bactericidal activity.,Pseudomonasaeruginosa
AKKIRVRLSA,51,2,1170,Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification.,Escherichiacoli
QAKIRVRLSA,51,2,1171,Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification.,Escherichiacoli
QKAIRVRLSA,51,2,1172,Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification.,Escherichiacoli
QKKARVRLSA,51,2,1173,Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification.,Escherichiacoli
QKKIAVRLSA,51,2,1174,Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification.,Escherichiacoli
QKKIRARLSA,51,2,1175,Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification.,Escherichiacoli
QKKIRVALSA,51,2,1176,Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification.,Escherichiacoli
QKKIRVRASA,51,2,1177,Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification.,Escherichiacoli
QKKIRVRLAA,51,2,1178,Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification.,Escherichiacoli
QRKIRVRLSA,51,2,1179,Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification.,Escherichiacoli
QKRIRVRLSA,51,2,1180,Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification.,Escherichiacoli
QRRIRVRLSA,51,2,1181,Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification.,Escherichiacoli
KIRVRLSA,51,2,1182,Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification.,Escherichiacoli
QKKIRVRLSA,51,2,1183,Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification.,Escherichiacoli
KWKLFKKIGAVLKVL,52,2,1187,Lysine-enriched cecropin-mellitin antimicrobial peptides with enhanced selectivity.,Escherichiacoli
KWKKFKKIGAVLKVL,52,2,1188,Lysine-enriched cecropin-mellitin antimicrobial peptides with enhanced selectivity.,Escherichiacoli
KWKLFKKIGKVLKVL,52,4,1189,Lysine-enriched cecropin-mellitin antimicrobial peptides with enhanced selectivity.,Staphylococcusaureus
KWKLFKKIGAVLKKL,52,2,1190,Lysine-enriched cecropin-mellitin antimicrobial peptides with enhanced selectivity.,Escherichiacoli
KWKKFKKIGKVLKVL,52,2,1191,Lysine-enriched cecropin-mellitin antimicrobial peptides with enhanced selectivity.,Escherichiacoli
KWKKFKKIGAVLKKL,52,2,1192,Lysine-enriched cecropin-mellitin antimicrobial peptides with enhanced selectivity.,Escherichiacoli
KWKLFKKIGKVLKKL,52,2,1193,Lysine-enriched cecropin-mellitin antimicrobial peptides with enhanced selectivity.,Escherichiacoli
KVDKGSYLPRP,53,2,1208,"Identification of crucial residues for the antibacterial activity of the proline-rich peptide, pyrrhocoricin",Escherichiacoli
VDKGRYLEAPTPPRPIYNRN,53,2,1209,"Identification of crucial residues for the antibacterial activity of the proline-rich peptide, pyrrhocoricin",Escherichiacoli
DKGRYLEAPTRPRPERNRK,53,2,1210,"Identification of crucial residues for the antibacterial activity of the proline-rich peptide, pyrrhocoricin",Escherichiacoli
VDKGSYLPRPTPYSPRPPIYNRN,53,2,1211,"Identification of crucial residues for the antibacterial activity of the proline-rich peptide, pyrrhocoricin",Escherichiacoli
VDKGSYLPRPTPTPRYRPIYNRN,53,2,1212,"Identification of crucial residues for the antibacterial activity of the proline-rich peptide, pyrrhocoricin",Escherichiacoli
ADADDDDDK,54,20,1220,"Small, anionic, and charge-neutralizing propeptide fragments of zymogens are antimicrobial.",Pasteurellahaemolytica
KGWGSFFKKAAHVGKHVGKAALTHYL,55,21,1227,Antimicrobial peptides protect coho salmon from Vibrio anguillarum infections.,Vibrioanguillarum
ALWKTMLKKAAHVGKHVGKAALTHYLN,55,21,1229,Antimicrobial peptides protect coho salmon from Vibrio anguillarum infections.,Vibrioanguillarum
SIGSAFKKAAHVGKHVGKAALTHYLN,55,21,1230,Antimicrobial peptides protect coho salmon from Vibrio anguillarum infections.,Vibrioanguillarum
GWGSFFKKAAHVGKHVGKAALGAAARRRK,55,21,1232,Antimicrobial peptides protect coho salmon from Vibrio anguillarum infections.,Vibrioanguillarum
ALWKTMLKKAAHVGKHVGKAALGAAARRRK,55,21,1233,Antimicrobial peptides protect coho salmon from Vibrio anguillarum infections.,Vibrioanguillarum
SIGSAFKKAAHVGKHVGKAALGAAARRRK,55,21,1235,Antimicrobial peptides protect coho salmon from Vibrio anguillarum infections.,Vibrioanguillarum
EFKRIVQRIKDFLRNLV,56,3,1242,"Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37",Pseudomonasaeruginosa
EWKRWVQRWKDWLRNLV,56,3,1244,"Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37",Pseudomonasaeruginosa
KYYGNGVTCGKHSCSVDWGKATTCIINNGAAAWATGGHQGNHKC,58,14,1255,Engineering increased stability in the antimicrobial peptide pediocin PA-1.,Lactobacillussakei
KYYGNGVTCGKHSCSVDWGKATTCIINNGAIAWATGGHQGNHKC,58,14,1256,Engineering increased stability in the antimicrobial peptide pediocin PA-1.,Lactobacillussakei
KYYGNGVTCGKHSCSVDWGKATTCIINNGALAWATGGHQGNHKC,58,14,1258,Engineering increased stability in the antimicrobial peptide pediocin PA-1.,Lactobacillussakei
KYYGNGVTCGKHSCSVDWGKATTCIINNGADAWATGGHQGNHKC,58,14,1260,Engineering increased stability in the antimicrobial peptide pediocin PA-1.,Lactobacillussakei
RVVRVVRRVVRR,59,3,1264,De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity.,Pseudomonasaeruginosa
RRVVRRVRRVVRRVVRVVRRVVRR,59,3,1265,De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity.,Pseudomonasaeruginosa
VRRVVRRVVRVVRRVVRRVRRVVRRVVRVVRRVVRR,59,3,1266,De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity.,Pseudomonasaeruginosa
RVVRVVRRVVRRVRRVVRRVVRVVRRVVRRVRRVVRRVVRVVRRVVRR,59,3,1267,De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity.,Pseudomonasaeruginosa
RVVRVVRRWVRR,59,3,1268,De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity.,Pseudomonasaeruginosa
RRWVRRVRRWVRRVVRVVRRWVRR,59,3,1269,De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity.,Pseudomonasaeruginosa
VRRVWRRVVRVVRRWVRRVRRWVRRVVRVVRRWVRR,59,3,1270,De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity.,Pseudomonasaeruginosa
RVVRVVRRWVRRVRRVWRRVVRVVRRWVRRVRRWVRRVVRVVRRWVRR,59,3,1271,De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity.,Pseudomonasaeruginosa
KKVVFKVKFKK,60,6,1274,In vitro antifungal activity and cytotoxicity of a novel membrane-active peptide.,Aspergillusfumigatus
LIKIVPAMICAVTKKC,61,4,1275,"Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.",Staphylococcusaureus
SNNFGAKLSSTKVGK,62,2,1277,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
SNKGAIKGLMVKGVK,62,2,1278,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
VTNVGGKVVTGKTAK,62,2,1279,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
GAAAAGKVVGGKGGK,62,2,1280,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
ALLSPYKYSTTKVVK,62,2,1281,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
GKSNFLKSYVSKHPK,62,2,1282,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
SQSSVDKLNWYKQRK,62,2,1283,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
GKAPKLKIFDTKNLK,62,2,1284,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
RSGTDFKLTISKLQK,62,2,1285,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
PDDFATKYSQQKYTK,62,2,1286,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
SNGPVKKWGSIKGLK,62,2,1287,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
DVSIEDKVISLKGDK,62,2,1288,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
HSIIGRKLVVHKKAK,62,2,1289,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
KHGATVKTALGKILK,62,2,1290,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
VKYLEFKSESIKQVK,62,2,1291,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
DMQSLFKQYFQKMTK,62,2,1292,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
AGTSLVKFFSSKMNK,62,2,1293,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
LPGSSKKFSVYKDQK,62,2,1294,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
TSLGGWKLIQQKMDK,62,2,1295,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
GNDYLHKLTQRKSVK,62,2,1296,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
EIENGVKWVSFKGAK,62,2,1297,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
YTGIFTKQVLSKLKK,62,2,1298,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
GSHLVEKLYLVKERK,62,2,1299,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
GISLANKMSLAKWEK,62,2,1300,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
DEKIYLIKVADVDQR,62,2,1301,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
LMEIHHRASQDTPKE,62,2,1302,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
WYADHSDQYQLLDTP,62,2,1303,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
DLVELAMLEADRMSR,62,2,1304,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
QDNYWVTQGLNILSG,62,2,1305,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
DEKIYLKKVADKDQK,62,2,1306,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
LMEIHHKASQDKPKK,62,2,1307,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
WYADHSKQYQLKDTK,62,2,1308,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
DLVELAKLEADKMSK,62,2,1309,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
QDNYWVKQGLNKLSK,62,2,1310,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
TPIESHQVEKRKSNT,62,2,1311,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
MHMNVQNGKWDSDPS,62,2,1312,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
TPIESHKVEKRKSNK,62,2,1313,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
MHMNVQKGKWDKDPK,62,2,1314,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli
GLIKIVPAMICAVTKKC,61,4,1315,"Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.",Staphylococcusaureus
GGLIKIVPAMICAVTKKC,61,4,1316,"Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.",Staphylococcusaureus
LGGLIKIVPAMICAVTKKC,61,4,1317,"Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.",Staphylococcusaureus
FLGGLIKIVPAMICAVTKK,61,4,1318,"Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.",Staphylococcusaureus
KYYGNGVTCGKHSCSVDWGKATTSIINNGAMAWATGGHQGNHKS,63,22,1326,A C-terminal disulfide bridge in pediocin-like bacteriocins renders bacteriocin activity less temperature dependent and is a major determinant of the antimicrobial spectrum.,Lactobacilluscoryneformis
KYYGNGVHCGKHSCTVDWGTAIGCIGNNAAANWATGGNAGWNKC,63,22,1327,A C-terminal disulfide bridge in pediocin-like bacteriocins renders bacteriocin activity less temperature dependent and is a major determinant of the antimicrobial spectrum.,Lactobacilluscoryneformis
KYYGNGVHCGKHSCTVDWGTAITCIGNNAAANWATGGNAGWNKC,63,22,1328,A C-terminal disulfide bridge in pediocin-like bacteriocins renders bacteriocin activity less temperature dependent and is a major determinant of the antimicrobial spectrum.,Lactobacilluscoryneformis
KYYGNGVHCGKHSCTVDWGTAITSIGNNAAANWATGGNAGWNKS,63,22,1329,A C-terminal disulfide bridge in pediocin-like bacteriocins renders bacteriocin activity less temperature dependent and is a major determinant of the antimicrobial spectrum.,Lactobacilluscoryneformis
KYYGNGVHCGKHSCTVDWGTAITSIGNNAAANWATGGNAGWNK,63,22,1330,A C-terminal disulfide bridge in pediocin-like bacteriocins renders bacteriocin activity less temperature dependent and is a major determinant of the antimicrobial spectrum.,Lactobacilluscoryneformis
KYYGNGVHCGKHSCTVDWGTAIGNIGNNAAANWATGGNAGWNKS,63,22,1331,A C-terminal disulfide bridge in pediocin-like bacteriocins renders bacteriocin activity less temperature dependent and is a major determinant of the antimicrobial spectrum.,Lactobacilluscoryneformis
KYYGNGVHCGKHSCTVDWGTAITNIGNNAAANWATGGNAGWNK,63,22,1332,A C-terminal disulfide bridge in pediocin-like bacteriocins renders bacteriocin activity less temperature dependent and is a major determinant of the antimicrobial spectrum.,Lactobacilluscoryneformis
TKCFQWQRNMRKVRGPPVSCIKRDS,64,2,1362,N-Acylated and D enantiomer derivatives of a nonamer core peptide of lactoferricin B showing improved antimicrobial activity.,Escherichiacoli
TKCFQWQRNMRKVR,65,2,1377,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli
KCFQWQRNMRKVR,65,2,1378,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli
CFQWQRNMRKVR,65,2,1379,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli
AFQWQRNMRKVR,65,2,1381,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli
CAQWQRNMRKVR,65,2,1382,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli
CFAWQRNMRKVR,65,2,1383,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli
CFQAQRNMRKVR,65,2,1385,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli
CFQWARNMRKVR,65,2,1386,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli
CFQWQANMRKVR,65,2,1387,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli
CFQWQRAMRKVR,65,2,1389,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli
CFQWQRNARKVR,65,2,1390,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli
CFQWQRNMAKVR,65,2,1391,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli
CFQWQRNMRAVR,65,2,1392,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli
CFQWQRNMRKAR,65,2,1393,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli
CFQWQRNMRKVA,65,2,1394,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli
CFQWKRNMRKVR,65,2,1396,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli
CFQWKRAMRKVR,65,2,1400,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli
CFAWKRNMRKVR,65,2,1401,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli
CFAWQRAMRKVR,65,2,1402,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli
CFALKKAMKKVR,65,2,1403,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli
FAKKLAKKLKKLAKKLAK,66,2,1417,Antimicrobial peptide therapeutics for cystic fibrosis.,Escherichiacoli
KRFHSVGSLIQRLQQMIRDLSEATRHGIRKITRPKLLLAS,67,2,1433,Structural and functional analysis of horse cathelicidin peptides.,Escherichiacoli
GWKKWLRKGAKHLGQAAIKGLAS,42,16,1435,Novel antimicrobial peptides derived from flatfish genes.,Aeromonassalmonicida
RGLRRLGRKIAHGVKKYG,68,23,1486,Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells.,Mannheimiahaemolytica
LGRKIAHGVKKYGPTVLRII,68,23,1487,Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells.,Mannheimiahaemolytica
KIAHGVKKYGPTVLRIIRIAG,68,23,1488,Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells.,Mannheimiahaemolytica
RGLRALGRKIAHGVKAYG,68,23,1489,Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells.,Mannheimiahaemolytica
KNIRRIIRKIIHIIKKYG,68,23,1498,Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells.,Mannheimiahaemolytica
NLRRIIRKIIHIIKKY,68,23,1500,Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells.,Mannheimiahaemolytica
NIRRIIRKIIHIIKKY,68,23,1508,Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells.,Mannheimiahaemolytica
LRRIIRKIIHIIKK,68,23,1509,Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells.,Mannheimiahaemolytica
IRRIIRKIIHIIKK,68,23,1510,Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells.,Mannheimiahaemolytica
RGPNCVGNFLGGLFAGAAAGVPLGPAGIVGGANLGMVGGALTCL,69,1,1529,Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P.,None_target
HGPNCVGNFLGGLFAGAAAGVPLGPAGIVGGANLGMVGGALTCL,69,1,1530,Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P.,None_target
KPHGPNCVGNFLGGLFAGAAAGVPLGPAGIVGGANLGMVGGALTCL,69,1,1531,Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P.,None_target
HRPGPNCVGNFLGGLFAGAAAGVPLGPAGIVGGANLGMVGGALTCL,69,1,1532,Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P.,None_target
KPRPNCVGNFLGGLFAGAAAGVPLGPAGIVGGANLGMVGGALTCL,69,1,1533,Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P.,None_target
KRGPNCVGNFLGGLFAGAAAGVPLGPAGIVGGANLGLVGGALTCL,69,1,1534,Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P.,None_target
KNGYGGSGNHWVHCGAGIVGGALIGAIGGPWSAVAGGISGGFASCH,69,1,1535,Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P.,None_target
KPNGYGGSGNHWVHCGAGIVGGALIGAIGGPWSAVAGGISGGFASCH,69,1,1536,Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P.,None_target
HNGYGGSGNHWVHCGAGIVGGALIGAIGGPWSAVAGGISGGFASCH,69,1,1537,Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P.,None_target
KNGYGGSGNR,69,1,1538,Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P.,None_target
RPWVHCGAGIVGGALIGAIGGPWSAVAGGISGGFASCH,69,1,1539,Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P.,None_target
ARGLTYNKPCLYGT,70,2,1572,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
AMRLTGNKPCLYGT,70,2,1573,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
AMRLTYNKPCLGGT,70,2,1574,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
AMRLTYNKGCLYGT,70,2,1575,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
AMRLTYNKPGLYGT,70,2,1576,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
AGRLTGNKGGLGGT,70,2,1577,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
SIITGTKEAKLPQLWKQIACRLYNTC,70,2,1579,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
SIITMTKEAKLGQLWKQIACRLYNTC,70,2,1580,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
SIITMTKEAKLPQLGKQIACRLYNTC,70,2,1581,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
SIITMTKEAKLPQLWKQIACRLGNTC,70,2,1582,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
SIITGTKEAKLGQLGKQIACRLGNTC,70,2,1583,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
FRSGILKLASKIGSVLCAVLKNC,70,2,1593,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
AKAGGIPPHVIPQIVPVRIRPLCGNV,70,2,1597,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
AKAWGIGGHVIGQIVGVRIRGLCGNV,70,2,1598,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
AKAWGIPPHVIPQIVPVRIRPLGGNV,70,2,1599,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
AKAGGIGGHVIGQIVGVRIRGLGGNV,70,2,1600,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
GFGDSVKEGLKNAAVTILNKIKCKISECPPA,70,2,1602,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
GFWDSVKEGLKNAAVTILNKIKCKISECGGA,70,2,1603,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
GFGDSVKEGLKNAAVTILNKIKCKISECGGA,70,2,1604,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
FIGGLRRLFATVVGTVVCAINKLGGG,70,2,1606,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
FIPGLRRLFATVVPTVVGAINKLPPG,70,2,1607,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
FIGGLRRLFATVVGTVVGAINKLGGG,70,2,1608,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
DDGDKGMLKWKNDFFQEF,70,2,1609,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
DDPDKGGLKWKNDFFQEF,70,2,1611,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
DDPDKGMLKGKNDFFQEF,70,2,1612,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
DDGDKGGLKGKNDFFQEF,70,2,1613,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
GLLDSVKEGLKKVAGQLLDTLKCKISGCTGA,71,2,1615,Antioxidant peptidomics reveals novel skin antioxidant system,Escherichiacoli
GFFDRIKALTKNVTLELLNTITGKLPVTPP,70,2,1616,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
GFFDRIKALTKNVTLELLNTITCKLGVTGG,70,2,1617,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
GFFDRIKALTKNVTLELLNTITGKLGVTGG,70,2,1618,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
SFGAKNAVKNGLQKLRNQCQANNGQGPFCDIFKKNP,70,2,1622,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
SFGAKNAVKNGLQKLRNQCQANNYQGGFCDIFKKNG,70,2,1623,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
SFGAKNAVKNGLQKLRNQCQANNGQGGFCDIFKKNG,70,2,1624,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
CVHWMTNTARTACIAP,71,2,1626,Antioxidant peptidomics reveals novel skin antioxidant system,Escherichiacoli
CVHGMTNTARTACIAP,70,2,1627,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
CVHWGTNTARTACIAP,70,2,1628,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
CVHWMTNTARTACIAG,70,2,1629,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
CVHGGTNTARTACIAG,70,2,1630,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli
ACHAHCQSVGRRGGYCGNFRMTCYCY,72,4,1633,Sequence characterization and expression patterns of two defensin-like antimicrobial peptides from the tick Haemaphysalis longicornis,Staphylococcusaureus
LVRVRRGFGCPFDER,72,4,1634,Sequence characterization and expression patterns of two defensin-like antimicrobial peptides from the tick Haemaphysalis longicornis,Staphylococcusaureus
NCIQQCVSKGAQGGYCTNEKCTCY,72,4,1635,Sequence characterization and expression patterns of two defensin-like antimicrobial peptides from the tick Haemaphysalis longicornis,Staphylococcusaureus
GFRTAHVDLVCPDNPD,72,4,1636,Sequence characterization and expression patterns of two defensin-like antimicrobial peptides from the tick Haemaphysalis longicornis,Staphylococcusaureus
HSSGYTRPLRKPSRPIFIRPI,73,24,1717,Solution structure of synthetic penaeidin-4 with structural and functional comparisons with penaeidin-3,Fusariumoxysporum
VKRFKKFFRKLKKSV,74,8,1738,Snake cathelicidin from Bungarus fasciatus is a potent peptide antibiotics.,Bacillussubtilis
AIHNLAHKLLKKLTRAVKKLAN,75,2,1912,Kinetic and thermodynamic analysis of the interactions of 23-residue peptides with endotoxin.,Escherichiacoli
AIHKLAHKLLKKLLKAVKKLAK,75,2,1913,Kinetic and thermodynamic analysis of the interactions of 23-residue peptides with endotoxin.,Escherichiacoli
AIHKLAHKLLKKLLRAVKKLAN,75,2,1914,Kinetic and thermodynamic analysis of the interactions of 23-residue peptides with endotoxin.,Escherichiacoli
AIHKLAHKLLKKTLRAVKKLAN,75,2,1915,Kinetic and thermodynamic analysis of the interactions of 23-residue peptides with endotoxin.,Escherichiacoli
AIHKLAHKLTKKTLRAVKKLAN,75,2,1916,Kinetic and thermodynamic analysis of the interactions of 23-residue peptides with endotoxin.,Escherichiacoli
AIHKLAHKTLKKTLRAVKKLAN,75,2,1917,Kinetic and thermodynamic analysis of the interactions of 23-residue peptides with endotoxin.,Escherichiacoli
AIHKLAHKLLPKTLRAVKKLAN,75,2,1918,Kinetic and thermodynamic analysis of the interactions of 23-residue peptides with endotoxin.,Escherichiacoli
GLVSSIGKALGGLLVDVVKSKGQPA,76,25,1994,"Host-defence peptide profiles of the skin secretions of interspecific hybrid tree frogs and their parents, female Litoria splendida and male Litoria caerulea.",Bacilluscereus
VFQFLGKIIKKVGNFVKGFSKVF,77,4,2004,Effects of pH and salinity on the antimicrobial properties of clavanins.,Staphylococcusaureus
GGHGGHGGHGGHGGHGGH,78,26,2011,"Characterization and cDNA cloning of two glycine- and histidine-rich antimicrobial peptides from the roots of shepherd's purse, Capsella bursa-pastoris.",Erwiniaherbicola
KWKSFLKTFKSAVKTVLHTALKAISS,79,2,2012,Interaction of cationic antimicrobial peptides with model membranes.,Escherichiacoli
KWKSFLRTLKSPAKTVFHTALKAISS,79,2,2013,Interaction of cationic antimicrobial peptides with model membranes.,Escherichiacoli
KWKSFLRTFKSPVRTVFHTALKPISS,79,2,2014,Interaction of cationic antimicrobial peptides with model membranes.,Escherichiacoli
RWSVYAYVRVRGVLVRYRRSW,80,4,2026,Multiple peptide resistance factor (MprF)-mediated Resistance of Staphylococcus aureus against antimicrobial peptides coincides with a modulated peptide interaction with artificial membranes comprising lysyl-phosphatidylglycerol.,Staphylococcusaureus
KWCVYAYVKVKGVLVKYKKCW,80,4,2027,Multiple peptide resistance factor (MprF)-mediated Resistance of Staphylococcus aureus against antimicrobial peptides coincides with a modulated peptide interaction with artificial membranes comprising lysyl-phosphatidylglycerol.,Staphylococcusaureus
GLFGRLRDSLQRGGQKILEKAERIWCKIKDIFRG,81,3,2030,Bactericidal activity of mammalian cathelicidin-derived peptides.,Pseudomonasaeruginosa
ISRLAGLVRKGGEKFGEKLRKIGQKIKEFFQKLALEIEQ,81,3,2032,Bactericidal activity of mammalian cathelicidin-derived peptides.,Pseudomonasaeruginosa
GLRKRLRKFRNKIKEKLKKIG,81,3,2035,Bactericidal activity of mammalian cathelicidin-derived peptides.,Pseudomonasaeruginosa
RKFRNKIKEKLKKIG,81,3,2036,Bactericidal activity of mammalian cathelicidin-derived peptides.,Pseudomonasaeruginosa
LRKFRNKIKEKLKKIGQKI,81,3,2037,Bactericidal activity of mammalian cathelicidin-derived peptides.,Pseudomonasaeruginosa
LRKFRNKIKEKLKKIGQKIQG,81,3,2038,Bactericidal activity of mammalian cathelicidin-derived peptides.,Pseudomonasaeruginosa
KIKEKLKKIGQKI,81,3,2039,Bactericidal activity of mammalian cathelicidin-derived peptides.,Pseudomonasaeruginosa
KIKEKLKKIGQKIQG,81,3,2040,Bactericidal activity of mammalian cathelicidin-derived peptides.,Pseudomonasaeruginosa
KIKEKLKKIGQKIQGLL,81,3,2041,Bactericidal activity of mammalian cathelicidin-derived peptides.,Pseudomonasaeruginosa
KLLLKLLK,82,27,2050,The antibiotic activity of cationic linear amphipathic peptides: lessons from the action of leucine/lysine copolymers on bacteria of the class Mollicutes.,Acholeplasmalaidlawii
LKLLLKLLK,82,27,2051,The antibiotic activity of cationic linear amphipathic peptides: lessons from the action of leucine/lysine copolymers on bacteria of the class Mollicutes.,Acholeplasmalaidlawii
KLLLKLLLKLLK,82,27,2053,The antibiotic activity of cationic linear amphipathic peptides: lessons from the action of leucine/lysine copolymers on bacteria of the class Mollicutes.,Acholeplasmalaidlawii
KLLKLLLKLLLKLLK,82,27,2055,The antibiotic activity of cationic linear amphipathic peptides: lessons from the action of leucine/lysine copolymers on bacteria of the class Mollicutes.,Acholeplasmalaidlawii
KLLKLLLKLLLKLWK,82,27,2056,The antibiotic activity of cationic linear amphipathic peptides: lessons from the action of leucine/lysine copolymers on bacteria of the class Mollicutes.,Acholeplasmalaidlawii
KLLKLLKLLKLLKLWK,82,27,2060,The antibiotic activity of cationic linear amphipathic peptides: lessons from the action of leucine/lysine copolymers on bacteria of the class Mollicutes.,Acholeplasmalaidlawii
RILSILRHQNLLKE,84,28,2107,"Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A.",Neurosporacrassa
TLRGDERILSILRHQNLLKE,84,28,2108,"Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A.",Neurosporacrassa
TLRGDERILSILRHQNLLKELQDLALQGAK,84,28,2109,"Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A.",Neurosporacrassa
RILSILRHQNLLKELQDLALQGAK,84,28,2110,"Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A.",Neurosporacrassa
LKIAKGIIKSL,85,4,2125,Conformation and lytic activity of eumenine mastoparan: a new antimicrobial peptide from wasp venom.,Staphylococcusaureus
GNNRPVYIPRPRPPHPRLV,86,2,2133,Antibiotic Peptides,Escherichiacoli
GNNRPVYIPQPRPPHPRPIRV,86,2,2134,Antibiotic Peptides,Escherichiacoli
KVNVNAIKKGGKAIGKGFKVISAASTAH,87,2,2155,The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella.,Escherichiacoli
VFIDILDKMENAIHKAAQAGIG,88,29,2256,Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells.,Leishmaniapanamensis
KWKLFKKIEKVGQNIRDGIIKAGPAVAWVGQATQIAK,88,29,2257,Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells.,Leishmaniapanamensis
KWKVFKKIEKNGRNIRNGIVKAGPAIAVLGEAKAL,88,29,2258,Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells.,Leishmaniapanamensis
SWLSKTAKKLENSAKKRISEGIAIAQGPR,88,29,2259,Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells.,Leishmaniapanamensis
GIGAVLTTGLPALISWIKRKRQQ,88,29,2260,Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells.,Leishmaniapanamensis
PRRRRSSSRP,88,29,2262,Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells.,Leishmaniapanamensis
VRRRRRPR,88,29,2263,Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells.,Leishmaniapanamensis
VSRRRRRRGGRRRR,88,29,2264,Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells.,Leishmaniapanamensis
NLVSGLIEARKYLEQLHRKLKNRKV,89,30,2295,Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.,HIV-1IIIB
LLAGLAANFLPTIICKISYKC,90,31,2317,In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines.,Humanlung
FAGLAANFLPTIICKISYKC,90,31,2319,In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines.,Humanlung
FLKLLKKLAAKFLPTIICKISYKC,90,31,2320,In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines.,Humanlung
FLKLLKKLAAKFL,90,31,2321,In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines.,Humanlung
FLKLLKKLAAKLF,90,31,2322,In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines.,Humanlung
FLGALFKALSKLL,90,31,2323,In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines.,Humanlung
FLKLLAGLLKNFA,90,31,2324,In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines.,Humanlung
GIWGTLAKIGIKAVPRVISMLKKKQ,91,32,2349,"Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",Lactococcuslactis
GANLAKKFYTYINKFINYAW,92,4,2350,Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Staphylococcusaureus
GANAAKKFATIAKKFINYLW,92,4,2351,Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Staphylococcusaureus
GANALKKYFTILKKFFKLAW,92,4,2352,Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Staphylococcusaureus
GIKIAKKAITIAKKIAKIYW,92,4,2353,Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Staphylococcusaureus
GAKYAKYIYNFYKYIAKYIW,92,4,2354,Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Staphylococcusaureus
GAKYAKIIYNYLKKIANALW,92,4,2355,Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Staphylococcusaureus
GAKALTKAATAFTKFYKTIW,92,4,2356,Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Staphylococcusaureus
GATYAKKIIKTITKIATTAW,92,4,2357,Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Staphylococcusaureus
GYNYAKKLANLAKKFANALW,92,4,2358,Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Staphylococcusaureus
GLTFLKKILNFAKKIYTAIW,92,4,2359,Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Staphylococcusaureus
GANAAKKLATFAKKIFTAYW,92,4,2360,Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Staphylococcusaureus
GANAAKKFANLIKKIFNYIW,92,4,2361,Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Staphylococcusaureus
GYKYINNIIKYINKFFKYIW,92,4,2362,Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Staphylococcusaureus
KVHGSLARAGKVRGQTPK,93,4,2375,Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice.,Staphylococcusaureus
KVAKQEKKKKKTGRAKRR,93,4,2376,Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice.,Staphylococcusaureus
FVNVVPTFGKKKGPNANS,93,4,2378,Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice.,Staphylococcusaureus
KVAKQEKKKKKT,93,4,2379,Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice.,Staphylococcusaureus
TGRAKRRMQYNRR,93,4,2380,Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice.,Staphylococcusaureus
RAKRRMQY,93,4,2381,Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice.,Staphylococcusaureus
QEKKKKKTGRAKRR,93,4,2382,Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice.,Staphylococcusaureus
SMLSVLKNLGKVGLGFVASKINKQS,94,2,2386,"Antimicrobial properties of the frog skin peptide, ranatuerin-1 and its [Lys-8]-substituted analog.",Escherichiacoli
SMLAVLKNLGKVGLGFVACKINKQC,94,2,2388,"Antimicrobial properties of the frog skin peptide, ranatuerin-1 and its [Lys-8]-substituted analog.",Escherichiacoli
SMLGVLKNLGKVGLGFVACKINKQC,94,2,2389,"Antimicrobial properties of the frog skin peptide, ranatuerin-1 and its [Lys-8]-substituted analog.",Escherichiacoli
SMLSVLRNLGKVGLGFVACKINKQC,94,2,2390,"Antimicrobial properties of the frog skin peptide, ranatuerin-1 and its [Lys-8]-substituted analog.",Escherichiacoli
SMLSVLKNLGRVGLGFVACKINKQC,94,2,2391,"Antimicrobial properties of the frog skin peptide, ranatuerin-1 and its [Lys-8]-substituted analog.",Escherichiacoli
SMLSVLKNLKKVGLGFVACKINKQC,94,2,2392,"Antimicrobial properties of the frog skin peptide, ranatuerin-1 and its [Lys-8]-substituted analog.",Escherichiacoli
SMLSVLKNLKKVKLKFVACKINKQC,94,2,2393,"Antimicrobial properties of the frog skin peptide, ranatuerin-1 and its [Lys-8]-substituted analog.",Escherichiacoli
SMLSVLKNLEKVELEFVACKINKQC,94,2,2394,"Antimicrobial properties of the frog skin peptide, ranatuerin-1 and its [Lys-8]-substituted analog.",Escherichiacoli
SMLKVLKNLGKVGLGFVACKINKQC,94,2,2395,"Antimicrobial properties of the frog skin peptide, ranatuerin-1 and its [Lys-8]-substituted analog.",Escherichiacoli
SMLSVLKNLGKVGLGFVAAKIAKQA,94,2,2396,"Antimicrobial properties of the frog skin peptide, ranatuerin-1 and its [Lys-8]-substituted analog.",Escherichiacoli
SMLSVLKNLGKVGLGFVA,94,2,2397,"Antimicrobial properties of the frog skin peptide, ranatuerin-1 and its [Lys-8]-substituted analog.",Escherichiacoli
SMLSVLKKLGKVGLGFVACKINKQC,94,2,2398,"Antimicrobial properties of the frog skin peptide, ranatuerin-1 and its [Lys-8]-substituted analog.",Escherichiacoli
SMLSVLKNLGKVGLGFVKCKINKQC,94,2,2399,"Antimicrobial properties of the frog skin peptide, ranatuerin-1 and its [Lys-8]-substituted analog.",Escherichiacoli
SMLSVLKNLGKVGLGFVACKIKKQC,94,2,2400,"Antimicrobial properties of the frog skin peptide, ranatuerin-1 and its [Lys-8]-substituted analog.",Escherichiacoli
SMLSVLKNLGKVGLGFVACKINKKC,94,2,2401,"Antimicrobial properties of the frog skin peptide, ranatuerin-1 and its [Lys-8]-substituted analog.",Escherichiacoli
KLKFKLKQ,95,33,2411,De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria.,Pseudomonassyringae
LKLKFKLKQ,95,33,2412,De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria.,Pseudomonassyringae
KLKLKFKLKQ,96,33,2413,De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria,Pseudomonassyringae
KLKLKLKQ,95,33,2420,De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria.,Pseudomonassyringae
KLKLKLKE,95,33,2421,De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria.,Pseudomonassyringae
LKLKLKLQ,95,33,2422,De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria.,Pseudomonassyringae
KKLKLKKQ,95,33,2423,De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria.,Pseudomonassyringae
PRLKVYLPRYKVYSTAAGRYQLLSRYWDAYR,97,25,2498,Identification of antimicrobial peptide regions derived from genomic sequences of phage lysins.,Bacilluscereus
PRLKVYLPRYKVYSTAAGRYQLLSRYW,97,25,2499,Identification of antimicrobial peptide regions derived from genomic sequences of phage lysins.,Bacilluscereus
KVYLPRYKVYSTAAGRYQLL,97,25,2500,Identification of antimicrobial peptide regions derived from genomic sequences of phage lysins.,Bacilluscereus
AAGRYQLLSRYWDAYR,97,25,2501,Identification of antimicrobial peptide regions derived from genomic sequences of phage lysins.,Bacilluscereus
GFMKYIGPLIPHAVKAISKLI,98,2,2512,"Antimicrobial and cytolytic properties of the frog skin peptide, kassinatuerin-1 and its L- and D-lysine-substituted derivatives.",Escherichiacoli
GFMKYIKPLIPHAVKAISKLI,98,2,2513,"Antimicrobial and cytolytic properties of the frog skin peptide, kassinatuerin-1 and its L- and D-lysine-substituted derivatives.",Escherichiacoli
GFMKYIKPLIPHAVKAIKKLI,98,2,2514,"Antimicrobial and cytolytic properties of the frog skin peptide, kassinatuerin-1 and its L- and D-lysine-substituted derivatives.",Escherichiacoli
FVGALFKALSKLL,99,4,2521,Correlation between the activities of alpha-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times.,Staphylococcusaureus
FLGAVFKALSKLL,99,4,2522,Correlation between the activities of alpha-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times.,Staphylococcusaureus
FLGALFKAVSKLL,99,4,2523,Correlation between the activities of alpha-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times.,Staphylococcusaureus
FLGALFKALSKVL,99,4,2525,Correlation between the activities of alpha-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times.,Staphylococcusaureus
FLGALFKALSKLV,99,4,2526,Correlation between the activities of alpha-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times.,Staphylococcusaureus
FLGALVKALSKLL,99,4,2527,Correlation between the activities of alpha-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times.,Staphylococcusaureus
FLGAVVKALSKLL,99,4,2529,Correlation between the activities of alpha-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times.,Staphylococcusaureus
FLGALFKVVSKLL,99,4,2530,Correlation between the activities of alpha-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times.,Staphylococcusaureus
FLGVLFKVLSKLL,99,4,2531,Correlation between the activities of alpha-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times.,Staphylococcusaureus
FLGALAKALSKLL,99,4,2532,Correlation between the activities of alpha-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times.,Staphylococcusaureus
FAGAAFKALSKLL,99,4,2533,Correlation between the activities of alpha-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times.,Staphylococcusaureus
FLKALFKALSKLL,99,4,2534,Correlation between the activities of alpha-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times.,Staphylococcusaureus
FLKALFKALKKLL,99,4,2535,Correlation between the activities of alpha-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times.,Staphylococcusaureus
CGGWHRLRC,100,34,2539,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity,Micrococcuslysodeikticus
SGGWHRLRS,101,34,2540,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus
CGGWKRLRC,101,34,2541,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus
CGGWKRKRC,101,34,2542,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus
SGGYCGGWHRLRC,101,34,2543,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus
CGGWHRLRCTSYRSG,101,34,2544,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus
CGGYSGGWHRLRSTSYRCG,101,34,2545,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus
CGGYSGGWKRKRSTSYRCG,101,34,2546,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus
SGGYCGGWHRLRCTSYRSG,101,34,2547,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus
SGGYCGGWKRKRCTSYRSG,101,34,2548,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus
CGGYCGGWHRLRCTSYRCG,101,34,2549,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus
CGGYCGGWKRKRCTSYRCG,101,34,2550,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus
GFGSPNNYQSHRHSKSIPGR,101,34,2551,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus
NYQSHRHSKS,101,34,2552,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus
SKSIPGRSG,101,34,2553,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus
CGGYSSSGSGSGSTSYRCG,101,34,2554,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus
CKSIPGRCG,101,34,2555,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus
CKKWKRKRC,101,34,2557,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus
SIGRRGGYCAGIIKQTCTCYR,102,2,2596,Babesial vector tick defensin against Babesia sp. parasites.,Escherichiacoli
RSGGYCNGKRVCVCR,103,4,2637,"Identification and characterization of the antimicrobial peptide corresponding to C-terminal beta-sheet domain of tenecin 1, an antibacterial protein of larvae of Tenebrio molitor.",Staphylococcusaureus
VLSAADKGNVKAAWGKVGGHAAEYGAEALERM,104,35,2644,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis
VLSAADKGNVKAAWGKVGGHAAEYGAEAL,104,35,2645,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis
VLSAADKGNVKAAWGKVGGHAAEYGAEA,104,35,2647,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis
VLSAADKGNVKAAWGKVGGHAAEYGAE,104,35,2648,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis
VLSAADKGNVKAAWGKVGGHAAE,104,35,2649,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis
FLSFPTTKTYFPHFDLSHGSAQVKGHGAKVAAALTKAVEHLDDLPGALSEL,104,35,2655,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis
LSFPTTKTYFPHFDLSHGSAQVKGHGAKVAAALTKAVEHLDDLPGALSEL,104,35,2656,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis
FLSFPTTKTYFPHFDLSHGSAQVKGHGAKVAAAL,104,35,2657,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis
LSFPTTKTYFPHFDLSHGSAQVKGHGAKVAAAL,104,35,2658,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis
FLSFPTTKTYFPHF,104,35,2659,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis
FLSFPTTKTYFPH,104,35,2660,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis
LSFPTTKTYFPHF,104,35,2661,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis
FPTTKTYFPH,104,35,2683,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis
PTTKTYFPHF,104,35,2684,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis
VTLASHLPSDFTPAVHASLDKFLANVSTVLTSKYR,104,35,2685,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis
VTLASHLPSDFTPAVHASLDKFLANVSTVL,104,35,2686,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis
VTLASHLPSDFTPAVHASLDKFLANVS,104,35,2687,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis
STVLTSKYR,104,35,2688,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis
ARNFGKFFTPVLQADFQKVVAGVANALAHRYH,104,35,2690,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis
FTPVLQADFQKVVAGVANALAHRYH,104,35,2692,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis
QADFQKVVAGVANALAHRYH,104,35,2693,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis
MLTAEEKAAVTAFWGKVKVDEVGGEALGRL,104,35,2696,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis
MLTAEEKAAVTAF,104,35,2697,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis
KGRGKQGGKVRAKAKTR,105,7,2720,"Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide",Streptococcusmutans
KGRGKQGGKVRAKAK,105,7,2721,"Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide",Streptococcusmutans
KGRGKQGGKVRAKA,105,7,2722,"Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide",Streptococcusmutans
GRGKQGGKVRAKAKTRSS,105,7,2723,"Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide",Streptococcusmutans
AGRGKQGGKVRAKAKTRSS,105,7,2724,"Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide",Streptococcusmutans
SGRGKQGGKVRAKAKTRSS,105,7,2725,"Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide",Streptococcusmutans
RGRGKQGGKVRAKAKTRSS,105,7,2726,"Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide",Streptococcusmutans
DGRGKQGGKVRAKAKTRSS,105,7,2727,"Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide",Streptococcusmutans
KRGKQGGKVRAKAKTRSS,105,7,2728,"Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide",Streptococcusmutans
FEDLPNFGHIQVKVFNHGEHIHH,106,36,2739,Crustacean immunity. Antifungal peptides are generated from the C terminus of shrimp hemocyanin in response to microbial challenge.,Alternariabrassicicola
AANIPFKVHFRCKSIFC,107,2,2825,"Inhibitory and antimicrobial activities of OGTI and HV-BBI peptides, fragments and analogs derived from amphibian skin",Escherichiacoli
AVNIPFKVHFR,107,2,2828,"Inhibitory and antimicrobial activities of OGTI and HV-BBI peptides, fragments and analogs derived from amphibian skin",Escherichiacoli
CWTKSIPPRPC,107,2,2835,"Inhibitory and antimicrobial activities of OGTI and HV-BBI peptides, fragments and analogs derived from amphibian skin",Escherichiacoli
CWTASIPPRPC,107,2,2836,"Inhibitory and antimicrobial activities of OGTI and HV-BBI peptides, fragments and analogs derived from amphibian skin",Escherichiacoli
CWTVSIPPRPC,107,2,2837,"Inhibitory and antimicrobial activities of OGTI and HV-BBI peptides, fragments and analogs derived from amphibian skin",Escherichiacoli
IGKEFKRIVQRIKDFLRNL,108,2,2841,Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37,Escherichiacoli
IGKKFKRIVQRIKDFLRNL,108,2,2842,Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37,Escherichiacoli
IGKKFKRIVQRIKKFLRNL,108,2,2843,Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37,Escherichiacoli
IGKKFKRIVQRIKKFLRKL,108,2,2844,Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37,Escherichiacoli
IGKKFKRIVKRIKKFLRKL,108,2,2845,Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37,Escherichiacoli
IGKLFKRIVQRIKKFLRNL,108,2,2846,Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37,Escherichiacoli
IGKLFKRIVQRILKFLRNL,108,2,2847,Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37,Escherichiacoli
IGKLFKRIVKRILKFLRKL,108,2,2848,Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37,Escherichiacoli
ILKLFKRIVKRILKFLRKL,108,2,2849,Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37,Escherichiacoli
IGKKWKRIVKRIKKFLRKL,108,2,2850,Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37,Escherichiacoli
IGKKFKRIVKRIKKWLRKL,108,2,2851,Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37,Escherichiacoli
KKKKKFLLLQ,109,33,2899,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KKKKLFKLLQ,109,33,2900,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KKKLKFKLLQ,109,33,2901,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KKLKKFKLLQ,109,33,2902,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KLKKKFKLLQ,109,33,2903,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
LKKKKFKLLQ,109,33,2905,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KKKKLFLKLQ,109,33,2906,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KKKLKFLKLQ,109,33,2907,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KKLKKFLKLQ,109,33,2908,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KLKKKFLKLQ,109,33,2909,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
LKKKKFLKLQ,109,33,2910,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KKKLLFKKLQ,109,33,2911,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KKLKLFKKLQ,109,33,2912,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KLKKLFKKLQ,109,33,2913,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
LKKKLFKKLQ,109,33,2914,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KKKKLFLLKQ,109,33,2915,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KKKLKFLLKQ,109,33,2916,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KKLKKFLLKQ,109,33,2917,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KLKKKFLLKQ,109,33,2931,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
LKKKKFLLKQ,109,33,2932,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KKKLLFKLKQ,109,33,2933,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KKLKLFKLKQ,109,33,2934,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KLKKLFKLKQ,109,33,2977,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
LKKKLFKLKQ,109,33,2978,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KKLLKFKLKQ,109,33,2987,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
LKKLKFKLKQ,109,33,2988,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KLLKKFKLKQ,109,33,3010,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
LKLKKFKLKQ,109,33,3011,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
RPVYIPQPRPPHPRL,110,2,3012,Functional and structural characterization of apidaecin,Escherichiacoli
YIPQPRPPHPRL,110,2,3013,Functional and structural characterization of apidaecin,Escherichiacoli
PQPRPPHPRL,110,2,3014,Functional and structural characterization of apidaecin,Escherichiacoli
QPRPPHPRL,110,2,3015,Functional and structural characterization of apidaecin,Escherichiacoli
LLKKKFKLKQ,109,33,3016,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KKKLLFLKKQ,109,33,3017,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KKLKLFLKKQ,109,33,3018,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KLKKLFLKKQ,109,33,3019,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
LKKKLFLKKQ,109,33,3020,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KKLLKFLKKQ,109,33,3021,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KLKLKFLKKQ,109,33,3022,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
LKKLKFLKKQ,109,33,3023,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KLLKKFLKKQ,109,33,3024,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
RREAEPEAEPGNNRPVYIPQPRPPHPRL,110,2,3026,Functional and structural characterization of apidaecin,Escherichiacoli
PRPPHPPRPPHPRL,110,2,3027,Functional and structural characterization of apidaecin,Escherichiacoli
PRPPHPPRPPHPPRPPHPRL,110,2,3028,Functional and structural characterization of apidaecin,Escherichiacoli
PRPPHPPRPPHPPRPPHPPRPPHPRL,110,2,3029,Functional and structural characterization of apidaecin,Escherichiacoli
LKLKKFLKKQ,109,33,3031,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
LLKKKFLKKQ,109,33,3032,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KKLLLFKKKQ,109,33,3033,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KLKLLFKKKQ,109,33,3034,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
LKKLLFKKKQ,109,33,3036,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KLLKLFKKKQ,109,33,3037,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
LKLKLFKKKQ,109,33,3038,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
LLKKLFKKKQ,109,33,3039,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KLLLKFKKKQ,109,33,3040,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
LKLLKFKKKQ,109,33,3041,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
LLKLKFKKKQ,109,33,3042,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
LLLKKFKKKQ,109,33,3043,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KKLLKFKKLQ,109,33,3044,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KLKLKFKKLQ,109,33,3045,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
LKKLKFKKLQ,109,33,3046,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KLLKKFKKLQ,109,33,3047,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
LKLKKFKKLQ,109,33,3048,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
LLKKKFKKLQ,109,33,3049,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KLLLKFKKLQ,109,33,3057,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KKKLKFKKLQ,109,33,3058,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
LLLKKFKKLQ,109,33,3059,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
LKKKKFKKLQ,109,33,3060,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
LKLLKFKKLQ,109,33,3061,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KKLKKFKKLQ,109,33,3062,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
LLKLKFKKLQ,109,33,3063,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KLKKKFKKLQ,109,33,3064,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
LLLLKFKKLQ,109,33,3066,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
KKKKKFKKLQ,109,33,3067,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae
GEKLKKIGQKIKNFFQKL,111,2,3073,"CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity",Escherichiacoli
GKKLKKIGQKIKNFFQKL,111,2,3074,"CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity",Escherichiacoli
GEKLKKIGKKIKNFFQKL,111,2,3075,"CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity",Escherichiacoli
GEKLKKIGQKIKKFFQKL,111,2,3076,"CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity",Escherichiacoli
GEKLKKIGQKIKNFFKKL,111,2,3077,"CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity",Escherichiacoli
VRRFGWWWGFLRR,112,2,3078,"Conformation-dependent antibiotic activity of tritrpticin, a cathelicidin-derived antimicrobial peptide",Escherichiacoli
VRRFAWWWAFLRR,112,2,3079,"Conformation-dependent antibiotic activity of tritrpticin, a cathelicidin-derived antimicrobial peptide",Escherichiacoli
VRRFPFFFPFLRR,112,2,3080,"Conformation-dependent antibiotic activity of tritrpticin, a cathelicidin-derived antimicrobial peptide",Escherichiacoli
VRRFPAAAPFLRR,112,2,3081,"Conformation-dependent antibiotic activity of tritrpticin, a cathelicidin-derived antimicrobial peptide",Escherichiacoli
GILDTLKQFAKGVGKDLVKGAAQGVLSTVS,113,18,3082,Solution structure and membrane interaction mode of an antimicrobial peptide gaegurin 4,Micrococcusluteus
GILDTLKQFAKGVGKDLVKGAAQGVLSTV,113,18,3083,Solution structure and membrane interaction mode of an antimicrobial peptide gaegurin 4,Micrococcusluteus
GILDTLKQFAKGVGKDLVKGAAQGVLST,113,18,3084,Solution structure and membrane interaction mode of an antimicrobial peptide gaegurin 4,Micrococcusluteus
GILDTLKQFAKGVGKDLVKGAAQGVLS,113,18,3085,Solution structure and membrane interaction mode of an antimicrobial peptide gaegurin 4,Micrococcusluteus
GILDTLKQFAKGVGKDLVKGAAQGVL,113,18,3086,Solution structure and membrane interaction mode of an antimicrobial peptide gaegurin 4,Micrococcusluteus
GILDTLKQFAKGVGKDLVKGAAQGV,113,18,3087,Solution structure and membrane interaction mode of an antimicrobial peptide gaegurin 4,Micrococcusluteus
GILDTLKQFAKGVGKDLVKGAAQG,113,18,3088,Solution structure and membrane interaction mode of an antimicrobial peptide gaegurin 4,Micrococcusluteus
YGRKKRRQRRRD,114,37,3089,Biological activity of Tat (47-58) peptide on human pathogenic fungi,Saccharomycescerevisiae
GEILCNLCTGLINTLENLLTTK,47,18,3090,"Cytolytic and antibacterial activity of synthetic peptides derived from amoebapore, the pore-forming peptide of Entamoeba histolytica.",Micrococcusluteus
DKVKDYISSLCNKAS,47,18,3091,"Cytolytic and antibacterial activity of synthetic peptides derived from amoebapore, the pore-forming peptide of Entamoeba histolytica.",Micrococcusluteus
ANAICAKIHAC,47,18,3092,"Cytolytic and antibacterial activity of synthetic peptides derived from amoebapore, the pore-forming peptide of Entamoeba histolytica.",Micrococcusluteus
RQKDKRPYSERKNQYTGPQFLYPPERIPP,116,8,3165,"Lumbricin I, a novel proline-rich antimicrobial peptide from the earthworm: purification, cDNA cloning and molecular characterization.",Bacillussubtilis
NNEAQCEQAGGICSKDHCFHLHTRAFGHCQRGRPCCRTRYD,117,2,3168,Modification of chicken avian beta-defensin-8 at positively selected amino acid sites enhances specific antimicrobial activity.,Escherichiacoli
NNEAQCEQAGGRCSKDHCFHLHTRAFGHCQRGVPCCRRVYD,117,2,3169,Modification of chicken avian beta-defensin-8 at positively selected amino acid sites enhances specific antimicrobial activity.,Escherichiacoli
NNEAQCEQAGGICSKDHCFHLHTRAFGHCQRGDPCCRTDYD,117,2,3170,Modification of chicken avian beta-defensin-8 at positively selected amino acid sites enhances specific antimicrobial activity.,Escherichiacoli
NNEAQCEQAGGDCSKDHCFHLHTRAFGHCQRGVPCCRDVYD,117,2,3171,Modification of chicken avian beta-defensin-8 at positively selected amino acid sites enhances specific antimicrobial activity.,Escherichiacoli
KIWWWWRKR,118,3,3203,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa
RWRRWKWWL,118,3,3204,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa
WRWWKIWKR,118,3,3205,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa
WKRWWKKWR,118,3,3206,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa
WKKWWKRRW,118,3,3207,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa
LRWWWIKRI,118,3,3209,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa
RKRLKWWIY,118,3,3210,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa
KKRWVWIRY,119,3,3211,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning ,Pseudomonasaeruginosa
KWKIFRRWW,118,3,3212,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa
RKWIWRWFL,118,3,3213,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa
IWWKWRRWV,118,3,3214,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa
RRFKFIRWW,118,3,3215,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa
AVWKFVKRV,118,3,3216,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa
AWRFKNIRK,118,3,3217,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa
KRIMKLKMR,118,3,3218,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa
AIRRWRIRK,118,3,3219,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa
VVLKIVRRF,118,3,3220,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa
RLARIVVIRVAR,118,3,3221,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa
FFHLHFHY,120,4,3229,"Plicatamide, an antimicrobial octapeptide from Styela plicata hemocytes.",Staphylococcusaureus
LLGDFFRKSKEK,121,2,3390,Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region.,Escherichiacoli
IGKEFKRIVQRIKDFLRNLVPRTES,121,2,3391,Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region.,Escherichiacoli
GKWGWLAWVDPAYEFIKGFGKGAIKEGNKDKWKNI,122,1,3502,None_article0,None_target
KPWGWLAWVDPAYEFIKGFGKGAIKEGNKDKWKNI,123,1,3505,None_article1,None_target
KKGGWLAWVDPAYEFIKGFGKGAIKEGNKDKWKNI,124,1,3508,None_article2,None_target
KKWKWLAWVDPAYEFIKGFGKGAIKEGNKDKWKNI,125,1,3511,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis,None_target
KKWGWLPWVDPAYEFIKGFGKGAIKEGNKDKWKNI,125,1,3514,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis,None_target
KKWGWLAWVQPAYEFIKGFGKGAIKEGNKDKWKNI,125,1,3517,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis,None_target
KPGKWLPWLQPAYDFVTGLAKGIGKEGNKNKWKNV,125,1,3520,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis,None_target
GKGKWLPWLQPAYDFVTGLAKGIGKEGNKNKWKNV,125,1,3521,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis,None_target
GPGGWLPWLQPAYDFVTGLAKGIGKEGNKNKWKNV,125,1,3522,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis,None_target
GPGKWLAWLQPAYDFVTGLAKGIGKEGNKNKWKNV,125,1,3523,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis,None_target
GPGKWLPWLDPAYDFVTGLAKGIGKEGNKNKWKNV,125,1,3524,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis,None_target
EGTWDDIGQGIGRVAYWVGKAMGNMSDVNQASRINRKKKH,126,1,3541,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target
GTWDDIGNGIGRVAYWVGKAMGNMSDVNQASRINRKKKH,126,1,3542,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target
GTWDDIGQGIGPVAYWVGKAMGNMSDVNQASRINRKKKH,126,1,3543,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target
SVFSKIGNAVGPAAYWILKGLGNMSDVNQADRINRKKH,126,1,3569,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target
SVFSKIGQAVGPAAYWILKGLGNMSDVNQADRINRKKH,126,1,3570,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target
SVFSKIGNAVGRAAYWILKGLGNMSDVNQADRINRKKH,126,1,3571,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target
KKWGWLAWVDPAYEFIKGFGKGAIKEGNKDKWKNV,126,1,3589,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target
KKWGWLAWVDPAYEFIKGFGKGAIKEGNKNKWKNV,126,1,3592,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target
KKWGWLAWVDPAYEFIKGFGKGIGKEGNKNKWKNV,126,1,3595,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target
KKKKPLFGLFFGLF,127,38,3598,KKKKPLFGLFFGLF: a cationic peptide designed to exert antibacterial activity.,Bacillusmegateriurm
KKWGWLAWVDPAYEFIKGLAKGIGKEGNKNKWKNV,126,1,3600,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target
KKWGWLAWVDPAYEFVTGLAKGIGKEGNKNKWKNV,126,1,3603,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target
KKWGWLAWVDPAYDFVTGLAKGIGKEGNKNKWKNV,126,1,3606,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target
KKWGWLAWLQPAYDFVTGLAKGIGKEGNKNKWKNV,126,1,3609,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target
KKWGWLPWLQPAYDFVTGLAKGIGKEGNKNKWKNV,126,1,3612,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target
GTWDDIGQGIGRVAYWVGKAMGNMSDVNQASRINRKKH,126,1,3620,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target
GTWDDIGQGIGRVAYWVGKAMGNMSDVNQADRINRKKKH,126,1,3623,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target
GTWDDIGQGIGRVAYWVGKGLGNMSDVNQASRINRKKKH,125,1,3626,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis,None_target
GTWDDIGQGIGRVAYWVGKGLGNMSDVNQADRINRKKKH,126,1,3629,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target
GTWDDIGQGIGRVAYWILKGLGNMSDVNQADRINRKKKH,126,1,3632,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target
GTWDDIGQGIGPAAYWILKGLGNMSDVNQADRINRKKKH,126,1,3635,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target
GTWDDIGNAVGPAAYWILKGLGNMSDVNQADRINRKKKH,126,1,3638,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target
ESVFSKIGNAVGPAAYWILKGLGNMSDVNQADRINRKKKH,126,1,3641,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target
GLFSKFAGKGIKNFLNKGVKHIGKE,128,2,3697,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
QVFTLIKGATQLIRKTLGEQ,128,2,3710,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
KVQNQHGQVVKIFHH,129,39,3756,Processing of an antibacterial peptide from hemocyanin of the freshwater crayfish Pacifastacus leniusculus.,Shigellaflexneri
VQNQHGQVVKIFHH,129,39,3757,Processing of an antibacterial peptide from hemocyanin of the freshwater crayfish Pacifastacus leniusculus.,Shigellaflexneri
NQHGQVVKIFHH,129,39,3758,Processing of an antibacterial peptide from hemocyanin of the freshwater crayfish Pacifastacus leniusculus.,Shigellaflexneri
GICRCICGRGICRCICGR,130,3,3807,Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1.,Pseudomonasaeruginosa
GICRCICGRRICRCICGR,131,40,3809,Activity of alpha- and theta-defensins against primary isolates of HIV-1.,HIV-1A
GVCRCVCRRGVCRCVCRR,132,2,3857,"The cyclic cystine ladder in ?-defensins is important for structure and stability, but not antibacterial activity.",Escherichiacoli
GRDYRTSLTIVQKLKKMVDKPTQRSVSNAATRVSR,133,41,3860,"Granulysin, a T cell product, kills bacteria by altering membrane permeability.",Mycobacteriumtuberculosis
TGRSRWRDVSRNFMRRYQSRVIQGLVAGETAQQIS,133,41,3861,"Granulysin, a T cell product, kills bacteria by altering membrane permeability.",Mycobacteriumtuberculosis
GRDYRTSLTIVQKLKKMVDK,133,41,3862,"Granulysin, a T cell product, kills bacteria by altering membrane permeability.",Mycobacteriumtuberculosis
TRVSRTGRSRWRDVSRNFMR,133,41,3863,"Granulysin, a T cell product, kills bacteria by altering membrane permeability.",Mycobacteriumtuberculosis
QRSVSNAATRVCRTGRSRWRDVCRNFMRR,134,42,3867,Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin.,Salmonellatyphimurium
QRSVSNAATRVSRTGRSRWRDVSRNFMRR,134,42,3868,Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin.,Salmonellatyphimurium
QRSVSNAATRVCRT,134,42,3869,Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin.,Salmonellatyphimurium
RDVCRNFMRR,134,42,3870,Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin.,Salmonellatyphimurium
RDVCRNFMRRYQSRVIQGLV,134,42,3871,Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin.,Salmonellatyphimurium
QRSVSNAATRVCRTGRSRW,134,42,3872,Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin.,Salmonellatyphimurium
GRSRWRDVCRNFMRR,134,42,3873,Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin.,Salmonellatyphimurium
GQSQWRDVCRNFMRR,134,42,3874,Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin.,Salmonellatyphimurium
RCVCRRGVCRCVCTRGFC,135,2,3891,De novo sequencing of two new cyclic theta-defensins from baboon (Papio hamadryas) leukocytes by matrix-assisted laser desorption/ionization mass spectrometry.,Escherichiacoli
ALYKKFKKKLLKSLKRLG,136,2,3901,Synthetic peptides that exert antimicrobial activities in whole blood and blood-derived matrices.,Escherichiacoli
ALYKRLFKKLKKF,136,2,3902,Synthetic peptides that exert antimicrobial activities in whole blood and blood-derived matrices.,Escherichiacoli
PLYKKIIKKLLES,137,2,3903,Peptides related to the carboxyl terminus of human platelet factor IV with antibacterial activity.,Escherichiacoli
ALYKKIIKKLLESAKKLG,137,2,3904,Peptides related to the carboxyl terminus of human platelet factor IV with antibacterial activity.,Escherichiacoli
ALYKKLLKKLLKSAKKLG,137,2,3905,Peptides related to the carboxyl terminus of human platelet factor IV with antibacterial activity.,Escherichiacoli
LYKKIIKKLLES,138,43,3907,Platelet factor 4 activity against P. falciparum and its translation to nonpeptidic mimics as antimalarials.,Plasmodiumfalciparum
LYAKIIKKLLES,138,43,3908,Platelet factor 4 activity against P. falciparum and its translation to nonpeptidic mimics as antimalarials.,Plasmodiumfalciparum
LYAAIIKKLLES,138,43,3909,Platelet factor 4 activity against P. falciparum and its translation to nonpeptidic mimics as antimalarials.,Plasmodiumfalciparum
LYAAIIAKLLES,138,43,3910,Platelet factor 4 activity against P. falciparum and its translation to nonpeptidic mimics as antimalarials.,Plasmodiumfalciparum
FLGVVFKLASKVFPAVFGKV,139,2,3949,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLKVVFKLASKVFPAVFGKV,139,2,3950,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGKVFKLASKVFPAVFGKV,139,2,3951,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGVVFKKASKVFPAVFGKV,139,2,3952,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGVVFKLASKVFKAVFGKV,139,2,3953,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGVVFKLASKVFPAVFKKV,139,2,3954,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLKKVFKLASKVFPAVFGKV,139,2,3955,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGKVFKKASKVFPAVFGKV,139,2,3956,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGKVFKLASKVFKAVFGKV,139,2,3957,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGKVFKLASKVFPKVFGKV,139,2,3958,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGKVFKLASKVFPAVFKKV,139,2,3959,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLKVVFKKASKVFPAVFGKV,139,2,3960,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGVVFKKASKVFKAVFGKV,139,2,3961,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGVVFKKASKVFPKVFGKV,139,2,3962,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGVVFKKASKVFPAVFKKV,139,2,3963,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGGVFKLASKVFPAVFGKV,139,2,3964,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGSVFKLASKVFPAVFGKV,139,2,3965,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGVVFKGASKVFPAVFGKV,139,2,3966,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGVVFKSASKVFPAVFGKV,139,2,3967,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGGVFKGASKVFPAVFGKV,139,2,3968,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGSVFKSASKVFPAVFGKV,139,2,3969,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGVVVKLASKVFPAVFGKV,139,2,3970,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGVVFKLVSKVFPAVFGKV,139,2,3971,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGVVFKLAVKVFPAVFGKV,139,2,3972,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGVVFKLASKVVPAVFGKV,139,2,3973,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGVVFKLASKVFPAVVGKV,139,2,3974,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGKVVKGASKVFPAVFGKV,139,2,3975,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGKVFKGVSKVFPAVFGKV,139,2,3976,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGKVFKGAVKVFPAVFGKV,139,2,3977,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGKVFKGASKVVPAVFGKV,139,2,3978,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGVVFKGASKVFPAVVGKV,139,2,3979,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGKVVKKASKVFPAVFGKV,139,2,3980,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGKVFKKVSKVFPAVFGKV,139,2,3981,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGKVFKKAVKVFPAVFGKV,139,2,3982,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGKVFKKASKVVPAVFGKV,139,2,3983,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGKVFKKASKVFPAVVGKV,139,2,3984,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGVVFKLASKVFGAVFGKV,139,2,3986,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLKVVFKLASKVFGAVFGKV,139,2,3987,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGKVFKLASKVFGAVFGKV,139,2,3988,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGVVFKKASKVFGAVFGKV,139,2,3989,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGVVFKLASKVFGKVFGKV,139,2,3990,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGVVFKLASKVFGAVFKKV,139,2,3991,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGKVFKGASKVFGAVFGKV,139,2,3992,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLGGVFKKASKVFGAVFGKV,139,2,3993,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
GVSVAGAKKVKVLFVFPFLF,139,2,3994,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLFRVASKVFPALIGKFKKK,139,2,3995,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
RKVAPALIKSFVFLFKFKKG,139,2,3996,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
LGALFRVASKVFPAVISMVK,139,2,3997,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
SVPSVGAVLFFKRAAVMKLI,139,2,3998,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
LPVLFKLASKVFPAVFSSLK,139,2,3999,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
VSVKKVLPFAPLKSLLSFAF,139,2,4000,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLFGLASKVFPAVYCKVTRK,139,2,4001,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLPVLVKVFRYSKKTAAGCF,139,2,4002,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
SFVFKLASKVVPSVFSALTR,139,2,4003,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
ASPTVFRSSVFLSLFVVAKK,139,2,4004,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
LPVVFRVASKVFPALISKLT,139,2,4005,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
KVFIATLVVSSFLLAKPPRV,139,2,4006,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
THIHMNARLLIRSPFTDPQL,139,2,4007,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
RKRKSDVDFEAEFELFEDDD,139,2,4008,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
AATGTGKTAAFALPVLERLI,139,2,4009,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
PYSLKNGENWLLSEEIIRYP,139,2,4010,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
KFDPLEGAPMARGIVLEKVG,139,2,4011,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
HTGRSGPATGHSGHSSTHGS,139,2,4012,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
ALFSLASKVVPSVFSMVTKK,139,2,4013,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
MVVFSVPKFKSTVAKLLSSA,139,2,4014,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
VVFRVASKVFPAVYCTVSKK,139,2,4015,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
TAKVVVFVSFSYVVPKKRAC,139,2,4016,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
LSAVGKIASKVVPSVIGAFK,139,2,4017,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
GVSSPIVAVKFKGAVASLIK,139,2,4018,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
PVIGKLASKVVPSVFSMIKR,139,2,4019,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
SRVPLKSPVKIVGSKVMIFA,139,2,4020,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
GLMSLVKDIAKLAAKQGAKQ,139,2,4021,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
GLKKDALQSIVKKAQLAAMG,139,2,4022,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
SALGRVASKVFPAVYCSITK,139,2,4023,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
LYSPTCVKAAVSRFIGKVSA,139,2,4024,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
GFIGKLASKVVPSVYCKVTG,139,2,4025,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
ALGKLASKVFPAVYCTISRK,139,2,4026,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
KYGPALVIAVKKSCSLTFRA,139,2,4027,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
PVVFSVASKVVPSLISALKR,139,2,4028,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
KSPFVLVVSSRVAAVIKSLP,139,2,4029,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
PAVFKIASKVVPSVYCKVSR,139,2,4030,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
KVYVVKIAVPCFPKSARSVS,139,2,4031,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
GALFGLASKVFPAVFGAFKK,139,2,4032,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
SAVGKLASKVFPAVFSMVTK,139,2,4033,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FMKVLAVFGSVVTSAPKASK,139,2,4034,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
VKDLAKFIAKTVAKQGGCYL,139,2,4035,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
ALVYAGIKKTAFLKVQKCDG,139,2,4036,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
GVVGKLASKVVPSVFGSFTK,139,2,4037,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
SVKPVGSSVVKGTALVKFFG,139,2,4038,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
SAVGSVASKVVPSLISKVTK,139,2,4039,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
STVKVASKLAVVVSPISKGS,139,2,4040,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
MKSIAKFIAKTVAKQGAKQG,139,2,4041,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
AKKAQKSGAQTIVKIFAKGM,139,2,4042,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
LPAVFKLASKVVPSVFGLVK,139,2,4043,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
VVAKKFFVLVKGLAPVLSPS,139,2,4044,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
SVIGKIASKVVPSVYCAISK,139,2,4045,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
IASAVPVCVKGKISKSYISV,139,2,4046,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
PVVGRVASKVFPAVIGLVKK,139,2,4047,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
VKRAGKGVAVVPSPLFKIVV,139,2,4048,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
LSFVGRVASKVVPSLISMIK,139,2,4049,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
SSSIPIKMVLVRALVFVKSG,139,2,4050,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
SALGRLASKVVPAVIGKVTT,139,2,4051,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
TLVGVVAKLVATKIGSSPRA,139,2,4052,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
LGVVGSLASKVVPAVISKVK,139,2,4053,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
PKVVGLSIVVVKAKVSSALG,139,2,4054,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
LPAVFKLASKVFPAVYCKAS,139,2,4055,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
PSLLYKAKAVFCKPSAVAVF,139,2,4056,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
VVGRVASKVVPSLIGLFTTK,139,2,4057,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FKVVISKPGLSVRVGTALVT,139,2,4058,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
SVVFGVASKVVPSVIGKVKT,139,2,4059,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
VFSVKGGKPSVVIKVVVAST,139,2,4060,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FLPFVGRIASKVVPSVIGKV,139,2,4061,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
GKKLAKTIAKEVAKQGAKFA,139,2,4062,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
SKFPLAGIFSVPGVKRVVVI,139,2,4063,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
VIAFAKTKEAKAKLKGQAKG,139,2,4064,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FVGSLASKVVPSVFGAIKTK,139,2,4065,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
KTVPVVLKASIKVSSAGFGF,139,2,4066,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
LPVVFKIASKVVPSVISKIT,139,2,4067,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
KIVKVITVKSISPASLVPVF,139,2,4068,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
GAVFGVASKVVPSVFSAIKK,139,2,4069,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
SVKVAKSVIPSAVFAGGKVF,139,2,4070,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
FVGGVASKVVPSVYCKVSKK,139,2,4071,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
KVGKGSYPCSFVKVVAKVSV,139,2,4072,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
VVFKLASKVVPSVYCTITKK,139,2,4073,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
VKTKCSVPAVVYILVKTFKS,139,2,4074,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
GALFSLASKVVPAVIGLIKK,139,2,4075,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
LPVLFSSAIAKVGIKLGAKV,139,2,4076,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli
KSKEKIGKEFKRIVQRIKDFLRNLVPRTES,141,4,4105,Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense.,Staphylococcusaureus
CLRIGMRGRELMGGIGKTM,142,4,4106,Antibacterial potential of hGlyrichin encoded by a human gene.,Staphylococcusaureus
VRLEFKLQQTSCRKRDWKKP,143,2,4114,Chemerin is an antimicrobial agent in human epidermis.,Escherichiacoli
QGSPARCRFCCRCCPRMRGCGICCRF,144,44,4124,Cloning and expression of a hepcidin gene from a marine fish (Pseudosciaena crocea) and the antimicrobial activity of its synthetic peptide.,Aeromonashydrophila
QRFSQPTFKLPQGRLTLSRKFR,145,2,4125,Functional analysis of four processing products from multiple precursors encoded by a lebocin-related gene from Manduca sexta.,Escherichiacoli
QRFSQPTFKLPQGRLTLSRKF,145,2,4126,Functional analysis of four processing products from multiple precursors encoded by a lebocin-related gene from Manduca sexta.,Escherichiacoli
ESGNEPLWLYQGDNIPKAPSTAEHPFLPSIIDDVKFNPDRRYAR,145,2,4127,Functional analysis of four processing products from multiple precursors encoded by a lebocin-related gene from Manduca sexta.,Escherichiacoli
ESGNEPLWLYQGDNIPKAPSTAEHPFLPSIIDDVKFNPDRRYA,145,2,4128,Functional analysis of four processing products from multiple precursors encoded by a lebocin-related gene from Manduca sexta.,Escherichiacoli
SLGTPDHYHGGRHSISRGSQSTGPTHPGYNRRNAR,145,2,4129,Functional analysis of four processing products from multiple precursors encoded by a lebocin-related gene from Manduca sexta.,Escherichiacoli
SLGTPDHYHGGRHSISRGSQSTGPTHPGYNRRNA,145,2,4130,Functional analysis of four processing products from multiple precursors encoded by a lebocin-related gene from Manduca sexta.,Escherichiacoli
SVETLASQEHLSSLPMDSQETLLRGTR,145,2,4131,Functional analysis of four processing products from multiple precursors encoded by a lebocin-related gene from Manduca sexta.,Escherichiacoli
SVETLASQEHLSSLPMDSQETLLRGT,145,2,4132,Functional analysis of four processing products from multiple precursors encoded by a lebocin-related gene from Manduca sexta.,Escherichiacoli
KRKSPKTPFDNTPGAWFAHLILGC,146,45,4144,Characterization of putative class II bacteriocins identified from a non-bacteriocin-producing strain Lactobacillus casei ATCC 334.,Lactobacillusrhamnosus
KRKSPKTPFDNTPGAWFAHLILGS,146,45,4145,Characterization of putative class II bacteriocins identified from a non-bacteriocin-producing strain Lactobacillus casei ATCC 334.,Lactobacillusrhamnosus
RRGFWKRLRRRLRRFGDRIRNRFRNFREKLPDPFPG,147,2,4176,Ancient antimicrobial peptides kill antibiotic-resistant pathogens: Australian mammals provide new options.,Escherichiacoli
GAARKSIRLHRLYTWKATIYTR,148,2,4180,Novel antimicrobial peptides identified from an endoparasitic wasp cDNA library.,Escherichiacoli
GSCSCSGTISPYGLRTCRATKTKPSHPTTKETHPQTLPT,148,2,4181,Novel antimicrobial peptides identified from an endoparasitic wasp cDNA library.,Escherichiacoli
GKWGWIYITILFADVGGFKSSRHPEERRVQERRFKRITRGPD,148,2,4182,Novel antimicrobial peptides identified from an endoparasitic wasp cDNA library.,Escherichiacoli
IKKVASVIGGL,150,2,4249,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli
KVASVIGGL,150,2,4250,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli
GLFDVIKKVASVIGG,150,2,4251,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli
GLFDVIKKVASVIG,150,2,4252,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli
GLFDVIKKVASVI,150,2,4253,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli
GLFDVIKKVASV,150,2,4254,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli
GLFDVIKKVAS,150,2,4255,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli
GLFDVIKKV,150,2,4256,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli
DVIKKVASVIG,150,2,4258,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli
GLFDVIKASVIGGL,150,2,4260,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli
GLFDVVIGGL,150,2,4261,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli
GLFAVIKKVASVIGG,150,2,4262,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli
GLFAVIKKVASVIG,150,2,4263,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli
GLFAVIKKVASVI,150,2,4264,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli
GLFAVIKKVASV,150,2,4265,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli
FLSLIPKLVKKIIKAFK,152,4,4299,"Two peptides, TsAP-1 and TsAP-2, from the venom of the Brazilian yellow scorpion, Tityus serrulatus: evaluation of their antimicrobial and anticancer activities.",Staphylococcusaureus
FLGMIPKLIKKLIKAFK,152,4,4300,"Two peptides, TsAP-1 and TsAP-2, from the venom of the Brazilian yellow scorpion, Tityus serrulatus: evaluation of their antimicrobial and anticancer activities.",Staphylococcusaureus
RRQRRTSKLMKRGGKLAKLAKKLAKLAK,153,46,4305,A proapoptotic peptide for the treatment of solid tumors.,Murinefibrosarcoma
GLWNSIKIAGKKLFVNVLDKIRCKVAGGCKTSPDVEYHK,154,2,4310,Identification and structure–activity relationship of an antimicrobial peptide of the palustrin-2 family isolated from the skin of the endangered frog Odorrana ishikawae.,Escherichiacoli
KTSPDVEYHK,154,2,4312,Identification and structure–activity relationship of an antimicrobial peptide of the palustrin-2 family isolated from the skin of the endangered frog Odorrana ishikawae.,Escherichiacoli
GLWNSIKIAGKKLFVNVLDKIRCKVAGGC,154,2,4313,Identification and structure–activity relationship of an antimicrobial peptide of the palustrin-2 family isolated from the skin of the endangered frog Odorrana ishikawae.,Escherichiacoli
GLWDSIKIAGKKLFVNVLDKIRCKVAGGC,154,2,4314,Identification and structure–activity relationship of an antimicrobial peptide of the palustrin-2 family isolated from the skin of the endangered frog Odorrana ishikawae.,Escherichiacoli
GLWNSIKIAGKNLFVNVLDKIRCKVAGGC,154,2,4315,Identification and structure–activity relationship of an antimicrobial peptide of the palustrin-2 family isolated from the skin of the endangered frog Odorrana ishikawae.,Escherichiacoli
GLWNSIKIAGKKLFVNVLDKIRSKVAGGS,154,2,4316,Identification and structure–activity relationship of an antimicrobial peptide of the palustrin-2 family isolated from the skin of the endangered frog Odorrana ishikawae.,Escherichiacoli
GKKLFVNVLDKIRCKVAGGC,154,2,4317,Identification and structure–activity relationship of an antimicrobial peptide of the palustrin-2 family isolated from the skin of the endangered frog Odorrana ishikawae.,Escherichiacoli
YKQCHKKGGHCFPKEKICLPPSSDFGKMDCRWRWKCCKKGSG,155,2,4322,"In vitro antibacterial and hemolytic activities of crotamine, a small basic myotoxin from rattlesnake Crotalus durissus.",Escherichiacoli
MPKRKAEGDAKGDKAKV,156,2,4325,HMGN2: a novel antimicrobial effector molecule of human mononuclear leukocytes?,Escherichiacoli
GEKVPKGKKGKADAGKEGNNPAENGDAKTDQAQKAEGAGDAK,156,2,4326,HMGN2: a novel antimicrobial effector molecule of human mononuclear leukocytes?,Escherichiacoli
KDEPQRRSARLSAKPAPPKPEPKPKKAPAKK,156,2,4327,HMGN2: a novel antimicrobial effector molecule of human mononuclear leukocytes?,Escherichiacoli
AWNTYDYMKREHSLVKPYQG,157,8,4334,"Macrobrachium rosenbergii mannose binding lectin: Synthesis of MrMBL-N20 and MrMBL-C16 peptides and their antimicrobial characterization, bioinformatics and relative gene expression analysis.",Bacillussubtilis
GPVSAVLTELRCTCLRVTLRVNPKTIGKLQVFPAGPQCSKVEVVASLKNG,158,47,4341,The human CXC chemokine granulocyte chemotactic protein 2 (GCP-2)/CXCL6 possesses membrane-disrupting properties and is antibacterial.,Streptococcuspyogenes
APFLKKVIQKILDSGNKKN,158,47,4342,The human CXC chemokine granulocyte chemotactic protein 2 (GCP-2)/CXCL6 possesses membrane-disrupting properties and is antibacterial.,Streptococcuspyogenes
HRKKHHGKRNSNRAHQGKHETYGHKTPY,159,3,4345,CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity.,Pseudomonasaeruginosa
GFSSIFRGVAKFASKGLGKKLAKLGVKLVACKISKQC,160,4,4386,"Esculentin-2CHa: a host-defense peptide with differential cytotoxicity against bacteria, erythrocytes and tumor cells.",Staphylococcusaureus
GFSSIFRGVAKFASKGLGKDLAKLGVDLVASKISKQS,160,4,4387,"Esculentin-2CHa: a host-defense peptide with differential cytotoxicity against bacteria, erythrocytes and tumor cells.",Staphylococcusaureus
GFSSIFRGVAKFASKGLGKDLAKLGVDLVA,160,4,4388,"Esculentin-2CHa: a host-defense peptide with differential cytotoxicity against bacteria, erythrocytes and tumor cells.",Staphylococcusaureus
RGVAKFASKGLGKDLAKLGVDLVACKISKQC,160,4,4389,"Esculentin-2CHa: a host-defense peptide with differential cytotoxicity against bacteria, erythrocytes and tumor cells.",Staphylococcusaureus
KFASKGLGKDLAKLGVDLVACKISKQC,160,4,4390,"Esculentin-2CHa: a host-defense peptide with differential cytotoxicity against bacteria, erythrocytes and tumor cells.",Staphylococcusaureus
KGLGKDLAKLGVDLVACKISKQC,160,4,4391,"Esculentin-2CHa: a host-defense peptide with differential cytotoxicity against bacteria, erythrocytes and tumor cells.",Staphylococcusaureus
GLGKDLAKLGVDLVACKISKQC,160,4,4392,"Esculentin-2CHa: a host-defense peptide with differential cytotoxicity against bacteria, erythrocytes and tumor cells.",Staphylococcusaureus
FLPILASLAAKFGPKLFSLVTKKS,161,4,4418,"Synthesis, conformational analysis and biological properties of a dicarba derivative of the antimicrobial peptide, brevinin-1BYa.",Staphylococcusaureus
GLPRKILAAIAKKKGKAKGPLKLVAKA,162,8,4441,"Lasiocepsin, a novel cyclic antimicrobial peptide from the venom of eusocial bee Lasioglossum laticeps (Hymenoptera: Halictidae).",Bacillussubtilis
GLPRKILCAIAKKKGKCKGPLKLVCKC,162,8,4442,"Lasiocepsin, a novel cyclic antimicrobial peptide from the venom of eusocial bee Lasioglossum laticeps (Hymenoptera: Halictidae).",Bacillussubtilis
GLPRKILCAIAKKKGKAKGPLKLVCKA,162,8,4446,"Lasiocepsin, a novel cyclic antimicrobial peptide from the venom of eusocial bee Lasioglossum laticeps (Hymenoptera: Halictidae).",Bacillussubtilis
GLPRKILAAIAKKKGKCKGPLKLVAKC,162,8,4447,"Lasiocepsin, a novel cyclic antimicrobial peptide from the venom of eusocial bee Lasioglossum laticeps (Hymenoptera: Halictidae).",Bacillussubtilis
AWLDKLKSLGKVVG,163,2,4470,Post-secretory events alter the peptide content of the skin secretion of Hypsiboas raniceps.,Escherichiacoli
KVALGVAQNYLNPQQ,163,2,4471,Post-secretory events alter the peptide content of the skin secretion of Hypsiboas raniceps.,Escherichiacoli
HNKQEGRDHDKSKGHFHRVVIHHKGGKAH,164,2,4479,Identification of novel semenogelin I-derived antimicrobial peptide from liquefied human seminal plasma.,Escherichiacoli
KKFFLKVLTKIRCKVAGGCRT,165,2,4498,Effects of thioredoxin: SUMO and intein on soluble fusion expression of an antimicrobial peptide OG2 in Escherichia coli.,Escherichiacoli
FLGALFHALSKLL,166,31,4524,Constructing bioactive peptides with pH-dependent activities.,Humanlung
FLGALFKALSHLL,166,31,4525,Constructing bioactive peptides with pH-dependent activities.,Humanlung
FLGALFHALSHLL,166,31,4526,Constructing bioactive peptides with pH-dependent activities.,Humanlung
PAWRKAFRWAWRMLKKAA,166,31,4527,Constructing bioactive peptides with pH-dependent activities.,Humanlung
PAWHHAFHWAWRMLKKAA,166,31,4528,Constructing bioactive peptides with pH-dependent activities.,Humanlung
PAWRKAFRWAWHMLHHAA,166,31,4529,Constructing bioactive peptides with pH-dependent activities.,Humanlung
PAWRHAFHWAWHMLHKAA,166,31,4530,Constructing bioactive peptides with pH-dependent activities.,Humanlung
GLFAVIKKVASVIGGL,166,31,4531,Constructing bioactive peptides with pH-dependent activities.,Humanlung
GLFAVIHKVASVIGGL,166,31,4532,Constructing bioactive peptides with pH-dependent activities.,Humanlung
GLFAVIKHVASVIGGL,166,31,4533,Constructing bioactive peptides with pH-dependent activities.,Humanlung
GLFAVIHHVASVIGGL,166,31,4534,Constructing bioactive peptides with pH-dependent activities.,Humanlung
GFGCNGPWNEDDLRCHNHCKSIKGYKGGYCAKGGFVCKCY,167,4,4535,"High expression of a plectasin-derived peptide NZ2114 in Pichia pastoris and its pharmacodynamics, postantibiotic and synergy against Staphylococcus aureus.",Staphylococcusaureus
KTLTGKTITLE,168,48,4546,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Bacillusmegaterium
CRRLCYKQRCVTYC,169,2,4547,Synthesis and properties of cyclic gomesin and analogues.,Escherichiacoli
QCRRLCYKQRCVTYCRGR,169,2,4548,Synthesis and properties of cyclic gomesin and analogues.,Escherichiacoli
MAFKKLEKVGRNIRDGIIKAGPAVAVIGQATSIARPTGK,170,4,4571,"cDNA cloning and characterization of the antibacterial peptide cecropin 1 from the diamondback moth, Plutella xylostella L.",Staphylococcusaureus
FKCRRWQWRWKKLGAKPVPIIYCNRRTGKCQRM,171,4,4586,"Recombinant expression, purification, and antimicrobial activity of a novel hybrid antimicrobial peptide LFT33.",Staphylococcusaureus
AAAAGSCVWGAVNYTSDCNGECKRRGYKGGHCGSFANVNCWCET,172,28,4596,Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.,Neurosporacrassa
DKLIGSCVWGAVNYTSDCAAECKRRGYKGGHCGSFANVNCWCET,172,28,4597,Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.,Neurosporacrassa
DKLIGSCVWGAVNYTSDCNGECLLRGYKGGHCGSFANVNCWCET,172,28,4598,Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.,Neurosporacrassa
DKLIGSCVWGAVNYTSDCNGECKRRGYKGGHCGSFANVNCWCRT,172,28,4599,Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.,Neurosporacrassa
AAAAGSCVWGAVNYTSDCNGECKRRGYKGGHCGSFANVNCWCRT,172,28,4600,Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.,Neurosporacrassa
AAAAGSCVWGAVNYTSDCAAECKRRGYKGGHCGSFANVNCWCET,172,28,4601,Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.,Neurosporacrassa
AAAAGSCVWGAVNYTSDCNGECLLRGYKGGHCGSFANVNCWCET,172,28,4602,Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.,Neurosporacrassa
DKLIGSCVWGAVNYTSDCAAECKRRGYKGGHCGSFANVNCWCRT,172,28,4603,Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.,Neurosporacrassa
DKLIGSCVWGAVNYTSDCNGECLLRGYKGGHCGSFANVNCWCRT,172,28,4604,Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.,Neurosporacrassa
DKLIGSCVWGAVNYTSDCAAECLLRGYKGGHCGSFANVNCWCET,172,28,4605,Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.,Neurosporacrassa
AAAAGSCVWGAVNYTSDCAAECKRRGYKGGHCGSFANVNCWCRT,172,28,4606,Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.,Neurosporacrassa
AAAAGSCVWGAVNYTSDCNGECLLRGYKGGHCGSFANVNCWCRT,172,28,4607,Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.,Neurosporacrassa
AAAAGSCVWGAVNYTSDCAAECLLRGYKGGHCGSFANVNCWCET,172,28,4608,Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.,Neurosporacrassa
DKLIGSCVWGAVNYTSDCAAECLLRGYKGGHCGSFANVNCWCRT,172,28,4609,Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.,Neurosporacrassa
AAAAGSCVWGAVNYTSDCAAECLLRGYKGGHCGSFANVNCWCRT,172,28,4610,Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.,Neurosporacrassa
SWLRDIWDWICEVLSDFK,173,49,4631,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,HepatitisC
SWLRDLWDWICEVLSDFK,173,49,4632,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,HepatitisC
SWLRDIWDWLCEVLSDFK,173,49,4633,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,HepatitisC
SWLRDIWDWICELLSDFK,173,49,4634,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,HepatitisC
SWLRDLWDWLCEVLSDFK,173,49,4635,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,HepatitisC
SWLRDLWDWICELLSDFK,173,49,4636,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,HepatitisC
SWLRDIWDWLCELLSDFK,173,49,4637,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,HepatitisC
SWLRDLWDWLCELLSDFK,173,49,4638,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,HepatitisC
SWLRDIWDWVCEVLSDFK,173,49,4639,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,HepatitisC
SWLRDIWDWACEVLSDFK,173,49,4640,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,HepatitisC
SWLRDIWDWGCEVLSDFK,173,49,4641,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,HepatitisC
SWLRDIWDWSCEVLSDFK,173,49,4642,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,HepatitisC
SWLRDIWDWECEVLSDFK,173,49,4643,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,HepatitisC
SWLRDIWDWKCEVLSDFK,173,49,4644,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,HepatitisC
ELLKAVRLIK,174,4,4645,Effects of positively charged arginine residues on membrane pore forming activity of Rev-NIS peptide in bacterial cells.,Staphylococcusaureus
RLRKAVRLIK,174,50,4646,Effects of positively charged arginine residues on membrane pore forming activity of Rev-NIS peptide in bacterial cells.,Enterococcusfaecium
ELSKAVRLIK,174,50,4647,Effects of positively charged arginine residues on membrane pore forming activity of Rev-NIS peptide in bacterial cells.,Enterococcusfaecium
RAGLQWPIGRLLRRLLRRLLR,175,2,4648,Mechanism of action and specificity of antimicrobial peptides designed based on buforin IIb,Escherichiacoli
RVVRQWPIGRVVRRVVRRVVR,175,2,4649,Mechanism of action and specificity of antimicrobial peptides designed based on buforin IIb,Escherichiacoli
KLLKQWPIGKLLKKLLKKLLK,175,2,4650,Mechanism of action and specificity of antimicrobial peptides designed based on buforin IIb,Escherichiacoli
KVVKQWPIGKVVKKVVKKVVK,175,2,4651,Mechanism of action and specificity of antimicrobial peptides designed based on buforin IIb,Escherichiacoli
RRLMAAKAESRK,176,51,4653,"Antimicrobial activity and mechanism of action of a novel cationic ?-helical dodecapeptide, a partial sequence of cyanate lyase from rice.",Porphyromonasgingivalis
RLMAAKAESRK,177,51,4655,"Antimicrobial activity and mechanism of action of a novel cationic ?-helical dodecapeptide, a partial sequence of cyanate lyase from rice",Porphyromonasgingivalis
RRLMAAKAESR,176,51,4657,"Antimicrobial activity and mechanism of action of a novel cationic ?-helical dodecapeptide, a partial sequence of cyanate lyase from rice.",Porphyromonasgingivalis
GRRRRSVQWCA,178,4,4663,Discovery and development of a synthetic peptide derived from lactoferrin for clinical use,Staphylococcusaureus
RRSVQWCA,178,4,4665,Discovery and development of a synthetic peptide derived from lactoferrin for clinical use,Staphylococcusaureus
APRKNVRW,179,2,4672,"A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: design, synthesis, activity against multidrug-resistant bacteria and Candida",Escherichiacoli
APRKNVRF,179,2,4673,"A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: design, synthesis, activity against multidrug-resistant bacteria and Candida",Escherichiacoli
APRKNVKW,179,2,4674,"A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: design, synthesis, activity against multidrug-resistant bacteria and Candida",Escherichiacoli
VCYCRRRFCVCVGR,180,2,4676,Driving engineering of novel antimicrobial peptides from simulations of peptide-micelle interactions,Escherichiacoli
ECYCRRRFCVCVGR,180,2,4677,Driving engineering of novel antimicrobial peptides from simulations of peptide-micelle interactions,Escherichiacoli
RGGRLCYCRRRFCVCT,180,2,4678,Driving engineering of novel antimicrobial peptides from simulations of peptide-micelle interactions,Escherichiacoli
RGGRLCYCRRRFCVCI,180,2,4680,Driving engineering of novel antimicrobial peptides from simulations of peptide-micelle interactions,Escherichiacoli
RGGRLCYCRRRFCVCE,180,2,4681,Driving engineering of novel antimicrobial peptides from simulations of peptide-micelle interactions,Escherichiacoli
LCYCRRRFCVC,180,2,4682,Driving engineering of novel antimicrobial peptides from simulations of peptide-micelle interactions,Escherichiacoli
CYCRRRFCVC,180,2,4683,Driving engineering of novel antimicrobial peptides from simulations of peptide-micelle interactions,Escherichiacoli
FKCRRWQWRMKKLGAPSITCVRRAF,181,2,4698,Comparative antimicrobial activity and mechanism of action of bovine lactoferricin-derived synthetic peptides.,Escherichiacoli
FKCRRWQWRMKKLGA,181,2,4699,Comparative antimicrobial activity and mechanism of action of bovine lactoferricin-derived synthetic peptides.,Escherichiacoli
RRWQWRMKK,181,2,4700,Comparative antimicrobial activity and mechanism of action of bovine lactoferricin-derived synthetic peptides.,Escherichiacoli
APRKNLKW,179,2,4701,"A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: design, synthesis, activity against multidrug-resistant bacteria and Candida",Escherichiacoli
APRKQLKW,179,2,4702,"A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: design, synthesis, activity against multidrug-resistant bacteria and Candida",Escherichiacoli
APRRQLKW,179,2,4704,"A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: design, synthesis, activity against multidrug-resistant bacteria and Candida",Escherichiacoli
APKKQLKW,179,2,4706,"A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: design, synthesis, activity against multidrug-resistant bacteria and Candida",Escherichiacoli
AFRKQLKW,179,2,4708,"A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: design, synthesis, activity against multidrug-resistant bacteria and Candida",Escherichiacoli
LFRKQLKW,179,2,4709,"A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: design, synthesis, activity against multidrug-resistant bacteria and Candida",Escherichiacoli
FWGALAKGALKLIVSLFSSFSKKD,182,4,4728,Amino acid substitutions in an alpha-helical antimicrobial arachnid peptide affect its chemical properties and biological activity towards pathogenic bacteria but improves its therapeutic index.,Staphylococcusaureus
FWGALAKGALKLIGVSLFSSFSKKD,182,4,4729,Amino acid substitutions in an alpha-helical antimicrobial arachnid peptide affect its chemical properties and biological activity towards pathogenic bacteria but improves its therapeutic index.,Staphylococcusaureus
FWGALAKGALKLIVGSLFSSFSKKD,182,4,4730,Amino acid substitutions in an alpha-helical antimicrobial arachnid peptide affect its chemical properties and biological activity towards pathogenic bacteria but improves its therapeutic index.,Staphylococcusaureus
FWGALAKGALKLIGVGSLFSSFSKKD,182,4,4731,Amino acid substitutions in an alpha-helical antimicrobial arachnid peptide affect its chemical properties and biological activity towards pathogenic bacteria but improves its therapeutic index.,Staphylococcusaureus
RCYCRRRFCVCVGR,26,2,4762,Protegrin structure-activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity.,Escherichiacoli
RGGRLCYCRRRFCVCR,26,2,4770,Protegrin structure-activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity.,Escherichiacoli
RCYCRRRFCVCR,26,2,4780,Protegrin structure-activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity.,Escherichiacoli
RCYARRRFAVCR,26,2,4782,Protegrin structure-activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity.,Escherichiacoli
RAYCRRRFCVAR,26,2,4785,Protegrin structure-activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity.,Escherichiacoli
LCYTRPRFTVCV,26,2,4787,Protegrin structure-activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity.,Escherichiacoli
YQWQRRMRKLGAPSIT,183,2,4849,Antimicrobial peptide of korean native goat lactoferrin and identification of the part essential for this activity.,Escherichiacoli
YQWQRRMKLGAPSIT,183,2,4850,Antimicrobial peptide of korean native goat lactoferrin and identification of the part essential for this activity.,Escherichiacoli
WQRRMRKLGAPSIT,183,2,4851,Antimicrobial peptide of korean native goat lactoferrin and identification of the part essential for this activity.,Escherichiacoli
WQRRMKLGAPSIT,183,2,4852,Antimicrobial peptide of korean native goat lactoferrin and identification of the part essential for this activity.,Escherichiacoli
YQWQRRMRLGAPSIT,183,2,4853,Antimicrobial peptide of korean native goat lactoferrin and identification of the part essential for this activity.,Escherichiacoli
YQWQRMRKLGAPSIT,183,2,4854,Antimicrobial peptide of korean native goat lactoferrin and identification of the part essential for this activity.,Escherichiacoli
WFRKQLKW,184,2,4855,"A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: design, synthesis, activity against multidrug-resistant bacteria and Candida.",Escherichiacoli
FRRWWKWFK,185,3,4864,Identification of novel antibacterial peptides by chemoinformatics and machine learning.,Pseudomonasaeruginosa
FFHHIFRAIVHVGKTIHRLVTG,186,2,4868,Solution structure and cell selectivity of piscidin 1 and its analogues.,Escherichiacoli
FFHHIFRGIVHVAKTIHRLVTG,186,2,4869,Solution structure and cell selectivity of piscidin 1 and its analogues.,Escherichiacoli
KNLRRIIRKGIHIIKKYF,188,2,4872,"Membrane interactions of novicidin, a novel antimicrobial peptide: phosphatidylglycerol promotes bilayer insertion.",Escherichiacoli
FFHHIFRAIVHVAKTIHRLVTG,186,2,4873,Solution structure and cell selectivity of piscidin 1 and its analogues.,Escherichiacoli
FFHHIFRPIVHVGKTIHRLVTG,186,2,4874,Solution structure and cell selectivity of piscidin 1 and its analogues.,Escherichiacoli
FFHHIFRGIVHVPKTIHRLVTG,186,2,4875,Solution structure and cell selectivity of piscidin 1 and its analogues.,Escherichiacoli
FFHHIFRPIVHVPKTIHRLVTG,186,2,4882,Solution structure and cell selectivity of piscidin 1 and its analogues.,Escherichiacoli
FFHHIFRAIVHVPKTIHRLVTG,186,2,4884,Solution structure and cell selectivity of piscidin 1 and its analogues.,Escherichiacoli
FFHHIFRPIVHVAKTIHRLVTG,186,2,4887,Solution structure and cell selectivity of piscidin 1 and its analogues.,Escherichiacoli
AAHHIARPIVHVGKTIHRLVTG,186,2,4894,Solution structure and cell selectivity of piscidin 1 and its analogues.,Escherichiacoli
FFAAIFRPIVHVGKTIHRLVTG,186,2,4896,Solution structure and cell selectivity of piscidin 1 and its analogues.,Escherichiacoli
FFAAIFAPIVHVGKTIHRLVTG,186,2,4897,Solution structure and cell selectivity of piscidin 1 and its analogues.,Escherichiacoli
KPWRFRRAIRRVRWRKVAPYIPFVVKTVGKK,189,4,4898,Activity of the novel peptide arminin against multiresistant human pathogens shows the considerable potential of phylogenetically ancient organisms as drug sources.,Staphylococcusaureus
KWCFCVCYRGICYCRCRG,190,2,4901,Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.,Escherichiacoli
KWCFCVCYRGICRCRCRG,190,2,4902,Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.,Escherichiacoli
KWCRCVCRRGICYCRCRG,190,2,4903,Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.,Escherichiacoli
KWCRCVCRRGICRCRCRG,190,2,4904,Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.,Escherichiacoli
KWCRCVCRRGICRCRCRK,190,2,4905,Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.,Escherichiacoli
GIINTLQKYYWRVRGGRWAVLSWLPKEEQIGKWSTRGRKWWRRKK,191,3,4938,Linear analogues of human beta-defensin 3: concepts for design of antimicrobial peptides with reduced cytotoxicity to mammalian cells.,Pseudomonasaeruginosa
GIINTLQKYYFRVRGGRFAVLSFLPKEEQIGKFSTRGRKFFRRKK,191,3,4939,Linear analogues of human beta-defensin 3: concepts for design of antimicrobial peptides with reduced cytotoxicity to mammalian cells.,Pseudomonasaeruginosa
GIINTLQKYYYRVRGGRYAVLSYLPKEEQIGKYSTRGRKYYRRKK,191,3,4940,Linear analogues of human beta-defensin 3: concepts for design of antimicrobial peptides with reduced cytotoxicity to mammalian cells.,Pseudomonasaeruginosa
GIINTLQKYYARVRGGRAAVLSALPKEEQIGKASTRGRKAARRKK,191,3,4941,Linear analogues of human beta-defensin 3: concepts for design of antimicrobial peptides with reduced cytotoxicity to mammalian cells.,Pseudomonasaeruginosa
GIINTLQKYYSRVRGGRSAVLSSLPKEEQIGKSSTRGRKSSRRKK,191,3,4942,Linear analogues of human beta-defensin 3: concepts for design of antimicrobial peptides with reduced cytotoxicity to mammalian cells.,Pseudomonasaeruginosa
MAGNSSNFIHKIKQIFTHR,192,52,4949,Induction of bacteriocin production in Lactobacillus sake by a secreted peptide.,Enterococcusfaecalis
FALLGDFFRKSKEKIGKEFKRIVQRIKDFFRNLVPRTES,194,2,5007,PCR-based site-specific mutagenesis of peptide antibiotics FALL-39 and its biologic activities.,Escherichiacoli
LFCKGGSCHFGGCPSHLIKVGSCFGFRSCCAWPWNA,195,25,5010,Initial insights into structure-activity relationships of avian defensins.,Bacilluscereus
FALLGDFFRKSKEKIGKEFKRIVQRIKDFFRKLVPRTES,194,2,5011,PCR-based site-specific mutagenesis of peptide antibiotics FALL-39 and its biologic activities.,Escherichiacoli
FALLGDFFRKSKEKIGKEFKRIVKRIKDFFRNLVPRTES,194,2,5013,PCR-based site-specific mutagenesis of peptide antibiotics FALL-39 and its biologic activities.,Escherichiacoli
KWRRWVRWI,196,2,5034,Novel short antibacterial and antifungal peptides with low cytotoxicity: Efficacy and action mechanisms.,Escherichiacoli
KLRRWVRWI,196,2,5035,Novel short antibacterial and antifungal peptides with low cytotoxicity: Efficacy and action mechanisms.,Escherichiacoli
KWRRWVRWL,196,2,5036,Novel short antibacterial and antifungal peptides with low cytotoxicity: Efficacy and action mechanisms.,Escherichiacoli
KLRRWVRWL,196,2,5037,Novel short antibacterial and antifungal peptides with low cytotoxicity: Efficacy and action mechanisms.,Escherichiacoli
KWRRWIRWL,196,2,5038,Novel short antibacterial and antifungal peptides with low cytotoxicity: Efficacy and action mechanisms.,Escherichiacoli
KWRRWIRWW,196,2,5039,Novel short antibacterial and antifungal peptides with low cytotoxicity: Efficacy and action mechanisms.,Escherichiacoli
KKLFKKILKFL,196,2,5041,Novel short antibacterial and antifungal peptides with low cytotoxicity: Efficacy and action mechanisms.,Escherichiacoli
KKLFKKIKKFL,196,2,5042,Novel short antibacterial and antifungal peptides with low cytotoxicity: Efficacy and action mechanisms.,Escherichiacoli
KKLFKKALKFL,196,2,5043,Novel short antibacterial and antifungal peptides with low cytotoxicity: Efficacy and action mechanisms.,Escherichiacoli
KKLFKKGLKFL,196,2,5044,Novel short antibacterial and antifungal peptides with low cytotoxicity: Efficacy and action mechanisms.,Escherichiacoli
GKLFKKILKFL,196,2,5045,Novel short antibacterial and antifungal peptides with low cytotoxicity: Efficacy and action mechanisms.,Escherichiacoli
GKLFKKILKIL,196,2,5046,Novel short antibacterial and antifungal peptides with low cytotoxicity: Efficacy and action mechanisms.,Escherichiacoli
KKLIKKILKIL,196,2,5047,Novel short antibacterial and antifungal peptides with low cytotoxicity: Efficacy and action mechanisms.,Escherichiacoli
KILRGVSKKIMRTFLRRISKDILTGKK,197,2,5048,Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens.,Escherichiacoli
VSAVAKVAMKKGAALLKKMGVKISPLK,198,53,5075,Lytic activity and structural differences of amphipathic peptides derived from trialysin.,Trypanosomacruzi
KQLKKVSAVAKVAMKKGAALLKKMGVK,198,53,5076,Lytic activity and structural differences of amphipathic peptides derived from trialysin.,Trypanosomacruzi
VGKVLKQLKKVSAVAKVAMKKGAALLK,198,53,5078,Lytic activity and structural differences of amphipathic peptides derived from trialysin.,Trypanosomacruzi
KFGKIVGKVLKQLKKVSAVAKVAMKKG,198,53,5079,Lytic activity and structural differences of amphipathic peptides derived from trialysin.,Trypanosomacruzi
GKVLDKFGKIVGKVLKQLKKVSAVAKV,198,53,5080,Lytic activity and structural differences of amphipathic peptides derived from trialysin.,Trypanosomacruzi
FKIKPGKVLDKFGKIVGKVLKQLKKVSAVAKV,198,53,5081,Lytic activity and structural differences of amphipathic peptides derived from trialysin.,Trypanosomacruzi
FKIKPGKVLDKFGKIVGKVLKQLKKVS,198,53,5083,Lytic activity and structural differences of amphipathic peptides derived from trialysin.,Trypanosomacruzi
FKIKASKVLDKFGKIVGKVLKQLKKVSAVAKV,198,53,5084,Lytic activity and structural differences of amphipathic peptides derived from trialysin.,Trypanosomacruzi
FSISPGKVLDKFGKIVGKVLKQLKKVSAVAKV,198,53,5085,Lytic activity and structural differences of amphipathic peptides derived from trialysin.,Trypanosomacruzi
GRLRNLIEKAGQNIRGKIQGIGRRIKDILKNLQPRPQV,199,54,5108,The cathelicidin-like peptide derived from panda genome is a potential antimicrobial peptide.,Acinetobactercalcoaceticus
ILENLLARSTNEDREGSIF,200,34,5113,Oyster hemocytes express a proline-rich peptide displaying synergistic antimicrobial activity with a defensin.,Micrococcuslysodeikticus
AKKVFKRLGIGAVLKVLTTG,201,8,5124,"Design of novel analogues with potent antibiotic activity based on the antimicrobial peptide, HP(2-9)-ME(1-12).",Bacillussubtilis
AKKVFKRLGIGAVLWVLTTG,201,8,5126,"Design of novel analogues with potent antibiotic activity based on the antimicrobial peptide, HP(2-9)-ME(1-12).",Bacillussubtilis
AKKVFKRLGIGAVLKVLTWG,201,8,5127,"Design of novel analogues with potent antibiotic activity based on the antimicrobial peptide, HP(2-9)-ME(1-12).",Bacillussubtilis
AKKVFKRLGIGAVLWVLTWG,201,8,5128,"Design of novel analogues with potent antibiotic activity based on the antimicrobial peptide, HP(2-9)-ME(1-12).",Bacillussubtilis
AWKVFKRLGIGAVLWVLTWG,201,8,5129,"Design of novel analogues with potent antibiotic activity based on the antimicrobial peptide, HP(2-9)-ME(1-12).",Bacillussubtilis
AKKVFKRLGIGAVLKVLKKG,201,8,5130,"Design of novel analogues with potent antibiotic activity based on the antimicrobial peptide, HP(2-9)-ME(1-12).",Bacillussubtilis
GFKLKGMARISCLPNGQWSNFPPKCIRECAMVSS,204,3,5159,High therapeutic index of factor C Sushi peptides: potent antimicrobials against Pseudomonas aeruginosa.,Pseudomonasaeruginosa
GFKLKGKAKISCLPNGQWSNFPPKCIRECAMVSS,204,3,5160,High therapeutic index of factor C Sushi peptides: potent antimicrobials against Pseudomonas aeruginosa.,Pseudomonasaeruginosa
HAEHKVKIGVEQKYGQFPQGTEVTYTCSGNYFLM,204,3,5162,High therapeutic index of factor C Sushi peptides: potent antimicrobials against Pseudomonas aeruginosa.,Pseudomonasaeruginosa
HAEHKVKIKVKQKYGQFPQGTEVTYTCSGNYFLM,204,3,5163,High therapeutic index of factor C Sushi peptides: potent antimicrobials against Pseudomonas aeruginosa.,Pseudomonasaeruginosa
AWASFFKKAAHVGKHVGKAALTHYL,205,4,5164,Interaction of pleurocidin and its analogs with phospholipid membrane and their antibacterial activity.,Staphylococcusaureus
GWGSFFKKAAHVAKHVAKAALTHYL,205,4,5165,Interaction of pleurocidin and its analogs with phospholipid membrane and their antibacterial activity.,Staphylococcusaureus
AWASFFKKAAHVAKHVAKAALTHYL,205,4,5166,Interaction of pleurocidin and its analogs with phospholipid membrane and their antibacterial activity.,Staphylococcusaureus
GWGSFFKKAAAVGKAVGKAALTAYL,205,4,5167,Interaction of pleurocidin and its analogs with phospholipid membrane and their antibacterial activity.,Staphylococcusaureus
SADVAGAVIDGASLSFKILKTVLEALGNVKRK,206,1,5168,Structure and activity of the N-terminal region of the eukaryotic cytolysin equinatoxin II.,None_target
GASLSFKILKTVLEALGNVKRK,206,1,5169,Structure and activity of the N-terminal region of the eukaryotic cytolysin equinatoxin II.,None_target
GASLSFKILKTVLEALGNV,206,1,5170,Structure and activity of the N-terminal region of the eukaryotic cytolysin equinatoxin II.,None_target
GSTLACRQSHGSCSFVACRAPSVDIGTCRGGKLKCCKWAPSS,207,55,5180,The beta-defensin gallinacin-6 is expressed in the chicken digestive tract and has antimicrobial activity against food-borne pathogens.,Campylobacterjejuni
KKVADKVLLLKQLRIMRL,208,2,5183,"Solution structure of termite-derived antimicrobial peptide, spinigerin, as determined in SDS micelle by NMR spectroscopy.",Escherichiacoli
GKIPVKAIKQAGKVIGKGLRAINIAGTTHDVVSFFRPKKKKH,209,2,5187,"Solution structure, antibacterial activity, and expression profile of Manduca sexta moricin.",Escherichiacoli
YGAAKKAAKAAKKAAKAA,210,2,5191,Promotion of peptide antimicrobial activity by fatty acid conjugation.,Escherichiacoli
YGAKAKAAKAAKAKAAKA,210,2,5192,Promotion of peptide antimicrobial activity by fatty acid conjugation.,Escherichiacoli
KLFKRHLKWKII,210,2,5193,Promotion of peptide antimicrobial activity by fatty acid conjugation.,Escherichiacoli
RRIRPRPPRLPRPRPRPLPFPRPGPRPIPRPLPFP,212,2,5243,Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates.,Escherichiacoli
PRPPRLPRPRPRPLPFPRPGPRPIPRPLPFP,212,2,5244,Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates.,Escherichiacoli
RRIRPRPPRLPRPRPRPLPFPRP,212,2,5245,Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates.,Escherichiacoli
PRPPRLPRPRPRPLPFPRP,212,2,5246,Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates.,Escherichiacoli
RRIRPRPPRLPRPRPRPL,212,2,5247,Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates.,Escherichiacoli
RRIRPRPPRLPRPRPR,212,2,5248,Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates.,Escherichiacoli
RRIRPRPPRLPRPRP,212,2,5249,Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates.,Escherichiacoli
RRIRPRPPRLPRP,212,2,5250,Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates.,Escherichiacoli
PRPLPFPRPGPRPI,212,2,5251,Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates.,Escherichiacoli
PRPLPFPRPGPRPIPRPLPFPRPGPRPI,212,2,5252,Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates.,Escherichiacoli
GSKGAPCAKKPCCGPLGHYKVDCSTIPDYPCCSKYGFCGSGPQYCG,214,24,5262,The chitin-binding capability of Cy-AMP1 from cycad is essential to antifungal activity.,Fusariumoxysporum
GSKGAPCAKKPCCGPLGHYKVDCSTIPDYPCCGKYGFCGSGPQYCG,214,24,5263,The chitin-binding capability of Cy-AMP1 from cycad is essential to antifungal activity.,Fusariumoxysporum
GSKGAPCAKKPCCGPLGHYKVDCSTIPDYPCCSKVGFCGSGPQYCG,214,24,5264,The chitin-binding capability of Cy-AMP1 from cycad is essential to antifungal activity.,Fusariumoxysporum
GSKGAPCAKKPCCGPLGHYKVDCSTIPDYPCCSKNGFCGSGPQYCG,214,24,5265,The chitin-binding capability of Cy-AMP1 from cycad is essential to antifungal activity.,Fusariumoxysporum
GSKGAPCAKKPCCGPLGHYKVDCSTIPDYPCCSKYGVCGSGPQYCG,214,24,5266,The chitin-binding capability of Cy-AMP1 from cycad is essential to antifungal activity.,Fusariumoxysporum
GSKGAPCAKKPCCGPLGHYKVDCSTIPDYPCCSKYGNCGSGPQYCG,214,24,5267,The chitin-binding capability of Cy-AMP1 from cycad is essential to antifungal activity.,Fusariumoxysporum
GSKGAPCAKKPCCGPLGHYKVDCSTIPDYPCCSKYGFCGSGPQVCG,214,24,5268,The chitin-binding capability of Cy-AMP1 from cycad is essential to antifungal activity.,Fusariumoxysporum
SIGSALKKALPVAKKIGKIALPIAKAALP,215,2,5300,Antibacterial activity and pore-forming properties of ceratotoxins: a mechanism of action based on the barrel stave model.,Escherichiacoli
NWKGIAAMAKKLL,216,1,5301,Design of a novel membrane-destabilizing peptide selectively acting on acidic liposomes.,None_target
SIGSALKKALPVAKKIG,215,2,5302,Antibacterial activity and pore-forming properties of ceratotoxins: a mechanism of action based on the barrel stave model.,Escherichiacoli
GKIALPIAKAALPVAAGLVG,215,2,5303,Antibacterial activity and pore-forming properties of ceratotoxins: a mechanism of action based on the barrel stave model.,Escherichiacoli
KNWKGIAGMAKKLLGENWELM,216,1,5304,Design of a novel membrane-destabilizing peptide selectively acting on acidic liposomes.,None_target
KNWKGIAGMAKKLLGENWKLM,216,1,5305,Design of a novel membrane-destabilizing peptide selectively acting on acidic liposomes.,None_target
KNWKKIAGMAKKLLKKNWKLM,216,1,5307,Design of a novel membrane-destabilizing peptide selectively acting on acidic liposomes.,None_target
KNWKGIAGMAKKLLGKNW,216,1,5308,Design of a novel membrane-destabilizing peptide selectively acting on acidic liposomes.,None_target
KNWKGIAGMAKKLLGKNWELMEK,216,1,5309,Design of a novel membrane-destabilizing peptide selectively acting on acidic liposomes.,None_target
KNWKGIAGMAKKLLGKNWELMKK,216,1,5310,Design of a novel membrane-destabilizing peptide selectively acting on acidic liposomes.,None_target
KNWKGIAGMAKKLLGKNWKLMKK,216,1,5311,Design of a novel membrane-destabilizing peptide selectively acting on acidic liposomes.,None_target
KNWKGIAGMAKKLLGKNWKLM,216,8,5313,Design of a novel membrane-destabilizing peptide selectively acting on acidic liposomes.,Bacillussubtilis
RIIDLLARVRRPQKPKFVTVWVR,217,2,5318,Effects of tryptophan residues of porcine myeloid antibacterial peptide PMAP-23 on antibiotic activity.,Escherichiacoli
RIIDLLWRVRRPQKPKFVTVAVR,217,2,5319,Effects of tryptophan residues of porcine myeloid antibacterial peptide PMAP-23 on antibiotic activity.,Escherichiacoli
ACPIFTKIQGTYRGKAKCK,218,2,5321,Effect of selectively introducing arginine and D-amino acids on the antimicrobial activity and salt sensitivity in analogs of human beta-defensins.,Escherichiacoli
ACPIFTKIQGTYRGRAKCR,218,2,5322,Effect of selectively introducing arginine and D-amino acids on the antimicrobial activity and salt sensitivity in analogs of human beta-defensins.,Escherichiacoli
SCLPKEEQIGKSTRGRKCRRKK,218,2,5325,Effect of selectively introducing arginine and D-amino acids on the antimicrobial activity and salt sensitivity in analogs of human beta-defensins.,Escherichiacoli
GLLCYCRKGHCKRGERVRGTCGIRFLYCCPRR,219,17,5335,Biosynthesis and antimicrobial evaluation of backbone-cyclized ?-defensins.,Listeriamonocytogenes
GWGSFFKKAAHVAKHVGKAALTHYL,220,2,5347,Effects of two glycine residues in positions 13 and 17 of pleurocidin on structure and bacterial cell selectivity.,Escherichiacoli
GWGSFFKKAAHVGKHVAKAALTHYL,220,2,5348,Effects of two glycine residues in positions 13 and 17 of pleurocidin on structure and bacterial cell selectivity.,Escherichiacoli
FSEAIKKIIDFLGEGLFDIIKKIAESF,221,2,5350,"Dimerization of aurein 1.2: effects in structure, antimicrobial activity and aggregation of Candida albicans cells.",Escherichiacoli
GLFDIIKKIAESFKFSEAIKKIIDFLG,221,2,5351,"Dimerization of aurein 1.2: effects in structure, antimicrobial activity and aggregation of Candida albicans cells.",Escherichiacoli
GIIKVIKSLIEQFTGK,222,56,5353,Novel phenol-soluble modulin derivatives in community-associated methicillin-resistant Staphylococcus aureus identified through imaging mass spectrometry.,Staphylococcusepidermidis
VGTIIKIIKAIIDIFAK,222,56,5355,Novel phenol-soluble modulin derivatives in community-associated methicillin-resistant Staphylococcus aureus identified through imaging mass spectrometry.,Staphylococcusepidermidis
RRRRRRPPCEDVNGQCQPRGNPCLRLRGACPRGSRCCMPTVAAH,223,2,5357,Structure and antimicrobial activity of platypus 'intermediate' defensin-like peptide.,Escherichiacoli
RRPPCEDVNGQCQPRGNPCLRLRGACPRGSRCCMPTVAAH,223,2,5358,Structure and antimicrobial activity of platypus 'intermediate' defensin-like peptide.,Escherichiacoli
GIRKWFKKAAHVGKEVGKVALNACL,224,57,5361,The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents.,Humanpromyelocytic
GLPKCGETCVGGTCNTPGCTCSWPVCTRN,225,1,5376,Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.,None_target
GLPVCGDTCVGGTCNTPGCTCSWPVCTRN,225,1,5377,Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.,None_target
GLPVCGEKCVGGTCNTPGCTCSWPVCTRN,225,1,5378,Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.,None_target
GLPVCGETCKGGTCNTPGCTCSWPVCTRN,225,1,5379,Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.,None_target
GLPVCGETCVGGTCKTPGCTCSWPVCTRN,225,1,5380,Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.,None_target
GLPVCGETCVGGTCNKPGCTCSWPVCTRN,225,1,5381,Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.,None_target
GLPVCGETCVGGTCNTPGCKCSWPVCTRN,225,1,5382,Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.,None_target
GLPVCGETCVGGTCNTPGCTCSWPKCTRN,225,1,5384,Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.,None_target
GLPVCGETCVGGTCNTPGCTCSWPVCTRK,225,1,5386,Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.,None_target
GLPVCGETCVGGTCNTPGCTCSKPVCTRN,225,1,5388,Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.,None_target
GLPVCGETCVGGTCNTPGCNCSWPVCTRK,225,1,5389,Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.,None_target
GLPVCGETCVGGTCNTPGCTCSWPVCTKN,225,1,5391,Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.,None_target
GLPVCGETCVGGTCNTPGCTCSWPVCTRN,225,1,5392,Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.,None_target
FGTGVKRKAQCDLKSK,226,2,5412,Mining antimicrobial peptides from small open reading frames in Ciona intestinalis.,Escherichiacoli
GIGRIGKVHAANLIKIPKG,226,2,5413,Mining antimicrobial peptides from small open reading frames in Ciona intestinalis.,Escherichiacoli
KKVIIEYVKIEA,226,2,5414,Mining antimicrobial peptides from small open reading frames in Ciona intestinalis.,Escherichiacoli
VKEEVKFSKKW,226,2,5415,Mining antimicrobial peptides from small open reading frames in Ciona intestinalis.,Escherichiacoli
KFKLKSLKIIEYKQ,226,2,5416,Mining antimicrobial peptides from small open reading frames in Ciona intestinalis.,Escherichiacoli
GIGKFLKKAKKFGKAFVKILKK,227,1,5419,Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides.,None_target
AIFIFIRWLLK,228,8,5420,"Salusin-beta, an antimicrobially active peptide against Gram-positive bacteria.",Bacillussubtilis
AIFIFIRWLLKLGHHGR,228,8,5421,"Salusin-beta, an antimicrobially active peptide against Gram-positive bacteria.",Bacillussubtilis
RWLLKLGHHGR,228,8,5422,"Salusin-beta, an antimicrobially active peptide against Gram-positive bacteria.",Bacillussubtilis
RWLLKLGHHGRAPP,228,8,5423,"Salusin-beta, an antimicrobially active peptide against Gram-positive bacteria.",Bacillussubtilis
KLGHHGRAPP,228,8,5424,"Salusin-beta, an antimicrobially active peptide against Gram-positive bacteria.",Bacillussubtilis
KQSHKKGGHSFPKEKIS,229,2,5438,Unraveling the antifungal activity of a South American rattlesnake toxin crotamine.,Escherichiacoli
KMDSRWRWKSSKK,229,2,5439,Unraveling the antifungal activity of a South American rattlesnake toxin crotamine.,Escherichiacoli
MASRAAGLAARLARLALRAL,230,25,5452,Modification of a synthetic antimicrobial peptide (ESF1) for improved inhibitory activity.,Bacilluscereus
MASRAARLAARLARLALRAL,230,58,5453,Modification of a synthetic antimicrobial peptide (ESF1) for improved inhibitory activity.,Carnobacteriummobile
MAARAARLAARLARLALRAL,230,58,5454,Modification of a synthetic antimicrobial peptide (ESF1) for improved inhibitory activity.,Carnobacteriummobile
LGRVDIHVWDGVYI,231,1,5457,Therapeutic potential of peptides with neutralizing ability towards the venom and toxin (CaTx-I) of crotalus adamanteus.,None_target
VDIHVWDGVVDIHVWDGV,231,1,5458,Therapeutic potential of peptides with neutralizing ability towards the venom and toxin (CaTx-I) of crotalus adamanteus.,None_target
VDIHVWDGV,231,1,5459,Therapeutic potential of peptides with neutralizing ability towards the venom and toxin (CaTx-I) of crotalus adamanteus.,None_target
VDIHVWAGV,231,1,5461,Therapeutic potential of peptides with neutralizing ability towards the venom and toxin (CaTx-I) of crotalus adamanteus.,None_target
VDIHVWSGV,231,1,5462,Therapeutic potential of peptides with neutralizing ability towards the venom and toxin (CaTx-I) of crotalus adamanteus.,None_target
VDIHVWEGV,231,1,5463,Therapeutic potential of peptides with neutralizing ability towards the venom and toxin (CaTx-I) of crotalus adamanteus.,None_target
VEIHVWEGV,231,1,5464,Therapeutic potential of peptides with neutralizing ability towards the venom and toxin (CaTx-I) of crotalus adamanteus.,None_target
CVDIHVWDGVC,231,1,5465,Therapeutic potential of peptides with neutralizing ability towards the venom and toxin (CaTx-I) of crotalus adamanteus.,None_target
RAGLQFPVGRLLRRLLR,232,1,5466,"A cancer specific cell-penetrating peptide, BR2, for the efficient delivery of an scFv into cancer cells.",None_target
GSKKPVPIIYCNRRSGKCQRM,233,2,5467,Effects of cations and pH on antimicrobial activity of thanatin and s-thanatin against Escherichia coli ATCC25922 and B. subtilis ATCC 21332.,Escherichiacoli
GILKTIKSIASKVANTVQKLKRKAKNAVA,234,59,5468,Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin.,Acinetobacterbaumannii
GILKTIKSIASKVANTVQKLKRKAKNAV,234,59,5469,Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin.,Acinetobacterbaumannii
IKSIASKVANTVQKLKRKAKNAV,234,4,5470,Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin.,Staphylococcusaureus
IKSIASKVANTVQKLKRKAKNAVA,234,4,5471,Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin.,Staphylococcusaureus
IASKVANTVQKLKRKAKNAV,234,4,5472,Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin.,Staphylococcusaureus
IASKVANTVQKLKRKAKNAVA,234,4,5473,Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin.,Staphylococcusaureus
KVANTVQKLKRKAKNAV,234,4,5474,Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin.,Staphylococcusaureus
KVANTVQKLKRKAKNAVA,234,4,5475,Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin.,Staphylococcusaureus
GILKTIKSIASKLKRKAK,234,2,5476,Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin.,Escherichiacoli
GILNTIKSIASKLKRKAK,234,2,5477,Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin.,Escherichiacoli
KLKRKAKNAV,234,4,5478,Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin.,Staphylococcusaureus
KLKRKAKNAVA,234,4,5479,Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin.,Staphylococcusaureus
KKLKKLKKKWKKLKKKLK,235,4,5491,Design and synthesis of amphiphilic alpha-helical model peptides with systematically varied hydrophobic-hydrophilic balance and their interaction with lipid- and bio-membranes.,Staphylococcusaureus
KKLKKLLKKWKKLLKKLK,235,4,5492,Design and synthesis of amphiphilic alpha-helical model peptides with systematically varied hydrophobic-hydrophilic balance and their interaction with lipid- and bio-membranes.,Staphylococcusaureus
KLLKKLLKLWKKLLKKLK,235,4,5493,Design and synthesis of amphiphilic alpha-helical model peptides with systematically varied hydrophobic-hydrophilic balance and their interaction with lipid- and bio-membranes.,Staphylococcusaureus
KLLKLLLKLWKKLLKLLK,235,4,5495,Design and synthesis of amphiphilic alpha-helical model peptides with systematically varied hydrophobic-hydrophilic balance and their interaction with lipid- and bio-membranes.,Staphylococcusaureus
KLLKLLLKLWLKLLKLLL,235,4,5496,Design and synthesis of amphiphilic alpha-helical model peptides with systematically varied hydrophobic-hydrophilic balance and their interaction with lipid- and bio-membranes.,Staphylococcusaureus
AGYLLGKINLKALAALAKKIL,236,43,5499,Cell-penetrating peptide TP10 shows broad-spectrum activity against both Plasmodium falciparum and Trypanosoma brucei brucei.,Plasmodiumfalciparum
KWKSFLKKLTSAAKKVLTTALKPISS,237,2,5520,Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides.,Escherichiacoli
KWKSFLKTLKSPVKTVFYTALKPISS,237,2,5521,Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides.,Escherichiacoli
KWKSFLKTFKSPVKTVFYTALKPISS,237,2,5522,Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides.,Escherichiacoli
KWKSFLKTFKSPARTVLYTALKPISS,237,2,5523,Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides.,Escherichiacoli
KWKSFLKTFKSPARTVLHTALKPISS,237,2,5524,Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides.,Escherichiacoli
KFFKFFKFF,238,2,5541,Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria.,Escherichiacoli
AVVKVPLKKFKSIRE,239,8,5548,"Antimicrobial peptides derived from pepsinogens in the stomach of the bullfrog, Rana catesbeiana.",Bacillussubtilis
AVVKVPLKKFKSIRETMKEKGLLEDF,239,8,5549,"Antimicrobial peptides derived from pepsinogens in the stomach of the bullfrog, Rana catesbeiana.",Bacillussubtilis
CVYAYVRVRGVLVRYRRCW,240,50,5582,The characteristic region of arenicin-1 involved with a bacterial membrane targeting mechanism.,Enterococcusfaecium
RWCVYAYVRVAGVLVRYRRCW,240,50,5583,The characteristic region of arenicin-1 involved with a bacterial membrane targeting mechanism.,Enterococcusfaecium
KKKKGIGKFLHSAKKFGKAFVGEIMNS,241,2,5611,Augmentation of the antibacterial activity of magainin by positive-charge chain extension.,Escherichiacoli
KKKKKKKKKKGIGKFLHSAKKFGKAFVGEIMNS,241,2,5612,Augmentation of the antibacterial activity of magainin by positive-charge chain extension.,Escherichiacoli
AAAAAAAAAAGIGKFLHSAKKFGKAFVGEIMNS,241,2,5613,Augmentation of the antibacterial activity of magainin by positive-charge chain extension.,Escherichiacoli
RRRRRRRRRRGIGKFLHSAKKFGKAFVGEIMNS,241,2,5614,Augmentation of the antibacterial activity of magainin by positive-charge chain extension.,Escherichiacoli
KKKKKKKKKKKKKKKKKKKKGIGKFLHSAKKFGKAFVGEIMNS,241,2,5615,Augmentation of the antibacterial activity of magainin by positive-charge chain extension.,Escherichiacoli
GIGKFLHSAKKFGKAFVGEIMNSKKKKKKKKKK,241,2,5616,Augmentation of the antibacterial activity of magainin by positive-charge chain extension.,Escherichiacoli
KKFLHSAKKWLKAFVKLFKNW,241,2,5617,Augmentation of the antibacterial activity of magainin by positive-charge chain extension.,Escherichiacoli
GIGKLFLHAAKKFAKAFVAEKMNS,241,2,5618,Augmentation of the antibacterial activity of magainin by positive-charge chain extension.,Escherichiacoli
KKKKKKKKKKGIGKLFLHAAKKFAKAFVAEKMNS,241,2,5619,Augmentation of the antibacterial activity of magainin by positive-charge chain extension.,Escherichiacoli
SPIHARYQRGVIPGPRWPYYRVGSGSGLKSVRNRWA,242,42,5621,Expression in Pichia Pastoris and biological activity of Avian ?-defensin 6 and its mutant peptide without cysteines.,Salmonellatyphimurium
GFFALIPKIISSPLFKTLLSAV,243,2,5629,"A class of highly potent antibacterial peptides derived from pardaxin, a pore-forming peptide isolated from Moses sole fish Pardachirus marmoratus.",Escherichiacoli
ISSPLFKTLLSAVGSALSSSGGQE,243,2,5631,"A class of highly potent antibacterial peptides derived from pardaxin, a pore-forming peptide isolated from Moses sole fish Pardachirus marmoratus.",Escherichiacoli
GFFALIPKIIS,243,2,5632,"A class of highly potent antibacterial peptides derived from pardaxin, a pore-forming peptide isolated from Moses sole fish Pardachirus marmoratus.",Escherichiacoli
PKLLKTFLSKWIG,244,2,5639,Biological activities of retro and diastereo analogs of a 13-residue peptide with antimicrobial and hemolytic activities.,Escherichiacoli
GIWKSLFTKLLKG,244,2,5640,Biological activities of retro and diastereo analogs of a 13-residue peptide with antimicrobial and hemolytic activities.,Escherichiacoli
FLPLLAGLCKITRKCAANFLPKIF,245,2,5645,Structure-function studies on the amphibian peptide brevinin 1E: translocating the cationic segment from the C-terminal end to a central position favors selective antibacterial activity.,Escherichiacoli
CKLLKTFLSKWIC,246,2,5657,Consequences of introducing a disulfide bond into an antibacterial and hemolytic peptide.,Escherichiacoli
PKLLKKFLKKWIG,247,2,5661,"Addition and omission analogs of the 13-residue antibacterial and hemolytic peptide PKLLKTFLSKWIG: structural preferences, model membrane binding and biological activities.",Escherichiacoli
PKLLKTFLSKWKKIG,247,2,5662,"Addition and omission analogs of the 13-residue antibacterial and hemolytic peptide PKLLKTFLSKWIG: structural preferences, model membrane binding and biological activities.",Escherichiacoli
PKLLKFLSKWIG,247,2,5663,"Addition and omission analogs of the 13-residue antibacterial and hemolytic peptide PKLLKTFLSKWIG: structural preferences, model membrane binding and biological activities.",Escherichiacoli
PKLLKTFLKWIG,247,2,5664,"Addition and omission analogs of the 13-residue antibacterial and hemolytic peptide PKLLKTFLSKWIG: structural preferences, model membrane binding and biological activities.",Escherichiacoli
PKLKTFLSKWIG,247,2,5665,"Addition and omission analogs of the 13-residue antibacterial and hemolytic peptide PKLLKTFLSKWIG: structural preferences, model membrane binding and biological activities.",Escherichiacoli
PKLLKFLKWIG,247,2,5666,"Addition and omission analogs of the 13-residue antibacterial and hemolytic peptide PKLLKTFLSKWIG: structural preferences, model membrane binding and biological activities.",Escherichiacoli
PKLKFLSKWIG,247,2,5667,"Addition and omission analogs of the 13-residue antibacterial and hemolytic peptide PKLLKTFLSKWIG: structural preferences, model membrane binding and biological activities.",Escherichiacoli
SLFGTFAKMALKGASKLIPHLLPSRQQ,248,2,5709,Origin and functional diversification of an amphibian defense peptide arsenal.,Escherichiacoli
GVFGLLAKAALKGASKLIPHLLPSRQQ,248,2,5710,Origin and functional diversification of an amphibian defense peptide arsenal.,Escherichiacoli
GLKEVAHSAKKFAKGFISGLTGS,248,2,5713,Origin and functional diversification of an amphibian defense peptide arsenal.,Escherichiacoli
GWLPTFGKILRKAMQLGPKLIQPI,248,2,5715,Origin and functional diversification of an amphibian defense peptide arsenal.,Escherichiacoli
GVWSTILGGLKKFAKGGLDAIVNPK,248,2,5716,Origin and functional diversification of an amphibian defense peptide arsenal.,Escherichiacoli
GFMSKVANFAKKFAKGGVNAIMNQK,248,2,5718,Origin and functional diversification of an amphibian defense peptide arsenal.,Escherichiacoli
GMATKAGTAFGKAAKAIIGAAL,248,2,5720,Origin and functional diversification of an amphibian defense peptide arsenal.,Escherichiacoli
FSPQMLQDIIEKKTKIL,249,31,5724,Functional analysis of an alpha-helical antimicrobial peptide derived from a novel mouse defensin-like gene.,Humanlung
FSPQMLQDIIEAATAIL,249,31,5725,Functional analysis of an alpha-helical antimicrobial peptide derived from a novel mouse defensin-like gene.,Humanlung
GFREKHFQRFVKYAVPESTLR,250,60,5727,"MeuTXKbeta1, a scorpion venom-derived two-domain potassium channel toxin-like peptide with cytolytic activity",Stenotrophomonassp.
TVLQTVVHKVGKTQFGCPAYQGYCDDHCQDIEKKEGFCHGFKCKCGIPMGF,250,60,5728,"MeuTXKbeta1, a scorpion venom-derived two-domain potassium channel toxin-like peptide with cytolytic activity",Stenotrophomonassp.
LLAIVGNLLKSLL,251,4,5733,"Design, structural and functional characterization of a Temporin-1b analog active against Gram-negative bacteria.",Staphylococcusaureus
LLPIVANLLKSLL,251,4,5734,"Design, structural and functional characterization of a Temporin-1b analog active against Gram-negative bacteria.",Staphylococcusaureus
LLPIVGALLKSLL,251,4,5735,"Design, structural and functional characterization of a Temporin-1b analog active against Gram-negative bacteria.",Staphylococcusaureus
LLPIVGNLLKALL,251,4,5737,"Design, structural and functional characterization of a Temporin-1b analog active against Gram-negative bacteria.",Staphylococcusaureus
LLPIVVNLLKSLL,251,4,5738,"Design, structural and functional characterization of a Temporin-1b analog active against Gram-negative bacteria.",Staphylococcusaureus
LLPIVINLLKSLL,251,4,5739,"Design, structural and functional characterization of a Temporin-1b analog active against Gram-negative bacteria.",Staphylococcusaureus
LLPIVANLLKALL,251,4,5740,"Design, structural and functional characterization of a Temporin-1b analog active against Gram-negative bacteria.",Staphylococcusaureus
KKLLPIVANLLKSLL,251,4,5741,"Design, structural and functional characterization of a Temporin-1b analog active against Gram-negative bacteria.",Staphylococcusaureus
KLVKWIIKTVNKFTKK,252,2,5745,Conformation and activity of delta-lysin and its analogs.,Escherichiacoli
KLPKWIIKTVNKFTKK,252,2,5746,Conformation and activity of delta-lysin and its analogs.,Escherichiacoli
IGKLVKWIIKTVNKFTKK,252,2,5747,Conformation and activity of delta-lysin and its analogs.,Escherichiacoli
IGKLPKWIIKTVNKFTKK,252,2,5748,Conformation and activity of delta-lysin and its analogs.,Escherichiacoli
STIGKLVKWIIKTVNKFTKK,252,2,5749,Conformation and activity of delta-lysin and its analogs.,Escherichiacoli
STIGKLPKWIIKTVNKFTKK,252,2,5750,Conformation and activity of delta-lysin and its analogs.,Escherichiacoli
IISTIGKLVKWIIKTVNKFTKK,252,2,5751,Conformation and activity of delta-lysin and its analogs.,Escherichiacoli
IISTIGKLPKWIIKTVNKFTKK,252,2,5752,Conformation and activity of delta-lysin and its analogs.,Escherichiacoli
AQKIISTIGKLVKWIIKTVNKFTKK,252,2,5753,Conformation and activity of delta-lysin and its analogs.,Escherichiacoli
AQKIISTIGKLPKWIIKTVNKFTKK,252,2,5754,Conformation and activity of delta-lysin and its analogs.,Escherichiacoli
MAQKIISTIGKLVKWIIKTVNKFTKK,252,2,5755,Conformation and activity of delta-lysin and its analogs.,Escherichiacoli
MAQKIISTIGKLPKWIIKTVNKFTKK,252,2,5756,Conformation and activity of delta-lysin and its analogs.,Escherichiacoli
IISTIGDLVKWIIDTV,253,2,5767,Generation of analogs having potent antimicrobial and hemolytic activities with minimal changes from an inactive 16-residue peptide corresponding to the helical region of Staphylococcus aureus delta-toxin.,Escherichiacoli
IISTIGKLVKWIIDTV,253,2,5768,Generation of analogs having potent antimicrobial and hemolytic activities with minimal changes from an inactive 16-residue peptide corresponding to the helical region of Staphylococcus aureus delta-toxin.,Escherichiacoli
IISTIGDLVKWIIKTV,253,2,5769,Generation of analogs having potent antimicrobial and hemolytic activities with minimal changes from an inactive 16-residue peptide corresponding to the helical region of Staphylococcus aureus delta-toxin.,Escherichiacoli
IISTIGKLVKWIIKTV,253,2,5770,Generation of analogs having potent antimicrobial and hemolytic activities with minimal changes from an inactive 16-residue peptide corresponding to the helical region of Staphylococcus aureus delta-toxin.,Escherichiacoli
HTCHFRRRPKVRKFKLYHEGKFWCPG,254,8,5777,Characterization of two isoforms of antiliopolysacchride factors (Sp-ALFs) from the mud crab Scylla paramamosain.,Bacillussubtilis
HTCHIRRRPKFRKFKLYHEGKFWCPG,254,8,5778,Characterization of two isoforms of antiliopolysacchride factors (Sp-ALFs) from the mud crab Scylla paramamosain.,Bacillussubtilis
YVPKIPKPQPNKPNFPSFPGHGPFNPHASRFPR,255,60,5784,Characterization of a chimeric antimicrobial peptide uncovers evolutionary significance of exon-shuffling.,Stenotrophomonassp.
PIPRPLPFPRPGPRPIPRPLPFPRPGPRPIPRP,256,2,5819,Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7.,Escherichiacoli
PLPFPRPGPRPIPRPLPFPRPGPRPIPRP,256,2,5820,Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7.,Escherichiacoli
PLPFPRPGPRPIPRP,256,2,5821,Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7.,Escherichiacoli
RRIRPRPPRLPRPRPRPLPFPRPG,256,2,5822,Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7.,Escherichiacoli
RRIRPRPPRLPRPRPRP,256,2,5823,Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7.,Escherichiacoli
PRPPRLPRPRPRPLPFPRPG,256,2,5825,Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7.,Escherichiacoli
PPRLPRPRPRPLPFPRPG,256,2,5826,Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7.,Escherichiacoli
RLPRPRPRPLPFPRPG,256,2,5827,Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7.,Escherichiacoli
PRPRPRPLPFPRPG,256,2,5829,Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7.,Escherichiacoli
PRPRPLPFPRPG,256,2,5830,Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7.,Escherichiacoli
PRPLPFPRPG,256,2,5831,Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7.,Escherichiacoli
FWGALAKGALKLIGSLFSSFSKKD,257,2,5842,Characterization of antibacterial and hemolytic activity of synthetic pandinin 2 variants and their inhibition against Mycobacterium tuberculosis.,Escherichiacoli
FWGALAKGALKLIGPGSLFSSFSKKD,257,2,5843,Characterization of antibacterial and hemolytic activity of synthetic pandinin 2 variants and their inhibition against Mycobacterium tuberculosis.,Escherichiacoli
FWGLKGLKKFSKKL,257,2,5844,Characterization of antibacterial and hemolytic activity of synthetic pandinin 2 variants and their inhibition against Mycobacterium tuberculosis.,Escherichiacoli
FWGLKGLKGPGKFSKKL,257,2,5845,Characterization of antibacterial and hemolytic activity of synthetic pandinin 2 variants and their inhibition against Mycobacterium tuberculosis.,Escherichiacoli
ARLKKCFNKVTGYCRKKCKVGERYEIGCLSGKLCCAN,258,2,5855,Engineering disulfide bonds of the novel human beta-defensins hBD-27 and hBD-28: differences in disulfide formation and biological activity among human beta-defensins.,Escherichiacoli
EQLKKCWNNYVQGHCRKICRVNEVPEALCENGRYCCLNIK,258,2,5856,Engineering disulfide bonds of the novel human beta-defensins hBD-27 and hBD-28: differences in disulfide formation and biological activity among human beta-defensins.,Escherichiacoli
LQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK,258,2,5857,Engineering disulfide bonds of the novel human beta-defensins hBD-27 and hBD-28: differences in disulfide formation and biological activity among human beta-defensins.,Escherichiacoli
LVQRGRFGRFLRKIRRFRPKVTITIQGSARF,259,2,5859,"The central kink region of fowlicidin-2, an alpha-helical host defense peptide, is critically involved in bacterial killing and endotoxin neutralization.",Escherichiacoli
LVQRGRFGRFLRKI,259,2,5860,"The central kink region of fowlicidin-2, an alpha-helical host defense peptide, is critically involved in bacterial killing and endotoxin neutralization.",Escherichiacoli
LVQRGRFGRFLRKIR,259,2,5861,"The central kink region of fowlicidin-2, an alpha-helical host defense peptide, is critically involved in bacterial killing and endotoxin neutralization.",Escherichiacoli
LVQRGRFGRFLRKIRRFR,259,2,5862,"The central kink region of fowlicidin-2, an alpha-helical host defense peptide, is critically involved in bacterial killing and endotoxin neutralization.",Escherichiacoli
RRFRPKVTITIQGSARF,259,2,5863,"The central kink region of fowlicidin-2, an alpha-helical host defense peptide, is critically involved in bacterial killing and endotoxin neutralization.",Escherichiacoli
PKVTITIQGSARF,259,2,5864,"The central kink region of fowlicidin-2, an alpha-helical host defense peptide, is critically involved in bacterial killing and endotoxin neutralization.",Escherichiacoli
TYMPVEEGEYIVNISYADQPKKNSPFTAKKQPGPKVDLSGVKAYGPG,260,56,5865,A novel antifungal peptide designed from the primary structure of a natural antimicrobial peptide purified from Argopecten purpuratus hemocytes.,Staphylococcusepidermidis
MPVGIVIAPKKSPFTAKKPGPVLSGVKAGPG,260,56,5866,A novel antifungal peptide designed from the primary structure of a natural antimicrobial peptide purified from Argopecten purpuratus hemocytes.,Staphylococcusepidermidis
RICSRGKNCVSRPGVGSIIGRPGGGSLIGRPGGGSV,261,2,5875,"Identification of a novel cathelicidin gene in the rainbow trout, Oncorhynchus mykiss.",Escherichiacoli
YVRTCMIKKEGWGKCLIDTTCAHSCKNRGYIGGDCKTCYCLVNC,262,24,5878,Cloning and functional expression of a mungbean defensin VrD1 in Pichia pastoris.,Fusariumoxysporum
SSMKLSFRARAYGFRGPGPQL,263,18,5879,New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A.,Micrococcusluteus
SSMKLSFRARAYGFRGPGLQL,263,18,5880,New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A.,Micrococcusluteus
SSMKLSFRARAYSFRGPGPQL,263,18,5881,New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A.,Micrococcusluteus
KPYLKRFQVYYKGRMWC,264,15,5890,Recombinant expression and anti-microbial activity of anti-lipopolysaccharide factor (ALF) from the black tiger shrimp Penaeus monodon.,Aerococcusviridans
QLLIRMIYKNILFYLVPGPGHGAEPERRNIKYL,265,61,5891,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1
VAPIAKYLATALAKWALKQGFAKLKS,266,2,5892,BTM-P1 polycationic peptide biological activity and 3D-dimensional structure.,Escherichiacoli
RMIYKNILFYLVPGPGHGAEPERRNIKYL,265,61,5893,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1
QLLIRMIYKNI,265,61,5894,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1
LFYLVPGPGHG,265,61,5895,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1
AEPERRNIKYL,265,61,5896,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1
YQLLIRMIYKNI,265,61,5897,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1
YALLIRMIYKNI,265,61,5898,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1
YQALIRMIYKNI,265,61,5899,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1
YQLAIRMIYKNI,265,61,5900,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1
YQLLARMIYKNI,265,61,5901,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1
YQLLIAMIYKNI,265,61,5902,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1
YQLLIRAIYKNI,265,61,5903,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1
YQLLIRMAYKNI,265,61,5904,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1
YQLLIRMIAKNI,265,61,5905,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1
YQLLIRMIYANI,265,61,5906,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1
YQLLIRMIYKAI,265,61,5907,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1
YQLLIRMIYKNA,265,61,5908,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1
MWKWFHNVLSSWQLLADKRPARDYNRK,267,62,5909,Functional and structural characteristics of anticancer peptide Pep27 analogues.,Acutemyeloid
MWKWFHNVLSWWWLLADKRPARDYNRK,267,62,5910,Functional and structural characteristics of anticancer peptide Pep27 analogues.,Acutemyeloid
MRKWFHNVLSSGQLLADKWPAWDYNWK,267,62,5911,Functional and structural characteristics of anticancer peptide Pep27 analogues.,Acutemyeloid
MWKEFHNVLSSGQLLADKRWARWYNRW,267,62,5912,Functional and structural characteristics of anticancer peptide Pep27 analogues.,Acutemyeloid
MWKWFHNVLSSGQLLADKWWAWWYNWW,267,62,5913,Functional and structural characteristics of anticancer peptide Pep27 analogues.,Acutemyeloid
YQLLIRMIY,265,61,5915,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1
YQLLIRMI,265,61,5916,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1
YQLLIRPIYKNI,265,61,5918,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1
LSELDDRADALQAGASQFETSAAKLKRKYWWKN,265,61,5919,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1
GVLDILKGAAKDLAGHVATKVI,268,4,5933,Antimicrobial peptide from the skin secretion of the frog Leptodactylus syphax.,Staphylococcusaureus
GVLDILKGAAKDLAGH,268,4,5934,Antimicrobial peptide from the skin secretion of the frog Leptodactylus syphax.,Staphylococcusaureus
MTPFWRGVSLRPIGASCRDDSECITRLCRKRRCSLSVAQE,269,8,5950,Structure-activity relationship of human liver-expressed antimicrobial peptide 2.,Bacillussubtilis
SNQGGSPLPRSV,270,61,5965,Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,HIV-1
LPLPAPSFHRTT,270,61,5966,Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,HIV-1
KPKQIKPPLPSV,270,61,5967,Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,HIV-1
AMDPTKYYGNGVYCNSKKCWVDWGQASGCIGQTVVGGWLGGAIPGKC,271,17,5974,In vivo activities of recombinant divercin V41 and its structural variants against Listeria monocytogenes.,Listeriamonocytogenes
AMDPTKYYGNGVYCNSKKCWVDFGQASGCIGQTVVGGWLGGAIPGKC,271,17,5975,In vivo activities of recombinant divercin V41 and its structural variants against Listeria monocytogenes.,Listeriamonocytogenes
AMDPTKYYGNGVYCNSKKCWVDWGSASGCIGQTVVGGWLGGAIPGKC,271,17,5976,In vivo activities of recombinant divercin V41 and its structural variants against Listeria monocytogenes.,Listeriamonocytogenes
AMDPTKYYGNGVYCNSKKCWVDWGQGSGCIGQTVVGGWLGGAIPGKC,271,17,5977,In vivo activities of recombinant divercin V41 and its structural variants against Listeria monocytogenes.,Listeriamonocytogenes
AMDPTKYYGNGVYCNSKKCWVDWGQASGCIGQTVVGGWLGGAIVGKC,271,17,5978,In vivo activities of recombinant divercin V41 and its structural variants against Listeria monocytogenes.,Listeriamonocytogenes
KFRRQRPRLSHKGPMPF,272,5,5981,Apelin peptides block the entry of human immunodeficiency virus (HIV).,HIV
RPRLSHKGPMPF,272,5,5983,Apelin peptides block the entry of human immunodeficiency virus (HIV).,HIV
PRLSHKGPMPF,272,5,5984,Apelin peptides block the entry of human immunodeficiency virus (HIV).,HIV
APKEWMEWDREINNYTSLIHSLIKQGI,273,61,5986,Design of a peptide inhibitor that blocks the cell fusion mediated by glycoprotein 41 of human immunodeficiency virus type 1.,HIV-1
APKEWMAWAREIAAYAKLIAALI,273,61,5987,Design of a peptide inhibitor that blocks the cell fusion mediated by glycoprotein 41 of human immunodeficiency virus type 1.,HIV-1
APKEWMAWAREIAAYAKLIAALIKQGI,273,61,5988,Design of a peptide inhibitor that blocks the cell fusion mediated by glycoprotein 41 of human immunodeficiency virus type 1.,HIV-1
KILEPFRKQNPDIVIYQYMD,274,61,5991,Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,HIV-1
SPAIFQSSMTKILEPFRKQN,274,61,5992,Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,HIV-1
PDIVIYQYMDDLYVGSDLEI,274,61,5993,Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,HIV-1
ELVNQIIEQLIKKEKVYLAW,274,61,5994,Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,HIV-1
IQAQPDQSESELVNQIIEQL,274,61,5995,Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,HIV-1
IKKEKVYLAWVPAHKGIGN,274,61,5996,Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,HIV-1
FRKQNPDIVIYQYMD,274,61,5997,Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,HIV-1
NQIIEQLIKKEKVY,274,61,5999,Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,HIV-1
ESELVSQIIEQLIKK,274,61,6000,Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,HIV-1
AEAMSQVTN,275,61,6010,Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.,HIV-1
AAAMSQVTN,275,61,6011,Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.,HIV-1
AEAASQVTN,275,61,6012,Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.,HIV-1
AEAMAQVTN,275,61,6013,Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.,HIV-1
AEAMSQVAN,275,61,6014,Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.,HIV-1
AEAMSQVT,275,61,6015,Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.,HIV-1
VTNTATIM,275,61,6020,Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.,HIV-1
AEAMSQVTNTATIM,275,61,6021,Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.,HIV-1
AEAASQVTNTATIM,275,61,6022,Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.,HIV-1
AEASQVTNTATIM,275,61,6023,Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.,HIV-1
AEAMSQVANTATIM,275,61,6024,Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.,HIV-1
TYGDTWAGVEAIIRI,276,61,6026,Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).,HIV-1
HFPRIWLHSLGQHIY,276,61,6027,Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).,HIV-1
TWAGVEAIIRILQQL,276,61,6028,Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).,HIV-1
VEAIIRILQQLLFIH,276,61,6029,Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).,HIV-1
IRILQQLLFIHFRIG,276,61,6030,Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).,HIV-1
QQLLFIHFRIGCQHS,276,61,6031,Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).,HIV-1
FIHFRIGCQHSRIGI,276,61,6032,Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).,HIV-1
KGEAMHGQVDCSPGIWQLDC,277,61,6033,Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.,HIV-1
ASCDKCQLKGEAMHG,277,61,6034,Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.,HIV-1
KCQLKGEAMHGQVDC,277,61,6035,Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.,HIV-1
KGEAMHGQVDCSPGI,277,61,6036,Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.,HIV-1
MHGQVDCSPGIWQLD,277,61,6037,Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.,HIV-1
VDCSPGIWQLDCTHL,277,61,6038,Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.,HIV-1
PGIWQLDCTHLEGKI,277,61,6039,Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.,HIV-1
FTQGVGNPVSCARNKGICVPSRCPGNNRQIGTCLGPPVKCCRRK,278,4,6040,Molecular cloning and characterization of lingual antimicrobial peptide cDNA of Bubalus bubalis.,Staphylococcusaureus
FKCRRWQWRMKKLGKRSKNKGFKEQAKSLLKWILD,279,63,6041,Bactericidal activity of LFchimera is stronger and less sensitive to ionic strength than its constituent lactoferricin and lactoferrampin peptides.,Aggregatibacteractinomycetemcomitans
WKLFKKILKVL,280,24,6043,Sporicidal activity of synthetic antifungal undecapeptides and control of Penicillium rot of apples.,Fusariumoxysporum
YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF,281,30,6056,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB
WQEWEQKITALLEQAQIQQEKNEYELQKLDKWASLWEWF,281,30,6058,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB
MTWMEWDREINNYTSLIHSLIEESQNQQEKNEQELL,281,30,6060,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB
MTWMEWDREINNYTSLIHSLIEESQNQQEKNEQELLEL,281,30,6061,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB
TTWEEWDREINEYTSRIESLIRESQEQQEKNEQELREL,281,30,6062,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB
MTWMAWDRAIANYAALIHALIEAAQNQQEKNEAALLEL,281,30,6064,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB
TTWEAWDRAIAEYAARIEALIRASQEQQEKNEAELREL,281,30,6066,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB
TTWEAWDRAIAEYAARIEALIRAAQEQQEKNEAALREL,281,30,6067,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB
ILGPVLGLVSRTLRRVLGIL,89,30,6069,Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.,HIV-1IIIB
GLRSRIWLWVLLMIWQESNRFKRM,89,30,6072,Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.,HIV-1IIIB
GLKKLLGKLLKKLGKLLLK,282,2,6073,APD2: the updated antimicrobial peptide database and its application in peptide design.,Escherichiacoli
GLRRLLGRLLRRLGRLLLR,89,30,6074,Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.,HIV-1IIIB
GGLKKLGKKLEGAGKRVFNAAEKALP,283,64,6078,Generation and characterization of the antibacterial activity of a novel hybrid antimicrobial peptide comprising functional domains from different insect cecropins.,Alcaligenesfaecalis
IAQQAANVAATARG,283,64,6079,Generation and characterization of the antibacterial activity of a novel hybrid antimicrobial peptide comprising functional domains from different insect cecropins.,Alcaligenesfaecalis
MGGLKKLGKKLEGAGKRVFNAAEKALPIAQQAANVAATARG,283,64,6080,Generation and characterization of the antibacterial activity of a novel hybrid antimicrobial peptide comprising functional domains from different insect cecropins.,Alcaligenesfaecalis
GIINTLQKYYARVRGGRYAVLSVLPKEEQIGKVSTRGRKKVRRKK,284,48,6082,"Structure, dynamics, and activity of an all-cysteine mutated human beta defensin-3 peptide analogue.",Bacillusmegaterium
GIINTLQKYYARVRGGRAAVLSALPKEEQIGKASTRGRKCARRKK,285,3,6084,Analysis and separation of residues important for the chemoattractant and antimicrobial activities of beta-defensin 3.,Pseudomonasaeruginosa
FLPKTLRKFFARIRGGRAAVLNALGKEEQIGRASNSGRKAARKKK,285,3,6085,Analysis and separation of residues important for the chemoattractant and antimicrobial activities of beta-defensin 3.,Pseudomonasaeruginosa
FLPKTLRKFFARIRGGRAAVLNA,285,3,6086,Analysis and separation of residues important for the chemoattractant and antimicrobial activities of beta-defensin 3.,Pseudomonasaeruginosa
LGKEEQIGRASNSGRKAARKKK,285,3,6087,Analysis and separation of residues important for the chemoattractant and antimicrobial activities of beta-defensin 3.,Pseudomonasaeruginosa
MTWEAWDRAIAEYAARIEALIRAAQEQQEKNEAALREL,281,30,6096,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB
TTWEAWDRAIAEYAARIEALIRAAQEQQEKNEAILREL,281,30,6097,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB
TTWEAWDRAIAEYAARIEALIRALQEQQEKNEAALREL,281,30,6098,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB
TTWEAWDRAIAEYAARIEALIRAAQELQEKNEAALREL,281,30,6099,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB
TTWEAWDRAIAEYAARIEALIRALQEQQEKNEAILREL,281,30,6100,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB
TTWEAWDRAIAEYAARIEALIRAAQEQQEKLEAALREL,281,30,6101,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB
TTWEAWDRAIAEYAARIEALIRAAQEQQEKLEAVLREL,281,30,6102,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB
TTWEAWDRAIAEYAARIEALIRALQELQEKNEAALREL,281,30,6103,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB
MLSLIFLHRLKSMRKRLDRKLRLWHRKNYP,286,2,6104,"Development of a novel antimicrobial peptide, AG-30, with angiogenic properties.",Escherichiacoli
TTWEAWDRAIAEYAARIEALIRALQELQEKNEAILREL,281,30,6105,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB
TTWEAWDRAIAEYAARIEALIRAAQELQEKLEAALRE,281,30,6106,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB
TTWEAWDRAIAEYAARIEALIRALQELQEKLEAILREL,281,30,6107,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB
WNSLKIDNLDV,287,61,6108,Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.,HIV-1
WASLKIDNLDV,287,61,6109,Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.,HIV-1
WNALKIDNLDV,287,61,6110,Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.,HIV-1
WNSAKIDNLDV,287,61,6112,Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.,HIV-1
FKCWRWQWRWKKLGA,288,2,6113,"Design and characterization of novel hybrid peptides from LFB15(W4,10), HP(2-20), and cecropin A based on structure parameters by computer-aided method.",Escherichiacoli
KWKLFKKIFKCWRWQWRWKKLGA,288,2,6114,"Design and characterization of novel hybrid peptides from LFB15(W4,10), HP(2-20), and cecropin A based on structure parameters by computer-aided method.",Escherichiacoli
FKCWRWQWRWKKLGAKVFKRLEKLFSKI,288,2,6115,"Design and characterization of novel hybrid peptides from LFB15(W4,10), HP(2-20), and cecropin A based on structure parameters by computer-aided method.",Escherichiacoli
WNSLAIDNLDV,287,61,6116,Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.,HIV-1
WNSLKADNLDV,287,61,6117,Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.,HIV-1
WNSLKIANLDV,287,61,6118,Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.,HIV-1
WNSLKIDALDV,287,61,6119,Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.,HIV-1
WNSLKIDNADV,287,61,6120,Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.,HIV-1
WNSLKIDNLAV,287,61,6121,Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.,HIV-1
RVRRPVYIPQPRPPHPRL,289,2,6122,"Targeted engineering of the antibacterial peptide apidaecin, based on an in vivo monitoring assay system.",Escherichiacoli
WNSLKIDNLDA,287,61,6123,Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.,HIV-1
WNSLKIANLAV,287,61,6124,Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.,HIV-1
RPVRPVYIPQPRPPHPRL,289,2,6125,"Targeted engineering of the antibacterial peptide apidaecin, based on an in vivo monitoring assay system.",Escherichiacoli
RGVRPVYIPQPRPPHPRL,289,2,6127,"Targeted engineering of the antibacterial peptide apidaecin, based on an in vivo monitoring assay system.",Escherichiacoli
WKFALKVDSPDV,287,61,6128,Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.,HIV-1
RNPRPVYIPQPRPPHPRL,289,2,6129,"Targeted engineering of the antibacterial peptide apidaecin, based on an in vivo monitoring assay system.",Escherichiacoli
RLNRPVYIPQPRPPHPRL,289,2,6130,"Targeted engineering of the antibacterial peptide apidaecin, based on an in vivo monitoring assay system.",Escherichiacoli
RLPRPVYIPQPRPPHPRL,289,2,6131,"Targeted engineering of the antibacterial peptide apidaecin, based on an in vivo monitoring assay system.",Escherichiacoli
VVRRPVYIPQPRPPHPRL,289,2,6132,"Targeted engineering of the antibacterial peptide apidaecin, based on an in vivo monitoring assay system.",Escherichiacoli
SSLLEKGLDGAKKAVGGLGKLGKDA,290,3,6135,Resistance to dermcidin-derived peptides is independent of bacterial protease activity.,Pseudomonasaeruginosa
GFCIPIRCPGHTRQIGTCFGPRVKSCRKW,291,2,6207,Artificial beta-defensin based on a minimal defensin template.,Escherichiacoli
RCPGHTRQIGTSFGPRVKSCRKW,291,2,6208,Artificial beta-defensin based on a minimal defensin template.,Escherichiacoli
EEHEKYHSNW,292,61,6210,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
ASCDKCQLKG,292,61,6211,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
HGQVDCSPGIWQLDCTH,292,61,6212,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
PAETGQET,292,61,6214,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
TAYFLLKLAGRW,292,61,6215,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
HTDNGSNF,292,61,6218,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
ACWWAGIKQEF,292,61,6219,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
FGIPYNPQSQ,292,61,6220,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
ESMNKELKKI,292,61,6221,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
VRDQAEHLKT,292,61,6222,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
FIHNFKRK,292,61,6223,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
GYSAGERIVD,292,61,6224,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
WKGPAKLLWK,292,61,6225,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
VPRRKAKI,292,61,6226,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
KWKLFKKIEKVGQRVRDAVISAGPAVATVAQATALAK,293,2,6228,Novel expression vector for secretion of cecropin AD in Bacillus subtilis with enhanced antimicrobial activity.,Escherichiacoli
AAYFLLKLAGRW,292,61,6230,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
TAAFLLKLAGRW,292,61,6231,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
TAYALLKLAGRW,292,61,6232,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
TAYFALKLAGRW,292,61,6233,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
TAYFLAKLAGRW,292,61,6237,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
TAYFLLALAGRW,292,61,6239,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
TAYFLLKAAGRW,292,61,6241,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
TAYFLLKLAARW,292,61,6244,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
TAYFLLKLAGAW,292,61,6245,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
RRRRWFWF,294,2,6246,"Cyclic antimicrobial R-, W-rich peptides: the role of peptide structure and E. coli outer and inner membranes in activity and the mode of action.",Escherichiacoli
RRRRRWFWFW,294,2,6247,"Cyclic antimicrobial R-, W-rich peptides: the role of peptide structure and E. coli outer and inner membranes in activity and the mode of action.",Escherichiacoli
TAYFLLKLAGRA,292,61,6248,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
RRRRRRWFWFWF,294,2,6249,"Cyclic antimicrobial R-, W-rich peptides: the role of peptide structure and E. coli outer and inner membranes in activity and the mode of action.",Escherichiacoli
AAWWAGIKQEF,292,61,6250,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
ACAWAGIKQEF,292,61,6252,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
ACWAAGIKQEF,292,61,6253,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
ACWWAAIKQEF,292,61,6254,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
ACWWAGAKQEF,292,61,6255,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
ACWWAGIAQEF,292,61,6256,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
SRSELIVHQR,295,65,6257,Functional characterization of a synthetic hydrophilic antifungal peptide derived from the marine snail Cenchritis muricatus.,Botrytiscinerea
ACWWAGIKAEF,292,61,6258,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
ACWWAGIKQAF,292,61,6259,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
ACWWAGIKQEA,292,61,6260,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
TASFLLKLAGRW,292,61,6261,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
TAYFLLILAGRW,292,61,6262,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
TAYFLLKLAGRL,292,61,6263,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
ASWWAGIKQEF,292,61,6264,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
ACGWAGIKQEF,292,61,6265,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
ACWGAGIKQEF,292,61,6266,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
ACWWAGIRQEF,292,61,6267,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
WRGALKLLFYAT,292,61,6290,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
FEQKIGAWWCA,292,61,6294,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1
WKLLSKAQEKFGKNKSRFKCRRWQWRMKKLG,296,2,6304,"Expression, purification, and antibacterial activity of bovine lactoferrampin-lactoferricin in Pichia pastoris.",Escherichiacoli
IHAEIKNSLKIDNLDVNRCIEAL,297,61,6319,Inhibitory profile of a LEDGF/p75 peptide against HIV-1 integrase: insight into integrase-DNA complex formation and catalysis.,HIV-1
AELRCMCIKTTSGIH,298,8,6322,Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements.,Bacillussubtilis
ELRCMCIKTTSGIHP,298,8,6323,Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements.,Bacillussubtilis
LRCMCIKTTSGIHPK,298,8,6324,Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements.,Bacillussubtilis
RCMCIKTTSGIHPKN,298,8,6325,Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements.,Bacillussubtilis
CMCIKTTSGIHPKNI,298,8,6326,Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements.,Bacillussubtilis
MCIKTTSGIHPKNIQ,298,8,6327,Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements.,Bacillussubtilis
DAPRIKKIVQKKLAG,298,8,6328,Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements.,Bacillussubtilis
APRIKKIVQKKLAGD,298,8,6329,Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements.,Bacillussubtilis
PRIKKIVQKKLAGDE,298,8,6330,Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements.,Bacillussubtilis
RIKKIVQKKLAGDES,298,8,6331,Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements.,Bacillussubtilis
QSHLSMCSVCCNCCKNYKGCGFCCRF,299,66,6333,Recombinant medaka (Oryzias melastigmus) pro-hepcidin: Multifunctional characterization.,Corynebacteriumglutamicum
GNNRPVYIPQPRPHPRL,300,2,6335,"Substitution of the arginine/leucine residues in apidaecin Ib with peptoid residues: effect on antimicrobial activity, cellular uptake, and proteolytic degradation.",Escherichiacoli
GNNRVYIPQPRPHPRL,300,2,6336,"Substitution of the arginine/leucine residues in apidaecin Ib with peptoid residues: effect on antimicrobial activity, cellular uptake, and proteolytic degradation.",Escherichiacoli
KQLTEAVQKITTESIVIWGK,301,61,6339,Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome.,HIV-1
ETWETWWTEYWQATWIPEWE,301,61,6340,Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome.,HIV-1
LQDSGLEVNIVTDSQYALGI,301,61,6341,Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome.,HIV-1
WQCLTLTHRGFVLLTITVLR,302,61,6357,Correlation between shiftide activity and HIV-1 integrase inhibition by a peptide selected from a combinatorial library.,HIV-1
RRRFVAEQDAIHSRVSREVPTLSDSV,303,4,6370,Generation of novel cationic antimicrobial peptides from natural non-antimicrobial sequences by acid-amide substitution.,Staphylococcusaureus
WQCLTLTHRG,304,61,6371,Peptide inhibitors of HIV-1 integrase: from mechanistic studies to improved lead compounds.,HIV-1
RRRFVAQQNAIHSRVSRQVPTLSNSV,303,4,6372,Generation of novel cationic antimicrobial peptides from natural non-antimicrobial sequences by acid-amide substitution.,Staphylococcusaureus
WFVLLTITVLR,304,61,6373,Peptide inhibitors of HIV-1 integrase: from mechanistic studies to improved lead compounds.,HIV-1
WQSLTLTHRG,304,61,6374,Peptide inhibitors of HIV-1 integrase: from mechanistic studies to improved lead compounds.,HIV-1
RRRFVVQQDTISPRLEVDERFLPNSVQEQI,303,4,6375,Generation of novel cationic antimicrobial peptides from natural non-antimicrobial sequences by acid-amide substitution.,Staphylococcusaureus
RRRFVVQQNTISPRLQVNQRFLPNSVQQQI,303,4,6376,Generation of novel cationic antimicrobial peptides from natural non-antimicrobial sequences by acid-amide substitution.,Staphylococcusaureus
RRRSVGEEDAIPSHIEVNKFFLRKPAKEHI,303,4,6377,Generation of novel cationic antimicrobial peptides from natural non-antimicrobial sequences by acid-amide substitution.,Staphylococcusaureus
RRRSVGQQNAIPSHIQVNKFFLRKPAKQHI,303,4,6378,Generation of novel cationic antimicrobial peptides from natural non-antimicrobial sequences by acid-amide substitution.,Staphylococcusaureus
HRRSVAHQEEASLHVKTDELPSPDTVREQL,303,4,6379,Generation of novel cationic antimicrobial peptides from natural non-antimicrobial sequences by acid-amide substitution.,Staphylococcusaureus
HRRSVAHQQQASLHVKTNQLPSPNTVRQQL,303,4,6380,Generation of novel cationic antimicrobial peptides from natural non-antimicrobial sequences by acid-amide substitution.,Staphylococcusaureus
KLLSHSLL,305,18,6412,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus
RRSQARKCSRGNGGKIGSIRCRGGGTRLGGGSLIGR,306,67,6414,Evidence of an antimicrobial-immunomodulatory role of Atlantic salmon cathelicidins during infection with Yersinia ruckeri.,Yersiniaruckeri
RRGKPSGGSRGSKMGSKDSKGGWRGRPGSGSRPGFG,306,67,6415,Evidence of an antimicrobial-immunomodulatory role of Atlantic salmon cathelicidins during infection with Yersinia ruckeri.,Yersiniaruckeri
LSFPTTKTYFPHFDLSHGSAQVKGHGAKVAAA,305,18,6416,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus
VTLASHLPSDFTPAVHASLDKF,305,18,6417,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus
SAADKGNVKAAWGKVGGHAAEYGAEALERMFLSF,305,18,6418,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus
VLSAADKGNVKAAWGKVGGHAAEYGAEALERMF,305,18,6419,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus
LDDLPGALSELSDLHAHKLRVDPVNFKLLSHSL,305,18,6420,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus
VNFKLLSHSLL,305,18,6421,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus
TKAVEHLDDLPGALSELSDLHAHKLRVDPVNFKLLSHSLL,305,18,6422,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus
LHAHKLRVDPVNFKLLSHSLLVTL,305,18,6423,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus
NKPFVFLM,307,30,6427,Short cyclic peptides derived from the C-terminal sequence of alpha1-antitrypsin exhibit significant anti-HIV-1 activity.,HIV-1IIIB
VLSAADKGNVKAAWGKVGGHAAEYGAEALERMFLSFPTTKTYFPHF,305,18,6428,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus
ASHLPSDFTPAVHASLDKFLANVSTVLTSKYR,305,18,6430,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus
LVTLASHLPSDFTPAVHASLDKFLANVSTVLTSKYR,305,18,6435,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus
HGKKVLDSFSNGMKHLDDLKGTFAALSELH,305,18,6436,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus
AALSELHCDKLHVDPENFKLL,305,18,6437,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus
ARNFGKEFTPV,305,18,6438,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus
DLKGTFAALSELHCDKLHVDPENFKL,305,18,6439,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus
LDDLKGTFAALSELHCDKLHVDPENFKLLGNVLVVVLARNFGKEFTPVL,305,18,6440,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus
ARNFGKEFTPVLQADFQKVVAGVANALAHRYH,305,18,6441,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus
LTAEEKAAVTAFWGKVKVDEVGGEALGRLLVVY,305,18,6443,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus
TKAVEHLDDLPGALSELSDL,305,18,6444,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus
EEYTKKIEEYTKKIEEYTKKIEEYTKKIEEYTKKI,308,61,6456,Rationally designed anti-HIV peptides containing multifunctional domains as molecule probes for studying the mechanisms of action of the first and second generation HIV fusion inhibitors.,HIV-1
WMEWDREIEEYTKKIEEYTKKIEEYTKKIEEYTKKI,308,61,6457,Rationally designed anti-HIV peptides containing multifunctional domains as molecule probes for studying the mechanisms of action of the first and second generation HIV fusion inhibitors.,HIV-1
EEYTKKIEEYTKKIEEYTKKIEEYTKKIWASLWNWF,308,61,6458,Rationally designed anti-HIV peptides containing multifunctional domains as molecule probes for studying the mechanisms of action of the first and second generation HIV fusion inhibitors.,HIV-1
WMEWDREIEEYTKKIEEYTKKIEEYTKKIWASLWNWF,308,61,6459,Rationally designed anti-HIV peptides containing multifunctional domains as molecule probes for studying the mechanisms of action of the first and second generation HIV fusion inhibitors.,HIV-1
WEEWDKKIEEYTKKIEELIKKS,310,68,6474,"SC29EK, a peptide fusion inhibitor with enhanced alpha-helicity, inhibits replication of human immunodeficiency virus type 1 mutants resistant to enfuvirtide.",HIV-1NL4-3
WMEWDREINNYTSLIHSLIEESQNQQEKN,310,68,6475,"SC29EK, a peptide fusion inhibitor with enhanced alpha-helicity, inhibits replication of human immunodeficiency virus type 1 mutants resistant to enfuvirtide.",HIV-1NL4-3
WEEWDKKIEEYTKKIEELIKKSEEQQKKN,310,68,6476,"SC29EK, a peptide fusion inhibitor with enhanced alpha-helicity, inhibits replication of human immunodeficiency virus type 1 mutants resistant to enfuvirtide.",HIV-1NL4-3
WMEWDREINNYTSLIHSLIEESQNQQEKNEQELL,310,68,6477,"SC29EK, a peptide fusion inhibitor with enhanced alpha-helicity, inhibits replication of human immunodeficiency virus type 1 mutants resistant to enfuvirtide.",HIV-1NL4-3
EWDREINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLW,311,61,6504,Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.,HIV-1
RQLLSGIVQQQNNLLRAIEAQQHLLQK,312,61,6534,Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain.,HIV-1
RKSYKCLHKRCR,313,7,6542,Antimicrobial and DNA-binding activities of the peptide fragments of human lactoferrin and histatin 5 against Streptococcus mutans.,Streptococcusmutans
RPPQFTRAQWFAIQHISLNPPRSTIAMRAINNYRWRSKNQNTFLR,314,2,6543,Refining the eosinophil cationic protein antibacterial pharmacophore by rational structure minimization.,Escherichiacoli
TIAMRAINNYRWRSKNQNTFLR,314,2,6544,Refining the eosinophil cationic protein antibacterial pharmacophore by rational structure minimization.,Escherichiacoli
RPPQFTRAQWFAIQHISLN,314,2,6545,Refining the eosinophil cationic protein antibacterial pharmacophore by rational structure minimization.,Escherichiacoli
AQWFAIQHISLNPPRSTIAMRAINNYRWRSKNQNTFLR,314,2,6546,Refining the eosinophil cationic protein antibacterial pharmacophore by rational structure minimization.,Escherichiacoli
AQWFAIQHISLNPPRSTIAMRAINNYRWR,314,2,6547,Refining the eosinophil cationic protein antibacterial pharmacophore by rational structure minimization.,Escherichiacoli
ISLNPPRSTIAMRAINNYRWRSKNQNTFLR,314,2,6551,Refining the eosinophil cationic protein antibacterial pharmacophore by rational structure minimization.,Escherichiacoli
RQLLSGIVQQQNNLLRAIEAQQHLL,312,61,6555,Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain.,HIV-1
RQLLSGIVQQQNNLLRAIEAQQH,312,61,6557,Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain.,HIV-1
SGIVQQQNNLLRAIEAQQHLLQ,312,61,6559,Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain.,HIV-1
RGGLSGIVQQQNNLLRAIEAQQHLLQ,312,61,6561,Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain.,HIV-1
HQTLSGIDQEQNNLTRLIEAQIHELQK,312,61,6563,Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain.,HIV-1
RQLLSGIDQEQNNLTRLIEAQIHELQK,312,61,6565,Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain.,HIV-1
FFTPVLQADFQKVVAGVANALAHRYH,315,35,6567,RYH: a minimal peptidic sequence obtained from beta-chain hemoglobin exhibiting an antimicrobial activity.,Salmonellaenteritidis
SGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARIL,316,61,6569,Membrane-anchored HIV-1 N-heptad repeat peptides are highly potent cell fusion inhibitors via an altered mode of action.,HIV-1
SGIDQEQNNLTRLIEAQIHELQLTQWKIKQLLARILK,316,61,6574,Membrane-anchored HIV-1 N-heptad repeat peptides are highly potent cell fusion inhibitors via an altered mode of action.,HIV-1
SGIVQQLNNQLRAEEANQHLEQLSVWGSKQNQARRLK,316,61,6576,Membrane-anchored HIV-1 N-heptad repeat peptides are highly potent cell fusion inhibitors via an altered mode of action.,HIV-1
GRKKRRQRRR,317,30,6581,Infection by CXCR4-Tropic Human Immunodeficiency Virus Type 1 Is Inhibited by the Cationic Cell-Penetrating Peptide Derived from HIV-1 Tat.,HIV-1IIIB
RRKKRRQRRR,317,30,6583,Infection by CXCR4-Tropic Human Immunodeficiency Virus Type 1 Is Inhibited by the Cationic Cell-Penetrating Peptide Derived from HIV-1 Tat.,HIV-1IIIB
GRKKRRRRRR,317,30,6584,Infection by CXCR4-Tropic Human Immunodeficiency Virus Type 1 Is Inhibited by the Cationic Cell-Penetrating Peptide Derived from HIV-1 Tat.,HIV-1IIIB
RRKKRRRRRR,317,30,6585,Infection by CXCR4-Tropic Human Immunodeficiency Virus Type 1 Is Inhibited by the Cationic Cell-Penetrating Peptide Derived from HIV-1 Tat.,HIV-1IIIB
RRRRRRRRRR,317,30,6586,Infection by CXCR4-Tropic Human Immunodeficiency Virus Type 1 Is Inhibited by the Cationic Cell-Penetrating Peptide Derived from HIV-1 Tat.,HIV-1IIIB
TGEKVWDRGNVTLLCDCP,318,61,6599,Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,HIV-1
LPAFCQAIGWGDPITHWS,318,61,6600,Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,HIV-1
FCQAIGWGDPITHWSHGQ,318,61,6601,Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,HIV-1
AIGWGDPITHWSHGQNRW,318,61,6602,Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,HIV-1
PITHWSHGQNRWPLSCPQ,318,61,6603,Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,HIV-1
HGQNRWPLSCPQYVYGSV,318,61,6604,Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,HIV-1
SDRDTVVELSEWGVPCAT,318,61,6605,Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,HIV-1
DTVVELSEWGVPCATCIL,318,61,6606,Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,HIV-1
VELSEWGVPCATCILDRR,318,61,6607,Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,HIV-1
RFPFHRCGAGPKLTKDLE,318,61,6608,Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,HIV-1
LVRRRSELMGRRNPVCPG,318,61,6610,Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,HIV-1
LQEVDAGNFIPPPRWLLL,318,61,6611,Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,HIV-1
WVNQLAVLGLPAVDAAVA,318,61,6612,Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,HIV-1
TRQARRNRRRRWRERQR,319,30,6616,"Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4.",HIV-1IIIB
TRQARRNRRRRWRERQRAAAAC,319,30,6617,"Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4.",HIV-1IIIB
TRQARRNRRRRWRERQRAAAACYGRKKRRQRRR,319,30,6618,"Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4.",HIV-1IIIB
MPKTRRRPRRSQRKRPPTPWP,319,30,6619,"Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4.",HIV-1IIIB
MPKTRRRPRRSQRKRPPTPWPYGRKKRRQRRR,319,30,6620,"Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4.",HIV-1IIIB
RPRGRRGSRPSGAERRRRRAAAA,319,30,6621,"Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4.",HIV-1IIIB
TDVILMCFSIDSPDSLENI,320,61,6624,A RhoA-derived peptide inhibits human immunodeficiency virus-1 entry in vitro.,HIV-1
DDMSVISELICTSPLDFIN,320,61,6625,A RhoA-derived peptide inhibits human immunodeficiency virus-1 entry in vitro.,HIV-1
YTSLIHSLIEEGQNQQEKNEQELLELDKWASLWNWF,321,61,6626,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1
YTSLIHSLIEEAQNQQEKNEQELLELDKWASLWNWF,321,61,6627,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1
YTSLIHSLIEEVQNQQEKNEQELLELDKWASLWNWF,321,61,6628,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1
YTSLIHSLIEELQNQQEKNEQELLELDKWASLWNWF,321,61,6629,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1
YTSLIHSLIEEIQNQQEKNEQELLELDKWASLWNWF,321,61,6630,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1
YTSLIHSLIEEMQNQQEKNEQELLELDKWASLWNWF,321,61,6631,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1
YTSLIHSLIEEPQNQQEKNEQELLELDKWASLWNWF,321,61,6632,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1
YTSLIHSLIEETQNQQEKNEQELLELDKWASLWNWF,321,61,6633,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1
YTSLIHSLIEEFQNQQEKNEQELLELDKWASLWNWF,321,61,6634,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1
YTSLIHSLIEEYQNQQEKNEQELLELDKWASLWNWF,321,61,6635,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1
YTSLIHSLIEEWQNQQEKNEQELLELDKWASLWNWF,321,61,6637,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1
YTSLIHSLIEENQNQQEKNEQELLELDKWASLWNWF,321,61,6638,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1
YTSLIHSLIEEQQNQQEKNEQELLELDKWASLWNWF,321,61,6639,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1
YTSLIHSLIEEDQNQQEKNEQELLELDKWASLWNWF,321,61,6640,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1
YTSLIHSLIEEEQNQQEKNEQELLELDKWASLWNWF,321,61,6641,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1
YTSLIHSLIEEHQNQQEKNEQELLELDKWASLWNWF,321,61,6642,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1
YTSLIHSLIEERQNQQEKNEQELLELDKWASLWNWF,321,61,6643,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1
GCKKYRRFRWKFKGKFWFWG,322,69,6647,A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic viruses.,HIV-1Ba-L
GKKYRRFRWKFKFGKWFWFG,322,69,6648,A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic viruses.,HIV-1Ba-L
RSQKEGLHYTCSSHFPYSQYQFWK,323,70,6656,Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.,HIV-1YU2
RSQKEGLHYTCS,323,70,6657,Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.,HIV-1YU2
CSSHFPYSQYQFWK,323,70,6659,Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.,HIV-1YU2
QKEGLHYTCSSHFPYSQYQF,323,70,6661,Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.,HIV-1YU2
EGLHYTCSSHFPYSQY,323,70,6662,Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.,HIV-1YU2
RINNIPWSEAMM,324,70,6670,Mode of action for linear peptide inhibitors of HIV-1 gp120 interactions.,HIV-1YU2
IYWNVSGW,327,61,6724,Peptide inhibitors of HIV-1 egress.,HIV-1
GRFKRFRKKFKKLFKKIS,7,5,6735,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV
KKTWWKTWWTKWSQPKKKRKV,328,2,6760,Cell selectivity and mechanism of action of short antimicrobial peptides designed from the cell-penetrating peptide Pep-1.,Escherichiacoli
KKTWWKTWWTKWSQPKK,328,2,6761,Cell selectivity and mechanism of action of short antimicrobial peptides designed from the cell-penetrating peptide Pep-1.,Escherichiacoli
KKTWWKTWWTKWSQP,328,2,6762,Cell selectivity and mechanism of action of short antimicrobial peptides designed from the cell-penetrating peptide Pep-1.,Escherichiacoli
KKTWWKTWWTKW,328,2,6763,Cell selectivity and mechanism of action of short antimicrobial peptides designed from the cell-penetrating peptide Pep-1.,Escherichiacoli
KKTWWKTWWTKWKK,328,2,6764,Cell selectivity and mechanism of action of short antimicrobial peptides designed from the cell-penetrating peptide Pep-1.,Escherichiacoli
KKPWWKPWWPKWKK,328,2,6765,Cell selectivity and mechanism of action of short antimicrobial peptides designed from the cell-penetrating peptide Pep-1.,Escherichiacoli
LRKLRKRLVRLASHLRKLRKRLL,329,2,6768,An apolipoprotein E mimetic peptide with activities against multidrug-resistant bacteria and immunomodulatory effects.,Escherichiacoli
LRKLRKRLLLRKLRKRLL,329,2,6769,An apolipoprotein E mimetic peptide with activities against multidrug-resistant bacteria and immunomodulatory effects.,Escherichiacoli
CLRKLRKRLLC,329,2,6770,An apolipoprotein E mimetic peptide with activities against multidrug-resistant bacteria and immunomodulatory effects.,Escherichiacoli
SHGAVSLTMCKLTSGKYPNCRYKEKRQNKSYVVACKPPQKKDSQQFHLVPVHLDRVL,330,2,6790,Contribution of structural domains to the activity of ribonuclease 7 against uropathogenic bacteria.,Escherichiacoli
TSGKYPNCRYKEKRQNKSYVVACKPPQKKDSQQFHLVPVHLDRVL,330,2,6791,Contribution of structural domains to the activity of ribonuclease 7 against uropathogenic bacteria.,Escherichiacoli
KPKGMTSSQWFKIQHMQPSPQACNSAMKNINKHTKRCKDLNTFLH,330,2,6797,Contribution of structural domains to the activity of ribonuclease 7 against uropathogenic bacteria.,Escherichiacoli
EPFSSVAATCQTPKIACKNGDKNCHQSHGAVSLTMCKLTSGKYPNCRYKEKR,330,2,6803,Contribution of structural domains to the activity of ribonuclease 7 against uropathogenic bacteria.,Escherichiacoli
GIGKHVGKALKGLKGLLKGLGEC,331,1,6806,None_article3,None_target
GLKGLLGKALKGIGKHIGKAQGC,332,1,6807,None_article4,None_target
RWKIFKKIEKMGGSYCNRRTGKCQRM,333,8,6852,Biological activities of cecropin B-thanatin hybrid peptides.,Bacillussubtilis
KLAKLAKKLAKLAK,334,59,6855,Mechanism of action and initial evaluation of a membrane active all-D-enantiomer antimicrobial peptidomimetic.,Acinetobacterbaumannii
AKVTMTCSAS,335,33,6868,Production of an engineered killer peptide in Nicotiana benthamiana by using a potato virus X expression system.,Pseudomonassyringae
WHWRIRKKLR,336,2,6872,Design of multifunctional peptides expressing both antimicrobial activity and shiga toxin neutralization activity.,Escherichiacoli
WHWTWLRIRKKLR,336,2,6873,Design of multifunctional peptides expressing both antimicrobial activity and shiga toxin neutralization activity.,Escherichiacoli
WHWTWLPKKKRKV,336,2,6874,Design of multifunctional peptides expressing both antimicrobial activity and shiga toxin neutralization activity.,Escherichiacoli
WHWTWLPRRRK,336,2,6875,Design of multifunctional peptides expressing both antimicrobial activity and shiga toxin neutralization activity.,Escherichiacoli
DDALKKLLKKLLKKL,337,72,6895,pH-dependent antifungal lipopeptides and their plausible mode of action.,Aspergillusflavus
DDALHHLLHHLLHHL,337,72,6896,pH-dependent antifungal lipopeptides and their plausible mode of action.,Aspergillusflavus
DDALRRLLRRLLRRL,337,72,6908,pH-dependent antifungal lipopeptides and their plausible mode of action.,Aspergillusflavus
DDALKHLLKHLLKHL,337,72,6909,pH-dependent antifungal lipopeptides and their plausible mode of action.,Aspergillusflavus
DDALRHLLRHLLRHL,337,72,6910,pH-dependent antifungal lipopeptides and their plausible mode of action.,Aspergillusflavus
LQKYYCRVRGGRCAVLS,338,2,6913,Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity.,Escherichiacoli
LQKYYARVRGGRAAVLSALPKEEQIGKASTRGRKAARRKK,338,2,6916,Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity.,Escherichiacoli
LQKYYWRVRGGRWAVLSWLPKEEQIGKWSTRGRKWWRRKK,338,2,6918,Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity.,Escherichiacoli
LQKYYARVRGGRAAVLS,338,2,6919,Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity.,Escherichiacoli
LQKYYWRVRGGRWAVLS,338,2,6920,Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity.,Escherichiacoli
AVLSALPKEEQIGKASTRGRKAARRKK,338,2,6921,Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity.,Escherichiacoli
AVLSWLPKEEQIGKWSTRGRKWWRRKK,338,2,6922,Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity.,Escherichiacoli
GLKALKKVFQGIHEAIKLINNHVQ,339,2,6923,"Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.",Escherichiacoli
GLNALKKVFKGIHEAIKLINNHVQ,339,2,6924,"Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.",Escherichiacoli
GLNALKKVFQGIHKAIKLINNHVQ,339,2,6925,"Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.",Escherichiacoli
GLNALKKVFQGIHEAIKLINKHVQ,339,2,6926,"Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.",Escherichiacoli
GLNALKKVFQGIHEAIKLINNHVK,339,2,6927,"Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.",Escherichiacoli
GLKALKKVFQGIHKAIKLINNHVQ,339,2,6928,"Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.",Escherichiacoli
GLKALKKVFKGIHKAIKLINNHVQ,339,2,6929,"Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.",Escherichiacoli
GLKALKKVFKGIHKAIKLINKHVQ,339,2,6931,"Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.",Escherichiacoli
GLKALKKVFKGIHKAIKLINKHVK,339,2,6932,"Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.",Escherichiacoli
GLNAFKKVFQGIHEAIKLINNHVQ,339,2,6933,"Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.",Escherichiacoli
GLNALKKFFQGIHEAIKLINNHVQ,339,2,6934,"Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.",Escherichiacoli
GLNALKKVFQGFHEAIKLINNHVQ,339,2,6935,"Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.",Escherichiacoli
GLNALKKVFQGIHEAFKLINNHVQ,339,2,6936,"Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.",Escherichiacoli
GLNALKKVFQGIHEAIKLFNNHVQ,339,2,6937,"Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.",Escherichiacoli
DKPKKKPPPPAGPPPPPPPPPGPPPPGP,340,73,7009,Structural and functional studies on a proline-rich peptide isolated from swine saliva endowed with antifungal activity towards Cryptococcus neoformans.,Cryptococcusneoformans
KFFRKLKKSVKKRAKKFFKKPRVIGVSIPF,341,2,7011,Effective antimicrobial activity of Cbf-K16 and Cbf-A7 A13 against NDM-1-carrying Escherichia coli by DNA binding after penetrating the cytoplasmic membrane in vitro.,Escherichiacoli
KFFRKLAKSVKKAAKEFFKKPRVIGVSIPF,341,2,7012,Effective antimicrobial activity of Cbf-K16 and Cbf-A7 A13 against NDM-1-carrying Escherichia coli by DNA binding after penetrating the cytoplasmic membrane in vitro.,Escherichiacoli
GCKFTVKPYLKRFQVYYKGRMWCG,342,15,7013,Functional divergence in shrimp anti-lipopolysaccharide factors (ALFs): from recognition of cell wall components to antimicrobial activity.,Aerococcusviridans
GCTYNVKPDIQGFELYFIGSVTCG,342,15,7015,Functional divergence in shrimp anti-lipopolysaccharide factors (ALFs): from recognition of cell wall components to antimicrobial activity.,Aerococcusviridans
GCRFTVKPYIKRIQLHYKGKMWCG,342,15,7016,Functional divergence in shrimp anti-lipopolysaccharide factors (ALFs): from recognition of cell wall components to antimicrobial activity.,Aerococcusviridans
SRWPSPGRPRPFPGRPKPIFRPR,343,2,7019,"Structure-activity relationships of the antimicrobial peptide arasin 1 - and mode of action studies of the N-terminal, proline-rich region.",Escherichiacoli
SRWPSPGRPRPFPGRPKPIF,343,2,7020,"Structure-activity relationships of the antimicrobial peptide arasin 1 - and mode of action studies of the N-terminal, proline-rich region.",Escherichiacoli
SRWPSPGRPRPFPG,343,2,7021,"Structure-activity relationships of the antimicrobial peptide arasin 1 - and mode of action studies of the N-terminal, proline-rich region.",Escherichiacoli
WPSPGRPRPFPGRPKPIFRPR,343,2,7022,"Structure-activity relationships of the antimicrobial peptide arasin 1 - and mode of action studies of the N-terminal, proline-rich region.",Escherichiacoli
SPGRPRPFPGRPKPIFRPR,343,2,7024,"Structure-activity relationships of the antimicrobial peptide arasin 1 - and mode of action studies of the N-terminal, proline-rich region.",Escherichiacoli
GRPRPFPGRPKPIFRPR,343,2,7025,"Structure-activity relationships of the antimicrobial peptide arasin 1 - and mode of action studies of the N-terminal, proline-rich region.",Escherichiacoli
PRPFPGRPKPIFRPR,343,2,7026,"Structure-activity relationships of the antimicrobial peptide arasin 1 - and mode of action studies of the N-terminal, proline-rich region.",Escherichiacoli
RRRPRPPYLPRPRPPPFFPPRLPPRI,343,2,7028,"Structure-activity relationships of the antimicrobial peptide arasin 1 - and mode of action studies of the N-terminal, proline-rich region.",Escherichiacoli
WKWLKKWIK,344,41,7041,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
ILRWKWRWWRWRR,344,41,7042,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
ILPWKWRWWKWRR,344,41,7043,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
FCPRRYKQIGTGLPGTKCK,345,2,7044,Antibacterial activities of synthetic peptides corresponding to the carboxy-terminal region of human beta-defensins 1-3.,Escherichiacoli
RWRRKWWWW,344,41,7045,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
WRKFWKYLK,344,41,7046,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
KRWWKWWRR,344,41,7047,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
RRWWKWWWR,344,41,7048,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
RLWWWWRRK,344,41,7049,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
KWKWWWRKI,344,41,7050,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
RIRRWKFRW,344,41,7051,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
RLKRWWKFL,344,41,7052,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
RWWRWRKWW,344,41,7053,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
KRWWWWRFR,344,41,7055,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
RGCICRCIGRGCICRCIG,346,74,7056,Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin.,Bacillusanthracis
KRWWRKWWR,344,41,7057,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
RRWWRWVVW,344,41,7058,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
GICRCICGGGICRCICGR,346,74,7059,Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin.,Bacillusanthracis
GICRCICGGGICRCICGG,346,74,7060,Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin.,Bacillusanthracis
WFKMRWWGR,344,41,7061,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
GICHCICGGGICHCICGG,346,74,7062,Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin.,Bacillusanthracis
KFKWWRMLI,344,41,7063,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
FIKWKFRWWKWRK,344,41,7064,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
RIKRWWWWR,344,41,7065,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
RWRWWWRVY,344,41,7066,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
HQFRFRFRVRRK,344,41,7067,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
LKRRWKWWI,344,41,7068,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
RRRIKIRWY,344,41,7069,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
RLWWKIWLK,344,41,7070,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
KRRWRIWLV,344,41,7071,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
FFIYVWRRR,344,41,7072,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
IRMRIRVLL,344,41,7073,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
RWWRKIWKW,344,41,7074,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
LRFILWWKR,344,41,7075,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
RWWIRIRWH,344,41,7076,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
RRRWWKLMM,344,41,7077,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
LRRWIRIRW,344,41,7078,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
RKFRWWVIR,344,41,7079,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
WKIVFWWRR,344,41,7080,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
RQRRVVIWW,344,41,7081,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
RRWRVIVKW,344,41,7082,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
RRWKIVVIRWRR,344,41,7083,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
RLWRIVVIRVKR,344,41,7084,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
RLRRIVVIRVFR,344,41,7085,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
VRLRIRVRVIRK,344,41,7086,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
RRYHWRIYI,344,41,7087,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
RKWKIKWYW,344,41,7088,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
YRLRVKWKW,344,41,7089,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
WKWRVRVTI,344,41,7090,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
RTKKWIVWI,344,41,7091,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
NWRKLYRRK,344,41,7092,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
GICRCICGGGICHCICGG,346,74,7093,Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin.,Bacillusanthracis
GICHCICGGGICRCICGG,346,74,7094,Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin.,Bacillusanthracis
YKFRWRIYI,344,41,7095,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
KRKKRFKWW,344,41,7096,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis
RICRCICGRRICRCICGR,346,74,7097,Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin.,Bacillusanthracis
GVCRCLCRRGVCRCICRR,346,74,7098,Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin.,Bacillusanthracis
GICRCICGKGICRCICGR,346,74,7099,Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin.,Bacillusanthracis
RWWRWWRRWWRR,347,4,7105,"Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens.",Staphylococcusaureus
RVVRQWPIGRVVRRVVRRVVRL,348,8,7106,Display of multimeric antimicrobial peptides on the Escherichia coli cell surface and its application as whole-cell antibiotics.,Bacillussubtilis
RVVRQWPIGRVVRRVVRRVVRF,348,8,7107,Display of multimeric antimicrobial peptides on the Escherichia coli cell surface and its application as whole-cell antibiotics.,Bacillussubtilis
RVVRQWPIGRVVRRVVRRVVRY,348,8,7108,Display of multimeric antimicrobial peptides on the Escherichia coli cell surface and its application as whole-cell antibiotics.,Bacillussubtilis
RWKRWWRRKK,349,2,7112,Antimicrobial functionalization of silicone surfaces with engineered short peptides having broad spectrum antimicrobial and salt-resistant properties.,Escherichiacoli
KPKGMTSSQWFKIQHMQPSPQASNSAMKNINKHTKRSKDLNTFLH,350,75,7120,"Two human host defense ribonucleases against mycobacteria, the eosinophil cationic protein (RNase 3) and RNase 7.",Mycobacteriumvaccae
RGVRPVVQGVKEKVR,351,8,7121,De novo generation of short antimicrobial peptides with enhanced stability and cell specificity.,Bacillussubtilis
RVVRPVVQGVKEKVR,351,8,7122,De novo generation of short antimicrobial peptides with enhanced stability and cell specificity.,Bacillussubtilis
RVVRPVVQGVKQKVR,351,8,7123,De novo generation of short antimicrobial peptides with enhanced stability and cell specificity.,Bacillussubtilis
RVVRPVVQVVKEKVR,351,8,7124,De novo generation of short antimicrobial peptides with enhanced stability and cell specificity.,Bacillussubtilis
RVVRPVVQVVKQKVR,351,8,7125,De novo generation of short antimicrobial peptides with enhanced stability and cell specificity.,Bacillussubtilis
RIIRPIIQIIKQKIR,351,8,7126,De novo generation of short antimicrobial peptides with enhanced stability and cell specificity.,Bacillussubtilis
RLLRPLLQLLKQKLR,351,8,7127,De novo generation of short antimicrobial peptides with enhanced stability and cell specificity.,Bacillussubtilis
GSKKPVPIIYCQRRTGKCQRM,352,2,7136,"Application of S-thanatin, an antimicrobial peptide derived from thanatin, in mouse model of Klebsiella pneumoniae infection.",Escherichiacoli
GSKKPVPIIYCNRRTAKCQRM,352,2,7137,"Application of S-thanatin, an antimicrobial peptide derived from thanatin, in mouse model of Klebsiella pneumoniae infection.",Escherichiacoli
GSKKPVPIIYCQRRSGKCQRM,352,2,7138,"Application of S-thanatin, an antimicrobial peptide derived from thanatin, in mouse model of Klebsiella pneumoniae infection.",Escherichiacoli
GSKKPVPIIYCQRRTAKCQRM,352,2,7139,"Application of S-thanatin, an antimicrobial peptide derived from thanatin, in mouse model of Klebsiella pneumoniae infection.",Escherichiacoli
GSKKPVPIIYCNRRSAKCQRM,352,2,7140,"Application of S-thanatin, an antimicrobial peptide derived from thanatin, in mouse model of Klebsiella pneumoniae infection.",Escherichiacoli
QKALNEINQF,353,25,7141,Structure-activity relationships of ?s-casein peptides with multifunctional biological activities.,Bacilluscereus
TKKTKLTEEEKNRL,353,25,7142,Structure-activity relationships of ?s-casein peptides with multifunctional biological activities.,Bacilluscereus
WLRRIKAWLRR,354,76,7163,Antibacterial Activity of Novel Cationic Peptides against Clinical Isolates of Multi-Drug Resistant Staphylococcus pseudintermedius from Infected Dogs.,Staphylococcuspseudintermedius
WLRRIKAWLRRIKA,354,76,7164,Antibacterial Activity of Novel Cationic Peptides against Clinical Isolates of Multi-Drug Resistant Staphylococcus pseudintermedius from Infected Dogs.,Staphylococcuspseudintermedius
KFFKFFKFFK,354,76,7166,Antibacterial Activity of Novel Cationic Peptides against Clinical Isolates of Multi-Drug Resistant Staphylococcus pseudintermedius from Infected Dogs.,Staphylococcuspseudintermedius
AFHHIFRGIVHVGKTIHRLVTG,355,2,7167,Role of phenylalanine and valine10 residues in the antimicrobial activity and cytotoxicity of piscidin-1.,Escherichiacoli
FAHHIFRGIVHVGKTIHRLVTG,355,2,7168,Role of phenylalanine and valine10 residues in the antimicrobial activity and cytotoxicity of piscidin-1.,Escherichiacoli
FFHHIARGIVHVGKTIHRLVTG,355,2,7169,Role of phenylalanine and valine10 residues in the antimicrobial activity and cytotoxicity of piscidin-1.,Escherichiacoli
KFHHIFRGIVHVGKTIHRLVTG,355,2,7170,Role of phenylalanine and valine10 residues in the antimicrobial activity and cytotoxicity of piscidin-1.,Escherichiacoli
GKPRPYSPRPTPHPRL,356,2,7173,Hydroxyproline substitutions stabilize non-glycosylated drosocin against serum proteases without challenging its antibacterial activity.,Escherichiacoli
GRPNPVNNKPTSHPRPIRV,356,2,7175,Hydroxyproline substitutions stabilize non-glycosylated drosocin against serum proteases without challenging its antibacterial activity.,Escherichiacoli
GRPNPVNNKPTPHPRPIRV,356,2,7177,Hydroxyproline substitutions stabilize non-glycosylated drosocin against serum proteases without challenging its antibacterial activity.,Escherichiacoli
KAANRIKYFQ,357,77,7180,Synthetic antimicrobial peptides: From choice of the best sequences to action mechanisms.,Klebsiellapneumoniae
GATIRAVNSR,357,77,7182,Synthetic antimicrobial peptides: From choice of the best sequences to action mechanisms.,Klebsiellapneumoniae
FKHHIFRGIVHVGKTIHRLVTG,355,2,7186,Role of phenylalanine and valine10 residues in the antimicrobial activity and cytotoxicity of piscidin-1.,Escherichiacoli
FFHHIKRGIVHVGKTIHRLVTG,355,2,7187,Role of phenylalanine and valine10 residues in the antimicrobial activity and cytotoxicity of piscidin-1.,Escherichiacoli
WFHHIFRGIVHVGKTIHRLVTG,355,2,7188,Role of phenylalanine and valine10 residues in the antimicrobial activity and cytotoxicity of piscidin-1.,Escherichiacoli
FWHHIFRGIVHVGKTIHRLVTG,355,2,7189,Role of phenylalanine and valine10 residues in the antimicrobial activity and cytotoxicity of piscidin-1.,Escherichiacoli
FFHHIWRGIVHVGKTIHRLVTG,355,2,7190,Role of phenylalanine and valine10 residues in the antimicrobial activity and cytotoxicity of piscidin-1.,Escherichiacoli
FFHHIFRGIKHVGKTIHRLVTG,355,2,7213,Role of phenylalanine and valine10 residues in the antimicrobial activity and cytotoxicity of piscidin-1.,Escherichiacoli
KFHHIFRGIKHVGKTIHRLVTG,355,2,7214,Role of phenylalanine and valine10 residues in the antimicrobial activity and cytotoxicity of piscidin-1.,Escherichiacoli
FKHHIFRGIKHVGKTIHRLVTG,355,2,7215,Role of phenylalanine and valine10 residues in the antimicrobial activity and cytotoxicity of piscidin-1.,Escherichiacoli
FFHHIKRGIKHVGKTIHRLVTG,355,2,7216,Role of phenylalanine and valine10 residues in the antimicrobial activity and cytotoxicity of piscidin-1.,Escherichiacoli
FLFKLIPKAIKKLISKFK,358,56,7227,"Enhanced Antimicrobial Activity of AamAP1-Lysine, a Novel Synthetic Peptide Analog Derived from the Scorpion Venom Peptide AamAP1.",Staphylococcusepidermidis
NSQIRPLPDKGLDLSIRDASIKIRGKWKARKNFIK,359,78,7234,Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.,Enterobacteraerogenes
VRIHISGSSLGWLIQLFRKRIESLLQKS,359,78,7235,Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.,Enterobacteraerogenes
KWKARKNFIKGSSLGWLIQLFRKR,359,78,7236,Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.,Enterobacteraerogenes
KKHRKHRKHRKHGGSGGSKNLRRIIRKGIHIIKKYG,360,3,7239,"Stability and activity in sputum of G10KHc, a potent anti-Pseudomonas antimicrobial peptide.",Pseudomonasaeruginosa
RAGLQFPVGKLLKKLLKRLKR,361,8,7241,High-level expression of an antimicrobial peptide histonin as a natural form by multimerization and furin-mediated cleavage.,Bacillussubtilis
RRWYRWWR,362,79,7292,Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.,HSV-1
RRWYRWWRRRWYRWWR,362,79,7293,Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.,HSV-1
RWWRWWRRWWRWWR,362,79,7295,Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.,HSV-1
YRWWRWARRW,362,79,7299,Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.,HSV-1
YRWWRWARRWYRWWRWARRW,362,79,7300,Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.,HSV-1
RRRRRRRWWWRRRRRRRR,362,79,7304,Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.,HSV-1
RRRRRRRRRRRRRRRWWW,362,79,7305,Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.,HSV-1
KIGAKIKIGAKIKIGAKI,363,8,7385,"Characterisation and evaluation of synthetic antimicrobial peptides against Bacillus globigii, Bacillus anthracis and Burkholderia thailandensis.",Bacillussubtilis
LGGAATGVIGYISNQTCPTTACTRAC,363,8,7389,"Characterisation and evaluation of synthetic antimicrobial peptides against Bacillus globigii, Bacillus anthracis and Burkholderia thailandensis.",Bacillussubtilis
KLKHVGLHVGKLK,364,3,7404,"Antimicrobial activity of pleurocidin is retained in Plc-2, a C-terminal 12-amino acid fragment.",Pseudomonasaeruginosa
KHVGKAALTHYL,364,3,7405,"Antimicrobial activity of pleurocidin is retained in Plc-2, a C-terminal 12-amino acid fragment.",Pseudomonasaeruginosa
KKAAHVGKHVGKAAKK,364,3,7406,"Antimicrobial activity of pleurocidin is retained in Plc-2, a C-terminal 12-amino acid fragment.",Pseudomonasaeruginosa
KKAAHVGKHVGKAAL,364,3,7407,"Antimicrobial activity of pleurocidin is retained in Plc-2, a C-terminal 12-amino acid fragment.",Pseudomonasaeruginosa
GWGSFFKKAAHVG,364,3,7408,"Antimicrobial activity of pleurocidin is retained in Plc-2, a C-terminal 12-amino acid fragment.",Pseudomonasaeruginosa
RRRPRPPYLPRPRPPPFFPPRL,365,2,7469,Antimicrobial and immunomodulatory activities of PR-39 derived peptides.,Escherichiacoli
RRRPRPPYLPRPRPPPFF,365,2,7470,Antimicrobial and immunomodulatory activities of PR-39 derived peptides.,Escherichiacoli
RRRPRPPYLPRPRPP,365,2,7471,Antimicrobial and immunomodulatory activities of PR-39 derived peptides.,Escherichiacoli
PFFPPRLPPRIPPGFPPRFPPRFP,365,2,7472,Antimicrobial and immunomodulatory activities of PR-39 derived peptides.,Escherichiacoli
PRLPPRIPPGFPPRFPPRFP,365,2,7473,Antimicrobial and immunomodulatory activities of PR-39 derived peptides.,Escherichiacoli
PRIPPGFPPRFPPRFP,365,2,7474,Antimicrobial and immunomodulatory activities of PR-39 derived peptides.,Escherichiacoli
VDKPPYLPRPPPPRRIYNNR,366,2,7475,Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens.,Escherichiacoli
VDKPPYLPRPTPPRRIYNNR,366,2,7476,Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens.,Escherichiacoli
VDKPPYLPRPHPPRRIYNNR,366,2,7477,Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens.,Escherichiacoli
VDKPPYLPRPKPPRRIYNNR,366,2,7478,Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens.,Escherichiacoli
VDKPPYLPRPRPPRRIYNNR,366,2,7479,Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens.,Escherichiacoli
VDKPPYLPRPRPPRRIYNRN,366,2,7481,Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens.,Escherichiacoli
VDKPPYLPRPRPPRRIYNR,366,2,7483,Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens.,Escherichiacoli
GFCWNVCVYRNGVRVCHRRCN,367,2,7485,Recombinant production of the antimicrobial peptide NZ17074 in Pichia pastoris using SUMO3 as a fusion partner.,Escherichiacoli
VDKPPYLPRPRPPRRIYN,366,2,7488,Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens.,Escherichiacoli
VYQHQKAMKPWIQPKTKVIPYVRYL,368,19,7503,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
KAMKPWIQPKTKVIPYVRYL,368,19,7504,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
WIQPKTKVIPYVRYL,368,19,7505,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
KAMKPWIQPKTKVIP,368,19,7506,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
AIQPKTKVIPYVRYL,368,19,7507,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
WAQPKTKVIPYVRYL,368,19,7510,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
WIAPKTKVIPYVRYL,368,19,7511,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
WIQAKTKVIPYVRYL,368,19,7512,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
WIQPATKVIPYVRYL,368,19,7513,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
WIQPKAKVIPYVRYL,368,19,7514,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
WIQPKTAVIPYVRYL,368,19,7515,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
WIQPKTKAIPYVRYL,368,19,7516,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
WIQPKTKVAPYVRYL,368,19,7517,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
WIQPKTKVIAYVRYL,368,19,7518,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
WIQPKTKVIPAVRYL,368,19,7519,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
WIQPKTKVIPYARYL,368,19,7520,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
WIQPKTKVIPYVAYL,368,19,7521,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
WIQPKTKVIPYVRAL,368,19,7522,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
WIQPKTKVIPYVRYA,368,19,7523,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
WIQPKTKVIPYV,368,19,7524,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
WIQPKTKVIP,368,19,7526,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
WIQPATAVIPYVAYL,368,19,7527,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
WIQPATAVIPYVRYL,368,19,7530,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
WIQPATKVIPYVAYL,368,19,7532,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
WIQAKTKVIAYVRYL,368,19,7534,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
TKVIPYVRYL,368,19,7535,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
WIQPKTKVIPAVRAL,368,19,7537,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
WIQPKTKVIPWWWWW,368,19,7538,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
TKVIPYVRYLWWWWW,368,19,7539,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
WIQPKTKVIPFFFFF,368,19,7540,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
TKVIPYVRYLFFFFF,368,19,7541,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii
TKNYGNGVTCGKHSCSVDWGKATTCIINNGAMAWATGGHQGNHKC,369,18,7543,Improved Antimicrobial Activities of Synthetic-Hybrid Bacteriocins Designed from Enterocin E50-52 and Pediocin PA-1.,Micrococcusluteus
KYYGNGVCNSVNWCQCGNVWASCNLATGCAAWLCKLA,369,18,7544,Improved Antimicrobial Activities of Synthetic-Hybrid Bacteriocins Designed from Enterocin E50-52 and Pediocin PA-1.,Micrococcusluteus
QPEWFKARRWQWRMKKLGA,370,2,7545,Designed low amphipathic peptides with alpha-helical propensity exhibiting antimicrobial activity via a lipid domain formation mechanism.,Escherichiacoli
TISQPEWFKARRWQWRMKKLGA,370,2,7546,Designed low amphipathic peptides with alpha-helical propensity exhibiting antimicrobial activity via a lipid domain formation mechanism.,Escherichiacoli
TISQAEWFKARRWQWRMKKLGA,370,2,7547,Designed low amphipathic peptides with alpha-helical propensity exhibiting antimicrobial activity via a lipid domain formation mechanism.,Escherichiacoli
TASQAEWFKARRWQWRMKKLGA,370,2,7548,Designed low amphipathic peptides with alpha-helical propensity exhibiting antimicrobial activity via a lipid domain formation mechanism.,Escherichiacoli
EWFKARRWQWRMKKLGA,370,2,7549,Designed low amphipathic peptides with alpha-helical propensity exhibiting antimicrobial activity via a lipid domain formation mechanism.,Escherichiacoli
EWFKARRWGWRMKKLQA,370,2,7550,Designed low amphipathic peptides with alpha-helical propensity exhibiting antimicrobial activity via a lipid domain formation mechanism.,Escherichiacoli
KGCALVKVRGLTLKVCK,371,3,7557,In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.,Pseudomonasaeruginosa
KWCRKWQWRGVKFIKCV,371,3,7558,In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.,Pseudomonasaeruginosa
HKCAKIKWRGVHVKYCA,371,3,7559,In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.,Pseudomonasaeruginosa
RWRLLLLKKH,372,50,7565,Synthesis and biological evaluation of novel peptide BF2 as an antibacterial agent against clinical isolates of vancomycin-resistant enterococci.,Enterococcusfaecium
RWRLLLLKKR,372,52,7566,Synthesis and biological evaluation of novel peptide BF2 as an antibacterial agent against clinical isolates of vancomycin-resistant enterococci.,Enterococcusfaecalis
RWRLLLLKKF,372,52,7567,Synthesis and biological evaluation of novel peptide BF2 as an antibacterial agent against clinical isolates of vancomycin-resistant enterococci.,Enterococcusfaecalis
HWRLLLLKKH,372,50,7568,Synthesis and biological evaluation of novel peptide BF2 as an antibacterial agent against clinical isolates of vancomycin-resistant enterococci.,Enterococcusfaecium
RWRLLLLKRH,372,52,7569,Synthesis and biological evaluation of novel peptide BF2 as an antibacterial agent against clinical isolates of vancomycin-resistant enterococci.,Enterococcusfaecalis
RWRLLLLKWH,372,52,7570,Synthesis and biological evaluation of novel peptide BF2 as an antibacterial agent against clinical isolates of vancomycin-resistant enterococci.,Enterococcusfaecalis
RWRLLLLLRWR,372,52,7571,Synthesis and biological evaluation of novel peptide BF2 as an antibacterial agent against clinical isolates of vancomycin-resistant enterococci.,Enterococcusfaecalis
RWRLLGLLKRH,372,52,7572,Synthesis and biological evaluation of novel peptide BF2 as an antibacterial agent against clinical isolates of vancomycin-resistant enterococci.,Enterococcusfaecalis
RWRLLLLLKRH,372,52,7573,Synthesis and biological evaluation of novel peptide BF2 as an antibacterial agent against clinical isolates of vancomycin-resistant enterococci.,Enterococcusfaecalis
ELDRICGYGTARRKKCR,373,2,7574,Antimicrobial activity of human ?-defensin 4 analogs: insights into the role of disulfide linkages in modulating activity.,Escherichiacoli
ELDRIGYGTARCRKKCR,373,2,7575,Antimicrobial activity of human ?-defensin 4 analogs: insights into the role of disulfide linkages in modulating activity.,Escherichiacoli
ELDRICGYGTARCRKKR,373,2,7576,Antimicrobial activity of human ?-defensin 4 analogs: insights into the role of disulfide linkages in modulating activity.,Escherichiacoli
ELCDRICGYGTARCRKKCR,373,2,7577,Antimicrobial activity of human ?-defensin 4 analogs: insights into the role of disulfide linkages in modulating activity.,Escherichiacoli
ELCCDRIGCYTARCRKKRSCCL,373,2,7578,Antimicrobial activity of human ?-defensin 4 analogs: insights into the role of disulfide linkages in modulating activity.,Escherichiacoli
KRSQEYRIGRCPNTYACLKR,373,2,7579,Antimicrobial activity of human ?-defensin 4 analogs: insights into the role of disulfide linkages in modulating activity.,Escherichiacoli
NGVQPKYRWWRWWRRWW,374,56,7584,Improving the antibacterial activity and selectivity of an ultra short peptide by hydrophobic and hydrophilic amino acid stretches.,Staphylococcusepidermidis
NGVQPKYRWWRWWRRWWW,374,56,7585,Improving the antibacterial activity and selectivity of an ultra short peptide by hydrophobic and hydrophilic amino acid stretches.,Staphylococcusepidermidis
KESRAKKFQRQHMDSDSSPSSSSTYSNQMMRRRNMTQGRSKPVNTFVH,375,2,7639,Ribonucleases as a host-defence family: evidence of evolutionarily conserved antimicrobial activity at the N-terminus.,Escherichiacoli
KPPQFTWAQWFETQHINMTSQQSTNAMQVINNYQRRSKNQNTFLL,375,2,7640,Ribonucleases as a host-defence family: evidence of evolutionarily conserved antimicrobial activity at the N-terminus.,Escherichiacoli
RPPQFTRAQWFAIQHISLNPPRSTIAMRAINNYRWRSKNQNTFL,375,2,7641,Ribonucleases as a host-defence family: evidence of evolutionarily conserved antimicrobial activity at the N-terminus.,Escherichiacoli
QDGMYQRFLRQHVHPEETGGSDRYSNLMMQRRKMTLYHSKRFNTFIH,375,2,7642,Ribonucleases as a host-defence family: evidence of evolutionarily conserved antimicrobial activity at the N-terminus.,Escherichiacoli
QDNSRYTHFLTQHYDAKPQGRDDRYSESIMRRRGLTSPSKDINTFIH,375,2,7643,Ribonucleases as a host-defence family: evidence of evolutionarily conserved antimicrobial activity at the N-terminus.,Escherichiacoli
WPKRLTKAHWFEIQHIQPSPLQSNRAMSGINNYTQHSKHQNTFLH,375,2,7644,Ribonucleases as a host-defence family: evidence of evolutionarily conserved antimicrobial activity at the N-terminus.,Escherichiacoli
KPKDMTSSQWFKTQHVQPSPQASNSAMSIINKYTERSKDLNTFLH,375,2,7645,Ribonucleases as a host-defence family: evidence of evolutionarily conserved antimicrobial activity at the N-terminus.,Escherichiacoli
GLFRALLRLLRSLWRLLLRA,377,42,7655,Selectivity for and destruction of Salmonella typhimurium via a membrane damage mechanism of a cell-penetrating peptide ppTG20 analogue.,Salmonellatyphimurium
GLRRALLRLLRSLRRLLLRA,377,42,7656,Selectivity for and destruction of Salmonella typhimurium via a membrane damage mechanism of a cell-penetrating peptide ppTG20 analogue.,Salmonellatyphimurium
SAVGRHLRRFGLRKHRKH,378,2,7659,"Rational design of anti-microbial peptides with enhanced activity and low cytotoxicity based on the structure of the arginine/histidine-rich peptide, chensinin-1.",Escherichiacoli
SAVGRHLRRFLLRKHRKH,378,2,7660,"Rational design of anti-microbial peptides with enhanced activity and low cytotoxicity based on the structure of the arginine/histidine-rich peptide, chensinin-1.",Escherichiacoli
SAVLRHLRRFLLRKHRKH,378,2,7661,"Rational design of anti-microbial peptides with enhanced activity and low cytotoxicity based on the structure of the arginine/histidine-rich peptide, chensinin-1.",Escherichiacoli
SKVGRHGRRFGHRAHRKL,378,2,7662,"Rational design of anti-microbial peptides with enhanced activity and low cytotoxicity based on the structure of the arginine/histidine-rich peptide, chensinin-1.",Escherichiacoli
SKVGRHLRRFGHRAHRKL,378,2,7663,"Rational design of anti-microbial peptides with enhanced activity and low cytotoxicity based on the structure of the arginine/histidine-rich peptide, chensinin-1.",Escherichiacoli
SKVGRHLRRFLHRAHRKL,378,2,7664,"Rational design of anti-microbial peptides with enhanced activity and low cytotoxicity based on the structure of the arginine/histidine-rich peptide, chensinin-1.",Escherichiacoli
SKVLRHLRRFLHRAHRKL,378,2,7665,"Rational design of anti-microbial peptides with enhanced activity and low cytotoxicity based on the structure of the arginine/histidine-rich peptide, chensinin-1.",Escherichiacoli
GLARALTRLLRQLTRQLTRA,379,42,7672,Antibacterial activity and dual mechanisms of peptide analog derived from cell-penetrating peptide against Salmonella typhimurium and Streptococcus pyogenes.,Salmonellatyphimurium
VQWRIRVCVIRA,380,4,7675,In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method.,Staphylococcusaureus
VQWRIRIAVIRA,380,4,7676,In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method.,Staphylococcusaureus
VCWRIRVAVIRA,380,4,7677,In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method.,Staphylococcusaureus
VQLRIRVCVIRR,380,4,7678,In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method.,Staphylococcusaureus
KQWRIRVAVIRA,380,4,7679,In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method.,Staphylococcusaureus
VQWRIRVAVIRK,380,4,7680,In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method.,Staphylococcusaureus
VQLRIRVCVIRK,380,4,7681,In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method.,Staphylococcusaureus
KQWRIRVCVIRA,380,4,7682,In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method.,Staphylococcusaureus
VQLRCRVCVIRK,380,4,7683,In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method.,Staphylococcusaureus
VQWRIRIAVIRK,380,4,7684,In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method.,Staphylococcusaureus
KFFKKLKKAVKKGFKKFAKV,381,2,7702,Efficacy of OH-CATH30 and its analogs against drug-resistant bacteria in vitro and in mouse models.,Escherichiacoli
RCPGRTRQIGTIFGPRIKCRSW,382,2,7703,N-terminal fatty acylation of peptides spanning the cationic C-terminal segment of bovine ?-defensin-2 results in salt-resistant antibacterial activity.,Escherichiacoli
LVQRFHAYLHKFREAFMNVGAAAAVEGTKAA,383,80,7717,Probing protein sequences as sources for encrypted antimicrobial peptides.,Xanthomonasaxonopodis
GLWSTIKQKGKE,383,80,7732,Probing protein sequences as sources for encrypted antimicrobial peptides.,Xanthomonasaxonopodis
HRILMRIRQMMT,384,81,7748,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,Porcinereproductive
ARILMRIRQMMT,384,81,7749,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,Porcinereproductive
HRALMRIRQMMT,384,81,7750,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,Porcinereproductive
HRIAMRIRQMMT,384,81,7751,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,Porcinereproductive
HRILARIRQMMT,384,81,7752,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,Porcinereproductive
HRILMRARQMMT,384,81,7753,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,Porcinereproductive
HRILMRIAQMMT,384,81,7754,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,Porcinereproductive
HRILMRIRAMMT,384,81,7755,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,Porcinereproductive
HRILMRIRQAMT,384,81,7756,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,Porcinereproductive
HRILMRIRQMAT,384,81,7757,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,Porcinereproductive
HRILMRIRQMMA,384,81,7758,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,Porcinereproductive
LMRIRQMMT,384,81,7759,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,Porcinereproductive
HRILMRIR,384,81,7760,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,Porcinereproductive
GGLFYVKHKEQQRKRF,157,8,7762,"Macrobrachium rosenbergii mannose binding lectin: Synthesis of MrMBL-N20 and MrMBL-C16 peptides and their antimicrobial characterization, bioinformatics and relative gene expression analysis.",Bacillussubtilis
GFGCNGPWQEDDVKCHNHCKSIKGYKGGYCAKGGFVCKCY,385,4,7764,"In vitro and in vivo characterization of a new recombinant antimicrobial peptide, MP1102, against methicillin-resistant Staphylococcus aureus.",Staphylococcusaureus
IAAAGLPQE,386,19,7771,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii
AKHQGLPQE,386,19,7772,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii
IKHQGLPQA,386,19,7773,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii
IKHAGLPQE,386,19,7774,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii
IKHRGLPQE,386,19,7780,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii
IKHQGRPQE,386,19,7782,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii
IRHQGLPQE,386,19,7784,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii
IRRQGLPE,386,19,7786,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii
IHHQGLPQE,386,19,7788,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii
IKQGLPQE,386,19,7789,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii
IHQGLPQE,386,19,7792,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii
IKHQGLPQEE,386,19,7793,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii
IKHQGLPQED,386,19,7795,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii
VLNENLAA,386,19,7798,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii
VLNENLRR,386,19,7801,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii
VLNENAAR,386,19,7802,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii
VINENLLR,386,19,7803,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii
VLNANLLR,386,19,7804,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii
VLNEALLR,386,19,7805,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii
VLNENLLH,386,19,7806,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii
VLNENARL,386,19,7807,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii
VALNENLLR,386,19,7808,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii
VLNDNLLR,386,19,7809,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii
VLNENLLK,386,19,7810,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii
VANENLLR,386,19,7813,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii
SFKKFWGGVKAIFKGARKGWK,387,2,7819,Identification of antimicrobial peptides from teleosts and anurans in expressed sequence tag databases using conserved signal sequences.,Escherichiacoli
FFKKFWGGVKAIFKGARKGWK,387,2,7820,Identification of antimicrobial peptides from teleosts and anurans in expressed sequence tag databases using conserved signal sequences.,Escherichiacoli
SVKKFWGGVKAIFKGARKGLK,387,2,7821,Identification of antimicrobial peptides from teleosts and anurans in expressed sequence tag databases using conserved signal sequences.,Escherichiacoli
FVKKFWGGVKAIFKGARKGLK,387,2,7824,Identification of antimicrobial peptides from teleosts and anurans in expressed sequence tag databases using conserved signal sequences.,Escherichiacoli
GWGDTFGKVLKNFAKVAGVKAAK,387,2,7827,Identification of antimicrobial peptides from teleosts and anurans in expressed sequence tag databases using conserved signal sequences.,Escherichiacoli
GWGDTFLKTMAKIAKVGPKLLHS,387,2,7830,Identification of antimicrobial peptides from teleosts and anurans in expressed sequence tag databases using conserved signal sequences.,Escherichiacoli
RKSKEKIGKEFKRIVQRIKDF,388,2,7832,Antimicrobial and membrane disrupting activities of a peptide derived from the human cathelicidin antimicrobial peptide LL37.,Escherichiacoli
LLGDFFRKSKEKIGKEFKRIVQR,389,2,7837,"Structure, dynamics, and antimicrobial and immune modulatory activities of human LL-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins.",Escherichiacoli
LLGDFFRKAKEKIGKEFKRIVQR,389,2,7838,"Structure, dynamics, and antimicrobial and immune modulatory activities of human LL-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins.",Escherichiacoli
LLGDFFRKVKEKIGKEFKRIVQR,389,2,7839,"Structure, dynamics, and antimicrobial and immune modulatory activities of human LL-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins.",Escherichiacoli
LLGDFFRKAKEKIGKEFKRIVQRIKDFLRNLVPRTES,389,2,7840,"Structure, dynamics, and antimicrobial and immune modulatory activities of human LL-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins.",Escherichiacoli
LLGDFFRKVKEKIGKEFKRIVQRIKDFLRNLVPRTES,389,2,7841,"Structure, dynamics, and antimicrobial and immune modulatory activities of human LL-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins.",Escherichiacoli
RGCVYAYVRVRGVLVRYRRCW,390,4,7856,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus
RSCVYAYVRVRGVLVRYRRCW,390,4,7857,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus
RRCVYAYVRVRGVLVRYRRCW,390,4,7858,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus
RWCGYAYVRVRGVLVRYRRCW,390,4,7859,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus
RWCSYAYVRVRGVLVRYRRCW,390,4,7860,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus
RWCRYAYVRVRGVLVRYRRCW,390,4,7861,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus
RWCVYGYVRVRGVLVRYRRCW,390,4,7864,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus
RWCVYSYVRVRGVLVRYRRCW,390,4,7865,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus
RWCVYRYVRVRGVLVRYRRCW,390,4,7866,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus
RWCVYAYGRVRGVLVRYRRCW,390,4,7867,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus
RWCVYAYSRVRGVLVRYRRCW,390,4,7868,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus
RWCVYAYRRVRGVLVRYRRCW,390,4,7869,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus
RWCVYAYVRGRGVLVRYRRCW,390,4,7870,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus
VTCDLLSFKGQVNDSACAANCLSLGKAGGHCEKGVCICRKTSFKDLWDKRF,392,4,7872,"Structure and antimicrobial activity relationship of royalisin, an antimicrobial peptide from royal jelly of Apis mellifera.",Staphylococcusaureus
VTCDLLSFKGQVNDSACAANCLSLGKAGGHCEKGVCICRK,392,4,7873,"Structure and antimicrobial activity relationship of royalisin, an antimicrobial peptide from royal jelly of Apis mellifera.",Staphylococcusaureus
RWCVYAYVRSRGVLVRYRRCW,390,4,7877,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus
RWCVYAYVRRRGVLVRYRRCW,390,4,7879,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus
RWCVYAYVRVRGGLVRYRRCW,390,4,7880,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus
RWCVYAYVRVRGSLVRYRRCW,390,4,7881,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus
RWCVYAYVRVRGRLVRYRRCW,390,4,7882,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus
RWCVYAYVRVRGVGVRYRRCW,390,4,7883,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus
RWCVYAYVRVRGVSVRYRRCW,390,4,7884,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus
RWCVYAYVRVRGVRVRYRRCW,390,4,7885,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus
RWCVYAYVRVRGVLGRYRRCW,390,4,7897,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus
RWCVYAYVRVRGVLSRYRRCW,390,4,7899,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus
RWCVYAYVRVRGVLRRYRRCW,390,4,7900,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus
RWCVYAYVRVRGVLVRYRRCG,390,4,7902,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus
RWCVYAYVRVRGVLVRYRRCS,390,4,7903,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus
RWCVYAYVRVRGVLVRYRRCR,390,4,7905,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus
NTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK,393,4,7910,N-terminus three residues deletion mutant of human beta-defensin 3 with remarkably enhanced salt-resistance.,Staphylococcusaureus
QKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK,393,4,7912,N-terminus three residues deletion mutant of human beta-defensin 3 with remarkably enhanced salt-resistance.,Staphylococcusaureus
KKLFKKILKYL,394,80,7913,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KKLFKKILKYLAGPA,394,80,7918,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KKLFKKILKYLKDEL,394,80,7919,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KKLFKKILKYLKKLFKKILKYL,394,80,7920,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KKLFKKILKYLAGPAKKLFKKILKYL,394,80,7921,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
GKKLFKKILKYLAGPAKKLFKKILKYL,394,80,7922,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
SKKLFKKILKYLAGPAKKLFKKILKYL,394,80,7923,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KKLFKKILKYLAGPAKKLFKKILKYLAGPA,394,80,7924,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KKLFKKILKYLKKLFKKILKYLKDEL,394,80,7926,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KKLFKKILKYLAGPAKKLFKKILKYLKDEL,394,80,7928,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KKLFKKILKYLAGPALYKLIKKFLKKKDEL,394,80,7929,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
GKKLFKKILKYLAGPAKKLFKKILKYLKDEL,394,80,7930,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
SKKLFKKILKYLAGPAKKLFKKILKYLKDEL,394,80,7931,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KKLFKKILKYLAGPAKKLFKKILKYLAGPAKDWEHLKDWEHLKDWEHLKDEL,394,80,7932,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KKLFKKILKYLKKLFKKILKYLKKLFKKILKYL,394,80,7933,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KKLFKKILKYLAGPAKKLFKKILKYLAGPAKKLFKKILKYL,394,80,7934,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KKLFKKILKYLAGPAKKLFKKILKYLAGPAKKLFKKILKYLKDEL,394,80,7935,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KDWEHLKDWEHLKDWEHL,394,80,7936,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KDWEHLKDWEHLKDWEHLKDEL,394,80,7937,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KKLFKKILKYLTTGLPALISW,394,80,7938,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KKLFKKILKYLAGPATTGLPALISW,394,80,7939,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
GKKLFKKILKYLAGPATTGLPALISW,394,80,7940,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
SKKLFKKILKYLAGPATTGLPALISW,394,80,7941,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KKLFKKILKYLTTGLPALISWKDEL,394,80,7942,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KKLFKKILKYLAGPATTGLPALISWKDEL,394,80,7943,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KKLFKKILKYLGIGAVLKVLTTGLKDEL,394,80,7944,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KKLFKKILKYLTTGLPALISAGPASILAPLGTTLYKLIKKFLKKKDEL,394,80,7945,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KKLFKKILKYLKFLHSAK,394,80,7947,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KKLFKKILKYLAGPAKFLHSAK,394,80,7949,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
GKKLFKKILKYLAGPAKFLHSAK,394,80,7950,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
SKKLFKKILKYLAGPAKFLHSAK,394,80,7951,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KKLFKKILKYLKFLHSAKKDEL,394,80,7952,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KKLFKKILKYLAGPAKFLHSAKKDEL,394,80,7954,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KKLFKKILKYLAGPAKFLHSAKAGPAKDWEHLKDWEHLKDWEHLKDEL,394,80,7955,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KKLFKKILKYLGIGKFLHSAK,394,80,7956,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KKLFKKILKYLAGPAGIGKFLHSAK,394,80,7958,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
GKKLFKKILKYLAGPAGIGKFLHSAK,394,80,7959,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
SKKLFKKILKYLAGPAGIGKFLHSAK,394,80,7960,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KKLFKKILKYLGIGKFLHSAKKDEL,394,80,7961,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KKLFKKILKYLAGPAGIGKFLHSAKKDEL,394,80,7962,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KKLFKKILKYLAVAVVGQATQIAKKDEL,394,80,7963,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
KKLFKKILKYLAGPAVAVVGQATQIAKKDEL,394,80,7964,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
AVAVVGQATQIAKKKLFKKILKYLKDEL,394,80,7965,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis
SPEEARVKILTAIPEMREEDLSEE,395,2,7996,"Centrocins: isolation and characterization of novel dimeric antimicrobial peptides from the green sea urchin, Strongylocentrotus droebachiensis.",Escherichiacoli
SKHWLWLW,396,4,8096,"Antibacterial agents based on the cyclic D,L-alpha-peptide architecture.",Staphylococcusaureus
RRGWLALRLVLAY,397,2,8100,A lack of synergy between membrane-permeabilizing cationic antimicrobial peptides and conventional antibiotics.,Escherichiacoli
SKVWRHWRRFWHRAHRKK,398,2,8105,Insights into the membrane interaction mechanism and antibacterial properties of chensinin-1b.,Escherichiacoli
KYLNFAKWLKGANLAKYANA,399,82,8108,Antimicrobial peptide GW-H1-induced apoptosis of human gastric cancer AGS cell line is enhanced by suppression of autophagy.,Humangastric
RRRRWWWW,400,4,8109,Antibacterial activities of amphiphilic cyclic cell-penetrating peptides against multidrug-resistant pathogens.,Staphylococcusaureus
EEEEWWWW,400,4,8112,Antibacterial activities of amphiphilic cyclic cell-penetrating peptides against multidrug-resistant pathogens.,Staphylococcusaureus
CNGRCGGKLAKLAKKLAKLAK,401,83,8125,An antimicrobial peptide containing NGR motif has potent antitumor activity against CD13+ and CD13- tumor cells.,Humanfibrosarcoma
VTCDLLSAEAKGVKVNHAACAAHCLLKRKRGGYCNKRRICVCRN,402,4,8150,A Defensin from the Model Beetle Tribolium castaneum Acts Synergistically with Telavancin and Daptomycin against Multidrug Resistant Staphylococcus aureus.,Staphylococcusaureus
KFFARLLASVRAAVKKFRKKPRLIGLSTLL,403,2,8158,"Identification and Characterization of the First Cathelicidin from Sea Snakes with Potent Antimicrobial and Anti-inflammatory Activity, and Special Mechanism.",Escherichiacoli
AFFARLLASVRAAVKAFAKKPRLIGLSTLL,403,2,8159,"Identification and Characterization of the First Cathelicidin from Sea Snakes with Potent Antimicrobial and Anti-inflammatory Activity, and Special Mechanism.",Escherichiacoli
LKKLKGRVSRSFLFFVKLRPAKRTLKKRIL,403,2,8160,"Identification and Characterization of the First Cathelicidin from Sea Snakes with Potent Antimicrobial and Anti-inflammatory Activity, and Special Mechanism.",Escherichiacoli
YSLKKTSMKIIPFTRL,404,2,8164,Bioprospecting the American alligator (Alligator mississippiensis) host defense peptidome.,Escherichiacoli
KKTSMKIIPFTRL,404,2,8165,Bioprospecting the American alligator (Alligator mississippiensis) host defense peptidome.,Escherichiacoli
PPPVIKFNRPFLMWIVERDTRSILFMGKIVNPKAP,404,2,8166,Bioprospecting the American alligator (Alligator mississippiensis) host defense peptidome.,Escherichiacoli
LQTKLKKLLGLESVF,404,2,8167,Bioprospecting the American alligator (Alligator mississippiensis) host defense peptidome.,Escherichiacoli
PPGASPRKKPRKQ,404,2,8168,Bioprospecting the American alligator (Alligator mississippiensis) host defense peptidome.,Escherichiacoli
VERIPLVRFKSIKKQLHERGDL,404,2,8169,Bioprospecting the American alligator (Alligator mississippiensis) host defense peptidome.,Escherichiacoli
YPYYGTNLYQRRPAIAINNPYVPRTYYANPAVVRPHAQIPQRQYLPNSHPPTVVRRP,405,7,8172,Identification of multifunctional peptides from human milk.,Streptococcusmutans
PCRGRSCGPRLRGGYTLIGRPVKNQNRPKYMWV,406,2,8202,A novel cathelicidin from Bufo bufo gargarizans Cantor showed specific activity to its habitat bacteria.,Escherichiacoli
GIGAVLKVLTTGLCALISWIKRKRQQ,407,4,8209,Melittin peptides exhibit different activity on different cells and model membranes.,Staphylococcusaureus
YWKKWKKLRRIFMLV,408,2,8214,Machine learning assisted design of highly active peptides for drug discovery.,Escherichiacoli
WWKRWKKLRRIFLML,408,2,8215,Machine learning assisted design of highly active peptides for drug discovery.,Escherichiacoli
WWKRWKRIRRIFMMV,408,2,8216,Machine learning assisted design of highly active peptides for drug discovery.,Escherichiacoli
WWKWWKRLRRLFLLV,408,2,8217,Machine learning assisted design of highly active peptides for drug discovery.,Escherichiacoli
KWKLFKGIRAVLKVL,408,2,8218,Machine learning assisted design of highly active peptides for drug discovery.,Escherichiacoli
GWRLIKKILRVFKGL,408,2,8219,Machine learning assisted design of highly active peptides for drug discovery.,Escherichiacoli
KWKLFLGILAVLKVL,408,2,8220,Machine learning assisted design of highly active peptides for drug discovery.,Escherichiacoli
RPHGAGEGIDRVPAGPSPSEVGLAIPSGK,409,51,8267,Novel antimicrobial peptide specifically active against Porphyromonas gingivalis.,Porphyromonasgingivalis
KWKLFKKIFKRIVQRIKDFLR,410,74,8268,"Design and characterization of novel hybrid antimicrobial peptides based on cecropin A, LL-37 and magainin II.",Bacillusanthracis
KWKLFKKIAKKFAKAFVAEIM,410,74,8269,"Design and characterization of novel hybrid antimicrobial peptides based on cecropin A, LL-37 and magainin II.",Bacillusanthracis
FKRIVQRIKDFLRGIGKFLHSAKKF,410,74,8270,"Design and characterization of novel hybrid antimicrobial peptides based on cecropin A, LL-37 and magainin II.",Bacillusanthracis
GIGKFLHSAKKFFKRIVQRIKDFLR,410,74,8271,"Design and characterization of novel hybrid antimicrobial peptides based on cecropin A, LL-37 and magainin II.",Bacillusanthracis
HLNKRVQRELIGWLDWLK,411,84,8278,Antimicrobial activity and mechanism of action of a novel cationic ?-helical octadecapeptide derived from ?-amylase of rice.,Eikenellacorrodens
DNRMVNHFVQEFKRKHKK,412,51,8279,Antimicrobial activity and mechanism of action of a novel cationic ?-helical octadecapeptide derived from heat shock protein 70 of rice.,Porphyromonasgingivalis
SQRQATKDAGVIS,412,51,8280,Antimicrobial activity and mechanism of action of a novel cationic ?-helical octadecapeptide derived from heat shock protein 70 of rice.,Porphyromonasgingivalis
RARFEELNMDLFRR,412,51,8281,Antimicrobial activity and mechanism of action of a novel cationic ?-helical octadecapeptide derived from heat shock protein 70 of rice.,Porphyromonasgingivalis
ACPIFTKIQGTYRGKAKRIGRRIC,413,2,8283,A hybrid cationic peptide composed of human ?-defensin-1 and humanized ?-defensin sequences exhibits salt-resistant antimicrobial activity.,Escherichiacoli
KGIRGYKGGYCKGAFKQTCKCY,414,8,8286,Structural and functional characterization of peptides derived from the carboxy-terminal region of a defensin from the tick Ornithodoros savignyi.,Bacillussubtilis
KGIRGYKGGYKGAFKQTKY,414,8,8287,Structural and functional characterization of peptides derived from the carboxy-terminal region of a defensin from the tick Ornithodoros savignyi.,Bacillussubtilis
CGNFLKRTCICVKK,415,17,8299,Ixodes ricinus defensins attack distantly-related pathogens.,Listeriamonocytogenes
CSGIIKQTCTCYRK,415,17,8303,Ixodes ricinus defensins attack distantly-related pathogens.,Listeriamonocytogenes
CNGPFNIVCSCY,415,17,8305,Ixodes ricinus defensins attack distantly-related pathogens.,Listeriamonocytogenes
GFLSILKKVLP,416,1,8333,Melectin MAPs: the influence of dendrimerization on antimicrobial and hemolytic activity.,None_target
FRKSKEKIGKEFKRI,417,85,8343,The ATPase activity of the mycobacterial plasma membrane is inhibited by the LL37-analogous peptide LLAP.,Mycobacteriumsmegmatis
GRKSAKKIGKRAKRI,417,85,8344,The ATPase activity of the mycobacterial plasma membrane is inhibited by the LL37-analogous peptide LLAP.,Mycobacteriumsmegmatis
MWITNGGVANWYFVLAR,418,4,8350,"Isolation, purification, and detection of the antimicrobial activity of the antimicrobial peptide CcAMP1 from Coridius chinensis (Hemiptera: Dinidoridae)",Staphylococcusaureus
GYLEQLLR,419,2,8358,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli
LGYLEQLLR,419,2,8359,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli
YLEQLLRL,419,2,8360,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli
YLEQLLRLK,419,2,8361,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli
LGYLEQLLRL,419,2,8362,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli
LEQLLRLKKY,419,2,8363,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli
LEQLLRLK,419,2,8364,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli
HIQKEDVPSERYLGYLEQLLRLK,419,2,8365,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli
HIQKEDVPSERYLGYLEQLLRLKK,419,2,8366,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli
HIQKEDVPSERYLGYLEQLLRLKKYK,419,2,8367,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli
NENLLRFF,419,2,8368,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli
LNENLLRF,419,2,8369,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli
RPKHPIKHQGLPQEVLNENLLRFF,419,2,8370,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli
RPKHPIKHQGLPQEVLNENLLRFFVAPFPEVFGK,419,2,8371,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli
RPKHPIKHQGLPQEVLNENLLRFFVAPFPEVFGKEK,419,2,8375,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli
RPKHPIKHQGLPQEVLNENLLRFFVAPFPEVFGKEKV,419,2,8376,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli
YPELFRQF,419,2,8377,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli
IVLNPWDQVK,419,2,8378,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli
TKLTEEEKNRLNFLKKISQRYQ,419,2,8379,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli
TVYQHQKAMKPWIQPKTKVIPYVRYL,419,2,8380,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli
TKLTEEEKNRLNFLKKISQRYQKFALPQYLK,419,2,8381,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli
VPYPQRDMPIQAFL,419,2,8382,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli
GIGKALHSAKKFGKAFVGEIMNS,420,2,8388,Influence of hydrophobic residues on the activity of the antimicrobial peptide magainin 2 and its synergy with PGLa.,Escherichiacoli
GIGKFAHSAKKFGKAFVGEIMNS,420,2,8389,Influence of hydrophobic residues on the activity of the antimicrobial peptide magainin 2 and its synergy with PGLa.,Escherichiacoli
GIGKFLHSAKKAGKAFVGEIMNS,420,2,8390,Influence of hydrophobic residues on the activity of the antimicrobial peptide magainin 2 and its synergy with PGLa.,Escherichiacoli
GIGKFLHSAKKFAKAFVGEIMNS,420,2,8391,Influence of hydrophobic residues on the activity of the antimicrobial peptide magainin 2 and its synergy with PGLa.,Escherichiacoli
GIGKFLHSAKKFGKAAVGEIMNS,420,2,8392,Influence of hydrophobic residues on the activity of the antimicrobial peptide magainin 2 and its synergy with PGLa.,Escherichiacoli
GIGKFLHSAKKFGKAFAGEIMNS,420,2,8393,Influence of hydrophobic residues on the activity of the antimicrobial peptide magainin 2 and its synergy with PGLa.,Escherichiacoli
GIGKFLHSAKKFGKAFVAEIMNS,420,2,8394,Influence of hydrophobic residues on the activity of the antimicrobial peptide magainin 2 and its synergy with PGLa.,Escherichiacoli
GIGKFLHSAKKFGKAFVGEAMNS,420,2,8395,Influence of hydrophobic residues on the activity of the antimicrobial peptide magainin 2 and its synergy with PGLa.,Escherichiacoli
FFGWLIKGAIHAGKAIHGLI,421,86,8421,Epinecidin-1 antimicrobial activity: In vitro membrane lysis and In vivo efficacy against Helicobacter pylori infection in a mouse model.,Helicobacterpylori
FWGFLGKLAMKAVPSLIGGNKSSSK,422,4,8439,Peptides from the scorpion Vaejovis punctatus with broad antimicrobial activity.,Staphylococcusaureus
FWGFLGKLAMKAVPSLIGGNKK,422,4,8440,Peptides from the scorpion Vaejovis punctatus with broad antimicrobial activity.,Staphylococcusaureus
WGIRRILKYGKRS,424,2,8497,Structural insights into and activity analysis of the antimicrobial peptide myxinidin.,Escherichiacoli
WGIRDILKYGKPS,424,2,8499,Structural insights into and activity analysis of the antimicrobial peptide myxinidin.,Escherichiacoli
WGIHRILKYGKPS,424,2,8501,Structural insights into and activity analysis of the antimicrobial peptide myxinidin.,Escherichiacoli
SKCKCSRKGPKIR,425,2,8502,CXCL14 displays antimicrobial activity against respiratory tract bacteria and contributes to clearance of Streptococcus pneumoniae pulmonary infection.,Escherichiacoli
LQSTKRFIKWYNAWNEKRR,425,2,8503,CXCL14 displays antimicrobial activity against respiratory tract bacteria and contributes to clearance of Streptococcus pneumoniae pulmonary infection.,Escherichiacoli
YSDVKKLEMKPKYPHCEEKMVIITTKSVSRYRGQEHCLHPK,425,2,8504,CXCL14 displays antimicrobial activity against respiratory tract bacteria and contributes to clearance of Streptococcus pneumoniae pulmonary infection.,Escherichiacoli
RRIRPRPPRLPRPRPC,426,2,8508,Effect of size and N-terminal residue characteristics on bacterial cell penetration and antibacterial activity of the proline-rich peptide Bac7.,Escherichiacoli
RRIRPRPPRLPRPC,426,2,8510,Effect of size and N-terminal residue characteristics on bacterial cell penetration and antibacterial activity of the proline-rich peptide Bac7.,Escherichiacoli
RRIRPRPR,426,2,8512,Effect of size and N-terminal residue characteristics on bacterial cell penetration and antibacterial activity of the proline-rich peptide Bac7.,Escherichiacoli
RRIRPRPRC,426,2,8513,Effect of size and N-terminal residue characteristics on bacterial cell penetration and antibacterial activity of the proline-rich peptide Bac7.,Escherichiacoli
IRPRPPRLPRPRPRPLPYPRP,426,2,8515,Effect of size and N-terminal residue characteristics on bacterial cell penetration and antibacterial activity of the proline-rich peptide Bac7.,Escherichiacoli
RRIRPRPPRLPRPRPRPLPYPRP,426,2,8517,Effect of size and N-terminal residue characteristics on bacterial cell penetration and antibacterial activity of the proline-rich peptide Bac7.,Escherichiacoli
ACYCRIPACIAGERRYGTCIYQGRLWAFCC,363,8,8589,"Characterisation and evaluation of synthetic antimicrobial peptides against Bacillus globigii, Bacillus anthracis and Burkholderia thailandensis.",Bacillussubtilis
DSHAKRHHGTKRKFHEKHHSHRGT,427,65,8605,De-novo design of antimicrobial peptides for plant protection.,Botrytiscinerea
FLGMLLHGVGHAIHGLIHGKQNVE,428,2,8611,"Molecular, genomic, and expressional delineation of a piscidin from rock bream (Oplegnathus fasciatus) with evidence for the potent antimicrobial activities of Of-Pis1 peptide.",Escherichiacoli
ALKYRLFKKLKKF,429,4,8641,In vitro determination of the short-chain synthetic peptide RP13 antimicrobial activity.,Staphylococcusaureus
VAVLVLGA,430,52,8642,Pheromone killing of multidrug-resistant Enterococcus faecalis V583 by native commensal strains.,Enterococcusfaecalis
IVSSMFVSA,430,52,8643,Pheromone killing of multidrug-resistant Enterococcus faecalis V583 by native commensal strains.,Enterococcusfaecalis
LLLGAATG,430,52,8644,Pheromone killing of multidrug-resistant Enterococcus faecalis V583 by native commensal strains.,Enterococcusfaecalis
KLRKLFRKLLKLIRKLLR,431,67,8646,Comparative Evaluation of the Antimicrobial Activity of Different Antimicrobial Peptides against a Range of Pathogenic Bacteria.,Yersiniaruckeri
RGRKVVRRKK,432,77,8647,N-Lipidated Peptide Dimers: Effective Antibacterial Agents against Gram-Negative Pathogens through Lipopolysaccharide Permeabilization.,Klebsiellapneumoniae
RGRKVVRR,432,1,8656,N-Lipidated Peptide Dimers: Effective Antibacterial Agents against Gram-Negative Pathogens through Lipopolysaccharide Permeabilization.,None_target
RGRKGGRRKK,432,77,8674,N-Lipidated Peptide Dimers: Effective Antibacterial Agents against Gram-Negative Pathogens through Lipopolysaccharide Permeabilization.,Klebsiellapneumoniae
RGRKGGRR,432,1,8683,N-Lipidated Peptide Dimers: Effective Antibacterial Agents against Gram-Negative Pathogens through Lipopolysaccharide Permeabilization.,None_target
GTVRRFPWWWPFLRR,433,2,8709,"Recombinant expression, antimicrobial activity and mechanism of action of tritrpticin analogs containing fluoro-tryptophan residues.",Escherichiacoli
GEGFLGMLLHGVGHAIHGLIHGK,434,2,8752,"Piscidin: Antimicrobial peptide of rock bream, Oplegnathus fasciatus.",Escherichiacoli
LLSNVAGLLKQFAK,435,2,8769,Prokaryotic expression and antimicrobial mechanism of XPF-St7-derived ?-helical peptides.,Escherichiacoli
LLRRVAGLLKQFAK,435,2,8770,Prokaryotic expression and antimicrobial mechanism of XPF-St7-derived ?-helical peptides.,Escherichiacoli
LLRRVARLLKRFAK,435,2,8771,Prokaryotic expression and antimicrobial mechanism of XPF-St7-derived ?-helical peptides.,Escherichiacoli
CAIEHMRTPLKPFSFGPPYNL,436,8,8779,Identification of candidate antimicrobial peptides derived from abalone hemocyanin.,Bacillussubtilis
PPYNLNSHTQEYSKPEDTFD,436,8,8780,Identification of candidate antimicrobial peptides derived from abalone hemocyanin.,Bacillussubtilis
DTFDYKKFGYRYDSLELEGR,436,8,8781,Identification of candidate antimicrobial peptides derived from abalone hemocyanin.,Bacillussubtilis
LEGRSISRIDELIQQRQEKD,436,8,8782,Identification of candidate antimicrobial peptides derived from abalone hemocyanin.,Bacillussubtilis
QEKDRTFAGFLLKGFGTSAS,436,8,8783,Identification of candidate antimicrobial peptides derived from abalone hemocyanin.,Bacillussubtilis
KFGYRYDSLELEGRSISRIDELIQQR,436,8,8784,Identification of candidate antimicrobial peptides derived from abalone hemocyanin.,Bacillussubtilis
TSASVSLQVCRVDHTCKDAGYF,436,8,8785,Identification of candidate antimicrobial peptides derived from abalone hemocyanin.,Bacillussubtilis
YFTILGGSAEMPWAFDRLYKYDITKTL,436,8,8786,Identification of candidate antimicrobial peptides derived from abalone hemocyanin.,Bacillussubtilis
TLISWIKNKRKQRPRVSRRRRRRGGRRRR,437,3,8787,Antimicrobial activity of four cationic peptides immobilised to poly-hydroxyethylmethacrylate.,Pseudomonasaeruginosa
KNKRKRRRRRRGGRRRR,437,3,8788,Antimicrobial activity of four cationic peptides immobilised to poly-hydroxyethylmethacrylate.,Pseudomonasaeruginosa
GPIRRPKPRPRPRPE,438,34,8791,"Expression, tissue localization and synergy of antimicrobial peptides and proteins in the immune response of the oyster Crassostrea gigas.",Micrococcuslysodeikticus
GPIRRPKPRPRQRPE,438,34,8792,"Expression, tissue localization and synergy of antimicrobial peptides and proteins in the immune response of the oyster Crassostrea gigas.",Micrococcuslysodeikticus
GPIRRPKPRPRPE,438,34,8793,"Expression, tissue localization and synergy of antimicrobial peptides and proteins in the immune response of the oyster Crassostrea gigas.",Micrococcuslysodeikticus
GPIRRPEPRPRPE,438,34,8794,"Expression, tissue localization and synergy of antimicrobial peptides and proteins in the immune response of the oyster Crassostrea gigas.",Micrococcuslysodeikticus
HTASDAAAAAALTAANAAAAAAASMA,439,2,8795,Structural and functional characterization of a multifunctional alanine-rich peptide analogue from Pleuronectes americanus.,Escherichiacoli
VDRGWGNGCGLFGKGG,440,2,8809,"Antimicrobial Peptides: Insights into Membrane Permeabilization, Lipopolysaccharide Fragmentation and Application in Plant Disease Control.",Escherichiacoli
VARGWGNGCGLFGKGG,440,2,8810,"Antimicrobial Peptides: Insights into Membrane Permeabilization, Lipopolysaccharide Fragmentation and Application in Plant Disease Control.",Escherichiacoli
VARGWKRKCPLFGKGG,440,2,8811,"Antimicrobial Peptides: Insights into Membrane Permeabilization, Lipopolysaccharide Fragmentation and Application in Plant Disease Control.",Escherichiacoli
LAAKLTKAATKLTAALTKLAAALT,441,52,8814,A polyalanine peptide derived from polar fish with anti-infectious activities,Enterococcusfaecalis
WKKILSKIKKLLK,442,4,8829,Investigation of the role of tryptophan residues in cationic antimicrobial peptides to determine the mechanism of antimicrobial action.,Staphylococcusaureus
IKKWLSKIKKLLK,442,4,8830,Investigation of the role of tryptophan residues in cationic antimicrobial peptides to determine the mechanism of antimicrobial action.,Staphylococcusaureus
IKKIWSKIKKLLK,442,4,8831,Investigation of the role of tryptophan residues in cationic antimicrobial peptides to determine the mechanism of antimicrobial action.,Staphylococcusaureus
IKKILSKIKKWLK,442,4,8832,Investigation of the role of tryptophan residues in cationic antimicrobial peptides to determine the mechanism of antimicrobial action.,Staphylococcusaureus
IKKILSKIKKLWK,442,4,8833,Investigation of the role of tryptophan residues in cationic antimicrobial peptides to determine the mechanism of antimicrobial action.,Staphylococcusaureus
IKKIWSKIKKWLK,442,4,8840,Investigation of the role of tryptophan residues in cationic antimicrobial peptides to determine the mechanism of antimicrobial action.,Staphylococcusaureus
IKKIWSKIKKLWK,442,4,8841,Investigation of the role of tryptophan residues in cationic antimicrobial peptides to determine the mechanism of antimicrobial action.,Staphylococcusaureus
IKKILSKIKKWWK,442,4,8842,Investigation of the role of tryptophan residues in cationic antimicrobial peptides to determine the mechanism of antimicrobial action.,Staphylococcusaureus
IKKIWSKIKKWWK,442,4,8843,Investigation of the role of tryptophan residues in cationic antimicrobial peptides to determine the mechanism of antimicrobial action.,Staphylococcusaureus
GFGCNGPWSEKDMHCHNHCKSIKGYKGGYCAKGGFICKCY,443,4,8870,Design and recombination expression of a novel plectasin-derived peptide MP1106 and its properties against Staphylococcus aureus.,Staphylococcusaureus
GIGAVLKVLTTGLPALKSWIKRKRQQ,444,17,8871,Characterization of antimicrobial activity against Listeria and cytotoxicity of native melittin and its mutant variants.,Listeriamonocytogenes
IIGAVLKVLTTGLPALISWIKRKRQQ,444,17,8872,Characterization of antimicrobial activity against Listeria and cytotoxicity of native melittin and its mutant variants.,Listeriamonocytogenes
GWWRRTVDKVRNAGRKVAGFASKACGALGH,445,8,8873,"Novel Antimicrobial Peptides EeCentrocins 1, 2 and EeStrongylocin 2 from the Edible Sea Urchin Echinus esculentus Have 6-Br-Trp Post-Translational Modifications.",Bacillussubtilis
WGHKLRSSWNKVKHAVKKGAGYASGACRVLGH,445,8,8878,"Novel Antimicrobial Peptides EeCentrocins 1, 2 and EeStrongylocin 2 from the Edible Sea Urchin Echinus esculentus Have 6-Br-Trp Post-Translational Modifications.",Bacillussubtilis
WWRRRRRRRR,446,4,8884,Membrane interaction and secondary structure of de novo designed arginine-and tryptophan peptides with dual function.,Staphylococcusaureus
WWWRRRRRRRR,446,4,8885,Membrane interaction and secondary structure of de novo designed arginine-and tryptophan peptides with dual function.,Staphylococcusaureus
WWWWRRRRRRRR,446,4,8886,Membrane interaction and secondary structure of de novo designed arginine-and tryptophan peptides with dual function.,Staphylococcusaureus
RRRRWWWWRRRR,446,4,8887,Membrane interaction and secondary structure of de novo designed arginine-and tryptophan peptides with dual function.,Staphylococcusaureus
RWRRWRRWRRWR,446,4,8888,Membrane interaction and secondary structure of de novo designed arginine-and tryptophan peptides with dual function.,Staphylococcusaureus
WRRRRRRRR,446,4,8889,Membrane interaction and secondary structure of de novo designed arginine-and tryptophan peptides with dual function.,Staphylococcusaureus
PMLRVRLASHLRKLRKRLLR,447,2,8920,A new cryptic cationic antimicrobial peptide (AMP) from human apolipoprotein E with anti-bacterial activity and immunomodulatory effects on human cells.,Escherichiacoli
LRVRLASHLRKLRKRLLR,447,2,8921,A new cryptic cationic antimicrobial peptide (AMP) from human apolipoprotein E with anti-bacterial activity and immunomodulatory effects on human cells.,Escherichiacoli
PGKYGFYTHVFRLKKWIQKVI,447,2,8925,A new cryptic cationic antimicrobial peptide (AMP) from human apolipoprotein E with anti-bacterial activity and immunomodulatory effects on human cells.,Escherichiacoli
GLPGPLGPAGPK,448,87,8929,"Collagencin, an antibacterial peptide from fish collagen: Activity, structure and interaction dynamics with membrane.",Listeriainnocua
KRKILILIKRK,449,2,8931,Rational design of artificial ?-strand-forming antimicrobial peptides with biocompatible properties.,Escherichiacoli
KRKILILILIL,449,2,8932,Rational design of artificial ?-strand-forming antimicrobial peptides with biocompatible properties.,Escherichiacoli
ILILILILKRK,449,2,8933,Rational design of artificial ?-strand-forming antimicrobial peptides with biocompatible properties.,Escherichiacoli
KRKILILIGSG,449,2,8934,Rational design of artificial ?-strand-forming antimicrobial peptides with biocompatible properties.,Escherichiacoli
GSGILILIKRK,449,2,8935,Rational design of artificial ?-strand-forming antimicrobial peptides with biocompatible properties.,Escherichiacoli
KRKSGSGSKRK,449,2,8936,Rational design of artificial ?-strand-forming antimicrobial peptides with biocompatible properties.,Escherichiacoli
GMAKLLAKVLPHVVKLIK,450,18,8944,Interaction of a novel antimicrobial peptide isolated from the venom of solitary bee Colletes daviesanus with phospholipid vesicles and Escherichia coli cells.,Micrococcusluteus
GMASKLAKVLPHVVKLIK,450,18,8945,Interaction of a novel antimicrobial peptide isolated from the venom of solitary bee Colletes daviesanus with phospholipid vesicles and Escherichia coli cells.,Micrococcusluteus
GMASLLAKVLPKVVKLIK,450,18,8946,Interaction of a novel antimicrobial peptide isolated from the venom of solitary bee Colletes daviesanus with phospholipid vesicles and Escherichia coli cells.,Micrococcusluteus
GMASLWAKVLPHVVKLIK,450,18,8947,Interaction of a novel antimicrobial peptide isolated from the venom of solitary bee Colletes daviesanus with phospholipid vesicles and Escherichia coli cells.,Micrococcusluteus
VKSWIRKLVHR,451,4,8949,Antimicrobial peptides design by evolutionary multiobjective optimization.,Staphylococcusaureus
WLKGLIKFIR,451,4,8950,Antimicrobial peptides design by evolutionary multiobjective optimization.,Staphylococcusaureus
KRRKWHSVVLI,451,4,8951,Antimicrobial peptides design by evolutionary multiobjective optimization.,Staphylococcusaureus
EHMDRILAQLL,451,4,8952,Antimicrobial peptides design by evolutionary multiobjective optimization.,Staphylococcusaureus
KWKLFKKIGAVLKVLTTG,451,4,8953,Antimicrobial peptides design by evolutionary multiobjective optimization.,Staphylococcusaureus
WKLFLKAVKKLL,451,4,8954,Antimicrobial peptides design by evolutionary multiobjective optimization.,Staphylococcusaureus
RIKRFWPVVIRTVVAGYNLYRAIKK,452,2,8956,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli
RIKRFWPVVIRTVVAGYNLYRAIK,452,2,8957,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli
RIKRFWPVVIRTVVAGYNLYRAI,452,2,8958,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli
RIKRFWPVVIRTVVAGYNLYRA,452,2,8959,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli
RIKRFWPVVIRTVVAGYNLYR,452,2,8960,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli
RIKRFWPVVIRTVVAGYNLY,452,2,8961,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli
RIKRFWPVVIRTVVAGYNL,452,2,8962,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli
RIKRFWPVVIRTVVAGYN,452,2,8963,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli
RIKRFWPVVIRTVVAGY,452,2,8964,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli
RIKRFWPVVIRTVVAG,452,2,8965,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli
KRKRKILILIKRK,449,2,8966,Rational design of artificial ?-strand-forming antimicrobial peptides with biocompatible properties.,Escherichiacoli
RKRKILILIKRK,449,2,8967,Rational design of artificial ?-strand-forming antimicrobial peptides with biocompatible properties.,Escherichiacoli
RKILILIKRK,449,2,8968,Rational design of artificial ?-strand-forming antimicrobial peptides with biocompatible properties.,Escherichiacoli
KILILIKRK,449,2,8969,Rational design of artificial ?-strand-forming antimicrobial peptides with biocompatible properties.,Escherichiacoli
ILILIKRK,449,2,8970,Rational design of artificial ?-strand-forming antimicrobial peptides with biocompatible properties.,Escherichiacoli
VAKGLIKGVKAKGELPAKGVFKGLKESIGKRAVLKG,453,2,8975,Aedesin: structure and antimicrobial activity against multidrug resistant bacterial strains.,Escherichiacoli
RIKRFWPVVIRTVVA,452,2,8976,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli
RIKRFWPVVIRTVV,452,2,8977,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli
RIKRFWPVVIRTV,452,2,8978,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli
RIKRFWPVVIRT,452,2,8979,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli
RIKRFWPVVIR,452,2,8980,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli
IKRFWPVVIRTVVAGYNLYRAIKKK,452,2,8981,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli
KRFWPVVIRTVVAGYNLYRAIKKK,452,2,8982,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli
RFWPVVIRTVVAGYNLYRAIKKK,452,2,8983,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli
FWPVVIRTVVAGYNLYRAIKKK,452,2,8984,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli
WPVVIRTVVAGYNLYRAIKKK,452,2,8985,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli
PVVIRTVVAGYNLYRAIKKK,452,2,8986,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli
VVIRTVVAGYNLYRAIKKK,452,2,8987,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli
VIRTVVAGYNLYRAIKKK,452,2,8988,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli
IRTVVAGYNLYRAIKKK,452,2,8989,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli
RTVVAGYNLYRAIKKK,452,2,8990,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli
TVVAGYNLYRAIKKK,452,2,8991,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli
VVAGYNLYRAIKKK,452,2,8992,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli
VAGYNLYRAIKKK,452,2,8993,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli
AGYNLYRAIKKK,452,2,8994,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli
LKAAAAAAKLAAKAAKAALKAAAAAAKL,454,2,9012,Structural and functional evaluation of the palindromic alanine-rich antimicrobial peptide Pa-MAP2.,Escherichiacoli
STLHLVLRLRGG,168,85,9024,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Mycobacteriumsmegmatis
RLGRLVSLHTLG,168,48,9025,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Bacillusmegaterium
ATLHLVLRLRGG,168,48,9026,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Bacillusmegaterium
SALHLVLRLRGG,168,48,9027,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Bacillusmegaterium
LKGCWTKSIPPKPCF,455,2,9028,Trypsin inhibitory loop is an excellent lead structure to design serine protease inhibitors and antimicrobial peptides,Escherichiacoli
STAHLVLRLRGG,168,48,9029,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Bacillusmegaterium
STLALVLRLRGG,168,48,9030,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Bacillusmegaterium
STLHAVLRLRGG,168,48,9031,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Bacillusmegaterium
STLHLALRLRGG,168,48,9032,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Bacillusmegaterium
STLHLVARLRGG,168,48,9033,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Bacillusmegaterium
STLHLVLALRGG,168,48,9034,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Bacillusmegaterium
CWTKSIPPKPCF,455,2,9035,Trypsin inhibitory loop is an excellent lead structure to design serine protease inhibitors and antimicrobial peptides,Escherichiacoli
STLHLVLRARGG,168,48,9036,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Bacillusmegaterium
STLHLVLRLAGG,168,48,9037,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Bacillusmegaterium
AALKGCWTKSIPPKPCFGF,455,2,9038,Trypsin inhibitory loop is an excellent lead structure to design serine protease inhibitors and antimicrobial peptides,Escherichiacoli
GCWTKSIPPKPCF,455,2,9039,Trypsin inhibitory loop is an excellent lead structure to design serine protease inhibitors and antimicrobial peptides,Escherichiacoli
STLHLVLRLRAG,168,48,9040,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Bacillusmegaterium
STLHLVLRLRGA,168,48,9041,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Bacillusmegaterium
LKGCWTKSIPPKPCFGK,455,2,9042,Trypsin inhibitory loop is an excellent lead structure to design serine protease inhibitors and antimicrobial peptides,Escherichiacoli
ALKGCWTKSIPPKPCFGK,455,2,9043,Trypsin inhibitory loop is an excellent lead structure to design serine protease inhibitors and antimicrobial peptides,Escherichiacoli
LKGCWTKSIPPKPCFG,455,2,9044,Trypsin inhibitory loop is an excellent lead structure to design serine protease inhibitors and antimicrobial peptides,Escherichiacoli
EVEPSDTIENVKAKIQ,168,48,9045,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Bacillusmegaterium
LKGCWTKSIPPKPCFGF,455,2,9046,Trypsin inhibitory loop is an excellent lead structure to design serine protease inhibitors and antimicrobial peptides,Escherichiacoli
LKGCWTKSIPPKPCFGG,455,2,9047,Trypsin inhibitory loop is an excellent lead structure to design serine protease inhibitors and antimicrobial peptides,Escherichiacoli
CWTKSIPPKPC,455,2,9048,Trypsin inhibitory loop is an excellent lead structure to design serine protease inhibitors and antimicrobial peptides,Escherichiacoli
CWTKSIPPKPG,455,2,9049,Trypsin inhibitory loop is an excellent lead structure to design serine protease inhibitors and antimicrobial peptides,Escherichiacoli
SKVWRHWRRFWHRAHRLH,456,4,9101,Structure-activity analysis and biological studies of chensinin-1b analogues ,Staphylococcusaureus
SKVWRHWRRFW,457,4,9104,Structure-activity analysis and biological studies of chensinin-1b analogues,Staphylococcusaureus
SKVWRHWRRFWHR,456,4,9108,Structure-activity analysis and biological studies of chensinin-1b analogues ,Staphylococcusaureus
WPKRLTKAHWFEIQHIQPSPLQCNRAMSGINNYTQHCKHQNTFLH,458,2,9115,Insights into the Antimicrobial Mechanism of Action of Human RNase6: Structural Determinants for Bacterial Cell Agglutination and Membrane Permeation.,Escherichiacoli
KRKILILIKRKRK,459,2,9116,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli
KRKILILIKRKR,459,2,9117,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli
KRKILILIKR,459,2,9118,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli
KRKILILIK,459,2,9119,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli
KRKILILI,459,2,9120,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli
GTFIKQQRKQKQQRHHTSGTRKRMAK,460,2,9124,De Novo Transcriptome Analysis and Detection of Antimicrobial Peptides of the American Cockroach Periplaneta americana (Linnaeus).,Escherichiacoli
ASITHVKNRGKYIYMHLKFRKTNVLI,460,2,9126,De Novo Transcriptome Analysis and Detection of Antimicrobial Peptides of the American Cockroach Periplaneta americana (Linnaeus).,Escherichiacoli
KKVWFIFHVCPKLKQRIL,460,2,9127,De Novo Transcriptome Analysis and Detection of Antimicrobial Peptides of the American Cockroach Periplaneta americana (Linnaeus).,Escherichiacoli
NYISFFRKCKNSQST,460,2,9128,De Novo Transcriptome Analysis and Detection of Antimicrobial Peptides of the American Cockroach Periplaneta americana (Linnaeus).,Escherichiacoli
GTKRGKLCRISRLAL,460,2,9129,De Novo Transcriptome Analysis and Detection of Antimicrobial Peptides of the American Cockroach Periplaneta americana (Linnaeus).,Escherichiacoli
MKTFLRLYRSLINKVLH,460,2,9131,De Novo Transcriptome Analysis and Detection of Antimicrobial Peptides of the American Cockroach Periplaneta americana (Linnaeus).,Escherichiacoli
VGRKHSILNCIPYLKKKKIMRL,460,2,9132,De Novo Transcriptome Analysis and Detection of Antimicrobial Peptides of the American Cockroach Periplaneta americana (Linnaeus).,Escherichiacoli
RMKLNAKKLSFC,460,2,9133,De Novo Transcriptome Analysis and Detection of Antimicrobial Peptides of the American Cockroach Periplaneta americana (Linnaeus).,Escherichiacoli
HNSSKQWSHWLWHNGIRI,460,2,9134,De Novo Transcriptome Analysis and Detection of Antimicrobial Peptides of the American Cockroach Periplaneta americana (Linnaeus).,Escherichiacoli
KRKILILILIKRK,459,2,9135,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli
KRKLILIKRK,459,2,9136,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli
KRKILIKRK,459,2,9137,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli
KRKLIKRK,459,2,9138,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli
KRKGSGKRK,459,2,9142,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli
VWRHWRRFWHR,456,4,9143,Structure-activity analysis and biological studies of chensinin-1b analogues ,Staphylococcusaureus
WRHWRRFWHR,457,4,9144,Structure-activity analysis and biological studies of chensinin-1b analogues,Staphylococcusaureus
VWRHWRRFW,457,4,9145,Structure-activity analysis and biological studies of chensinin-1b analogues,Staphylococcusaureus
VWRHWRRFWH,457,4,9146,Structure-activity analysis and biological studies of chensinin-1b analogues,Staphylococcusaureus
RHWRRFWHR,457,4,9147,Structure-activity analysis and biological studies of chensinin-1b analogues,Staphylococcusaureus
RHWRRFWH,457,4,9148,Structure-activity analysis and biological studies of chensinin-1b analogues,Staphylococcusaureus
RRFWHRAH,457,4,9151,Structure-activity analysis and biological studies of chensinin-1b analogues,Staphylococcusaureus
VWRKWRRFW,457,4,9153,Structure-activity analysis and biological studies of chensinin-1b analogues,Staphylococcusaureus
VWRRWRRFW,457,4,9154,Structure-activity analysis and biological studies of chensinin-1b analogues,Staphylococcusaureus
VWRKWRRFWKR,457,4,9155,Structure-activity analysis and biological studies of chensinin-1b analogues,Staphylococcusaureus
VWRRWRRFWRR,461,4,9156,Structure-activity analysis and biological studies of chensinin-1b analogues.,Staphylococcusaureus
GIGKFLKKAKKGIGAVLKVLTTGL,462,2,9158,"Structure, interactions, and antibacterial activities of MSI-594 derived mutant peptide MSI-594F5A in lipopolysaccharide micelles: role of the helical hairpin conformation in outer-membrane permeabilization.",Escherichiacoli
GIGKALKKAKKGIGAVLKVLTTGL,462,2,9159,"Structure, interactions, and antibacterial activities of MSI-594 derived mutant peptide MSI-594F5A in lipopolysaccharide micelles: role of the helical hairpin conformation in outer-membrane permeabilization.",Escherichiacoli
RKRKLILILIKRKR,459,2,9161,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli
KRKLILKRILIKRK,459,2,9162,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli
RKLILKRKRILIKR,459,2,9163,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli
KLILKRKRKRILIK,459,2,9164,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli
LILKRKRKRKRILI,459,2,9165,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli
RRRIIIIIRRR,459,2,9166,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli
KKKIIIIIKKK,459,2,9167,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli
RRRLLLLLRRR,459,2,9168,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli
KKKLLLLLKKK,459,2,9169,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli
RRRVVVVVRRR,459,2,9170,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli
KKKVVVVVKKK,459,2,9171,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli
RRRFFFFFRRR,459,2,9172,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli
KKKFFFFFKKK,459,2,9173,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli
KKKIIIIIIKKK,459,2,9174,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli
NKKAGLFVVQFPKKY,463,48,9191,"Design and synthesis of cationic antibacterial peptide based on Leucrocin I sequence, antibacterial peptide from crocodile (Crocodylus siamensis) white blood cell extracts",Bacillusmegaterium
KKKKQSWYAAAGDAIVSFGEG,464,1,9200,Structure-activity relationships of an antimicrobial peptide plantaricin s from two-peptide class IIb bacteriocins.,None_target
AMAINNWVRVPPCDQVCSRSNPEKDECCRAHGHAFHAHCNGGMNCYRR,465,88,9209,"Characterization and regulation of expression of an antifungal peptide from hemolymph of an insect, Manduca sexta.",Listeriafleischmannii
RTCENLADKYRGPCFSGCDTHCTTKENAVSGRCRGFRRRCWCTKRC,466,89,9213,Structure-activity determinants in antifungal plant defensins MsDef1 and MtDef4 with different modes of action against Fusarium graminearum.,Fusariumgraminearum
RTCENLADKYRGPCFSGCDTHCTTKENAVSGRCRDDFQCWCTKRC,466,89,9214,Structure-activity determinants in antifungal plant defensins MsDef1 and MtDef4 with different modes of action against Fusarium graminearum.,Fusariumgraminearum
GRCRDDFRCWCTKRC,466,89,9215,Structure-activity determinants in antifungal plant defensins MsDef1 and MtDef4 with different modes of action against Fusarium graminearum.,Fusariumgraminearum
GRCRGFRRRCFCTTHC,466,89,9216,Structure-activity determinants in antifungal plant defensins MsDef1 and MtDef4 with different modes of action against Fusarium graminearum.,Fusariumgraminearum
GRCRDDFRC,466,89,9217,Structure-activity determinants in antifungal plant defensins MsDef1 and MtDef4 with different modes of action against Fusarium graminearum.,Fusariumgraminearum
GRCRGFRRRC,466,89,9218,Structure-activity determinants in antifungal plant defensins MsDef1 and MtDef4 with different modes of action against Fusarium graminearum.,Fusariumgraminearum
GPCASDHNC,466,89,9222,Structure-activity determinants in antifungal plant defensins MsDef1 and MtDef4 with different modes of action against Fusarium graminearum.,Fusariumgraminearum
GLLKSLCKKFVKGHLGELIEELTTSDD,467,4,9227,"Identification, expression and antibacterial activities of an antimicrobial peptide NK-lysin from a marine fish Larimichthys crocea.",Staphylococcusaureus
VCNEIGLLKSLCKKFVKGHLGE,467,4,9228,"Identification, expression and antibacterial activities of an antimicrobial peptide NK-lysin from a marine fish Larimichthys crocea.",Staphylococcusaureus
SGKLCCRRKK,468,2,9229,"Design of Short Membrane Selective Antimicrobial Peptides Containing Tryptophan and Arginine Residues for Improved Activity, Salt-Resistance, and Biocompatibility",Escherichiacoli
FLGGLIKIVPAMICAVTKKCHHHHHH,469,4,9230,Secretory ranalexin produced in recombinant Pichia pastoris exhibits additive or synergistic bactericidal activity when used in combination with polymyxin B or linezolid against multi-drug resistant bacteria.,Staphylococcusaureus
SGKLYYRRKK,468,2,9231,"Design of Short Membrane Selective Antimicrobial Peptides Containing Tryptophan and Arginine Residues for Improved Activity, Salt-Resistance, and Biocompatibility",Escherichiacoli
SGKLWWRRKK,468,2,9232,"Design of Short Membrane Selective Antimicrobial Peptides Containing Tryptophan and Arginine Residues for Improved Activity, Salt-Resistance, and Biocompatibility",Escherichiacoli
SGKRWWRRKK,468,2,9233,"Design of Short Membrane Selective Antimicrobial Peptides Containing Tryptophan and Arginine Residues for Improved Activity, Salt-Resistance, and Biocompatibility",Escherichiacoli
RGKRWWRRKK,468,2,9234,"Design of Short Membrane Selective Antimicrobial Peptides Containing Tryptophan and Arginine Residues for Improved Activity, Salt-Resistance, and Biocompatibility",Escherichiacoli
RKKRWWRRKK,468,2,9236,"Design of Short Membrane Selective Antimicrobial Peptides Containing Tryptophan and Arginine Residues for Improved Activity, Salt-Resistance, and Biocompatibility",Escherichiacoli
GRKKRRQRRRPPQ,470,2,9244,Effects of dimerization of the cell-penetrating peptide Tat analog on antimicrobial activity and mechanism of bactericidal action.,Escherichiacoli
GRKKRRQRRRPWQ,470,1,9246,Effects of dimerization of the cell-penetrating peptide Tat analog on antimicrobial activity and mechanism of bactericidal action.,None_target
KKKFPWWWPFKKK,471,1,9313,"Effect of dimerization of a beta-turn antimicrobial peptide, PST13-RK, on antimicrobial activity and mammalian cell toxicity.",None_target
GRRPRPRPRP,472,4,9326,Highly selective end-tagged antimicrobial peptides derived from PRELP.,Staphylococcusaureus
GRRPRPRPRPWWW,472,4,9327,Highly selective end-tagged antimicrobial peptides derived from PRELP.,Staphylococcusaureus
GRRPRPRPRPWWWW,472,4,9328,Highly selective end-tagged antimicrobial peptides derived from PRELP.,Staphylococcusaureus
GRRPRPRPRPWWWWW,472,4,9329,Highly selective end-tagged antimicrobial peptides derived from PRELP.,Staphylococcusaureus
GRRPRPRPRPFFF,472,4,9333,Highly selective end-tagged antimicrobial peptides derived from PRELP.,Staphylococcusaureus
GRRPRPRPRPFFFF,472,4,9334,Highly selective end-tagged antimicrobial peptides derived from PRELP.,Staphylococcusaureus
GRRPRPRPRPFFFFF,472,4,9335,Highly selective end-tagged antimicrobial peptides derived from PRELP.,Staphylococcusaureus
RRPRPRPRPFFFFF,472,4,9340,Highly selective end-tagged antimicrobial peptides derived from PRELP.,Staphylococcusaureus
TVVRRRGRSPRRRTPSPRRRRSQSPRRRRSQSRESQC,473,3,9344,Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD).,Pseudomonasaeruginosa
TVVRRRGRSPRRRTPSPRRRRSQSPRRRR,473,3,9345,Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD).,Pseudomonasaeruginosa
TVVRRRGRSPRRRTPSPRRRR,473,3,9346,Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD).,Pseudomonasaeruginosa
TVVRRRGRSPRRR,473,3,9347,Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD).,Pseudomonasaeruginosa
GRSPRRRTPSPRRRRSQSPRRRRS,473,3,9348,Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD).,Pseudomonasaeruginosa
RRRTPSPRRRRSQSPRRRRS,473,3,9349,Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD).,Pseudomonasaeruginosa
RRRRSQSPRRRRS,473,3,9350,Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD).,Pseudomonasaeruginosa
GRSPRRRTPSPRRRRSQSPRRRR,473,3,9351,Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD).,Pseudomonasaeruginosa
SPRRRTPSPRRRRSQSPRRRR,473,3,9352,Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD).,Pseudomonasaeruginosa
RRRTPSPRRRRSQSPRRRR,473,3,9353,Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD).,Pseudomonasaeruginosa
SPRRRRSQSPRRRR,473,3,9354,Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD).,Pseudomonasaeruginosa
TVVRRRGRSPRRRTPSPRAARSQSPRAARSQSRESQC,473,3,9361,Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD).,Pseudomonasaeruginosa
AAKIILNPKFRCFAAFC,474,2,9366,Kunitzins: Prototypes of a new class of protease inhibitor from the skin secretions of European and Asian frogs.,Escherichiacoli
AVNIPFKVHLRCKAAFC,474,2,9367,Kunitzins: Prototypes of a new class of protease inhibitor from the skin secretions of European and Asian frogs.,Escherichiacoli
AVNIPFKVHLRCFAAFC,474,2,9368,Kunitzins: Prototypes of a new class of protease inhibitor from the skin secretions of European and Asian frogs.,Escherichiacoli
VHLRCKAAFC,474,2,9369,Kunitzins: Prototypes of a new class of protease inhibitor from the skin secretions of European and Asian frogs.,Escherichiacoli
LKKLLKLLKKLLKLAG,475,2,9370,Reduction of helical content by insertion of a disulfide bond leads to an antimicrobial peptide with decreased hemolytic activity.,Escherichiacoli
CKKLLKLCKKLLKLAG,475,2,9379,Reduction of helical content by insertion of a disulfide bond leads to an antimicrobial peptide with decreased hemolytic activity.,Escherichiacoli
CKKLLKLLKKLCKLAG,475,2,9380,Reduction of helical content by insertion of a disulfide bond leads to an antimicrobial peptide with decreased hemolytic activity.,Escherichiacoli
LKKLLKLCKKLCKLAG,475,2,9381,Reduction of helical content by insertion of a disulfide bond leads to an antimicrobial peptide with decreased hemolytic activity.,Escherichiacoli
GIGAVLKVLTTGLPACISWCKRKRQQ,475,2,9385,Reduction of helical content by insertion of a disulfide bond leads to an antimicrobial peptide with decreased hemolytic activity.,Escherichiacoli
EIEKFDKSKLK,476,4,9402,A peptide from human β thymosin as a platform for the development of new anti-biofilm agents for Staphylococcus spp. and Pseudomonas aeruginosa.,Staphylococcusaureus
RRWVAWRNR,477,2,9436,Improved antimicrobial activity of h-lysozyme (107-115) by rational Ala substitution.,Escherichiacoli
RKWVAWRNR,477,2,9437,Improved antimicrobial activity of h-lysozyme (107-115) by rational Ala substitution.,Escherichiacoli
RWWVAWRNR,477,2,9438,Improved antimicrobial activity of h-lysozyme (107-115) by rational Ala substitution.,Escherichiacoli
RYWVAWRNR,477,2,9439,Improved antimicrobial activity of h-lysozyme (107-115) by rational Ala substitution.,Escherichiacoli
RKWVKWRNR,477,2,9440,Improved antimicrobial activity of h-lysozyme (107-115) by rational Ala substitution.,Escherichiacoli
RKWVYWRNR,477,2,9441,Improved antimicrobial activity of h-lysozyme (107-115) by rational Ala substitution.,Escherichiacoli
KKVVFKVKFK,479,4,9471,Structure-activity relationship study: short antimicrobial peptides.,Staphylococcusaureus
FVVKKKKKVF,479,4,9477,Structure-activity relationship study: short antimicrobial peptides.,Staphylococcusaureus
FKVKFKVKVK,479,4,9478,Structure-activity relationship study: short antimicrobial peptides.,Staphylococcusaureus
LKVVFKVLFK,479,4,9479,Structure-activity relationship study: short antimicrobial peptides.,Staphylococcusaureus
KKVVFKVKFH,479,4,9480,Structure-activity relationship study: short antimicrobial peptides.,Staphylococcusaureus
HKVVFKVKFH,479,4,9481,Structure-activity relationship study: short antimicrobial peptides.,Staphylococcusaureus
FFFLRRIF,480,2,9489,Structure-Activity Relationship-based Optimization of Small Temporin-SHf Analogs with Potent Antibacterial Activity,Escherichiacoli
GSKKPVPIIYCNRRTGKCQRM,481,4,9490,The Disulfide Bond of the Peptide Thanatin Is Dispensible for Its Antimicrobial Activity In Vivo and In Vitro.,Staphylococcusaureus
INLKILARLAKKIL,482,2,9494,Selective amino acid substitution reduces cytotoxicity of the antimicrobial peptide mastoparan.,Escherichiacoli
RQIKIWFQNRRMKWKK,483,2,9524,Antimicrobial and cytolytic activities and plausible mode of bactericidal action of the cell penetrating peptide penetratin and its lys-linked two-stranded peptide.,Escherichiacoli
KWKLFKKIFKRIVQRIKDFLRN,484,2,9530,Novel Hybrid Peptide Cecropin A (1-8)-LL37 (17-30) with Potential Antibacterial Activity.,Escherichiacoli
ILSLRWRWKWWKK,485,41,9531,Combined Bioinformatic and Rational Design Approach To Develop Antimicrobial Peptides against Mycobacterium tuberculosis.,Mycobacteriumtuberculosis
ILSLRWWRKWWKK,485,41,9532,Combined Bioinformatic and Rational Design Approach To Develop Antimicrobial Peptides against Mycobacterium tuberculosis.,Mycobacteriumtuberculosis
ILSLRWRWWKWKK,485,41,9533,Combined Bioinformatic and Rational Design Approach To Develop Antimicrobial Peptides against Mycobacterium tuberculosis.,Mycobacteriumtuberculosis
IRKLKSWKWLRWL,485,41,9534,Combined Bioinformatic and Rational Design Approach To Develop Antimicrobial Peptides against Mycobacterium tuberculosis.,Mycobacteriumtuberculosis
GWGRFFKKWWRVGKRVGK,486,7,9538,Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts,Streptococcusmutans
GWGRFFKKAARVGKRVGK,486,7,9542,Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts,Streptococcusmutans
GWGKFFKKAAKVGKKVG,486,7,9543,Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts,Streptococcusmutans
GWGKFFKKFFKVGK,486,7,9550,Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts,Streptococcusmutans
GWKKFFKKAAKVGK,486,7,9551,Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts,Streptococcusmutans
GWKKFFKKAKKVGK,486,7,9552,Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts,Streptococcusmutans
GWKKFFKKAKKVWK,486,7,9553,Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts,Streptococcusmutans
GWGKFFKKFFKFGK,486,7,9554,Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts,Streptococcusmutans
GWKKFFKKWKKVWK,486,7,9555,Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts,Streptococcusmutans
WGKFFKKFFKFGK,486,7,9556,Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts,Streptococcusmutans
WFKFFKKFFKKWK,486,7,9557,Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts,Streptococcusmutans
WGKFFKKFFKKGK,486,7,9566,Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts,Streptococcusmutans
FKFFKKFFKKWK,486,7,9567,Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts,Streptococcusmutans
FKFFKKFFKKW,486,7,9568,Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts,Streptococcusmutans
KFFKKFFKKW,486,7,9569,Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts,Streptococcusmutans
RKLKHMRF,487,4,9582,"A Head-to-Head Comparison of the Antimicrobial Activities of 30 Ultra-Short Antimicrobial Peptides Against Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans",Staphylococcusaureus
IWSFLIKAATKLLGVGSLFGGGKKDS,488,90,9593,Characterisation of three alpha-helical antimicrobial peptides from the venom of Scorpio maurus palmatus.,Bacilussubtilis
IWSFLIKAATKLLPSLFGG,488,90,9594,Characterisation of three alpha-helical antimicrobial peptides from the venom of Scorpio maurus palmatus.,Bacilussubtilis
VLSAADKNNVKGIFTKIAGHAEEYGAETLERMFTTYPPTKTY,489,2,9604,"Novel hemoglobin-derived antimicrobial peptides from chicken (Gallus gallus) blood: purification, structural aspects, and biological activity.",Escherichiacoli
MLTAEDKKLIQQAWEKAASHQEEFGAEALTRMFTTYPQTKTY,489,2,9605,"Novel hemoglobin-derived antimicrobial peptides from chicken (Gallus gallus) blood: purification, structural aspects, and biological activity.",Escherichiacoli
WWRRWWRR,490,3,9662,Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine.,Pseudomonasaeruginosa
WWKKWWKK,490,3,9663,Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine.,Pseudomonasaeruginosa
WRWWRRWWRR,490,3,9664,Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine.,Pseudomonasaeruginosa
WKWWKKWWKK,490,3,9665,Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine.,Pseudomonasaeruginosa
WRRWWRWWRRWWRR,490,3,9666,Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine.,Pseudomonasaeruginosa
WKKWWKWWKKWWKK,490,3,9667,Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine.,Pseudomonasaeruginosa
RWWRRWWRWWRRWWRR,490,3,9668,Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine.,Pseudomonasaeruginosa
KWWKKWWKWWKKWWKK,490,3,9669,Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine.,Pseudomonasaeruginosa
WRRWWRRWWRWWRRWWRR,490,3,9670,Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine.,Pseudomonasaeruginosa
WKKWWKKWWKWWKKWWKK,490,3,9671,Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine.,Pseudomonasaeruginosa
KWWKWWKKWWKK,490,3,9672,Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine.,Pseudomonasaeruginosa
IPRPIDTCRLRNGICFPGICRRPYYWIGTCNNGIGSCCARGWRS,491,91,9702,The Unusual Resistance of Avian Defensin AvBD7 to Proteolytic Enzymes Preserves Its Antibacterial Activity.,Streptococcussalivarius
FIFHIIKGLFHAGKMIHGLVT,492,2,9707,"Two isoforms of piscidin from Malabar grouper, Epinephelus malabaricus: Expression and functional characterization.",Escherichiacoli
FFFHIIKGLFHAGRMIHGLVNRRRHRH,492,2,9709,"Two isoforms of piscidin from Malabar grouper, Epinephelus malabaricus: Expression and functional characterization.",Escherichiacoli
QKLCERPSGTWSGVCGNNNACKN,493,92,9727,Comparative Analysis of the Antimicrobial Activities of Plant Defensin-Like and Ultrashort Peptides against Food-Spoiling Bacteria,Lactobacillusbrevis
MQFITDLIKKAVDFFKGLFDNK,494,93,9736,Specific Anti-Leukemic Activity of the Peptide Warnericin RK and Analogues and Visualization of Their Effect on Cancer Cells by Chemical Raman Imaging.,Jurkatcancer
MQFITDLIKKAVDVFKGLFGNK,494,93,9737,Specific Anti-Leukemic Activity of the Peptide Warnericin RK and Analogues and Visualization of Their Effect on Cancer Cells by Chemical Raman Imaging.,Jurkatcancer
KWLRRPWRRWR,495,2,9740,NOVEL PEPTIDE AND USES THEREOF,Escherichiacoli
KWLRWVRRRWW,495,2,9741,NOVEL PEPTIDE AND USES THEREOF,Escherichiacoli
KWLRRVWRWWR,495,2,9744,NOVEL PEPTIDE AND USES THEREOF,Escherichiacoli
GIFPIFAKLLGKVIKVASSLISKGRTK,496,31,9752,Conformational Analysis of the Host-Defense Peptides Pseudhymenochirin-1Pb and -2Pa and Design of Analogues with Insulin-Releasing Activities and Reduced Toxicities.,Humanlung
LVVAVTDGEADAAVEGLHDNTDFIHYGSHGKYPDNRPHGYPLD,497,24,9756,Molecular cloning of hemocyanin cDNA from Fenneropenaeus chinensis and antimicrobial analysis of two C-terminal fragments.,Fusariumoxysporum
FEVLPNFKHIQVKVFNHGEHIHHH,497,24,9757,Molecular cloning of hemocyanin cDNA from Fenneropenaeus chinensis and antimicrobial analysis of two C-terminal fragments.,Fusariumoxysporum
ENFFKEKERKGQRIRDAIISRRPRVETLAQAQKIIKGGD,498,94,9761,Galleria mellonella native and analogue peptides Gm1 and ΔGm1. II) anti-bacterial and anti-endotoxic effects.,Salmonellaenterica
KKSLLAKAKNFGGKVITIFKA,499,95,9763,Cysteine-rich toxins from Lachesana tarabaevi spider venom with amphiphilic C-terminal segments.,Arthrobacterglobiformis
GGFGCPFNIDNQGNCHNHCQSIRGRKGGYCHGIFKQTCKCYKPMGYKTRPPFILG,500,17,9781,Antiplasmodial Activity Is an Ancient and Conserved Feature of Tick Defensins.,Listeriamonocytogenes
LRKRLRKFRNKIKEKLKKIGQKIQGFVPKL,501,25,9793,Positive selection in cathelicidin host defense peptides: adaptation to exogenous pathogens or endogenous receptors?,Bacilluscereus
LLRKRLRKFRNKIKEKLKKIGQKIQGFVPKLVPRTES,501,25,9794,Positive selection in cathelicidin host defense peptides: adaptation to exogenous pathogens or endogenous receptors?,Bacilluscereus
RLRKRLRKFRNKIKEKLKKIGQKIQGFVPKLQPSKQS,501,25,9795,Positive selection in cathelicidin host defense peptides: adaptation to exogenous pathogens or endogenous receptors?,Bacilluscereus
FTCDVLSAEGSFRGVSVKLNHSACATHCLFLKKRGGYCNNKAICVCRN,502,18,9796,Tribolium castaneum defensins are primarily active against Gram-positive bacteria.,Micrococcusluteus
FTCDVLSAEGGFRGVSIKLNHAACAAHCLYLKKRGGYCNDKAVCVCRK,502,18,9797,Tribolium castaneum defensins are primarily active against Gram-positive bacteria.,Micrococcusluteus
GFGCPFNANECHAHCLSIGRKFGFCAGPLRATCTCGKQ,503,48,9812,Single-point mutation-mediated local amphipathic adjustment dramatically enhances antibacterial activity of a fungal defensin.,Bacillusmegaterium
GFGCPFNKNECHAHCLSIGRKFGFCAGPLRATCTCGKQ,503,48,9813,Single-point mutation-mediated local amphipathic adjustment dramatically enhances antibacterial activity of a fungal defensin.,Bacillusmegaterium
GFGCPFNRNECHAHCLSIGRKFGFCAGPLRATCTCGKQ,503,48,9814,Single-point mutation-mediated local amphipathic adjustment dramatically enhances antibacterial activity of a fungal defensin.,Bacillusmegaterium
GFGCPFNQNECHAHCLSIGRKFGFCAGPLRATCTCGKQ,503,48,9815,Single-point mutation-mediated local amphipathic adjustment dramatically enhances antibacterial activity of a fungal defensin.,Bacillusmegaterium
GFGCPFNLNECHAHCLSIGRKFGFCAGPLRATCTCGKQ,503,48,9816,Single-point mutation-mediated local amphipathic adjustment dramatically enhances antibacterial activity of a fungal defensin.,Bacillusmegaterium
WWWLSRIW,504,2,9817,Design and surface immobilization of short anti-biofilm peptides.,Escherichiacoli
WWWLKRIW,504,2,9818,Design and surface immobilization of short anti-biofilm peptides.,Escherichiacoli
WWWLRKIW,504,2,9819,Design and surface immobilization of short anti-biofilm peptides.,Escherichiacoli
WWWLKKIW,504,2,9820,Design and surface immobilization of short anti-biofilm peptides.,Escherichiacoli
WWWLRRIW,504,2,9821,Design and surface immobilization of short anti-biofilm peptides.,Escherichiacoli
ATYRTGRATRESLSGVEISGRLYRLR,505,2,9850,Antimicrobial activity of human α-defensin 5 and its linear analogs: N-terminal fatty acylation results in enhanced antimicrobial activity of the linear analogs.,Escherichiacoli
GKYGFYTHVFRLKKWIQKVIDQFGE,506,2,9884,Proteolysis of human thrombin generates novel host defense peptides.,Escherichiacoli
WMQKVIDRFGG,507,4,9904,The C-terminal sequences of porcine thrombin are active as antimicrobial peptides.,Staphylococcusaureus
KKWMQKVIDRFGG,507,4,9905,The C-terminal sequences of porcine thrombin are active as antimicrobial peptides.,Staphylococcusaureus
RLKKWMQKVIDRFGG,507,4,9906,The C-terminal sequences of porcine thrombin are active as antimicrobial peptides.,Staphylococcusaureus
VFRLKKWMQKVIDRFGG,507,4,9907,The C-terminal sequences of porcine thrombin are active as antimicrobial peptides.,Staphylococcusaureus
THVFRLKKWMQKVIDRFGG,507,4,9908,The C-terminal sequences of porcine thrombin are active as antimicrobial peptides.,Staphylococcusaureus
FYTHVFRLKKWMQKVIDRFGG,507,4,9909,The C-terminal sequences of porcine thrombin are active as antimicrobial peptides.,Staphylococcusaureus
YGFYTHVFRLKKWMQKVIDRFGG,507,4,9910,The C-terminal sequences of porcine thrombin are active as antimicrobial peptides.,Staphylococcusaureus
GKYGFYTHVFRLKKWMQKVIDRFGG,507,4,9911,The C-terminal sequences of porcine thrombin are active as antimicrobial peptides.,Staphylococcusaureus
GNGNLLGGLLRPVLGVVKGLTGGLGKK,508,4,9917,Thaulin-1: The first antimicrobial peptide isolated from the skin of a Patagonian frog Pleurodema thaul (Anura: Leptodactylidae: Leiuperinae) with activity against Escherichia coli.,Staphylococcusaureus
KKYRYHLKPFSKK,509,2,9922,Synthesis and characterization of an antibacterial and non-toxic dimeric peptide derived from the C-terminal region of Bothropstoxin-I.,Escherichiacoli
KKYRYHLKPFCKK,509,2,9924,Synthesis and characterization of an antibacterial and non-toxic dimeric peptide derived from the C-terminal region of Bothropstoxin-I.,Escherichiacoli
FLFSLIPSAIGGLISAFK,510,56,9959,Peptide consensus sequence determination for the enhancement of the antimicrobial activity and selectivity of antimicrobial peptides.,Staphylococcusepidermidis
VTQPLAPVHNPISV,511,4,9960,"Antimicrobial activity and mechanism of PDC213, an endogenous peptide from human milk.",Staphylococcusaureus
LGGDNYGTFSGSNGNNFQHGSN,512,96,9967,Molecular characterization and functional analysis of a piscidin gene in large yellow croaker (Larimichthys crocea).,Edwardsiellatarda
PHVALKPGKLKFIIPSPKRPVKLLSGGNTLHLVSTTKT,513,2,9968,Novel human bioactive peptides identified in apolipoprotein B: evaluation of their therapeutic potential.,Escherichiacoli
PHVALKPGKLKFIIPSPKRPVKLLSG,513,2,9969,Novel human bioactive peptides identified in apolipoprotein B: evaluation of their therapeutic potential.,Escherichiacoli
KIKKGFKKIFKRLPPIGVGVSIPLAGKR,514,59,9973,Cathelicidin antimicrobial peptide from Alligator mississippiensis has antibacterial activity against multi-drug resistant Acinetobacter baumanii and Klebsiella pneumoniae.,Acinetobacterbaumannii
GLFKKLRRKIKKGFKKIFKRL,514,59,9974,Cathelicidin antimicrobial peptide from Alligator mississippiensis has antibacterial activity against multi-drug resistant Acinetobacter baumanii and Klebsiella pneumoniae.,Acinetobacterbaumannii
AAGGVKKPKKAAAAKKSPKKPKKPAAA,515,4,9976,Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo dragon) by Large Scale Analyses and De Novo-Assisted Sequencing using Electron Transfer Dissociation Mass Spectrometry.,Staphylococcusaureus
KAAAAKKSPKKPKKPAAAKK,515,4,9977,Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo dragon) by Large Scale Analyses and De Novo-Assisted Sequencing using Electron Transfer Dissociation Mass Spectrometry.,Staphylococcusaureus
ARTKQTARKSTGGKAPRKQLAT,515,4,9978,Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo dragon) by Large Scale Analyses and De Novo-Assisted Sequencing using Electron Transfer Dissociation Mass Spectrometry.,Staphylococcusaureus
AKAVKPKTAKPKTAKPKTAKA,515,4,9979,Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo dragon) by Large Scale Analyses and De Novo-Assisted Sequencing using Electron Transfer Dissociation Mass Spectrometry.,Staphylococcusaureus
AVKPKTAKPKTAKPKTA,515,4,9980,Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo dragon) by Large Scale Analyses and De Novo-Assisted Sequencing using Electron Transfer Dissociation Mass Spectrometry.,Staphylococcusaureus
AKKPVAKKAAGGVKKPK,515,4,9981,Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo dragon) by Large Scale Analyses and De Novo-Assisted Sequencing using Electron Transfer Dissociation Mass Spectrometry.,Staphylococcusaureus
AKKPVAKKAAGGVKKPKK,515,4,9982,Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo dragon) by Large Scale Analyses and De Novo-Assisted Sequencing using Electron Transfer Dissociation Mass Spectrometry.,Staphylococcusaureus
SPKKTKPVKPKKVA,515,4,9983,Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo dragon) by Large Scale Analyses and De Novo-Assisted Sequencing using Electron Transfer Dissociation Mass Spectrometry.,Staphylococcusaureus
SAVWRHWRRFWLRKHRKH,516,2,9988,Antimicrobial and anti-inflammatory activities of three chensinin-1 peptides containing mutation of glycine and histidine residues.,Escherichiacoli
SAVWRWRRFWLRKRK,516,2,9989,Antimicrobial and anti-inflammatory activities of three chensinin-1 peptides containing mutation of glycine and histidine residues.,Escherichiacoli
SAVWRRWRRFWLRKRRKR,516,2,9990,Antimicrobial and anti-inflammatory activities of three chensinin-1 peptides containing mutation of glycine and histidine residues.,Escherichiacoli
RYRRKKKMKKALQYIKLLKE,518,4,10040,A New Synthetic Peptide Having Two Target of Antibacterial Action in E. coli ML35.,Staphylococcusaureus
RRWQWRLCYCRRRFCVCVG,519,2,10041,Design of hybrid ?-hairpin peptides with enhanced cell specificity and potent anti-inflammatory activity,Escherichiacoli
KWKLFKKIRGGRLCYCRRRFCVCV,519,2,10042,Design of hybrid ?-hairpin peptides with enhanced cell specificity and potent anti-inflammatory activity,Escherichiacoli
NTVKETIKYLKSLFSHAFEVVKT,520,87,10043,"Design, Characterization and Antimicrobial activity of Novel Antimicrobial Peptide Derived from Bovine Lactophoricin.",Listeriainnocua
NTVKETIKYLKSLFS,520,87,10044,"Design, Characterization and Antimicrobial activity of Novel Antimicrobial Peptide Derived from Bovine Lactophoricin.",Listeriainnocua
NWVKEWIKYLKSLFSHAFEVVKT,520,87,10045,"Design, Characterization and Antimicrobial activity of Novel Antimicrobial Peptide Derived from Bovine Lactophoricin.",Listeriainnocua
NKVKEWIKYLKSLFS,520,87,10046,"Design, Characterization and Antimicrobial activity of Novel Antimicrobial Peptide Derived from Bovine Lactophoricin.",Listeriainnocua
KKSAGWVIPIGTLVK,521,2,10063,Antimicrobial effects of novel peptides cOT2 and sOT2 derived from Crocodylus siamensis and Pelodiscus sinensis ovotransferrins.,Escherichiacoli
KKSCHTGLKKSAGWVIPIGTLVKNGIIVR,521,2,10064,Antimicrobial effects of novel peptides cOT2 and sOT2 derived from Crocodylus siamensis and Pelodiscus sinensis ovotransferrins.,Escherichiacoli
KKSCHTGLDRSAGWVIPIGTLVKKAILPWDRK,521,2,10065,Antimicrobial effects of novel peptides cOT2 and sOT2 derived from Crocodylus siamensis and Pelodiscus sinensis ovotransferrins.,Escherichiacoli
SRSEKAGLQFPVGRIGRMLKK,522,50,10072,"A novel antimicrobial peptide, scolopendin, from Scolopendra subspinipes mutilans and its microbicidal mechanism.",Enterococcusfaecium
KCRQWQSKIRRTNPIFCIRR,523,2,10073,Comparing bacterial membrane interactions and antimicrobial activity of porcine lactoferricin-derived peptides.,Escherichiacoli
KARQWQSKIRRTNPIFAIRR,523,2,10074,Comparing bacterial membrane interactions and antimicrobial activity of porcine lactoferricin-derived peptides.,Escherichiacoli
KARQWQWKIRRTWPIFAIRR,523,2,10075,Comparing bacterial membrane interactions and antimicrobial activity of porcine lactoferricin-derived peptides.,Escherichiacoli
KSRQWQWKIRRTWPIFSIRR,523,2,10076,Comparing bacterial membrane interactions and antimicrobial activity of porcine lactoferricin-derived peptides.,Escherichiacoli
KWRQWQSKWRRTNPWFWIRR,523,2,10077,Comparing bacterial membrane interactions and antimicrobial activity of porcine lactoferricin-derived peptides.,Escherichiacoli
RWQWRWQWR,524,2,10099,"Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Antimicrobial Activity against E. coli ATCC 11775, S. maltophilia ATCC 13636 and S. enteritidis ATCC 13076",Escherichiacoli
GWLDVAKKIGKAAFNVAKNFLK,525,1,10138,Effects of dimerization on the structure and biological activity of antimicrobial peptide Ctx-Ha.,None_target
FKCRRWQWRMKKLGAPS,526,2,10150,Killing of Staphylococcus aureus and Salmonella enteritidis and neutralization of lipopolysaccharide by 17-residue bovine lactoferricins: improved activity of Trp/Ala-containing molecules.,Escherichiacoli
FKAFRWAWRMKKLAAPS,526,2,10152,Killing of Staphylococcus aureus and Salmonella enteritidis and neutralization of lipopolysaccharide by 17-residue bovine lactoferricins: improved activity of Trp/Ala-containing molecules.,Escherichiacoli
FKAWRWAWRMKKLAAPS,526,2,10153,Killing of Staphylococcus aureus and Salmonella enteritidis and neutralization of lipopolysaccharide by 17-residue bovine lactoferricins: improved activity of Trp/Ala-containing molecules.,Escherichiacoli
FKAFRWAWRWKKLAAPS,526,2,10154,Killing of Staphylococcus aureus and Salmonella enteritidis and neutralization of lipopolysaccharide by 17-residue bovine lactoferricins: improved activity of Trp/Ala-containing molecules.,Escherichiacoli
FKCWRWQWRWKKLGAPS,526,2,10156,Killing of Staphylococcus aureus and Salmonella enteritidis and neutralization of lipopolysaccharide by 17-residue bovine lactoferricins: improved activity of Trp/Ala-containing molecules.,Escherichiacoli
RWKIFKKIERVGQNVRDGIIKAGKAIQVLGTAKALGK,527,97,10181,Selective cytotoxicity of the antibacterial peptide ABP-dHC-Cecropin A and its analog towards leukemia cells.,Humanmyelogenous
KKKKKKKK,528,8,10231,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis
FFFHIVKGLFHAGRMIHGLV,529,2,10233,"Three new piscidins from orange-spotted grouper (Epinephelus coioides): Phylogeny, expression and functional characterization.",Escherichiacoli
IFGLLLHGAIHVGKLIHGLVRRH,529,2,10235,"Three new piscidins from orange-spotted grouper (Epinephelus coioides): Phylogeny, expression and functional characterization.",Escherichiacoli
FFRHIKSFWKGAKAIFRGARQG,529,2,10237,"Three new piscidins from orange-spotted grouper (Epinephelus coioides): Phylogeny, expression and functional characterization.",Escherichiacoli
KKKKKKKKK,528,8,10238,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis
KKKKKKKKKK,528,8,10239,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis
KKKKKKKKKKK,528,8,10240,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis
KKKKKKKKKKKK,528,8,10241,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis
KKKKKKKKKKKKK,528,8,10242,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis
KKKKKKKKKKKKKK,528,8,10243,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis
FFPGIIKVASAILPTAICAITKRC,530,4,10248,"Identification and characterization of novel host defense peptides from the skin secretion of the fungoid frog, Hydrophylax bahuvistara (Anura: Ranidae).",Staphylococcusaureus
FFPGIIKVAGAILPTAICAITKRC,530,4,10251,"Identification and characterization of novel host defense peptides from the skin secretion of the fungoid frog, Hydrophylax bahuvistara (Anura: Ranidae).",Staphylococcusaureus
QGDGNFVIYTWKP,531,98,10254,Bacterial membrane binding and pore formation abilities of carbohydrate recognition domain of fish lectin.,Bacillusmycoides
KAFAKLAARKA,533,4,10260,Targeting methicillin-resistant Staphylococcus aureus with short salt-resistant synthetic peptides.,Staphylococcusaureus
RRRRRRRR,528,8,10262,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis
RRRRRRRRR,528,8,10263,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis
RRRRRRRRRRR,528,8,10264,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis
RRRRRRRRRRRR,528,8,10265,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis
RRRRRRRRRRRRR,528,8,10266,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis
RRRRRRRRRRRRRR,528,8,10267,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis
PPPPPPPP,528,8,10269,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis
PPPPPPPPP,528,8,10270,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis
PPPPPPPPPP,528,8,10271,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis
PPPPPPPPPPP,528,8,10272,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis
PPPPPPPPPPPP,528,8,10273,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis
PPPPPPPPPPPPP,528,8,10274,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis
PPPPPPPPPPPPPP,528,8,10275,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis
FAKLAARLYRKA,533,4,10276,Targeting methicillin-resistant Staphylococcus aureus with short salt-resistant synthetic peptides.,Staphylococcusaureus
GLNALKKVFQGIHEAIKKINNHVQ,534,2,10295,Investigation of cationicity and structure of pseudin-2 analogues for enhanced bacterial selectivity and anti-inflammatory activity.,Escherichiacoli
GLNALKKVFQGIHKAIKKINNHVQ,534,2,10296,Investigation of cationicity and structure of pseudin-2 analogues for enhanced bacterial selectivity and anti-inflammatory activity.,Escherichiacoli
GLNALKKVFQPIHEAIKLINNHVQ,534,2,10297,Investigation of cationicity and structure of pseudin-2 analogues for enhanced bacterial selectivity and anti-inflammatory activity.,Escherichiacoli
GLNALKKVFQPIHEAIKKINNHVQ,534,2,10298,Investigation of cationicity and structure of pseudin-2 analogues for enhanced bacterial selectivity and anti-inflammatory activity.,Escherichiacoli
GLNALKKVFQPIHKAIKKINNHVQ,534,2,10299,Investigation of cationicity and structure of pseudin-2 analogues for enhanced bacterial selectivity and anti-inflammatory activity.,Escherichiacoli
KRKIFLRTKILV,535,4,10304,Effect of tacticity-derived topological constraints in bactericidal peptides.,Staphylococcusaureus
VLIKTRLFIKRK,535,4,10305,Effect of tacticity-derived topological constraints in bactericidal peptides.,Staphylococcusaureus
RWKRWWRLL,536,3,10316,Optimization of antibacterial peptides by genetic algorithms and cheminformatics.,Pseudomonasaeruginosa
KWKRWWWFR,536,3,10317,Optimization of antibacterial peptides by genetic algorithms and cheminformatics.,Pseudomonasaeruginosa
RWKRWWRWI,536,3,10318,Optimization of antibacterial peptides by genetic algorithms and cheminformatics.,Pseudomonasaeruginosa
KWWRWRRWW,536,3,10319,Optimization of antibacterial peptides by genetic algorithms and cheminformatics.,Pseudomonasaeruginosa
RWKKWWRWL,536,3,10320,Optimization of antibacterial peptides by genetic algorithms and cheminformatics.,Pseudomonasaeruginosa
KKRWWWWWR,536,3,10321,Optimization of antibacterial peptides by genetic algorithms and cheminformatics.,Pseudomonasaeruginosa
RKRWWWWFR,536,3,10322,Optimization of antibacterial peptides by genetic algorithms and cheminformatics.,Pseudomonasaeruginosa
IWKRWWWKR,536,3,10323,Optimization of antibacterial peptides by genetic algorithms and cheminformatics.,Pseudomonasaeruginosa
RIWKIWWKR,536,3,10324,Optimization of antibacterial peptides by genetic algorithms and cheminformatics.,Pseudomonasaeruginosa
IKKRWWWFR,536,3,10325,Optimization of antibacterial peptides by genetic algorithms and cheminformatics.,Pseudomonasaeruginosa
IKWKRWWWR,536,3,10326,Optimization of antibacterial peptides by genetic algorithms and cheminformatics.,Pseudomonasaeruginosa
KWWKIWRWR,536,3,10327,Optimization of antibacterial peptides by genetic algorithms and cheminformatics.,Pseudomonasaeruginosa
RIWKRWWFR,536,3,10328,Optimization of antibacterial peptides by genetic algorithms and cheminformatics.,Pseudomonasaeruginosa
RLWKRWWIR,536,3,10329,Optimization of antibacterial peptides by genetic algorithms and cheminformatics.,Pseudomonasaeruginosa
FKKFFKKLKNSVKKRAKKFFKKPRVIGVSIPF,537,2,10339,Structure-function relationship of king cobra cathelicidin.,Escherichiacoli
KRFKKFFKKLKNSVKKRAKKFFKK,537,2,10340,Structure-function relationship of king cobra cathelicidin.,Escherichiacoli
KRFKKFFKKLKKFVKKGFKKFAKV,537,2,10341,Structure-function relationship of king cobra cathelicidin.,Escherichiacoli
FKKFFKKLKNSVKKR,537,2,10342,Structure-function relationship of king cobra cathelicidin.,Escherichiacoli
AKKFFKKPRVIGVSIPF,537,2,10343,Structure-function relationship of king cobra cathelicidin.,Escherichiacoli
YKWKIRFKR,539,3,10359,Improving short antimicrobial peptides despite elusive rules for activity.,Pseudomonasaeruginosa
RWCVYARVRGVRYRRCW,540,4,10385,Bioengineering and functional characterization of arenicin shortened analogs with enhanced antibacterial activity and cell selectivity.,Staphylococcusaureus
RWCVYACVRGVCYRRCW,540,4,10386,Bioengineering and functional characterization of arenicin shortened analogs with enhanced antibacterial activity and cell selectivity.,Staphylococcusaureus
RWCVRARVRGVRYRRCW,540,4,10387,Bioengineering and functional characterization of arenicin shortened analogs with enhanced antibacterial activity and cell selectivity.,Staphylococcusaureus
RWCVYARRRGVRYRRCW,540,4,10388,Bioengineering and functional characterization of arenicin shortened analogs with enhanced antibacterial activity and cell selectivity.,Staphylococcusaureus
RWCVYARVRGRRYRRCW,540,4,10389,Bioengineering and functional characterization of arenicin shortened analogs with enhanced antibacterial activity and cell selectivity.,Staphylococcusaureus
RWCVYARVRGVRYRRCR,540,4,10390,Bioengineering and functional characterization of arenicin shortened analogs with enhanced antibacterial activity and cell selectivity.,Staphylococcusaureus
ENFFKRIRRAGKRIRDAIISAAPAVETLAQAQKIIKGGD,541,2,10398,Antimicrobial activity and interactions of cationic peptides derived from Galleria mellonella cecropin D-like peptide with model membranes.,Escherichiacoli
RNFFKRIRRAGKRIRKAIISAAPAVETLAQAQKIIKGGD,541,2,10399,Antimicrobial activity and interactions of cationic peptides derived from Galleria mellonella cecropin D-like peptide with model membranes.,Escherichiacoli
RLLFRKIRRLKR,542,4,10402,A peptide derived from phage display library exhibits antibacterial activity against E. coli and Pseudomonas aeruginosa.,Staphylococcusaureus
WGWRDIVRGIRKVAAPVLST,544,44,10438,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila
DLIWKLLSKAQEKFGKNKSK,545,99,10439,Effects of lactoferrin derived peptides on simulants of biological warfare agents.,Bacillusglobigii
DLIWRLLSRAQERFGKNRSR,545,99,10440,Effects of lactoferrin derived peptides on simulants of biological warfare agents.,Bacillusglobigii
FKCKKWQWKMKKLG,545,99,10441,Effects of lactoferrin derived peptides on simulants of biological warfare agents.,Bacillusglobigii
FRCRRWQWRMRRLG,545,99,10442,Effects of lactoferrin derived peptides on simulants of biological warfare agents.,Bacillusglobigii
RLLRKFFRKLKKSV,546,4,10450,Effective antimicrobial activity of a peptide mutant Cbf-14-2 against penicillin-resistant bacteria based on its unnatural amino acids.,Staphylococcusaureus
TLEEFSAKL,544,44,10456,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila
AGWRDIVRGIRKVAAPVLST,544,44,10457,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila
WAWRDIVRGIRKVAAPVLST,544,44,10458,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila
WGARDIVRGIRKVAAPVLST,544,44,10459,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila
WGWADIVRGIRKVAAPVLST,544,44,10460,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila
WGWRAIVRGIRKVAAPVLST,544,44,10461,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila
WGWRDAVRGIRKVAAPVLST,544,44,10468,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila
WGWRDIARGIRKVAAPVLST,547,44,10469,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases,Aeromonashydrophila
WGWRDIVAGIRKVAAPVLST,544,44,10470,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila
WGWRDIVRAIRKVAAPVLST,544,44,10471,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila
WGWRDIVRGARKVAAPVLST,544,44,10472,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila
WGWRDIVRGIAKVAAPVLST,544,44,10473,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila
WGWRDIVRGIRAVAAPVLST,544,44,10474,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila
WGWRDIVRGIRKAAAPVLST,544,44,10475,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila
WGWRDIVRGIRKVAAAVLST,544,44,10476,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila
WGWRDIVRGIRKVAAPALST,544,44,10477,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila
WGWRDIVRGIRKVAAPVAST,544,44,10478,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila
WGWRDIVRGIRKVAAPVLAT,544,44,10479,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila
WGWRDIVRGIRKVAAPVLSA,544,44,10480,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila
FFGWLIKPAIHAGKAIHGLIHRRRH,548,2,10485,Identification of GXXXXG motif in Chrysophsin-1 and its implication in the design of analogs with cell-selective antimicrobial and anti-endotoxin activities.,Escherichiacoli
FFGWLIKGAIHAPKAIHGLIHRRRH,548,2,10486,Identification of GXXXXG motif in Chrysophsin-1 and its implication in the design of analogs with cell-selective antimicrobial and anti-endotoxin activities.,Escherichiacoli
FFGWLIKGAIHAGKAIHPLIHRRRH,548,2,10487,Identification of GXXXXG motif in Chrysophsin-1 and its implication in the design of analogs with cell-selective antimicrobial and anti-endotoxin activities.,Escherichiacoli
FFGWLIKGAIHAPKAIHPLIHRRRH,548,2,10488,Identification of GXXXXG motif in Chrysophsin-1 and its implication in the design of analogs with cell-selective antimicrobial and anti-endotoxin activities.,Escherichiacoli
GRKKRRQRRRGGWMWVTNLRTD,549,59,10519,The Anticancer Peptide TAT-RasGAP317-326 Exerts Broad Antimicrobial Activity.,Acinetobacterbaumannii
MAGGKAGKDSGKAKAKAVSRSARAGLQFPVGRIHRHLK,550,34,10521,Mechanism study on a new antimicrobial peptide Sphistin derived from the N-terminus of crab histone H2A identified in haemolymphs of Scylla paramamosain.,Micrococcuslysodeikticus
KAKAKAVSRSARAGLQFPVGRIHRHLK,551,34,10522,A truncated Sph12-38 with potent antimicrobial activity showing resistance against bacterial challenge in Oryzias melastigma.,Micrococcuslysodeikticus
RSARAGLQFPVGRIHRHLK,551,34,10523,A truncated Sph12-38 with potent antimicrobial activity showing resistance against bacterial challenge in Oryzias melastigma.,Micrococcuslysodeikticus
VGRIHRHLK,551,34,10524,A truncated Sph12-38 with potent antimicrobial activity showing resistance against bacterial challenge in Oryzias melastigma.,Micrococcuslysodeikticus
NLLNKALGTVNGLLGRS,552,2,10526,"Dendropsophin 1, a novel antimicrobial peptide from the skin secretion of the endemic Colombian frog Dendropsophus columbianus.",Escherichiacoli
GLPVCGETCTLGTCSTQGCTCSWPICKRN,553,2,10534,Bactericidal activity of cyclotides where phosphatidylethanolamine-lipid selectivity determines antimicrobial spectra.,Escherichiacoli
FKARRWQWRMKK,554,2,10549,Antibacterial activity of synthetic peptides derived from lactoferricin against Escherichia coli ATCC 25922 and Enterococcus faecalis ATCC 29212.,Escherichiacoli
FKARRWQWRM,554,2,10550,Antibacterial activity of synthetic peptides derived from lactoferricin against Escherichia coli ATCC 25922 and Enterococcus faecalis ATCC 29212.,Escherichiacoli
FKARLWQWRM,554,2,10552,Antibacterial activity of synthetic peptides derived from lactoferricin against Escherichia coli ATCC 25922 and Enterococcus faecalis ATCC 29212.,Escherichiacoli
FKALLWQWRM,554,2,10553,Antibacterial activity of synthetic peptides derived from lactoferricin against Escherichia coli ATCC 25922 and Enterococcus faecalis ATCC 29212.,Escherichiacoli
KKKLFKKKLQ,555,33,10570,Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.,Pseudomonassyringae
KLKKKKFKLQ,555,33,10571,Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.,Pseudomonassyringae
LKKKKKKFLQ,555,33,10572,Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.,Pseudomonassyringae
LKKKKKKLFQ,555,33,10573,Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.,Pseudomonassyringae
KLKKKKLKFQ,555,33,10574,Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.,Pseudomonassyringae
KKLKKLKKFQ,555,33,10575,Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.,Pseudomonassyringae
KKKLLKKKFQ,555,33,10576,Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.,Pseudomonassyringae
LKKKKFLKKQ,555,33,10577,Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.,Pseudomonassyringae
LKKFKKKKLQ,555,33,10578,Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.,Pseudomonassyringae
KLKKKFLKKQ,555,33,10579,Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.,Pseudomonassyringae
KLKFKKKKLQ,555,33,10580,Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.,Pseudomonassyringae
KFKKKLKKLQ,555,33,10581,Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.,Pseudomonassyringae
KFKKKLLKKQ,555,33,10582,Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.,Pseudomonassyringae
KFKLKKKKLQ,555,33,10583,Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.,Pseudomonassyringae
KLKKKLKKFQ,555,33,10584,Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.,Pseudomonassyringae
GCRRLCYKQRCVTYCRGR,556,2,10601,Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties.,Escherichiacoli
GCRRLCWKQRCVTYCRGR,556,2,10602,Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties.,Escherichiacoli
GCRRLCYKQRCVTWCRGR,556,2,10603,Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties.,Escherichiacoli
GCRRLCYRQRCVTYCRGR,556,2,10604,Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties.,Escherichiacoli
GCRRLCWRQRCVTWCRGR,556,2,10605,Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties.,Escherichiacoli
GCRALCYKQRCVTYCRGA,556,2,10606,Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties.,Escherichiacoli
KCRRLCYRQRCVTYCRGR,556,2,10607,Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties.,Escherichiacoli
GCRRWCYKQRCVTYCRGR,556,2,10609,Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties.,Escherichiacoli
KCRRYCYRQRCVTYCRGR,556,2,10611,Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties.,Escherichiacoli
WKRRIKIWKKIR,557,3,10625,A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.,Pseudomonasaeruginosa
WIRRIKKWIRRVHK,557,3,10626,A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.,Pseudomonasaeruginosa
WLRRIKAWLRRKRK,557,3,10627,A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.,Pseudomonasaeruginosa
VTADVLSFEAKGIAVNHSACALHCIALRKKGGSAQNGVCVCRN,558,2,10671,"Structure-activity relationships of the intramolecular disulfide bonds in coprisin, a defensin from the dung beetle.",Escherichiacoli
VTCDVLSFEAKGIAVNHSAAALHCIALRKKGGSCQNGVAVCRN,558,2,10672,"Structure-activity relationships of the intramolecular disulfide bonds in coprisin, a defensin from the dung beetle.",Escherichiacoli
VTCDVLSFEAKGIAVNHSACALHAIALRKKGGSCQNGVCVARN,558,2,10673,"Structure-activity relationships of the intramolecular disulfide bonds in coprisin, a defensin from the dung beetle.",Escherichiacoli
RECKTESHRFKGPCITKPPCRKACISEKFTDGHCSKILRRCLCTKPC,559,24,10685,Nicotiana alata Defensin Chimeras Reveal Differences in the Mechanism of Fungal and Tumor Cell Killing and an Enhanced Antifungal Variant.,Fusariumoxysporum
RTCESQSNTFPGICITKPPCRKACISEKFTDGHCSKILRRCLCTKPC,559,24,10686,Nicotiana alata Defensin Chimeras Reveal Differences in the Mechanism of Fungal and Tumor Cell Killing and an Enhanced Antifungal Variant.,Fusariumoxysporum
RECKTESNTFPGICITKPPCRKACLTEGFTDGHCSKILRRCLCTKPC,559,24,10687,Nicotiana alata Defensin Chimeras Reveal Differences in the Mechanism of Fungal and Tumor Cell Killing and an Enhanced Antifungal Variant.,Fusariumoxysporum
RECKTESNTFPGICITKPPCRKACISEKFSGGDCSKILRRCLCTKPC,559,24,10688,Nicotiana alata Defensin Chimeras Reveal Differences in the Mechanism of Fungal and Tumor Cell Killing and an Enhanced Antifungal Variant.,Fusariumoxysporum
RECKTESNTFPGICITKPPCRKACISEKFTDGHCRGFRRRCLCTKPC,559,24,10689,Nicotiana alata Defensin Chimeras Reveal Differences in the Mechanism of Fungal and Tumor Cell Killing and an Enhanced Antifungal Variant.,Fusariumoxysporum
RECKTESNTFPGICITKPPCRKACISEKFTDGHCSKILRRCFCTRPC,559,24,10690,Nicotiana alata Defensin Chimeras Reveal Differences in the Mechanism of Fungal and Tumor Cell Killing and an Enhanced Antifungal Variant.,Fusariumoxysporum
FLGGLIKIVPAMICAVRKKC,560,100,10698,Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae ,Streptococcuspneumoniae
GIHHILKYGKPS,561,2,10699,"Design and membrane-disruption mechanism of charge-enriched AMPs exhibiting cell selectivity, high-salt resistance, and anti-biofilm properties.",Escherichiacoli
KIKWILKYWKWS,561,2,10700,"Design and membrane-disruption mechanism of charge-enriched AMPs exhibiting cell selectivity, high-salt resistance, and anti-biofilm properties.",Escherichiacoli
RIRWILRYWRWS,561,2,10701,"Design and membrane-disruption mechanism of charge-enriched AMPs exhibiting cell selectivity, high-salt resistance, and anti-biofilm properties.",Escherichiacoli
FLGGLIKPVPAMICAVRKKC,562,100,10702,Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae   ,Streptococcuspneumoniae
FLGGLIKRVPAMICAVRKKC,560,100,10704,Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae ,Streptococcuspneumoniae
FLGGLIKRPPAMICAVRKKC,560,100,10705,Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae ,Streptococcuspneumoniae
RRRRRFRRVIRRIRLPKYLTINTE,563,2,10715,"Myticalins: A Novel Multigenic Family of Linear, Cationic Antimicrobial Peptides from Marine Mussels (Mytilus spp.)",Escherichiacoli
RRRRRYRYWRRGLTIQGRPKSLPLNTGD,563,2,10716,"Myticalins: A Novel Multigenic Family of Linear, Cationic Antimicrobial Peptides from Marine Mussels (Mytilus spp.)",Escherichiacoli
WGRRWRIRIPRLPRPWPPRPKWPRSATINTDQ,563,2,10717,"Myticalins: A Novel Multigenic Family of Linear, Cationic Antimicrobial Peptides from Marine Mussels (Mytilus spp.)",Escherichiacoli
WPRFPKPRKPTYPGPTYPGPTWPRPTWRRSATIDTEH,563,2,10718,"Myticalins: A Novel Multigenic Family of Linear, Cationic Antimicrobial Peptides from Marine Mussels (Mytilus spp.)",Escherichiacoli
GFGCPFNARRCHRHCRSIRRRAGYCAGRLRLTCTCVR,564,101,10719,"Functional characterization of two defensins, HlDFS1 and HlDFS2, from the hard tick Haemaphysalis longicornis.",Bacilluspumilus
GFGCPLNQGACHRHCRSIRRRGGYCSGIIKQTCTCY,564,101,10720,"Functional characterization of two defensins, HlDFS1 and HlDFS2, from the hard tick Haemaphysalis longicornis.",Bacilluspumilus
RKLPDAPGMHTWGGGGINTLQKYYCRVRG,565,102,10725,Engineered chimeric peptides with antimicrobial and titanium-binding functions to inhibit biofilm formation on Ti implants.,Streptococcusoralis
RKLPDAPGMHTWGGGGRCAVLSCLPKEQI,565,102,10726,Engineered chimeric peptides with antimicrobial and titanium-binding functions to inhibit biofilm formation on Ti implants.,Streptococcusoralis
RKLPDAPGMHTWGGGGKCSTRGRKCCRRKK,565,102,10727,Engineered chimeric peptides with antimicrobial and titanium-binding functions to inhibit biofilm formation on Ti implants.,Streptococcusoralis
NPEKALEPLIAIQIAIKGMLNGWFTGVGFRRKR,566,59,10752,Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2.,Acinetobacterbaumannii
EKALEKLIAIQKAIKGMLNGWFTGVGFRRKR,566,59,10753,Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2.,Acinetobacterbaumannii
EKALEKLIAIQKAIKGMLAGWFTGVGARRKR,566,59,10754,Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2.,Acinetobacterbaumannii
NPEKALEKLIAIQKAIKGMLNGWFTGVGFRRKR,566,59,10755,Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2.,Acinetobacterbaumannii
ACPIFTKIQGTCYRG,567,41,10756,Activity of human beta defensin-1 and its motif against active and dormant Mycobacterium tuberculosis.,Mycobacteriumtuberculosis
PRVIETKVHGREVTGLARNVSEENVDRLAKRWIK,568,41,10788,"A mycobacteriophage-derived trehalose-6,6'-dimycolate-binding peptide containing both antimycobacterial and anti-inflammatory abilities.",Mycobacteriumtuberculosis
ECYRKSDIVTCEPWQKFCYREVTFFPNHPVYLSGCASECTETNSKWCCTTDKCNRARGG,569,41,10790,In vitro activities of small peptides from snake venom against clinical isolates of drug-resistant Mycobacterium tuberculosis.,Mycobacteriumtuberculosis
SFGVTIGIGPAGSPLLVGVGVSHSQD,570,2,10813,Four novel antimicrobial peptides derived from human C8?-MACPF,Escherichiacoli
CFGGSLGIQYEDKINVGGGLSGDHC,570,2,10814,Four novel antimicrobial peptides derived from human C8?-MACPF,Escherichiacoli
VDNANDLLSKVKKDKSD,570,2,10815,Four novel antimicrobial peptides derived from human C8?-MACPF,Escherichiacoli
TSFLNELNKYNEKKFI,570,2,10816,Four novel antimicrobial peptides derived from human C8?-MACPF,Escherichiacoli
VIDKAKMESLGITSRDTT,570,2,10817,Four novel antimicrobial peptides derived from human C8?-MACPF,Escherichiacoli
KKFGGGKTERARKAMAVE,570,2,10818,Four novel antimicrobial peptides derived from human C8?-MACPF,Escherichiacoli
IIPLPLGYFAKKKKKKDPVPLDQ,571,4,10828,"Induction of antimicrobial peptides from Rana dybowskii under Rana grylio virus stress, and bioactivity analysis.",Staphylococcusaureus
VLPLLETCSMTCWENNQTFGK,571,4,10830,"Induction of antimicrobial peptides from Rana dybowskii under Rana grylio virus stress, and bioactivity analysis.",Staphylococcusaureus
KCNTATCVTQRLADFLVRSSNTIGTVYAPTNVGAAAY,572,18,10831,High-Throughput Identification of Antimicrobial Peptides from Amphibious Mudskippers.,Micrococcusluteus
RLLGNCLTVVMAAKLGTAFSPEIQCAWQK,572,18,10832,High-Throughput Identification of Antimicrobial Peptides from Amphibious Mudskippers.,Micrococcusluteus
EFELDRICCGYGTARCRKKRSQEYRIGRCPNTYACCLRK,573,2,10860,Human ?-defensin 4 with non-native disulfide bridges exhibit antimicrobial activity.,Escherichiacoli
EFELDRISSGYGTARCRKKRSQEYRIGRSPNTYASCLRK,573,2,10862,Human ?-defensin 4 with non-native disulfide bridges exhibit antimicrobial activity.,Escherichiacoli
ELDRISSGYGTARCRKKRSQEYRIGRSPNTYASCLRK,573,2,10863,Human ?-defensin 4 with non-native disulfide bridges exhibit antimicrobial activity.,Escherichiacoli
GCPLNQGACHNHCRSIGRRGGYCAGIIKQTCTCYRK,574,4,10867,Activity of tick antimicrobial peptide from Ixodes persulcatus (persulcatusin) against cell membranes of drug-resistant Staphylococcus aureus.,Staphylococcusaureus
RWRWNRRTGRWRWY,575,2,10876,Biological consequences of improving the structural stability of hairpins that have antimicrobial activity.,Escherichiacoli
LPRRNRWSKIWKKVVTVFS,576,4,10878,The rumen microbiome: an underexplored resource for novel antimicrobial discovery.,Staphylococcusaureus
HLRRINKLLTRIGLYRHAFG,576,4,10879,The rumen microbiome: an underexplored resource for novel antimicrobial discovery.,Staphylococcusaureus
NRFTARFRRTPWRLCLQFRQ,576,4,10880,The rumen microbiome: an underexplored resource for novel antimicrobial discovery.,Staphylococcusaureus
VLHTGYRKFLHRSKRFFHLR,576,4,10881,The rumen microbiome: an underexplored resource for novel antimicrobial discovery.,Staphylococcusaureus
TMSLRFWRWKVR,576,4,10882,The rumen microbiome: an underexplored resource for novel antimicrobial discovery.,Staphylococcusaureus
AWRWKAFRNCWRVRSSSL,576,4,10883,The rumen microbiome: an underexplored resource for novel antimicrobial discovery.,Staphylococcusaureus
RSITRPVLVRRRWRVRPVF,576,4,10884,The rumen microbiome: an underexplored resource for novel antimicrobial discovery.,Staphylococcusaureus
SIKILKIYFIQGKRHWSF,576,4,10885,The rumen microbiome: an underexplored resource for novel antimicrobial discovery.,Staphylococcusaureus
QVRWWGRYWRRKWATCR,576,4,10886,The rumen microbiome: an underexplored resource for novel antimicrobial discovery.,Staphylococcusaureus
GTAWRWHYRARS,576,4,10887,The rumen microbiome: an underexplored resource for novel antimicrobial discovery.,Staphylococcusaureus
KFVRLKIYCRDKNKGRGISF,576,4,10888,The rumen microbiome: an underexplored resource for novel antimicrobial discovery.,Staphylococcusaureus
GSKRWRKFEKRVKKIFEETKEALPVVQGVVAVATAVGRR,577,2,10889,Identification and characterization of novel cecropins from the Oxysternon conspicillatum neotropic dung beetle.,Escherichiacoli
GSKRWRKFEKKVKKALEDAKEKLQEERVQKIVEHTKEALPVIKAVATVVGVVGRR,577,2,10890,Identification and characterization of novel cecropins from the Oxysternon conspicillatum neotropic dung beetle.,Escherichiacoli
GSKRWRKFEKRVKKVFEHTKEALPVIQGVATVVGAVGRR,577,2,10891,Identification and characterization of novel cecropins from the Oxysternon conspicillatum neotropic dung beetle.,Escherichiacoli
KWICRRLWYRGRWITYCRWR,578,2,10897,Hairpin structure stability plays a role in the activity of two antimicrobial peptides.,Escherichiacoli
KWWCFRVCYRGICYRRCRWK,578,2,10898,Hairpin structure stability plays a role in the activity of two antimicrobial peptides.,Escherichiacoli
KWWVFRVVYRGIVYRRVRWK,578,2,10899,Hairpin structure stability plays a role in the activity of two antimicrobial peptides.,Escherichiacoli
KQKLAKLKAKLQKLKQKLAKL,579,2,10912,Nanoscale imaging reveals laterally expanding antimicrobial pores in lipid bilayers.,Escherichiacoli
QIAALEQEIAALEQEIAALQ,579,2,10913,Nanoscale imaging reveals laterally expanding antimicrobial pores in lipid bilayers.,Escherichiacoli
RRGYGLKLALAKDGWALMLRLGFGRR,580,2,10914,Beta-sheet pore-forming peptides selected from a rational combinatorial library: mechanism of pore formation in lipid vesicles and activity in biological membranes.,Escherichiacoli
RRGFSLKLALAKDGWALMLRLGYGRR,580,2,10915,Beta-sheet pore-forming peptides selected from a rational combinatorial library: mechanism of pore formation in lipid vesicles and activity in biological membranes.,Escherichiacoli
RRGAGLGLALAKDGWALMLKLGFGRR,580,2,10916,Beta-sheet pore-forming peptides selected from a rational combinatorial library: mechanism of pore formation in lipid vesicles and activity in biological membranes.,Escherichiacoli
RRGGGLELALAKDGWALMLDLGAGRR,580,2,10917,Beta-sheet pore-forming peptides selected from a rational combinatorial library: mechanism of pore formation in lipid vesicles and activity in biological membranes.,Escherichiacoli
GRPNPVPNPKPPHPRL,581,2,10920,The presence of arginine in the Pro-Arg-Pro motif augments the lethality of proline rich antimicrobial peptides of insect source.,Escherichiacoli
GRPNPVPNPRPPHPRL,581,2,10921,The presence of arginine in the Pro-Arg-Pro motif augments the lethality of proline rich antimicrobial peptides of insect source.,Escherichiacoli
GNNRPVYIPQPKPPHPRL,581,2,10922,The presence of arginine in the Pro-Arg-Pro motif augments the lethality of proline rich antimicrobial peptides of insect source.,Escherichiacoli
GKPKPYSPRPTSHPRPIRV,581,2,10923,The presence of arginine in the Pro-Arg-Pro motif augments the lethality of proline rich antimicrobial peptides of insect source.,Escherichiacoli
GKPRPYSPKPTSHPRPIRV,581,2,10924,The presence of arginine in the Pro-Arg-Pro motif augments the lethality of proline rich antimicrobial peptides of insect source.,Escherichiacoli
GKPRPYSPRPTSHPKPIRV,581,2,10925,The presence of arginine in the Pro-Arg-Pro motif augments the lethality of proline rich antimicrobial peptides of insect source.,Escherichiacoli
GKPRPYSPRPSSHPRPIRV,582,2,10926,"Understanding the importance of glycosylated threonine and stereospecific action of Drosocin, a Proline rich antimicrobial peptide.",Escherichiacoli
GKPRPYPPRPPPHPRPIRV,582,2,10928,"Understanding the importance of glycosylated threonine and stereospecific action of Drosocin, a Proline rich antimicrobial peptide.",Escherichiacoli
RCYNGCCRRGYYGGCRCCAHPDEIPDPEYRAEPAYGHP,583,103,10932,A potent antimicrobial peptide derived from the protein LsGRP1 of Lilium.,Agrobacteriumtumefaciens
LKKISQRYQKFALPQYLKTVYQHQKAMKPWIQPKTKVIPYVRYL,584,87,10933,A Simple Method to Separate the Antimicrobial Peptides from Complex Peptic Casein Hydrolysate and Identification of a Novel Antibacterial Domains within the Sequence of Bovine ?s-Casein,Listeriainnocua
RLVRILVSKRPVAIKPYFRL,585,2,10944,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli
TTSIRRRYQVSLIRRHRGKR,585,2,10945,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli
TCRTNRPCFYDLDLNVCRCS,585,2,10946,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli
SNGDGTLDAGSTCAPFYARA,585,2,10947,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli
YYNPLPHDCGRDNNTDICSR,585,2,10948,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli
LSVDKRPVLHPEHIYGHNHY,585,2,10949,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli
IHRDQQHESFLDARPEPGLTE,585,2,10950,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli
TIDFGVRNINQSNLVYDTER,585,2,10951,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli
PCNPDHDYRPFGNFRIAFTT,585,2,10952,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli
TRDTNDLISSRTAAPSMV,585,2,10953,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli
LPLPSCSSHGGDADNTSQRN,585,2,10954,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli
PNDPDSPCVYRMPNARGCSI,585,2,10955,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli
YDLSDSNCLPANRDKRYYVI,585,2,10956,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli
SMLAYVDKNDHINPPHSPRS,585,2,10957,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli
DATPHAALFFTVKDHTAGDN,585,2,10958,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli
SDDAQRCYPHNRTPFTYTYI,585,2,10959,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli
EPCSPKNNYHDLFYRT,585,2,10960,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli
CNPLNGADRRTDSFPRFTVI,585,2,10961,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli
PDRAIDTYRTSPVADQRYNA,585,2,10964,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli
WKKIRVRLSA,586,1,11027,Rational modification of a dendrimeric peptide with antimicrobial activity: consequences on membrane-binding and biological properties.,None_target
KWKIRVRLSA,586,1,11030,Rational modification of a dendrimeric peptide with antimicrobial activity: consequences on membrane-binding and biological properties.,None_target
KEFKRIVKRIKKFLRKLV,587,85,11036,Cathelicidin is involved in the intracellular killing of mycobacteria in macrophages.,Mycobacteriumsmegmatis
GIGKFLKSKGKFGKA,588,41,11037,Effect of antimicrobial peptides on ATPase activity and proton pumping in plasma membrane vesicles obtained from mycobacteria.,Mycobacteriumtuberculosis
KLIPIASKTCPAGKNLCYKI,589,2,11043,Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity.,Escherichiacoli
KLIPILSKTIPAIKNLFYKI,589,2,11044,Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity.,Escherichiacoli
KLIWILSKTIPAIKNLFYKI,589,2,11045,Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity.,Escherichiacoli
KLIFILSKTIPAIKNLFYKI,589,2,11046,Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity.,Escherichiacoli
KLILILSKTIPAIKNLFYKI,589,2,11047,Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity.,Escherichiacoli
DRVFKFACRRNKAAR,590,2,11048,Discovery of novel antimicrobial peptides: A transcriptomic study of the sea anemone Cnidopus japonicus.,Escherichiacoli
NGKTWKKNRKACQVK,590,2,11049,Discovery of novel antimicrobial peptides: A transcriptomic study of the sea anemone Cnidopus japonicus.,Escherichiacoli
RNSVRNRVMLWRTKR,590,2,11050,Discovery of novel antimicrobial peptides: A transcriptomic study of the sea anemone Cnidopus japonicus.,Escherichiacoli
KAKRRARNLNQKKRK,590,2,11051,Discovery of novel antimicrobial peptides: A transcriptomic study of the sea anemone Cnidopus japonicus.,Escherichiacoli
GIWTCRKKRA,590,2,11052,Discovery of novel antimicrobial peptides: A transcriptomic study of the sea anemone Cnidopus japonicus.,Escherichiacoli
KKAKRRLLKK,590,2,11053,Discovery of novel antimicrobial peptides: A transcriptomic study of the sea anemone Cnidopus japonicus.,Escherichiacoli
RQIKKAFRKMA,590,2,11054,Discovery of novel antimicrobial peptides: A transcriptomic study of the sea anemone Cnidopus japonicus.,Escherichiacoli
KVKYFKRWLR,590,2,11055,Discovery of novel antimicrobial peptides: A transcriptomic study of the sea anemone Cnidopus japonicus.,Escherichiacoli
AKRRLLKKMK,590,2,11056,Discovery of novel antimicrobial peptides: A transcriptomic study of the sea anemone Cnidopus japonicus.,Escherichiacoli
RLKKHLKKIK,590,2,11057,Discovery of novel antimicrobial peptides: A transcriptomic study of the sea anemone Cnidopus japonicus.,Escherichiacoli
RVKASRRSASHPTYSEMIAAAIRAEKSRGG,591,17,11068,Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides.,Listeriamonocytogenes
VGHNADLQIKLSIRRLLAAGVLKQTKGVGA,591,17,11069,Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides.,Listeriamonocytogenes
LSIRRLLAAGVLKQTKGVGA,591,17,11070,Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides.,Listeriamonocytogenes
VLKQTKGVGASGSFRLAKSD,591,17,11071,Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides.,Listeriamonocytogenes
EMIAAAIRAEKSRGGSSRQS,591,17,11072,Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides.,Listeriamonocytogenes
EMIAAAIRAEKSRGGSSRQSIQKYIKSHYK,591,17,11073,Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides.,Listeriamonocytogenes
FLPKLLAGLPSFLCLVFKKC,592,4,11076,"Identification of novel Amurin-2 variants from the skin secretion of Rana amurensis, and the design of cationicity-enhanced analogues.",Staphylococcusaureus
FLPLLLAGLPKFLCLVFKKC,592,4,11077,"Identification of novel Amurin-2 variants from the skin secretion of Rana amurensis, and the design of cationicity-enhanced analogues.",Staphylococcusaureus
KRFKKFFRKLKKSVKKRKKEFKKKPRVIKVSIPF,593,4,11085,The antimicrobial potential of a new derivative of cathelicidin from Bungarus fasciatus against methicillin-resistant Staphylococcus aureus.,Staphylococcusaureus
KRFKKFFRKLKKSVKKRKKEFKKKPRVIGVSIPF,593,4,11086,The antimicrobial potential of a new derivative of cathelicidin from Bungarus fasciatus against methicillin-resistant Staphylococcus aureus.,Staphylococcusaureus
AWKKTIRQYLKNKIKKKGRKAVIAW,594,2,11117,"Rational design of syn-safencin, a novel linear antimicrobial peptide derived from the circular bacteriocin safencin AS-48.",Escherichiacoli
AGKKTIRQYLKNKIKKKWRKAVIAW,594,2,11118,"Rational design of syn-safencin, a novel linear antimicrobial peptide derived from the circular bacteriocin safencin AS-48.",Escherichiacoli
AGKKTIRQYLKNKIKKKGRKWVIAW,594,2,11119,"Rational design of syn-safencin, a novel linear antimicrobial peptide derived from the circular bacteriocin safencin AS-48.",Escherichiacoli
AWKKTIRQYLKNEIKKKWRKAVIAW,594,2,11120,"Rational design of syn-safencin, a novel linear antimicrobial peptide derived from the circular bacteriocin safencin AS-48.",Escherichiacoli
AWKETIRQYLKNKIKKKWRKAVIAW,594,2,11121,"Rational design of syn-safencin, a novel linear antimicrobial peptide derived from the circular bacteriocin safencin AS-48.",Escherichiacoli
AWKKTIRQYLKNKIKKKWRKAVIAW,594,2,11122,"Rational design of syn-safencin, a novel linear antimicrobial peptide derived from the circular bacteriocin safencin AS-48.",Escherichiacoli
AWKEKIRQYLKNEIKKKWRKAVIAW,594,2,11123,"Rational design of syn-safencin, a novel linear antimicrobial peptide derived from the circular bacteriocin safencin AS-48.",Escherichiacoli
AWKETIRKYLKNEIKKKWRKAVIAW,594,2,11124,"Rational design of syn-safencin, a novel linear antimicrobial peptide derived from the circular bacteriocin safencin AS-48.",Escherichiacoli
AWKEKIRKKLKNEIKKKWRKAVIAW,594,2,11125,"Rational design of syn-safencin, a novel linear antimicrobial peptide derived from the circular bacteriocin safencin AS-48.",Escherichiacoli
LSLIAAAGKETIRQYLKNEIKKKGRKAVIAW,594,80,11126,"Rational design of syn-safencin, a novel linear antimicrobial peptide derived from the circular bacteriocin safencin AS-48.",Xanthomonasaxonopodis
GPHSANHVRGLARVGNANPGLYLAKYAFIPVILAAKPLSPTPTKT,595,2,11158,"Novel synthetic analogues of avian ?-defensin-12: the role of charge, hydrophobicity, and disulfide bridges in biological functions.",Escherichiacoli
GPRSSNHKRGLSRVGNSNPGKYLAKYSFRPVILSSKPLSPTPTKT,595,2,11159,"Novel synthetic analogues of avian ?-defensin-12: the role of charge, hydrophobicity, and disulfide bridges in biological functions.",Escherichiacoli
GPRSANHKRGLARVGNANPGKYLAKYSFRPVILSSKPLSPTPTKT,595,2,11160,"Novel synthetic analogues of avian ?-defensin-12: the role of charge, hydrophobicity, and disulfide bridges in biological functions.",Escherichiacoli
GPHSCNHQRGLCRVGNCNPGYYLAKYCFSPVILCCKPLSPTPTKT,595,2,11164,"Novel synthetic analogues of avian ?-defensin-12: the role of charge, hydrophobicity, and disulfide bridges in biological functions.",Escherichiacoli
RRIRFRPPYLPRPGRRPRFPPPFPIPRIPRIP,596,2,11184,The Dolphin Proline-Rich Antimicrobial Peptide Tur1A Inhibits Protein Synthesis by Targeting the Bacterial Ribosome.,Escherichiacoli
RRIRFRPPYLPRPGRR,596,2,11185,The Dolphin Proline-Rich Antimicrobial Peptide Tur1A Inhibits Protein Synthesis by Targeting the Bacterial Ribosome.,Escherichiacoli
PYLPRPGRRPRFPPPFP,596,2,11186,The Dolphin Proline-Rich Antimicrobial Peptide Tur1A Inhibits Protein Synthesis by Targeting the Bacterial Ribosome.,Escherichiacoli
RPRFPPPFPIPRIPRIP,596,2,11187,The Dolphin Proline-Rich Antimicrobial Peptide Tur1A Inhibits Protein Synthesis by Targeting the Bacterial Ribosome.,Escherichiacoli
RRIPFWPPNWPGPWLPPWSPPDFRIPRILRKR,596,2,11188,The Dolphin Proline-Rich Antimicrobial Peptide Tur1A Inhibits Protein Synthesis by Targeting the Bacterial Ribosome.,Escherichiacoli
NLVSALIEGRKYLKNVLK,597,4,11213,"Discovery of Distinctin-Like-Peptide-PH (DLP-PH) From the Skin Secretion of Phyllomedusa hypochondrialis, a Prototype of a Novel Family of Antimicrobial Peptide.",Staphylococcusaureus
KLNRLKEKNKAKNSKENN,597,4,11214,"Discovery of Distinctin-Like-Peptide-PH (DLP-PH) From the Skin Secretion of Phyllomedusa hypochondrialis, a Prototype of a Novel Family of Antimicrobial Peptide.",Staphylococcusaureus
NVLKKLNRLKEKNKAKNSKENN,597,4,11215,"Discovery of Distinctin-Like-Peptide-PH (DLP-PH) From the Skin Secretion of Phyllomedusa hypochondrialis, a Prototype of a Novel Family of Antimicrobial Peptide.",Staphylococcusaureus
GFLEKLKKGAKDFASALVNSIKGT,598,4,11217,"A Combined Molecular Cloning and Mass Spectrometric Method to Identify, Characterize, and Design Frenatin Peptides from the Skin Secretion of Litoria infrafrenata.",Staphylococcusaureus
IKYLLVKLQGASQKTITLMLRRNNLYVMGYS,599,2,11272,"Novel bioactive peptides from PD-L1/2, a type 1 ribosome inactivating protein from Phytolacca dioica L. Evaluation of their antimicrobial properties and anti-biofilm activities.",Escherichiacoli
IKYLLVKLQGASQKTITLMLRRN,599,2,11273,"Novel bioactive peptides from PD-L1/2, a type 1 ribosome inactivating protein from Phytolacca dioica L. Evaluation of their antimicrobial properties and anti-biofilm activities.",Escherichiacoli
AFTHRRSYSTEYRYGTTVRGIRHRFL,600,2,11288,Antimicrobial activity of human ?-defensin 6 analogs: insights into the physico-chemical reasons behind weak bactericidal activity of HD6 in vitro.,Escherichiacoli
ELDRIGYGTARRKKR,601,2,11295,Engineering of a linear inactive analog of human ?-defensin 4 to generate peptides with potent antimicrobial activity.,Escherichiacoli
GIGRFLHSARRFGRAFVGEIMNS,602,2,11301,Improving the Activity of Trp-Rich Antimicrobial Peptides by Arg/Lys Substitutions and Changing the Length of Cationic Residues.,Escherichiacoli
GLPVCGECFGGTCNTPGCSCDPWPMCSRN,603,16,11308,Chemical Synthesis and Functional Analysis of VarvA Cyclotide.,Aeromonassalmonicida
TFFRLFNRSFT,604,7,11309,Selective activities of STAMPs against Streptococcus mutans.,Streptococcusmutans
LSTFFRLFN,604,7,11310,Selective activities of STAMPs against Streptococcus mutans.,Streptococcusmutans
STFFRLFNRSFTQ,604,7,11311,Selective activities of STAMPs against Streptococcus mutans.,Streptococcusmutans
LSTFFRLFNRSFTQ,604,7,11312,Selective activities of STAMPs against Streptococcus mutans.,Streptococcusmutans
TFFRLFNRGRRRRSVQWCA,604,7,11313,Selective activities of STAMPs against Streptococcus mutans.,Streptococcusmutans
TFFRLFNRSFTGRRRRSVQWCA,604,7,11314,Selective activities of STAMPs against Streptococcus mutans.,Streptococcusmutans
LSTFFRLFNGRRRRSVQWCA,604,7,11315,Selective activities of STAMPs against Streptococcus mutans.,Streptococcusmutans
STFFRLFNRSFTQGRRRRSVQWCA,604,7,11316,Selective activities of STAMPs against Streptococcus mutans.,Streptococcusmutans
LSTFFRLFNRSFTQGRRRRSVQWCA,604,7,11317,Selective activities of STAMPs against Streptococcus mutans.,Streptococcusmutans
FKFGSFIKRMWRSKLAKKLRAKGKELLRDYA,605,25,11320,"Meucin-49, a multifunctional scorpion venom peptide with bactericidal synergy with neurotoxins.",Bacilluscereus
RGRKYYRRKK,606,3,11331,Structure-dependent charge density as a determinant of antimicrobial activity of peptide analogues of defensin,Pseudomonasaeruginosa
CRWRWKCCKK,607,2,11335,CyLoP-1: Membrane-active peptide with cell-penetrating and antimicrobial properties.,Escherichiacoli
SRWRWKSSKK,607,2,11336,CyLoP-1: Membrane-active peptide with cell-penetrating and antimicrobial properties.,Escherichiacoli
MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTK,608,2,11339,Functional characterization of alpha-synuclein protein with antimicrobial activity.,Escherichiacoli
KKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA,608,2,11342,Functional characterization of alpha-synuclein protein with antimicrobial activity.,Escherichiacoli
KWRRKLKKLRPKKKRKV,609,104,11345,Antifungal activity of Latarcin 1 derived cell-penetrating peptides against Fusarium solani.,Fusariumsolani
KWRRKLKKLR,609,104,11346,Antifungal activity of Latarcin 1 derived cell-penetrating peptides against Fusarium solani.,Fusariumsolani
AWRRKLKALAPAKKAKV,609,104,11347,Antifungal activity of Latarcin 1 derived cell-penetrating peptides against Fusarium solani.,Fusariumsolani
RKKRRQRRRRKKRRQRRR,609,104,11348,Antifungal activity of Latarcin 1 derived cell-penetrating peptides against Fusarium solani.,Fusariumsolani
ASEELLLRFQATSSGPILREEFE,610,2,11361,IQ-motif peptides as novel anti-microbial agents.,Escherichiacoli
EQEENVVKIQAFWKGYKQRKEYM,610,2,11362,IQ-motif peptides as novel anti-microbial agents.,Escherichiacoli
DNTDSVVKIQSWFRMATARKSYL,610,2,11363,IQ-motif peptides as novel anti-microbial agents.,Escherichiacoli
DHNNEIVKIQSLLRANKARDDYK,610,2,11364,IQ-motif peptides as novel anti-microbial agents.,Escherichiacoli
ANVGFVIQLQARLRGFLVRQKFA,610,2,11365,IQ-motif peptides as novel anti-microbial agents.,Escherichiacoli
TWLPAVIKIQAHWRGYRQRKIYL,610,2,11366,IQ-motif peptides as novel anti-microbial agents.,Escherichiacoli
ANLDAIIKIQAWARMWAARRQYL,610,2,11367,IQ-motif peptides as novel anti-microbial agents.,Escherichiacoli
KNVNSIVKIQAFFRARKAQDDYR,610,2,11370,IQ-motif peptides as novel anti-microbial agents.,Escherichiacoli
GRFRRLGRKFKKLFKKYGP,611,2,11381,Design of synthetic antimicrobial peptides based on sequence analogy and amphipathicity.,Escherichiacoli
GLLRRLRKKIGEIFKKYG,611,2,11383,Design of synthetic antimicrobial peptides based on sequence analogy and amphipathicity.,Escherichiacoli
RGGRLCYCRRRFCVCVGR,612,2,11385,Membranolytic selectivity of cystine-stabilized cyclic protegrins.,Escherichiacoli
RGGCLCYCRRRFCVCVCR,612,2,11386,Membranolytic selectivity of cystine-stabilized cyclic protegrins.,Escherichiacoli
FKCRRWQWRMK,613,2,11392,The effects of charge and lipophilicity on the antibacterial activity of undecapeptides derived from bovine lactoferricin.,Escherichiacoli
FKARRWAWRMK,613,2,11393,The effects of charge and lipophilicity on the antibacterial activity of undecapeptides derived from bovine lactoferricin.,Escherichiacoli
YKARRWAWRMK,613,2,11394,The effects of charge and lipophilicity on the antibacterial activity of undecapeptides derived from bovine lactoferricin.,Escherichiacoli
YKARRWAWRWK,613,2,11395,The effects of charge and lipophilicity on the antibacterial activity of undecapeptides derived from bovine lactoferricin.,Escherichiacoli
YKAWRWAWRWK,613,2,11396,The effects of charge and lipophilicity on the antibacterial activity of undecapeptides derived from bovine lactoferricin.,Escherichiacoli
LGDFFRKSKEKIGKEFKRIVQRIKDFLRNLAKRHHGYKRKFH,614,4,11405,Expression in Escherichia coli of novel recombinant hybrid antimicrobial peptide AL32-P113 with enhanced antimicrobial activity in vitro.,Staphylococcusaureus
ALGDFFRKSKEKIGKEFKRIVQRIKDFLRNLAKRHHGYKRKFHLEY,614,4,11406,Expression in Escherichia coli of novel recombinant hybrid antimicrobial peptide AL32-P113 with enhanced antimicrobial activity in vitro.,Staphylococcusaureus
LKRLYKRLAKLIKRLYRYLKKPVR,615,4,11414,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus
LKRVWKRVFKLLKRYWRQLKKPVR,615,4,11415,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus
LKRLYKRVFRLLKRYYRQLRRPVR,615,4,11416,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus
LKRVWKAVFKLLKRYWRQLKPVR,615,4,11417,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus
LKKLWKRVFRIWKRIFRYLKRPVR,615,4,11418,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus
LRRLWKRLVRIIKRIYRQLKRPVR,615,4,11419,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus
LRRLYKRVFRLLKRWWRYLKRPVR,615,4,11420,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus
LRRLWKRLVKILKRWFRYLRRPVR,615,4,11421,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus
LRRLYKRVVKLWKRLFRQLRRPVR,615,4,11422,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus
LKKLYKRVAKIWKRWIRYLKKPVR,615,4,11423,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus
LKKLYKRLFKILKRILRYLRKPVR,615,4,11424,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus
LKKLWKRLARLLKRFIRQLRRPVR,615,4,11425,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus
LKKVYKRLARLLKRYIRYLRRPVR,615,4,11426,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus
LKKVWKRVARLIKRWFRYLRRPVR,615,4,11427,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus
LKKLYKRLFKLWKRLYRYLKKPVR,615,4,11428,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus
LRRVYKRLARLIKRYLRQLKKPVR,615,4,11429,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus
LRKLWKRVVKIWKRYLRQLRRPVR,615,4,11430,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus
LRKLWKRLAKIIKRLYRYLRRPVR,615,4,11431,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus
LKKVYKRVARLIKRLFRYLKRPVR,615,4,11432,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus
LRRLWKRLVKLWKRFFRYLKKPVR,615,4,11433,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus
LKKVWKRVFRILKRFLRYLKRPVR,615,4,11434,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus
LRRVYKRLFRLWKRIIRQLRRPVR,615,4,11435,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus
LKKLWKRLARLWKRIIRQLKKPVR,615,4,11436,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus
LRRVWKRVARIIKRLYRYLKRPVR,615,4,11437,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus
LKRLWKRLFKILKRYYRYLRRPVR,615,4,11438,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus
LRRLWKRVFKIIKRLFRQLKKPVR,615,4,11439,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus
KFKKLFKKLSPVIGKEFKRIVERIKRFLR,616,4,11495,Hybridization and antibiotic synergism as a tool for reducing the cytotoxicity of antimicrobial peptides.,Staphylococcusaureus
VNFLLHKIYGNIRYS,617,105,11496,Prediction and characterization of a novel hemocyanin-derived antimicrobial peptide from shrimp Litopenaeus vannamei.,Vibrioparahaemolyticus
GGEAVQKLVREVKDG,617,105,11497,Prediction and characterization of a novel hemocyanin-derived antimicrobial peptide from shrimp Litopenaeus vannamei.,Vibrioparahaemolyticus
GVARIRDLLIIESRI,617,105,11498,Prediction and characterization of a novel hemocyanin-derived antimicrobial peptide from shrimp Litopenaeus vannamei.,Vibrioparahaemolyticus
RIRDAIAHGYIVDKV,617,105,11499,Prediction and characterization of a novel hemocyanin-derived antimicrobial peptide from shrimp Litopenaeus vannamei.,Vibrioparahaemolyticus
YYGALHNTAHIVLGR,617,105,11500,Prediction and characterization of a novel hemocyanin-derived antimicrobial peptide from shrimp Litopenaeus vannamei.,Vibrioparahaemolyticus
VNGLLHKIYGNIRYS,617,105,11501,Prediction and characterization of a novel hemocyanin-derived antimicrobial peptide from shrimp Litopenaeus vannamei.,Vibrioparahaemolyticus
VNFLLHKIYDNIRYS,617,105,11502,Prediction and characterization of a novel hemocyanin-derived antimicrobial peptide from shrimp Litopenaeus vannamei.,Vibrioparahaemolyticus
VNFLLHKIYGNIRDS,617,105,11503,Prediction and characterization of a novel hemocyanin-derived antimicrobial peptide from shrimp Litopenaeus vannamei.,Vibrioparahaemolyticus
SKFFRKARKKLGKGLQKIKNVLRKY,618,2,11519,"The novel cathelicidin of naked mole rats, Hg-CATH, showed potent antimicrobial activity and low cytotoxicity.",Escherichiacoli
KWKIFKKIEKVGRNIRNGIIKAVAVLGEAKAL,619,2,11526,A novel cecropin B-derived peptide with antibacterial and potential anti-inflammatory properties.	,Escherichiacoli
CKILSKTIKCRIPCGRRKEY,620,44,11531,Identification and Characterization of Novel Antimicrobial Peptide from Hippocampus comes by In Silico and Experimental Studies.,Aeromonashydrophila
KRCKNKMEGDDVAVSGRGARKAAKK,620,44,11532,Identification and Characterization of Novel Antimicrobial Peptide from Hippocampus comes by In Silico and Experimental Studies.,Aeromonashydrophila
LEYWGKCTKAENRCKYKNDKGKDVLQNCPKFDNKKCTKDGNSCKWDSASKALTCY,621,106,11555,Characterization of a novel cysteine-rich antifungal protein from Fusarium graminearum with activity against maize fungal pathogens.,Fusariumverticillioides
LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTESDYKDDDDKTKKTLRT,622,2,11556,Collagen tethering of synthetic human antimicrobial peptides cathelicidin LL37 and its effects on antimicrobial activity and cytotoxicity.,Escherichiacoli
LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTESDYKDDDDKCQDSERTFY,622,2,11557,Collagen tethering of synthetic human antimicrobial peptides cathelicidin LL37 and its effects on antimicrobial activity and cytotoxicity.,Escherichiacoli
KKKKPLFGL,624,107,11579,Behavior of Antimicrobial Peptide K4 in a Marine Environment.,Vibriosplendidus
WWLWWLRWL,625,4,11624,Designing an ultra-short antibacterial peptide with potent activity against Mupirocin-resistant MRSA,Staphylococcusaureus
GNPLKLFLPSTWVHFFKFLR,626,4,11674,"Identification, Recombinant Expression, and Characterization of LHG2, a Novel Antimicrobial Peptide of Lactobacillus casei HZ1.",Staphylococcusaureus
FKKLYIEPVETKVDEINDNRRKANRKRFSAHQG,626,4,11675,"Identification, Recombinant Expression, and Characterization of LHG2, a Novel Antimicrobial Peptide of Lactobacillus casei HZ1.",Staphylococcusaureus
AGWLIERYLVPNWHAFTSWLTAGKDAFSKGK,626,4,11676,"Identification, Recombinant Expression, and Characterization of LHG2, a Novel Antimicrobial Peptide of Lactobacillus casei HZ1.",Staphylococcusaureus
KWRMCVDYTGFNKVCSKVFYFLFRID,626,4,11677,"Identification, Recombinant Expression, and Characterization of LHG2, a Novel Antimicrobial Peptide of Lactobacillus casei HZ1.",Staphylococcusaureus
AWCFRVCYRGICYRRCR,627,2,11699,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
KACFRVCYRGICYRRCR,627,2,11700,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
KWAFRVCYRGICYRRSR,627,2,11701,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
KWCARVCYRGICYRRCR,627,2,11702,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
RNCMEVCVKGEKKHTGQGMIRRLRRNKNNSIFVVRKRV,628,108,11721,"TC38, a teleost TFPI-2 peptide that kills bacteria via penetration of the cell membrane and interaction with nucleic acids",Vibrioichthyoenteri
CVKGGKKYKRQGKGHRMRRYRNNH,629,109,11731,A teleost TFPI-2 peptide that possesses a broad antibacterial spectrum and immunestimulatory properties,Vibriolitoralis
DLIWKLLVKAQEKFGRGKPSKRVKKMRRQWQACKSSHHHHHH,630,4,11733,Heterologous expression of a broad-spectrum chimeric antimicrobial peptide in Lactococcus lactis: Its safety and molecular modeling evaluation,Staphylococcusaureus
KWCFAVCYRGICYRRCR,627,2,11734,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
KWCFRACYRGICYRRCR,627,2,11735,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
KWCFRVAYRGISYRRCR,627,2,11736,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
KWCFRVCARGICYRRCR,627,2,11737,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
KWCFRVCYAGICYRRCR,627,2,11738,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
KWCFRVCYRAICYRRCR,627,2,11739,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
KWCFRVCYRGACYRRCR,627,2,11740,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
KWCFRVSYRGIAYRRCR,627,2,11741,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
KWCFRVCYRGICARRCR,627,2,11742,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
KWCFRVCYRGICYARCR,627,2,11743,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
KWCFRVCYRGICYRACR,627,2,11744,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
KWSFRVCYRGICYRRAR,627,2,11745,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
KWCFRVCYRGICYRRCA,627,2,11746,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
KWAFRVCYRGICYRRAR,627,2,11747,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
KWCFRVAYRGIAYRRCR,627,2,11748,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
KWAFRVAYRGIAYRRAR,627,2,11749,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
KWCFRRCYAGICYRRCR,627,2,11750,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
RWCFRVCYRGICYRRCR,627,2,11751,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
KWCGRVCYRGICYRRCR,627,2,11752,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
KWCSRVCYRGICYRRCR,627,2,11753,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
KWCFRVCGRGICYRRCR,627,2,11754,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
KWCFRVCYRGGCYRRCR,627,2,11755,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
KWCARVCARGACYRRCR,627,2,11756,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
KWCFVCYRGICYRRCG,627,2,11757,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
AWCARVCYRGICYRRCR,627,2,11758,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
AWCFRVCARGICYRRCR,627,2,11759,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
AWCFRVCYRGACYRRCR,627,2,11760,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
KWCFRVCYAGICYRRCA,627,2,11761,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli
SVFGQLVMGLILSSVFYNDD,631,4,11770,Peptides as adjuvants for ampicillin and oxacillin against methicillin-resistant Staphylococcus aureus (MRSA).,Staphylococcusaureus
DDRGAAMFAVLFNAFSSLLE,631,4,11771,Peptides as adjuvants for ampicillin and oxacillin against methicillin-resistant Staphylococcus aureus (MRSA).,Staphylococcusaureus
KLAMSMSFNFVFYFMVNFDD,631,4,11772,Peptides as adjuvants for ampicillin and oxacillin against methicillin-resistant Staphylococcus aureus (MRSA).,Staphylococcusaureus
DDRFFFYWLMCIWCTFVMSH,631,4,11773,Peptides as adjuvants for ampicillin and oxacillin against methicillin-resistant Staphylococcus aureus (MRSA).,Staphylococcusaureus
LATLLFTMCLNFCGVLAGDD,631,4,11774,Peptides as adjuvants for ampicillin and oxacillin against methicillin-resistant Staphylococcus aureus (MRSA).,Staphylococcusaureus
DDGIFIAFIAINIILTVIFY,631,4,11775,Peptides as adjuvants for ampicillin and oxacillin against methicillin-resistant Staphylococcus aureus (MRSA).,Staphylococcusaureus
GLRKRPRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY,632,2,11776,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides.,Escherichiacoli
RRHCIKKCMKSRKHNERMIRIRRK,633,18,11777,"Molecular characterization, expression analysis, and bactericidal activity of the derivative peptides of TFPI-1 and TFPI-2 in half-smooth tongue sole, Cynoglossus semilaevis",Micrococcusluteus
GLRKRLRKFRNKDKEKLKKIGQKIQGLLPKLAPRTDY,634,2,11778,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli
GLRKRLRKFRNKPKEKLKKIGQKIQGLLPKLAPRTDY,634,2,11779,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli
GLRKRLRKFRNKRKEKLKKIGQKIQGLLPKLAPRTDY,634,2,11780,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli
GLRKRLRKFRNKFKEKLKKIGQKIQGLLPKLAPRTDY,634,2,11781,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli
GLRKRLRKFRNKHKEKLKKIGQKIQGLLPKLAPRTDY,634,2,11782,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli
GLRKRLRKFRNKMKEKLKKIGQKIQGLLPKLAPRTDY,634,2,11783,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli
GLRKRLRKFRNKIKECLKKIGQKIQGLLPKLAPRTDY,634,2,11784,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli
GLRKRLRKFRNKIKEDLKKIGQKIQGLLPKLAPRTDY,634,2,11785,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli
GLRKRLRKFRNKIKEKDKKIGQKIQGLLPKLAPRTDY,634,2,11786,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli
GLRKRLRKFRNKIKEKKKKIGQKIQGLLPKLAPRTDY,634,2,11787,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli
GLRKRLRKFRNKIKEKPKKIGQKIQGLLPKLAPRTDY,634,2,11788,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli
GLRKRLRKFRNKIKEKLPKIGQKIQGLLPKLAPRTDY,634,2,11789,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli
GLRKRLRKFRNKIKEKLKKEGQKIQGLLPKLAPRTDY,634,2,11790,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli
GLRKRLRKFRNKIKEKLKKNGQKIQGLLPKLAPRTDY,634,2,11791,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli
GLRKRLRKFRNKIKEKLKKIGQKDQGLLPKLAPRTDY,634,2,11798,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli
GLRKRLRKFRNKIKEKLKKIGQKGQGLLPKLAPRTDY,634,2,11799,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli
GLRKRLRKFRNKIKEKLKKIGQKNQGLLPKLAPRTDY,634,2,11800,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli
GLRKRLRKFRNKIKEKLKKIGQKIQTLLPKLAPRTDY,634,2,11801,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli
GLRKRLRKFRNKIKEKLKKIGQKIQGPLPKLAPRTDY,634,2,11802,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli
KCRRRKVHGPMIRIRKK,635,18,11803,"TO17: A teleost antimicrobial peptide that induces degradation of bacterial nucleic acids and inhibits bacterial infection in red drum, Sciaenops ocellatus.",Micrococcusluteus
EVASFDKSKLK,636,4,11809,"Paracentrin 1, a synthetic antimicrobial peptide from the sea-urchin Paracentrotus lividus, interferes with staphylococcal and Pseudomonas aeruginosa biofilm formation.",Staphylococcusaureus
GFGLGGLARILCLGNRQWSNFFKKLNRKCAMVKK,637,2,11818,An engineered arginine-rich ?-helical antimicrobial peptide exhibits broad-spectrum bactericidal activity against pathogenic bacteria and reduces bacterial infections in mice.,Escherichiacoli
GFALAGLARILCLWFREFSGFFRRLNRRFAMRRR,637,2,11819,An engineered arginine-rich ?-helical antimicrobial peptide exhibits broad-spectrum bactericidal activity against pathogenic bacteria and reduces bacterial infections in mice.,Escherichiacoli
GAALAGLAKILCLWAKEFTGAFKKLNKKFAMKKK,637,2,11820,An engineered arginine-rich ?-helical antimicrobial peptide exhibits broad-spectrum bactericidal activity against pathogenic bacteria and reduces bacterial infections in mice.,Escherichiacoli
MSGSHHHHHHGSSGENLYFQSLEVASFDKSKLK,638,4,11841,Antimicrobial and Antibiofilm Activity of a Recombinant Fragment of ?-Thymosin of Sea Urchin Paracentrotus lividus.,Staphylococcusaureus
FLGAVLKVAGKLVPAAI,639,4,11880,Evaluating the Bioactivity of a Novel Broad-Spectrum Antimicrobial Peptide Brevinin-1GHa from the Frog Skin Secretion of Hylarana guentheri and Its Analogues.,Staphylococcusaureus
FLGAVLKVCKISKKCAGKLVPAAI,639,4,11881,Evaluating the Bioactivity of a Novel Broad-Spectrum Antimicrobial Peptide Brevinin-1GHa from the Frog Skin Secretion of Hylarana guentheri and Its Analogues.,Staphylococcusaureus
TPFLLVGTQIDLR,640,18,11934,Sarconesin: Sarconesiopsis magellanica Blowfly Larval Excretions and Secretions With Antibacterial Properties.,Micrococcusluteus
LSKYGGQCSLKHNTCTYLKGGRNVIVNCPWFWNKKRCKSDRHHCEYDEHHRRVDCQTPV,641,110,11937,Rational Design and Biotechnological Production of Novel AfpB-PAF26 Chimeric Antifungal Proteins.,Penicilliumdigitatum
GGLRSLGRKILRAWKKYG,642,2,11938,Structural insight into the mechanism of action of antimicrobial peptide BMAP-28(1-18) and its analogue mutBMAP18.,Escherichiacoli
IGLRGLGRKIALIHKKYG,642,2,11939,Structural insight into the mechanism of action of antimicrobial peptide BMAP-28(1-18) and its analogue mutBMAP18.,Escherichiacoli
AAAARRRR,643,4,11942,"Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents.",Staphylococcusaureus
RRRRRRRWWWWWWW,643,4,11946,"Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents.",Staphylococcusaureus
RRRRWWWWW,643,4,11947,"Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents.",Staphylococcusaureus
FFFFRRRR,643,4,11958,"Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents.",Staphylococcusaureus
LLLLRRRR,643,4,11959,"Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents.",Staphylococcusaureus
IIIIRRRR,643,4,11960,"Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents.",Staphylococcusaureus
YYYYRRRR,643,4,11961,"Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents.",Staphylococcusaureus
TQQAFQKFLAAVTSALGKQYH,644,8,11963,"Antimicrobial function of SH?AP, a novel hemoglobin ? chain-related antimicrobial peptide, isolated from the liver of skipjack tuna, Katsuwonus pelamis.",Bacillussubtilis
KKKKWWWW,643,4,11975,"Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents.",Staphylococcusaureus
RRRRRRRWWWWW,643,4,11977,"Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents.",Staphylococcusaureus
RRRRRRRWWWWWW,643,4,11978,"Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents.",Staphylococcusaureus
GLRKRLRKFRNKIKEK,645,8,12019,Novel imidazolium salt--peptide conjugates and their antimicrobial activity.,Bacillussubtilis
KKRKAPKKKRKFA,646,1,12034,Generation of carrier peptides for the delivery of nucleic acid drugs in primary cells.,None_target
LRLKKYKVPQL,647,2,12073,Broad-Spectrum Antimicrobial Activity and Low Cytotoxicity against Human Cells of a Peptide Derived from Bovine ?S1-Casein,Escherichiacoli
AKKPFVQRVKNAASKAYNKLKGLAMQSQYG,648,2,12101,Chemical synthesis of a two-domain scorpion toxin LaIT2 and its single-domain analogs to elucidate structural factors important for insecticidal and antimicrobial activities.,Escherichiacoli
QSQYGCPIISNMCEDHCRRKKMEGQCDLLDCVCS,648,2,12102,Chemical synthesis of a two-domain scorpion toxin LaIT2 and its single-domain analogs to elucidate structural factors important for insecticidal and antimicrobial activities.,Escherichiacoli
RNCTWLFSTKLKLPA,649,48,12107,Identification of the first Crocodylus siamensis cathelicidin gene and RN15 peptide derived from cathelin domain exhibiting antibacterial activity.,Bacillusmegaterium
PKILNKILGKILRLAAAFK,650,2,12113,"Fast and potent bactericidal membrane lytic activity of PaDBS1R1, a novel cationic antimicrobial peptide.",Escherichiacoli
GFGCNGPWSEDDLRCHRHCKSIKGYRGGYCAKGGFVCKCY,651,4,12115,Reverse micelle-lipid nanocapsules: a novel strategy for drug delivery of the plectasin derivate AP138 antimicrobial peptide.,Staphylococcusaureus
LKKLLKLLKLLKL,652,2,12127,Chain length dependence of antimicrobial peptide-fatty acid conjugate activity.,Escherichiacoli
KGVSGHGQHGVHG,653,79,12132,Further studies on the antiviral activity of alloferon and its analogues,HSV-1
RGVSGHGQHGVHG,653,79,12133,Further studies on the antiviral activity of alloferon and its analogues,HSV-1
AGVSGHGQHGVHG,653,79,12134,Further studies on the antiviral activity of alloferon and its analogues,HSV-1
HGVSGHGQHGTHG,654,4,12135,"ZL-2, a cathelicidin-derived antimicrobial peptide, has a broad antimicrobial activity against gram-positive bacteria and gram-negative bacteria in vitro and in vivo",Staphylococcusaureus
GIMDTVKNAAKNLAGQLLDKLK,655,4,12185,"A novel antimicrobial peptide, Ranatuerin-2PLx, showing therapeutic potential in inhibiting proliferation of cancer cells",Staphylococcusaureus
GIMDTVKNAAKNLAGQLLDKLKCSITAC,655,4,12186,"A novel antimicrobial peptide, Ranatuerin-2PLx, showing therapeutic potential in inhibiting proliferation of cancer cells",Staphylococcusaureus
VQWLEQQVAKRRTKR,656,2,12188,"Cell-Selective Pore Forming Antimicrobial Peptides of the Prodomain of Human Furin: A Conserved Aromatic/Cationic Sequence Mapping, Membrane Disruption, and Atomic-Resolution Structure and Dynamics.",Escherichiacoli
QREPQVQWLEQQVAKRRTKR,657,2,12189,"Cell-Selective Pore Forming Antimicrobial Peptides of the Prodomain of Human Furin: A Conserved Aromatic/Cationic Sequence Mapping, Membrane Disruption, and Atomic-Resolution Structure and Dynamics",Escherichiacoli
RHSRLQREPQVQWLEQQVAKRRTKR,656,2,12190,"Cell-Selective Pore Forming Antimicrobial Peptides of the Prodomain of Human Furin: A Conserved Aromatic/Cationic Sequence Mapping, Membrane Disruption, and Atomic-Resolution Structure and Dynamics.",Escherichiacoli
SPHRPRHSRLQREPQVQWLEQQVAKRRTKR,656,2,12191,"Cell-Selective Pore Forming Antimicrobial Peptides of the Prodomain of Human Furin: A Conserved Aromatic/Cationic Sequence Mapping, Membrane Disruption, and Atomic-Resolution Structure and Dynamics.",Escherichiacoli
TKRSLSPHRPRHSRLQREPQVQWLEQQVAKRRTKR,656,2,12192,"Cell-Selective Pore Forming Antimicrobial Peptides of the Prodomain of Human Furin: A Conserved Aromatic/Cationic Sequence Mapping, Membrane Disruption, and Atomic-Resolution Structure and Dynamics.",Escherichiacoli
QKVFTNTWAVRIPGGPAVANSVARKHGFLNLQGIF,656,2,12193,"Cell-Selective Pore Forming Antimicrobial Peptides of the Prodomain of Human Furin: A Conserved Aromatic/Cationic Sequence Mapping, Membrane Disruption, and Atomic-Resolution Structure and Dynamics.",Escherichiacoli
RKHGFLNLQGIFGDYYHFWHRGV,656,2,12194,"Cell-Selective Pore Forming Antimicrobial Peptides of the Prodomain of Human Furin: A Conserved Aromatic/Cationic Sequence Mapping, Membrane Disruption, and Atomic-Resolution Structure and Dynamics.",Escherichiacoli
YYHFWHRGVTKRSLSPHRPRHSRLQR,656,4,12195,"Cell-Selective Pore Forming Antimicrobial Peptides of the Prodomain of Human Furin: A Conserved Aromatic/Cationic Sequence Mapping, Membrane Disruption, and Atomic-Resolution Structure and Dynamics.",Staphylococcusaureus
GLPVCGETCVGGTCYTPGCTCSWPVCTRN,658,111,12200,Anticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targeting,Humanskin
GLPVCGETCVGGTCDTPGCTCSWPVCTRN,658,111,12201,Anticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targeting,Humanskin
YYHFWHRGVTKRSLSPHRPRHSR,656,4,12202,"Cell-Selective Pore Forming Antimicrobial Peptides of the Prodomain of Human Furin: A Conserved Aromatic/Cationic Sequence Mapping, Membrane Disruption, and Atomic-Resolution Structure and Dynamics.",Staphylococcusaureus
YYHFWHRGVTKRSLSPHRPR,656,4,12203,"Cell-Selective Pore Forming Antimicrobial Peptides of the Prodomain of Human Furin: A Conserved Aromatic/Cationic Sequence Mapping, Membrane Disruption, and Atomic-Resolution Structure and Dynamics.",Staphylococcusaureus
YYHFWHRGVTKRSLSPH,656,2,12204,"Cell-Selective Pore Forming Antimicrobial Peptides of the Prodomain of Human Furin: A Conserved Aromatic/Cationic Sequence Mapping, Membrane Disruption, and Atomic-Resolution Structure and Dynamics.",Escherichiacoli
GLPVCGETCVGGTCNYPGCTCSWPVCTRN,658,111,12205,Anticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targeting,Humanskin
YYHFWHRGVTKRSL,656,2,12206,"Cell-Selective Pore Forming Antimicrobial Peptides of the Prodomain of Human Furin: A Conserved Aromatic/Cationic Sequence Mapping, Membrane Disruption, and Atomic-Resolution Structure and Dynamics.",Escherichiacoli
YYHFWHRGVTKR,656,2,12207,"Cell-Selective Pore Forming Antimicrobial Peptides of the Prodomain of Human Furin: A Conserved Aromatic/Cationic Sequence Mapping, Membrane Disruption, and Atomic-Resolution Structure and Dynamics.",Escherichiacoli
GLPVCGETCVGGTCNSPGCTCSWPVCTRN,658,112,12208,Anticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targeting,Humancervical
GNFLRNGGSYYIVPAFRG,659,2,12209,"Adevonin, a novel synthetic antimicrobial peptide designed from the Adenanthera pavonina trypsin inhibitor (ApTI) sequence.",Escherichiacoli
GLPVCGETCVGGTCNTPGCTCSYPVCTRN,658,111,12210,Anticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targeting,Humanskin
GLPVCGETCVGGTCNTPGCTCSWWPVCTRN,658,111,12211,Anticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targeting,Humanskin
CPAIQRCC,660,4,12212,"Mo-CBP3-PepI, Mo-CBP3-PepII, and Mo-CBP3-PepIII are synthetic antimicrobial peptides active against human pathogens by stimulating ROS generation and increasing plasma membrane permeability",Staphylococcusaureus
NIQPPCRCC,660,4,12213,"Mo-CBP3-PepI, Mo-CBP3-PepII, and Mo-CBP3-PepIII are synthetic antimicrobial peptides active against human pathogens by stimulating ROS generation and increasing plasma membrane permeability",Staphylococcusaureus
RKYVRFLHRWVKYFRAYL,659,2,12215,"Adevonin, a novel synthetic antimicrobial peptide designed from the Adenanthera pavonina trypsin inhibitor (ApTI) sequence.",Escherichiacoli
GLLSGILGAGKKIV,661,4,12221,"Modification Targeting the ""Rana Box"" Motif of a Novel Nigrocin Peptide From Hylarana latouchii Enhances and Broadens Its Potency Against Multiple Bacteria.",Staphylococcusaureus
NNLRHIVAWCKNRNYSLAVCARFKPQ,662,4,12225,Membrane-active antimicrobial peptide identified in Rana arvalis by targeted DNA sequencing.,Staphylococcusaureus
NLLGFLQGAKDILKECEADNYQGWLCESYKPQ,662,4,12226,Membrane-active antimicrobial peptide identified in Rana arvalis by targeted DNA sequencing.,Staphylococcusaureus
KWKLFKKIHKVGQNIRKGIIKAGPAVAVVGQAAQIAK,663,2,12232,"Design, expression, and characterization of a novel cecropin A-derived peptide with high antibacterial activity.",Escherichiacoli
GFWSSVWDGAKNVGTAI,664,18,12237,Novel Antimicrobial Peptides from the Arctic Polychaeta Nicomache minor Provide New Molecular Insight into Biological Role of the BRICHOS Domain.,Micrococcusluteus
IKNAKVCVYAVCVSHK,664,18,12238,Novel Antimicrobial Peptides from the Arctic Polychaeta Nicomache minor Provide New Molecular Insight into Biological Role of the BRICHOS Domain.,Micrococcusluteus
TSVRQRWRWRQRVRTS,665,2,12240,The activity and action mechanism of novel short selective LL-37-derived anticancer peptides against clinical isolates of Escherichia coli.,Escherichiacoli
KRSKRKRRIHQRVRIS,665,2,12241,The activity and action mechanism of novel short selective LL-37-derived anticancer peptides against clinical isolates of Escherichia coli.,Escherichiacoli
TLSKEKERIVQRVRTS,665,2,12242,The activity and action mechanism of novel short selective LL-37-derived anticancer peptides against clinical isolates of Escherichia coli.,Escherichiacoli
VLLVTLTRLHQRGVIYRKWRHFSGRKYR,666,2,12244,The identification of a novel Sulfolobus islandicus CAMP-like peptide points to archaeal microorganisms as cell factories for the production of antimicrobial molecules.,Escherichiacoli
KRKKHRCRVYNNGMPTGMYRWC,667,4,12245,Structure-activity relationships of the bacteriocin bactofencin A and its interaction with bacterial membrane.,Staphylococcusaureus
KRKKHRCRVYNNGLPTGLYRWC,667,4,12246,Structure-activity relationships of the bacteriocin bactofencin A and its interaction with bacterial membrane.,Staphylococcusaureus
VWNQPVRGFKVYE,668,113,12251,Antimicrobial peptide KSL-W and analogues: Promising agents to control plant diseases.,Erwiniaamylovora
KRKKHRCRVSNNGLPTGLYRWC,667,4,12261,Structure-activity relationships of the bacteriocin bactofencin A and its interaction with bacterial membrane.,Staphylococcusaureus
RRLRPRRPRLPRPRPR,669,18,12308,Combined Antibacterial Effects of Goat Cathelicidins With Different Mechanisms of Action.,Micrococcusluteus
DVIVVGAGIMGSSAAYQLAKRGQKTLL,670,4,12311,Discovery and identification of antimicrobial peptides in Sichuan pepper (Zanthoxylum bungeanum Maxim) seeds by peptidomics and bioinformatics.,Staphylococcusaureus
VLVPQGFAVVKKANFVAFYT,670,4,12312,Discovery and identification of antimicrobial peptides in Sichuan pepper (Zanthoxylum bungeanum Maxim) seeds by peptidomics and bioinformatics.,Staphylococcusaureus
AGDKKIKIGINGFGRIGRL,670,4,12313,Discovery and identification of antimicrobial peptides in Sichuan pepper (Zanthoxylum bungeanum Maxim) seeds by peptidomics and bioinformatics.,Staphylococcusaureus
GKVKIGINGFGRIGRLVA,670,4,12314,Discovery and identification of antimicrobial peptides in Sichuan pepper (Zanthoxylum bungeanum Maxim) seeds by peptidomics and bioinformatics.,Staphylococcusaureus
HARIKPTFRRLKWKYKGKFW,671,31,12315,The Antitumor Peptide CIGB-552 Increases COMMD1 and Inhibits Growth of Human Lung Cancer Cells.,Humanlung
PMPVSQECFETLRGHERILSILRHQNLLKELQDLALQGAKERAHQQ,672,114,12329,"Molecular Design, Structural Analysis and Antifungal Activity of Derivatives of Peptide CGA-N46.",Candidaglabrata
ERILSILRHQNLLKE,672,114,12330,"Molecular Design, Structural Analysis and Antifungal Activity of Derivatives of Peptide CGA-N46.",Candidaglabrata
LQDLALQGAKERAHQQ,672,114,12331,"Molecular Design, Structural Analysis and Antifungal Activity of Derivatives of Peptide CGA-N46.",Candidaglabrata
GGLRKLGRKILRAWKKYGPIIVPIIRI,673,59,12333,A bovine myeloid antimicrobial peptide (BMAP-28) and its analogs kill pan-drug-resistant Acinetobacter baumannii by interacting with outer membrane protein A (OmpA).,Acinetobacterbaumannii
KGLRKLGRKILRAWKKYGPIIVPIIRI,673,59,12334,A bovine myeloid antimicrobial peptide (BMAP-28) and its analogs kill pan-drug-resistant Acinetobacter baumannii by interacting with outer membrane protein A (OmpA).,Acinetobacterbaumannii
GGLRSLGRKILRAWKKGGPIIVPIIRI,673,59,12335,A bovine myeloid antimicrobial peptide (BMAP-28) and its analogs kill pan-drug-resistant Acinetobacter baumannii by interacting with outer membrane protein A (OmpA).,Acinetobacterbaumannii
KGLRKLGRKILRAWKKGGPIIVPIIRI,673,59,12336,A bovine myeloid antimicrobial peptide (BMAP-28) and its analogs kill pan-drug-resistant Acinetobacter baumannii by interacting with outer membrane protein A (OmpA).,Acinetobacterbaumannii
RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFP,674,2,12342,"Copy number variation of PR-39 cathelicidin, and identification of PR-35, a natural variant of PR-39 with reduced mammalian cytotoxicity.",Escherichiacoli
ALQGAKERAHQQ,672,114,12356,"Molecular Design, Structural Analysis and Antifungal Activity of Derivatives of Peptide CGA-N46.",Candidaglabrata
GAKERAHQ,672,114,12357,"Molecular Design, Structural Analysis and Antifungal Activity of Derivatives of Peptide CGA-N46.",Candidaglabrata
ACFLTRLGTYVC,675,2,12358,"Host-defense peptides AC12, DK16 and RC11 with immunomodulatory activity isolated from Hypsiboas raniceps skin secretion.",Escherichiacoli
DKERPICSNTFRGRKC,675,2,12359,"Host-defense peptides AC12, DK16 and RC11 with immunomodulatory activity isolated from Hypsiboas raniceps skin secretion.",Escherichiacoli
RCFRRRGKLTC,675,2,12360,"Host-defense peptides AC12, DK16 and RC11 with immunomodulatory activity isolated from Hypsiboas raniceps skin secretion.",Escherichiacoli
KKLIKVWAKGFKKAKKLFKGIG,676,2,12363,Antimicrobial activity of a porphyrin binding peptide.,Escherichiacoli
KKLIKVFAKGWKKAKKLFKGIG,676,112,12364,Antimicrobial activity of a porphyrin binding peptide.,Humancervical
KKLIKVFAKGFKKAKKLWKGIG,676,112,12365,Antimicrobial activity of a porphyrin binding peptide.,Humancervical
KKAAKAWAKGAKKAKKLAKGAG,676,112,12367,Antimicrobial activity of a porphyrin binding peptide.,Humancervical
NNNPRPPYLPRPRPP,677,2,12368,Anti-microbial activity and cell binding are controlled by sequence determinants in the anti-microbial peptide PR-39.,Escherichiacoli
KKKPRPPYLPRPRPP,677,2,12369,Anti-microbial activity and cell binding are controlled by sequence determinants in the anti-microbial peptide PR-39.,Escherichiacoli
RRRPRPPYLPPRRPP,677,2,12370,Anti-microbial activity and cell binding are controlled by sequence determinants in the anti-microbial peptide PR-39.,Escherichiacoli
RRRPRPPYWPRPRPP,677,2,12371,Anti-microbial activity and cell binding are controlled by sequence determinants in the anti-microbial peptide PR-39.,Escherichiacoli
RRRPRPPYLRPRPPP,677,2,12372,Anti-microbial activity and cell binding are controlled by sequence determinants in the anti-microbial peptide PR-39.,Escherichiacoli
RRRPRPPYLNRPRPP,677,2,12373,Anti-microbial activity and cell binding are controlled by sequence determinants in the anti-microbial peptide PR-39.,Escherichiacoli
RVKRFKKFFRKIKKGFRKIFKKTKIFIG,678,2,12374,Genomewide Analysis of the Antimicrobial Peptides in Python bivittatus and Characterization of Cathelicidins with Potent Antimicrobial Activity and Low Cytotoxicity.,Escherichiacoli
HRVKRNGFRKFMRRLKKFFAGG,678,2,12375,Genomewide Analysis of the Antimicrobial Peptides in Python bivittatus and Characterization of Cathelicidins with Potent Antimicrobial Activity and Low Cytotoxicity.,Escherichiacoli
TRSRWRRFIRGAGRFARRYGWRIA,678,2,12376,Genomewide Analysis of the Antimicrobial Peptides in Python bivittatus and Characterization of Cathelicidins with Potent Antimicrobial Activity and Low Cytotoxicity.,Escherichiacoli
LVQIGTKIVGVGRNYAAH,679,2,12379,Phytohormone treatment induces generation of cryptic peptides with antimicrobial activity in the Moss Physcomitrella patens.,Escherichiacoli
INIINAPLQGFKIA,679,2,12380,Phytohormone treatment induces generation of cryptic peptides with antimicrobial activity in the Moss Physcomitrella patens.,Escherichiacoli
GACHRQGFGFACFCYKKC,680,24,12383,Plant defensin peptides have antifungal and antibacterial activity against human and plant pathogens.,Fusariumoxysporum
GSCNYVFPAHKCICYFP,680,24,12384,Plant defensin peptides have antifungal and antibacterial activity against human and plant pathogens.,Fusariumoxysporum
GDCKGIRRRCMCSKPL,680,24,12385,Plant defensin peptides have antifungal and antibacterial activity against human and plant pathogens.,Fusariumoxysporum
SFIKRSLKLIKSLVLIK,682,2,12397,A New Synthetic Peptide with In vitro Antibacterial Potential Against Escherichia coli O157:H7 and Methicillin-Resistant Staphylococcus aureus (MRSA).,Escherichiacoli
KIFGAIWPLALGALKNLIK,683,115,12405,Evaluation of cytotoxicity features of antimicrobial peptides with potential to control bacterial diseases of citrus.,Xanthomonascitri
KLLKFVTKVGKAIFKALIKAI,683,115,12406,Evaluation of cytotoxicity features of antimicrobial peptides with potential to control bacterial diseases of citrus.,Xanthomonascitri
IETFLKQLRSAANKIVGL,683,115,12407,Evaluation of cytotoxicity features of antimicrobial peptides with potential to control bacterial diseases of citrus.,Xanthomonascitri
LESLASSAVRTANKARAKL,683,115,12408,Evaluation of cytotoxicity features of antimicrobial peptides with potential to control bacterial diseases of citrus.,Xanthomonascitri
GFAWNVCVYRNGVRVCHRRAN,684,2,12415,Deleting the first disulphide bond in an arenicin derivative enhances its expression in Pichia pastoris,Escherichiacoli
QSVACTSYYCSKFCGSAG,685,2,12439,"Structural and Antimicrobial Features of Peptides Related to Myticin C, a Special Defense Molecule from the Mediterranean Mussel Mytilus galloprovincialis.",Escherichiacoli
YCSKFCGSAGCSLYGCYLLH,685,2,12440,"Structural and Antimicrobial Features of Peptides Related to Myticin C, a Special Defense Molecule from the Mediterranean Mussel Mytilus galloprovincialis.",Escherichiacoli
CSLYGCYLLHPGKICYCLHCSR,685,2,12441,"Structural and Antimicrobial Features of Peptides Related to Myticin C, a Special Defense Molecule from the Mediterranean Mussel Mytilus galloprovincialis.",Escherichiacoli
CSLYGSYLLHPGKISYSLHCSR,685,2,12442,"Structural and Antimicrobial Features of Peptides Related to Myticin C, a Special Defense Molecule from the Mediterranean Mussel Mytilus galloprovincialis.",Escherichiacoli
GCYLLHPGKICY,685,2,12444,"Structural and Antimicrobial Features of Peptides Related to Myticin C, a Special Defense Molecule from the Mediterranean Mussel Mytilus galloprovincialis.",Escherichiacoli
PGKICYCLHCSR,685,2,12446,"Structural and Antimicrobial Features of Peptides Related to Myticin C, a Special Defense Molecule from the Mediterranean Mussel Mytilus galloprovincialis.",Escherichiacoli
DKPKKKPPPPAGPPPPPPPPPG,686,2,12451,"The activity of a mammalian proline-rich peptide against Gram-negative bacteria, including drug-resistant strains, relies on a nonmembranolytic mode of action.",Escherichiacoli
DKPKKKPPPPAGP,686,2,12452,"The activity of a mammalian proline-rich peptide against Gram-negative bacteria, including drug-resistant strains, relies on a nonmembranolytic mode of action.",Escherichiacoli
KLLKHKLLVTLA,687,2,12453,"HJH-1, a Broad-Spectrum Antimicrobial Activity and Low Cytotoxicity Antimicrobial Peptide.",Escherichiacoli
FKLLSHSLLVTLASHLP,688,116,12485,Purification and characterization of Hb 98-114: a novel hemoglobin-derived antimicrobial peptide from the midgut of Rhipicephalus (Boophilus) microplus.,Candidaparapsilosis
FLPFFAACAITRKC,690,4,12497,"Effects of C-terminal amidation and heptapeptide ring on the biological activities and advanced structure of amurin-9KY, a novel antimicrobial peptide identified from the brown frog, Rana kunyuensis.",Staphylococcusaureus
YGRKKRRQRRR,692,4,12522,DNA/Lysozyme-binding affinity study of novel peptides from TAT (47-57) and BRCA1 (782-786) in vitro by spectroscopic analysis.,Staphylococcusaureus
SISLLYGRKKRRQRRR,692,4,12523,DNA/Lysozyme-binding affinity study of novel peptides from TAT (47-57) and BRCA1 (782-786) in vitro by spectroscopic analysis.,Staphylococcusaureus
YGRKKRRQRRRSISLL,692,4,12524,DNA/Lysozyme-binding affinity study of novel peptides from TAT (47-57) and BRCA1 (782-786) in vitro by spectroscopic analysis.,Staphylococcusaureus
GLPLLISWIKRKRQQAGPGSKKPVPIIYCNRRTGKCQRM,693,2,12528,Design and activity study of a melittin-thanatin hybrid peptide.,Escherichiacoli
GLLRASSKWGRKYYVDLAGCAKA,694,4,12529,Selection and redesign for high selectivity of membrane-active antimicrobial peptides from a dedicated sequence/function database.,Staphylococcusaureus
RFRPPIRRPPIRPPFYPPFRPPIRP,695,2,12531,Search for Shorter Portions of the Proline-Rich Antimicrobial Peptide Fragment Bac5(1-25) That Retain Antimicrobial Activity by Blocking Protein Synthesis.,Escherichiacoli
GGGGLRKRLRKFRNKIKEKLKKIGQKIQGLLPKLA,696,2,12533,Antibody-Bactericidal Macrocyclic Peptide Conjugates To Target Gram-Negative Bacteria.,Escherichiacoli
GGGGLRKRLRKFRNKCKEKLKKCGQKIQGLLPKLA,696,2,12534,Antibody-Bactericidal Macrocyclic Peptide Conjugates To Target Gram-Negative Bacteria.,Escherichiacoli
GGGRGLRRLGRKIAHGVKKYGPTVLRIIRIAG,696,2,12535,Antibody-Bactericidal Macrocyclic Peptide Conjugates To Target Gram-Negative Bacteria.,Escherichiacoli
GGGCGLRRLGCKIAHGVKKYGPTVLRIIRIAG,696,2,12536,Antibody-Bactericidal Macrocyclic Peptide Conjugates To Target Gram-Negative Bacteria.,Escherichiacoli
GGGGRFKRFRKKFKKLFKKLSPVIPLLHLG,696,2,12537,Antibody-Bactericidal Macrocyclic Peptide Conjugates To Target Gram-Negative Bacteria.,Escherichiacoli
GGGGRFKRFRKKCKKLFKKCSPVIPLLHLG,696,2,12538,Antibody-Bactericidal Macrocyclic Peptide Conjugates To Target Gram-Negative Bacteria.,Escherichiacoli
GGGGKKCKKLFKKCSPVIPLLHLG,696,2,12539,Antibody-Bactericidal Macrocyclic Peptide Conjugates To Target Gram-Negative Bacteria.,Escherichiacoli
RRRGRSPRRRTPSPRRRRSQSPRRRRS,697,4,12540,Adding a C-terminal Cysteine (CTC) Can Enhance the Bactericidal Activity of Three Different Antimicrobial Peptides.,Staphylococcusaureus
RRRGRSPRRRTPSPRRRRSQSPRRRRSC,697,4,12541,Adding a C-terminal Cysteine (CTC) Can Enhance the Bactericidal Activity of Three Different Antimicrobial Peptides.,Staphylococcusaureus
RRRGRSPRRRTPSPRRRRSQSPRRRRSQ,697,4,12542,Adding a C-terminal Cysteine (CTC) Can Enhance the Bactericidal Activity of Three Different Antimicrobial Peptides.,Staphylococcusaureus
RRRGRSPRRRTPSPRRRRSC,697,4,12543,Adding a C-terminal Cysteine (CTC) Can Enhance the Bactericidal Activity of Three Different Antimicrobial Peptides.,Staphylococcusaureus
RRRTPSPRRRRSQSPRRRRSC,697,4,12544,Adding a C-terminal Cysteine (CTC) Can Enhance the Bactericidal Activity of Three Different Antimicrobial Peptides.,Staphylococcusaureus
RRRRSQSPRRRRSC,697,4,12545,Adding a C-terminal Cysteine (CTC) Can Enhance the Bactericidal Activity of Three Different Antimicrobial Peptides.,Staphylococcusaureus
EVSLNSGYY,698,2,12558,Antimicrobial activity of antihypertensive food-derived peptides and selected alanine analogues.,Escherichiacoli
FLFSLIRKAIGGLISAFK,699,4,12573,"A3, a Scorpion Venom Derived Peptide Analogue with Potent Antimicrobial and Potential Antibiofilm Activity against Clinical Isolates of Multi-Drug Resistant Gram Positive Bacteria.",Staphylococcusaureus
RFRPPIRRPPIRPPFYPPFRPPI,695,2,12574,Search for Shorter Portions of the Proline-Rich Antimicrobial Peptide Fragment Bac5(1-25) That Retain Antimicrobial Activity by Blocking Protein Synthesis.,Escherichiacoli
RFRPPIRRPPIRPPFYPPFRP,695,2,12575,Search for Shorter Portions of the Proline-Rich Antimicrobial Peptide Fragment Bac5(1-25) That Retain Antimicrobial Activity by Blocking Protein Synthesis.,Escherichiacoli
RFRPPIRRPPIRPPFYPPF,695,2,12576,Search for Shorter Portions of the Proline-Rich Antimicrobial Peptide Fragment Bac5(1-25) That Retain Antimicrobial Activity by Blocking Protein Synthesis.,Escherichiacoli
RFRPPIRRPPIRPPFYP,695,2,12577,Search for Shorter Portions of the Proline-Rich Antimicrobial Peptide Fragment Bac5(1-25) That Retain Antimicrobial Activity by Blocking Protein Synthesis.,Escherichiacoli
RFRPPIRRPPIRPPF,695,2,12578,Search for Shorter Portions of the Proline-Rich Antimicrobial Peptide Fragment Bac5(1-25) That Retain Antimicrobial Activity by Blocking Protein Synthesis.,Escherichiacoli
RPPIRRPPIRPPFYPPFRPPIRP,695,2,12579,Search for Shorter Portions of the Proline-Rich Antimicrobial Peptide Fragment Bac5(1-25) That Retain Antimicrobial Activity by Blocking Protein Synthesis.,Escherichiacoli
PIRRPPIRPPFYPPFRPPIRP,695,2,12580,Search for Shorter Portions of the Proline-Rich Antimicrobial Peptide Fragment Bac5(1-25) That Retain Antimicrobial Activity by Blocking Protein Synthesis.,Escherichiacoli
KYYGNGVTCGKHSCSVDWGKATTCIINNGAMAWATGGHQGNHKC,700,117,12581,"Synthesis, antimicrobial activity and conformational analysis of the class IIa bacteriocin pediocin PA-1 and analogs thereof.",Listeriaivanovii
KYYGNGVTAGKHSASVDWGKATTAIINNGAMAWATGGHQGNHKA,700,117,12586,"Synthesis, antimicrobial activity and conformational analysis of the class IIa bacteriocin pediocin PA-1 and analogs thereof.",Listeriaivanovii
KKWRWWLKALAKK,701,2,12609,Rational design of tryptophan-rich antimicrobial peptides with enhanced antimicrobial activities and specificities.,Escherichiacoli
KKWRKWLKALAKK,701,2,12610,Rational design of tryptophan-rich antimicrobial peptides with enhanced antimicrobial activities and specificities.,Escherichiacoli
KKWRAWLKWLAKK,701,2,12611,Rational design of tryptophan-rich antimicrobial peptides with enhanced antimicrobial activities and specificities.,Escherichiacoli
KKWRKWLKWLAKK,701,2,12612,Rational design of tryptophan-rich antimicrobial peptides with enhanced antimicrobial activities and specificities.,Escherichiacoli
RQCKAESNTFTGICIAKPPCRKACIREKFTDGHCSKVLRRCLCTKRC,702,112,12617,Structural and functional characterization of the membrane-permeabilizing activity of Nicotiana occidentalis defensin NoD173 and protein engineering to enhance oncolysis.,Humancervical
RQCKRESNTFTGICIAKPPCRQACIREKFTDGHCSKVLRRCLCTKRC,702,112,12618,Structural and functional characterization of the membrane-permeabilizing activity of Nicotiana occidentalis defensin NoD173 and protein engineering to enhance oncolysis.,Humancervical
HHHHHHCETPSKHFDGLCIRSSDCASVCHGEHFTDGRCEGVRRRCMCLKPC,703,17,12622,"Recombinant expression, purification and antimicrobial activity of a novel antimicrobial peptide PaDef in Pichia pastoris.",Listeriamonocytogenes
LRCMCIKWWSGKHPK,704,8,12623,Synthetic antimicrobial peptides delocalize membrane bound proteins thereby inducing a cell envelope stress response.,Bacillussubtilis
LRAMCIKWWSGKHPK,704,8,12624,Synthetic antimicrobial peptides delocalize membrane bound proteins thereby inducing a cell envelope stress response.,Bacillussubtilis
GKWKLFKKAFKKFLKILAC,704,8,12625,Synthetic antimicrobial peptides delocalize membrane bound proteins thereby inducing a cell envelope stress response.,Bacillussubtilis
WFGKLYRGKTKVVKKVKGLLKG,705,2,12632,Fish-derived antimicrobial peptides: Activity of a chionodracine mutant against bacterial models and human bacterial pathogens.,Escherichiacoli
FIFHIIRFFNFRVFRI,706,52,12633,Design of antimicrobial peptides from a cuttlefish database.,Enterococcusfaecalis
KIFDAEILLNGKRKGLG,706,17,12634,Design of antimicrobial peptides from a cuttlefish database.,Listeriamonocytogenes
FIKIFHHIFKGNPKFSIIK,706,17,12635,Design of antimicrobial peptides from a cuttlefish database.,Listeriamonocytogenes
KIRFTRTVSRLLKAALAST,706,17,12636,Design of antimicrobial peptides from a cuttlefish database.,Listeriamonocytogenes
AKAFKKAFEKLAAVVPFGGT,706,17,12637,Design of antimicrobial peptides from a cuttlefish database.,Listeriamonocytogenes
GKSNKPALTLIQARILKHKT,706,17,12638,Design of antimicrobial peptides from a cuttlefish database.,Listeriamonocytogenes
VILTRFRFLNRIVEPLLKKA,706,17,12639,Design of antimicrobial peptides from a cuttlefish database.,Listeriamonocytogenes
GSTSFHLIYNKWFAVKRRRKR,706,17,12640,Design of antimicrobial peptides from a cuttlefish database.,Listeriamonocytogenes
FFHHIFDPQIKSGLLVSMYD,706,17,12641,Design of antimicrobial peptides from a cuttlefish database.,Listeriamonocytogenes
SLSGCWTKSFPRKPCLRNR,707,2,12642,Antimicrobial peptides from Rana [Lithobates] catesbeiana: Gene structure and bioinformatic identification of novel forms from tadpoles.,Escherichiacoli
NPSNLRALEELVKEECSEIPVERCKKLIYGYRK,707,2,12643,Antimicrobial peptides from Rana [Lithobates] catesbeiana: Gene structure and bioinformatic identification of novel forms from tadpoles.,Escherichiacoli
GGVGKIIEYFIGGGVGYYG,708,2,12668,Discovery and structure of the antimicrobial lasso peptide citrocin.,Escherichiacoli
SNCWARCPGYPNGDSLCCRQYGACCSTSYPVPYKG,709,2,12672,The New Antimicrobial Peptide SpHyastatin from the Mud Crab Scylla paramamosain with Multiple Antimicrobial Mechanisms and High Effect on Bacterial Infection.,Escherichiacoli
QLGKKKHRRRPSKKKRHW,710,2,12674,HEXIM1 Peptide Exhibits Antimicrobial Activity Against Antibiotic Resistant Bacteria Through Guidance of Cell Penetrating Peptide.,Escherichiacoli
QLGRRRHRRRPSRRRRHW,710,118,12675,HEXIM1 Peptide Exhibits Antimicrobial Activity Against Antibiotic Resistant Bacteria Through Guidance of Cell Penetrating Peptide.,Humanbreast
RQIKIWFQNRRWGGQLGKKKHRRRPSKKKRHW,710,2,12676,HEXIM1 Peptide Exhibits Antimicrobial Activity Against Antibiotic Resistant Bacteria Through Guidance of Cell Penetrating Peptide.,Escherichiacoli
RQIKIWFQNRRWGGQLGRRRHRRRPSRRRRHW,710,2,12677,HEXIM1 Peptide Exhibits Antimicrobial Activity Against Antibiotic Resistant Bacteria Through Guidance of Cell Penetrating Peptide.,Escherichiacoli
AAVALLPAVLLALLAPMPFSTGKRIMLGE,711,62,12678,Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy.,Acutemyeloid
AAVALLPAVLLALLAPQLGKKKHRRRPSKKKRHW,711,62,12679,Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy.,Acutemyeloid
LTVSPWYGCGQLGKKKHRRRPSKKKRHW,711,118,12680,Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy.,Humanbreast
LTVSPWYGCGQLGRRRHRRRPSRRRRHW,711,118,12681,Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy.,Humanbreast
MPFSTGKRIMLGE,711,118,12682,Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy.,Humanbreast
LTVSPWYGCGMPFSTGKRIMLGE,711,118,12683,Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy.,Humanbreast
LTVSPWYGCGKLAKLAKKLAKLAK,711,119,12684,Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy.,Humanmultiple
AAVALLPAVLLALLAPQLGRRRHRRRPSRRRRHW,711,120,12685,Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy.,Humancolon
AAVALLPAVLLALLAPQLGKKILAARPSKKKRHW,711,120,12686,Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy.,Humancolon
QSCPTRRGLCFTSGLAACRAHCRGCHLGSNGRDCVRCPNGAQCTGVIGQTCTCLNPCPVC,712,8,12689,Induction of antibacterial proteins and peptides in the coprophilous mushroom Coprinopsis cinerea in response to bacteria.,Bacillussubtilis
GIGAVLKVLTTGLPALIKRKRQQ,713,4,12691,"Action mechanism of melittin-derived antimicrobial peptides, MDP1 and MDP2, de novo designed against multidrug resistant bacteria.",Staphylococcusaureus
GIGAVLKWLPALIKRKRQQ,713,4,12697,"Action mechanism of melittin-derived antimicrobial peptides, MDP1 and MDP2, de novo designed against multidrug resistant bacteria.",Staphylococcusaureus
LEHGSCVTTMAKDKPTL,714,121,12753,In vitro analysis of synthetic peptides in blocking the entry of dengue virus.,Aedesalbopictus
DRGWGNGCGLFG,714,121,12754,In vitro analysis of synthetic peptides in blocking the entry of dengue virus.,Aedesalbopictus
GQGKAHNGRLITANP,714,121,12755,In vitro analysis of synthetic peptides in blocking the entry of dengue virus.,Aedesalbopictus
GLLDLLKLLLKAAG,715,4,12756,Simulation-Guided Rational de Novo Design of a Small Pore-Forming Antimicrobial Peptide.,Staphylococcusaureus
HLGHHALDHLLK,716,4,12769,Immune mediators of sea-cucumber Holothuria tubulosa (Echinodermata) as source of novel antimicrobial and anti-staphylococcal biofilm agents.,Staphylococcusaureus
ASHLGHHALDHLLK,716,4,12770,Immune mediators of sea-cucumber Holothuria tubulosa (Echinodermata) as source of novel antimicrobial and anti-staphylococcal biofilm agents.,Staphylococcusaureus
MRGSHHHHHHGSSGENLYFQSL,718,17,12802,A Synthetic Derivative of Antimicrobial Peptide Holothuroidin 2 from Mediterranean Sea Cucumber (Holothuria tubulosa) in the Control of Listeria monocytogenes.,Listeriamonocytogenes
MRGSHHHHHHGSSGENLYFQSLASHLGHHALDHLLK,718,17,12803,A Synthetic Derivative of Antimicrobial Peptide Holothuroidin 2 from Mediterranean Sea Cucumber (Holothuria tubulosa) in the Control of Listeria monocytogenes.,Listeriamonocytogenes
AFCWNVCVYRNAVRVCHRRCN,719,2,12811,Antibacterial and detoxifying activity of NZ17074 analogues with multi-layers of selective antimicrobial actions against Escherichia coli and Salmonella enteritidis.,Escherichiacoli
GFCKAVCVYRNGVRVCHRRCN,719,2,12812,Antibacterial and detoxifying activity of NZ17074 analogues with multi-layers of selective antimicrobial actions against Escherichia coli and Salmonella enteritidis.,Escherichiacoli
WGFCWNVCVYRNGVRVCHRRCN,719,2,12813,Antibacterial and detoxifying activity of NZ17074 analogues with multi-layers of selective antimicrobial actions against Escherichia coli and Salmonella enteritidis.,Escherichiacoli
GFWNVVYRNGVRVHRRN,719,2,12814,Antibacterial and detoxifying activity of NZ17074 analogues with multi-layers of selective antimicrobial actions against Escherichia coli and Salmonella enteritidis.,Escherichiacoli
GFCWNVAVYRNGVRVAHRRCN,719,2,12815,Antibacterial and detoxifying activity of NZ17074 analogues with multi-layers of selective antimicrobial actions against Escherichia coli and Salmonella enteritidis.,Escherichiacoli
GFAWNVAVYRNGVRVAHRRAN,719,2,12816,Antibacterial and detoxifying activity of NZ17074 analogues with multi-layers of selective antimicrobial actions against Escherichia coli and Salmonella enteritidis.,Escherichiacoli
HLNKRVQRLLIRWLDWLK,720,51,12819,Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-18 and its amino acid-substituted analogs.,Porphyromonasgingivalis
HLLKRVQRLLIGWLDWLK,720,51,12820,Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-18 and its amino acid-substituted analogs.,Porphyromonasgingivalis
HLLKRVQRELIRWLDWLK,720,51,12821,Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-18 and its amino acid-substituted analogs.,Porphyromonasgingivalis
HWRRFWHR,721,2,12822,Antimicrobial activity and membrane interaction mechanism of the antimicrobial peptides derived from Rana chensinensis with short sequences,Escherichiacoli
RWRRFWRR,721,2,12823,Antimicrobial activity and membrane interaction mechanism of the antimicrobial peptides derived from Rana chensinensis with short sequences,Escherichiacoli
KKLLPIVKNLLKSLL,722,2,12830,Effect of Acylation on the Antimicrobial Activity of Temporin B Analogues.,Escherichiacoli
PMARNKKLLKKLRLKIAFK,723,3,12842,Selective antibacterial activity of the cationic peptide PaDBS1R6 against Gram-negative bacteria.,Pseudomonasaeruginosa
MKKLFAALALAAVVAPVW,724,2,12853,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli
PMKKKLAARILAKIVAPVW,724,2,12854,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli
PMKKLFAAKILARVVAKIW,724,2,12855,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli
KKINNTILSGLDSVASFS,724,2,12856,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli
PKKINKLLLRILDKIASFS,724,2,12857,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli
PKKINNTILKLLDRVASKI,724,2,12858,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli
MARNKPLGKKLRLAAAFK,724,2,12859,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli
PMKLLKRLGKKIRLAAAFK,724,2,12860,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli
PMARNKILGKILRKIAAFK,724,2,12861,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli
MNAINFTCTVHKKVAISV,724,2,12863,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli
PKLAIRITCKIHKKVAISV,724,2,12864,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli
PMNAIKLLCRVHKKIAISV,724,2,12865,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli
NRESQFYQSRRKKLSSQV,724,2,12866,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli
PNRESQFYKILRKILSKIV,724,2,12867,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli
PNRESQFYQKLLKKLSSKI,724,2,12868,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli
MSAEVVVKKVDGDALELG,724,2,12869,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli
PMKLLVRVKKKIGDALELG,724,2,12870,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli
LPKPPKPVSKMRMATPLLMQALPM,725,2,12882,Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentials.,Escherichiacoli
GWRTLLKKAEVKTVGKLALKHYL,726,4,12887,Characterization and Antimicrobial Activity of Amphiphilic Peptide AP3 and Derivative Sequences.,Staphylococcusaureus
GIWKKWIKKWLKKLLKKLWKKG,727,4,12894,"Antimicrobial and antibiofilm activity of designed and synthesized antimicrobial peptide, KABT-AMP.",Staphylococcusaureus
GWKTLLKKAEVKTVGKLALKHYL,726,4,12898,Characterization and Antimicrobial Activity of Amphiphilic Peptide AP3 and Derivative Sequences.,Staphylococcusaureus
GYRTLLKKAEVKTVGKLALKHWL,726,4,12899,Characterization and Antimicrobial Activity of Amphiphilic Peptide AP3 and Derivative Sequences.,Staphylococcusaureus
KKAEVKTVGKLALKHWL,726,4,12900,Characterization and Antimicrobial Activity of Amphiphilic Peptide AP3 and Derivative Sequences.,Staphylococcusaureus
KTVGKLALKHWL,726,4,12901,Characterization and Antimicrobial Activity of Amphiphilic Peptide AP3 and Derivative Sequences.,Staphylococcusaureus
AKKKLSRWWLRWWVK,728,41,12905,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
AKKKLVRWWLRWWSK,728,41,12906,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
ASKKLVRWWLRWWKK,728,41,12907,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
ALKKLSRWWKRWWVK,728,41,12908,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
AVKKLSRWWLRWWKK,728,41,12909,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
ALKKLVRWWKRWWSK,728,41,12910,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
AVKKLLRWWSRWWKK,728,41,12911,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
AKKKLSAWWLAWWVK,728,41,12912,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
AAAALSRWWLRWWVA,728,41,12913,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
AKKKLSRAALRAAVK,728,41,12914,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
AKKKLSAAALAAAVK,728,41,12915,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
AAAALSRAALRAAVA,728,41,12916,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
AVKKLLAWWSAWWKK,728,41,12917,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
AVAALLRWWSRWWAA,728,41,12918,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
AVKKLLRAASRAAKK,728,41,12919,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
AVKKLLAAASAAAKK,728,41,12920,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
AVAALLRAASRAAAA,728,41,12921,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
WSKWKRKAWVRLWLK,728,41,12922,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
RRERIEGDRRKEVA,728,41,12929,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
RRLDRKDYLRRVMP,728,41,12930,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
IEWGNVSRQPKPKATYI,728,41,12931,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
AAHRAGRPIHDAGVVKQ,728,41,12932,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
ARNVSEENVDRLAKRWIK,728,41,12933,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
KREMKRPGKGNRNNWKKEY,728,41,12934,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
RPPGFYFEFRANIIPYLGRR,728,41,12935,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
ARRLGMNPWKTPPAKPKGSK,728,41,12936,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
RKPRTTKPKPAPKQEPATEE,728,41,12937,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
ARRRELRARRKRPPERHPGRR,728,41,12938,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
RNRIREMKRPGKGNRNNWKKEH,728,41,12939,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
RLFGLSIRQHEVMTGHTVKVKSQ,728,41,12940,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
RRMTFDADFELKVAQLNALIAIAELLKEKN,728,41,12941,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
RLIRVERDSVEALMRPIGK,728,41,12942,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
MLLKKLLKKM,728,41,12943,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis
MQFITDLIGKAVDFFKGLFGNK,729,122,12948,Effect of amino acid substitution in the staphylococcal peptides warnericin RK and PSM? on their anti-Legionella and hemolytic activities.,Legionellapneumophila
MQFITDLIGKAVDFFKGLFDNK,729,122,12949,Effect of amino acid substitution in the staphylococcal peptides warnericin RK and PSM? on their anti-Legionella and hemolytic activities.,Legionellapneumophila
MNGFILGKFFDVAKKILDTIFQK,729,122,12950,Effect of amino acid substitution in the staphylococcal peptides warnericin RK and PSM? on their anti-Legionella and hemolytic activities.,Legionellapneumophila
MQTFQDILGKVIEVIKAIVDAK,729,122,12952,Effect of amino acid substitution in the staphylococcal peptides warnericin RK and PSM? on their anti-Legionella and hemolytic activities.,Legionellapneumophila
MAGVIAKIVEIVKGLIDQFTQK,729,122,12953,Effect of amino acid substitution in the staphylococcal peptides warnericin RK and PSM? on their anti-Legionella and hemolytic activities.,Legionellapneumophila
VNFKLLSHSLLVTLASHL,730,2,12966,Potential of novel antimicrobial peptide P3 from bovine erythrocytes and its analogs to disrupt bacterial membranes in vitro and display activity against drug-resistant bacteria in a mouse model.,Escherichiacoli
KLLSHSLLVTLA,730,2,12967,Potential of novel antimicrobial peptide P3 from bovine erythrocytes and its analogs to disrupt bacterial membranes in vitro and display activity against drug-resistant bacteria in a mouse model.,Escherichiacoli
MADVIAKIVEIVKKLIDQFTQK,729,122,13018,Effect of amino acid substitution in the staphylococcal peptides warnericin RK and PSM? on their anti-Legionella and hemolytic activities.,Legionellapneumophila
MAGVIAKIVEIVKKLIDQFTQK,729,122,13019,Effect of amino acid substitution in the staphylococcal peptides warnericin RK and PSM? on their anti-Legionella and hemolytic activities.,Legionellapneumophila
MADFIAKIVEIVKGLIDQFTQK,729,122,13020,Effect of amino acid substitution in the staphylococcal peptides warnericin RK and PSM? on their anti-Legionella and hemolytic activities.,Legionellapneumophila
MADVIAKIFEIVKGLIDQFTQK,729,122,13021,Effect of amino acid substitution in the staphylococcal peptides warnericin RK and PSM? on their anti-Legionella and hemolytic activities.,Legionellapneumophila
MADVIAKFVEIVKGLIDQFTQK,729,122,13022,Effect of amino acid substitution in the staphylococcal peptides warnericin RK and PSM? on their anti-Legionella and hemolytic activities.,Legionellapneumophila
MADVIAKFFEIVKGLIDQFTQK,729,122,13023,Effect of amino acid substitution in the staphylococcal peptides warnericin RK and PSM? on their anti-Legionella and hemolytic activities.,Legionellapneumophila
MQFITDLIKKAVDFFKGLVGNK,729,122,13024,Effect of amino acid substitution in the staphylococcal peptides warnericin RK and PSM? on their anti-Legionella and hemolytic activities.,Legionellapneumophila
MQFITDLIKKAVDFIKGLFGNK,729,122,13025,Effect of amino acid substitution in the staphylococcal peptides warnericin RK and PSM? on their anti-Legionella and hemolytic activities.,Legionellapneumophila
MQFITDLIKKAVDVIKGLFGNK,729,122,13026,Effect of amino acid substitution in the staphylococcal peptides warnericin RK and PSM? on their anti-Legionella and hemolytic activities.,Legionellapneumophila
KLLRHRLLVTLA,730,2,13042,Potential of novel antimicrobial peptide P3 from bovine erythrocytes and its analogs to disrupt bacterial membranes in vitro and display activity against drug-resistant bacteria in a mouse model.,Escherichiacoli
VRFKLLSHSLLVTLASHL,730,2,13043,Potential of novel antimicrobial peptide P3 from bovine erythrocytes and its analogs to disrupt bacterial membranes in vitro and display activity against drug-resistant bacteria in a mouse model.,Escherichiacoli
RRFKLLSHSLLVTLASHL,730,2,13044,Potential of novel antimicrobial peptide P3 from bovine erythrocytes and its analogs to disrupt bacterial membranes in vitro and display activity against drug-resistant bacteria in a mouse model.,Escherichiacoli
LKKWWKTSKGLLGGLLGKVTSVIK,732,3,13047,"Antibacterial Properties and Efficacy of a Novel SPLUNC1-Derived Antimicrobial Peptide, ?4-Short, in a Murine Model of Respiratory Infection.",Pseudomonasaeruginosa
VDFPNKGGKCDRKECRKTCKKLNYRGKCFNNYCRCFPG,733,4,13049,Loop Replacement Enhances the Ancestral Antibacterial Function of a Bifunctional Scorpion Toxin.,Staphylococcusaureus
VDFPNKGGKCDRKECRKTCKKLNYRGKCKFGGICRCFPG,733,4,13050,Loop Replacement Enhances the Ancestral Antibacterial Function of a Bifunctional Scorpion Toxin.,Staphylococcusaureus
KETWWETWWTEWSQPKKKRKV,734,2,13074,Design and mechanism of action of a novel bacteria-selective antimicrobial peptide from the cell-penetrating peptide Pep-1.,Escherichiacoli
GLRKRDRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY,735,32,13075,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis
GLRKRRRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY,735,32,13076,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis
GLRKRLRKFLNKIKEKLKKIGQKIQGLLPKLAPRTDY,735,94,13077,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Salmonellaenterica
GLRKRLRKFRNKNKEKLKKIGQKIQGLLPKLAPRTDY,735,32,13078,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis
GLRKRLRKFRNKQKEKLKKIGQKIQGLLPKLAPRTDY,735,32,13079,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis
GLRKRLRKFRNKSKEKLKKIGQKIQGLLPKLAPRTDY,735,32,13080,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis
GLRKRLRKFRNKIKEFLKKIGQKIQGLLPKLAPRTDY,735,32,13081,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis
GLRKRLRKFRNKIKEILKKIGQKIQGLLPKLAPRTDY,735,32,13082,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis
GLRKRLRKFRNKIKELLKKIGQKIQGLLPKLAPRTDY,735,32,13083,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis
GLRKRLRKFRNKIKEMLKKIGQKIQGLLPKLAPRTDY,735,32,13084,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis
GLRKRLRKFRNKIKEYLKKIGQKIQGLLPKLAPRTDY,735,32,13085,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis
GLRKRLRKFRNKIKEKCKKIGQKIQGLLPKLAPRTDY,735,32,13086,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis
GLRKRLRKFRNKIKEKHKKIGQKIQGLLPKLAPRTDY,735,32,13087,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis
GLRKRLRKFRNKIKEKLKKHGQKIQGLLPKLAPRTDY,735,32,13088,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis
GLRKRLRKFRNKIKEKLKKQGQKIQGLLPKLAPRTDY,735,32,13089,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis
GLRKRLRKFRNKIKEKLKKRGQKIQGLLPKLAPRTDY,735,32,13090,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis
GLRKRLRKFRNKIKEKLKKICQKIQGLLPKLAPRTDY,735,32,13091,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis
GLRKRLRKFRNKIKEKLKKIIQKIQGLLPKLAPRTDY,735,32,13092,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis
GLRKRLRKFRNKIKEKLKKILQKIQGLLPKLAPRTDY,735,32,13093,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis
GLRKRLRKFRNKIKEKLKKIGQKCQGLLPKLAPRTDY,735,32,13094,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis
GLRKRLRKFRNKIKEKLKKIGQKEQGLLPKLAPRTDY,735,32,13095,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis
GLRKRLRKFRNKIKEKLKKIGQKHQGLLPKLAPRTDY,735,32,13096,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis
GLRKRLRKFRNKIKEKLKKIGQKSQGLLPKLAPRTDY,735,32,13097,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis
GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKCAPRTDY,735,32,13098,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis
GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKLAPRHDY,735,32,13099,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis
GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDD,735,32,13100,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis
KLCKIVVIKVCK,736,2,13161,A significantly enhanced antibacterial spectrum of D-enantiomeric lipopeptide bactenecin.,Escherichiacoli
RLCRIWWIRWCR,736,2,13162,A significantly enhanced antibacterial spectrum of D-enantiomeric lipopeptide bactenecin.,Escherichiacoli
ATCYCRTGR,737,59,13173,Paneth cell ?-defensins HD-5 and HD-6 display differential degradation into active antimicrobial fragments.,Acinetobacterbaumannii
ATCYCRTGRCATR,737,59,13174,Paneth cell ?-defensins HD-5 and HD-6 display differential degradation into active antimicrobial fragments.,Acinetobacterbaumannii
ATCYCRTGRCATRESLSGVCEISGRLYR,737,59,13175,Paneth cell ?-defensins HD-5 and HD-6 display differential degradation into active antimicrobial fragments.,Acinetobacterbaumannii
TGRCATRESLSGVCEISGRLYRLCCR,737,59,13176,Paneth cell ?-defensins HD-5 and HD-6 display differential degradation into active antimicrobial fragments.,Acinetobacterbaumannii
CATRESLSGVCEISGRLYRLCCR,737,59,13177,Paneth cell ?-defensins HD-5 and HD-6 display differential degradation into active antimicrobial fragments.,Acinetobacterbaumannii
ESLSGVCEISGRLYRLCCR,737,59,13178,Paneth cell ?-defensins HD-5 and HD-6 display differential degradation into active antimicrobial fragments.,Acinetobacterbaumannii
CATRESLSGVCEISGRLY,737,59,13179,Paneth cell ?-defensins HD-5 and HD-6 display differential degradation into active antimicrobial fragments.,Acinetobacterbaumannii
RFRPPIRRPPIRPPFRPPFRPPVRP,738,2,13181,Fragments of the Nonlytic Proline-Rich Antimicrobial Peptide Bac5 Kill Escherichia coli Cells by Inhibiting Protein Synthesis.,Escherichiacoli
RFRPPIRRPPIRPPFNPPFRPPVRP,738,2,13182,Fragments of the Nonlytic Proline-Rich Antimicrobial Peptide Bac5 Kill Escherichia coli Cells by Inhibiting Protein Synthesis.,Escherichiacoli
RFRPPIRRPPIRPPFYPPFRPPIRPPIFPPI,738,2,13183,Fragments of the Nonlytic Proline-Rich Antimicrobial Peptide Bac5 Kill Escherichia coli Cells by Inhibiting Protein Synthesis.,Escherichiacoli
YLARAIRRTLARLLL,739,2,13184,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli
SWKKFFKKARSLPKLF,739,2,13189,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli
KFKKLFKKLSPVFKRIVQRIKDFLR,740,4,13190,Design and characterization of a new hybrid peptide from LL-37 and BMAP-27.,Staphylococcusaureus
CGIYRSLKLIKSLVLIK,741,2,13191,New Synthetic Peptides Conjugated to Gold Nanoclusters: Antibiotic Activity Against Escherichia coli O157:H7 and Methicillin-Resistant Staphylococcus aureus (MRSA).,Escherichiacoli
CALKLTKAKRLVRKIGF,741,2,13192,New Synthetic Peptides Conjugated to Gold Nanoclusters: Antibiotic Activity Against Escherichia coli O157:H7 and Methicillin-Resistant Staphylococcus aureus (MRSA).,Escherichiacoli
EWRVARRAVQRLRHLARRYH,739,2,13193,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli
ALKKMLRLAKRLS,739,2,13194,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli
VLSAFHKVIKIIHHISHF,739,2,13195,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli
RKFRKILHRARKWI,739,2,13196,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli
RRWGRWHRMRRRGR,739,2,13205,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli
FWKGLVKAAFKIVHAGS,739,2,13213,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli
GWKAIHKAAKGIHTYVN,739,2,13245,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli
YKRWKKWRSKAKKIL,739,2,13246,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli
KWKCLAKVGIAAH,739,2,13247,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli
KRSWDIVKKYVGVVVGTIH,739,2,13248,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli
AGEKRIIKKIDEAFQ,739,2,13249,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli
AIARTRRRLLLYLLA,739,2,13250,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli
AAARLRLLLYLITRR,739,2,13251,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli
RKLAFKPLKKFFSWKS,739,2,13252,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli
SKFLSKKPKKLFWFRA,739,2,13253,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli
FAKKFAKKFKKFAKKFAKFAFAF,742,3,13330,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
FKLRAKIKVRLRAKIKL,742,3,13331,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
FAVAVKAVAVKAVAVKAVKKAVKKVKKAVKKAVKKKK,743,123,13332,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,Felineimmunodeficiency
FLAAARIAKRVAKKARKLAKRAARKRK,743,123,13333,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,Felineimmunodeficiency
FRFKIKFRLKFRFKARFKFRAKFRA,743,123,13334,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,Felineimmunodeficiency
KRKRAVKRVGRRLKKLARKIARLGVAKLAGLRAVKLF,743,123,13335,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,Felineimmunodeficiency
FAVGLRAIKRALKKLRRGVRKVAKDL,743,123,13336,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,Felineimmunodeficiency
GAKKGAKKGKKGAKKGAKGAGAKGAGAFKKKK,743,123,13337,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,Felineimmunodeficiency
KKKKFVKKVAKKVKKVAKKVAKVAVAV,743,123,13338,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,Felineimmunodeficiency
FLFAFRIFKRVFKKFRKLFKRAF,743,123,13339,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,Felineimmunodeficiency
KRKRAVKRVGRRLKKKLARKIARLGVAF,743,123,13340,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,Felineimmunodeficiency
KRKRFAKKFLRFLRKVIRFLKRFIRRF,743,123,13341,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,Felineimmunodeficiency
FAIAIKAIKKAIKKIKKAIKKAI,743,123,13342,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,Felineimmunodeficiency
FKVKAKVKAKVKAKVKAKKKK,743,123,13344,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,Felineimmunodeficiency
AVKRVGRRLKKLARKIARLGVAF,743,123,13345,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,Felineimmunodeficiency
KFAKKFAK,742,3,13352,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
KFAKKFAKKFAK,742,3,13353,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
KFAKKFAKKFAKKFAK,742,3,13354,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
KFAKKFAKKFAKKFAKKFAK,742,3,13355,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
KFAKKFAKKFAKKFAKKFAKKFAK,742,3,13356,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
KFAKKFAKKFAKKFAKKFAKKFAKKFAK,742,3,13357,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
KFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAK,742,3,13358,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
KFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAK,742,3,13359,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
RFARRFARRFARRFARRFARRFAR,742,3,13361,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
RFARRFARRFARRFARRFARRFARRFAR,742,3,13362,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
RFARRFARRFARRFARRFARRFARRFARRFAR,742,3,13363,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
FAKKFAKKFAKKFAKKFAKKFAKK,742,3,13364,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
AKKFAKKFAKKFAKKFAKKFAKKF,742,3,13365,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
KKFAKKFAKKFAKKFAKKFAKKFA,742,3,13366,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
LKKLLKKLLKKLLKKLLKKL,742,3,13367,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
LKKLLKKLLKKLLKKLLKKLLKKL,742,3,13368,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
LKKLLKKLLKKLLKKLLKKLLKKLLKKL,742,3,13369,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
LKKLLKKLLKKLLKKLLKKLLKKLLKKLLKKL,742,3,13370,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
KFAFKFAFKFAFKFAFKFAFKFAFKFAF,742,3,13371,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
KFFKKFFKKFFKKFFKKFFKKFFKKFFK,742,3,13372,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
KAAKKAAKKAAKKAAKKAAKKAAKKAAK,742,3,13373,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
KKAKKKAKKKAKKKAKKKAKKKAKKKAK,742,3,13374,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
KFKKFKKFKKFKKFKKFK,742,3,13375,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
KFKKFKKFKKFKKFKKFKKFK,742,3,13376,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
KFKKFKKFKKFKKFKKFKKFKKFK,742,3,13377,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
KFKKFKKFKKFKKFKKFKKFKKFKKFK,742,3,13378,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
KFKKFKKFKKFKKFKKFKKFKKFKKFKKFK,742,3,13379,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
KFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFK,742,3,13380,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
KFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFK,742,3,13381,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
FKAFKAFKAFKA,742,3,13384,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
FKAFKAFKAFKAFKAFKA,742,3,13385,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
FKAFKAFKAFKAFKAFKAFKA,742,3,13386,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
FKAFKAFKAFKAFKAFKAFKAFKA,742,3,13387,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
FKAFKAFKAFKAFKAFKAFKAFKAFKA,742,3,13388,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
FKAFKAFKAFKAFKAFKAFKAFKAFKAFKA,742,3,13389,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
FKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKA,742,3,13390,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
LKLKLKLKLK,742,3,13393,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
LKLKLKLKLKLKLK,742,3,13394,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
LKLKLKLKLKLKLKLK,742,3,13395,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
LKLKLKLKLKLKLKLKLK,742,3,13396,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
LKLKLKLKLKLKLKLKLKLK,742,3,13397,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
LKLKLKLKLKLKLKLKLKLKLK,742,3,13398,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
LKLKLKLKLKLKLKLKLKLKLKLK,742,3,13399,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
LKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLK,742,3,13400,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
LKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLK,742,3,13401,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
LRLRLRLRLRLRLR,742,3,13402,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
LRLRLRLRLRLRLRLRLR,742,3,13403,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
LALALALALALALALALALALA,742,3,13404,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
KFKKFKKFK,742,3,13406,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
KFKKFKKFKKFK,742,3,13407,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
KGKKGKKGKKGKKGKKGKKGK,742,3,13408,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
KGKKGKKGKKGKKGKKGKKGKKGKKGKKGKKGK,742,3,13409,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
KGKKGKKGKKGKKGKKGKKGKKGKKGKKGKKGKKGKKGKKGKKGK,742,3,13410,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
KTKKTKKTKKTKKTKKTKKTK,742,3,13411,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
KFAKKFAKKFAKKAAK,742,3,13412,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
KFAKKFAKKAAKKAAK,742,3,13413,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
KFAKKAAKKFAKKAAK,742,3,13414,Periodic antimicrobial peptides.,Pseudomonasaeruginosa
AMAYLAKDNLGEKITEVITILLNRLTDRLEKYAG,744,2,13415,"Cathelicidin-like helminth defence molecules (HDMs): absence of cytotoxic, anti-microbial and anti-protozoan activities imply a specific adaptation to immune modulation.",Escherichiacoli
MDKYIRKEDLGMKMLDVAKILGRRIEKRMEYIAKK,744,2,13416,"Cathelicidin-like helminth defence molecules (HDMs): absence of cytotoxic, anti-microbial and anti-protozoan activities imply a specific adaptation to immune modulation.",Escherichiacoli
IDTYSRKDDLDKKLLEVAKIIGRRLEKRHEYLAMK,744,2,13417,"Cathelicidin-like helminth defence molecules (HDMs): absence of cytotoxic, anti-microbial and anti-protozoan activities imply a specific adaptation to immune modulation.",Escherichiacoli
IRKYLEEDNLGEKLAAVVSIYVKRLNKRLDMR,744,2,13423,"Cathelicidin-like helminth defence molecules (HDMs): absence of cytotoxic, anti-microbial and anti-protozoan activities imply a specific adaptation to immune modulation.",Escherichiacoli
ITEVITILLNRLTDRLEK,745,3,13425,Helminth Defense Molecules as Design Templates for Membrane Active Antibiotics.,Pseudomonasaeruginosa
ITKVITKLLNRLTKILSK,745,3,13426,Helminth Defense Molecules as Design Templates for Membrane Active Antibiotics.,Pseudomonasaeruginosa
ITKQITKQLNRQTKIQSK,745,3,13427,Helminth Defense Molecules as Design Templates for Membrane Active Antibiotics.,Pseudomonasaeruginosa
IQKVIQKLLNRLQKILQK,745,3,13428,Helminth Defense Molecules as Design Templates for Membrane Active Antibiotics.,Pseudomonasaeruginosa
ITKVIAKLLNRLTKILSK,745,3,13429,Helminth Defense Molecules as Design Templates for Membrane Active Antibiotics.,Pseudomonasaeruginosa
ITKVITKLLNRLSKILSK,745,3,13430,Helminth Defense Molecules as Design Templates for Membrane Active Antibiotics.,Pseudomonasaeruginosa
VRLPPPVRLPPPVRLPPP,746,2,13488,Membrane-active peptides and the clustering of anionic lipids.,Escherichiacoli
GWTLNSAGYLLGKINLKALAALAKKIL,746,2,13489,Membrane-active peptides and the clustering of anionic lipids.,Escherichiacoli
PMNAIKLLCR,747,3,13491,A short peptide with selective antibiofilm activity against Pseudomonas aeruginosa and Klebsiella pneumoniae carbapenemase-producing bacteria.,Pseudomonasaeruginosa
MNAIKLLCRV,747,3,13492,A short peptide with selective antibiofilm activity against Pseudomonas aeruginosa and Klebsiella pneumoniae carbapenemase-producing bacteria.,Pseudomonasaeruginosa
NAIKLLCRVH,747,3,13493,A short peptide with selective antibiofilm activity against Pseudomonas aeruginosa and Klebsiella pneumoniae carbapenemase-producing bacteria.,Pseudomonasaeruginosa
AIKLLCRVHK,747,3,13494,A short peptide with selective antibiofilm activity against Pseudomonas aeruginosa and Klebsiella pneumoniae carbapenemase-producing bacteria.,Pseudomonasaeruginosa
IKLLCRVHKK,747,3,13495,A short peptide with selective antibiofilm activity against Pseudomonas aeruginosa and Klebsiella pneumoniae carbapenemase-producing bacteria.,Pseudomonasaeruginosa
KLLCRVHKKI,747,3,13496,A short peptide with selective antibiofilm activity against Pseudomonas aeruginosa and Klebsiella pneumoniae carbapenemase-producing bacteria.,Pseudomonasaeruginosa
LLCRVHKKIA,747,3,13497,A short peptide with selective antibiofilm activity against Pseudomonas aeruginosa and Klebsiella pneumoniae carbapenemase-producing bacteria.,Pseudomonasaeruginosa
LCRVHKKIAI,747,3,13498,A short peptide with selective antibiofilm activity against Pseudomonas aeruginosa and Klebsiella pneumoniae carbapenemase-producing bacteria.,Pseudomonasaeruginosa
CRVHKKIAIS,747,3,13499,A short peptide with selective antibiofilm activity against Pseudomonas aeruginosa and Klebsiella pneumoniae carbapenemase-producing bacteria.,Pseudomonasaeruginosa
RVHKKIAISV,747,3,13500,A short peptide with selective antibiofilm activity against Pseudomonas aeruginosa and Klebsiella pneumoniae carbapenemase-producing bacteria.,Pseudomonasaeruginosa
RWCRRYRVRVRGVLVYAYVCW,748,2,13505,"Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization.",Escherichiacoli
RRWCVYAYVRVRGVRVYAYVCW,748,2,13506,"Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization.",Escherichiacoli
WCRRYRVLVRGVLVRYRRCW,748,2,13507,"Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization.",Escherichiacoli
RWCVYAYVRV,748,1,13509,"Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization.",None_target
WCRRYRVLV,748,1,13512,"Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization.",None_target
RFCVYAYVRVRGVLVRYRRCF,748,2,13515,"Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization.",Escherichiacoli
RWCVYAYVRVRGVLVRYRRCW,748,2,13517,"Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization.",Escherichiacoli
CKGKGAKCSRLMYDCCTGSCRSGKCGS,749,2,13518,Macrocyclic Antimicrobial Peptides Engineered from ?-Conotoxin.,Escherichiacoli
AKGKGAKASRLMYDAATGSARSGKAGS,749,2,13528,Macrocyclic Antimicrobial Peptides Engineered from ?-Conotoxin.,Escherichiacoli
GNNKPVYKPQPRPPHPRL,750,2,13539,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli
GNNKPVYRPQPRPPHPRL,750,2,13541,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli
GNNKPVYIPQPRPPRPRL,750,2,13542,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli
GNNRPVYKPQPRPPRPRL,750,2,13543,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli
GNNRPVYRPQPRPPRPRL,750,2,13545,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli
GNNKPVYKPQPRPPRPRL,750,2,13546,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli
GNNKPVYRPQPRPPRPRL,750,2,13547,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli
VDKGSYKPRPTPPKPIYNRN,750,2,13549,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli
VDKGSYRPRPTPPKPIYNRN,750,2,13550,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli
RRIKKRPPRLPRPRPR,750,2,13551,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli
RRIKPRPPRLPRPRPK,750,2,13552,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli
RRIRKRPPRLPRPRPK,750,2,13553,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli
RRIKKRPPRLPRPRPK,750,2,13554,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli
GNNKPVYIPQPRPPHPRL,750,2,13555,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli
GNNRPVYKPQPRPPHPRL,750,2,13556,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli
GNNRPVYRPQPRPPHPRL,750,2,13557,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli
GNNRPVYIPQPRPPRPRL,750,2,13558,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli
VDKGSYKPRPTPPRPIYNRN,750,2,13559,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli
VDKGSYRPRPTPPRPIYNRN,750,2,13560,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli
VDKGSYLPRPTPPKPIYNRN,750,2,13561,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli
KRIRPRPPRLPRPRPR,750,2,13562,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli
RKIRPRPPRLPRPRPR,750,2,13563,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli
RRKRPRPPRLPRPRPR,750,2,13564,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli
RRRRPRPPRLPRPRPR,750,2,13565,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli
RRIKPRPPRLPRPRPR,750,2,13566,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli
RRIRKRPPRLPRPRPR,750,2,13567,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli
RRIRPRKPRLPRPRPR,750,2,13568,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli
RRIRPRRPRLPRPRPR,750,2,13569,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli
RRIRPRPPRLPRPRPK,750,2,13570,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli
VPKPPYLPRPRPPRRIYNRG,751,3,13599,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa
VRKPPYLPRPRPPRRIYNRG,751,3,13600,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa
VDKKPYLPRPRPPRRIYNRG,751,3,13601,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa
VDKPPYLPRPRFPRRIYNRG,751,3,13602,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa
VDKPPYLPRPRGPRRIYNRG,751,3,13603,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa
VDKPPYLPRPRKPRRIYNRG,751,3,13604,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa
VDKPPYLPRPRLPRRIYNRG,751,3,13605,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa
VDKPPYLPRPRMPRRIYNRG,751,3,13606,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa
VDKPPYLPRPRQPRRIYNRG,751,3,13607,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa
VDKPPYLPRPRRPRRIYNRG,751,3,13608,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa
VDKPPYLPRPRSPRRIYNRG,751,3,13609,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa
VDKPPYLPRPRWPRRIYNRG,751,3,13610,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa
VDKPPYLPRPRYPRRIYNRG,751,3,13611,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa
VDKPPYLPRPRPRRRIYNRG,751,3,13612,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa
VDKPPYLPRPRPPKRIYNRG,751,3,13613,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa
VDKPPYLPRPRPPRRCYNRG,751,3,13614,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa
VDKPPYLPRPRPPRRFYNRG,751,3,13615,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa
VDKPPYLPRPRPPRRKYNRG,751,3,13616,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa
VDKPPYLPRPRPPRRIYCRG,751,3,13617,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa
VDKPPYLPRPRPPRRIYKRG,751,3,13618,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa
VDKPPYLPRPRPPRRIYWRG,751,3,13619,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa
VDKPPYLPRPRPPRRIYYRG,751,3,13620,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa
VDKPPYLPRPRPPRRIYNHG,751,3,13621,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa
VDKPPYLPRPRPPRRIYNKG,751,3,13622,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa
SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGC,752,2,13625,Bioevaluation of Ranatuerin-2Pb from the Frog Skin Secretion of Rana pipiens and its Truncated Analogues.,Escherichiacoli
EVAKKLLASALKLALAI,753,2,13630,A Uniform In Vitro Efficacy Dataset to Guide Antimicrobial Peptide Design,Escherichiacoli
EDWNHLGAAVHTLKHVYK,754,2,13637,A Uniform In Vitro Efficacy Dataset to Guide Antimicrobial Peptide Design.,Escherichiacoli
AIVEQLRKRC,754,2,13638,A Uniform In Vitro Efficacy Dataset to Guide Antimicrobial Peptide Design.,Escherichiacoli
KLSASLKHVAHRARHLS,754,2,13639,A Uniform In Vitro Efficacy Dataset to Guide Antimicrobial Peptide Design.,Escherichiacoli
ESRAGKLAAKAAFKAAKR,754,2,13640,A Uniform In Vitro Efficacy Dataset to Guide Antimicrobial Peptide Design.,Escherichiacoli
EWAAARQVIIHATRKY,754,2,13641,A Uniform In Vitro Efficacy Dataset to Guide Antimicrobial Peptide Design.,Escherichiacoli
EILSKALSALSPLAN,754,2,13642,A Uniform In Vitro Efficacy Dataset to Guide Antimicrobial Peptide Design.,Escherichiacoli
EKAILSALKLLRLAL,754,2,13643,A Uniform In Vitro Efficacy Dataset to Guide Antimicrobial Peptide Design.,Escherichiacoli
ETAKGVAKHLPPAIA,754,2,13644,A Uniform In Vitro Efficacy Dataset to Guide Antimicrobial Peptide Design.,Escherichiacoli
KVYARLHAVIKRLHRRLH,754,2,13645,A Uniform In Vitro Efficacy Dataset to Guide Antimicrobial Peptide Design.,Escherichiacoli
SRSSRAGLQFPVGRIHRLLRK,755,25,13663,"A histone H2A derived antimicrobial peptide, Fi-Histin from the Indian White shrimp, Fenneropenaeus indicus: Molecular and functional characterization.",Bacilluscereus
ATCYCRTGRCATRESLSGVCEISGRLYRLCCR,756,2,13695,Roles of the Conserved Amino Acid Residues in Reduced Human Defensin 5: Cysteine and Arginine Are Indispensable for Its Antibacterial Action and LPS Neutralization.,Escherichiacoli
ATCYCRTGRCATRESLSAVCEISGRLYRLCCR,756,2,13696,Roles of the Conserved Amino Acid Residues in Reduced Human Defensin 5: Cysteine and Arginine Are Indispensable for Its Antibacterial Action and LPS Neutralization.,Escherichiacoli
ATCYCATGRCATRESLSGVCEISGRLYRLCCR,756,2,13697,Roles of the Conserved Amino Acid Residues in Reduced Human Defensin 5: Cysteine and Arginine Are Indispensable for Its Antibacterial Action and LPS Neutralization.,Escherichiacoli
ATAYARTGRAATRESLSGVAEISGRLYRLAAR,756,2,13698,Roles of the Conserved Amino Acid Residues in Reduced Human Defensin 5: Cysteine and Arginine Are Indispensable for Its Antibacterial Action and LPS Neutralization.,Escherichiacoli
ATCYCKTGKCATKESLSGVCEISGKLYKLCCK,756,2,13699,Roles of the Conserved Amino Acid Residues in Reduced Human Defensin 5: Cysteine and Arginine Are Indispensable for Its Antibacterial Action and LPS Neutralization.,Escherichiacoli
ATCYARTGRAATRESLSGVAEISGRLYRLACR,757,59,13704,A Simplified Derivative of Human Defensin 5 with Potent and Efficient Activity against Multidrug-Resistant Acinetobacter baumannii.,Acinetobacterbaumannii
ATAYCRTGRAATRESLSGVCEISGRLYRLAAR,757,59,13705,A Simplified Derivative of Human Defensin 5 with Potent and Efficient Activity against Multidrug-Resistant Acinetobacter baumannii.,Acinetobacterbaumannii
ATAYARTGRCATRESLSGVAEISGRLYRLCAR,757,59,13706,A Simplified Derivative of Human Defensin 5 with Potent and Efficient Activity against Multidrug-Resistant Acinetobacter baumannii.,Acinetobacterbaumannii
ARARCRRGRAARRRRLRGVCRIRGRLRRLAAR,757,59,13707,A Simplified Derivative of Human Defensin 5 with Potent and Efficient Activity against Multidrug-Resistant Acinetobacter baumannii.,Acinetobacterbaumannii
AKAKCRKGRAAKRKKLKGVCRIKGRLKRLAAR,757,59,13708,A Simplified Derivative of Human Defensin 5 with Potent and Efficient Activity against Multidrug-Resistant Acinetobacter baumannii.,Acinetobacterbaumannii
ATCYCRRGRCATRESLSGVCEISGRLYRLCCR,758,2,13709,Design of a potent antibiotic peptide based on the active region of human defensin 5.,Escherichiacoli
ATCYCRTGRCATRESLSGVCRISGRLYRLCCR,758,2,13710,Design of a potent antibiotic peptide based on the active region of human defensin 5.,Escherichiacoli
ATCYCRTGRCATRESLSGVCEIRGRLYRLCCR,758,2,13711,Design of a potent antibiotic peptide based on the active region of human defensin 5.,Escherichiacoli
ATCYCRTGRCATRESLSGVCEISRRLYRLCCR,758,2,13712,Design of a potent antibiotic peptide based on the active region of human defensin 5.,Escherichiacoli
ATCYCRRGRCATRESLSGVCRISGRLYRLCCR,758,2,13713,Design of a potent antibiotic peptide based on the active region of human defensin 5.,Escherichiacoli
IKIVAPKKIKL,759,2,13714,Medicinal leech antimicrobial peptides lacking toxicity represent a promising alternative strategy to combat antibiotic-resistant pathogens.,Escherichiacoli
WKKLVPYKIHAGI,759,2,13715,Medicinal leech antimicrobial peptides lacking toxicity represent a promising alternative strategy to combat antibiotic-resistant pathogens.,Escherichiacoli
FRIMRILRVLKL,759,2,13716,Medicinal leech antimicrobial peptides lacking toxicity represent a promising alternative strategy to combat antibiotic-resistant pathogens.,Escherichiacoli
WKIFKLKLRMLW,759,2,13717,Medicinal leech antimicrobial peptides lacking toxicity represent a promising alternative strategy to combat antibiotic-resistant pathogens.,Escherichiacoli
LRWLGTKVGILK,759,2,13718,Medicinal leech antimicrobial peptides lacking toxicity represent a promising alternative strategy to combat antibiotic-resistant pathogens.,Escherichiacoli
KFKKVIWKSFL,759,2,13719,Medicinal leech antimicrobial peptides lacking toxicity represent a promising alternative strategy to combat antibiotic-resistant pathogens.,Escherichiacoli
LIVLTCRKKKKPF,759,2,13720,Medicinal leech antimicrobial peptides lacking toxicity represent a promising alternative strategy to combat antibiotic-resistant pathogens.,Escherichiacoli
RPILIRVRRIRVI,759,2,13721,Medicinal leech antimicrobial peptides lacking toxicity represent a promising alternative strategy to combat antibiotic-resistant pathogens.,Escherichiacoli
RWRLVCFLCRRKKV,759,2,13722,Medicinal leech antimicrobial peptides lacking toxicity represent a promising alternative strategy to combat antibiotic-resistant pathogens.,Escherichiacoli
GFIVKRFKILV,759,2,13723,Medicinal leech antimicrobial peptides lacking toxicity represent a promising alternative strategy to combat antibiotic-resistant pathogens.,Escherichiacoli
CLIMKVRRKK,759,2,13724,Medicinal leech antimicrobial peptides lacking toxicity represent a promising alternative strategy to combat antibiotic-resistant pathogens.,Escherichiacoli
ISRACLIMKVRRKK,759,2,13725,Medicinal leech antimicrobial peptides lacking toxicity represent a promising alternative strategy to combat antibiotic-resistant pathogens.,Escherichiacoli
KKCWNGGRCRKKCKENEKPIGYCRNGKKCCVN,760,41,13731,Antimicrobial activity and structure of a consensus human ?-defensin and its comparison to a novel putative hBD10.,Mycobacteriumtuberculosis
KWKSFIKKLTSVLKKVVTTALPALIS,761,2,13734,Antimicrobial Cationic Peptides,Escherichiacoli
KWKSFIKNLTKVLKKVVTTALPALIS,761,2,13737,Antimicrobial Cationic Peptides,Escherichiacoli
KWKLFKKKGTGAVLTVLTTGLPALIS,761,2,13738,Antimicrobial Cationic Peptides,Escherichiacoli
KKWWRRVLSGLKTAGPAIQSVLNK,761,2,13739,Antimicrobial Cationic Peptides,Escherichiacoli
KKWWRRALQGLKTAGPAIQSVLNK,761,2,13740,Antimicrobial Cationic Peptides,Escherichiacoli
KKSFFKKLTSVASSVLS,761,2,13741,Antimicrobial Cationic Peptides,Escherichiacoli
KWKSFIKNLEKVLKPGGLLSNIVTSL,761,2,13742,Antimicrobial Cationic Peptides,Escherichiacoli
KWKSFIKNLEKVLKKGPILANLVSIV,761,2,13743,Antimicrobial Cationic Peptides,Escherichiacoli
KWKEFIKKLTTAVKKVLTTGLPALIS,761,2,13744,Antimicrobial Cationic Peptides,Escherichiacoli
KWKKFIKELQKVLAPGGLLSNIVTSL,761,2,13745,Antimicrobial Cationic Peptides,Escherichiacoli
KWKLFKKIGIGAVLTTGLPALIS,761,4,13747,Antimicrobial Cationic Peptides,Staphylococcusaureus
GLFDVIRRVASVIGGL,762,4,13760,Understanding interactions of Citropin 1.1 analogues with model membranes and their influence on biological activity.,Staphylococcusaureus
GLFDVIRKVASVIGGL,762,4,13761,Understanding interactions of Citropin 1.1 analogues with model membranes and their influence on biological activity.,Staphylococcusaureus
GLFDVIKKGVASVIGGL,762,4,13762,Understanding interactions of Citropin 1.1 analogues with model membranes and their influence on biological activity.,Staphylococcusaureus
GLFEVIKKVASVIGGL,762,4,13763,Understanding interactions of Citropin 1.1 analogues with model membranes and their influence on biological activity.,Staphylococcusaureus
GLWDVIKKVASVIGGL,762,4,13764,Understanding interactions of Citropin 1.1 analogues with model membranes and their influence on biological activity.,Staphylococcusaureus
GLWRVIRKVASVIGGL,762,4,13765,Understanding interactions of Citropin 1.1 analogues with model membranes and their influence on biological activity.,Staphylococcusaureus
KVEIVAINDPFIDL,763,48,13786,Identification of A Novel Antibacterial Peptide from Atlantic Mackerel belonging to the GAPDH-Related Antimicrobial Family and Its In Vitro Digestibility.,Bacillusmegaterium
LRRLLRWLRRLLRR,764,2,13787,Design and characterization of short antimicrobial peptides using leucine zipper templates with selectivity towards microorganisms.,Escherichiacoli
LRRAARWARRLLRR,764,2,13788,Design and characterization of short antimicrobial peptides using leucine zipper templates with selectivity towards microorganisms.,Escherichiacoli
LRRPPRWPRRLLRR,764,2,13790,Design and characterization of short antimicrobial peptides using leucine zipper templates with selectivity towards microorganisms.,Escherichiacoli
RKKRRQRRR,765,4,13834,Discovery and Rational Design of a Novel Bowman-Birk Related Protease Inhibitor.,Staphylococcusaureus
RKKRRQRRRCWTKSIPPKPC,765,4,13836,Discovery and Rational Design of a Novel Bowman-Birk Related Protease Inhibitor.,Staphylococcusaureus
RVKRVWYLVIRTVIAGYNLPRAIKKK,766,2,13888,Improving Cell Selectivity of Fowlicidin-1 by Swapping Residues between Pro-7 and Tyr-20,Escherichiacoli
KWCFRVCYRGICYRRCRG,767,2,13889,Characterization of Tachyplesin Peptides and Their Cyclized Analogues to Improve Antimicrobial and Anticancer Properties.,Escherichiacoli
RWCFRVCYRGICYRKCRG,767,2,13890,Characterization of Tachyplesin Peptides and Their Cyclized Analogues to Improve Antimicrobial and Anticancer Properties.,Escherichiacoli
KWCFRVCYRGICYRKCRG,767,2,13891,Characterization of Tachyplesin Peptides and Their Cyclized Analogues to Improve Antimicrobial and Anticancer Properties.,Escherichiacoli
RVKRVWPLVIRTVIAGYNL,768,2,13892,The design of a cell-selective fowlicidin-1-derived peptide with both antimicrobial and anti-inflammatory activities.,Escherichiacoli
KRVWPLVIRTVIAGYNLYR,768,2,13893,The design of a cell-selective fowlicidin-1-derived peptide with both antimicrobial and anti-inflammatory activities.,Escherichiacoli
VWPLVIRTVIAGYNLYRAI,768,2,13894,The design of a cell-selective fowlicidin-1-derived peptide with both antimicrobial and anti-inflammatory activities.,Escherichiacoli
NLCASLRARHTIPQCRKFGRR,769,2,13896,"Structural and Functional Assessment of mBjAMP1, an Antimicrobial Peptide from Branchiostoma japonicum, Revealed a Novel ?-Hairpinin-like Scaffold with Membrane Permeable and DNA Binding Activity.",Escherichiacoli
NLSASLRARHTIPQSRKFGRR,769,2,13898,"Structural and Functional Assessment of mBjAMP1, an Antimicrobial Peptide from Branchiostoma japonicum, Revealed a Novel ?-Hairpinin-like Scaffold with Membrane Permeable and DNA Binding Activity.",Escherichiacoli
NLASLRARHTIPQRKFGRR,769,2,13899,"Structural and Functional Assessment of mBjAMP1, an Antimicrobial Peptide from Branchiostoma japonicum, Revealed a Novel ?-Hairpinin-like Scaffold with Membrane Permeable and DNA Binding Activity.",Escherichiacoli
FLPAIAGLAAKFLPKIFCAITKKC,770,2,13908,Identification and molecular cloning of novel antimicrobial peptides from skin secretions of the Chinese bamboo leaf odorous frog (Odorrana versabilis) and the North American pickerel frog (Rana palustris),Escherichiacoli
FLPAIAGVAAKFLPKIFCAITKKC,770,2,13909,Identification and molecular cloning of novel antimicrobial peptides from skin secretions of the Chinese bamboo leaf odorous frog (Odorrana versabilis) and the North American pickerel frog (Rana palustris),Escherichiacoli
KKLRLKIAFK,771,2,13929,Short Cationic Peptide Derived from Archaea with Dual Antibacterial Properties and Anti-Infective Potential.,Escherichiacoli
GWLKKIGKKIERVGQNTRDATIQAIGVAQQAANVAATLKG,772,59,13933,Antibacterial mechanism of peptide Cec4 against Acinetobacter baumannii.,Acinetobacterbaumannii
GWVKKIGKKIERVGQNTRDATIQVIGVAQQAANVAATLKG,772,59,13935,Antibacterial mechanism of peptide Cec4 against Acinetobacter baumannii.,Acinetobacterbaumannii
FLGALWKALSKLL,773,2,13991,Activity and selectivity of histidine-containing lytic peptides to antibiotic-resistant bacteria.,Escherichiacoli
FLGALWHALSKLL,773,2,13992,Activity and selectivity of histidine-containing lytic peptides to antibiotic-resistant bacteria.,Escherichiacoli
FLGALWKALSHLL,773,2,13994,Activity and selectivity of histidine-containing lytic peptides to antibiotic-resistant bacteria.,Escherichiacoli
FLGALWHALSHLL,773,124,13995,Activity and selectivity of histidine-containing lytic peptides to antibiotic-resistant bacteria.,Humanpancreatic
KPCTKLSKGWRGLCAPHKCSSYCIHHEGAYHGRCRGFRRRCYCYYRHCY,774,24,14008,Antifungal potency and modes of action of a novel olive tree defensin against closely related ascomycete fungal pathogens.,Fusariumoxysporum
KPCTKLSKGWRGLCAPHKCSSYCIHHEGAYHGACHVRNGKHMCYCYYRHCY,774,24,14009,Antifungal potency and modes of action of a novel olive tree defensin against closely related ascomycete fungal pathogens.,Fusariumoxysporum
KPCTKLSKGWRGLCAPHKCSSYCIHHEGAYHGACAAARHSKHYGCYCYYRHCY,774,24,14010,Antifungal potency and modes of action of a novel olive tree defensin against closely related ascomycete fungal pathogens.,Fusariumoxysporum
KPCTKLSKGWRGLCAPHKCSSYCIHHEGAYHGACLKNAAAKHYGCYCYYRHCY,774,24,14011,Antifungal potency and modes of action of a novel olive tree defensin against closely related ascomycete fungal pathogens.,Fusariumoxysporum
KPCTKLSKGWRGLCAPHKCSSYCIHHEGAYHGACLKNRHSAAAACYCYYRHCY,774,24,14012,Antifungal potency and modes of action of a novel olive tree defensin against closely related ascomycete fungal pathogens.,Fusariumoxysporum
HTLCMDGGATY,775,125,14013,"M-Brucin, an antibacterial peptide against Staphylococcus epidermidis and Streptococcus pyogenes",Acinetobacteranitratus
HTLCMGKATY,775,125,14014,"M-Brucin, an antibacterial peptide against Staphylococcus epidermidis and Streptococcus pyogenes",Acinetobacteranitratus
HTLCMDKKATY,775,47,14015,"M-Brucin, an antibacterial peptide against Staphylococcus epidermidis and Streptococcus pyogenes",Streptococcuspyogenes
HTLCMDRRATY,775,56,14016,"M-Brucin, an antibacterial peptide against Staphylococcus epidermidis and Streptococcus pyogenes",Staphylococcusepidermidis
HTLCMDPPATY,775,56,14017,"M-Brucin, an antibacterial peptide against Staphylococcus epidermidis and Streptococcus pyogenes",Staphylococcusepidermidis
HTLCMGGATY,775,56,14018,"M-Brucin, an antibacterial peptide against Staphylococcus epidermidis and Streptococcus pyogenes",Staphylococcusepidermidis
GLLSRLRDFLSDIGRRLGEKIERIGQKIKDLSEFFQS,776,4,14020,Enhancing the antibacterial activity of PMAP-37 by increasing its hydrophobicity.,Staphylococcusaureus
GLLSRLRDFLSDRGRRLGEIIERIGQIIKDLSEFFQS,776,4,14021,Enhancing the antibacterial activity of PMAP-37 by increasing its hydrophobicity.,Staphylococcusaureus
MGIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK,777,2,14029,Bacterial expression and antibiotic activities of recombinant variants of human ?-defensins on pathogenic bacteria and M. tuberculosis.,Escherichiacoli
CRKPTFRRLKWKIKFKFKC,778,2,14040,Synergistic antibiotic effect of looped antimicrobial peptide CLP-19 with bactericidal and bacteriostatic agents.,Escherichiacoli
GIIKKIIKKIIKKI,779,2,14044,Hydrophobic Control of the Bioactivity and Cytotoxicity of de Novo-Designed Antimicrobial Peptides.,Escherichiacoli
GFGCPGSEKKCHNHCKSVKGYKGGYCDGPYIPFVGRPRCKCY,780,4,14052,Invasive fungi-derived defensins kill drug-resistant bacterial pathogens.,Staphylococcusaureus
GFGCPGNEKKCHNHCKSVKGYKGGYCDGPYIPFVGRPRCKCY,780,4,14053,Invasive fungi-derived defensins kill drug-resistant bacterial pathogens.,Staphylococcusaureus
GFGCPGSEKKCHNHCKTIKGYKGGYCDGPYIPFVGRPRCKCY,780,4,14054,Invasive fungi-derived defensins kill drug-resistant bacterial pathogens.,Staphylococcusaureus
VAIALKAAHYATHKE,781,52,14071,Bioinorganic chemistry of calcitermin - the picklock of its antimicrobial activity.,Enterococcusfaecalis
KKHRKHRKHRKHGGG,782,1,14074,Design and activity of a 'dual-targeted' antimicrobial peptide.,None_target
DAANEAGGG,782,1,14076,Design and activity of a 'dual-targeted' antimicrobial peptide.,None_target
FKARRWQWRMKKLGA,783,2,14093,"Synergistic bactericide and antibiotic effects of dimeric, tetrameric, or palindromic peptides containing the RWQWR motif against Gram-positive and Gram-negative strains",Escherichiacoli
GRFRRLRKKTRKRLKKIGKVLKWIWWIVGSIPLGCG,784,50,14099,Antimicrobial activity of the antibacterial peptide PMAP-36 and its analogues.,Enterococcusfaecium
GRFRRLRKKTRKRLKKIGKVLKWIKKIVGSIPLGCG,784,50,14100,Antimicrobial activity of the antibacterial peptide PMAP-36 and its analogues.,Enterococcusfaecium
MGFKLRAKIKVRLRAKIKL,785,50,14105,Designed Host Defense Peptides for the Treatment of Bacterial Keratitis.,Enterococcusfaecium
GRFKRFRKKLKKLFKKLSPVIPLLHLG,786,126,14106,Cathelicidin Peptides Restrict Bacterial Growth via Membrane Perturbation and Induction of Reactive Oxygen Species.,Enterobactercloacae
FRKKLKKLFKKLSPVIPLLKLG,786,126,14107,Cathelicidin Peptides Restrict Bacterial Growth via Membrane Perturbation and Induction of Reactive Oxygen Species.,Enterobactercloacae
CKLRFRGPGRIKVRLC,785,50,14113,Designed Host Defense Peptides for the Treatment of Bacterial Keratitis.,Enterococcusfaecium
CPGFAKKFAKKFKKFAKKFAKFAFAF,785,50,14114,Designed Host Defense Peptides for the Treatment of Bacterial Keratitis.,Enterococcusfaecium
KIRAKLCLGRFCIRAKLR,785,50,14115,Designed Host Defense Peptides for the Treatment of Bacterial Keratitis.,Enterococcusfaecium
KKKPKPPYLPKPKPPPFFPPKLPPKI,785,50,14116,Designed Host Defense Peptides for the Treatment of Bacterial Keratitis.,Enterococcusfaecium
FAFAFKAFKKAFKKFKKAFKKAFGPC,785,50,14117,Designed Host Defense Peptides for the Treatment of Bacterial Keratitis.,Enterococcusfaecium
FAFAFAFKKAFKKFKKAFKKAF,785,50,14118,Designed Host Defense Peptides for the Treatment of Bacterial Keratitis.,Enterococcusfaecium
FAKKFAKKFKKFAKKFAFAFAF,785,50,14121,Designed Host Defense Peptides for the Treatment of Bacterial Keratitis.,Enterococcusfaecium
VAEARQGSFSY,787,3,14134,Antimicrobial activity and mechanism of action of a novel peptide present in the ecdysis process of centipede Scolopendra subspinipes subspinipes.,Pseudomonasaeruginosa
RPFTRAQWFAIQHISPRTIAMRAINNYRWR,788,3,14140,"A Novel RNase 3/ECP Peptide for Pseudomonas aeruginosa Biofilm Eradication That Combines Antimicrobial, Lipopolysaccharide Binding, and Cell-Agglutinating Activities.",Pseudomonasaeruginosa
RPFIRAQWFAIQHISPRTIAMRAINNYRWR,789,3,14141,Positional scanning library applied to the human eosinophil cationic protein/RNase3 N-terminus reveals novel and potent anti-biofilm peptides.,Pseudomonasaeruginosa
RPFTRAQIFAIQHISPRTIAMRAINNYRWR,789,3,14142,Positional scanning library applied to the human eosinophil cationic protein/RNase3 N-terminus reveals novel and potent anti-biofilm peptides.,Pseudomonasaeruginosa
RPFTRAQWFAIIHISPRTIAMRAINNYRWR,789,3,14143,Positional scanning library applied to the human eosinophil cationic protein/RNase3 N-terminus reveals novel and potent anti-biofilm peptides.,Pseudomonasaeruginosa
ACYCRIPACIAGERRYATCIYQGRLWAFCC,790,2,14144,"Invariant gly residue is important for ?-defensin folding, dimerization, and function: a case study of the human neutrophil ?-defensin HNP1.",Escherichiacoli
LKLSPKTKKTLKKVLKGAIKGAIAIASMA,791,4,14145,"Conformational analysis and cytotoxic activities of the frog skin host-defense peptide, hymenochirin-1Pa.",Staphylococcusaureus
GIGKWLHSAKKFGKAFVGEIMNS,793,8,14162,Conjugation of Cell-Penetrating Peptides to Antimicrobial Peptides Enhances Antibacterial Activity.,Bacillussubtilis
RRRRRRRRRGGGGIGKWLHSAKKFGKAFVGEIMNS,793,8,14163,Conjugation of Cell-Penetrating Peptides to Antimicrobial Peptides Enhances Antibacterial Activity.,Bacillussubtilis
KWKKLLKKLLKLLKK,793,8,14164,Conjugation of Cell-Penetrating Peptides to Antimicrobial Peptides Enhances Antibacterial Activity.,Bacillussubtilis
RRRRRRRRRGGGKWKKLLKKPLKLLKK,793,8,14165,Conjugation of Cell-Penetrating Peptides to Antimicrobial Peptides Enhances Antibacterial Activity.,Bacillussubtilis
KRKARKKGRFSKK,794,51,14180,Identification of cationic peptides derived from low protein rice by-products and evaluation of their multifunctional activities.,Porphyromonasgingivalis
FKRIVQRIKDFLRNLV,795,3,14181,Cathelicidin-Derived Synthetic Peptide Improves Therapeutic Potential of Vancomycin Against Pseudomonas aeruginosa.,Pseudomonasaeruginosa
KIAGKIAKIAGKIAKIAGKIA,796,2,14201,Influence of C-terminal amidation on the antimicrobial and hemolytic activities of cationic a-helical peptides,Escherichiacoli
KLALKLALKALKAALKLA,796,2,14202,Influence of C-terminal amidation on the antimicrobial and hemolytic activities of cationic a-helical peptides,Escherichiacoli
GLKRIFKSGLGKLVKGISAHVAS,798,4,14272,Increases in Hydrophilicity and Charge on the Polar Face of Alyteserin 1c Helix Change its Selectivity towards Gram-Positive Bacteria.,Staphylococcusaureus
TIVRRRGGSRATRSPRRRTPSPRRRRSQSPRRRRSQSPASSNC,799,3,14276,Improvement of in vivo antimicrobial activity of HBcARD peptides by D-arginine replacement.,Pseudomonasaeruginosa
TVIRRRGGARASRSPRRRTPSPRRRRSQSPRRRRSQSPSANC,799,3,14277,Improvement of in vivo antimicrobial activity of HBcARD peptides by D-arginine replacement.,Pseudomonasaeruginosa
RKPRGLEPRRRKVKTTVVYGRRRSKSRERRAPTPQR,799,3,14278,Improvement of in vivo antimicrobial activity of HBcARD peptides by D-arginine replacement.,Pseudomonasaeruginosa
RKPRGLEPRRRKVKTTVVYGRRRSKSRGRRSSPSQR,799,3,14279,Improvement of in vivo antimicrobial activity of HBcARD peptides by D-arginine replacement.,Pseudomonasaeruginosa
ATKKCGLFKILKGVGKI,800,2,14392,"Antimicrobial activity of a new synthetic peptide loaded in polylactic acid or poly(lactic-co-glycolic) acid nanoparticles against Pseudomonas aeruginosa, Escherichia coli O157:H7 and methicillin resistant Staphylococcus aureus (MRSA).",Escherichiacoli
SQRKLAAKLTSK,801,3,14393,Development of a Novel Hybrid Antimicrobial Peptide for Targeted Killing of Pseudomonas Aeruginosa.,Pseudomonasaeruginosa
SQRKLAAKLTSKGGGRLLRPLLQLLKQKLR,801,3,14394,Development of a Novel Hybrid Antimicrobial Peptide for Targeted Killing of Pseudomonas Aeruginosa.,Pseudomonasaeruginosa
AKLIPTIAL,802,2,14396,"RcAlb-PepII, a Synthetic Small Peptide Bioinspired in the 2S Albumin From the Seed Cake of Ricinus Communis, Is a Potent Antimicrobial Agent Against Klebsiella Pneumoniae and Candida Parapsilosis.",Escherichiacoli
GLRRLLRKIRGRWK,803,18,14398,Enhancement of the antimicrobial activity and selectivity of GNU7 against Gram-negative bacteria by fusion with LPS-targeting peptide.,Micrococcusluteus
NIKISGKWKAQKRFLK,803,18,14400,Enhancement of the antimicrobial activity and selectivity of GNU7 against Gram-negative bacteria by fusion with LPS-targeting peptide.,Micrococcusluteus
GLRRLLRKIRGRWKGGGRLLRPLLQLLKQKLR,803,18,14401,Enhancement of the antimicrobial activity and selectivity of GNU7 against Gram-negative bacteria by fusion with LPS-targeting peptide.,Micrococcusluteus
RKVRGPPGGGRLLRPLLQLLKQKLR,803,18,14403,Enhancement of the antimicrobial activity and selectivity of GNU7 against Gram-negative bacteria by fusion with LPS-targeting peptide.,Micrococcusluteus
NIKISGKWKAQKRFLKGGGRLLRPLLQLLKQKLR,803,18,14404,Enhancement of the antimicrobial activity and selectivity of GNU7 against Gram-negative bacteria by fusion with LPS-targeting peptide.,Micrococcusluteus
KAVKKRKKKLAKAKK,804,51,14405,Identification and characterization of multifunctional cationic peptides from enzymatic hydrolysates of soybean proteins.,Porphyromonasgingivalis
LPLRTRLLKVL,804,51,14406,Identification and characterization of multifunctional cationic peptides from enzymatic hydrolysates of soybean proteins.,Porphyromonasgingivalis
FRAPYIASLLR,804,51,14407,Identification and characterization of multifunctional cationic peptides from enzymatic hydrolysates of soybean proteins.,Porphyromonasgingivalis
RKSREWRSKKTQPRRPR,805,51,14408,Identification and characterization of multifunctional cationic and amphipathic peptides from soybean proteins.,Porphyromonasgingivalis
KNQYGRIRVLQRFNQR,805,51,14409,Identification and characterization of multifunctional cationic and amphipathic peptides from soybean proteins.,Porphyromonasgingivalis
RIRLLQRFNKR,805,51,14410,Identification and characterization of multifunctional cationic and amphipathic peptides from soybean proteins.,Porphyromonasgingivalis
RDNIQGITKPAIRRLARRGGVKRISGLIY,806,2,14426,Chemical modifications of short antimicrobial peptides from insects and vertebrates to fight multi-drug resistant bacteria.,Escherichiacoli
VYPKTKTYFPHFDLHHGSAQVRTHGKKVLNALG,806,2,14427,Chemical modifications of short antimicrobial peptides from insects and vertebrates to fight multi-drug resistant bacteria.,Escherichiacoli
VDKPPYLPRPPPPRRIYN,806,2,14428,Chemical modifications of short antimicrobial peptides from insects and vertebrates to fight multi-drug resistant bacteria.,Escherichiacoli
VDKPPYLPRPTPPRRIYN,806,2,14429,Chemical modifications of short antimicrobial peptides from insects and vertebrates to fight multi-drug resistant bacteria.,Escherichiacoli
VDKPPYLPRPHPPRRIYN,806,2,14430,Chemical modifications of short antimicrobial peptides from insects and vertebrates to fight multi-drug resistant bacteria.,Escherichiacoli
VDKPPYLPRPKPPRRIYN,806,2,14431,Chemical modifications of short antimicrobial peptides from insects and vertebrates to fight multi-drug resistant bacteria.,Escherichiacoli
RWRPPIRRPPIRPPFYP,808,2,14453,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RFRGPIRRPPIRPPFYP,808,2,14454,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RFRRPIRRPPIRPPFYP,808,2,14455,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RFRFPIRRPPIRPPFYP,808,2,14456,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RFRWPIRRPPIRPPFYP,808,2,14457,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RFRPPWRRPPIRPPFYP,808,2,14458,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RFRPPIRRRPIRPPFYP,808,2,14459,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RFRPPIRRPPIRPPWYP,808,2,14460,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RFRPPIRRPPIRPPFWP,808,2,14461,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RFRPPIRRPPIRPPFYR,808,2,14462,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RFRPPIRRPPIRPPFYW,808,2,14463,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RFRRPIRRRPIRPPFYP,808,2,14464,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RFRRPIRRPPIRPPFYR,808,2,14465,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RFRWPIRRPPIRPPWYP,808,2,14466,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RWRWPIRRPPIRPPFYP,808,2,14467,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RWRWPIRRPPIRPPWYP,808,2,14468,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RFRWPIRRRPIRPPFYP,808,2,14469,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RFRWPIRRPPIRPPFYR,808,2,14470,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RWRRPIRRPPIRPPFYP,808,2,14471,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RWRRPIRRPPIRPPFYR,808,2,14472,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RWRRPIRRPPIRPPWYP,808,2,14473,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RWRRPIRRRPIRPPFYP,808,2,14474,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RWRWPIRRPPIRPPFYR,808,2,14475,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RFRWPIRRRPIRPPFYR,808,2,14476,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RFRWPIRRRPIRPPFYW,808,2,14477,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RWRRPIRRRPIRPPFYW,808,2,14478,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RWRRPIRRRPIRPPFYR,808,2,14479,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RWRRPIRRRPIRPPWYP,808,2,14480,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RFRWPIRRRPIRPPWYR,808,2,14481,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RFRRPIRRRPIRPPFWR,808,2,14482,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RFRWPIRRRPIRPPFWR,808,2,14483,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RFRRPIRRRPIRPPWYR,808,2,14484,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RRRRPIRRRPIRPPWYP,808,2,14485,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RWRRPIRRRPIRPPWYR,808,2,14486,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RWRRPIRRRPIRPPFWR,808,2,14487,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RWRRPWRRRPIRPPFYR,808,2,14488,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RWRWPIRRRPIRPPWYR,808,2,14489,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RWRWPIRRRPIRPPFWR,808,2,14490,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RRRRPWRRRPIRPPFYW,808,2,14491,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RFRRPIRRRPIRPPFYR,808,2,14492,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RWRPPIRRPPIRPPWYP,808,2,14493,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RFRRPIRRPPIRPPWYP,808,2,14494,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RRRRPIRRRPIRPPFYR,808,2,14495,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
RRRRPIRRRPIRPPWYR,808,2,14496,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli
KGIRGYKGGY,809,8,14575,Antimicrobial Function of Short Amidated Peptide Fragments From the Tick-Derived OsDef2 Defensin.,Bacillussubtilis
IRGYKGGYCK,809,8,14576,Antimicrobial Function of Short Amidated Peptide Fragments From the Tick-Derived OsDef2 Defensin.,Bacillussubtilis
GYKGGYCKGA,809,8,14577,Antimicrobial Function of Short Amidated Peptide Fragments From the Tick-Derived OsDef2 Defensin.,Bacillussubtilis
KGGYCKGAFK,809,8,14578,Antimicrobial Function of Short Amidated Peptide Fragments From the Tick-Derived OsDef2 Defensin.,Bacillussubtilis
GYCKGAFKQT,809,8,14579,Antimicrobial Function of Short Amidated Peptide Fragments From the Tick-Derived OsDef2 Defensin.,Bacillussubtilis
CKGAFKQTCK,809,8,14580,Antimicrobial Function of Short Amidated Peptide Fragments From the Tick-Derived OsDef2 Defensin.,Bacillussubtilis
GAFKQTCKCY,809,8,14581,Antimicrobial Function of Short Amidated Peptide Fragments From the Tick-Derived OsDef2 Defensin.,Bacillussubtilis
CKGAFKQTCKCY,809,8,14582,Antimicrobial Function of Short Amidated Peptide Fragments From the Tick-Derived OsDef2 Defensin.,Bacillussubtilis
GLSRLFTALK,810,4,14616,Targeted separation of antibacterial peptide from protein hydrolysate of anchovy cooking wastewater by equilibrium dialysis.,Staphylococcusaureus
WDPYFAGVKKLTKAILAVRA,811,2,14620,Rational Design of Membrane-Pore-Forming Peptides.,Escherichiacoli
TKCFQWQWRMKKLGAPSITCVRRAF,812,2,14653,Bovine and human lactoferricin peptides: chimeras and new cyclic analogs.,Escherichiacoli
FKCRRWQRNMRKVRGPPVSCIKRDS,812,2,14654,Bovine and human lactoferricin peptides: chimeras and new cyclic analogs.,Escherichiacoli
FKCRRWQWNMRKVRGPPVSCIKRDS,812,2,14655,Bovine and human lactoferricin peptides: chimeras and new cyclic analogs.,Escherichiacoli
FKCRRWQWRMRKVRGPPVSCIKRDS,812,2,14656,Bovine and human lactoferricin peptides: chimeras and new cyclic analogs.,Escherichiacoli
GGFKCRRWQWRMKKLGAPSITCVRRAFLPETGG,812,2,14661,Bovine and human lactoferricin peptides: chimeras and new cyclic analogs.,Escherichiacoli
GGFKCRRWQWRMKKLGAPSITCVRRAFLPET,812,2,14662,Bovine and human lactoferricin peptides: chimeras and new cyclic analogs.,Escherichiacoli
GGRRWQWRMKKLGAPSITLPETGG,812,2,14663,Bovine and human lactoferricin peptides: chimeras and new cyclic analogs.,Escherichiacoli
GGRRWQWRMKKLGAPSITLPET,812,2,14664,Bovine and human lactoferricin peptides: chimeras and new cyclic analogs.,Escherichiacoli
GEFAQFEQEAQSLEQELSQLEQQLESL,813,2,14676,Anti-antimicrobial Peptides: Folding-Mediated Host Defense Antagonists,Escherichiacoli
KWKVLKKKIKMLRNRINGLVKAGPALKVKLQALAL,813,2,14678,Anti-antimicrobial Peptides: Folding-Mediated Host Defense Antagonists,Escherichiacoli
EAQNLEKEIAALEQAIQGLEKEIPALAQQIQALEL,813,2,14679,Anti-antimicrobial Peptides: Folding-Mediated Host Defense Antagonists,Escherichiacoli
SRSELIVHQRLFK,814,1,14693,"Design of a Helical-Stabilized, Cyclic, and Nontoxic Analogue of the Peptide Cm-p5 With Improved Antifungal Activity.",None_target
GKSLVKWIVKSVRKA,815,2,14705,In Silico Design of Polycationic Antimicrobial Peptides Active Against Pseudomonas Aeruginosa and Staphylococcus Aureus,Escherichiacoli
KVFTLFQARAQGKLMRI,815,2,14707,In Silico Design of Polycationic Antimicrobial Peptides Active Against Pseudomonas Aeruginosa and Staphylococcus Aureus,Escherichiacoli
KVWTLFRAAGKLMAK,815,2,14708,In Silico Design of Polycationic Antimicrobial Peptides Active Against Pseudomonas Aeruginosa and Staphylococcus Aureus,Escherichiacoli
AILRKATRRLVQLIVSG,815,2,14710,In Silico Design of Polycationic Antimicrobial Peptides Active Against Pseudomonas Aeruginosa and Staphylococcus Aureus,Escherichiacoli
RILAKATRRLVKLIVSG,815,2,14711,In Silico Design of Polycationic Antimicrobial Peptides Active Against Pseudomonas Aeruginosa and Staphylococcus Aureus,Escherichiacoli
LRKATRRLVQLIVSG,815,2,14714,In Silico Design of Polycationic Antimicrobial Peptides Active Against Pseudomonas Aeruginosa and Staphylococcus Aureus,Escherichiacoli
ATAILRKATRRLVQLI,815,2,14715,In Silico Design of Polycationic Antimicrobial Peptides Active Against Pseudomonas Aeruginosa and Staphylococcus Aureus,Escherichiacoli
PMKKLKLALRLAAKIAPVW,816,59,14716,A Computationally Designed Peptide Derived From Escherichia Coli as a Potential Drug Template for Antibacterial and Antibiofilm Therapies,Acinetobacterbaumannii
GILDTLKQFAKGVGKDLVKGAAQGVLSTVSCKLAKTC,817,18,14718,Biophysical Studies on the Antimicrobial Activity of Linearized Esculentin 2EM.,Micrococcusluteus
GWWRRTVDKVRNAGRK,818,66,14719,Structure-activity Relationship Studies of Shortened Analogues of the Antimicrobial Peptide EeCentrocin 1 From the Sea Urchin Echinus Esculentus.,Corynebacteriumglutamicum
LLKLFFPFLETGE,819,7,14760,"A Novel Non-Cytotoxic Synthetic Peptide, Pug-1, Exhibited an Antibiofilm Effect on Streptococcus Mutans Adhesion.",Streptococcusmutans
FPSFLVGR,819,7,14763,"A Novel Non-Cytotoxic Synthetic Peptide, Pug-1, Exhibited an Antibiofilm Effect on Streptococcus Mutans Adhesion.",Streptococcusmutans
KSAFELPHYGL,820,52,14765,Human Salivary MUC7 Mucin Fragment and Its Analogues. Coordination and Biological Studies.,Enterococcusfaecalis
KSHFELPAYGL,820,52,14766,Human Salivary MUC7 Mucin Fragment and Its Analogues. Coordination and Biological Studies.,Enterococcusfaecalis
KSHFELPHYGL,820,52,14767,Human Salivary MUC7 Mucin Fragment and Its Analogues. Coordination and Biological Studies.,Enterococcusfaecalis
GLLSRLRDRLSDRGRRLGEKIERIGQKIKDLSEFFQS,822,4,14867,Antimicrobial Peptide PMAP-37 Analogs: Increasing the Positive Charge to Enhance the Antibacterial Activity of PMAP-37.,Staphylococcusaureus
GLLSRLRDFLSDRGRRLGEKIERIGQKIKDLSERFQS,822,4,14868,Antimicrobial Peptide PMAP-37 Analogs: Increasing the Positive Charge to Enhance the Antibacterial Activity of PMAP-37.,Staphylococcusaureus
GLLSRLRDRLSDRGRRLGEKIERIGQKIKDLSERFQS,822,4,14869,Antimicrobial Peptide PMAP-37 Analogs: Increasing the Positive Charge to Enhance the Antibacterial Activity of PMAP-37.,Staphylococcusaureus
LLKKLLKK,823,1,14951,Branched and 4-arm Starlike ?-Helical Peptide Structures With Enhanced Antimicrobial Potency and Selectivity,None_target
LLKKLLKKKC,823,1,14955,Branched and 4-arm Starlike ?-Helical Peptide Structures With Enhanced Antimicrobial Potency and Selectivity,None_target
ALWKKLLKKLLKSAKKLG,824,2,14963,Effects of Hydrophobic Amino Acid Substitutions on Antimicrobial Peptide Behavior,Escherichiacoli
AFWKKFFKKFFKSAKKFG,824,2,14964,Effects of Hydrophobic Amino Acid Substitutions on Antimicrobial Peptide Behavior,Escherichiacoli
AIWKKIIKKIIKSAKKIG,824,2,14965,Effects of Hydrophobic Amino Acid Substitutions on Antimicrobial Peptide Behavior,Escherichiacoli
AVWKKVVKKVVKSAKKVG,824,2,14966,Effects of Hydrophobic Amino Acid Substitutions on Antimicrobial Peptide Behavior,Escherichiacoli
IRIRPIRIRP,825,2,14972,Simplified Head-to-Tail Cyclic Polypeptides as Biomaterial-Associated Antimicrobials With Endotoxin Neutralizing and Anti-Inflammatory Capabilities,Escherichiacoli
IRIRIRPIRIRIRP,825,2,14973,Simplified Head-to-Tail Cyclic Polypeptides as Biomaterial-Associated Antimicrobials With Endotoxin Neutralizing and Anti-Inflammatory Capabilities,Escherichiacoli
SKVWRHWRRFWHRAHRKL,826,2,14980,Antimicrobial Activity and Self-Assembly Behavior of Antimicrobial Peptide chensinin-1b With Lipophilic Alkyl Tails,Escherichiacoli
VKRTKRGARRGLTKVLKKIFGSIVKKAVSKGV,827,2,14984,Opossum Cathelicidins Exhibit Antimicrobial Activity Against a Broad Spectrum of Pathogens Including West Nile Virus,Escherichiacoli
VRRSKRGIKVPSFVKKVLKDVVSESIS,827,2,14986,Opossum Cathelicidins Exhibit Antimicrobial Activity Against a Broad Spectrum of Pathogens Including West Nile Virus,Escherichiacoli
ARIVQRIKDFLR,828,2,15032,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli
KAIVQRIKDFLR,828,2,15033,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli
KRAVQRIKDFLR,828,2,15034,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli
KRIAQRIKDFLR,828,2,15035,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli
RLFDKIRQVIRK,829,2,15036,Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability.,Escherichiacoli
AGGKRIVQRIKDFLRGAGGRLFDKIRQVIRKG,829,2,15037,Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability.,Escherichiacoli
AGKRIVQRIKDFLRGAGRLFDKIRQVIRKG,829,2,15038,Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability.,Escherichiacoli
AKRIVQRIKDFLRGARLFDKIRQVIRKG,829,2,15039,Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability.,Escherichiacoli
AGGKRIVQRIKDFLRGAGGKRIVQRIKDFLRG,829,2,15040,Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability.,Escherichiacoli
AGKRIVQRIKDFLRGAGKRIVQRIKDFLRG,829,2,15041,Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability.,Escherichiacoli
AKRIVQRIKDFLRGAKRIVQRIKDFLRG,829,2,15042,Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability.,Escherichiacoli
AGGKRIVKRIKKFLRGAGGKRIVKRIKKFLRG,829,2,15043,Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability.,Escherichiacoli
CGGRLFDKIRQVIRKGAGGRLFDKIRQVIRKG,829,2,15044,Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability.,Escherichiacoli
CGGKRIVQRIKDFLRGAGGRLFDKIRQVIRKG,829,2,15045,Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability.,Escherichiacoli
CGGKRIVQRIKDFLRGAGGKRIVQRIKDFLRG,829,2,15046,Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability.,Escherichiacoli
KRIVARIKDFLR,828,2,15049,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli
KRIVQAIKDFLR,828,2,15050,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli
KRIVQRAKDFLR,828,2,15051,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli
KRIVQRIADFLR,828,2,15052,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli
KRIVQRIKAFLR,828,2,15053,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli
KRIVQRIKDALR,828,2,15054,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli
KRIVQRIKDFAR,828,2,15055,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli
KRIVQRIKDFLA,828,2,15056,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli
KKIVQRIKDFLR,828,2,15057,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli
KRKVQRIKDFLR,828,2,15058,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli
KRIKQRIKDFLR,828,2,15059,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli
KRIVKRIKDFLR,828,2,15060,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli
KRIVQKIKDFLR,828,2,15061,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli
KRIVQRKKDFLR,828,2,15062,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli
KRIVQRIKKFLR,828,2,15063,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli
KRIVQRIKDKLR,828,2,15064,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli
KRIVQRIKDFKR,828,2,15065,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli
KRIVQRIKDFLK,828,2,15066,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli
KRIVARIKAFLR,828,127,15067,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Humanhistiocytic
KRIVKRIKKFLR,828,127,15068,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Humanhistiocytic
KRIVKRIKAFLR,828,2,15069,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli
KRKVKRIKKFLR,828,2,15070,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli
KRIVARIKAALR,828,2,15071,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli
KRIAQRIKAFLR,828,2,15072,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli
KRAAQRIKAFLR,828,2,15073,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli
KRIVQRKKDKKR,828,2,15074,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli
KRIVQRKKDFKR,828,2,15075,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli
LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,830,128,15076,"Synthesis, biological activity and conformational analysis of head-to-tail cyclic analogues of LL37 and histatin 5",Rhodococcusequi
LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTESC,831,1,15077,Native oligomerization determines the mode of action and biological activities of human cathelicidin LL-37.,None_target
CLLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,831,1,15078,Native oligomerization determines the mode of action and biological activities of human cathelicidin LL-37.,None_target
QQCRRPLYCRRR,832,52,15086,Potent Chimeric Antimicrobial Derivatives of the Medicago truncatula NCR247 Symbiotic Peptide.,Enterococcusfaecalis
QQCRRPLYCRRRWSHPQFEK,832,52,15087,Potent Chimeric Antimicrobial Derivatives of the Medicago truncatula NCR247 Symbiotic Peptide.,Enterococcusfaecalis
RPLNFKMLRFWGQQQCRRPLYCRRR,832,52,15088,Potent Chimeric Antimicrobial Derivatives of the Medicago truncatula NCR247 Symbiotic Peptide.,Enterococcusfaecalis
RPLNFKMLRFWGQQQCRRPLYCRRRWSHPQFEK,832,52,15089,Potent Chimeric Antimicrobial Derivatives of the Medicago truncatula NCR247 Symbiotic Peptide.,Enterococcusfaecalis
QQCRRPLYCRRRKALAALAKKIL,832,52,15090,Potent Chimeric Antimicrobial Derivatives of the Medicago truncatula NCR247 Symbiotic Peptide.,Enterococcusfaecalis
QQCRRPLYCRRRKALAALAKKILWSHPQFEK,832,52,15091,Potent Chimeric Antimicrobial Derivatives of the Medicago truncatula NCR247 Symbiotic Peptide.,Enterococcusfaecalis
KALAALAKKILQQCRRPLYCRRR,832,52,15092,Potent Chimeric Antimicrobial Derivatives of the Medicago truncatula NCR247 Symbiotic Peptide.,Enterococcusfaecalis
KALAALAKKIL,832,52,15093,Potent Chimeric Antimicrobial Derivatives of the Medicago truncatula NCR247 Symbiotic Peptide.,Enterococcusfaecalis
GFGCNGPWSEDDIQCHNHCKSIKGYKGGYCARGGFVCKCY,833,41,15094,A novel derivative of the fungal antimicrobial peptide plectasin is active against Mycobacterium tuberculosis.,Mycobacteriumtuberculosis
RKGSRMGKKCECP,834,2,15104,Design of Bioactive Peptides Derived From CART Sequence Isolated From the Toadfish Thalassophryne nattereri.,Escherichiacoli
RKGSQMGKKCECP,834,2,15105,Design of Bioactive Peptides Derived From CART Sequence Isolated From the Toadfish Thalassophryne nattereri.,Escherichiacoli
ILPWKWRWWKWWR,835,129,15107,Antimicrobial peptides against drug resistant Mycobacterium abscessus.,Mycobacteriumabscessus
WWWLRRRW,836,4,15113,Membrane Activity of Two Short Trp-rich Amphipathic Peptides.,Staphylococcusaureus
RRRWWWWL,836,4,15114,Membrane Activity of Two Short Trp-rich Amphipathic Peptides.,Staphylococcusaureus
KYEITTIHNLFRKLTHRLFRRNFGYTLR,837,73,15115,Role of Aromatic Amino Acids in Lipopolysaccharide and Membrane Interactions of Antimicrobial Peptides for Use in Plant Disease Control,Cryptococcusneoformans
KYEITTIHNLARKLTHRLARRNAGATLR,837,73,15116,Role of Aromatic Amino Acids in Lipopolysaccharide and Membrane Interactions of Antimicrobial Peptides for Use in Plant Disease Control,Cryptococcusneoformans
VGGTICGPACAVAGAHYLPI,838,3,15117,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa
GWFKTYKDWPVIISNVPGVI,838,3,15118,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa
IKKIGKKAAKKVIVKAIQAI,838,3,15119,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa
KKIGKKAAKKVIVKAIQAIV,838,3,15120,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa
FLGEWLFVTRKAKRKHKHAA,838,3,15121,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa
VKFAIKKIGKKAAKKVIVKA,838,3,15122,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa
SFLGEWLFVTRKAKRKHKHA,838,3,15123,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa
QAAKKMSNKEKAAKRWIAMR,838,3,15124,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa
AKAIVRTIEQAPKTAKAKKS,838,3,15125,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa
EVVPKVKKHFKDKENKKKLF,838,3,15126,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa
KKIAIITKNLKNFFIMLNII,838,3,15127,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa
KKSINSLHLAMLKKQRLNRD,838,3,15128,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa
LLLGIKYKKIGANNFREVKK,838,3,15129,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa
FMKKIVKIGKIARYSHKAKK,838,3,15130,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa
LFRKKRHHWFVRTKNSLSKN,838,3,15131,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa
VNHGYRKVTLTKTVRIKKFM,838,3,15132,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa
KAAKKWAKAAKKWAKAWKKAA,839,46,15133,Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity.,Murinefibrosarcoma
KAAKKWAKAWKKAAKAWKKAA,839,46,15134,Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity.,Murinefibrosarcoma
KAAKKAWKAWKKAAKAWKKAA,839,46,15135,Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity.,Murinefibrosarcoma
KAAKKAWKAAKKAAKWWKKAA,839,46,15136,Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity.,Murinefibrosarcoma
KAAKKAWKWAKKAAKWAKKAA,839,46,15137,Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity.,Murinefibrosarcoma
KWWKKAAKAAKKAAKAAKKWA,839,46,15138,Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity.,Murinefibrosarcoma
KAAKKAWKAAKKAWKAWKKAA,839,46,15139,Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity.,Murinefibrosarcoma
KWAKKAAKWAKKAAKWAKKAA,839,46,15140,Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity.,Murinefibrosarcoma
KAWKKAWKAAKKAWKAAKKAA,839,46,15141,Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity.,Murinefibrosarcoma
AAKKWAKAKKWAKAKKWAKAA,839,46,15142,Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity.,Murinefibrosarcoma
WKWKWKNGKWKWKW,840,52,15144,Conversion of Broad-Spectrum Antimicrobial Peptides into Species-Specific Antimicrobials Capable of Precisely Targeting Pathogenic Bacteria.,Enterococcusfaecalis
LVTLVFVGGGWKWKWKNGKWKWKW,840,52,15145,Conversion of Broad-Spectrum Antimicrobial Peptides into Species-Specific Antimicrobials Capable of Precisely Targeting Pathogenic Bacteria.,Enterococcusfaecalis
WKWKWKNGKWKWKWGGGLVTLVFV,840,52,15146,Conversion of Broad-Spectrum Antimicrobial Peptides into Species-Specific Antimicrobials Capable of Precisely Targeting Pathogenic Bacteria.,Enterococcusfaecalis
WKWKWENGKWKWKW,840,52,15147,Conversion of Broad-Spectrum Antimicrobial Peptides into Species-Specific Antimicrobials Capable of Precisely Targeting Pathogenic Bacteria.,Enterococcusfaecalis
LVTLVFVGGGWKWKWENGKWKWKW,840,52,15148,Conversion of Broad-Spectrum Antimicrobial Peptides into Species-Specific Antimicrobials Capable of Precisely Targeting Pathogenic Bacteria.,Enterococcusfaecalis
WKWKWENGKWKWQW,840,52,15149,Conversion of Broad-Spectrum Antimicrobial Peptides into Species-Specific Antimicrobials Capable of Precisely Targeting Pathogenic Bacteria.,Enterococcusfaecalis
LVTLVFVGGGWKWKWENGKWKWQW,840,52,15150,Conversion of Broad-Spectrum Antimicrobial Peptides into Species-Specific Antimicrobials Capable of Precisely Targeting Pathogenic Bacteria.,Enterococcusfaecalis
YSTCFIMGGGWKWKWENGKWKWKW,840,52,15151,Conversion of Broad-Spectrum Antimicrobial Peptides into Species-Specific Antimicrobials Capable of Precisely Targeting Pathogenic Bacteria.,Enterococcusfaecalis
SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL,841,130,15152,Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.,SARS-CoV
LKVLLYEEFKLLESLIMEILEYQKDSDIKENAEDTK,841,131,15162,Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.,SARS-CoV-2
ANQFNKAISQIQESLTTTSTALGKLQDVVNQNAQALNTLVKQ,842,130,15163,A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.,SARS-CoV
DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL,842,130,15164,A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.,SARS-CoV
AASFNKAMTNIVDAFTGVNDAITQTSQALQTVATALNKIQDVVNQQGNSLNHLTSQ,842,130,15165,A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.,SARS-CoV
VVEQYNQTILNLTSEISTLENKSAELNYTVQKLQTLIDNINSTLVDLKWL,842,130,15166,A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.,SARS-CoV
ANKFNQALGAMQTGFTTTNEAFRKVQDAVNNNAQALSKLASE,842,130,15167,A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.,SARS-CoV
SLTQINTTLLDLTYEMLSLQQVVKALNESYIDLKEL,842,130,15168,A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.,SARS-CoV
AASFNKAINNIVASFSSVNDAITQTAEAIHTVTIALNKIQDVVNQQGSALNHLTSQ,842,130,15169,A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.,SARS-CoV
DLTPFNLTYLNLSSELKQLEAKTASLFQTTVELQGLIDQINSTYVDLKLL,842,130,15170,A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.,SARS-CoV
ANAFNNALDAIQEGFDATNSALVKIQAVVNADAEALNNLLQQ,842,130,15171,A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.,SARS-CoV
SLDYINVTFLDLQDEMNRLQEAIKVLNQSYINLKDI,842,130,15172,A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.,SARS-CoV
SLDYINVTFLDLQDEMKKLEEAIKKLEQSYINLKDI,842,130,15173,A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.,SARS-CoV
SLDYINVTFLDLEDEMKKLEEAIKKLEESYINLKEI,842,132,15174,A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.,MERS-CoV
SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEI,842,132,15175,A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.,MERS-CoV
RGRKVVRRKKK,843,1,15176,Synthetic multivalent antifungal peptides effective against fungi.,None_target
RGRKVVRRK,843,1,15178,Synthetic multivalent antifungal peptides effective against fungi.,None_target
GPNFAEISKINTTLLDLSDEMAMLQEVVKQLNDSYI,844,132,15181,Potent MERS-CoV Fusion Inhibitory Peptides Identified From HR2 Domain in Spike Protein of Bat Coronavirus HKU4.,MERS-CoV
EISKINTTLLDLSDEMAMLQEVVKQLNDSYIDLKEL,844,132,15182,Potent MERS-CoV Fusion Inhibitory Peptides Identified From HR2 Domain in Spike Protein of Bat Coronavirus HKU4.,MERS-CoV
LDLSDEMAMLQEVVKQLNDSYIDLKELGNYTYYNKW,844,132,15183,Potent MERS-CoV Fusion Inhibitory Peptides Identified From HR2 Domain in Spike Protein of Bat Coronavirus HKU4.,MERS-CoV
SLTQINTTLLDLEYEMKKLEEVVKKLEESYIDLKEL,845,132,15196,De Novo Design of alpha-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery.,MERS-CoV
GINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE,846,132,15198,Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection.,MERS-CoV
MWKTPTLKYFGGFNFSQIL,847,130,15199,Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.,SARS-CoV
ATAGWTFGAGAALQIPFAMQMAY,847,130,15200,Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.,SARS-CoV
GYHLMSFPQAAPHGVVFLHVTW,847,130,15201,Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.,SARS-CoV
GVFVFNGTSWFITQRNFFS,847,130,15202,Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.,SARS-CoV
NEVAKNLNESLIDLQELGKYEQYIKWPWYVW,847,130,15203,Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.,SARS-CoV
AACEVAKNLNESLIDLQELGKYEQYIKW,847,130,15204,Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.,SARS-CoV
GNHILSLVQNAPYGLYFIHFSW,847,133,15205,Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.,MurineHepatitis
GYFVQDDGEWKFTGSSYYY,847,133,15206,Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.,MurineHepatitis
GINASVVNIQKEIDRLNEVAKNLNESLIDL,848,130,15207,Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors.,SARS-CoV
GINASVVNIQKEIDRLNEVAKNL,848,130,15208,Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors.,SARS-CoV
QKQIANQFNKAISQIQESLTTTSTALGKLQDVVNQNAQALNTLVKQ,848,130,15209,Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors.,SARS-CoV
QNQSANQFQKEISQINEVLTTTNTSLGKLQDDVNQNNQSLNTLQKE,848,130,15210,Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors.,SARS-CoV
KKKKYRNIRRPG,849,130,15212,"Design, synthesis and screening of antisense peptide based combinatorial peptide libraries towards an aromatic region of SARS-CoV.",SARS-CoV
LTQINTTLLDLTYEMLSLQQVVKALNESYIDLKEL,850,134,15213,Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus.,MERS-CoVPsV
SLTQINTTLLDLEYEMRSLQQVVKALNESYIDLKEL,851,132,15214,Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor.,MERS-CoV
NGAICWGPCPTAFRQIGNCGHFKVRCCKIR,852,135,15216,A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses.,HumanInfluenza
KGSVVIVGRIILSGRK,853,49,15239,Inhibition of hepatitis C virus NS2/3 processing by NS4A peptides. Implications for control of viral processing.,HepatitisC
AKDLEVVCSTYVLVEA,854,49,15241,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC
ADLEVVAATYVDVA,854,49,15242,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC
ADLEVVAATHVLVA,854,49,15243,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC
AKDLEVVTSTYVLVEA,854,49,15244,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC
KKKKVAAATYVLV,854,49,15245,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC
DDSVVSAAMSYSYA,854,49,15246,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC
KKKKVTAATYVLV,854,49,15247,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC
ADLEVVAATFVLVA,854,49,15248,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC
ADLEVVAATYVLVA,854,49,15249,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC
KKKKVVKATYVLV,854,49,15250,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC
AECVVSCSMSYTKA,854,49,15251,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC
KKKKVVLPFLFFF,854,49,15252,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC
KKKKFVAATYVLV,854,49,15253,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC
ADLEVVAATYVLDD,854,49,15254,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC
KKKKVVLATYVLV,854,49,15255,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC
KKKKLLAAFLFFF,854,49,15256,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC
KKKKLVLPFLFVF,854,49,15257,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC
PLDVFNATYLKLTGEIADLEQRSESLRNTTEELQSLIYNINNTLVDLEWLNRVET,855,136,15258,Identification of a peptide derived from the heptad repeat 2 region of the porcine epidemic diarrhea virus (PEDV) spike glycoprotein that is capable of suppressing PEDV entry and inducing neutralizing antibodies.,Porcineepidemic
FNATYLKLTGEIADLEQRSESLRNTTEELQSLIYNINNTLVDLEWLNRVE,855,136,15259,Identification of a peptide derived from the heptad repeat 2 region of the porcine epidemic diarrhea virus (PEDV) spike glycoprotein that is capable of suppressing PEDV entry and inducing neutralizing antibodies.,Porcineepidemic
FNATYLKLTGEIADLEQRSESLRNTTEELQSLIYNINNTLVDL,855,136,15260,Identification of a peptide derived from the heptad repeat 2 region of the porcine epidemic diarrhea virus (PEDV) spike glycoprotein that is capable of suppressing PEDV entry and inducing neutralizing antibodies.,Porcineepidemic
LKLTGEIADLEQRSESLRNTTEELQSLIYNINNTLVDLEWL,855,136,15261,Identification of a peptide derived from the heptad repeat 2 region of the porcine epidemic diarrhea virus (PEDV) spike glycoprotein that is capable of suppressing PEDV entry and inducing neutralizing antibodies.,Porcineepidemic
ISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL,856,130,15262,Heptad repeat-derived peptides block protease-mediated direct entry from the cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal pathway.,SARS-CoV
ISGINASVVNIQEEIKKLNEEAKKLNESLIDLQEL,856,130,15263,Heptad repeat-derived peptides block protease-mediated direct entry from the cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal pathway.,SARS-CoV
IEEINKKVEEIQKKIEELNKKAEELNKKLEELQKK,856,130,15264,Heptad repeat-derived peptides block protease-mediated direct entry from the cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal pathway.,SARS-CoV
TLKPIFKLPLGINITNFR,857,137,15280,Identification of a New Region of SARS-CoV S Protein Critical for Viral Entry,SARS-CoVPsV
YENQKQIANQFNKAISQIQESLTTTSTA,858,137,15282,Fusion Core Structure of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV): In Search of Potent SARS-CoV Entry Inhibitors.,SARS-CoVPsV
IQESLTTTSTALGKLQDVVNQNAQALNTLVKQLSS,858,137,15283,Fusion Core Structure of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV): In Search of Potent SARS-CoV Entry Inhibitors.,SARS-CoVPsV
DVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYI,858,137,15284,Fusion Core Structure of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV): In Search of Potent SARS-CoV Entry Inhibitors.,SARS-CoVPsV
FKLPLGINITNFRAILTAFS,859,130,15285,Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof,SARS-CoV
PTTFMLKYDENGTITDAVDC,859,130,15286,Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof,SARS-CoV
VLYNSTFFSTFKCYGVSATK,859,130,15287,Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof,SARS-CoV
PALNCYWPLNDYGFYTTTGI,859,130,15288,Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof,SARS-CoV
RDVSDFTDSVRDPKTSEILD,859,130,15289,Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof,SARS-CoV
YQDVNCTDVSTAIHADQLTP,859,130,15290,Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof,SARS-CoV
SNNTIAIPTNFSISITTEVM,859,130,15291,Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof,SARS-CoV
QYGSFCTQLNRALSGIAAEQ,859,130,15292,Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof,SARS-CoV
GIGVTQNVLYENQKQIANQF,859,130,15293,Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof,SARS-CoV
IQKEIDRLNEVAKNLNESLI,859,130,15294,Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof,SARS-CoV
NGIGVTQNVLYENQKQIANQFNKAISQIQESLTTTSTA,860,130,15305,Suppression of SARS-CoV Entry by Peptides Corresponding to Heptad Regions on Spike Glycoprotein,SARS-CoV
IQKEIDRLNEVAKNLNESLIDLQELGK,860,130,15306,Suppression of SARS-CoV Entry by Peptides Corresponding to Heptad Regions on Spike Glycoprotein,SARS-CoV
PKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE,861,130,15308,Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection Inhibition Using Spike Protein Heptad Repeat-Derived Peptides,SARS-CoV
LDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE,861,130,15309,Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection Inhibition Using Spike Protein Heptad Repeat-Derived Peptides,SARS-CoV
DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE,861,130,15310,Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection Inhibition Using Spike Protein Heptad Repeat-Derived Peptides,SARS-CoV
ELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL,861,130,15312,Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection Inhibition Using Spike Protein Heptad Repeat-Derived Peptides,SARS-CoV
DLSLDFEKLNVTLLDLTYEMNRIQDAIKKLNESYINLKE,861,130,15313,Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection Inhibition Using Spike Protein Heptad Repeat-Derived Peptides,SARS-CoV
NQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLIT,861,130,15314,Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection Inhibition Using Spike Protein Heptad Repeat-Derived Peptides,SARS-CoV
EEQAKTFLDK,862,137,15315,Identification of Critical Determinants on ACE2 for SARS-CoV Entry and Development of a Potent Entry Inhibitor.,SARS-CoVPsV
DKFNHEAED,862,137,15316,Identification of Critical Determinants on ACE2 for SARS-CoV Entry and Development of a Potent Entry Inhibitor.,SARS-CoVPsV
NHEAEDLFY,862,137,15317,Identification of Critical Determinants on ACE2 for SARS-CoV Entry and Development of a Potent Entry Inhibitor.,SARS-CoVPsV
EEQAKTFLDKFNHEAEDLFYQSS,862,137,15318,Identification of Critical Determinants on ACE2 for SARS-CoV Entry and Development of a Potent Entry Inhibitor.,SARS-CoVPsV
EEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNITEE,862,137,15319,Identification of Critical Determinants on ACE2 for SARS-CoV Entry and Development of a Potent Entry Inhibitor.,SARS-CoVPsV
EEQAKTFLDKFNHEAEDLFYQSSGLGKGDFR,862,137,15320,Identification of Critical Determinants on ACE2 for SARS-CoV Entry and Development of a Potent Entry Inhibitor.,SARS-CoVPsV
SWLRDIWDWICEVLSD,863,49,15322,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC
SWLRDIWDWICEVL,863,49,15323,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC
SWLRDIWDWICEV,863,49,15324,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC
LRDIWDWICEVLSDFK,863,49,15325,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC
SGSWLRDIWDWICEVLSDFK,863,49,15326,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC
GSWLRDIWDWICEVLSDFK,863,49,15327,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC
SWLRDIWDWICEVLSDFKT,863,49,15328,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC
SWLRDIWDWICEVLSDFKTW,863,49,15329,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC
SWRLIDWDWICEVLSDFK,863,49,15330,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC
SWRLDIWDWICESVLDFK,863,49,15331,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC
VLDLIYSLHKQINRGLKKIVL,863,49,15332,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC
KFDSLVECIWDWIDRLWS,863,49,15333,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC
KWLCRIWSWISDVLDDFE,863,49,15335,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC
SIWRDWVDLICEFLSDWK,863,49,15336,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC
SWLRDVWDWICTVLTDFK,863,49,15337,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC
SWLRDVWDWVCTILTDFK,863,49,15338,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC
DWLRIIWDWVCSVVSDFK,863,49,15339,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC
SWLWEVWDWVLHVLSDFK,863,49,15340,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC
TWLRAIWDWVCTALTDFK,863,49,15341,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC
SWLRDVWDWVCTVLSDFK,863,49,15342,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC
SWLRDIWDWISEVLSDFK,863,49,15343,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC
SWLRDIWDWIREVLSDFK,863,49,15344,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC
SWLRDIWDWIEEVLSDFK,863,49,15345,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC
SWLDDIWDWICEVLSDFE,863,49,15346,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC
SWLRDIWDWICKVLSDFK,863,49,15347,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC
SWLDRIWRWICKVLSRFE,863,49,15348,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC
SWLRDIWRWICKVLSRFK,863,49,15349,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC
SWLRRIWRWICKVLSRFK,863,49,15350,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC
GVTQNVLYENQKQIANQFNKAISQIQESLTTTSTALGKLQ,864,130,15351,Interaction Between Heptad Repeat 1 and 2 Regions in Spike Protein of SARS-associated Coronavirus: Implications for Virus Fusogenic Mechanism and Identification of Fusion Inhibitors.,SARS-CoV
LTTTSTALGKLQDVVNQNAQALNTLVKQLSSNFG,864,130,15352,Interaction Between Heptad Repeat 1 and 2 Regions in Spike Protein of SARS-associated Coronavirus: Implications for Virus Fusogenic Mechanism and Identification of Fusion Inhibitors.,SARS-CoV
KQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITG,864,130,15353,Interaction Between Heptad Repeat 1 and 2 Regions in Spike Protein of SARS-associated Coronavirus: Implications for Virus Fusogenic Mechanism and Identification of Fusion Inhibitors.,SARS-CoV
GRLQSLQTYVTQQLIRAAEIRASANLAATKMSEC,864,130,15354,Interaction Between Heptad Repeat 1 and 2 Regions in Spike Protein of SARS-associated Coronavirus: Implications for Virus Fusogenic Mechanism and Identification of Fusion Inhibitors.,SARS-CoV
KEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPWYVW,864,130,15355,Interaction Between Heptad Repeat 1 and 2 Regions in Spike Protein of SARS-associated Coronavirus: Implications for Virus Fusogenic Mechanism and Identification of Fusion Inhibitors.,SARS-CoV
SFAIKWEYVLLLFLL,865,49,15358,A Peptide Derived From Hepatitis C Virus E2 Envelope Protein Inhibits a Post-Binding Step in HCV Entry,HepatitisC
FAIKWEYVLLLFLL,865,49,15359,A Peptide Derived From Hepatitis C Virus E2 Envelope Protein Inhibits a Post-Binding Step in HCV Entry,HepatitisC
AIKWEYVLLLFLL,865,49,15360,A Peptide Derived From Hepatitis C Virus E2 Envelope Protein Inhibits a Post-Binding Step in HCV Entry,HepatitisC
LLFLLLVYEWKIA,865,49,15362,A Peptide Derived From Hepatitis C Virus E2 Envelope Protein Inhibits a Post-Binding Step in HCV Entry,HepatitisC
IKWEYVLLLFLL,865,49,15364,A Peptide Derived From Hepatitis C Virus E2 Envelope Protein Inhibits a Post-Binding Step in HCV Entry,HepatitisC
KWEYVLLLFLL,865,49,15365,A Peptide Derived From Hepatitis C Virus E2 Envelope Protein Inhibits a Post-Binding Step in HCV Entry,HepatitisC
WEYVLLLFLL,865,49,15366,A Peptide Derived From Hepatitis C Virus E2 Envelope Protein Inhibits a Post-Binding Step in HCV Entry,HepatitisC
VSFAIKWEYVLLLFL,865,49,15367,A Peptide Derived From Hepatitis C Virus E2 Envelope Protein Inhibits a Post-Binding Step in HCV Entry,HepatitisC
VSFAIKWEYVLLLF,865,49,15368,A Peptide Derived From Hepatitis C Virus E2 Envelope Protein Inhibits a Post-Binding Step in HCV Entry,HepatitisC
VSFAIKWEYVLLL,865,49,15369,A Peptide Derived From Hepatitis C Virus E2 Envelope Protein Inhibits a Post-Binding Step in HCV Entry,HepatitisC
VSFAIKWEYVLL,865,49,15370,A Peptide Derived From Hepatitis C Virus E2 Envelope Protein Inhibits a Post-Binding Step in HCV Entry,HepatitisC
VSFAIKWEYVL,865,49,15371,A Peptide Derived From Hepatitis C Virus E2 Envelope Protein Inhibits a Post-Binding Step in HCV Entry,HepatitisC
LKLFEVYLILWLA,865,49,15372,A Peptide Derived From Hepatitis C Virus E2 Envelope Protein Inhibits a Post-Binding Step in HCV Entry,HepatitisC
VSFAIKWEYVLLLFLL,865,49,15373,A Peptide Derived From Hepatitis C Virus E2 Envelope Protein Inhibits a Post-Binding Step in HCV Entry,HepatitisC
WEEWDKKIEEYTKKIEELIKKSQNQQ,866,30,15375,Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.,HIV-1IIIB
MTWEEWDKKIEEYTKKIEELIKKSQNQQ,866,30,15376,Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.,HIV-1IIIB
WEEWDKKIEEYTKKIEELIKKSQNQQSM,866,30,15377,Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.,HIV-1IIIB
WEEWDKKIEEYTKKIEELIKKSQNQQSW,866,30,15378,Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.,HIV-1IIIB
WEEWDKKIEEYTKKIEELIKKSQNQQSY,866,30,15379,Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.,HIV-1IIIB
WEEWDKKIEEYTKKIEELIKKSQNQQSDLD,866,30,15380,Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.,HIV-1IIIB
WEEWDKKIEEYTKKIEELIKKSQNQQLDL,866,30,15381,Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.,HIV-1IIIB
WEEWDKKIEEYTKKIEELIKKSQNQQIDI,866,30,15382,Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.,HIV-1IIIB
WEEWDKKIEEYTKKIEELIKKSQNQQLDI,866,30,15383,Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.,HIV-1IIIB
WEEWDKKIEEYTKKIEELIKKSQNQQIDL,866,30,15384,Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.,HIV-1IIIB
MTWEEWDKKIEEYTKKIEELIKKSQNQQIDL,866,30,15385,Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.,HIV-1IIIB
EEQKTQLKNKIEIDWTKMELEQDWSKIYKEI,866,30,15386,Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.,HIV-1IIIB
TTLLDLTYEMLSLQQVVKALNESYIDLKEL,866,132,15387,Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.,MERS-CoV
EANTTLLDLTYEMLSLQQVVKALNESYIDLKEL,866,132,15388,Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.,MERS-CoV
CEELRVRLASHLRKLRKRLLRDADDLQKRLAVY,867,49,15390,Human Apolipoprotein E Peptides Inhibit Hepatitis C Virus Entry by Blocking Virus Binding,HepatitisC
EELRVRLASHLRKLRKRLLRDADDLQKRLAVY,867,49,15391,Human Apolipoprotein E Peptides Inhibit Hepatitis C Virus Entry by Blocking Virus Binding,HepatitisC
CEEIRARLSTHLRKMRKRLMRDADDLQKRLAVY,867,49,15392,Human Apolipoprotein E Peptides Inhibit Hepatitis C Virus Entry by Blocking Virus Binding,HepatitisC
CEEQAQQIRLQAEAFQARLKSWFEPLVEDM,867,49,15393,Human Apolipoprotein E Peptides Inhibit Hepatitis C Virus Entry by Blocking Virus Binding,HepatitisC
CVRLASHLRKLRKRLLRDADDL,867,49,15394,Human Apolipoprotein E Peptides Inhibit Hepatitis C Virus Entry by Blocking Virus Binding,HepatitisC
CIRLQAEAFQARLKSWFEPLV,867,49,15395,Human Apolipoprotein E Peptides Inhibit Hepatitis C Virus Entry by Blocking Virus Binding,HepatitisC
VRLASHLRKLRKRLLRDADDLIRLQAEAFQARLKSWFEPLV,867,49,15396,Human Apolipoprotein E Peptides Inhibit Hepatitis C Virus Entry by Blocking Virus Binding,HepatitisC
LRVRLASHLRKLRKRLLRDADDLQKRLAVY,867,49,15397,Human Apolipoprotein E Peptides Inhibit Hepatitis C Virus Entry by Blocking Virus Binding,HepatitisC
EELRVRLASHLRKLRKRLLRDADDL,867,49,15398,Human Apolipoprotein E Peptides Inhibit Hepatitis C Virus Entry by Blocking Virus Binding,HepatitisC
VRLASHLRKLRKRLLRDADDLQKRLAVY,867,49,15399,Human Apolipoprotein E Peptides Inhibit Hepatitis C Virus Entry by Blocking Virus Binding,HepatitisC
CVRLASHLRKLRKRLLRDADDLQKRLAVY,867,49,15400,Human Apolipoprotein E Peptides Inhibit Hepatitis C Virus Entry by Blocking Virus Binding,HepatitisC
CLRVRLASHLRKLRKRLLRDADDL,867,49,15401,Human Apolipoprotein E Peptides Inhibit Hepatitis C Virus Entry by Blocking Virus Binding,HepatitisC
CLRKLRKRLLRC,867,49,15402,Human Apolipoprotein E Peptides Inhibit Hepatitis C Virus Entry by Blocking Virus Binding,HepatitisC
GELDELVYLLDGPGYDPIHSRQIKIWFQNRRMKWKK,868,49,15403,High Affinity Peptide Inhibitors of the Hepatitis C Virus NS3-4A Protease Refractory to Common Resistant Mutants,HepatitisC
RQIKIWFQNRRMKWKKGELDELVYLLDGPGYDPIHS,868,49,15404,High Affinity Peptide Inhibitors of the Hepatitis C Virus NS3-4A Protease Refractory to Common Resistant Mutants,HepatitisC
AKGSRAIWFMWLGARFLE,869,49,15405,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
KREKKLGEFGKAKGSRAI,869,49,15406,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
WVLNNPHMKDKTTVKEWR,869,49,15407,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
LLDWCVRLGRYLLRRLKT,869,49,15408,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
IWQYVCNFFVICFNVLKA,869,49,15409,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
LWEWIMRQVRMVMSRLRA,869,49,15410,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
VLDLIYSLHKQINRGLKK,869,49,15411,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
ILELLYKFRDNIKSSVRE,869,49,15412,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
LLDCWVRLGRYLLRRLKT,869,49,15413,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
LLDCWVRLGRYLLRRLKTPFTRL,869,49,15414,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
LLDCWVRLGRYLLRRLKTPFT,869,49,15415,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
LLDCWVRLGRYLLRRLKTP,869,49,15416,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
LLDCWVRLGRYLLRRLK,869,49,15417,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
LDCWVRLGRYLLRRLKTPFTRL,869,49,15418,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
CWVRLGRYLLRRLKTPFTRL,869,49,15419,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
LDCWVRLGRYLLRRLKTP,869,49,15420,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
DCWVRLGRYLLRRLKTPF,869,49,15421,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
CWVRLGRYLLRRLKTPFT,869,49,15422,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
WVRLGRYLLRRLKTPFTR,869,49,15423,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
VRLGRYLLRRLKTPFTRL,869,49,15424,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
CWVRLGRYKLRRLKTPFT,869,49,15434,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
CWVRLGRYSLRRLKTPFT,869,49,15435,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
CWVRLGRYALRRLKTPFT,869,49,15436,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
CWVRLGRYVLRRLKTPFT,869,49,15437,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
CWVRLARYLLRRLKTPFT,869,49,15438,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
CWVRLVRYLLRRLKTPFT,869,49,15439,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
CWVRLLRYLLRRLKTPFT,869,49,15440,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
CWVRLLRYLLRRLKTLFT,869,49,15441,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
CWVRLGRYLLRRLKTLFT,869,49,15442,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
CWVRLGRYILRRLKTPFT,869,49,15443,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
CWVRLGRYILRRIKTPFT,869,49,15444,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
CWVRIGRYILRRIKTPFT,869,49,15445,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
KWVRLGRKLLRRLKKPFK,869,49,15446,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
CWVRLGRKLLRRLKTPFT,869,49,15447,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
EWVRLGRELLRRLKEPFE,869,49,15448,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
CWVRLGRELLRRLKTPFT,869,49,15449,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC
QGSWFGCTWMNSTGF,870,49,15450,A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2.,HepatitisC
FGCTWMNSTGFTKTC,870,49,15451,A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2.,HepatitisC
GLLHLHQNIVDVQYM,870,49,15452,A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2.,HepatitisC
LHQNIVDVQYMYGLS,870,49,15453,A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2.,HepatitisC
MTWEEWDKKIEEYTKKIEELIKKS,871,30,15454,IgG Fc-binding Motif-Conjugated HIV-1 Fusion Inhibitor Exhibits Improved Potency and in Vivo Half-Life: Potential Application in Combination With Broad Neutralizing Antibodies.,HIV-1IIIB
MTWEEWDKKIEEYTKKIEELIKKSDCAWHLGELVWCT,871,30,15455,IgG Fc-binding Motif-Conjugated HIV-1 Fusion Inhibitor Exhibits Improved Potency and in Vivo Half-Life: Potential Application in Combination With Broad Neutralizing Antibodies.,HIV-1IIIB
DCAWHLGELVWCTMTWEEWDKKIEEYTKKIEELIKKS,871,30,15456,IgG Fc-binding Motif-Conjugated HIV-1 Fusion Inhibitor Exhibits Improved Potency and in Vivo Half-Life: Potential Application in Combination With Broad Neutralizing Antibodies.,HIV-1IIIB
DCAWHLGELVWCT,871,30,15457,IgG Fc-binding Motif-Conjugated HIV-1 Fusion Inhibitor Exhibits Improved Potency and in Vivo Half-Life: Potential Application in Combination With Broad Neutralizing Antibodies.,HIV-1IIIB
FNATYLNLTGEIDDLEFRSEKL,872,138,15458,Peptides corresponding to the predicted heptad repeat 2 domain of the feline coronavirus spike protein are potent inhibitors of viral infection.,FCoV
FNATYLNLTGEIDDLEFRSEKLHNTTVEL,872,138,15459,Peptides corresponding to the predicted heptad repeat 2 domain of the feline coronavirus spike protein are potent inhibitors of viral infection.,FCoV
FNATYLNLTGEIDDLEFRSEKLHNTTVELAILIDNI,872,138,15460,Peptides corresponding to the predicted heptad repeat 2 domain of the feline coronavirus spike protein are potent inhibitors of viral infection.,FCoV
FNATYLNLTGEIDDLEFRSEKLHNTTVELAILIDNINNTLVNL,872,138,15461,Peptides corresponding to the predicted heptad repeat 2 domain of the feline coronavirus spike protein are potent inhibitors of viral infection.,FCoV
FNATYLNLTGEIDDLEFRSEKLHNTTVELAILIDNINNTLVNLEWLNRIE,872,138,15462,Peptides corresponding to the predicted heptad repeat 2 domain of the feline coronavirus spike protein are potent inhibitors of viral infection.,FCoV
PWLKPGDLDL,873,139,15503,Inhibition of dengue virus entry into target cells using synthetic antiviral peptides.,DENV-2
AGVKDGKLDF,873,139,15504,Inhibition of dengue virus entry into target cells using synthetic antiviral peptides.,DENV-2
AWLVHTQWFLDLPLPWLPGADTQGSNWI,874,139,15505,Structural optimization and de novo design of dengue virus entry inhibitory peptides.,DENV-2
RWMVWRHWFHRLRLPYNPGKNKQNQQWP,874,139,15506,Structural optimization and de novo design of dengue virus entry inhibitory peptides.,DENV-2
MVDRGWGNHAGLFGKGSIV,874,139,15507,Structural optimization and de novo design of dengue virus entry inhibitory peptides.,DENV-2
AWLVHRQWFLDLPLPWLPG,874,139,15508,Structural optimization and de novo design of dengue virus entry inhibitory peptides.,DENV-2
RQMRAWGQDYQHGGMGYSC,874,139,15509,Structural optimization and de novo design of dengue virus entry inhibitory peptides.,DENV-2
FWFTLIKTQAKQPARYRRFC,874,139,15510,Structural optimization and de novo design of dengue virus entry inhibitory peptides.,DENV-2
MAILGDTAWDFGSLGGVFTSIGKALHQVFGAIY,875,139,15511,Release of dengue virus genome induced by a peptide inhibitor.,DENV-2
MVDRGWGNGCGLF,876,139,15512,Peptides P4 and P7 derived from E protein inhibit entry of dengue virus serotype 2 via interacting with ?3 integrin.,DENV-2
CKIPFEIMDLEKRHV,876,139,15513,Peptides P4 and P7 derived from E protein inhibit entry of dengue virus serotype 2 via interacting with ?3 integrin.,DENV-2
VEPGQLKLNWFKK,876,139,15514,Peptides P4 and P7 derived from E protein inhibit entry of dengue virus serotype 2 via interacting with ?3 integrin.,DENV-2
WDFGSLGGV,876,139,15516,Peptides P4 and P7 derived from E protein inhibit entry of dengue virus serotype 2 via interacting with ?3 integrin.,DENV-2
LCLRNWDQGHRP,877,79,15517,Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins.,HSV-1
KKVTMTCSAS,877,79,15518,Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins.,HSV-1
NQVSATCSVK,877,140,15519,Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins.,VesicularStomatitis
SEETKENEGFTVTAEGK,877,141,15520,Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins.,Adenovirus
KKLVAASQAALGL,877,142,15521,Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins.,Coxsackievirus
DSGEGDFLAEGGGVR,877,142,15522,Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins.,Coxsackievirus
GLEEELQFSLGSKINVK,877,142,15523,Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins.,Coxsackievirus
STLGKAFSTTLKGAQRLAALGDTAWDFG,878,143,15524,Antiviral activity of peptide inhibitors derived from the protein E stem against Japanese encephalitis and Zika viruses.,Japaneseencephalitis
SIGGVFNSIGRAVHQVFGGAFRTL,878,143,15525,Antiviral activity of peptide inhibitors derived from the protein E stem against Japanese encephalitis and Zika viruses.,Japaneseencephalitis
AALGDTAWDFGSIGGVFNSIGRAVHQVFGGAFRTL,878,143,15526,Antiviral activity of peptide inhibitors derived from the protein E stem against Japanese encephalitis and Zika viruses.,Japaneseencephalitis
AWDFGSIGGVFNSIGRAVHQVFGGAFRTL,878,143,15527,Antiviral activity of peptide inhibitors derived from the protein E stem against Japanese encephalitis and Zika viruses.,Japaneseencephalitis
AWDFGSIGGVFNSIGRAVHQVF,878,143,15528,Antiviral activity of peptide inhibitors derived from the protein E stem against Japanese encephalitis and Zika viruses.,Japaneseencephalitis
AWDFGSVGGVFNSLGKGIHQIFGAAFKSL,878,144,15529,Antiviral activity of peptide inhibitors derived from the protein E stem against Japanese encephalitis and Zika viruses.,Zikavirus
VSGHGQHGVHG,879,145,15530,New alloferon analogues: synthesis and antiviral properties.,Humanepidermoid
SGHGQHGVHG,879,145,15531,New alloferon analogues: synthesis and antiviral properties.,Humanepidermoid
GHGQHGVHG,879,79,15532,New alloferon analogues: synthesis and antiviral properties.,HSV-1
HGQHGVHG,879,145,15533,New alloferon analogues: synthesis and antiviral properties.,Humanepidermoid
HGVSGHGQHGV,879,146,15538,New alloferon analogues: synthesis and antiviral properties.,HSV-1McIntyre
HGVSGHGQHG,879,146,15539,New alloferon analogues: synthesis and antiviral properties.,HSV-1McIntyre
HGVSGHGQ,879,146,15540,New alloferon analogues: synthesis and antiviral properties.,HSV-1McIntyre
FGVSGHGQHGVHG,879,79,15542,New alloferon analogues: synthesis and antiviral properties.,HSV-1
YGVSGHGQHGVHG,879,146,15548,New alloferon analogues: synthesis and antiviral properties.,HSV-1McIntyre
WGVSGHGQHGVHG,879,146,15554,New alloferon analogues: synthesis and antiviral properties.,HSV-1McIntyre
DLTTKLWSSWGYYLGKKARWNLKHPYVQF,880,56,15570,Plantaricin NC8 alpha beta Exerts Potent Antimicrobial Activity Against Staphylococcus Spp. And Enhances the Effects of Antibiotics.,Staphylococcusepidermidis
SVPTSVYTLGIKILWSAYKHRKTIEKSFNKGFYH,880,56,15571,Plantaricin NC8 alpha beta Exerts Potent Antimicrobial Activity Against Staphylococcus Spp. And Enhances the Effects of Antibiotics.,Staphylococcusepidermidis
SWGYYLGKKARWNLKHPYVQF,880,56,15572,Plantaricin NC8 alpha beta Exerts Potent Antimicrobial Activity Against Staphylococcus Spp. And Enhances the Effects of Antibiotics.,Staphylococcusepidermidis
SWGYYLGKKARWNL,880,56,15573,Plantaricin NC8 alpha beta Exerts Potent Antimicrobial Activity Against Staphylococcus Spp. And Enhances the Effects of Antibiotics.,Staphylococcusepidermidis
DLTTKLWSSWGYYLGKKARWNL,880,56,15574,Plantaricin NC8 alpha beta Exerts Potent Antimicrobial Activity Against Staphylococcus Spp. And Enhances the Effects of Antibiotics.,Staphylococcusepidermidis
DLTTKLWSSWGYYLG,880,56,15576,Plantaricin NC8 alpha beta Exerts Potent Antimicrobial Activity Against Staphylococcus Spp. And Enhances the Effects of Antibiotics.,Staphylococcusepidermidis
YTLGIKILWSAYKHRKTIEKSFNKGFYH,880,56,15577,Plantaricin NC8 alpha beta Exerts Potent Antimicrobial Activity Against Staphylococcus Spp. And Enhances the Effects of Antibiotics.,Staphylococcusepidermidis
YTLGIKILWSAYKH,880,56,15578,Plantaricin NC8 alpha beta Exerts Potent Antimicrobial Activity Against Staphylococcus Spp. And Enhances the Effects of Antibiotics.,Staphylococcusepidermidis
SVPTSVYTLGIKILWSAYKH,880,56,15579,Plantaricin NC8 alpha beta Exerts Potent Antimicrobial Activity Against Staphylococcus Spp. And Enhances the Effects of Antibiotics.,Staphylococcusepidermidis
LLKKVLKAAAKAALNAVLVGANA,881,147,15594,Dermaseptins as Potential Antirabies Compounds,Rabiesvirus
KTAATLADTLADTAATLAKAAAA,882,79,15595,Linear Antimicrobial Peptides With Activity Against Herpes Simplex Virus 1 and Aichi Virus,HSV-1
LKAALTAAKTALTAALTALKAALTAAKT,882,79,15596,Linear Antimicrobial Peptides With Activity Against Herpes Simplex Virus 1 and Aichi Virus,HSV-1
LAAALTAKATALTAKLTALAAALTAKAT,882,79,15597,Linear Antimicrobial Peptides With Activity Against Herpes Simplex Virus 1 and Aichi Virus,HSV-1
LAAKLTKAAKLTAALTKLAAALTAAAT,882,79,15598,Linear Antimicrobial Peptides With Activity Against Herpes Simplex Virus 1 and Aichi Virus,HSV-1
VCSCRLVFCRR,883,148,15599,The Human ?-Defensin-Derived Peptide HD5(1-9) Inhibits Cellular Attachment and Entry of Human Cytomegalovirus,Humancytomegalovirus
EMTWEEWEKKIEEYTKKIEEILKKSQNQQIDL,884,30,15603,A Peptide-Based HIV-1 Fusion Inhibitor With Two Tail-Anchors and Palmitic Acid Exhibits Substantially Improved In Vitro and Ex Vivo Anti-HIV-1 Activity and Prolonged In Vivo Half-Life.,HIV-1IIIB
EMTWEEWEKKIEEYIKKIEEILKKSQNQQIDL,884,30,15604,A Peptide-Based HIV-1 Fusion Inhibitor With Two Tail-Anchors and Palmitic Acid Exhibits Substantially Improved In Vitro and Ex Vivo Anti-HIV-1 Activity and Prolonged In Vivo Half-Life.,HIV-1IIIB
GFLKKIGKKLEGAVQRTRDATIQTIAVAQAAANVAATAKQG,885,4,15606,Antimicrobial Peptides from Rat-Tailed Maggots of the Drone Fly Eristalis tenax Show Potent Activity against Multidrug-Resistant Gram-Negative Bacteria.,Staphylococcusaureus
GWLRDFGKRIERTGQNIRDATIQTIGIAQEAANVAATLKG,885,4,15608,Antimicrobial Peptides from Rat-Tailed Maggots of the Drone Fly Eristalis tenax Show Potent Activity against Multidrug-Resistant Gram-Negative Bacteria.,Staphylococcusaureus
GFLKKVGKKLEGASDLTRDATIQTIAVAQAAANVAATAKQG,885,4,15621,Antimicrobial Peptides from Rat-Tailed Maggots of the Drone Fly Eristalis tenax Show Potent Activity against Multidrug-Resistant Gram-Negative Bacteria.,Staphylococcusaureus
AACSLGSLLNVGCNSCACAAHCLATRGKNGACNSQRRCVCNK,885,4,15624,Antimicrobial Peptides from Rat-Tailed Maggots of the Drone Fly Eristalis tenax Show Potent Activity against Multidrug-Resistant Gram-Negative Bacteria.,Staphylococcusaureus
ATCDLLSFLNVKDAACAAHCLAKGYRGGYCDGRKVCNCRK,885,4,15625,Antimicrobial Peptides from Rat-Tailed Maggots of the Drone Fly Eristalis tenax Show Potent Activity against Multidrug-Resistant Gram-Negative Bacteria.,Staphylococcusaureus
SSRRKPCKGWLCKLKLRGGYTLIGSATNLNRP,886,4,15627,Cathelicidin-DM is an Antimicrobial Peptide from Duttaphrynus melanostictus and Has Wound-Healing Therapeutic Potential.,Staphylococcusaureus
SSRRKPCKGWLCKLKLRGGYTL,886,149,15628,Cathelicidin-DM is an Antimicrobial Peptide from Duttaphrynus melanostictus and Has Wound-Healing Therapeutic Potential.,Staphylococcushaemolyticus
SSRRKPCKGWLCKLKLR,886,149,15629,Cathelicidin-DM is an Antimicrobial Peptide from Duttaphrynus melanostictus and Has Wound-Healing Therapeutic Potential.,Staphylococcushaemolyticus
KPCKGWLCKLKLRGGYTLIGSATNLNRPTYVRA,886,149,15630,Cathelicidin-DM is an Antimicrobial Peptide from Duttaphrynus melanostictus and Has Wound-Healing Therapeutic Potential.,Staphylococcushaemolyticus
KPCKGWLCKLKLRGGYTLIGSATNLNRP,886,149,15631,Cathelicidin-DM is an Antimicrobial Peptide from Duttaphrynus melanostictus and Has Wound-Healing Therapeutic Potential.,Staphylococcushaemolyticus
KPCKGWLCKLKLR,886,149,15632,Cathelicidin-DM is an Antimicrobial Peptide from Duttaphrynus melanostictus and Has Wound-Healing Therapeutic Potential.,Staphylococcushaemolyticus
HVTTTFAPPPPR,887,150,15636,Phage displayed peptides recognizing porcine aminopeptidase N inhibit transmissible gastroenteritis coronavirus infection in vitro.,Transmissiblegastroenteritis
SVVPSKATWGFA,887,150,15637,Phage displayed peptides recognizing porcine aminopeptidase N inhibit transmissible gastroenteritis coronavirus infection in vitro.,Transmissiblegastroenteritis
FKPSSPPSITLW,887,150,15638,Phage displayed peptides recognizing porcine aminopeptidase N inhibit transmissible gastroenteritis coronavirus infection in vitro.,Transmissiblegastroenteritis
FKLPLGIKITNFRAILTAFL,888,130,15639,Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus.,SARS-CoV
PTKFMLKYDENGTITDAVDC,888,130,15640,Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus.,SARS-CoV
VLYNSTSFSTFKCYGVSATK,888,130,15641,Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus.,SARS-CoV
PALNCYWPLKDYGFYTTSGI,888,130,15642,Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus.,SARS-CoV
RDVSDITDSVRDPKTSEILD,888,130,15643,Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus.,SARS-CoV
YQDVNCTDVPTAIHADQLTP,888,130,15644,Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus.,SARS-CoV
SNNTIAIPTNFLISITTEVM,888,130,15645,Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus.,SARS-CoV
QYGSFCAQLNRALSGIAVEQ,888,130,15646,Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus.,SARS-CoV
GIGVAQNVLYENQKQIANQF,888,130,15647,Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus.,SARS-CoV
IQEEIDRLNEVAKNLNESLI,888,130,15648,Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus.,SARS-CoV
ANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNTLVKQ,889,131,15659,Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein.,SARS-CoV-2
VNKKIEEIDKKIEELNKKLEELEKKLEEVNKK,890,151,15660,Characterisation and evaluation of antiviral recombinant peptides based on the heptad repeat regions of NDV and IBV fusion glycoproteins.,NewcastleDisease
EKINQSLAFIRKSDELLHNV,891,152,15678,A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.,Respiratorysyncytial
FDASISQVNEKINQSLAFIRKSDELLHNVNAGKST,891,152,15702,A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.,Respiratorysyncytial
MANAGLQLLGFILAFLGW,892,49,15777,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC
GLQLLGFILAFLGWIGAI,892,49,15778,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC
LLGFILAFLGWIGAIVST,892,49,15779,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC
FILAFLGWIGAIVSTALP,892,49,15780,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC
AFLGWIGAIVSTALPQWR,892,49,15781,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC
GWIGAIVSTALPQWRIYS,892,49,15782,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC
GAIVSTALPQWRIYSYAG,892,49,15783,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC
VSTALPQWRIYSYAGDNI,892,49,15784,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC
ALPQWRIYSYAGDNIVTA,892,49,15785,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC
MANAGLQLLGFILA,892,49,15786,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC
MANAGLQLLGFILAFL,892,49,15787,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC
MANAGLQLLGFILAFLGWIG,892,49,15788,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC
MANAGLQLLGFILAFLGWIGAI,892,49,15789,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC
MANAGLQLLGFILAFLGWIGAIVS,892,49,15790,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC
AGALMFAWLLLGLQGIFN,892,49,15792,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC
MASAGMQILGVVLTLLGW,892,49,15794,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC
MANSGLQLLGFSMALLGW,892,49,15795,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC
MASTGLELLGMTLAVLGW,892,49,15796,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC
ALNCYWPLNDYGFYTTTGIGYQPYRVVVLSFEL,893,130,15803,Screening and identification of linear B-cell epitopes and entry-blocking peptide of severe acute respiratory syndrome (SARS)-associated coronavirus using synthetic overlapping peptide library.,SARS-CoV
TDVSTAIHADQLTPAWRIYSTG,893,130,15804,Screening and identification of linear B-cell epitopes and entry-blocking peptide of severe acute respiratory syndrome (SARS)-associated coronavirus using synthetic overlapping peptide library.,SARS-CoV
LMGGIGKTMMQSGGTFGTFMAIGMGIRC,894,3,15807,Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent Against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.,Pseudomonasaeruginosa
GGIGKTMMQSGGTFGTFMAIGMGIRC,894,3,15808,Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent Against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.,Pseudomonasaeruginosa
IGKTMMQSGGTFGTFMAIGMGIRC,894,3,15809,Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent Against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.,Pseudomonasaeruginosa
GKTMMQSGGTFGTFMAIGMGIRC,894,3,15810,Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent Against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.,Pseudomonasaeruginosa
KTMMQSGGTFGTFMAIGMGIRC,894,3,15811,Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent Against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.,Pseudomonasaeruginosa
MMQSGGTFGTFMAIGMGIRC,894,3,15812,Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent Against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.,Pseudomonasaeruginosa
LMGGIGKTMMQSGGTFGTFMAIGMGIR,894,3,15813,Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent Against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.,Pseudomonasaeruginosa
GGIGKTMMQSGGTFGTFMAIGMGIR,894,3,15814,Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent Against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.,Pseudomonasaeruginosa
IGKTMMQSGGTFGTFMAIGMGIR,894,3,15815,Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent Against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.,Pseudomonasaeruginosa
GKTMMQSGGTFGTFMAIGMGIR,894,3,15816,Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent Against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.,Pseudomonasaeruginosa
KTMMQSGGTFGTFMAIGMGIR,894,3,15817,Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent Against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.,Pseudomonasaeruginosa
MMQSGGTFGTFMAIGMGIR,894,3,15818,Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent Against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.,Pseudomonasaeruginosa
KTMMQSGGTFGTFMAIGMGI,894,3,15819,Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent Against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.,Pseudomonasaeruginosa
KTMMQSGGTFGTFMAIGMG,894,3,15820,Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent Against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.,Pseudomonasaeruginosa
KTMMQSGGTFGTFMAIGM,894,3,15821,Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent Against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.,Pseudomonasaeruginosa
PRPISYLKGSSGGPL,895,49,15822,Inhibition of the interaction between NS3 protease and HCV IRES with a small peptide: a novel therapeutic strategy.,HepatitisC
CLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP,896,4,15841,Antibacterial Activity of Rationally Designed Antimicrobial Peptides.,Staphylococcusaureus
WNPFKELEKAGQRVRDAIISAKPAVDVVGQATAIIK,896,4,15842,Antibacterial Activity of Rationally Designed Antimicrobial Peptides.,Staphylococcusaureus
AWDFGSLGGVFTSIGKALHQVFGAIYGAA,897,153,15858,Peptide inhibitors of flavivirus entry derived from the E protein stem.,DENV-1
AWDFGSVGGVLNSLGKMVHQIFGSAYTAL,897,153,15859,Peptide inhibitors of flavivirus entry derived from the E protein stem.,DENV-1
AWDFGSVGGLFTSLGKAVHQVFGSVYTTM,897,153,15860,Peptide inhibitors of flavivirus entry derived from the E protein stem.,DENV-1
AWDFGSIGGVFTSVGKLVHQVFGTAYGVL,897,153,15861,Peptide inhibitors of flavivirus entry derived from the E protein stem.,DENV-1
AWDFGSLGGVFTSIGKALHQVFGGAFGAA,897,139,15862,Peptide inhibitors of flavivirus entry derived from the E protein stem.,DENV-2
AWDFGSVGGVFTSVGKAVHQVFGGAFRSL,897,139,15863,Peptide inhibitors of flavivirus entry derived from the E protein stem.,DENV-2
AWDFGSVGGVFTSVGKAVHQVFGWWWRSL,897,139,15864,Peptide inhibitors of flavivirus entry derived from the E protein stem.,DENV-2
NKVKEWIKYLKSLFK,898,87,15867,"Design and Engineering of Antimicrobial Peptides Based on LPcin-YK3, an Antimicrobial Peptide Derivative from Bovine Milk.",Listeriainnocua
NKVKEWIKYLKSKFK,898,87,15868,"Design and Engineering of Antimicrobial Peptides Based on LPcin-YK3, an Antimicrobial Peptide Derivative from Bovine Milk.",Listeriainnocua
NKVKEWWKWLKKL,898,87,15869,"Design and Engineering of Antimicrobial Peptides Based on LPcin-YK3, an Antimicrobial Peptide Derivative from Bovine Milk.",Listeriainnocua
RPQFFEAVGDFVENVGEGVGDFFEGVGDFFSNVFSGSSR,899,4,15907,Maturation of an Antimicrobial Peptide Inhibits Aeromonas hydrophila Infection in Crayfish.,Staphylococcusaureus
WFGHLYRGITSVVKHVHGLLSG,900,77,15908,Design and characterization of chionodracine-derived antimicrobial peptides with enhanced activity against drug-resistant human pathogens,Klebsiellapneumoniae
WFGHLYRGITKVVKHVHGLLKG,900,77,15909,Design and characterization of chionodracine-derived antimicrobial peptides with enhanced activity against drug-resistant human pathogens,Klebsiellapneumoniae
WFGKLYRGITSVVKKVKGLLSG,900,77,15910,Design and characterization of chionodracine-derived antimicrobial peptides with enhanced activity against drug-resistant human pathogens,Klebsiellapneumoniae
WFGKLYRGITKVVKKVKGLLKG,900,77,15911,Design and characterization of chionodracine-derived antimicrobial peptides with enhanced activity against drug-resistant human pathogens,Klebsiellapneumoniae
ATCYCRTGRCATRESRSGVCEISGRLYRLCCR,901,154,15912,Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites.,HSV-2
FALALKALKKALKKLKKALKKAL,902,4,15913,Short bioactive peptides,Staphylococcusaureus
MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG,902,4,15915,Short bioactive peptides,Staphylococcusaureus
FAKKLAKKLKKLAKKLAKLALAL,902,4,15918,Short bioactive peptides,Staphylococcusaureus
FALALKALKKLKKALKKAL,902,2,15919,Short bioactive peptides,Escherichiacoli
FAKKLAKKLKKLAKLALAL,902,2,15920,Short bioactive peptides,Escherichiacoli
GGHKWKLFKKIGAVLKVL,903,2,15932,Antimicrobial and Antibiofilm Activities of Helical Antimicrobial Peptide Sequences Incorporating Metal-Binding Motifs.,Escherichiacoli
VIHKWKLFKKIGAVLKVL,903,2,15933,Antimicrobial and Antibiofilm Activities of Helical Antimicrobial Peptide Sequences Incorporating Metal-Binding Motifs.,Escherichiacoli
KKIRVRLSA,904,1,15934,A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo.,None_target
KKIRVRLSAK,904,1,15935,A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo.,None_target
FAKKLAKLAKKLAKLAL,902,2,15951,Short bioactive peptides,Escherichiacoli
FAKKLAKKLKKLAKKLAKKWKL,902,2,15956,Short bioactive peptides,Escherichiacoli
KTKLFKKFAKKLAKKLKKLAKKL,902,4,15963,Short bioactive peptides,Staphylococcusaureus
KWKLFKKKTKLFKKFAKKLAKKL,902,4,15964,Short bioactive peptides,Staphylococcusaureus
FAKKLAKKLKKLAKKLIGAVLKV,902,4,15979,Short bioactive peptides,Staphylococcusaureus
GAGIGPGHRRTWRRWPRRRWR,905,155,15996,Prediction and Characterization of Cationic Arginine-Rich Plant Antimicrobial Peptide SM-985 From Teosinte ( Zea mays ssp. mexicana),Clavibacterfangii
MSLLERKLLMHFLRV,906,2,15997,Antimicrobial peptide selection from Lippia spp leaf transcriptomes,Escherichiacoli
GLMKLLRELLHMFSRVG,906,2,15998,Antimicrobial peptide selection from Lippia spp leaf transcriptomes,Escherichiacoli
MRIGLRFVLM,906,2,15999,Antimicrobial peptide selection from Lippia spp leaf transcriptomes,Escherichiacoli
SVAGRAMRIGLRFVLM,906,2,16000,Antimicrobial peptide selection from Lippia spp leaf transcriptomes,Escherichiacoli
GIAGLLRSFVRMLAKIMGG,906,2,16001,Antimicrobial peptide selection from Lippia spp leaf transcriptomes,Escherichiacoli
GSVLRAIMRMFAKLMG,906,2,16002,Antimicrobial peptide selection from Lippia spp leaf transcriptomes,Escherichiacoli
GIHGVVRSFMRMLGHLG,906,2,16003,Antimicrobial peptide selection from Lippia spp leaf transcriptomes,Escherichiacoli
GSVIRALMRMFARLVG,906,2,16004,Antimicrobial peptide selection from Lippia spp leaf transcriptomes,Escherichiacoli
FFRKVLKLIRKIWR,908,59,16006,Studies on the Antibacterial Activity and Mechanism of Antimicrobial Peptides Against Drug-Resistant Bacteria.,Acinetobacterbaumannii
EPRWKVFKKIEKMGRNIRDGIIKAGPAVAVLGDAKALGK,909,2,16020,"Identification and characteristics of a novel cecropin from the armyworm, Mythimna separata.",Escherichiacoli
AIPAVDPFGRVKRSPWHGGTWGCKPIWACQNSPPYLG,910,4,16051,"Characterization and antimicrobial evaluation of a new Spgly-AMP, glycine-rich antimicrobial peptide from the mud crab Scylla paramamosain.",Staphylococcusaureus
GRVKRSPWHGGTWGCKPIWACQNSPPYLG,910,4,16052,"Characterization and antimicrobial evaluation of a new Spgly-AMP, glycine-rich antimicrobial peptide from the mud crab Scylla paramamosain.",Staphylococcusaureus
RYIYLSGTDRIIRAKLGK,911,156,16053,Development of a novel anti-biofilm peptide derived from profilin of Spodoptera frugiperda,Candidatropicalis
ITRYLDKILRILRKYLKA,911,156,16054,Development of a novel anti-biofilm peptide derived from profilin of Spodoptera frugiperda,Candidatropicalis
KCWDTWSRCTRFTSVFTGSVWNTCQKRCQCLGHATGSCVLRRSECPLTSQAYRCECS,912,2,16055,"The molecular characterization, expression analysis and antimicrobial activity of theromacin from Asian polychaeta (Perinereis linea)",Escherichiacoli
GLRRLLRKIRGRWKGGGRGGRLCYCRRRFCVCVGR,913,2,16098,"The Addition of a Synthetic LPS-Targeting Domain Improves Serum Stability While Maintaining Antimicrobial, Antibiofilm, and Cell Stimulating Properties of an Antimicrobial Peptide.",Escherichiacoli
FALGAVTCLIRTKCKVLPKLF,914,4,16102,"Characterisation of a novel peptide, Brevinin-1H, from the skin secretion of Amolops hainanensis and rational design of several analogues.",Staphylococcusaureus
FALGAVTKVLYKLFCLITRKC,914,4,16103,"Characterisation of a novel peptide, Brevinin-1H, from the skin secretion of Amolops hainanensis and rational design of several analogues.",Staphylococcusaureus
FLRNGGSYYIVPAFRGKG,915,2,16117,"Adepamycin: design, synthesis and biological properties of a new peptide with antimicrobial properties",Escherichiacoli
FQRYFHRYARFLAKIWKG,915,2,16118,"Adepamycin: design, synthesis and biological properties of a new peptide with antimicrobial properties",Escherichiacoli
SNVMEERKIKVYLPRMKMEE,916,157,16119,Antimicrobial activity and secondary structure of a novel peptide derived from ovalbumin,Streptococcusepidermidis
RKIKVYLPRMK,916,157,16120,Antimicrobial activity and secondary structure of a novel peptide derived from ovalbumin,Streptococcusepidermidis
RKIKVYLRRMK,916,157,16121,Antimicrobial activity and secondary structure of a novel peptide derived from ovalbumin,Streptococcusepidermidis
RKIKRYLRRMK,916,157,16122,Antimicrobial activity and secondary structure of a novel peptide derived from ovalbumin,Streptococcusepidermidis
RKIKRYLRRMI,916,157,16123,Antimicrobial activity and secondary structure of a novel peptide derived from ovalbumin,Streptococcusepidermidis
RKIKRYLRRMW,916,157,16124,Antimicrobial activity and secondary structure of a novel peptide derived from ovalbumin,Streptococcusepidermidis
RLIKRYLRRMW,916,157,16125,Antimicrobial activity and secondary structure of a novel peptide derived from ovalbumin,Streptococcusepidermidis
RKIKRYLRRMIW,916,157,16126,Antimicrobial activity and secondary structure of a novel peptide derived from ovalbumin,Streptococcusepidermidis
RKIKRYLRRMIIW,916,157,16127,Antimicrobial activity and secondary structure of a novel peptide derived from ovalbumin,Streptococcusepidermidis
RKIKRYLRRMIIIW,916,157,16128,Antimicrobial activity and secondary structure of a novel peptide derived from ovalbumin,Streptococcusepidermidis
RKMKRVWKRFKL,916,157,16129,Antimicrobial activity and secondary structure of a novel peptide derived from ovalbumin,Streptococcusepidermidis
RKLKRFWKRVKM,916,157,16130,Antimicrobial activity and secondary structure of a novel peptide derived from ovalbumin,Streptococcusepidermidis
RKVKRLFKRWKM,916,157,16131,Antimicrobial activity and secondary structure of a novel peptide derived from ovalbumin,Streptococcusepidermidis
WWLSRRRSSLFYWR,917,2,16138,In silico identification and functional validation of linear cationic ?-helical antimicrobial peptides in the ascidian Ciona intestinalis,Escherichiacoli
SRRRFDFSRRRIYVARRRSLAFAHRRR,917,2,16139,In silico identification and functional validation of linear cationic ?-helical antimicrobial peptides in the ascidian Ciona intestinalis,Escherichiacoli
TINKKFRWHGKRKWWLRFVKQ,917,2,16140,In silico identification and functional validation of linear cationic ?-helical antimicrobial peptides in the ascidian Ciona intestinalis,Escherichiacoli
KGGKFLNFLKKAAKVGAKVGMAALG,917,2,16141,In silico identification and functional validation of linear cationic ?-helical antimicrobial peptides in the ascidian Ciona intestinalis,Escherichiacoli
KLKTWPKNYWRKVWSKKNWRKFVKKFKHW,917,2,16142,In silico identification and functional validation of linear cationic ?-helical antimicrobial peptides in the ascidian Ciona intestinalis,Escherichiacoli
KLDLKLDLKLDL,918,2,16144,"Variants of self-assembling peptide, KLD-12 that show both rapid fracture healing and antimicrobial properties.",Escherichiacoli
RKLDLKLDLKLDL,918,2,16145,"Variants of self-assembling peptide, KLD-12 that show both rapid fracture healing and antimicrobial properties.",Escherichiacoli
RRKLDLKLDLKLDL,918,2,16146,"Variants of self-assembling peptide, KLD-12 that show both rapid fracture healing and antimicrobial properties.",Escherichiacoli
RRRKLDLKLDLKLDL,918,2,16147,"Variants of self-assembling peptide, KLD-12 that show both rapid fracture healing and antimicrobial properties.",Escherichiacoli
RRRRKLDLKLDLKLDL,918,2,16148,"Variants of self-assembling peptide, KLD-12 that show both rapid fracture healing and antimicrobial properties.",Escherichiacoli
FLPLIAGLAAKFLPKIFCAITKKC,919,4,16153,Modification and Targeted Design of N-Terminal Truncates Derived from Brevinin with Improved Therapeutic Efficacy,Staphylococcusaureus
FLPLIAGLAAKCAITKKC,919,4,16154,Modification and Targeted Design of N-Terminal Truncates Derived from Brevinin with Improved Therapeutic Efficacy,Staphylococcusaureus
FLPKIFCAITKKC,919,4,16155,Modification and Targeted Design of N-Terminal Truncates Derived from Brevinin with Improved Therapeutic Efficacy,Staphylococcusaureus
KFLPKIFCAITKKC,919,4,16156,Modification and Targeted Design of N-Terminal Truncates Derived from Brevinin with Improved Therapeutic Efficacy,Staphylococcusaureus
KKFLPKIFCAITKKC,919,4,16157,Modification and Targeted Design of N-Terminal Truncates Derived from Brevinin with Improved Therapeutic Efficacy,Staphylococcusaureus
KFLPWKIFCAITKKC,919,4,16158,Modification and Targeted Design of N-Terminal Truncates Derived from Brevinin with Improved Therapeutic Efficacy,Staphylococcusaureus
KKFLPWKIFCAITKKC,919,4,16159,Modification and Targeted Design of N-Terminal Truncates Derived from Brevinin with Improved Therapeutic Efficacy,Staphylococcusaureus
KFWPWKIFCAITKKC,919,4,16160,Modification and Targeted Design of N-Terminal Truncates Derived from Brevinin with Improved Therapeutic Efficacy,Staphylococcusaureus
KFLPWKWFCAITKKC,919,4,16161,Modification and Targeted Design of N-Terminal Truncates Derived from Brevinin with Improved Therapeutic Efficacy,Staphylococcusaureus
GFGCNIFGGNDYRCHRHCKSIRGYKGGYCKLGGICKCY,920,4,16164,"The second N-terminal aromatic residue of the fungal defensin, blapersin, of Blastomyces percursus is essential for its antibacterial activity.",Staphylococcusaureus
GYGCNIFGGNDYRCHRHCKSIRGYKGGYCKLGGICKCY,920,4,16165,"The second N-terminal aromatic residue of the fungal defensin, blapersin, of Blastomyces percursus is essential for its antibacterial activity.",Staphylococcusaureus
GAGCNIFGGNDYRCHRHCKSIRGYKGGYCKLGGICKCY,920,4,16166,"The second N-terminal aromatic residue of the fungal defensin, blapersin, of Blastomyces percursus is essential for its antibacterial activity.",Staphylococcusaureus
GLFNIIKKTIGKLR,921,8,16196,Alignment-based design and synthesis of new antimicrobial Aurein-derived peptides with improved activity against Gram-negative bacteria and evaluation of their toxicity on human cells.,Bacillussubtilis
GLFWIIKKTIGKLR,921,8,16197,Alignment-based design and synthesis of new antimicrobial Aurein-derived peptides with improved activity against Gram-negative bacteria and evaluation of their toxicity on human cells.,Bacillussubtilis
IGRHFKRRNSIWGICWF,922,2,16198,The Hirudo Medicinalis Microbiome Is a Source of New Antimicrobial Peptides.,Escherichiacoli
VLIRGLIHMLRGG,922,2,16199,The Hirudo Medicinalis Microbiome Is a Source of New Antimicrobial Peptides.,Escherichiacoli
FVKILAKLVNYAKN,922,2,16200,The Hirudo Medicinalis Microbiome Is a Source of New Antimicrobial Peptides.,Escherichiacoli
FLIGKAIKRKFCLRSVWNA,922,2,16201,The Hirudo Medicinalis Microbiome Is a Source of New Antimicrobial Peptides.,Escherichiacoli
KKGKSFKQLHIIVHLVKSWLRTILTHI,922,2,16202,The Hirudo Medicinalis Microbiome Is a Source of New Antimicrobial Peptides.,Escherichiacoli
IVKRFFRISYKLQSLKIIKGKRTFT,922,2,16203,The Hirudo Medicinalis Microbiome Is a Source of New Antimicrobial Peptides.,Escherichiacoli
LRCDYGRFFASKSLYDPLKKRR,923,4,16204,Anti-Acne Action of Peptides Isolated from Burdock Root-Preliminary Studies and Pilot Testing.,Staphylococcusaureus
ILPWKWPWWPWRR,924,2,16253,Indolicidin analogs with broad-spectrum antimicrobial activity and low hemolytic activity,Escherichiacoli
RRIPFWPPNLPGPRRPPWFLPDFRIPRIPRKR,926,2,16331,Characterization of Cetacean Proline-Rich Antimicrobial Peptides Displaying Activity against ESKAPE Pathogens.,Escherichiacoli
RRIPFWPIPLRWQWPPPWFPPSFPIPRISRKR,926,2,16332,Characterization of Cetacean Proline-Rich Antimicrobial Peptides Displaying Activity against ESKAPE Pathogens.,Escherichiacoli
RRIRFPFPPFPWQWPPAGFPTFHIPRIPRKQ,926,2,16333,Characterization of Cetacean Proline-Rich Antimicrobial Peptides Displaying Activity against ESKAPE Pathogens.,Escherichiacoli
RRIRFRPPRLPRPRPRPWIPPRFPFPRIPGKR,926,2,16354,Characterization of Cetacean Proline-Rich Antimicrobial Peptides Displaying Activity against ESKAPE Pathogens.,Escherichiacoli
RRIRIRPPRLPRPRPRPWFPPRFPIPRIPGKR,926,2,16355,Characterization of Cetacean Proline-Rich Antimicrobial Peptides Displaying Activity against ESKAPE Pathogens.,Escherichiacoli
WIKIWKKIIKKWKK,928,2,16406,Multiple Strategy Optimization of Specifically Targeted Antimicrobial Peptide Based on Structure - Activity Relationships to Enhance Bactericidal Efficiency.,Escherichiacoli
QKRPRVRLSA,928,2,16411,Multiple Strategy Optimization of Specifically Targeted Antimicrobial Peptide Based on Structure - Activity Relationships to Enhance Bactericidal Efficiency.,Escherichiacoli
AQRCGDQARGAKCPNCLCCGKYGFCGSGDAYCGVGSCQSQCRGCR,929,158,16439,Genes Encoding Hevein-Like Antimicrobial Peptides from Elytrigia repens (L.) Desv. ex Nevski.,Bipolarissorokiniana
AQRCGDQARGAKC,930,158,16440,Hevein-Like Antimicrobial Peptides Wamps: Structure-Function Relationship in Antifungal Activity and Sensitization of Plant Pathogenic Fungi to Tebuconazole by WAMP-2-Derived Peptides.,Bipolarissorokiniana
IAAERRYATIYQARLWAF,931,2,16441,Inhibition and eradication activity of truncated alpha-defensin analogs against multidrug resistant uropathogenic Escherichia coli biofilm,Escherichiacoli
GVVDILKGAAKDLAGH,932,2,16442,Novel Ocellatin Peptides Mitigate LPS-induced ROS Formation and NF-kB Activation in Microglia and Hippocampal Neurons.,Escherichiacoli
GVVDILKGAAKDLAGHLASKV,932,2,16443,Novel Ocellatin Peptides Mitigate LPS-induced ROS Formation and NF-kB Activation in Microglia and Hippocampal Neurons.,Escherichiacoli
KCAGSIAWAIGSGLFGGAKLIKIKKYIAELGGLQ,933,3,16444,"New Antibacterial Peptides from the Freshwater Mollusk Pomacea poeyana (Pilsbry, 1927).",Pseudomonasaeruginosa
KEIERAGQRIRDAIISAAPAVETLAQAQKIIKGG,933,3,16445,"New Antibacterial Peptides from the Freshwater Mollusk Pomacea poeyana (Pilsbry, 1927).",Pseudomonasaeruginosa
LCCGKYGFCGSG,930,158,16450,Hevein-Like Antimicrobial Peptides Wamps: Structure-Function Relationship in Antifungal Activity and Sensitization of Plant Pathogenic Fungi to Tebuconazole by WAMP-2-Derived Peptides.,Bipolarissorokiniana
CCGKYGFCGSGDAYC,930,158,16451,Hevein-Like Antimicrobial Peptides Wamps: Structure-Function Relationship in Antifungal Activity and Sensitization of Plant Pathogenic Fungi to Tebuconazole by WAMP-2-Derived Peptides.,Bipolarissorokiniana
GKGSCQSQCRGCR,930,158,16452,Hevein-Like Antimicrobial Peptides Wamps: Structure-Function Relationship in Antifungal Activity and Sensitization of Plant Pathogenic Fungi to Tebuconazole by WAMP-2-Derived Peptides.,Bipolarissorokiniana
RIIDRLWRVRRPQKPKFVTVWVR,934,4,16453,Analogs of the Cathelicidin-Derived Antimicrobial Peptide PMAP-23 Exhibit Improved Stability and Antibacterial Activity.,Staphylococcusaureus
RIIDLLWRVRRPQKPKFVIVWVR,934,4,16454,Analogs of the Cathelicidin-Derived Antimicrobial Peptide PMAP-23 Exhibit Improved Stability and Antibacterial Activity.,Staphylococcusaureus
RIIDRLWRVRRPQKPKFVIVWVR,934,4,16455,Analogs of the Cathelicidin-Derived Antimicrobial Peptide PMAP-23 Exhibit Improved Stability and Antibacterial Activity.,Staphylococcusaureus
GILDTLKQFAKGVGKWLVKGAAQGVLSTVSCKLAKTC,935,18,16456,Effects of a tryptophanyl substitution on the structure and antimicrobial activity of C-terminally truncated gaegurin 4.,Micrococcusluteus
GILDTLKQFAKGVGKDLVKGAAQ,935,18,16457,Effects of a tryptophanyl substitution on the structure and antimicrobial activity of C-terminally truncated gaegurin 4.,Micrococcusluteus
GILDTLKQFAKGVGKWLVKGAAQ,935,18,16458,Effects of a tryptophanyl substitution on the structure and antimicrobial activity of C-terminally truncated gaegurin 4.,Micrococcusluteus
GILDTLKQFAKGVGKFLVKGAAQ,935,18,16459,Effects of a tryptophanyl substitution on the structure and antimicrobial activity of C-terminally truncated gaegurin 4.,Micrococcusluteus
GILDTLKQFAKGVGWDLVKGAAQ,935,18,16460,Effects of a tryptophanyl substitution on the structure and antimicrobial activity of C-terminally truncated gaegurin 4.,Micrococcusluteus
FLPGILKVAANVVPGVI,936,4,16463,Enhanced Antimicrobial Activity of N-Terminal Derivatives of a Novel Brevinin-1 Peptide from The Skin Secretion of Odorrana schmackeri.,Staphylococcusaureus
GIKKFLHIIWKFIKAFVGEIMNS,937,2,16469,Position-dependent hydrophobicity of the antimicrobial magainin peptide affects the mode of peptide-lipid interactions and selective toxicity.,Escherichiacoli
IIKKFLHSIWKFGKAFVGEIMNI,937,2,16470,Position-dependent hydrophobicity of the antimicrobial magainin peptide affects the mode of peptide-lipid interactions and selective toxicity.,Escherichiacoli
GLARCLAGTL,938,2,16489,New cationic antimicrobial peptide screened from boiled-dried anchovies by immobilized bacterial membrane liposome chromatography.,Escherichiacoli
GLFDVIKKVASVIGPLG,939,159,16496,The design and anticancer activity of a citropin1.1 hybrid peptide with selective activity against highly invasive metastatic cell lines.,Humanprostate
GLFDVIKKVASVIGPLGIAGQGGD,939,159,16497,The design and anticancer activity of a citropin1.1 hybrid peptide with selective activity against highly invasive metastatic cell lines.,Humanprostate
PFWRIRIRRPFWRIRIRR,940,160,16503,Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies.,Humanmelanoma
FLFKLIKHAIKGLIKAFK,941,118,16518,In Vitro and MD Simulation Study to Explore Physicochemical Parameters for Antibacterial Peptide to Become Potent Anticancer Peptide.,Humanbreast
GITDLRGMLKRLKKMK,942,2,16520,Antibacterial Activity and Potential Application in Food Packaging of Peptides Derived from Turbot Viscera Hydrolysate.,Escherichiacoli
ATLTAKDLTFLQDYKKTKKRVK,942,2,16521,Antibacterial Activity and Potential Application in Food Packaging of Peptides Derived from Turbot Viscera Hydrolysate.,Escherichiacoli
HTMWRCVRLSACLFSVRRR,942,2,16522,Antibacterial Activity and Potential Application in Food Packaging of Peptides Derived from Turbot Viscera Hydrolysate.,Escherichiacoli
PAWFKARRWAWRMLKKAA,943,2,16526,Short antibacterial peptides and erythromycin act synergically against Escherichia coli,Escherichiacoli
RRWQWRMKKLGA,943,2,16528,Short antibacterial peptides and erythromycin act synergically against Escherichia coli,Escherichiacoli
LLKQLWTKMKGAGKAVLGKIKGLL,944,2,16531,Investigation of the structure-activity relationship in ponericin L1 from Neoponera goeldii.,Escherichiacoli
LLKKLWTKMKGAGKAVLGKIKGLL,944,2,16532,Investigation of the structure-activity relationship in ponericin L1 from Neoponera goeldii.,Escherichiacoli
LLRELWTRMRGAGRAVLGRIRGLL,944,2,16533,Investigation of the structure-activity relationship in ponericin L1 from Neoponera goeldii.,Escherichiacoli
AFRPIPTHSC,946,2,16557,Discovery and characterization of New Delhi metallo-beta-lactamase-1 inhibitor peptides that potentiate meropenem-dependent killing of carbapenemase-producing Enterobacteriaceae.,Escherichiacoli
YNYSYIITRS,946,2,16558,Discovery and characterization of New Delhi metallo-beta-lactamase-1 inhibitor peptides that potentiate meropenem-dependent killing of carbapenemase-producing Enterobacteriaceae.,Escherichiacoli
PTTVHIIYRI,946,2,16559,Discovery and characterization of New Delhi metallo-beta-lactamase-1 inhibitor peptides that potentiate meropenem-dependent killing of carbapenemase-producing Enterobacteriaceae.,Escherichiacoli
ASVTWLLYAM,946,2,16560,Discovery and characterization of New Delhi metallo-beta-lactamase-1 inhibitor peptides that potentiate meropenem-dependent killing of carbapenemase-producing Enterobacteriaceae.,Escherichiacoli
LRCLMLKFPI,946,2,16561,Discovery and characterization of New Delhi metallo-beta-lactamase-1 inhibitor peptides that potentiate meropenem-dependent killing of carbapenemase-producing Enterobacteriaceae.,Escherichiacoli
CLRPSIISRA,946,2,16562,Discovery and characterization of New Delhi metallo-beta-lactamase-1 inhibitor peptides that potentiate meropenem-dependent killing of carbapenemase-producing Enterobacteriaceae.,Escherichiacoli
WRYQWTILFI,946,2,16563,Discovery and characterization of New Delhi metallo-beta-lactamase-1 inhibitor peptides that potentiate meropenem-dependent killing of carbapenemase-producing Enterobacteriaceae.,Escherichiacoli
FCIRLATYVI,946,2,16564,Discovery and characterization of New Delhi metallo-beta-lactamase-1 inhibitor peptides that potentiate meropenem-dependent killing of carbapenemase-producing Enterobacteriaceae.,Escherichiacoli
PGHRVSCWLS,946,2,16565,Discovery and characterization of New Delhi metallo-beta-lactamase-1 inhibitor peptides that potentiate meropenem-dependent killing of carbapenemase-producing Enterobacteriaceae.,Escherichiacoli
RRWQWRAFCWNVCVYRNAVRVCHRRCN,947,42,16573,Improved antibacterial activity of a marine peptide-N2 against intracellular Salmonella typhimurium by conjugating with cell-penetrating peptides-bLFcin6/Tat11.,Salmonellatyphimurium
YGRKKRRQRRRAFCWNVCVYRNAVRVCHRRCN,947,42,16574,Improved antibacterial activity of a marine peptide-N2 against intracellular Salmonella typhimurium by conjugating with cell-penetrating peptides-bLFcin6/Tat11.,Salmonellatyphimurium
GKHKNKGKKNGKHNGWKWWW,948,4,16593,"Cubosomes post-loaded with antimicrobial peptides: characterization, bactericidal effect and proteolytic stability.",Staphylococcusaureus
DGRCLLIIKLAKLAKKLAKLAK,949,118,16628,Antitumor activity of antimicrobial peptides containing CisoDGRC in CD13 negative breast cancer cells.,Humanbreast
GLLDIIKTTGKDFAVKILDNLKCKLAGGCPP,950,4,16630,AMPlify: attentive deep learning model for discovery of novel antimicrobial peptides effective against WHO priority pathogens,Staphylococcusaureus
FFPIIARLAAKVIPSLVCAVTKKC,950,4,16631,AMPlify: attentive deep learning model for discovery of novel antimicrobial peptides effective against WHO priority pathogens,Staphylococcusaureus
GLWETIKTTGKSIALNLLDKIKCKIAGGCPP,950,4,16632,AMPlify: attentive deep learning model for discovery of novel antimicrobial peptides effective against WHO priority pathogens,Staphylococcusaureus
FLTFPGMTFGKLLGK,950,4,16633,AMPlify: attentive deep learning model for discovery of novel antimicrobial peptides effective against WHO priority pathogens,Staphylococcusaureus
GLLDIIKDTGKTTGILMDTLKCQMTGRCPPSS,950,4,16634,AMPlify: attentive deep learning model for discovery of novel antimicrobial peptides effective against WHO priority pathogens,Staphylococcusaureus
ATAWRIPPPGMQPIIPIRIRPLCGKQ,950,4,16635,AMPlify: attentive deep learning model for discovery of novel antimicrobial peptides effective against WHO priority pathogens,Staphylococcusaureus
FFPRVLPLANKFLPTIYCALPKSVGN,950,4,16636,AMPlify: attentive deep learning model for discovery of novel antimicrobial peptides effective against WHO priority pathogens,Staphylococcusaureus
FPAIICKVSKNC,950,4,16637,AMPlify: attentive deep learning model for discovery of novel antimicrobial peptides effective against WHO priority pathogens,Staphylococcusaureus
FYFPVSRKFGGK,950,4,16638,AMPlify: attentive deep learning model for discovery of novel antimicrobial peptides effective against WHO priority pathogens,Staphylococcusaureus
ALVAKIQKFPVFNTLKLCKLELEII,950,4,16639,AMPlify: attentive deep learning model for discovery of novel antimicrobial peptides effective against WHO priority pathogens,Staphylococcusaureus
SNRDFFKVNIFRLCG,950,4,16640,AMPlify: attentive deep learning model for discovery of novel antimicrobial peptides effective against WHO priority pathogens,Staphylococcusaureus
RFRLPFRRIHPPPFVRIHPPPFYRRFL,951,2,16646,Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor Drugs.,Escherichiacoli
RFRLPFRRPWPIRIHPPPFYPWPFRRFL,951,2,16648,Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor Drugs.,Escherichiacoli
VHISHREARGPSFRICVGFLGPRWARGCSTGN,952,2,16654,The human male reproductive tract antimicrobial peptides of the HE2 family exhibit potent synergy with standard antibiotics.,Escherichiacoli
GDVPPGIRNTICRMQQGICRLFFCHSGTGQQHRQRCG,952,2,16655,The human male reproductive tract antimicrobial peptides of the HE2 family exhibit potent synergy with standard antibiotics.,Escherichiacoli
PIMYKVPLIRKKSLRRTLSERGLLKD,953,2,16845,Identification of Novel Cryptic Multifunctional Antimicrobial Peptides from the Human Stomach Enabled by a Computational-Experimental Platform.,Escherichiacoli
PFLKKHNLNPARKYFPQWKAPTL,953,2,16846,Identification of Novel Cryptic Multifunctional Antimicrobial Peptides from the Human Stomach Enabled by a Computational-Experimental Platform.,Escherichiacoli
PIMYKVPLIRKKSLRRTLSERGLLKDPFLKKHNLNPARKYFPQWKAPTL,953,2,16847,Identification of Novel Cryptic Multifunctional Antimicrobial Peptides from the Human Stomach Enabled by a Computational-Experimental Platform.,Escherichiacoli
RLKWVRIWRR,954,2,16849,A Safe and Multitasking Antimicrobial Decapeptide: The Road from De Novo Design to Structural and Functional Characterization.,Escherichiacoli
RLIVKVRIWRR,954,2,16850,A Safe and Multitasking Antimicrobial Decapeptide: The Road from De Novo Design to Structural and Functional Characterization.,Escherichiacoli
FKCRRWQWRMKKLGAPSITGVRRAF,955,161,16854,Effect of intramolecular disulfide bond of bovine lactoferricin on its molecular structure and antibacterial activity against Trueperella pyogenes separated from cow milk with mastitis.,Trueperellapyogenes
ILIACLGLKLLRYRRIY,956,77,16863,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Klebsiellapneumoniae
ILIACWGLKLLRYRRIY,956,2,16865,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli
WRWACWGLKLLRYRRIY,956,2,16866,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli
ILWACWGLKLLRYRRIY,956,2,16867,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli
ILWACWGLKLLKYKKIY,956,2,16868,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli
WRWACWGLKLLKYKKIY,956,2,16869,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli
WRWAKWGLKLLKYKKIY,956,2,16870,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli
ILWAKWGLKLLRYRRIY,956,2,16872,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli
IWWAKWGLKLLRYRRIY,956,2,16873,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli
IWWAKWGLKWLRYRRIY,956,2,16874,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli
IWWAKWGLKLLRYRRIW,956,2,16875,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli
IWWAKWGLKLLDYRRIW,956,2,16877,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli
IWWAKWGLDLLRYRRIW,956,2,16878,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli
WRWAKWGLKLWKWKKIY,956,2,16879,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli
IWWAKWGLKLLRYRRWY,956,2,16880,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli
IWWAKLGLKLLRYRRWY,956,2,16881,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli
WWWAKLGLKLLRYRRWY,956,2,16882,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli
FTILKKLKSFIK,957,4,16906,"Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes.",Staphylococcusaureus
KLVKKLLKKYITF,957,4,16907,"Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes.",Staphylococcusaureus
LARFVLRILKYGFK,957,4,16908,"Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes.",Staphylococcusaureus
IPLLRKGKKIIWW,957,4,16909,"Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes.",Staphylococcusaureus
GLKKVIKLLRPLL,957,4,16910,"Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes.",Staphylococcusaureus
ILKPKLWKLTVVARKIIK,957,4,16911,"Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes.",Staphylococcusaureus
IVIKSLGKFLKNVGGFAG,957,4,16912,"Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes.",Staphylococcusaureus
FKLVWKLLKKLALKL,957,3,16913,"Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes.",Pseudomonasaeruginosa
ITKWLLNAIKKGFKL,957,4,16914,"Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes.",Staphylococcusaureus
IHKLVKLWLNLGKKF,957,3,16915,"Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes.",Pseudomonasaeruginosa
LFSIIWKLNRKLIKA,957,4,16916,"Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes.",Staphylococcusaureus
ILGKIWKGIKSLF,958,8,16937,Anticancer Activities of Antimicrobial BmKn2 Peptides Against Oral and Colon Cancer Cells,Bacillussubtilis
AGKETIRQYLKNEIKKKGRKAVIAW,959,77,16951,Synthetic Antimicrobial Peptide Tuning Permits Membrane Disruption and Interpeptide Synergy.,Klebsiellapneumoniae
AGKEKIRKKLKNEIKKKGRKAVIAW,959,77,16952,Synthetic Antimicrobial Peptide Tuning Permits Membrane Disruption and Interpeptide Synergy.,Klebsiellapneumoniae
AWKEKIRKKLKNEIKKKGRKAVIAW,959,77,16953,Synthetic Antimicrobial Peptide Tuning Permits Membrane Disruption and Interpeptide Synergy.,Klebsiellapneumoniae
AGKEKIRKKLKNEIKKKWRKAVIAW,959,77,16954,Synthetic Antimicrobial Peptide Tuning Permits Membrane Disruption and Interpeptide Synergy.,Klebsiellapneumoniae
AFALIAGALYRIFHRR,960,78,16955,"LHH1, a novel antimicrobial peptide with anti-cancer cell activity identified from Lactobacillus casei HZ1.",Enterobacteraerogenes
DKEWILQKIYEIMRLLDELGHAEASMRVSDLIYEFMKKGDERLLEEAERLLEEVER,961,131,16962,De novo design of picomolar SARS-CoV-2 miniprotein inhibitors.,SARS-CoV-2
GDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELG,962,130,16964,Following the rule: formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitors.,SARS-CoV
NGAICWGPCPTAFRQIGNCGRFRVRCCRIR,963,131,16965,A broad-spectrum virus- and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2.,SARS-CoV-2
SRDSRPVQPRVQPPPPPPKQKPSIYDTPIRRPGGRKTMYA,964,2,16977,Design and Characterization of a Novel Hybrid Antimicrobial Peptide OM19R Based on Oncocin and MDAP-2.,Escherichiacoli
FPVTWRWWKWWKG,965,2,16980,Effects of Rationally Designed Physico-Chemical Variants of the Peptide PuroA on Biocidal Activity towards Bacterial and Mammalian Cells.,Escherichiacoli
FPVTWRWWKWWKGKFPVTWRWWKWWKG,965,2,16981,Effects of Rationally Designed Physico-Chemical Variants of the Peptide PuroA on Biocidal Activity towards Bacterial and Mammalian Cells.,Escherichiacoli
AKLIPTIA,967,162,17029,Synthetic peptides against Trichophyton mentagrophytes and T. rubrum: Mechanisms of action and efficiency compared to griseofulvin and itraconazole.,Trichophytonmentagrophytes
VQWRRIRVWVIR,968,52,17042,Host defense peptide IDR-1002 associated with ciprofloxacin as a new antimicrobial and immunomodulatory strategy for dental pulp revascularization therapy.,Enterococcusfaecalis
AKKLLKLLKKLLKLAG,969,2,17049,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
LKKALKLLKKLLKLAG,969,2,17050,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
LKKLAKLLKKLLKLAG,969,2,17051,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
LKKLLKALKKLLKLAG,969,2,17052,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
LKKLLKLAKKLLKLAG,969,2,17053,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
LKKLLKLLKKALKLAG,969,2,17054,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
LKKLLKLLKKLAKLAG,969,2,17055,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
LKKLLKLLKKLLKAAG,969,2,17056,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
LKKLLKLGKKLLKLAG,969,2,17057,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
LKKLLKLSKKLLKLAG,969,2,17058,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
LKKLLKLPKKLLKLAG,969,2,17059,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
LKKLLKLNKKLLKLAG,969,2,17060,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
LKKLLKLQKKLLKLAG,969,2,17061,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
LKKLLKLDKKLLKLAG,969,2,17062,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
LKKLLKLEKKLLKLAG,969,2,17063,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
LKKLLKLKKKLLKLAG,969,2,17064,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
LKKLLKLHKKLLKLAG,969,2,17065,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
AKRIVQRIKDFLR,969,2,17066,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
FKRAVQRIKDFLR,969,2,17067,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
FKRIAQRIKDFLR,969,2,17068,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
FKRIVQRAKDFLR,969,2,17069,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
FKRIVQRIKDALR,969,2,17070,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
FKRIVQRIKDFAR,969,2,17071,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
FKRGVQRIKDFLR,969,2,17072,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
FKRSVQRIKDFLR,969,2,17073,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
FKRNVQRIKDFLR,969,2,17074,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
FKRQVQRIKDFLR,969,2,17075,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
FKRHVQRIKDFLR,969,2,17076,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
FKRIGQRIKDFLR,969,2,17077,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
FKRISQRIKDFLR,969,2,17078,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
FKRINQRIKDFLR,969,2,17079,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
FKRIQQRIKDFLR,969,2,17080,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
FKRIHQRIKDFLR,969,2,17081,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
FKRIVQRIKDGLR,969,2,17082,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
FKRIVQRIKDSLR,969,2,17083,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
FKRIVQRIKDNLR,969,2,17084,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
FKRIVQRIKDQLR,969,2,17085,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
FKRIVQRIKDHLR,969,2,17086,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli
KRLFKKLLKYLRKF,970,2,17119,D- and Unnatural Amino Acid Substituted Antimicrobial Peptides With Improved Proteolytic Resistance and Their Proteolytic Degradation Characteristics.,Escherichiacoli
KRLFKRLFKYLRRF,970,2,17120,D- and Unnatural Amino Acid Substituted Antimicrobial Peptides With Improved Proteolytic Resistance and Their Proteolytic Degradation Characteristics.,Escherichiacoli
RRIFKRLFKYLRRF,970,2,17121,D- and Unnatural Amino Acid Substituted Antimicrobial Peptides With Improved Proteolytic Resistance and Their Proteolytic Degradation Characteristics.,Escherichiacoli
AGRQTIKAYLRREIRKRGRKAVIAW,971,2,17135,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
WGTQRIKAYLRREIRKRGRKAVIAW,971,2,17136,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
WGTNRIAKELRRYIRKVGRIARKAW,971,2,17137,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AWRQTIAKYLRREIRKRGRKAVIAW,971,2,17138,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AWTQRIKAYLRREIRKRGRKAVIAW,971,2,17139,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGRQWIKAYLRREIRKRGRKAVIAW,971,2,17140,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGRQWIAKYLRREIRKRGRKAVIAW,971,2,17141,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGWQRIKAYLRREIRKRGRKAVIAW,971,2,17142,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGRQWIKAYLRREIRKVGRKARIAW,971,2,17143,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGRQTIAKYLRREIRKRGRKWVIAW,971,2,17144,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGTNRIAKELRRYIRKVGRIARKWW,971,2,17145,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGTNRIAKELRRYIRKVKRIARKAW,971,2,17146,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGTNRIAKELRRYIRKVGRIKRKAW,971,2,17147,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGTNRIAKELRRYIRKVGRIARKKW,971,2,17148,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AKTNRIAKELRRYIRKVGRIARKAW,971,2,17149,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGKETIRQFLKKKIQEKGKRATIAW,971,2,17150,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGKETIFQRLKKKIQEKGKRAWIAW,971,2,17151,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGTEKIFQRLKKKIQEGKKIAKRAW,971,2,17152,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AWTEKIFQRLKKTIQEGKKIAKRAW,971,2,17153,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AWTEKIFNRLKKTINEGKKIAKRAW,971,2,17154,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGKETIFQRLKKKIQEKWKRATIAW,971,2,17155,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGKETIRQFLKKKIQEWKKRATIAW,971,2,17156,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGTEKIFNRLKKTINEWKKIAKRAW,971,2,17157,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGKETIFQRLKKKIQEKGKRATIWW,971,2,17158,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGKETIRQFLKKTIQEKGKRAKIWW,971,2,17159,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGTEKIFQRLKKTIQEGKKIAKRWW,971,2,17160,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGTEKIFNRLKKTINEGKKIAKRWW,971,2,17161,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGKEKIFQRLKKTIQEGKKIAKRAW,971,2,17162,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGKETIFQRLKKKIQEKGKRAKIAW,971,2,17163,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGKETIRQFLKKKIQEGKKRAKIAW,971,2,17164,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGRQALTLYLKEELRKRGKKAFIAW,971,2,17165,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGAQRLTKELLEYLRKFGKIARKAW,971,2,17166,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
WGRQALTKYLLEELRKRGKKAFIAW,971,2,17167,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
WGRQALTLYLKEELRKFGKKARIAW,971,2,17168,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
WGAQRLTKELLEYLRKFGKIARKAW,971,2,17169,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGRQALTKYLLEELRKRWKKAFIAW,971,2,17170,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGRQALTLYLKEELRKRGKKAFIWW,971,2,17171,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGRQALTKYLLEELRKRGKKAFIWW,971,2,17172,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGRQKLTLELKEYLRKRGKKAFIAW,971,2,17173,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AKRQALTKYLLEELRKRGKKAFIAW,971,2,17174,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AKANRLTKELLEYLRKFGKIARKAW,971,2,17175,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGRESIKAYLKKEIKKKGKRAVIAW,971,2,17176,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGSERIWKELKKYIKKGKKVIRAAW,971,2,17177,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AWRESIKAYLKKEIKKKGKRIVAAW,971,2,17178,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGRESIKAYLKKEIKKKWKRAVIAW,971,2,17179,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
AGRESIKAYLKKEIKKKWKRIVAAW,971,2,17180,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli
CVRRFPWWWPFLRRC,972,8,17182,Cyclic Tritrpticin Analogs with Distinct Biological Activities.,Bacillussubtilis
KWCFKVCYKGICYKKCKG,973,163,17195,Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties.,Humanmetastatic
KSCFRVCYRGICYRRCRG,973,111,17196,Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties.,Humanskin
KWCFRVCSRGSCYRRCRG,973,111,17197,Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties.,Humanskin
KWCSRVCYRGICSRRCRG,973,111,17198,Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties.,Humanskin
KWCFRVCYSGICYRRCRG,973,118,17199,Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties.,Humanbreast
KWCFRVCYRGICYSRCRG,973,111,17200,Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties.,Humanskin
KWCFRVCYRGICYRRCSG,973,111,17201,Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties.,Humanskin
KWCFRVCYSGICYSRCSG,973,164,17202,Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties.,Humanmalignant
KWCFRVCYRGICYRRCRK,973,111,17203,Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties.,Humanskin
KWCFRVCYRGFCYRRCRK,973,111,17204,Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties.,Humanskin
TFLDKFNHEAEDLFYQ,974,165,17208,Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2.,SARS-CoV-2PsV
EDLFYQSSL,974,165,17209,Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2.,SARS-CoV-2PsV
QAKTFLDKFNHEA,974,165,17210,Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2.,SARS-CoV-2PsV
LAREYKKIVEKLKRWLRQVLRTLR,975,59,17217,"Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates.",Acinetobacterbaumannii
GFCWYVCARRNGARVCYRRCN,976,2,17218,An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria.,Escherichiacoli
GFCWRVCASRNGLRVCYRRCN,976,2,17219,An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria.,Escherichiacoli
GFCWYACAKRNGLRVCYRRCN,976,2,17220,An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria.,Escherichiacoli
GFCWNVCVRRNGVRVCHRRCN,976,2,17221,An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria.,Escherichiacoli
GFCWYVCVKRNGVRSCYRRCN,976,2,17222,An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria.,Escherichiacoli
GFCWNVCVYRNGVRICHRRCN,976,2,17223,An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria.,Escherichiacoli
GFCWHVCARRNGVRVCYRRCN,976,2,17224,An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria.,Escherichiacoli
GFCWRACVYRNGVRACYRRCN,976,2,17225,An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria.,Escherichiacoli
GFCWRACVYRNGVRVCYRRCN,976,2,17226,An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria.,Escherichiacoli
KWCFRSCYRGICYRRCR,977,4,17227,Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity.,Staphylococcusaureus
KWCFRRCYRGICYRRCR,977,4,17228,Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity.,Staphylococcusaureus
KWCFRVCSRGICYRRCR,977,4,17229,Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity.,Staphylococcusaureus
KWCFRVCRRGICYRRCR,977,4,17230,Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity.,Staphylococcusaureus
KWCFRVCYRGSCYRRCR,977,4,17231,Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity.,Staphylococcusaureus
KWCFRVCYRGRCYRRCR,977,4,17232,Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity.,Staphylococcusaureus
KFLNRFWHWLQLKPGQPMY,978,2,17233,Moonlighting peptides with emerging function.,Escherichiacoli
RRYGTCIYQGRLWAF,979,41,17234,Exploiting chitosan and gold nanoparticles for antimycobacterial activity of in silico identified antimicrobial motif of human neutrophil peptide-1.,Mycobacteriumtuberculosis
RVQGRWKVRASFFK,981,2,17274,Development of chimeric peptides to facilitate the neutralisation of lipopolysaccharides during bactericidal targeting of multidrug-resistant Escherichia coli.,Escherichiacoli
RVQGRWKVRASFFKEAAAKEAAAKGFAWNVCVYRNGVRVCHRRAN,981,2,17275,Development of chimeric peptides to facilitate the neutralisation of lipopolysaccharides during bactericidal targeting of multidrug-resistant Escherichia coli.,Escherichiacoli
RVQGRWKVRASFFKGGGGSGFAWNVCVYRNGVRVCHRRAN,981,2,17276,Development of chimeric peptides to facilitate the neutralisation of lipopolysaccharides during bactericidal targeting of multidrug-resistant Escherichia coli.,Escherichiacoli
RVQGRWKVRASFFKGFAWNVCVYRNGVRVCHRRAN,981,2,17277,Development of chimeric peptides to facilitate the neutralisation of lipopolysaccharides during bactericidal targeting of multidrug-resistant Escherichia coli.,Escherichiacoli
VCVYRGFAWNCHRRANNGVRV,981,2,17278,Development of chimeric peptides to facilitate the neutralisation of lipopolysaccharides during bactericidal targeting of multidrug-resistant Escherichia coli.,Escherichiacoli
RVQGRWKVRASFFKEAAAKEAAAKVCVYRGFAWNCHRRANNGVRV,981,2,17279,Development of chimeric peptides to facilitate the neutralisation of lipopolysaccharides during bactericidal targeting of multidrug-resistant Escherichia coli.,Escherichiacoli
RVQGRWKVRASFFKGGGGSVCVYRGFAWNCHRRANNGVRV,981,2,17280,Development of chimeric peptides to facilitate the neutralisation of lipopolysaccharides during bactericidal targeting of multidrug-resistant Escherichia coli.,Escherichiacoli
ATCDLLSPFKVGHAACAAHCIARGKRGGWCDGRAVCNCRK,982,4,17281,An Enhanced Variant Designed From DLP4 Cationic Peptide Against Staphylococcus aureus CVCC 546.,Staphylococcusaureus
KKGWAKKLAFAFGKK,983,2,17306,"Synthetic molecular evolution of host cell-compatible, antimicrobial peptides effective against drug-resistant, biofilm-forming bacteria.",Escherichiacoli
NIRPRPTARPPYINRPPNPFKPRW,984,48,17336,Antimicrobial peptide-like genes in Nasonia vitripennis: a genomic perspective.,Bacillusmegaterium
FLPKLFAKITKKNMAHIRC,986,2,17349,A Peptide-Nanoparticle System with Improved Efficacy against Multidrug Resistant Bacteria.,Escherichiacoli
CFLPKLFAKITKKNMAHIR,986,2,17350,A Peptide-Nanoparticle System with Improved Efficacy against Multidrug Resistant Bacteria.,Escherichiacoli
AAHHIIGGLFSAGKAIHRLIRRRRR,987,3,17361,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa
FIAAIIGGLFSAGKAIHRLIRRRRR,987,3,17362,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa
FIHHAAGGLFSAGKAIHRLIRRRRR,987,3,17363,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa
FIHHIIGGAASAGKAIHRLIRRRRR,987,3,17364,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa
FIHHIIGGLFSAGKAAHRLIRRRRR,987,3,17365,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa
FIHHIIGGLFSAGKARHRLIRRRRR,987,3,17366,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa
FIHHIIGGLFSAGKAEHRLIRRRRR,987,3,17367,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa
FIHHIIGGLFSAGKAIHRHHRRRRR,987,3,17368,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa
HHIIGGLFSAGKAIHRLIRRRRR,987,3,17369,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa
IIGGLFSAGKAIHRLIRRRRR,987,3,17370,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa
FIHHIIGGLFSAGKAIHRLIRRR,987,3,17371,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa
FIHHIIGGLFSAGKAIHRLIR,987,3,17372,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa
FIHHIIGGLFSVGKHIHRLIRRRRR,987,3,17373,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa
FIHHIIGGLFSIGKIIHRLIRRRRR,987,3,17374,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa
FIHHIIGGLFSAGKAIHSLIHRRRR,987,3,17378,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa
FIHHIIGGLFSVGKHIHSLIHRRRR,987,3,17379,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa
LNWKAILKHIIK,988,2,17392,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli
VLPKVMAHMK,988,2,17393,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli
LNWGAVLKHVVK,988,2,17394,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli
LNWGAIKKHIIK,988,2,17395,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli
LNWGAFLKHFFK,988,2,17396,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli
VDLKNLLK,988,2,17397,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli
LRRLRLRLLRLLRRLLRLL,988,2,17398,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli
LNWGAWLKHWWK,988,2,17399,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli
LVKRVKKVL,988,2,17400,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli
VNLKNLLR,988,2,17401,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli
KWKLWKKIEKWGQGIGAVLKWLTTWL,988,2,17402,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli
FFFHIIKGLFHAGRMIHGLV,988,2,17403,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli
FFFKLLPKAIGALKKI,988,2,17404,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli
FKIKASKKLLKKVGKGALGAVAKALAQQA,988,2,17405,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli
KWKKFIKKLTSAAKKVLTTGLPALIS,988,2,17406,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli
KWKKFLKKLTSAAKKVLTTALKPISS,988,2,17407,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli
FFKKFIGGVAKIAGKAAPHGVGQLIPHVTP,988,2,17408,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli
RVKRVWPLVIRTVIAGYNLYRAIKKK,32,94,11,"Structure-activity relationships of fowlicidin-1, a cathelicidin antimicrobial peptide in chicken",Salmonellaenterica
ENREVPPGFTALIKTLRKCKII,989,2,16,A novel heterodimeric antimicrobial peptide from the tree-frog Phyllomedusa distincta,Escherichiacoli
NLVSGLIEARKYLEQLHRKLKNCKV,989,2,36,A novel heterodimeric antimicrobial peptide from the tree-frog Phyllomedusa distincta,Escherichiacoli
VRRFPWWWPFLRR,8,6,160,Antimicrobial activity of a 13 amino acid tryptophan-rich peptide derived from a putative porcine precursor protein of a novel family of antibacterial peptides,Aspergillusfumigatus
GIGKFLHSAKKFGKAFVGEIMNS,15,8,360,Helix stability confers salt resistance upon helical antimicrobial peptides,Bacillussubtilis
DCLSGRYKGPCAVWDNETCRRVCKEEGRSSGHCSPSLKCWCEGC,990,28,461,Insect immunity. Septic injury of Drosophila induces the synthesis of a potent antifungal peptide with sequence homology to plant antifungal peptides,Neurosporacrassa
ISDYSIAMDKIRQQDFVNWLLAQKGKKSDWKHNITQ,991,48,462,"Isolation of three antibacterial peptides from pig intestine: gastric inhibitory polypeptide (7-42), diazepam-binding inhibitor (32-86) and a novel factor, peptide 3910",Bacillusmegaterium
KTCENLADTY,992,65,500,"Sesquin, a potent defensin-like antimicrobial peptide from ground beans with inhibitory activities toward tumor cells and HIV-1 reverse transcriptase.",Botrytiscinerea
SMWSGMWRRKLKKLRNALKKKLKGE,993,95,535,"Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.",Arthrobacterglobiformis
GLFGKLIKKFGRKAISYAVKKARGKH,993,95,536,"Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.",Arthrobacterglobiformis
QAFQTFKPDWNKIRYDAMKMQTSLGQMKKRFNL,993,95,567,"Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.",Arthrobacterglobiformis
GETFDKLKEKLKTFYQKLVEKAEDLKGDLKAKLS,993,95,568,"Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.",Arthrobacterglobiformis
SWLSKTAKKLENSAKKRISEGIAIAIQGGPR,994,2,569,"he structure of the mammalian antibacterial peptide cecropin P1 in solution, determined by proton-NMR.",Escherichiacoli
KSCCRNTWARNCYNVCRLPGTISREICAKKCDCKIISGTTCPSDYPK,22,12,595,Structural dissection of a highly knotted peptide reveals minimal motif with antimicrobial activity,Clavibactermichiganensis
ALWMTLLKKVLKAAAKAALNAVLVGANA,23,2,606,Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity,Escherichiacoli
FLGALFKVASKVLPSVKCAITKKC,24,8,626,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis
NPVSCVRNKGICVPIRCPGSMKQIGTCVGRAVKCCRKK,997,2,659,"Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA.",Escherichiacoli
ALWKNMLKGIGKLAGQAALGAVKTLVGA,998,4,660,"Structure, synthesis, and molecular cloning of dermaseptins B, a family of skin peptide antibiotics.",Staphylococcusaureus
RSVCRQIKICRRRGGCYYKCTNRPY,999,18,694,Characterization of novel cysteine-rich antimicrobial peptides from scorpion blood.,Micrococcusluteus
YVPLPNVPQPGRRPFPTFPGQGPFNPKIKWPQGY,1000,103,698,"Isolation and characterization of abaecin, a major antibacterial response peptide in the honeybee (Apis mellifera).",Agrobacteriumtumefaciens
GRFRRLRKKTRKRLKKIGKVLKWIPPIVGSIPLGCG,1001,2,707,Chemical synthesis and biological activity of a novel antibacterial peptide deduced from a pig myeloid cDNA.,Escherichiacoli
GLLSRLRDFLSDRGRRLGEKIERIGQKIKDLSEFFQS,1002,2,708,"PMAP-37, a novel antibacterial peptide from pig myeloid cells. cDNA cloning, chemical synthesis and activity.",Escherichiacoli
GIPCGESCVWIPCISAALGCSCKNKVCYRN,1003,2,755,An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides.,Escherichiacoli
SIPCGESCVFIPCTVTALLGCSCKSKVCYKN,1003,2,756,An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides.,Escherichiacoli
GVIPCGESCVFIPCISTLLGCSCKNKVCYRN,1003,2,757,An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides.,Escherichiacoli
VTCFCRRRGCASRERHIGYCRFGNTIYRLCCRR,1006,4,768,"Isolation, antimicrobial activities, and primary structures of hamster neutrophil defensins",Staphylococcusaureus
CFCKRPVCDSGETQIGYCRLGNTFYRLCCRQ,1006,4,769,"Isolation, antimicrobial activities, and primary structures of hamster neutrophil defensins",Staphylococcusaureus
VTCFCRRRGCASRERLIGYCRFGNTIYGLCCRR,1006,4,770,"Isolation, antimicrobial activities, and primary structures of hamster neutrophil defensins",Staphylococcusaureus
VTCFCKRPVCDSGETQIGYCRLGNTFYRLCCRQ,1006,4,771,"Isolation, antimicrobial activities, and primary structures of hamster neutrophil defensins",Staphylococcusaureus
KTCEHLADTYRGVCFTNASCDDHCKNKAHLISGTCHNWKCFCTQNC,1007,166,782,Characterization of two novel defense peptides from pea (Pisum sativum) seeds,Aspergillusniger
KTCENLSGTFKGPCIPDGNCNKHCRNNEHLLSGRCRDDFRCWCTNRC,1007,166,813,Characterization of two novel defense peptides from pea (Pisum sativum) seeds,Aspergillusniger
SDEKASPDKHHRFSLSRYAKLANRLANPKLLETFLSKWIGDRGNRSVK,33,2,818,Identification of the region that plays an important role in determining antibacterial activity of bovine seminalplasmin.,Escherichiacoli
FRGLAKLLKIGLKSFARVLKKVLPKAAKAGKALAKSMADENAIRQQNQ,1008,2,822,"Oxyopinins, large amphipathic peptides isolated from the venom of the wolf spider Oxyopes kitabensis with cytolytic properties and positive insecticidal cooperativity with spider neurotoxins.",Escherichiacoli
GFCRCLCRRGVCRCICTR,1009,4,823,Microbicidal properties and cytocidal selectivity of rhesus macaque theta defensins.,Staphylococcusaureus
GVCRCLCRRGVCRCLCRR,1009,4,824,Microbicidal properties and cytocidal selectivity of rhesus macaque theta defensins.,Staphylococcusaureus
GFCRCICTRGFCRCICTR,1009,4,825,Microbicidal properties and cytocidal selectivity of rhesus macaque theta defensins.,Staphylococcusaureus
GVLSNVIGYLKKLGTGALNAVLKQ,1010,2,826,Antimicrobial peptides in the stomach of Xenopus laevis.,Escherichiacoli
YSLQMGATAIKQVKKLFKKWGW,1011,167,828,"Antagonistic activity of Lactobacillus plantarum C11: two new two-peptide bacteriocins, plantaricins EF and JK, and the induction factor plantaricin A.",Pediococcuspentosaceus
GIGGKILSGLKTALKGAAKELASTYLH,1012,2,835,Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.,Escherichiacoli
SIGAKILGGVKTFFKGALKELASTYLQ,1012,2,843,Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.,Escherichiacoli
GLLNTFKDWAISIAKGAGKGVLTTLSCKLDKSC,1013,4,845,"Isolation and characterization of novel antimicrobial peptides, rugosins A, B and C, from the skin of the frog, Rana rugosa.",Staphylococcusaureus
SLFSLIKAGAKFLGKNLLKQGAQYAACKVSKEC,1013,4,846,"Isolation and characterization of novel antimicrobial peptides, rugosins A, B and C, from the skin of the frog, Rana rugosa.",Staphylococcusaureus
SLGGVISGAKKVAKVAIPIGKAVLPVVAKLVG,1014,2,848,"Molecular characterization of ceratotoxin C, a novel antibacterial female-specific peptide of the ceratotoxin family from the medfly Ceratitis capitata.",Escherichiacoli
HRHQGPIFDTRPSPFNPNQPRPGPIY,1015,18,849,"Metchnikowin, a novel immune-inducible proline-rich peptide from Drosophila with antibacterial and antifungal properties.",Micrococcusluteus
ACYCRIGACVSGERLTGACGLNGRIYRLCCR,1016,4,871,Purification and antimicrobial properties of three defensins from rat neutrophils.,Staphylococcusaureus
TRSSRAGLQFPVGRVHRLLRK,37,8,872,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis
FLPKTLRKFFCRIRGGRCAVLNCLGKEEQIGRCSNSGRKCCRKKK,1018,4,917,"Mouse beta-defensin-14, an antimicrobial ortholog of human beta-defensin-3.",Staphylococcusaureus
FLGALFKVASKVLPSVFCAITKKC,1019,8,918,"Antimicrobial peptides from the skin of a Korean frog, Rana rugosa.",Bacillussubtilis
GKVWDWIKSAAKKIWSSEPVSQLKGQVLNAAKNYVAEKIGATPT,1020,3,947,Characterization of unique amphipathic antimicrobial peptides from venom of the scorpion Pandinus imperator.,Pseudomonasaeruginosa
FWGALAKGALKLIPSLFSSFSKKD,1020,3,948,Characterization of unique amphipathic antimicrobial peptides from venom of the scorpion Pandinus imperator.,Pseudomonasaeruginosa
ATRSYGNGVYCNNSKCWVNWGEAKENIAGIVISGWASGLAGMGH,1021,168,949,"Biochemical and genetic characterization of enterocin P, a novel sec-dependent bacteriocin from Enterococcus faecium P13 with a broad antimicrobial spectrum.",Lactobacilluscurvatus
FKLGSFLKKAWKSKLAKKLRAKGKEMLKDYAKGLLEGGSEEVPGQ,1022,2,964,"Antibacterial and antifungal properties of alpha-helical, cationic peptides in the venom of scorpions from southern Africa.",Escherichiacoli
KYYGNGVHCGKHSCTVDWGTAIGNIGNNAAANWATGGNAGWNK,192,52,965,Induction of bacteriocin production in Lactobacillus sake by a secreted peptide.,Enterococcusfaecalis
GKVWDWIKSTAKKLWNSEPVKELKNTALNAAKNLVAEKIGATPS,1023,2,966,"ntibacterial and antifungal properties of alpha-helical, cationic peptides in the venom of scorpions from southern Africa.",Escherichiacoli
GLVTSLIKGAGKLLGGLFGSVTGGQS,1024,2,988,Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain.,Escherichiacoli
FLPIIAGIAAKVFPKIFCAISKKC,1025,2,990,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",Escherichiacoli
ALWKTMLKKLGTMALHAGKAALGAAADTISQGTQ,1026,169,991,Isolation and structure of novel defensive peptides from frog skin.,Microsporumcanis
GWGSFFKKAAHVGKHVGKAALTHYL,1027,2,1003,"Characterization of a fish antimicrobial peptide: gene expression, subcellular localization, and spectrum of activity.",Escherichiacoli
GFGALFKFLAKKVAKTVAKQAAKQGAKYVVNKQME,1028,2,1006,"Cupiennin 1, a new family of highly basic antimicrobial peptides in the venom of the spider Cupiennius salei (Ctenidae)",Escherichiacoli
GFGSLFKFLAKKVAKTVAKQAAKQGAKYVANKHME,1029,2,1008,"Cupiennin 1, a new family of highly basic antimicrobial peptides in the venom of the spider Cupiennius salei (Ctenidae).",Escherichiacoli
FLPVVAGLAAKVLPSIICAVTKKC,1030,4,1009,"Induction of synthesis of an antimicrobial peptide in the skin of the freeze-tolerant frog, Rana sylvatica, in response to environmental stimuli.",Staphylococcusaureus
SMLSVLKNLGKVGLGFVACKINKQC,1031,4,1010,"Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana",Staphylococcusaureus
GLFLDTLKGAAKDVAGKLEGLKCKITGCKLP,1031,4,1011,"Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana",Staphylococcusaureus
GFLDIINKLGKTFAGHMLDKIKCTIGTCPPSP,1031,4,1012,"Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana",Staphylococcusaureus
FLPFIARLAAKVFPSIICSVTKKC,1031,4,1013,"Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana",Staphylococcusaureus
FLPIASLLGKYL,1031,4,1014,"Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana",Staphylococcusaureus
FISAIASMLGKFL,1031,4,1015,"Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana",Staphylococcusaureus
FLSAIASMLGKFL,1031,4,1016,"Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana",Staphylococcusaureus
FISAIASFLGKFL,1031,4,1017,"Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana",Staphylococcusaureus
FLFPLITSFLSKVL,1031,4,1018,"Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana",Staphylococcusaureus
SMLSVLKNLGKVGLGLVACKINKQC,1032,4,1019,Purification and characterization of antimicrobial peptides from the skin of the North American green frog Rana clamitans.,Staphylococcusaureus
FLGGLMKAFPALICAVTKKC,1032,4,1020,Purification and characterization of antimicrobial peptides from the skin of the North American green frog Rana clamitans.,Staphylococcusaureus
GLFLDTLKGLAGKLLQGLKCIKAGCKP,1032,4,1021,Purification and characterization of antimicrobial peptides from the skin of the North American green frog Rana clamitans.,Staphylococcusaureus
IAPIIVAGLGYLVKDAWDHSDQIISGFKKGWNGGRRK,1033,52,1028,"Enterocin X, a novel two-peptide bacteriocin from Enterococcus faecium KU-B5, has an antibacterial spectrum entirely different from those of its component peptides.",Enterococcusfaecalis
SNDSLWYGVGQFMGKQANCITNHPVKHMIIPGYCLSKILG,1033,52,1029,"Enterocin X, a novel two-peptide bacteriocin from Enterococcus faecium KU-B5, has an antibacterial spectrum entirely different from those of its component peptides.",Enterococcusfaecalis
GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY,44,3,1058,Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis.,Pseudomonasaeruginosa
GIMDTLKNLAKTAGKGALQSLLNKASCKLSGQC,1034,2,1069,Novel antimicrobial peptides from skin secretion of the European frog Rana esculenta.,Escherichiacoli
GLLRKGGEKIGEKLKKIGQKIKNFFQKLVPQPEQ,44,3,1071,Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis.,Pseudomonasaeruginosa
GLVRKGGEKFGEKLRKIGQKIKEFFQKLALEIEQ,44,3,1072,Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis.,Pseudomonasaeruginosa
RGLRRLGRKIAHGVKKYGPTVLRIIRIAG,44,3,1073,Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis.,Pseudomonasaeruginosa
FLPLLAGLAANFLPKIFCKITRKC,1035,2,1077,Novel antimicrobial peptides from skin secretion of the European frog Rana esculenta,Escherichiacoli
GIFSKLGRKKIKNLLISGLKNVGKEVGMDVVRTGIDIAGCKIKGEC,1034,2,1078,Novel antimicrobial peptides from skin secretion of the European frog Rana esculenta.,Escherichiacoli
ALWKNMLKGIGKLAGKAALGAVKKLVGAES,1036,43,1098,Selective cytotoxicity of dermaseptin S3 toward intraerythrocytic Plasmodium falciparum and the underlying molecular basis,Plasmodiumfalciparum
ATCDLLSGFGVGDSACAAHCIARGNRGGYCNSKKVCVCRN,1037,48,1099,Full sequence and characterization of two insect defensins: immune peptides from the mosquito Aedes aegypti.,Bacillusmegaterium
GIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP,1038,2,1121,Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung.,Escherichiacoli
QQCGRQAGNRRCANNLCCSQYGYCGRTNEYCCTSQGCQSQCRRCG,1039,36,1134,Five disulfide bridges stabilize a hevein-type antimicrobial peptide from the bark of spindle tree (Euonymus europaeus L.).,Alternariabrassicicola
VGECVRGRCPSGMCCSQFGYCGKGPKYCGR,1039,36,1135,Five disulfide bridges stabilize a hevein-type antimicrobial peptide from the bark of spindle tree (Euonymus europaeus L.).,Alternariabrassicicola
FDITKLNIKKLTKATCKVISKGASMCKVLFDKKKQE,1040,170,1143,"Molecular cloning and biological characterization of novel antimicrobial peptides, pilosulin 3 and pilosulin 4, from a species of the Australian ant genus Myrmecia.",Lactococcusgarvieae
GNNRPIYIPQPRPPHPRL,1042,103,1159,Apidaecins: antibacterial peptides from honeybees.,Agrobacteriumtumefaciens
GNNRPVYIPQPRPPHPRL,1042,103,1160,Apidaecins: antibacterial peptides from honeybees.,Agrobacteriumtumefaciens
GNNRPVYIPQPRPPHPR,1042,103,1161,Apidaecins: antibacterial peptides from honeybees.,Agrobacteriumtumefaciens
VQETQKLAKTVGANLEETNKKLAPQIKSAYDDFVKQAQEVQKKLHEAASKQ,1043,18,1213,Purification and characterization of eight peptides from Galleria mellonella immune hemolymph,Micrococcusluteus
DIQIPGIKKPTHRDIIIPNWNPNVRTQPWQRFGGNKS,1043,18,1214,Purification and characterization of eight peptides from Galleria mellonella immune hemolymph,Micrococcusluteus
EIRLPEPFRFPSPTVPKPIDIDPILPHPWSPRQTYPIIARRS,1044,18,1215,Purification and characterization of eight peptides from Galleria mellonella immune hemolymph.,Micrococcusluteus
RQRVEELSKFSKKGAAARRRK,55,21,1231,Antimicrobial peptides protect coho salmon from Vibrio anguillarum infections.,Vibrioanguillarum
DKLIGSCVWGATNYTSDCNAECKRRGYKGGHCGSFWNVNCWCEE,1044,18,1234,Purification and characterization of eight peptides from Galleria mellonella immune hemolymph.,Micrococcusluteus
EADEPLWLYKGDNIERAPTTADHPILPSIIDDVKLDPNRRYA,1044,18,1236,Purification and characterization of eight peptides from Galleria mellonella immune hemolymph.,Micrococcusluteus
ETESTPDYLKNIQQQLEEYTKNFNTQVQNAFDSDKIKSEVNNFIESLGKILNTEKKEAPK,1044,18,1237,Purification and characterization of eight peptides from Galleria mellonella immune hemolymph.,Micrococcusluteus
ENFFKEIERAGQRIRDAIISAAPAVETLAQAQKIIKGGD,1044,18,1238,Purification and characterization of eight peptides from Galleria mellonella immune hemolymph.,Micrococcusluteus
DTLIGSCVWGATNYTSDCNAECKRRGYKGGHCGSFLNVNCWCE,1044,18,1239,Purification and characterization of eight peptides from Galleria mellonella immune hemolymph.,Micrococcusluteus
GLMSSIGKALGGLIVDVLKPKTPAS,1045,25,1262,The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.,Bacilluscereus
GILSLVKGVAKLAGKGLAKEGGKFGLELIACKIAKQC,1046,2,1272,Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.,Escherichiacoli
FLGGLIKIVPAMICAVTKKC,61,4,1273,"Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.",Staphylococcusaureus
GLFDVIKKVASVIGLASP,1048,25,1325,Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.,Bacilluscereus
SIWGDIGQGVGKAAYWVGKAMGNMSDVNQASRINRKKKH,1049,32,1333,"Lactococcin Q, a novel two-peptide bacteriocin produced by Lactococcus lactis QU 4.",Lactococcuslactis
KKWGWLAWVEPAGEFLKGFGKGAIKEGNKDKWKNI,1049,32,1334,"Lactococcin Q, a novel two-peptide bacteriocin produced by Lactococcus lactis QU 4.",Lactococcuslactis
GLIGSIGKALGGLLVDVLKPKL,1048,25,1335,Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.,Bacilluscereus
GTWDDIGQGIGRVAYWVGKAMGNMSDVNQASRINRKKKH,1049,32,1336,"Lactococcin Q, a novel two-peptide bacteriocin produced by Lactococcus lactis QU 4.",Lactococcuslactis
GLIGSIGKALGGLLVDVLKPKLQAAS,1048,25,1337,Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.,Bacilluscereus
HVDKKVADKVLLLKQLRIMRLLTRL,1050,8,1339,Insect immunity. Constitutive expression of a cysteine-rich antifungal and a linear antibacterial peptide in a termite insect.,Bacillussubtilis
KKWGWLAWVDPAYEFIKGFGKGAIKEGNKDKWKNI,1049,32,1347,"Lactococcin Q, a novel two-peptide bacteriocin produced by Lactococcus lactis QU 4.",Lactococcuslactis
GLFTLIKGAVKMIGKTVAKEAGKTGLELMACKVTNQC,1051,4,1353,Cloning from tissue surrogates: antimicrobial peptide (esculentin) cDNAs from the defensive skin secretions of Chinese ranid frogs.,Staphylococcusaureus
GLFSKFAGKGIKNMIIKGIKGIGKEVGMDVIRTGIDVAGCKIKGEC,1051,4,1354,Cloning from tissue surrogates: antimicrobial peptide (esculentin) cDNAs from the defensive skin secretions of Chinese ranid frogs.,Staphylococcusaureus
GIFSKFAGKGIKDLIIKGVKGIAKEAGMDVIRTGIDIAGCKIKGEC,1051,4,1355,Cloning from tissue surrogates: antimicrobial peptide (esculentin) cDNAs from the defensive skin secretions of Chinese ranid frogs.,Staphylococcusaureus
GIFTLFKGAAKLLGKTLAKEAGKTGLELMACKVTNQC,1051,4,1356,Cloning from tissue surrogates: antimicrobial peptide (esculentin) cDNAs from the defensive skin secretions of Chinese ranid frogs.,Staphylococcusaureus
GIFSKLAGKKIKNLLISGLKNVGKEVGMDVVRTGIDIAGCKIKGEC,1051,4,1357,Cloning from tissue surrogates: antimicrobial peptide (esculentin) cDNAs from the defensive skin secretions of Chinese ranid frogs.,Staphylococcusaureus
GIFSLIKGAAKVVAKGLGKEVGKFGLDLMACKVTNQC,1051,4,1358,Cloning from tissue surrogates: antimicrobial peptide (esculentin) cDNAs from the defensive skin secretions of Chinese ranid frogs.,Staphylococcusaureus
GRKSDCFRKSGFCAFLKCPSLTLISGKCSRFYLCCKRIR,1052,2,1359,Isolation of antimicrobial peptides from avian heterophils.,Escherichiacoli
GKREKCLRRNGFCAFLKCPTLSVISGTCSRFQVCC,1052,2,1360,Isolation of antimicrobial peptides from avian heterophils.,Escherichiacoli
LFCKRGTCHFGRCPSHLIKVGSCFGFRSCCKWPWDA,1052,2,1374,Isolation of antimicrobial peptides from avian heterophils.,Escherichiacoli
LSCKRGTCHFGRCPSHLIKGSCSGG,1052,2,1375,Isolation of antimicrobial peptides from avian heterophils.,Escherichiacoli
KRFGRLAKSFLRMRILLPRRKILLAS,67,2,1430,Structural and functional analysis of horse cathelicidin peptides.,Escherichiacoli
KRRHWFPLSFQEFLEQLRRFRDQLPFP,67,2,1431,Structural and functional analysis of horse cathelicidin peptides.,Escherichiacoli
KRFHSVGSLIQRHQQMIRDKSEATRHGIRIITRPKLLLAS,67,2,1432,Structural and functional analysis of horse cathelicidin peptides.,Escherichiacoli
GLLDAIKDTAQNLFANVLDKIKCKFTKC,1053,2,1459,Expression of genes encoding antimicrobial and bradykinin-related peptides in skin of the stream brown frog Rana sakuraii.,Escherichiacoli
GLFNVFKKVGKNVLKNVAGSLMDNLKCKVSGEC,1053,2,1462,Expression of genes encoding antimicrobial and bradykinin-related peptides in skin of the stream brown frog Rana sakuraii.,Escherichiacoli
GLFSAFKKVGKNVLKNVAGSLMDNLKCKVSGEC,1053,2,1463,Expression of genes encoding antimicrobial and bradykinin-related peptides in skin of the stream brown frog Rana sakuraii.,Escherichiacoli
GIFSKLAGKKLKNLLISGLKNVGKEVGMDVVRTGIDIAGCKIKGEC,1046,2,1467,Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.,Escherichiacoli
FLSLALAALPKFLCLVFKKC,1054,2,1468,"Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii.",Escherichiacoli
FLSLALAALPKLFCLIFKKC,1054,2,1469,"Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii.",Escherichiacoli
FLPLLLAGLPKLLCLFFKKC,1054,2,1470,"Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii.",Escherichiacoli
GLFDVVKGVLKGAGKNVAGSLLEQLKCKLSGGC,1054,2,1471,"Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii.",Escherichiacoli
GLFSVVTGVLKAVGKNVAKNVGGSLLEQLKCKISGGC,1054,2,1472,"Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii.",Escherichiacoli
FLIGMTHGLICLISRKC,1055,18,1476,Purification and characterization of antimicrobial peptides from the skin secretion of Rana dybowskii.,Micrococcusluteus
FLIGMTQGLICLITRKC,1055,18,1477,Purification and characterization of antimicrobial peptides from the skin secretion of Rana dybowskii.,Micrococcusluteus
GLFDVVKGVLKGVGKNVAGSLLEQLKCKLSGGC,1055,18,1478,Purification and characterization of antimicrobial peptides from the skin secretion of Rana dybowskii.,Micrococcusluteus
VWPLGLVICKALKIC,1055,18,1479,Purification and characterization of antimicrobial peptides from the skin secretion of Rana dybowskii.,Micrococcusluteus
FLPLLLAGLPLKLCFLFKKC,1055,18,1480,Purification and characterization of antimicrobial peptides from the skin secretion of Rana dybowskii.,Micrococcusluteus
GIINTIQRYFCRVRGGRCAALTCLPRETQIGRCSVKGRKCCRTRK,1056,171,1481,Identification and characterization of a mucosal antimicrobial peptide expressed by the chinchilla (Chinchilla lanigera) airway.,Haemophilusinfluenzae
VVKCSYRLGSPDSRCN,1057,2,1482,Anti-infection peptidomics of amphibian skin.,Escherichiacoli
AALKGCWTKSIPPKPCFGKR,1057,2,1483,Anti-infection peptidomics of amphibian skin.,Escherichiacoli
GVLGAVKDLLIGAGKSAAQSVLKTLSCKLSNDC,1057,2,1484,Anti-infection peptidomics of amphibian skin.,Escherichiacoli
GFLDTFKNLALNAAKSAGVSVLNSLSCKLFKTC,1057,2,1491,Anti-infection peptidomics of amphibian skin.,Escherichiacoli
GLGGAKKNFIIAANKTAPQSVKKTFSCKLYNG,1057,2,1492,Anti-infection peptidomics of amphibian skin.,Escherichiacoli
GFMDTAKNAAKNVAVTLLDNLKCKITKAC,1057,2,1493,Anti-infection peptidomics of amphibian skin.,Escherichiacoli
FMPILSCSRFKRC,1057,2,1494,Anti-infection peptidomics of amphibian skin.,Escherichiacoli
GIFGKILGVGKKVLCGLSGVC,1057,2,1495,Anti-infection peptidomics of amphibian skin.,Escherichiacoli
GFFTLIKAANKLINKTVNKEAGKGGLEIMA,1057,2,1497,Anti-infection peptidomics of amphibian skin.,Escherichiacoli
GLFTLIKCAYQLIAPTVACN,1057,2,1499,Anti-infection peptidomics of amphibian skin.,Escherichiacoli
GLFTLIKGAAKLIGKTVPKKQARLGMNLWLVKLPTNVKT,1057,2,1501,Anti-infection peptidomics of amphibian skin.,Escherichiacoli
VEVQVRDKGKGIYGLSPLRQPAP,1057,2,1502,Anti-infection peptidomics of amphibian skin.,Escherichiacoli
ATAWDFGPHGLLPIRPIRIRPLCGKDKS,1057,2,1503,Anti-infection peptidomics of amphibian skin.,Escherichiacoli
DEKGPKWKR,1057,2,1504,Anti-infection peptidomics of amphibian skin.,Escherichiacoli
AVPLIYNRPGIYVTKRPKGK,1057,2,1505,Anti-infection peptidomics of amphibian skin.,Escherichiacoli
VIPFVASVAAEMMQHVYCAASKKC,1057,2,1506,Anti-infection peptidomics of amphibian skin.,Escherichiacoli
GLLSGILGAGKHIVCGLSGPCQSLNRKSSDVEYHLAKC,1057,2,1507,Anti-infection peptidomics of amphibian skin.,Escherichiacoli
APFCLGYLSPKLKDMEPKPRG,1057,2,1517,Anti-infection peptidomics of amphibian skin.,Escherichiacoli
GFSPNLPGKGLRIS,1057,2,1518,Anti-infection peptidomics of amphibian skin.,Escherichiacoli
FLPPSPWKETFRTS,1057,2,1519,Anti-infection peptidomics of amphibian skin.,Escherichiacoli
TSRCYIGYRRKVVCS,1057,2,1520,Anti-infection peptidomics of amphibian skin.,Escherichiacoli
GCSRWIIGIHGQICRD,1057,2,1521,Anti-infection peptidomics of amphibian skin.,Escherichiacoli
GLLSGTSVRGSI,1057,2,1522,Anti-infection peptidomics of amphibian skin.,Escherichiacoli
GLFGKSSVWGRKYYVDLAGCAKA,1057,2,1523,Anti-infection peptidomics of amphibian skin.,Escherichiacoli
GLLSGILGAGKHIVCGLSGLC,1058,2,1524,Anti-infection peptidomics of amphibian skin,Escherichiacoli
GLLSGVLGVGKKVLCGLSGLC,1058,2,1525,Anti-infection peptidomics of amphibian skin,Escherichiacoli
GLLSGILGAGKHIVCGLSGLR,1058,2,1526,Anti-infection peptidomics of amphibian skin,Escherichiacoli
KRGPNCVGNFLGGLFAGAAAGVPLGPAGIVGGANLGMVGGALTCL,1059,87,1527,Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P,Listeriainnocua
KNGYGGSGNRWVHCGAGIVGGALIGAIGGPWSAVAGGISGGFASCH,1059,87,1528,Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P,Listeriainnocua
GLLSGILGAGKHIICGLSGLC,1058,2,1542,Anti-infection peptidomics of amphibian skin,Escherichiacoli
GLLSGILGAGKQKVCGLSGLC,1058,2,1543,Anti-infection peptidomics of amphibian skin,Escherichiacoli
GLLGKILGVEKKVLCGLSGMC,1058,2,1544,Anti-infection peptidomics of amphibian skin,Escherichiacoli
CLMARPNYRCKIFKQC,1060,4,1548,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus
GLHKVMREVLGYERNSYKKFFLR,1061,4,1562,"A novel antimicrobial peptide from salivary glands of the hard tick, Ixodes sinensis",Staphylococcusaureus
SNDIYFNFQR,1062,172,1568,An antifungal protein from flageolet beans,Mycosphaerellaarachidicola
FLPLAVSLAANFLPKLFCKITKKC,1063,4,1569,"Two families of antimicrobial peptides with multiple functions from skin of rufous-spotted torrent frog, Amolops loloensis",Staphylococcusaureus
FLPIVGKLLSGLSGLL,958,8,1570,Anticancer Activities of Antimicrobial BmKn2 Peptides Against Oral and Colon Cancer Cells,Bacillussubtilis
AMRLTYNKPCLYGT,71,2,1571,Antioxidant peptidomics reveals novel skin antioxidant system,Escherichiacoli
SIITMTKEAKLPQLWKQIACRLYNTC,71,2,1578,Antioxidant peptidomics reveals novel skin antioxidant system,Escherichiacoli
AGETHTVMINHAGRGAPKLVVGGKKLS,1064,65,1586,"Ganodermin, an antifungal protein from fruiting bodies of the medicinal mushroom Ganoderma lucidum",Botrytiscinerea
GFSSLFKAGAKYLLKSVGKAGAQQLACKAANNCA,1065,4,1588,Purification and characterization of novel antimicrobial peptides from the skin secretion of Hylarana guentheri,Staphylococcusaureus
GVITDALKGAAKTVAAELLRKAHCKLTNSC,1065,4,1589,Purification and characterization of novel antimicrobial peptides from the skin secretion of Hylarana guentheri,Staphylococcusaureus
FLGGLLASLLGKI,71,2,1590,Antioxidant peptidomics reveals novel skin antioxidant system,Escherichiacoli
YPELQQDLIARLL,71,2,1591,Antioxidant peptidomics reveals novel skin antioxidant system,Escherichiacoli
FLSGILKLAFKIPSVLCAVLKNC,71,2,1592,Antioxidant peptidomics reveals novel skin antioxidant system,Escherichiacoli
FRSGILKLASKIPSVLCAVLKNC,71,2,1594,Antioxidant peptidomics reveals novel skin antioxidant system,Escherichiacoli
SIWEGIKNAGKGFLVSILDKVRCKVAGGCNP,1065,4,1595,Purification and characterization of novel antimicrobial peptides from the skin secretion of Hylarana guentheri,Staphylococcusaureus
AKAWGIPPHVIPQIVPVRIRPLCGNV,71,2,1596,Antioxidant peptidomics reveals novel skin antioxidant system,Escherichiacoli
GFWDSVKEGLKNAAVTILNKIKCKISECPPA,71,2,1601,Antioxidant peptidomics reveals novel skin antioxidant system,Escherichiacoli
FIPGLRRLFATVVPTVVCAINKLPPG,71,2,1605,Antioxidant peptidomics reveals novel skin antioxidant system,Escherichiacoli
DDPDKGMLKWKNDFFQEF,71,2,1610,Antioxidant peptidomics reveals novel skin antioxidant system,Escherichiacoli
GLLDSVKEGLKKVAGQLLDTLKCKISGCTPA,71,2,1614,Antioxidant peptidomics reveals novel skin antioxidant system,Escherichiacoli
GFFDRIKALTKNVTLELLNTITCKLPVTPP,71,2,1619,Antioxidant peptidomics reveals novel skin antioxidant system,Escherichiacoli
SFGAKNAVKNGLQKLRNQCQANNYQGPFCDIFKKNP,71,2,1620,Antioxidant peptidomics reveals novel skin antioxidant system,Escherichiacoli
VIDDLKKVAKKVRRELLCKKHHKKLN,1065,4,1631,Purification and characterization of novel antimicrobial peptides from the skin secretion of Hylarana guentheri,Staphylococcusaureus
EWEPVQNGGSSYYMVPRIWA,1066,173,1637,"Psc-AFP, an antifungal protein with trypsin inhibitor activity from Psoralea corylifolia seeds",Alternariabrassicae
SIITMTKEAKLPQSWKQIACRLYNTC,1067,2,1638,A new family of antimicrobial peptides from skin secretions of Rana pleuraden.,Escherichiacoli
GLLRASSVWGRKYYVDLAGCAKA,1068,2,1639,An antimicrobial peptide with antimicrobial activity against Helicobacter pylori.,Escherichiacoli
CIGNGGRCNENVGPPYCCSGFCLRQPNQGYGVCRNR,1069,36,1643,Isolation and characterization of a novel class of plant antimicrobial peptides form Mirabilis jalapa L. seeds,Alternariabrassicicola
FFPIGVFCKIFKTC,1070,2,1644,Antimicrobial peptides with atypical structural features from the skin of the Japanese brown frog Rana japonica,Escherichiacoli
FGLPMLSILPKALCILLKRKC,1070,2,1645,Antimicrobial peptides with atypical structural features from the skin of the Japanese brown frog Rana japonica,Escherichiacoli
NEYHGFVDKANNENKRKKQQGRDDFVVKPNNFANRRRKDDYNENYYDDVDAADVV,1071,65,1647,"Isolation of cicadin, a novel and potent antifungal peptide from dried juvenile cicadas",Botrytiscinerea
VCSCRLVFCRRTELRVGNCLIGGVSFTYCCTRV,1072,2,1648,"Purification and characterization of human neutrophil peptide 4, a novel member of the defensin family.",Escherichiacoli
KTCENLADDY,1073,24,1650,"Gymnin, a potent defensin-like antifungal peptide from the Yunnan bean (Gymnocladus chinensis Baill)",Fusariumoxysporum
DNGEAGRAAR,1074,24,1655,"A ribonuclease with antimicrobial, antimitogenic and antiproliferative activities from the edible mushroom Pleurotus sajor-caju",Fusariumoxysporum
KQTENLADTY,1075,172,1665,"Coccinin, an antifungal peptide with antiproliferative and HIV-1 reverse transcriptase inhibitory activities from large scarlet runner beans",Mycosphaerellaarachidicola
ANDPQCLYGNVAAKF,1076,172,1666,"Agrocybin, an antifungal peptide from the edible mushroom Agrocybe cylindracea",Mycosphaerellaarachidicola
CVISAGWNHKIRCKLTGNC,1077,4,1667,"Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata",Staphylococcusaureus
FKTWKRPPFQTSCWGIIKE,1077,4,1668,"Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata",Staphylococcusaureus
CVHWQTNTARTSCIGP,1077,4,1669,"Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata",Staphylococcusaureus
DCTRWIIGINGRICRD,1077,4,1670,"Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata",Staphylococcusaureus
SLWETIKNAGKGFIQNILDKIR,1077,4,1671,"Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata",Staphylococcusaureus
SLWETIKNAGKGFILNILDKIRCKVAGGCKT,1077,4,1672,"Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata",Staphylococcusaureus
FIGPVLKIAAGILPTAICKIFKKC,1077,4,1673,"Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata",Staphylococcusaureus
FVGPVLKIAAGILPTAICKIYKKC,1077,4,1674,"Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata",Staphylococcusaureus
FLGPIIKIATGILPTAICKFLKKC,1077,4,1675,"Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata",Staphylococcusaureus
SIRDKIKTIAIDLAKSAGTGVLKTLICKLDKSC,1077,4,1676,"Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata",Staphylococcusaureus
SIRDKIKTIAIDLAKSAGMGILKTLICKLDKSC,1077,4,1677,"Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata",Staphylococcusaureus
SIRDKIKTIAIDLAKSAGTGVLKTLICKLNKSC,1077,4,1678,"Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata",Staphylococcusaureus
DDFLCAGGCL,1078,172,1681,"Isolation of alliumin, a novel protein with antimicrobial and antiproliferative activities from multiple-cloved garlic bulbs",Mycosphaerellaarachidicola
DKLIGSCVWGAVNYTSDCNGECKRRGYKGGHCGSFANVNCWCET,1079,2,1686,Insect immunity. Isolation from the lepidopteran Heliothis virescens of a novel insect defensin with potent antifungal activity,Escherichiacoli
KGRGKQGGKVRAKAKTRSS,1081,16,1718,Cathepsin D produces antimicrobial peptide parasin I from histone H2A in the skin mucosa of fish.,Aeromonassalmonicida
KFFRKLKKSVKKRAKEFFKKPRVIGVSIPF,74,8,1737,Snake cathelicidin from Bungarus fasciatus is a potent peptide antibiotics.,Bacillussubtilis
GIPCGESCVWIPCISSAIGCSCKSKVCYRN,1083,174,1740,Cyclotides: a novel type of cytotoxic agents,HumanMyeloma
GLPVCGETCVGGTCNTPGCSCSWPVCTRN,1084,174,1770,Cyclotides: a novel type of cytotoxic agents.,HumanMyeloma
GVPICGETCTLGTCYTAGCSCSWPVCTRN,1084,174,1771,Cyclotides: a novel type of cytotoxic agents.,HumanMyeloma
AFTCHCRRSCYSTEYSYGTCTVMGINHRFCCL,1080,2,1772,"Crystal structures of human alpha-defensins HNP4, HD5, and HD6",Escherichiacoli
RLGNFFRKAKKKIGRGLKKIGQKIKDFLGNLVPRTES,1085,2,1775,Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity,Escherichiacoli
RLGDILQKAREKIEGGLKKLVQKIKDFFGKFAPRTES,1085,2,1776,Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity,Escherichiacoli
LLGDFFRKAREKIGEEFKRIVQRIKDFLRNLVPRTES,1085,2,1777,Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity,Escherichiacoli
RLGNFFRKVKEKIGGGLKKVGQKIKDFLGNLVPRTAS,1085,2,1778,Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity,Escherichiacoli
GIGKFLHSAGKFGKAFVGEIMKS,1087,2,1781,Synthetic magainin analogues with improved antimicrobial activity,Escherichiacoli
ATCDLLSAFGVGHAACAAHCIGHGYRGGYCNSKAVCTCRR,1088,4,1799,Characterization of a defensin from the sand fly Phlebotomus duboscqi induced by challenge with bacteria or the protozoan parasite Leishmania major,Staphylococcusaureus
HSHACTSYWCGKFCGTASCTHYLCRVLHPGKMCACVHCSR,1089,18,1800,"Myticin, a novel cysteine-rich antimicrobial peptide isolated from haemocytes and plasma of the mussel Mytilus galloprovincialis",Micrococcusluteus
HPHVCTSYYCSKFCGTAGCTRYGCRNLHRGKLCFCLHCSR,1089,18,1801,"Myticin, a novel cysteine-rich antimicrobial peptide isolated from haemocytes and plasma of the mussel Mytilus galloprovincialis",Micrococcusluteus
FLPMLAGLAASMVPKFVCLITKKC,1090,4,1802,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Staphylococcusaureus
GILSLFTGGIKALGKTLFKMAGKAGAEHLACKATNQC,1090,4,1803,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Staphylococcusaureus
GILDSFKGVAKGVAKDLAGKLLDKLKCKITGC,1090,4,1804,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Staphylococcusaureus
GILSSIKGVAKGVAKNVAAQLLDTLKCKITGC,1090,4,1805,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Staphylococcusaureus
FLPFIAGMAAKFLPKIFCAISKKC,1090,4,1809,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Staphylococcusaureus
FLPAIAGMAAKFLPKIFCAISKKC,1090,4,1810,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Staphylococcusaureus
FLPFIAGVAAKFLPKIFCAISKKC,1090,4,1811,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Staphylococcusaureus
FLPAIAGVAAKFLPKIFCAISKKC,1090,4,1812,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Staphylococcusaureus
FLPAIVGAAAKFLPKIFCVISKKC,1090,4,1813,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Staphylococcusaureus
FLPFIAGMAANFLPKIFCAISKKC,1090,4,1814,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Staphylococcusaureus
GLFSILRGAAKFASKGLGKDLTKLGVDLVACKISKQC,1090,4,1815,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Staphylococcusaureus
GLLDTIKGVAKTVAASMLDKLKCKISGC,1090,4,1816,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Staphylococcusaureus
FLPIIAGVAAKVFPKIFCAISKKC,1090,4,1817,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Staphylococcusaureus
FLPIIASVAAKVFSKIFCAISKKC,1090,4,1818,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Staphylococcusaureus
FLPIIASVAANVFSKIFCAISKKC,1090,4,1819,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Staphylococcusaureus
GFSSIFRGVAKFASKGLGKDLARLGVNLVACKISKQC,1090,2,1820,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Escherichiacoli
YSRCQLQGFNCVVRSYGLPTIPCCRGLTCRSYFPGSTYGRCQRY,1093,2,1849,"Horseshoe crab hemocyte-derived antimicrobial polypeptides, tachystatins, with sequence similarity to spider neurotoxins",Escherichiacoli
YVSCLFRGARCRVYSGRSCCFGYYCRRDFPGSIFGTCSRRNF,1093,2,1850,"Horseshoe crab hemocyte-derived antimicrobial polypeptides, tachystatins, with sequence similarity to spider neurotoxins",Escherichiacoli
DYDWSLRGPPKCATYGQKCRTWSPPNCCWNLRCKAFRCRPR,1093,2,1851,"Horseshoe crab hemocyte-derived antimicrobial polypeptides, tachystatins, with sequence similarity to spider neurotoxins",Escherichiacoli
VFIDILDKVENAIHNAAQVGIGFAKPFEKLINPK,1095,2,1853,"The andropin gene and its product, a male-specific antibacterial peptide in Drosophila melanogaster",Escherichiacoli
SFGLCRLRRGFCARGRCRFPSIPIGRCSRFVQCCRRVW,1096,18,1854,"Spheniscins, avian beta-defensins in preserved stomach contents of the king penguin, Aptenodytes patagonicus",Micrococcusluteus
GIFALIKTAAKFVGKNLLKQAGKAGLEHLACKANNQC,1097,4,1857,"Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis",Staphylococcusaureus
GIFSLIKTAAKFVGKNLLKQAGKAGVEHLACKANNQC,1097,4,1858,"Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis",Staphylococcusaureus
GIFSKFAGKGIKNLLVKGVKNIGKEVGMDVIRTGIDIAGCKIKGEC,1098,2,1872,Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae,Escherichiacoli
RIFSKIGGKAIKNLILKGIKNIGKEVGMDVIRTGIDVAGCKIKGEC,1098,2,1873,Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae,Escherichiacoli
GIFSLIKGAAKLITKTVAKEAGKTGLELMACKVTNQC,1098,2,1874,Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae,Escherichiacoli
GFMDTAKNVAKNVAVTLLDKLKCKITGGC,1098,2,1875,Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae,Escherichiacoli
SLLDTFKNLAVNAAKSAGVSVLNALSCKISRTC,1098,2,1876,Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae,Escherichiacoli
SFLTTFKDLAIKAAKSAGQSVLSTLSCKLSNTC,1098,2,1877,Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae,Escherichiacoli
SVLGTVKDLLIGAGKSAAQSVLTTLSCKLSNSC,1098,2,1878,Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae,Escherichiacoli
GIFSTVFKAGKGIVCGLTGLC,1098,2,1879,Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae,Escherichiacoli
GILGTVFKAGKGIVCGLTGLC,1098,2,1880,Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae,Escherichiacoli
SLFSIFKTAAKFVGKNLLKQAGKAGLETLACKAKNEC,1099,175,1886,Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis,Rhodococcusrhodochrous
GLWNTIKEAGKKFAINVLDKIRCGIAGGCKT,1099,175,1887,Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis,Rhodococcusrhodochrous
FLSTALKVAANVVPTLFCKITKKC,1099,175,1888,Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis,Rhodococcusrhodochrous
FLPIVAGLAANFLPKIVCKITKKC,1099,175,1889,Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis,Rhodococcusrhodochrous
FLSTLLNVASNVVPTLICKITKKC,1099,175,1890,Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis,Rhodococcusrhodochrous
FLSTLLNVASKVVPTLFCKITKKC,1099,175,1891,Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis,Rhodococcusrhodochrous
FLPMLAGLAANFLPKIVCKITKKC,1099,175,1892,Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis,Rhodococcusrhodochrous
GILDKLKEFGISAARGVAQSLLNTASCKLAKTC,1099,175,1893,Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis,Rhodococcusrhodochrous
GFMDTAKNVAKNVAATLLDKLKCKITGGC,1101,2,1895,Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning,Escherichiacoli
GFMSTASNVLTNVAGTVMDKLKCKFTGAC,1101,2,1896,Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning,Escherichiacoli
GILSTVFKAGKGIVCGLSGLC,1101,2,1897,Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning,Escherichiacoli
FLPGVLRLVTKVGPAVVCAITRNC,1101,2,1898,Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning,Escherichiacoli
ATAWNLGPHGLRPIRPIRIRPLCGKDKS,1101,2,1899,Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning,Escherichiacoli
AAGYPFGIKV,1101,2,1900,Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning,Escherichiacoli
AAIYPFGIKIRCKAAFC,1101,2,1901,Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning,Escherichiacoli
NFYEIFRNRNRGGLIKDAATPWLPCEILRPC,1101,2,1902,Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning,Escherichiacoli
NIFEIFRNRNRGGLIKDAATPWLPCEILRPC,1101,2,1903,Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning,Escherichiacoli
SPYRCGSPDSRGSENTRCLIKK,1101,2,1904,Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning,Escherichiacoli
RLMKCYKPNSRGFQLCE,1101,2,1905,Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning,Escherichiacoli
CGYRHGRLNCGRG,1101,2,1906,Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning,Escherichiacoli
GIFSVLNEVCKKNDYKPEICAHFSQNKP,1101,2,1907,Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning,Escherichiacoli
GIFSSRKCKTPSKTFKGYCTRDSNCDTSCRYEGYPAGD,1102,12,1908,Novel defensin subfamily from spinach (Spinacia oleracea).,Clavibactermichiganensis
GIFSSRKCKTPSKTFKGICTRDSNCDTSCRYEGYPAGDCKGIRRRCMCSKPC,1102,12,1909,Novel defensin subfamily from spinach (Spinacia oleracea).,Clavibactermichiganensis
ATCDLLSGTGINHSACAAHCLLRGNRGGYCNGKAVCVCRN,1104,4,1911,"Purification of three antibacterial proteins from the culture medium of NIH-Sape-4, an embryonic cell line of Sarcophaga peregrina.",Staphylococcusaureus
LCNERPSQTWSGNCGNTAHCDKQCQDWEKASHGACHKRENHWKCFCYFNC,1105,65,1920,"Isolation and characterisation of plant defensins from seeds of Asteraceae, Fabaceae, Hippocastanaceae and Saxifragaceae.",Botrytiscinerea
NLCERASLTWTGNCGNTGHCDTQCRNWESAKHGACHKRGNWKCFCYFNC,1106,65,1921,"Isolation and characterisation of plant defensins from seeds of Asteraceae, Fabaceae, Hippocastanaceae and Saxifragaceae",Botrytiscinerea
ELCEKASKTWSGNCGNTGHCDNQCKSWEGAAHGACHVRNGKHMCFCYFNC,1106,65,1922,"Isolation and characterisation of plant defensins from seeds of Asteraceae, Fabaceae, Hippocastanaceae and Saxifragaceae",Botrytiscinerea
DGVKLCDVPSGTWSGHCGSSSKCSQQCKDREHFAYGGACHYQFPSVKCFCKRQC,1106,65,1924,"Isolation and characterisation of plant defensins from seeds of Asteraceae, Fabaceae, Hippocastanaceae and Saxifragaceae",Botrytiscinerea
RVCMGKSQHHSFPCISDRLCSNECVKEEGGWTAGYCHLRYCRCQKAC,1106,65,1925,"Isolation and characterisation of plant defensins from seeds of Asteraceae, Fabaceae, Hippocastanaceae and Saxifragaceae",Botrytiscinerea
ATYNGKCYKKDNICKYKAQSGKTAICKCYVKKCPRDGAKCEFDSYKGKCYC,1107,176,1943,The antifungal protein from Aspergillus giganteus causes membrane permeabilization.,Fusariumsporotrichioides
FMPIIGRLMSGSL,1108,2,1947,Antimicrobial peptides from the venoms of Vespa bicolor Fabricius.,Escherichiacoli
INMKASAAVAKKLL,1108,2,1948,Antimicrobial peptides from the venoms of Vespa bicolor Fabricius.,Escherichiacoli
GTCKAECPTWEGICINKAPCVKCCKAQPEKFTDGHCSKILRRCLCTKPC,1109,24,1953,Isolation and properties of floral defensins from ornamental tobacco and petunia.,Fusariumoxysporum
ATCKAECPTWDSVCINKKPCVACCKKAKFSDGHCSKILRRCLCTKEC,1109,24,1954,Isolation and properties of floral defensins from ornamental tobacco and petunia.,Fusariumoxysporum
RECKTESNTFPGICITKPPCRKACISEKFTDGHCSKILRRCLCTKPC,1109,24,1955,Isolation and properties of floral defensins from ornamental tobacco and petunia.,Fusariumoxysporum
YSRCQLQGFNCVVRSYGLPTIPCCRGLTCRSYFPGSTYGRCQRF,1110,2,1956,"Horseshoe crab hemocyte-derived antimicrobial polypeptides, tachystatins, with sequence similarity to spider neurotoxins.",Escherichiacoli
QLINSPVTCMSYGGSCQRSCNGGFRLGGHCGHPKIRCCRRK,1111,2,1957,"A novel mouse beta-defensin, mBD-6, predominantly expressed in skeletal muscle.",Escherichiacoli
KTCMTKKEGWGRCLIDTTCAHSCRKYGYMGGKCQGITRRCYCLLNC,1112,4,1964,Identification of a cowpea gamma-thionin with bactericidal activity.,Staphylococcusaureus
KLCERSSGTWSGVCGNNNACKNQCIRLEGAQHGSCNYVFPAHKCICYFPC,1113,36,1966,Small cysteine-rich antifungal proteins from radish: their role in host defense.,Alternariabrassicicola
KSCCPSTTARNIYNTCRLTGASRSVCASLSGCKIISGSTCDSGWNH,1114,127,1967,"Ligatoxin B, a new cytotoxic protein with a novel helix-turn-helix DNA-binding domain from the mistletoe Phoradendron liga.",Humanhistiocytic
GAFGDLLKGVAKEAGMKLLNMAQCKLSGKC,1115,4,1970,"Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii",Staphylococcusaureus
SILDKIKNVALGVARGAGTGILKALLCKLDKSC,1115,4,1971,"Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii",Staphylococcusaureus
GVLDTFKDVAIGVAKGAGTGVLKALLCKLDKSC,1115,4,1974,"Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii",Staphylococcusaureus
RISFKKGKGSWIKNGLIKGIKGLGKEISLDVIRTGIDIAGCKIKGEC,1116,4,1975,"Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii.",Staphylococcusaureus
GIFSLFKAGAKFFGKHLLKQAGKAGAEHLACKATNQC,1116,4,1976,"Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii.",Staphylococcusaureus
SLWENFKNAGKQFILNILDKIRCRVAGGCRT,1116,4,1977,"Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii.",Staphylococcusaureus
FLPLLAGVVANFLPQIICKIARKC,1117,4,1979,Identification and characterization of antimicrobial peptides from skin of Amolops ricketti (Anura: Ranidae).,Staphylococcusaureus
FLGSLLGLVGKVVPTLFCKISKKC,1117,4,1980,Identification and characterization of antimicrobial peptides from skin of Amolops ricketti (Anura: Ranidae).,Staphylococcusaureus
GLMSTLKDFGKTAAKEIAQSLLSTASCKLAKTC,1117,4,1981,Identification and characterization of antimicrobial peptides from skin of Amolops ricketti (Anura: Ranidae).,Staphylococcusaureus
GILDTLKEFGKTAAKGIAQSLLSTASCKLAKTC,1117,4,1982,Identification and characterization of antimicrobial peptides from skin of Amolops ricketti (Anura: Ranidae).,Staphylococcusaureus
LVQRGRFGRFLRKIRRFRPKVTITIQGSARFG,1118,2,1983,Identification and functional characterization of three chicken cathelicidins with potent antimicrobial activity.,Escherichiacoli
GLVSSIGRALGGLLADVVKSKEQPA,1119,25,1992,"Host-defence peptide profiles of the skin secretions of interspecific hybrid tree frogs and their parents, female Litoria splendida and male Litoria caerulea",Bacilluscereus
GLVSSIGKVLGGLLADVVKSKGQPA,1119,25,1993,"Host-defence peptide profiles of the skin secretions of interspecific hybrid tree frogs and their parents, female Litoria splendida and male Litoria caerulea",Bacilluscereus
AEILFGDVRPPWMPPPIFPEMP,1119,25,1997,"Host-defence peptide profiles of the skin secretions of interspecific hybrid tree frogs and their parents, female Litoria splendida and male Litoria caerulea",Bacilluscereus
VFQFLGKIIHHVGNFVHGFSHVF,1120,4,2003,Effects of pH and salinity on the antimicrobial properties of clavanins,Staphylococcusaureus
PIRNWWIRIWEWLNGIRKRLRQRSPFYVRGHLNVTSTPQP,1121,2,2005,"Chicken cathelicidin-B1, an antimicrobial guardian at the mucosal M cell gateway",Escherichiacoli
GYGGHGGHGGHGGHGGHGGHGHGGGGHG,1123,26,2009,"Characterization and cDNA cloning of two glycine- and histidine-rich antimicrobial peptides from the roots of shepherd's purse, Capsella bursa-pastoris",Erwiniaherbicola
GYHGGHGGHGGGYNGGGGHGGHGGGYNGGGHHGGGGHG,1123,26,2010,"Characterization and cDNA cloning of two glycine- and histidine-rich antimicrobial peptides from the roots of shepherd's purse, Capsella bursa-pastoris",Erwiniaherbicola
GFGCPGNQLKCNNHCKSISCRAGYCDAATLWLRCTCTDCNGKK,1125,34,2017,"Characterization of a defensin from the oyster Crassostrea gigas. Recombinant production, folding, solution structure, antimicrobial activities, and gene expression",Micrococcuslysodeikticus
ISRLAGLLRKGGEKIGEKLKKIGQKIKNFFQKLVPQPE,1126,2,2028,"Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse",Escherichiacoli
ISRLAGLLRKGGEKIGEKLKKIGQKIKNFFQKLVPQPEQ,81,3,2031,Bactericidal activity of mammalian cathelicidin-derived peptides.,Pseudomonasaeruginosa
FALLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,81,3,2033,Bactericidal activity of mammalian cathelicidin-derived peptides.,Pseudomonasaeruginosa
DTHFPICIFCCGCCHRSKCGMCCKT,1127,8,2042,"LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity.",Bacillussubtilis
ICIFCCGCCHRSKCGMCCKT,1128,2,2043,"Hepcidin, a urinary antimicrobial peptide synthesized in the liver.",Escherichiacoli
APGNKAECEREKGYCGFLKCSFPFVVSGKCSRFFFCCKNIW,1129,4,2045,Identification of three novel ostricacins: an update on the phylogenetic perspective of beta-defensins.,Staphylococcusaureus
LFCRKGTCHFGGCPAHLVKVGSCFGFRACCKWPWDV,1129,2,2046,Identification of three novel ostricacins: an update on the phylogenetic perspective of beta-defensins.,Escherichiacoli
IPRPLDPCIAQNGRCFTGICRYPYFWIGTCRNGKSCCRRR,1129,2,2047,Identification of three novel ostricacins: an update on the phylogenetic perspective of beta-defensins.,Escherichiacoli
LPVNEAQCRQVGGYCGLRICNFPSRFLGLCTRNHPCCSRVWV,1129,2,2048,Identification of three novel ostricacins: an update on the phylogenetic perspective of beta-defensins.,Escherichiacoli
GNNRPVYIPQPRPPHPRI,86,2,2090,Antibiotic Peptides,Escherichiacoli
GGAGHVPEYFVGIGTPISFYG,1131,2,2121,"Microcin 25, a novel antimicrobial peptide produced by Escherichia coli.",Escherichiacoli
INLLKIAKGIIKSL,85,4,2123,Conformation and lytic activity of eumenine mastoparan: a new antimicrobial peptide from wasp venom.,Staphylococcusaureus
LNLKGLIKKVASLLN,1132,4,2126,Chemical and biological characterization of four new linear cationic a-helical peptides from the venoms of two solitary eumenine wasps.,Staphylococcusaureus
LNLKGLFKKVASLLT,1132,4,2127,Chemical and biological characterization of four new linear cationic a-helical peptides from the venoms of two solitary eumenine wasps.,Staphylococcusaureus
AKIPIKAIKTVGKAVGKGLRAINIASTANDVFNFLKPKKRKH,1133,2,2135,"Moricin, a novel type of antibacterial peptide isolated from the silkworm, Bombyx mori.",Escherichiacoli
WFYQGMNIAIYANIGGVANIIGYTEAAVATLLGAVVAVAPVVP,1134,178,2136,"Molecular and genetic characterization of propionicin F, a bacteriocin from Propionibacterium freudenreichii.",Propionibacteriumacidipropionici
VIEPKCYKYEGKKCPPDINPVCGTDKRTYYNECALCVFIRQSTKKADKAIKIKKWGKC,1135,2,2137,A Kazal prolyl endopeptidase inhibitor isolated from the skin of Phyllomedusa sauvagii.,Escherichiacoli
GGLKKLGKKLEGAGKRVFNAAEKALPVVAGAKAL,1136,2,2138,"Antimicrobial activity spectrum, cDNA cloning, and mRNA expression of a newly isolated member of the cecropin family from the mosquito vector Aedes aegypti.",Escherichiacoli
RPEIKKKNVFSKPGYCPEYRVPCPFVLIPKCRRDKGCKDALKCCFFYCQMRCVDPWESPE,1137,2,2139,Mouse SWAM1 and SWAM2 are antibacterial proteins composed of a single whey acidic protein motif.,Escherichiacoli
DLHIPPPDNKINWPQLSGGGGGSPKTGYDININAQQK,1138,2,2141,Purification and characterization of a diptericin homologue from Sarcophaga peregrina (flesh fly).,Escherichiacoli
FFGHLFKLATKIIPSLFQ,1139,179,2144,Structural and functional characterization of two genetically related meucin peptides highlights evolutionary divergence and convergence in antimicrobial peptides.,Bacillussp.
KVNVNAIKKGGKAIGKGFKVISAASTAHDVYEHIKNRRH,87,2,2148,The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella.,Escherichiacoli
GKIPVKAIKKGGQIIGKALRGINIASTAHDIISQFKPKKKKNH,87,2,2149,The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella.,Escherichiacoli
KVPIGAIKKGGKIIKKGLGVIGAAGTAHEVYSHVKNRH,87,2,2150,The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella.,Escherichiacoli
KVPIGAIKKGGKIIKKGLGVLGAAGTAHEVYNHVRNRQ,87,2,2151,The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella.,Escherichiacoli
KVPIGAIKKGGKIIKKGLGVIGAAGTAHEVYSHVKNRQ,87,2,2152,The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella.,Escherichiacoli
KVPVGAIKKGGKAIKTGLGVVGAAGTAHEVYSHIRNRH,87,2,2153,The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella.,Escherichiacoli
KGIGSALKKGGKIIKGGLGALGAIGTGQQVYEHVQNRQ,87,2,2154,The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella.,Escherichiacoli
AGRGKQGGKVRAKAKTRSSRAGLQFPVGRVHRLLRKGNY,1141,8,2158,A novel antimicrobial peptide from Bufo bufo gargarizans.,Bacillussubtilis
FLPLIAGLAANFLPKIFCAITKKC,1142,2,2168,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli
FLPVIAGVAAKFLPKIFCAITKKC,1142,2,2169,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli
GLFSILKGVGKIALKGLAKNMGKMGLDLVSCKISKEC,1142,2,2170,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli
GIMDTVKNVAKNLAGQLLDKLKCKITAC,1142,2,2171,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli
GIMDTVKNAAKDLAGQLLDKLKCRITGC,1142,2,2172,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli
GLLDTIKNTAKNLAVGLLDKIKCKMTGC,1142,2,2173,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli
GIMDSVKNVAKNIAGQLLDKLKCKITGC,1142,2,2174,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli
GIMDSVKNAAKNLAGQLLDTIKCKITAC,1142,2,2175,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli
GIMDTVKNAAKDLAGQLDKLKCRITGC,1142,2,2176,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli
GLFPKINKKKAKTGVFNIIKTVGKEAGMDLIRTGIDTIGCKIKGEC,1142,2,2177,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli
GIFTKINKKKAKTGVFNIIKTIGKEAGMDVIRAGIDTISCKIKGEC,1142,2,2178,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli
ALFSILRGLKKLGNMGQAFVNCKIYKKC,1142,2,2180,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli
ALSILKGLEKLAKMGIALTNCKATKKC,1142,2,2181,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli
GFFSTVKNLATNVAGTVIDTLKCKVTGGCRS,1142,2,2182,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli
GFLSTVKNLATNVAGTVIDTLKCKVTGGCRS,1142,2,2183,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli
GIFPKIIGKGIKTGIVNGIKSLVKGVGMKVFKAGLNNIGNTGCNEDEC,1142,2,2184,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli
GIFPKIIGKGIKTGIVNGIKSLVKGVGMKVFKAGLSNIGNTGCNEDEC,1142,2,2185,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli
ALSILRGLEKLAKMGIALTNCKATKKC,1142,2,2186,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli
GSNTGFNFKTLDKE,1143,4,2188,"Maximins S, a novel group of antimicrobial peptides from toad Bombina maxima.",Staphylococcusaureus
QGYKSGHTGPYPRPLYGSRPIGLRPITRPDPSCAGCRILTLDDAIACCRRLGRCCSALKG,1144,4,2191,Characterization and expression of a new subfamily member of penaeidin antimicrobial peptides (penaeidin 5) from Fenneropenaeus chinensis.,Staphylococcusaureus
SRWPSPGRPRPFPGRPKPIFRPRPCNCYAPPCPCDRW,1145,180,2192,"Arasin 1, a proline-arginine-rich antimicrobial peptide isolated from the spider crab, Hyas araneus.",Listonellaanguillarum
GLFSKFAGKGIKNLIFKGVKHIGKEVGMDVIRTGIDVAGCKIKGEC,1146,2,2193,"Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami.",Escherichiacoli
GLLDTFKNLALNAAKSAGVSVLNSLSCKLSKTC,1146,2,2194,"Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami.",Escherichiacoli
FLPLLAGLAANFLPKIFCKITKKC,1146,2,2195,"Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami.",Escherichiacoli
GLFTLIKGAAKLIGKTVAKEAGKTGLELMACKITNQC,1146,4,2196,"Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami.",Staphylococcusaureus
GLLSGILGAGKNIVCGLSGLC,1146,2,2197,"Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami.",Escherichiacoli
GLFGKILGVGKKVLCGLSGMC,1146,2,2198,"Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami.",Escherichiacoli
GVLGTVKNLLIGAGKSAAQSVLKTLSCKLSNDC,1146,2,2199,"Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami.",Escherichiacoli
GILSSFKGVAKGVAKDLAGKLLETLKCKITGC,1147,2,2200,Peptide defenses of the Cascades frog Rana cascadae: implications for the evolutionary history of frogs of the Amerana species group.,Escherichiacoli
FLPILAGLAAKIVPKLFCLATKKC,1147,2,2201,Peptide defenses of the Cascades frog Rana cascadae: implications for the evolutionary history of frogs of the Amerana species group.,Escherichiacoli
GIMSLFKGVLKTAGKHVAGSLVDQLKCKITGGC,1148,2,2210,Antimicrobial peptides from the skin of the Tsushima brown frog Rana tsushimensis.,Escherichiacoli
GFLDSFKNAMIGVAKSVGKTALSTLACKIDKSC,1149,2,2213,"Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",Escherichiacoli
GLLDSLKNLAINAAKGAGQSVLNTLSCKLSKTC,1149,2,2214,"Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",Escherichiacoli
GIFSKFGGKAIKNLFIKGAKNIGKEVGMDVIRTGIDVAGCKIKGEC,1149,2,2215,"Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",Escherichiacoli
GIFSLIKGAAQLIGKTVAKEAGKTGLELMACKVTKQC,1149,2,2216,"Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",Escherichiacoli
FLPAVLRVAAKIVPTVFCAISKKC,1149,2,2217,"Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",Escherichiacoli
FLPAVLRVAAQVVPTVFCAISKKC,1149,2,2218,"Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",Escherichiacoli
GLLGSLFGAGKKVACALSGLC,1149,2,2219,"Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",Escherichiacoli
GLLGSIFGAGKKIACALSGLC,1149,2,2220,"Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",Escherichiacoli
FMGGLIKAATKIVPAAYCAITKKC,1149,2,2221,"Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",Escherichiacoli
GAIKDALKGAAKTVAVELLKKAQCKLEKTC,1149,2,2222,"Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",Escherichiacoli
GFKGAFKNVMFGIAKSAGKSALNALACKIDKSC,1149,2,2223,"Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",Escherichiacoli
GLLDSFKNAMIGIAKSAGKTALNKIACKIDKTC,1149,2,2224,"Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",Escherichiacoli
VDKPDYRPRPRPPNM,89,30,2249,Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.,HIV-1IIIB
FLPKMSTKLRVPYRRGTKDYH,1151,2,2251,Two novel antimicrobial peptides from centipede venoms.,Escherichiacoli
GILKKFMLHRGTKVYKMRTLSKRSH,1151,2,2252,Two novel antimicrobial peptides from centipede venoms.,Escherichiacoli
FRPALIVRTKGTRL,89,30,2254,Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.,HIV-1IIIB
KWCFRVCYRGICYRRCR,88,29,2261,Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells.,Leishmaniapanamensis
GLASFLGKALKAGLKIGSHLLGGAPQQ,1152,2,2270,"Host-defense peptides from skin secretions of the tetraploid frogs Xenopus petersii and Xenopus pygmaeus, and the octoploid frog Xenopus lenduensis (Pipidae).",Escherichiacoli
GFGSFLGKALKAALKIGANVLGGAPQQ,1152,2,2271,"Host-defense peptides from skin secretions of the tetraploid frogs Xenopus petersii and Xenopus pygmaeus, and the octoploid frog Xenopus lenduensis (Pipidae).",Escherichiacoli
GFGSFLGKALKAALKIGANVLGGAPEQ,1152,2,2272,"Host-defense peptides from skin secretions of the tetraploid frogs Xenopus petersii and Xenopus pygmaeus, and the octoploid frog Xenopus lenduensis (Pipidae).",Escherichiacoli
GFGSFLGKALKAALKIGADVLGGAPQQ,1152,2,2273,"Host-defense peptides from skin secretions of the tetraploid frogs Xenopus petersii and Xenopus pygmaeus, and the octoploid frog Xenopus lenduensis (Pipidae).",Escherichiacoli
GVIIDTLKGAAKTVAAELLRKAHCKLTNSC,1153,181,2281,Peptides with antimicrobial and anti-inflammatory activities that have therapeutic potential for treatment of acne vulgaris.,Propionibacteriumacnes
GLKEVLHSTKKFAKGFITGLTGQ,1154,2,2284,Host-defense peptides in skin secretions of the tetraploid frog Silurana epitropicalis with potent activity against methicillin-resistant Staphylococcus aureus (MRSA).,Escherichiacoli
GLFLDTLKKFAKAGMEAVTNPK,1154,2,2287,Host-defense peptides in skin secretions of the tetraploid frog Silurana epitropicalis with potent activity against methicillin-resistant Staphylococcus aureus (MRSA).,Escherichiacoli
GLASTIGSLLGKFAKGGAQAFLQPK,1154,2,2288,Host-defense peptides in skin secretions of the tetraploid frog Silurana epitropicalis with potent activity against methicillin-resistant Staphylococcus aureus (MRSA).,Escherichiacoli
GFWTTAAEGLKKFAKAGLASILNPK,1154,2,2289,Host-defense peptides in skin secretions of the tetraploid frog Silurana epitropicalis with potent activity against methicillin-resistant Staphylococcus aureus (MRSA).,Escherichiacoli
GVWTTILGGLKKFAKGGLEALTNPK,1154,2,2290,Host-defense peptides in skin secretions of the tetraploid frog Silurana epitropicalis with potent activity against methicillin-resistant Staphylococcus aureus (MRSA).,Escherichiacoli
GFLGPLLKLGLKGVAKVIPHLIPSRQQ,1154,2,2291,Host-defense peptides in skin secretions of the tetraploid frog Silurana epitropicalis with potent activity against methicillin-resistant Staphylococcus aureus (MRSA).,Escherichiacoli
GFLGPLLKLGLKGAAKLLPQLLPSRQQ,1154,2,2292,Host-defense peptides in skin secretions of the tetraploid frog Silurana epitropicalis with potent activity against methicillin-resistant Staphylococcus aureus (MRSA).,Escherichiacoli
KIKWFKTMKSIAKFIAKEQMKKHLGGE,1155,2,2297,"Lycotoxins, antimicrobial peptides from venom of the wolf spider Lycosa carolinensis.",Escherichiacoli
GAWKNFWSSLRKGFYDGEAGRAIRR,89,30,2299,Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.,HIV-1IIIB
GFKDLLKGAAKALVKTVLF,1156,2,2302,"The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei.",Escherichiacoli
GFRDVLKGAAKAFVKTVAGHIAN,1156,2,2303,"The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei.",Escherichiacoli
GIKDWIKGAAKKLIKTVASHIANQ,1156,2,2305,"The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei.",Escherichiacoli
RPKHPIKHQGLPQEVLNENLLRF,1157,2,2307,"Antimicrobial activity of two peptides casecidin 15 and 17, found naturally in bovine colostrum.",Escherichiacoli
YQEPVLGPVRGPFPI,1157,2,2308,"Antimicrobial activity of two peptides casecidin 15 and 17, found naturally in bovine colostrum.",Escherichiacoli
YQEPVLGPVRGPFPIIV,1157,2,2309,"Antimicrobial activity of two peptides casecidin 15 and 17, found naturally in bovine colostrum.",Escherichiacoli
GILSTIKDFAIKAGKGAAKGLLEMASCKLSGQC,1158,2,2310,Characterization of novel antimicrobial peptides from the skins of frogs of the Rana esculenta complex.,Escherichiacoli
GIFLDKLKNFAKGVAQSLLNKASCKLSGQC,1158,2,2311,Characterization of novel antimicrobial peptides from the skins of frogs of the Rana esculenta complex.,Escherichiacoli
GLGSILGKILNVAGKVGKTIGKVADAVGNKE,1158,2,2313,Characterization of novel antimicrobial peptides from the skins of frogs of the Rana esculenta complex.,Escherichiacoli
GLGSFLKNAIKIAGKVGSTIGKVADAIGNKE,1158,2,2314,Characterization of novel antimicrobial peptides from the skins of frogs of the Rana esculenta complex.,Escherichiacoli
GLGSFFKNAIKIAGKVGSTIGKVADAIGNKE,1158,2,2315,Characterization of novel antimicrobial peptides from the skins of frogs of the Rana esculenta complex.,Escherichiacoli
GWKDWAKKAGGWLKKKGPGMAKAALKAAMQ,91,32,2316,"Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",Lactococcuslactis
FLPLLAGLAANFLPTIICKISYKC,90,31,2318,In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines.,Humanlung
WLGSALKIGAKLLPSVVGLFKKKKQ,91,32,2334,"Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",Lactococcuslactis
VFQFLGRIIHHVGNFVHGFSHVF,1159,4,2364,Database screening and in vivo efficacy of antimicrobial peptides against methicillin-resistant Staphylococcus aureus USA300.,Staphylococcusaureus
IWLTALKFLGKHAAKHLAKQQLSKL,1159,4,2367,Database screening and in vivo efficacy of antimicrobial peptides against methicillin-resistant Staphylococcus aureus USA300.,Staphylococcusaureus
INLKAIAALAKKLL,1160,4,2368,Antimicrobial peptides from the venom gland of the social wasp Vespa tropica.,Staphylococcusaureus
GLNTLKKVFQGLHEAIKLINNHVQ,1159,4,2372,Database screening and in vivo efficacy of antimicrobial peptides against methicillin-resistant Staphylococcus aureus USA300.,Staphylococcusaureus
KVHGSLARAGKVRGQTPKVAKQEKKKKKTGRAKRRMQYNRRFVNVVPTFGKKKGPNANS,93,4,2374,Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice.,Staphylococcusaureus
GIFNVFKGALKTAGKHVAGSLLNQLKCKVSGEC,1162,182,2424,"Activity of antimicrobial skin peptides from ranid frogs against Batrachochytrium dendrobatidis, the chytrid fungus associated with global amphibian declines.",Batrachochytriumdendrobatidis
FLPVIAGIAANVLPKLFCKLTKRC,1163,182,2430,"Antimicrobial peptide defenses of the Tarahumara frog, Rana tarahumarae.",Batrachochytriumdendrobatidis
GIMDSIKGAAKEIAGHLLDNLKCKITGC,1163,182,2431,"Antimicrobial peptide defenses of the Tarahumara frog, Rana tarahumarae.",Batrachochytriumdendrobatidis
TTLTLHNLCPYPVWWLVTPNNGGFPIIDNTPVVLG,1164,24,2432,"Dendrocin, a distinctive antifungal protein from bamboo shoots.",Fusariumoxysporum
QWGRRCCGWGPGRRYCRRWC,1165,54,2434,Bactericidal properties of the antimicrobial peptide Ib-AMP4 from Impatiens balsamina produced as a recombinant fusion-protein in Escherichia coli.,Acinetobactercalcoaceticus
SCIPKHEECTNDKHNCCRKGLFKLKCQCSTFDDESGQPTERCACGRPMGHQAIETGLNIF,1166,2,2441,"A venom-derived neurotoxin, CsTx-1, from the spider Cupiennius salei exhibits cytolytic activities.",Escherichiacoli
RESPSSRMECYEQAERYGYGGYGGGRYGGGYGSGRGQPVGQGVERSHDDNRNQPR,1167,2,2445,Identification of a novel storage glycine-rich peptide from guava (Psidium guajava) seeds with activity against Gram-negative bacteria.,Escherichiacoli
GLPICGETCVGGTCNTPGCSCSWPVCTRN,1168,183,2451,Isolation and characterization of cytotoxic cyclotides from Viola tricolor.,Humanglioblastoma
GIPCGESCVWIPCITSAIGCSCKSKVCYRN,1168,183,2452,Isolation and characterization of cytotoxic cyclotides from Viola tricolor.,Humanglioblastoma
GLPVCGETCFGGTCNTPGCSCETWPVCSRN,1168,183,2453,Isolation and characterization of cytotoxic cyclotides from Viola tricolor.,Humanglioblastoma
GLPICGETCVGGSCNTPGCSCSWPVCTRN,1168,183,2454,Isolation and characterization of cytotoxic cyclotides from Viola tricolor.,Humanglioblastoma
GYPICGESCVGGICNIPGCSCSWPVCTTN,1168,183,2493,Isolation and characterization of cytotoxic cyclotides from Viola tricolor.,Humanglioblastoma
GLPICGETCVGGTCNTPGCFCTWPVCTRN,1168,183,2494,Isolation and characterization of cytotoxic cyclotides from Viola tricolor.,Humanglioblastoma
GLPVCGETCFTGSCYTPGCSCNWPVCNRN,1168,183,2495,Isolation and characterization of cytotoxic cyclotides from Viola tricolor.,Humanglioblastoma
GLPVCGETCVGGTCNTPGCSCSWPVCFRN,1168,183,2496,Isolation and characterization of cytotoxic cyclotides from Viola tricolor.,Humanglioblastoma
GTLPCGESCVWIPCISSVVGCACKSKVCYKD,1168,183,2497,Isolation and characterization of cytotoxic cyclotides from Viola tricolor.,Humanglioblastoma
GFMKYIGPLIPHAVKAISDLI,98,2,2511,"Antimicrobial and cytolytic properties of the frog skin peptide, kassinatuerin-1 and its L- and D-lysine-substituted derivatives.",Escherichiacoli
GSVLNCGETCLLGTCYTTGCTCNKYRVCTKD,1169,61,2536,"Kalata B8, a novel antiviral circular protein, exhibits conformational flexibility in the cystine knot motif.",HIV-1
SISCGESCAMISFCFTEVIGCSCKNKVCYLN,1170,5,2537,"Isolation and characterization of novel cyclotides from Viola hederaceae: solution structure and anti-HIV activity of vhl-1, a leaf-specific expressed cyclotide.",HIV
GFGCPNNYQCHRHCKSIPGRCGGYCGGWHRLRCTCYRC,1171,18,2538,A member of the arthropod defensin family from edible Mediterranean mussels (Mytilus galloprovincialis),Micrococcusluteus
KTCENLADTFRGPCFATSNCDDHCKNKEHLLSGRCRDDFRCWCTRNC,1172,65,2570,A mitogenic defensin from white cloud beans (Phaseolus vulgaris).,Botrytiscinerea
ATCENLANTYRGPCFGGCDFHCKTKEHLLSGRCRDDFRCWCTRNC,1173,65,2571,"Peptides from pinto bean and red bean with sequence homology to cowpea 10-kDa protein precursor exhibit antifungal, mitogenic, and HIV-1 reverse transcriptase-inhibitory activities.",Botrytiscinerea
GCASRCKAKCAGRRCKGWASASFRGRCYCKCFRC,1174,18,2594,"Innate immunity. Isolation of several cysteine-rich antimicrobial peptides from the blood of a mollusc, Mytilus edulis.",Micrococcusluteus
QDDESDVPHVRVRRGFGCPLNQGACHNHCRSIGRRGGYCAGIIKQTCTCYRK,102,2,2595,Babesial vector tick defensin against Babesia sp. parasites.,Escherichiacoli
ATCDILSFQSQWVTPNHAGCALHCVIKGYKGGQCKITVCHCRR,1175,18,2609,"Novel inducible antibacterial peptides from a hemipteran insect, the sap-sucking bug Pyrrhocoris apterus.",Micrococcusluteus
VTCDLLSFEAKGFAANHSLCAAHCLAIGRRGGSCERGVCICRR,1176,4,2628,Synthesis and characterization of bactericidal oligopeptides designed on the basis of an insect anti-bacterial peptide.,Staphylococcusaureus
ATCDLLSGTGINHSACAAHCLLRGNRGGYCNGKGVCVCRN,1177,2,2629,Insect immunity. Isolation from the lepidopteran Heliothis virescens of a novel insect defensin with potent antifungal activity.,Escherichiacoli
ATCDLASGFGVGSSLCAAHCIARRYRGGYCNSKAVCVCRN,1178,4,2630,Characterization of a defensin from the sand fly Phlebotomus duboscqi induced by challenge with bacteria or the protozoan parasite Leishmania major.,Staphylococcusaureus
FTCDVLSVEAKGVKLNHAACGIHCLFRRRTGGYCNKKRVCICR,1180,25,2632,"Purification and cDNA cloning of an insect defensin from larvae of the longicorn beetle, Acalolepta luxuriosa.",Bacilluscereus
DFGCGQGMIFMCQRRCMRLYPGSTGFCRGFRCMCDTHIPLRPPFMVG,1181,2,2646,"A novel defensin-like peptide from salivary glands of the hard tick, Haemaphysalis longicornis. ",Escherichiacoli
FFGTALKIAANVLPTAICKILKKC,1182,4,2732,"The novel antimicrobial peptides from skin of Chinese broad-folded frog, Hylarana latouchii (Anura:Ranidae).",Staphylococcusaureus
KSCCRSTQARNIYNAPRFAGGSRPLCALGSGCKIVDDKKTPPND,1183,184,2733,"Amino acid sequence and antimicrobial activity of chitin-binding peptides, Pp-AMP 1 and Pp-AMP 2, from Japanese bamboo shoots (Phyllostachys pubescens). ",Erwiniacarotovora
KSCCRSTTARTARVPCAKKSNIYNGCRVPGGCKIQEAKKCEPPYD,1184,184,2734,"Amino acid sequence and antimicrobial activity of chitin-binding peptides, Pp-AMP 1 and Pp-AMP 2, from Japanese bamboo shoots (Phyllostachys pubescens).",Erwiniacarotovora
KSCCRNTVARNCYNVCRIPGTPRPVCAATCDCKLITGTKCPPGYEK,1185,184,2736,"Purification, characterization, and sequencing of novel antimicrobial peptides,Tu-AMP 1 and Tu-AMP 2, from bulbs of ulip (Tulipa gesneriana L.).",Erwiniacarotovora
AQCGAQGGGATCPGGLCCSQWGWCGSTPKYCGAGCQSNCK,1186,184,2737,"Purification, characterization, and sequencing of a novel type of antimicrobial peptides,Fa-AMP1 and Fa-AMP2, from seeds of buckwheat (Fagopyrum esculentum Moench.).",Erwiniacarotovora
AQCGAQGGGATCPGGLCCSQWGWCGSTPKYCGAGCQSNCR,1186,184,2738,"Purification, characterization, and sequencing of a novel type of antimicrobial peptides,Fa-AMP1 and Fa-AMP2, from seeds of buckwheat (Fagopyrum esculentum Moench.).",Erwiniacarotovora
DPQTDCQQCQRRCRQQESGPRQQQYCQRRCKEICEEEEEYN,1187,185,2740, A family of antimicrobial peptides is produced by processing of a 7Sglobulin protein in Macadamia integrifolia kernels. ,Leptosphaeriamaculans
KRDPQQREYEDCRRRCEQQEPRQQYQCQRRCREQQ,1188,185,2741,A family of antimicrobial peptides is produced by processing of a 7Sglobulin protein in Macadamia integrifolia kernels.,Leptosphaeriamaculans
RQRDPQQQYEQCQERCQRHETEPRHMQTCQQRCERRYEKEKRKQQ,1188,177,2742,A family of antimicrobial peptides is produced by processing of a 7Sglobulin protein in Macadamia integrifolia kernels.,Alternariahelianthi
RQRDPQQQYEQCQERCQRHETEPRHMQTCQQRCERRYEKEKRKQQKR,1189,177,2743,A family of antimicrobial peptides is produced by processing of a 7S globulin protein in Macadamia integrifolia kernels.,Alternariahelianthi
INWLKLGKKMMSAL,1190,2,2796,New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs,Escherichiacoli
AANIPFKVHFRCKAAFC,107,2,2824,"Inhibitory and antimicrobial activities of OGTI and HV-BBI peptides, fragments and analogs derived from amphibian skin",Escherichiacoli
GFGCPLDQMQCHRHCQTITGRSGGYCSGPLKLTCTCYR,1192,18,2852,"A novel insect defensin mediates the inducible antibacterial activity in larvae of the dragonfly Aeschna cyanea (Paleoptera, Odonata)",Micrococcusluteus
FTCDVLGFEIAGTKLNSAACGAHCLALGRTGGYCNSKSVCVCR,1193,18,2868,Insect immunity. Isolation from a coleopteran insect of a novel inducible antibacterial peptide and of new members of the insect defensin family,Micrococcusluteus
GLLNGLALRLGKRALKKIIKRLCR,1194,8,2967,"Isolation and functional analysis of a 24-residue linear alpha-helical antimicrobial peptide from Korean blackish cicada, Cryptotympana dubia (Homoptera)",Bacillussubtilis
GLPVCGETCFGGRCNTPGCTCSYPICTRN,1195,127,2970,"The alpine violet, Viola biflora, is a rich source of cyclotides with potent cytotoxicity",Humanhistiocytic
GIPCAESCVWIPCTVTALIGCGCSNKVCYN,1195,127,2971,"The alpine violet, Viola biflora, is a rich source of cyclotides with potent cytotoxicity",Humanhistiocytic
GTFPCGESCVFIPCLTSAIGCSCKSKVCYKN,1195,127,2972,"The alpine violet, Viola biflora, is a rich source of cyclotides with potent cytotoxicity",Humanhistiocytic
GLLPCAESCVYIPCLTTVIGCSCKSKVCYKN,1195,127,2973,"The alpine violet, Viola biflora, is a rich source of cyclotides with potent cytotoxicity",Humanhistiocytic
FLPAIVGAAGQFLPKIFCAISKKC,1196,2,2974,"Peptides with antimicrobial activity of the brevinin-1 family isolated from skin secretions of the southern leopard frog, Rana sphenocephala",Escherichiacoli
PGMGIYLPM,1197,186,2980,Two cyclopeptides from the seeds of Annona cherimola,Humannasopharyngeal
GDPTFCGETCRVIPVCTYSAALGCTCDDRSDGLCKRN,1198,187,2981,A novel anti-HIV macrocyclic peptide from Palicourea condensata,HIV-1RF
GIPCGESCVFIPCITSVAGCSCKSKVCYRN,1199,30,2982,New circulin macrocyclic polypeptides from Chassalia parvifolia,HIV-1IIIB
KIPCGESCVWIPCVTSIFNCKCENKVCYHD,1199,61,2983,New circulin macrocyclic polypeptides from Chassalia parvifolia,HIV-1
KIPCGESCVWIPCLTSVFNCKCENKVCYHD,1199,61,2984,New circulin macrocyclic polypeptides from Chassalia parvifolia,HIV-1
AIPCGESCVWIPCISAAIGCSCKNKVCYR,1199,61,2985,New circulin macrocyclic polypeptides from Chassalia parvifolia,HIV-1
GLLSFLPKVIGVIGHLIHPPS,1200,25,2990,The fallaxidin peptides from the skin secretion of the Eastern Dwarf Tree Frog Litoria fallax. Sequence determination by positive and negative ion electrospray mass spectrometry: antimicrobial activity and cDNA cloning of the fallaxidins,Bacilluscereus
KRFKKFFKKLKNSVKKRAKKFFKKPRVIGVSIPF,1201,2,3001,Identification and characterization of novel reptile cathelicidins from elapid snakes,Escherichiacoli
FHPSLWVLIPQYIQLIRKILKSG,1202,2,3006,Conolysin-Mt: a conus peptide that disrupts cellular membranes,Escherichiacoli
ALWKTIIKGAGKMIGSLAKNLLGSQAQPES,1203,27,3007,"Synthesis, antimicrobial activity and gene structure of a novel member of the dermaseptin B family",Acholeplasmalaidlawii
FLPVLAGIAAKVVPALFCKITKKC,1204,8,3008,"Brevinin-1 and -2, unique antimicrobial peptides from the skin of the frog, Rana brevipoda porsa",Bacillussubtilis
GLLDSLKGFAATAGKGVLQSLLSTASCKLAKTC,1204,8,3009,"Brevinin-1 and -2, unique antimicrobial peptides from the skin of the frog, Rana brevipoda porsa",Bacillussubtilis
FFGLHNLVPSMLCVVRKKC,1205,2,3106,"Purification and characterization of antimicrobial peptides from the skin secretions of the carpenter frog Rana virgatipes (Ranidae, Aquarana).",Escherichiacoli
FLGGLFKLVPSVICAVTKKC,1205,2,3107,"Purification and characterization of antimicrobial peptides from the skin secretions of the carpenter frog Rana virgatipes (Ranidae, Aquarana).",Escherichiacoli
GFGCNGPWDEDDMQCHNHCKSIKGYKGGYCAKGGFVCKCY,1206,100,3114,Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus.,Streptococcuspneumoniae
GFLGPLLKLAAKGVAKVIPHLIPSRQQ,1207,4,3154,"Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).",Staphylococcusaureus
GVWSTVLGGLKKFAKGGLEAIVNPK,1207,4,3155,"Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).",Staphylococcusaureus
GVFLDALKKFAKGGMNAVLNPK,1207,4,3156,"Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).",Staphylococcusaureus
GLLGPLLKIAAKVGSNLL,1207,2,3159,"Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).",Escherichiacoli
CIKNGNGCQPDGSQGNCCSRYCHKEPGWVAGYCR,1208,114,3160,Solution structure of Alo-3: a new knottin-type antifungal peptide from the insect Acrocinus longimanus.,Candidaglabrata
CIANRNGCQPDGSQGNCCSGYCHKEPGWVAGYCR,1208,114,3161,Solution structure of Alo-3: a new knottin-type antifungal peptide from the insect Acrocinus longimanus.,Candidaglabrata
CIKNGNGCQPNGSQGNCCSGYCHKQPGWVAGYCRRK,1208,114,3162,Solution structure of Alo-3: a new knottin-type antifungal peptide from the insect Acrocinus longimanus.,Candidaglabrata
AGECVQGRCPSGMCCSQFGYCGRGPKYCGR,1209,188,3163,An antimicrobial peptide Ar-AMP from amaranth (Amaranthus retroflexus L.) seeds.,Helminthosporiumsativum
KKINNPVSCLRKGGRCWNRCIGNTRQIGSCGVPFLKCCKRK,1210,3,3166,Mouse beta-defensin 3 is an inducible antimicrobial peptide expressed in the epithelia of multiple organs.,Pseudomonasaeruginosa
NNEAQCEQAGGICSKDHCFHLHTRAFGHCQRGVPCCRTVYD,117,2,3167,Modification of chicken avian beta-defensin-8 at positively selected amino acid sites enhances specific antimicrobial activity.,Escherichiacoli
LVAYGIAQGTAEKVVSLINAGLTVGSIISILGGVTVGLSGVFTAVKAAIAKQGIKKAIQL,1211,2,3172,"Isolation and characterization of carnocyclin a, a novel circular bacteriocin produced by Carnobacterium maltaromaticum UAL307.",Escherichiacoli
SLLSLIRKLIT,1212,4,3176,"Decoralin, a novel linear cationic alpha-helical peptide from the venom of the solitary eumenine wasp Oreumenes decoratus.",Staphylococcusaureus
RRICRCRIGRCLGLEVYFGVCFLHGRLARRCCR,1213,2,3186,alpha-Defensins from blood leukocytes of the monkey Papio hamadryas.,Escherichiacoli
RICRCRIGRCLGLEVYFGVCFLHGRLARRCCR,1213,2,3187,alpha-Defensins from blood leukocytes of the monkey Papio hamadryas.,Escherichiacoli
RTCRCRLGRCSRRESYSGSCNINGRIYSLCCR,1213,2,3188,alpha-Defensins from blood leukocytes of the monkey Papio hamadryas.,Escherichiacoli
RTCQSQSHKFKGACFSDTNCDSVCRTENFPRGQCNQHHVERKCYCERDC,1214,189,3189,Seed defensins of barnyard grass Echinochloa crusgalli (L.) Beauv.,Alternariaconsortiale
RECQSQSHRYKGACVHDTNCASVCQTEGFSGGKCVGFRGRCFCTKHC,1214,24,3190,Seed defensins of barnyard grass Echinochloa crusgalli (L.) Beauv.,Fusariumoxysporum
RECQSQSHRYKGACVHDTNCASVCQTEGFSGGKCVGFRGRCFCTKAC,1214,89,3191,Seed defensins of barnyard grass Echinochloa crusgalli (L.) Beauv.,Fusariumgraminearum
ALWKTLLKNVGKAAGKAALNAVTDMVNQ,1215,52,3193,Antimicrobial peptides from the Brazilian frog Phyllomedusa distincta.,Enterococcusfaecalis
ALWKTMLKKLGTMALHAGKAAFGAAADTISQ,1215,52,3194,Antimicrobial peptides from the Brazilian frog Phyllomedusa distincta.,Enterococcusfaecalis
ALWKNMLKGIGKLAGQAALGAVKTLVGAES,1215,52,3195,Antimicrobial peptides from the Brazilian frog Phyllomedusa distincta.,Enterococcusfaecalis
GLWSKIKEAAKTAGLMAMGFVNDMV,1215,52,3196,Antimicrobial peptides from the Brazilian frog Phyllomedusa distincta.,Enterococcusfaecalis
SLGSFLKGVGTTLASVGKVVSDQFGKLLQAGQ,1216,27,3197,"Isolation of dermatoxin from frog skin, an antibacterial peptide encoded by a novel member of the dermaseptin genes family.",Acholeplasmalaidlawii
SSLLEKGLDGAKKAVGGLGKLGKDAVEDLESVGKGAVHDVKDVLDSVL,1217,2,3198,Dermcidin: a novel human antibiotic peptide secreted by sweat glands.,Escherichiacoli
YDPEAASAPGSGNPCHEASAAQKENAGEDP,1217,2,3199,Dermcidin: a novel human antibiotic peptide secreted by sweat glands.,Escherichiacoli
SHQDCYEALHKCMASHSKPFSCSMKFHMCLQQQ,1218,2,3222,A novel antimicrobial peptide from the sea hare Dolabella auricularia.,Escherichiacoli
YCSYTMEA,1219,2,3224,Identification and structural insights of three novel antimicrobial peptides isolated from green coconut water.,Escherichiacoli
SVAGRAQGM,1219,2,3225,Identification and structural insights of three novel antimicrobial peptides isolated from green coconut water.,Escherichiacoli
TESYFVFSVGM,1219,2,3226,Identification and structural insights of three novel antimicrobial peptides isolated from green coconut water.,Escherichiacoli
RCVCTRGFCRCVCRRGVC,1220,4,3233,"Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes.",Staphylococcusaureus
RCVCRRGVCRCVCRRGVC,1220,4,3234,"Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes.",Staphylococcusaureus
RCVCTRGFCRCVCTRGFC,1220,4,3235,"Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes.",Staphylococcusaureus
RCVCTRGFCRCICLLGIC,1220,4,3236,"Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes.",Staphylococcusaureus
RCVCTRGFCRCFCRRGVC,1220,4,3237,"Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes.",Staphylococcusaureus
AWKLFDDGV,1221,56,3238,Identification and characterization of a bactericidal and proapoptotic peptide from Cycas revoluta seeds with DNA binding properties.,Staphylococcusepidermidis
IIIQYEGHKH,1222,18,3240,Rondonin an antifungal peptide from spider (Acanthoscurria rondoniae) haemolymph.,Micrococcusluteus
FLPGLLAGLL,1223,2,3241,Identification and characterization of novel antibacterial peptides from skin secretions of Euphlyctis cyanophlyctis.,Escherichiacoli
RAGLKFPVGRVHRLLR,1223,2,3242,Identification and characterization of novel antibacterial peptides from skin secretions of Euphlyctis cyanophlyctis.,Escherichiacoli
FLNALKNFAKTAGKRLKSLLN,1223,2,3243,Identification and characterization of novel antibacterial peptides from skin secretions of Euphlyctis cyanophlyctis.,Escherichiacoli
IFGAIWNGIKS,1224,8,3246,"Purification, structure-function analysis, and molecular characterization of novel linear peptides from scorpion Opisthacanthus madagascariensis.",Bacillussubtilis
ILGKIWEGIKS,1224,8,3248,"Purification, structure-function analysis, and molecular characterization of novel linear peptides from scorpion Opisthacanthus madagascariensis.",Bacillussubtilis
IGGIISFFKRLF,1225,8,3330,Further isolation and characterization of grammistins from the skin secretion of the soapfish Grammistes sexlineatus.,Bacillussubtilis
FIGGIISFFKRLF,1225,8,3331,Further isolation and characterization of grammistins from the skin secretion of the soapfish Grammistes sexlineatus.,Bacillussubtilis
FIGGIISFIKKLF,1225,8,3332,Further isolation and characterization of grammistins from the skin secretion of the soapfish Grammistes sexlineatus.,Bacillussubtilis
LFGFLIKLIPSLFGALSNIGRNRNQ,1225,8,3333,Further isolation and characterization of grammistins from the skin secretion of the soapfish Grammistes sexlineatus.,Bacillussubtilis
LFGFLIPLLPHIIGAIPQVIGAIR,1225,8,3334,Further isolation and characterization of grammistins from the skin secretion of the soapfish Grammistes sexlineatus.,Bacillussubtilis
WWRELLKKLAFTAAGHLGSVLAAKQSGW,1225,8,3335,Further isolation and characterization of grammistins from the skin secretion of the soapfish Grammistes sexlineatus.,Bacillussubtilis
NWRKILGKIAKVAAGLLGSMLAGYQV,1225,8,3336,Further isolation and characterization of grammistins from the skin secretion of the soapfish Grammistes sexlineatus.,Bacillussubtilis
NWRKILGQIASVGAGLLGSLLAGYE,1225,8,3337,Further isolation and characterization of grammistins from the skin secretion of the soapfish Grammistes sexlineatus.,Bacillussubtilis
FFPLALLCKVFKKC,1226,2,3345,"Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.",Escherichiacoli
IIPLPLGYFAKKT,1226,2,3347,"Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.",Escherichiacoli
SAVGRHGRRFGLRKHRKH,1226,2,3348,"Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.",Escherichiacoli
GLMSVLGHAVGNVLGGLFKPKS,1227,25,3351,The structures of the frenatin peptides from the skin secretion of the giant tree frog Litoria infrafrenata.,Bacilluscereus
GFLDKLKKGASDFANALVNSIKGT,1227,25,3352,The structures of the frenatin peptides from the skin secretion of the giant tree frog Litoria infrafrenata.,Bacilluscereus
GLNALKKVFQGIHEAIKLINNHVQ,1228,2,3357,Pseudin-2: an antimicrobial peptide with low hemolytic activity from the skin of the paradoxical frog.,Escherichiacoli
LDVKKIICVACKIKPNPACKKICPK,1229,18,3383,"Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae).",Micrococcusluteus
LDVKKIICVACKIRPNPACKKICPK,1229,18,3385,"Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae).",Micrococcusluteus
GIHDILKYGKPS,1230,2,3389,"Myxinidin, a novel antimicrobial peptide from the epidermal mucus of hagfish, Myxine glutinosa L.",Escherichiacoli
GLMSLFKGVLKTAGKHIFKNVGGSLLDQAKCKITGEC,1231,2,3396,"A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica.",Escherichiacoli
GLMSLFRGVLKTAGKHIFKNVGGSLLDQAKCKITGEC,1231,2,3397,"A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica.",Escherichiacoli
GLMSVTKGVLKTAGKHIFKNVGGSLLDQAKCKISGQC,1231,2,3398,"A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica.",Escherichiacoli
GLMSVLKGVLKTAGKHIFKNVGGSLLDQAKCKITGQC,1231,2,3399,"A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica.",Escherichiacoli
GLLSVLKGVLKTTGKHIFKNVGGSLLDQAKCKISGQC,1231,2,3400,"A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica.",Escherichiacoli
GLMDVFKGAAKNLLASALDKIRCKVTKC,1231,2,3401,"A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica.",Escherichiacoli
VNWKKILGKIIKVVK,1232,8,3420,Lasioglossins: three novel antimicrobial peptides from the venom of the eusocial bee Lasioglossum laticeps (Hymenoptera: Halictidae).,Bacillussubtilis
FLPLFLPKIICVITKKC,1234,2,3486,"Antimicrobial peptide diversity in the skin of the torrent frog, Amolops jingdongensis.",Escherichiacoli
FLPIVENCSLVCWENNQKC,1234,2,3487,"Antimicrobial peptide diversity in the skin of the torrent frog, Amolops jingdongensis.",Escherichiacoli
KSSAYSLQMGATAIKQVKKLFKKWGW,1011,167,3488,"Antagonistic activity of Lactobacillus plantarum C11: two new two-peptide bacteriocins, plantaricins EF and JK, and the induction factor plantaricin A.",Pediococcuspentosaceus
RRSRKNGIGYAIGYAFGAVERAVLGGSRDYNK,1235,1,3492,None_article5,None_target
FNRGGYNFGKSVRHVVDAIGSVAGIRGILKSIR,1236,1,3494,None_article6,None_target
VFHAYSARGVRNNYKSAVGPADWVISAVRGFIHG,1237,1,3495,None_article7,None_target
ESVFSKIGNAVGPAAYWILKGLGNMSDVNQADRINRKKH,1238,1,3497,None_article8,None_target
GPGKWLPWLQPAYDFVTGLAKGIGKEGNKNKWKNV,1239,1,3498,None_article9,None_target
SMISVLKNLGKVGLGFVACKVNKQC,1241,4,3558,Purification and characterization of antimicrobial and vasorelaxant peptides from skin extracts and skin secretions of the North American pig frog Rana grylio.,Staphylococcusaureus
FLGGLMKIIPAAFCAVTKKC,1241,4,3559,Purification and characterization of antimicrobial and vasorelaxant peptides from skin extracts and skin secretions of the North American pig frog Rana grylio.,Staphylococcusaureus
GLLLDTLKGAAKDIAGIALEKLKCKITGCKP,1241,4,3560,Purification and characterization of antimicrobial and vasorelaxant peptides from skin extracts and skin secretions of the North American pig frog Rana grylio.,Staphylococcusaureus
FLPLIASLAANFVPKIFCKITKKC,1242,50,3563,"Novel antimicrobial peptides isolated from the skin secretions of Hainan odorous frog, Odorrana hainanensis.",Enterococcusfaecium
FLPLIASVAANLVPKIFCKITKKC,1242,50,3564,"Novel antimicrobial peptides isolated from the skin secretions of Hainan odorous frog, Odorrana hainanensis.",Enterococcusfaecium
SLLGTVKDLLIGAGKSAAQSVLKGLSCKLSKDC,1242,50,3565,"Novel antimicrobial peptides isolated from the skin secretions of Hainan odorous frog, Odorrana hainanensis.",Enterococcusfaecium
GVFSFLKTGAKLLGSTLLKMAGKAGAEHLACKATNQC,1243,2,3566,Host defense peptides in skin secretions of the Oregon spotted frog Rana pretiosa: implications for species resistance to chytridiomycosis.,Escherichiacoli
GIFSALAAGVKLLGNTLFKMAGKAGAEHLACKATNQC,1243,2,3567,Host defense peptides in skin secretions of the Oregon spotted frog Rana pretiosa: implications for species resistance to chytridiomycosis.,Escherichiacoli
GILDTFKGVAKGVAKDLAVHMLENLKCKMTGC,1243,2,3568,Host defense peptides in skin secretions of the Oregon spotted frog Rana pretiosa: implications for species resistance to chytridiomycosis.,Escherichiacoli
GIMNTVKDVATGVATHLLNMVKCKITGC,1243,2,3581,Host defense peptides in skin secretions of the Oregon spotted frog Rana pretiosa: implications for species resistance to chytridiomycosis.,Escherichiacoli
FLPVLTGLTPSIVPKLVCLLTKKC,1243,2,3582,Host defense peptides in skin secretions of the Oregon spotted frog Rana pretiosa: implications for species resistance to chytridiomycosis.,Escherichiacoli
FLPVLAGLTPSIVPKLVCLLTKKC,1243,2,3583,Host defense peptides in skin secretions of the Oregon spotted frog Rana pretiosa: implications for species resistance to chytridiomycosis.,Escherichiacoli
FFPMLAGVAARVVPKVICLITKKC,1243,2,3584,Host defense peptides in skin secretions of the Oregon spotted frog Rana pretiosa: implications for species resistance to chytridiomycosis.,Escherichiacoli
FLPMLAGLAASMVPKLVCLITKKC,1243,2,3585,Host defense peptides in skin secretions of the Oregon spotted frog Rana pretiosa: implications for species resistance to chytridiomycosis.,Escherichiacoli
LNLKGIFKKVASLLT,1244,4,3644,"Eumenitin, a novel antimicrobial peptide from the venom of the solitary eumenine wasp Eumenes rubronotatus.",Staphylococcusaureus
VIVFVASVAAEMMQHVYCAASKKC,128,2,3645,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
FIFPKKNIINSLFGR,128,2,3646,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
TSRCIFYRRKKCS,128,2,3647,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
KEKLKLKCKAPKCYNDKLACT,128,2,3648,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
VAIYGRDDRSDVCRQVQHNWLVCDTY,128,2,3649,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
ENMFNIKSSVESDSFWG,128,2,3650,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
EMLKKKKEVKMERKT,128,2,3651,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
FLPAVIRVAANVLPTAFCAISKKC,128,2,3652,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
LPFVAGVAAEMMQHVYCAASKKC,128,2,3653,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
ILPFVAGVAAEMMQHVYCAASKKC,128,2,3654,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
IDPFVAGVAAEMMQHVYCAASKKC,128,2,3655,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
INPFVAGVAAEMMQHVYCAASKKC,128,2,3656,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
ILPFVAGVAAEMMKHVYCAASKKC,128,2,3657,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
IIPFVAGVAAEMMEHVYCAASKKC,128,2,3658,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
QLPFVAGVACEMCQCVYCAASKKC,128,2,3659,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
ILPFVAGVAAEMMEHVYCAASKKC,128,2,3660,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
ILPFVAGVAAMEMEHVYCAASKKC,128,2,3668,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
FLPAVLLVATHVLPTVFCAITRKC,128,2,3669,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
LAFVAGVAAEMMQHVYCAASKKC,128,2,3670,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GILDTFKNMALNAAKSAGVSVLNALSCKLSKTC,128,2,3671,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GLLDTFKNMALNAAKSAGVSVLNALSCKLSKTC,128,2,3672,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GLLDTFKNMAINAAHGAGVSVLNALSCKLKKTC,128,2,3673,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GLLDTFKNLALNAAESAGVSVLNSLSCKLSKTC,128,2,3674,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GLLDGILNANFNAAKSAGTSVLNALSCKLSKTC,128,2,3675,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GVLATVKNLLIGTGDGAAQSVLKTLSCKLSNDC,128,2,3676,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GVLGTVKDLLIGAGKSAAQSTLKTLSCKISNDC,128,2,3677,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GVLATVKNLLNGTGDGAAQSVLKTLSCKLSNDC,128,2,3678,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
SVLGTVKDLLIGAGKSAAQSVLTALSCKLSNSC,128,2,3679,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GLLDTIKNMALNAAKSAGVSVLNSLSCKLSKTC,128,2,3680,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GLIDTIKNMALNAAKSAGVSVLNTLSCKLSKTC,128,2,3681,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
SVLGTVKDLLIGAGKSAAQSVLTANSCKLSNSC,128,2,3682,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
SFLDTLKNLAISAAKGAGQSVLSTLSCKLSETC,128,2,3683,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GLLDTIKNMALNAAKSAGVSVLNSLSCKDSKTC,128,2,3684,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GLLDTIKNMALNAAKSAGVSVLNTLSCKLSKTC,128,2,3685,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
SFLDTLKNLAISAAKGAGQSVLSTLSCKLSKTC,128,2,3686,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
SFLSTFKELAINAAKNAGQSILHTLSCKLDKTC,128,2,3687,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
SFLSTFKELAINAAKNAGQSLLHTLSCKLDKTC,128,2,3688,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
SVMGTVKDLLIGAGKSAAQSVLKSLSCKISNDC,128,2,3689,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
SVMGTVKDLLIGAGKSAAQSVLKSLSCKLSNDC,128,2,3690,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
SVMGTVKDLLIGAGKSAAQSVLKALSCKLSKDC,128,2,3691,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GLFSKFVGKGIKNFLIKGVKHIGKEVGMDVIRVGIDVAGCKIKGVC,128,2,3692,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GLFSKFSGKGIKNFLIKGVKHIGKEVGMDVIRTGIDVAGCKIKGEC,128,2,3693,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GLFSKFAGKGIKDLIFKGVKHIGKEVGMDVIRTGIDVAGCKIKGEC,128,2,3694,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GLFTKFAGKGIKDLIFKGVKHIGKEVGMDVIRTGIDVAGCKIKGEC,128,2,3695,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GLFSKFAGKGIKNFLIKGVKHIGKEVGMDVIRTGIDVAGCKIKGEC,128,2,3696,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GIFSKISGKAIKNLFIKGAKNVGKEVGMDVVRTGIDVVGCKIKGEC,128,2,3698,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
KISGKAIKNLFIKGAKNVGKEVGMDVVRTGIDVVGCKIKGEC,128,2,3699,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GIFSKISGKAIKNLFIKGAKNVGKRVGMDVVRTGMDVVGCKIKGEC,128,2,3700,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GIFSKISGKAIKNLFIKGAENVGKHVGMDVVRTGIDVVGCKIKGEC,128,2,3701,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GIFSKISGKAIKNLFIKGAKNVGKEVGMDVVRTGMDVVGCKIKGEC,128,2,3702,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GIFTLIKGAAKLIGKTVAKEAGKTGLELMACKITNQC,128,2,3703,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GLFTLIKGAAKLIGKTTAKEAGKTGKLEMACKITNQC,128,2,3704,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GVFTLIKGATQLIGKTLGKELGKTGLELMACKITNQC,128,2,3705,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GVFTLIKGATQLIGKTLGKEVGKTGLELMACKITKQC,128,2,3706,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GVFTLLKGATQLIGKTLGKELGKTGLELMACKITNQC,128,2,3707,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GVFTLIKGATQLIGKTLGKELGKTGLELMACKITEQC,128,2,3708,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GVFTLIKGATQLIGKTLGKELGKTGLEIMACKITKQC,128,2,3709,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GLLSGVLGVGKKIVCGLSGLC,128,2,3711,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GIFGKILGVGKKTLCELSGMC,128,2,3712,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GIFLKVLGVGKKVLCGVSGLC,128,2,3713,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GILSGILGVGKKLVCGLSGLC,128,2,3714,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GILSGILGVGKMLVCGLSGLC,128,2,3715,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GILSGLLGVGKMLVCGLSGLC,128,2,3716,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GILSGVLGMGKKIVCGLSGLC,128,2,3717,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GILGNIVGMGKKIVCGLSGLC,128,2,3718,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GILGNIVGMGKKVVCGLSGLC,128,2,3719,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GILSGVLGMGKKIVCGLRGLC,128,2,3720,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GILGNIVGMGKQVVCGLSGLC,128,2,3721,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
VVKCSYRLGSPDSQCN,128,2,3722,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GFMDTAKNVAKNMAGNLLDNLKCKITKAC,128,2,3723,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GFMDTAKNVAKNMAVTLLDNLKCKITKAC,128,2,3724,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GFMDTAKNVAKNEAGNLLDNLKCKITKAC,128,2,3725,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GFMATAKNVAKNMDVTLLDNLKCKITKAC,128,2,3726,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GFMNTAKNVAKNVAVTLLDNLKCKITGGC,128,2,3727,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GLFTLIKGAYKLDAPTVACN,128,2,3728,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GLFTLIKGAYKNDAPTVACN,128,2,3729,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
ATNIPFKVHFRCKAAFC,128,2,3730,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
AVNIPFKVHFRCKAAFC,128,2,3731,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
GLFSKFAGKGIVNFLIEGVE,128,2,3732,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
FLPKLFAKITKKNMAHIR,128,2,3733,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
FLPKLFAGIISKNF,128,2,3734,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
VVKCSYRQGSPDSR,128,2,3735,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
VVKFSYRKGSPAPQKN,128,2,3736,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
ENAEEDIVLMENLFCSYIVGSADSFWT,128,2,3737,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
DANVENGEDAEDLTDKFIGLMG,128,2,3738,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
RFIYMKGFGKPRFGKR,128,2,3739,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
SADQTGMNKAALSPIRFISKSV,128,2,3740,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
IPWKLPATFRPVERPFSKPFCRKD,128,2,3741,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
KNNFCQVLYVWLLRLGKQCFVKFSKDVET,128,2,3742,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
FLPGLECVW,128,2,3743,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
VTPPWARIYYGCAKA,128,2,3744,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
FFSTSCRSGC,128,2,3745,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
AAPRGGKGFFCKLFKDC,128,2,3746,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
LLPPWLRPRNG,128,2,3747,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
APDRPRKFCGILG,128,2,3748,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
VFLGNIVSMGKKI,128,2,3749,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
DAAVEPELYHWGKVWLPN,128,2,3750,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
CVDIGFSPTGKRPPFCPYPG,128,2,3751,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli
FKVQNQHGQVVKIFHH,129,39,3755,Processing of an antibacterial peptide from hemocyanin of the freshwater crayfish Pacifastacus leniusculus.,Shigellaflexneri
SFPFFPPGICKRLKRC,1245,2,3760,Limnonectins: a new class of antimicrobial peptides from the skin secretion of the Fujian large-headed frog (Limnonectes fujianensis).,Escherichiacoli
SFHVFPPWMCKSLKKC,1245,2,3761,Limnonectins: a new class of antimicrobial peptides from the skin secretion of the Fujian large-headed frog (Limnonectes fujianensis).,Escherichiacoli
PSCVCSGFETSGIHFC,1246,56,3762,Purification and structural characterization of a novel antibacterial peptide from Bellamya bengalensis: activity against ampicillin and chloramphenicol resistant Staphylococcus epidermidis.,Staphylococcusepidermidis
YVPPVQKPHPNGPKFPTFP,1247,2,3763,Characterization of an abaecin-like antimicrobial peptide identified from a Pteromalus puparum cDNA clone.,Escherichiacoli
GKFLHSAGKFGKAFLGEVMIG,1248,2,3764,Antimicrobial peptides with therapeutic potential from skin secretions of the Marsabit clawed frog Xenopus borealis (Pipidae).,Escherichiacoli
GIGKFLHSAGKFGKAFLGEVMKS,1248,2,3765,Antimicrobial peptides with therapeutic potential from skin secretions of the Marsabit clawed frog Xenopus borealis (Pipidae).,Escherichiacoli
GLGSLLGKAFKIGLKTVGKMMGGAPREQ,1248,2,3767,Antimicrobial peptides with therapeutic potential from skin secretions of the Marsabit clawed frog Xenopus borealis (Pipidae).,Escherichiacoli
GWASKIGTQLGKMAKVGLKEFVQS,1248,2,3768,Antimicrobial peptides with therapeutic potential from skin secretions of the Marsabit clawed frog Xenopus borealis (Pipidae).,Escherichiacoli
GVGKFLHSAKKFGQALASEIMKS,1249,2,3769,Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae),Escherichiacoli
GVGKFLHSAKKFGQALVSEIMKS,1249,2,3770,Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae),Escherichiacoli
GWASKIGQALGKVAKVGLQQFIQPK,1249,2,3771,Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae),Escherichiacoli
GLGSLLGKALKFGLKAAGKFMGGEPQQ,1249,2,3773,Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae),Escherichiacoli
GFLGPLLKLGLKGVAKVLPHLIPSRQQ,1250,2,3774,Genome duplications within the Xenopodinae do not increase the multiplicity of antimicrobial peptides in Silurana paratropicalis and Xenopus andrei skin secretions.,Escherichiacoli
GFWSSALEGLKKFAKGGLEALTNPK,1250,2,3775,Genome duplications within the Xenopodinae do not increase the multiplicity of antimicrobial peptides in Silurana paratropicalis and Xenopus andrei skin secretions.,Escherichiacoli
GVSKILHSAGKFGKAFLGEIMKS,1250,2,3776,Genome duplications within the Xenopodinae do not increase the multiplicity of antimicrobial peptides in Silurana paratropicalis and Xenopus andrei skin secretions.,Escherichiacoli
GWASKIGQTLGKMAKVGLQELIQPK,1250,2,3777,Genome duplications within the Xenopodinae do not increase the multiplicity of antimicrobial peptides in Silurana paratropicalis and Xenopus andrei skin secretions.,Escherichiacoli
GIGKFLHSAGKFGKAFIGEIMKS,1251,2,3779,Peptidomic analysis of skin secretions demonstrates that the allopatric populations of Xenopus muelleri (Pipidae) are not conspecific.,Escherichiacoli
GLGSLLGKAFKFGLKTVGKMMAGAPREQ,1251,2,3780,Peptidomic analysis of skin secretions demonstrates that the allopatric populations of Xenopus muelleri (Pipidae) are not conspecific.,Escherichiacoli
GLGSLLGKAFKFGLKTVGKMMGGAPREQ,1251,2,3783,Peptidomic analysis of skin secretions demonstrates that the allopatric populations of Xenopus muelleri (Pipidae) are not conspecific.,Escherichiacoli
GLGSLLGKAFKFGLKTVGKMMGGAPREE,1251,2,3784,Peptidomic analysis of skin secretions demonstrates that the allopatric populations of Xenopus muelleri (Pipidae) are not conspecific.,Escherichiacoli
LKIPGFVKDTLKKVAKGIFSAVAGAMTPS,1252,2,3786,The hymenochirins: a family of host-defense peptides from the Congo dwarf clawed frog Hymenochirus boettgeri (Pipidae).,Escherichiacoli
IKIPAVVKDTLKKVAKGVLSAVAGALTQ,1252,2,3787,The hymenochirins: a family of host-defense peptides from the Congo dwarf clawed frog Hymenochirus boettgeri (Pipidae).,Escherichiacoli
IKIPAFVKDTLKKVAKGVISAVAGALTQ,1252,2,3788,The hymenochirins: a family of host-defense peptides from the Congo dwarf clawed frog Hymenochirus boettgeri (Pipidae).,Escherichiacoli
IKIPPIVKDTLKKVAKGVLSTIAGALST,1252,2,3789,The hymenochirins: a family of host-defense peptides from the Congo dwarf clawed frog Hymenochirus boettgeri (Pipidae).,Escherichiacoli
GFGSFLGSLFKTGLKIIPKLLPSIQQ,1253,2,3791,Hybridization between the African clawed frogs Xenopus laevis and Xenopus muelleri (Pipidae) increases the multiplicity of antimicrobial peptides in skin secretions of female offspring.,Escherichiacoli
RWCVYAYVRIRGVLVRYRRCW,1254,2,3792,"Purification and primary structure of two isoforms of arenicin, a novel antimicrobial peptide from marine polychaeta Arenicola marina.",Escherichiacoli
SALVGCWTKSYPPKPCFGR,1255,4,3802,Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.,Staphylococcusaureus
SALVGCGTKSYPPKPCFGR,1255,4,3803,Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.,Staphylococcusaureus
SALVGCWTKSWPPKPCFGRG,1255,4,3805,Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.,Staphylococcusaureus
SALVGCWTKSWPPKPCFGR,1255,4,3806,Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.,Staphylococcusaureus
GIKEFAHSLGKFGKAFVGGILNQ,1256,2,3817,"Orthologs of magainin, PGLa, procaerulein-derived, and proxenopsin-derived peptides from skin secretions of the octoploid frog Xenopus amieti (Pipidae).",Escherichiacoli
GWASKIGQTLGKMAKVGLQEIIQPK,1257,2,3818,Host-defense peptides from skin secretions of Fraser's clawed frog Xenopus fraseri (Pipidae): Further insight into the evolutionary history of the Xenopodinae.,Escherichiacoli
FMGSALRIAAKVLPAALCQIFKKC,1258,4,3835,"Isolation, characterization and molecular cloning of new antimicrobial peptides belonging to the brevinin-1 and temporin families from the skin of Hylarana latouchii (Anura: Ranidae).",Staphylococcusaureus
GFLSALKKYLPIVLKHV,1259,18,3837,Structural identification by mass spectrometry of a novel antimicrobial peptide from the venom of the solitary bee Osmia rufa (Hymenoptera: Megachilidae).,Micrococcusluteus
FIGPVLKMATSILPTAICKGFKKC,1260,4,3846,"Five novel antimicrobial peptides from the Kuhl's wart frog skin secretions, Limnonectes kuhlii.",Staphylococcusaureus
FLGPIIKMATGILPTAICKGLKKC,1260,4,3848,"Five novel antimicrobial peptides from the Kuhl's wart frog skin secretions, Limnonectes kuhlii.",Staphylococcusaureus
SIRDKIKTMAIDLAKSAGTGVLKTLICKLDKSC,1260,4,3849,"Five novel antimicrobial peptides from the Kuhl's wart frog skin secretions, Limnonectes kuhlii.",Staphylococcusaureus
SIRDKGKTIAIDLAKSAGTGVLKTLMCKLDKSC,1260,4,3850,"Five novel antimicrobial peptides from the Kuhl's wart frog skin secretions, Limnonectes kuhlii.",Staphylococcusaureus
NALSMPRNKCNRALMCFG,1262,4,3887,Novel family of antimicrobial peptides from the skin of Rana shuchinae.,Staphylococcusaureus
NALSSPRNKCDRASSCFG,1262,4,3888,Novel family of antimicrobial peptides from the skin of Rana shuchinae.,Staphylococcusaureus
ACYCRIPACFAGERRYGTCFYLGRVWAFCC,135,2,3890,De novo sequencing of two new cyclic theta-defensins from baboon (Papio hamadryas) leukocytes by matrix-assisted laser desorption/ionization mass spectrometry.,Escherichiacoli
GLWSKIKEAAKAAGKAALNAVTGLVNQGDQPS,1263,2,3894,Peptides with differential cytolytic activity from skin secretions of the lemur leaf frog Hylomantis lemur (Hylidae: Phyllomedusinae).,Escherichiacoli
GLVSSIGRALGGLLADVVKSKGQPA,1264,25,3918,"Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",Bacilluscereus
GLWEKIKEKASELVSGIVEGVK,1264,25,3919,"Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",Bacilluscereus
GLLSSLGLNL,1264,25,3923,"Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",Bacilluscereus
GLLDVVGNLLGGLGL,1264,25,3924,"Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",Bacilluscereus
AGGLDDLLEPVLNSADNLVHGL,1264,25,3926,"Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",Bacilluscereus
EGPVGLADPDGPASAPLGAP,1265,190,3927,Two novel antimicrobial peptides purified from the symbiotic bacteria Xenorhabdus budapestensis NMC-10.,Phytophthoracapsici
GPVGLLSSPGSLPPVGGAP,1265,191,3928,Two novel antimicrobial peptides purified from the symbiotic bacteria Xenorhabdus budapestensis NMC-10.,Verticilliumdahliae
FALGAVTKLLPSLLCMITRKC,1266,4,3929,"Hainanenins: a novel family of antimicrobial peptides with strong activity from Hainan cascade-frog, Amolops hainanensis.",Staphylococcusaureus
FALGAVTKRLPSLFCLITRKC,1266,4,3930,"Hainanenins: a novel family of antimicrobial peptides with strong activity from Hainan cascade-frog, Amolops hainanensis.",Staphylococcusaureus
GIKCRFCCGCCTPGICGVCCRF,1267,17,3936,"Three different hepcidins from tilapia, Oreochromis mossambicus: analysis of their expressions and biological functions.",Listeriamonocytogenes
QSHLSLCRWCCNCCRSNKGC,1267,17,3937,"Three different hepcidins from tilapia, Oreochromis mossambicus: analysis of their expressions and biological functions.",Listeriamonocytogenes
GIKCCFCCGCCNSGVCELCCRF,1267,17,3938,"Three different hepcidins from tilapia, Oreochromis mossambicus: analysis of their expressions and biological functions.",Listeriamonocytogenes
CRFCCRCCPRMRGCGLCCRF,1268,21,3939,The antimicrobial peptide hepcidin exerts an important role in the innate immunity against bacteria in the bony fish gilthead seabream.,Vibrioanguillarum
GKLNLFLSRLEILKLFVGAL,1269,2,3940,"Isolation and identification of pelteobagrin, a novel antimicrobial peptide from the skin mucus of yellow catfish (Pelteobagrus fulvidraco)",Escherichiacoli
KSLRPRCWIKIKFRCKSLKF,1270,4,3943,Two antimicrobial and nematicidal peptides derived from sequences encoded Picea sitchensis.,Staphylococcusaureus
RPRCWIKIKFRCKSLKF,1270,4,3944,Two antimicrobial and nematicidal peptides derived from sequences encoded Picea sitchensis.,Staphylococcusaureus
FLGAIAAALPHVINAVTNAL,1271,2,3945,"A family of kassinatuerin-2 related peptides from the skin secretion of the African hyperoliid frog, Kassina maculata.",Escherichiacoli
FFGAIAAALPHVISAIKNAL,1271,2,3946,"A family of kassinatuerin-2 related peptides from the skin secretion of the African hyperoliid frog, Kassina maculata.",Escherichiacoli
FVGAIAAALPHVISAIKNAL,1271,2,3947,"A family of kassinatuerin-2 related peptides from the skin secretion of the African hyperoliid frog, Kassina maculata.",Escherichiacoli
IIGAIAAALPHVINAIKNTF,1271,2,3948,"A family of kassinatuerin-2 related peptides from the skin secretion of the African hyperoliid frog, Kassina maculata.",Escherichiacoli
GLVPNLLNNLGL,1264,25,4078,"Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",Bacilluscereus
GLVSNLGI,1264,25,4079,"Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",Bacilluscereus
GLISNLGI,1264,25,4080,"Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",Bacilluscereus
GAVSGLLTNL,1264,25,4081,"Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",Bacilluscereus
GAVSGLLTNLGL,1264,25,4082,"Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",Bacilluscereus
AGPVSKLVSGIGL,1264,25,4083,"Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",Bacilluscereus
GLVSSIGKALGGLLADVVKSKGQPA,1272,25,4085,"Differences in the skin peptides of the male and female Australian tree frog Litoria splendida. The discovery of the aquatic male sex pheromone splendipherin, together with phe8 caerulein and a new antibiotic peptide caerin 1.10.",Bacilluscereus
KIKIPWGKVKDFLVGGMKAV,1273,4,4108,Identification and characterization of a novel antimicrobial peptide from the venom of the ant Tetramorium bicarinatum.,Staphylococcusaureus
LFKEILEKIKAKL,1273,4,4110,Identification and characterization of a novel antimicrobial peptide from the venom of the ant Tetramorium bicarinatum.,Staphylococcusaureus
FLLFPLMCKIQGKC,1274,4,4111,"Novel families of antimicrobial peptides with multiple functions from skin of Xizang plateau frog, Nanorana parkeri.",Staphylococcusaureus
FVLPLVMCKILRKC,1274,4,4112,"Novel families of antimicrobial peptides with multiple functions from skin of Xizang plateau frog, Nanorana parkeri.",Staphylococcusaureus
GWANTLKNVAGGLCKITGAA,1274,4,4113,"Novel families of antimicrobial peptides with multiple functions from skin of Xizang plateau frog, Nanorana parkeri.",Staphylococcusaureus
FLPAVIRVAANVLPTVFCAISKKC,1275,2,4116,"Antimicrobial peptides from the skin of the Asian frog, Odorrana jingdongensis: de novo sequencing and analysis of tandem mass spectrometry data.",Escherichiacoli
GIFGKILGAGKKVLCGLSGLC,1275,2,4117,"Antimicrobial peptides from the skin of the Asian frog, Odorrana jingdongensis: de novo sequencing and analysis of tandem mass spectrometry data.",Escherichiacoli
GIFGKILGVGKKVLCGLSGMC,1275,2,4118,"Antimicrobial peptides from the skin of the Asian frog, Odorrana jingdongensis: de novo sequencing and analysis of tandem mass spectrometry data.",Escherichiacoli
FLPAVLRVAAKVVPTVFCLISKKC,1275,2,4119,"Antimicrobial peptides from the skin of the Asian frog, Odorrana jingdongensis: de novo sequencing and analysis of tandem mass spectrometry data.",Escherichiacoli
GLLSKVLGVGKKVLCGVSGLC,1278,18,4122,"Structural study of novel antimicrobial peptides, nigrocins, isolated from Rana nigromaculata.",Micrococcusluteus
GLLDSIKGMAISAGKGALQNLLKVASCKLDKTC,1278,18,4123,"Structural study of novel antimicrobial peptides, nigrocins, isolated from Rana nigromaculata.",Micrococcusluteus
FLHHIVGLIHHGLSLFGDRAD,1279,34,4133,Differential expression and biological activity of two piscidin paralogues and a novel splice variant in Atlantic cod (Gadus morhua L.).,Micrococcuslysodeikticus
FIHHIIGWISHGVRAIHRAIHG,1279,34,4134,Differential expression and biological activity of two piscidin paralogues and a novel splice variant in Atlantic cod (Gadus morhua L.).,Micrococcuslysodeikticus
FLHHIVGLIHHGKLDMYRSNN,1279,34,4135,Differential expression and biological activity of two piscidin paralogues and a novel splice variant in Atlantic cod (Gadus morhua L.).,Micrococcuslysodeikticus
GILSGILGMGKKLVCGLSGLC,1280,4,4136,Nigrocin-2 peptides from Chinese Odorrana frogs--integration of UPLC/MS/MS with molecular cloning in amphibian skin peptidome analysis.,Staphylococcusaureus
GILSGILGAGKSLVCGLSGLC,1280,4,4137,Nigrocin-2 peptides from Chinese Odorrana frogs--integration of UPLC/MS/MS with molecular cloning in amphibian skin peptidome analysis.,Staphylococcusaureus
GILSNVLGMGKKIVCGLSGLC,1280,4,4138,Nigrocin-2 peptides from Chinese Odorrana frogs--integration of UPLC/MS/MS with molecular cloning in amphibian skin peptidome analysis.,Staphylococcusaureus
SILSGNFGVGKKIVCGLSGLC,1280,4,4139,Nigrocin-2 peptides from Chinese Odorrana frogs--integration of UPLC/MS/MS with molecular cloning in amphibian skin peptidome analysis.,Staphylococcusaureus
GLLGGLLGPLLGGGGGGGGGLL,1281,3,4141,Leptoglycin: a new Glycine/Leucine-rich antimicrobial peptide isolated from the skin secretion of the South American frog Leptodactylus pentadactylus (Leptodactylidae).,Pseudomonasaeruginosa
DSIRDVSPTFNKIRRWFDGLFK,146,87,4142,Characterization of putative class II bacteriocins identified from a non-bacteriocin-producing strain Lactobacillus casei ATCC 334.,Listeriainnocua
KRKCPKTPFDNTPGAWFAHLILGC,146,87,4143,Characterization of putative class II bacteriocins identified from a non-bacteriocin-producing strain Lactobacillus casei ATCC 334.,Listeriainnocua
MQFITDLIKKAVDFFKGLFGNK,1282,48,4146,Characterization of anti-Legionella activity of warnericin RK and delta-lysin I from Staphylococcus warneri.,Bacillusmegaterium
MAADIISTIGDLVKLIINTVKKFQK,1282,48,4147,Characterization of anti-Legionella activity of warnericin RK and delta-lysin I from Staphylococcus warneri.,Bacillusmegaterium
KRGFGKKLRKRLKKFRNSIKKRLKNFNVVIPIPLPG,147,2,4172,Ancient antimicrobial peptides kill antibiotic-resistant pathogens: Australian mammals provide new options.,Escherichiacoli
KRGLWESLKRKATKLGDDIRNTLRNFKIKFPVPRQG,147,2,4173,Ancient antimicrobial peptides kill antibiotic-resistant pathogens: Australian mammals provide new options.,Escherichiacoli
RTKRRIKLIKNGVKKVKDILKNNNIIILPGSNEK,147,2,4174,Ancient antimicrobial peptides kill antibiotic-resistant pathogens: Australian mammals provide new options.,Escherichiacoli
RPWAGNGSVHRYTVLSPRLKTQ,147,2,4175,Ancient antimicrobial peptides kill antibiotic-resistant pathogens: Australian mammals provide new options.,Escherichiacoli
FFGHLYRGITSVVKHVHGLLSG,1283,192,4179,"A piscidin-like antimicrobial peptide from the icefish Chionodraco hamatus (Perciformes: Channichthyidae): molecular characterization, localization and bactericidal activity.",Psychrobactersp.
RIGVLLARLPKLFSLFKLMGKKV,1284,2,4189,"Evidence from peptidomic analysis of skin secretions that the red-legged frogs, Rana aurora draytonii and Rana aurora aurora, are distinct species.",Escherichiacoli
GLLSGILGAGKHIVCGLTGCAKA,1285,2,4192,A novel antimicrobial peptide from amphibian skin secretions of Odorrana grahami.,Escherichiacoli
DSMGAVKLAKLLIDKMKCEVTKAC,1286,4,4194,"Two novel families of antimicrobial peptides from skin secretions of the Chinese torrent frog, Amolops jingdongensis.",Staphylococcusaureus
GFMDTAKNVAKNVAVTLIDKLRCKVTGGC,1286,4,4195,"Two novel families of antimicrobial peptides from skin secretions of the Chinese torrent frog, Amolops jingdongensis.",Staphylococcusaureus
VIPFVASVAAEMMHHVYCAASKRC,1287,18,4204,Structure-activity relationships of antimicrobial peptides from the skin of Rana esculenta inhabiting in Korea.,Micrococcusluteus
GIFSKLAGKKIKNLLISGLKNIGKEVGMDVVRTGIDIAGCKIKGEC,1287,18,4205,Structure-activity relationships of antimicrobial peptides from the skin of Rana esculenta inhabiting in Korea.,Micrococcusluteus
SPAGCRFCCGCCPNMRGCGVCCRF,1288,4,4206,Molecular characterization of hepcidin AS-hepc2 and AS-hepc6 in black porgy (Acanthopagrus schlegelii): expression pattern responded to bacterial challenge and in vitro antimicrobial activity.,Staphylococcusaureus
GRGREFMSNLKEKLSGVKEKMKNS,1289,48,4207,Characterization of two linear cationic antimalarial peptides in the scorpion Mesobuthus eupeus.,Bacillusmegaterium
VKLIQIRIWIQYVTVLQMFSMKTKQ,1289,48,4208,Characterization of two linear cationic antimalarial peptides in the scorpion Mesobuthus eupeus.,Bacillusmegaterium
FFPIIAGMAAKLIPSLFCKITKKC,1290,2,4209,Purification and characterization of antimicrobial peptides from the skin secretions of the mink frog (Rana septentrionalis).,Escherichiacoli
FLPIIAGMAAKVICAITKKC,1290,2,4210,Purification and characterization of antimicrobial peptides from the skin secretions of the mink frog (Rana septentrionalis).,Escherichiacoli
FFPIIAGMAAKVICAITKKC,1291,2,4211,Purification and characterization of antimicrobial peptides from the skin secretions of the mink frog (Rana septentrionalis),Escherichiacoli
FLPAIVGAAAKFLPKIFCAISKKC,1292,2,4213,"Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis.",Escherichiacoli
FLPVIAGVAANFLPKLFCAISKKC,1292,2,4215,"Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis.",Escherichiacoli
FLPIIAGAAAKVVQKIFCAISKKC,1292,2,4216,"Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis.",Escherichiacoli
FLPIIAGAAAKVVEKIFCAISKKC,1292,2,4217,"Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis.",Escherichiacoli
GLMDTIKGVAKTVAASWLDKLKCKITGC,1292,2,4218,"Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis.",Escherichiacoli
GILSSFKGVAKGVAKNLAGKLLDELKCKITGC,1293,2,4219,Host-defense peptides isolated from the skin secretions of the Northern red-legged frog Rana aurora aurora.,Escherichiacoli
FLPILAGLAAKLVPKVFCSITKKC,1294,2,4220,Host-defense peptides isolated from the skin secretions of the Northern red-legged frog Rana aurora aurora,Escherichiacoli
FLPILAGLAANILPKVFCSITKKC,1293,2,4221,Host-defense peptides isolated from the skin secretions of the Northern red-legged frog Rana aurora aurora.,Escherichiacoli
FLPIIAGVAAKVLPKLFCAITKKC,1295,2,4226,Characterization of antimicrobial peptides in skin secretions from discrete populations of Lithobates chiricahuensis (Ranidae) from central and southern Arizona.,Escherichiacoli
FLPVIAGLAAKVLPKLFCAITKKC,1295,2,4227,Characterization of antimicrobial peptides in skin secretions from discrete populations of Lithobates chiricahuensis (Ranidae) from central and southern Arizona.,Escherichiacoli
FFPTIAGLTKLFCAITKKC,1295,2,4228,Characterization of antimicrobial peptides in skin secretions from discrete populations of Lithobates chiricahuensis (Ranidae) from central and southern Arizona.,Escherichiacoli
GFSSIFRGVAKFASKGLGKDLAKLGVDLVACKISKQC,1295,2,4229,Characterization of antimicrobial peptides in skin secretions from discrete populations of Lithobates chiricahuensis (Ranidae) from central and southern Arizona.,Escherichiacoli
GLMDTVKNAAKNLAGQLLDRLKCKITGC,1295,2,4230,Characterization of antimicrobial peptides in skin secretions from discrete populations of Lithobates chiricahuensis (Ranidae) from central and southern Arizona.,Escherichiacoli
GLMDTIKGVAKNVAASLLEKLKCKVTGC,1295,2,4231,Characterization of antimicrobial peptides in skin secretions from discrete populations of Lithobates chiricahuensis (Ranidae) from central and southern Arizona.,Escherichiacoli
GLLSTFKNLATNVAGTVIDTLKCKVTGGCRT,1295,2,4232,Characterization of antimicrobial peptides in skin secretions from discrete populations of Lithobates chiricahuensis (Ranidae) from central and southern Arizona.,Escherichiacoli
SVSNIPESIGF,1296,25,4244,The host-defence skin peptide profiles of Peron's Tree Frog Litoria peronii in winter and summer. Sequence determination by electrospray mass spectrometry and activities of the peptides.,Bacilluscereus
DVIKKVASVIGGL,150,2,4248,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli
GWKDWLNKGKEWLKKKGPGIMKAALKAATQ,91,166,4268,"Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",Aspergillusniger
DFKDWMKTAGEWLKKKGPGILKAAMAAAT,91,117,4269,"Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",Listeriaivanovii
GIWGTALKWGVKLLPKLVGMAQTKKQ,91,193,4271,"Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",Proteusmirabilis
FWGALIKGAAKLIPSVVGLFKKKQ,91,193,4272,"Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",Proteusmirabilis
KPPPWVPV,1297,159,4274,"PsT-1: a new tryptophyllin peptide from the skin secretion of Waxy Monkey Leaf Frog, Phyllomedusa sauvagei.",Humanprostate
GEFLKCGESCVQGECYTPGCSCDWPICKKN,1298,4,4275,Discovery and characterization of novel cyclotides originated from chimeric precursors consisting of albumin-1 chain a and cyclotide domains in the Fabaceae family.,Staphylococcusaureus
GIPCGESCVFIPCITGAIGCSCKSKVCYRN,1298,4,4276,Discovery and characterization of novel cyclotides originated from chimeric precursors consisting of albumin-1 chain a and cyclotide domains in the Fabaceae family.,Staphylococcusaureus
GLPTCGETCTLGTCYVPDCSCSWPICMKN,1298,4,4277,Discovery and characterization of novel cyclotides originated from chimeric precursors consisting of albumin-1 chain a and cyclotide domains in the Fabaceae family.,Staphylococcusaureus
GIPCGESCVFIPCITAAIGCSCKSKVCYRN,1298,4,4278,Discovery and characterization of novel cyclotides originated from chimeric precursors consisting of albumin-1 chain a and cyclotide domains in the Fabaceae family.,Staphylococcusaureus
GIPCGESCVFIPCTVTALLGCSCKDKVCYKN,1299,31,4279,Chemosensitizing activities of cyclotides from Clitoria ternatea in paclitaxel-resistant lung cancer cells.,Humanlung
GVPCAESCVWIPCTVTALLGCSCKDKVCYLN,1299,31,4280,Chemosensitizing activities of cyclotides from Clitoria ternatea in paclitaxel-resistant lung cancer cells.,Humanlung
GIPCGESCVYIPCTVTALLGCSCKDKVCYKN,1299,31,4281,Chemosensitizing activities of cyclotides from Clitoria ternatea in paclitaxel-resistant lung cancer cells.,Humanlung
GDACGETCFTGICFTAGCSCNPWPTCTRN,1300,4,4282,Novel cyclotides and uncyclotides with highly shortened precursors from Chassalia chartacea and effects of methionine oxidation on bioactivities.,Staphylococcusaureus
GIPCAESCVWIPCTITALMGCSCKNNVCYNN,1300,4,4283,Novel cyclotides and uncyclotides with highly shortened precursors from Chassalia chartacea and effects of methionine oxidation on bioactivities.,Staphylococcusaureus
GASCGETCFTGICFTAGCSCNPWPTCTRN,1300,4,4285,Novel cyclotides and uncyclotides with highly shortened precursors from Chassalia chartacea and effects of methionine oxidation on bioactivities.,Staphylococcusaureus
IPCGESCVWIPCITAIAGCSCKNKVCYT,1300,2,4286,Novel cyclotides and uncyclotides with highly shortened precursors from Chassalia chartacea and effects of methionine oxidation on bioactivities.,Escherichiacoli
AIPCGESCVWIPCISTVIGCSCSNKVCYR,1300,2,4287,Novel cyclotides and uncyclotides with highly shortened precursors from Chassalia chartacea and effects of methionine oxidation on bioactivities.,Escherichiacoli
GEYCGESCYLIPCFTPGCYCVSRQCVNKN,1300,2,4288,Novel cyclotides and uncyclotides with highly shortened precursors from Chassalia chartacea and effects of methionine oxidation on bioactivities.,Escherichiacoli
IPCGESCVWIPCISGMFGCSCKDKVCYS,1300,2,4289,Novel cyclotides and uncyclotides with highly shortened precursors from Chassalia chartacea and effects of methionine oxidation on bioactivities.,Escherichiacoli
GSGRGSCRSQCMRRHEDEPWRVQECVSQCRRRRGGGD,1301,194,4291,Disulfide-stabilized helical hairpin structure and activity of a novel antifungal peptide EcAMP1 from seeds of barnyard grass (Echinochloa crus-galli).,Alternariaalternata
DRCSQQCQHHRDPDRKQQCMRECRRHQGRSD,1302,33,4292,Defense peptides from barnyard grass (Echinochloa crusgalli L.) seeds.,Pseudomonassyringae
DRCSQQCQHHRDPDRKQQCMRECRRH,1302,33,4293,Defense peptides from barnyard grass (Echinochloa crusgalli L.) seeds.,Pseudomonassyringae
RKGWFKAMKSIAKFIAKEKLKEHL,1303,2,4294,"Antimicrobial potential of lycosin-I, a cationic and amphiphilic peptide from the venom of the spider Lycosa singorensis.",Escherichiacoli
FLSLIPSLVGGSISAFK,152,4,4297,"Two peptides, TsAP-1 and TsAP-2, from the venom of the Brazilian yellow scorpion, Tityus serrulatus: evaluation of their antimicrobial and anticancer activities.",Staphylococcusaureus
FLGMIPGLIGGLISAFK,152,4,4298,"Two peptides, TsAP-1 and TsAP-2, from the venom of the Brazilian yellow scorpion, Tityus serrulatus: evaluation of their antimicrobial and anticancer activities.",Staphylococcusaureus
RLGDGCTR,1304,118,4301,Identification and structural characterization of a new pro-apoptotic cyclic octapeptide cyclosaplin from somatic seedlings of Santalum album L.,Humanbreast
GIACGESCVFLGCFIPGCSCKSKVCYFN,1305,127,4302,"Isolation, characterization, and bioactivity of cyclotides from the Micronesian plant Psychotria leptothyrsa.",Humanhistiocytic
GVIPCGESCVFIPCISSVLGCSCKNKVCYRD,1305,127,4303,"Isolation, characterization, and bioactivity of cyclotides from the Micronesian plant Psychotria leptothyrsa.",Humanhistiocytic
KLCGETCFKFKCYTPGCSCSYPFCK,1305,127,4304,"Isolation, characterization, and bioactivity of cyclotides from the Micronesian plant Psychotria leptothyrsa.",Humanhistiocytic
GLWNSIKIAGKKLFVNVLDKIRCKVAGGCKTSPDVE,154,2,4309,Identification and structure–activity relationship of an antimicrobial peptide of the palustrin-2 family isolated from the skin of the endangered frog Odorrana ishikawae.,Escherichiacoli
SWLSKTYKKLENSAKKRISEGIAIAIQGGPR,1306,4,4324,Cecropin P1 and novel nematode cecropins: a bacteria-inducible antimicrobial peptide family in the nematode Ascaris suum.,Staphylococcusaureus
AANFGPSVFTPEVHETWQKFLNVVVAALGKQYH,1307,195,4338,"Antimicrobial peptides derived from hemoglobin are expressed in epithelium of channel catfish (Ictalurus punctatus, Rafinesque).",Vibrioalginolyticus
GGSVPCGESCVFIPCITSLAGCSCKNKVCYYD,1308,2,4343,Identification and structural characterization of novel cyclotide with activity against an insect pest of sugar cane.,Escherichiacoli
FSFKRLKGFAKKLWNSKLARKIRTKGLKYVKNFAKDMLSEGEEAPPAAEPPVEAPQ,1310,2,4348,A novel amphipathic linear peptide with both insect toxicity and antimicrobial activity from the venom of the scorpion Isometrus maculatus.,Escherichiacoli
GLRSKIWLWVLLMIWQESNKFKKM,1311,2,4349,"Dermaseptin S9, an alpha-helical antimicrobial peptide with a hydrophobic core and cationic termini.",Escherichiacoli
RSGRGECRRQCLRRHEGQPWETQECMRRCRRRG,1312,2,4350,Purification and characterization of a novel antimicrobial peptide from maize (Zea mays L.) kernels.,Escherichiacoli
QGVRNSQSCRRNKGICVPIRCPGSMRQIGTCLGAQVKCCRRK,1313,2,4351,Epithelial antibiotics induced at sites of inflammation.,Escherichiacoli
RTCMIKKEGWGKCLIDTTCAHSCKNRGYIGGNCKGMTRTCYCLVNC,262,2,4352,Cloning and functional expression of a mungbean defensin VrD1 in Pichia pastoris.,Escherichiacoli
FLGLIFHGLVHAGKLIHGLIHRNRG,1314,4,4353,"Identification, synthesis and characterization of a novel antimicrobial peptide HKPLP derived from Hippocampus kuda Bleeker.",Staphylococcusaureus
GILDSFKDVAKGVATHLLNMAKCKMTGC,1315,182,4381,Evaluation of the skin peptide defenses of the Oregon spotted frog Rana pretiosa against infection by the chytrid fungus Batrachochytrium dendrobatidis.,Batrachochytriumdendrobatidis
GILDTFKGVAKGVAKDLAVHMLEKLKCKMTGC,1315,182,4382,Evaluation of the skin peptide defenses of the Oregon spotted frog Rana pretiosa against infection by the chytrid fungus Batrachochytrium dendrobatidis.,Batrachochytriumdendrobatidis
GILSSFKDVAKGVAKNVAAQLLDKLKCKITGC,1315,182,4383,Evaluation of the skin peptide defenses of the Oregon spotted frog Rana pretiosa against infection by the chytrid fungus Batrachochytrium dendrobatidis.,Batrachochytriumdendrobatidis
GILDTVKGVAKDVAAHLLNMVKCKITGC,1315,182,4384,Evaluation of the skin peptide defenses of the Oregon spotted frog Rana pretiosa against infection by the chytrid fungus Batrachochytrium dendrobatidis.,Batrachochytriumdendrobatidis
GLMDTVKNAAKNLAGQMLDKLKCKITGSC,1316,2,4395,"Primary structures of skin antimicrobial peptides indicate a close, but not conspecific, phylogenetic relationship between the leopard frogs Lithobates onca and Lithobates yavapaiensis (Ranidae).",Escherichiacoli
ITIPPIVKDTLKKFFKGGIAGVMGKSQ,1317,4,4398,Characterization of the host-defense peptides from skin secretions of Merlin's clawed frog Pseudhymenochirus merlini: insights into phylogenetic relationships among the Pipidae.,Staphylococcusaureus
FKIPPIVKDTLKKFFKGGIAGVMGQ,1317,4,4399,Characterization of the host-defense peptides from skin secretions of Merlin's clawed frog Pseudhymenochirus merlini: insights into phylogenetic relationships among the Pipidae.,Staphylococcusaureus
ITIPPIIKDTLKKFFKGGIAGVMGKSQ,1317,4,4400,Characterization of the host-defense peptides from skin secretions of Merlin's clawed frog Pseudhymenochirus merlini: insights into phylogenetic relationships among the Pipidae.,Staphylococcusaureus
ITIPPIVKDTLKKFFKGGIAGVMGQ,1317,4,4401,Characterization of the host-defense peptides from skin secretions of Merlin's clawed frog Pseudhymenochirus merlini: insights into phylogenetic relationships among the Pipidae.,Staphylococcusaureus
ITIPPIVKNTLKKFIKGAVSALMS,1317,4,4404,Characterization of the host-defense peptides from skin secretions of Merlin's clawed frog Pseudhymenochirus merlini: insights into phylogenetic relationships among the Pipidae.,Staphylococcusaureus
IKIPSFFRNILKKVGKEAVSLIAGALKQS,1317,4,4405,Characterization of the host-defense peptides from skin secretions of Merlin's clawed frog Pseudhymenochirus merlini: insights into phylogenetic relationships among the Pipidae.,Staphylococcusaureus
GIFPIFAKLLGKVIKVASSLISKGRTE,1317,4,4406,Characterization of the host-defense peptides from skin secretions of Merlin's clawed frog Pseudhymenochirus merlini: insights into phylogenetic relationships among the Pipidae.,Staphylococcusaureus
APAHRSSTFPKWVTKTERGRQPLRS,1318,4,4439,"Alarin but not its alternative-splicing form, GALP (Galanin-like peptide) has antimicrobial activity.",Staphylococcusaureus
FFGSLLSLGSKLLPSVFKLFQRKKE,1319,2,4451,Antimicrobial peptides from arachnid venoms and their microbicidal activity in the presence of commercial antibiotics.,Escherichiacoli
FWGHIWNAVKRVGANALHGAVTGALS,1320,18,4452,"Halocyntin and papillosin, two new antimicrobial peptides isolated from hemocytes of the solitary tunicate, Halocynthia papillosa.",Micrococcusluteus
GFWKKVGSAAWGGVKAAAKGAAVGGLNALAKHIQ,1320,18,4453,"Halocyntin and papillosin, two new antimicrobial peptides isolated from hemocytes of the solitary tunicate, Halocynthia papillosa.",Micrococcusluteus
RCLPAGKTCVRGPMRVPCCGSCSQNKCT,1321,2,4466,Isolation and characterization of Psalmopeotoxin I and II: two novel antimalarial peptides from the venom of the tarantula Psalmopoeus cambridgei.,Escherichiacoli
AWLDKLKSLGKVVGKVALGVAQNYLNPQQ,163,2,4469,Post-secretory events alter the peptide content of the skin secretion of Hypsiboas raniceps.,Escherichiacoli
VGECVRGRCPSGMCCSQFGYCGKGPKYCG,1322,36,4476,Antimicrobial peptides from Amaranthus caudatus seeds with sequence homology to the cysteine/glycine-rich domain of chitin-binding proteins.,Alternariabrassicicola
RVRRFWPLVPVAINTVAAGINLYKAIRRK,1323,4,4477,"Gene cloning, expression and characterization of avian cathelicidin orthologs, Cc-CATHs, from Coturnix coturnix.",Staphylococcusaureus
LVQRGRFGRFLKKVRRFIPKVIIAAQIGSRFG,1323,4,4478,"Gene cloning, expression and characterization of avian cathelicidin orthologs, Cc-CATHs, from Coturnix coturnix.",Staphylococcusaureus
GIRCPKSWKCKAFKQRVLKRLLAMLRQHAF,1324,8,4480,Novel lynx spider toxin shares common molecular architecture with defense peptides from frog skin.,Bacillussubtilis
SPRVSRRYGRPFGGRPFVGGQFGGRPGCVCIRSPCPCANYG,1325,149,4481,"Two novel antimicrobial peptides, arasin-likeSp and GRPSp, from the mud crab Scylla paramamosain, exhibit the activity against some crustacean pathogenic bacteria.",Staphylococcushaemolyticus
IPAMEPAARVKRSPGYGGCSPRWACGGYG,1325,149,4482,"Two novel antimicrobial peptides, arasin-likeSp and GRPSp, from the mud crab Scylla paramamosain, exhibit the activity against some crustacean pathogenic bacteria.",Staphylococcushaemolyticus
GLPVCGETCVGGTCNTPGCACSWPVCTRN,1326,111,4484,Isolation and characterization of cytotoxic cyclotides from Viola philippica.,Humanskin
GLPVCGETCVGGTCNTPGCGCSWPVCTRN,1326,111,4485,Isolation and characterization of cytotoxic cyclotides from Viola philippica.,Humanskin
GIPCGESCVFIPCLTSAIGCSCKSKVCYRN,1326,111,4486,Isolation and characterization of cytotoxic cyclotides from Viola philippica.,Humanskin
GSIPCGESCVFIPCISSVIGCACKSKVCYKN,1326,111,4487,Isolation and characterization of cytotoxic cyclotides from Viola philippica.,Humanskin
GIPCGESCVFIPCISSVIGCSCSSKVCYRN,1326,111,4488,Isolation and characterization of cytotoxic cyclotides from Viola philippica.,Humanskin
GSIPCGESCVFIPCISAVIGCSCSNKVCYKN,1326,111,4489,Isolation and characterization of cytotoxic cyclotides from Viola philippica.,Humanskin
GSIPCGESCVFIPCISAIIGCSCSSKVCYKN,1326,111,4490,Isolation and characterization of cytotoxic cyclotides from Viola philippica.,Humanskin
GSIPCGESCVFIPCISAIIGCSCSNKVCYKN,1326,111,4491,Isolation and characterization of cytotoxic cyclotides from Viola philippica.,Humanskin
KRFWPLVPVAINTVAAGINLYKAIRRK,1327,2,4492,Fowlicidin-3 is an alpha-helical cationic host defense peptide with potent antibacterial and lipopolysaccharide-neutralizing activities.,Escherichiacoli
GLWDTIKQAGKKFFLNVLDKIRCKVAGGCRT,165,2,4497,Effects of thioredoxin: SUMO and intein on soluble fusion expression of an antimicrobial peptide OG2 in Escherichia coli.,Escherichiacoli
RKCNFLCKLKEKLRTVITSHIDKVLRPQG,1328,2,4536,Structure and function of a potent lipopolysaccharide-binding antimicrobial and anti-inflammatory peptide.,Escherichiacoli
QLKVDLWGTRSGIQPEQHSSGKSDVRRWRSRY,1329,2,4555,"Purification and cloning of a novel antimicrobial peptide from salivary glands of the hard tick, Ixodes sinensis.",Escherichiacoli
KNIGNSVSCLRNKGVCMPGKCAPKMKQIGTCGMPQVKCCKRK,1330,196,4570,The host defense peptide beta-defensin 1 confers protection against Bordetella pertussis in newborn piglets.,Bordetellapertussis
VKVGINGFGRIGRLVTRAAFHGKKVEVVAIND,1331,8,4577,"Purification and characterization of YFGAP, a GAPDH-related novel antimicrobial peptide, from the skin of yellowfin tuna, Thunnus albacares.",Bacillussubtilis
FRFGSFLKKVWKSKLAKKLRSKGKQLLKDYANKVLNGPEEEAAAPAE,1332,2,4592,"Characterization of BmKbpp, a multifunctional peptide from the Chinese scorpion Mesobuthus martensii Karsch: gaining insight into a new mechanism for the functional diversification of scorpion venom peptides.",Escherichiacoli
ACQFWSCNSSCISRGYRQGYCWGIQYKYCQCQ,1333,2,4611,Antimicrobial peptide induction in the haemolymph of the Mexican scorpion Centruroides limpidus limpidus in response to septic injury.,Escherichiacoli
GFFALIPKIISSPLFKTLLSAVGSALSSSGEQE,1334,2,4612,Specific antimicrobial and hemolytic activities of 18-residue peptides derived from the amino terminal region of the toxin pardaxin.,Escherichiacoli
FFGWLIKGAIHAGKAIHGLIHRRRH,1335,7,4652,Effect of a novel antimicrobial peptide chrysophsin-1 on oral pathogens and Streptococcus mutans biofilms,Streptococcusmutans
INLKGLIKKVASLLT,1336,2,4684,Venom peptides from solitary hunting wasps induce feeding disorder in lepidopteran larvae.,Escherichiacoli
VHVPPICSHRECRK,1336,2,4691,Venom peptides from solitary hunting wasps induce feeding disorder in lepidopteran larvae.,Escherichiacoli
FGPVIGLLSGILKSLL,1336,2,4692,Venom peptides from solitary hunting wasps induce feeding disorder in lepidopteran larvae.,Escherichiacoli
GTRCGETCFVLPCWSAKFGCYCQKGFCYRN,1337,4,4696,Discovery of a linear cyclotide from the bracelet subfamily and its disulfide mapping by top-down mass spectrometry.,Staphylococcusaureus
IQCGESCVWIPCISSAWGCSCKNKICSS,1337,4,4697,Discovery of a linear cyclotide from the bracelet subfamily and its disulfide mapping by top-down mass spectrometry.,Staphylococcusaureus
GIWSSIKNLASKAWNSDIGQSLRNKAAGAINKFVADKIGVTPSQAAS,1338,2,4724,"Vejovine, a new antibiotic from the scorpion venom of Vaejovis mexicanus.",Escherichiacoli
RIKRFWPVVIRTVVAGYNLYRAIKKK,1339,4,4725,Molecular cloning and characterization of novel cathelicidin-derived myeloid antimicrobial peptide from Phasianus colchicus.,Staphylococcusaureus
NAGSLLSGWG,1340,56,4727,Characterization of the novel antibacterial peptide Leucrocin from crocodile (Crocodylus siamensis) white blood cell extracts.,Staphylococcusepidermidis
RWKIFKKIEKVGRNVRDGIIKAGPAVAVVGQAATVVKG,1341,2,4743,"Characterization and cDNA cloning of a cecropin-like antimicrobial peptide, papiliocin, from the swallowtail butterfly, Papilio xuthus.",Escherichiacoli
GMWSKIKNAGKAAKAAAKAAGKAALGAVSEAM,1342,2,4749,"Dermaseptin DA4, although closely related to dermaseptin B2, presents chemotactic and Gram-negative selective bactericidal activities.",Escherichiacoli
RGGGLCYCRRRFCVCVGR,26,2,4756,Protegrin structure-activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity.,Escherichiacoli
RGGRLCYCRGWICFCVGR,26,2,4757,Protegrin structure-activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity.,Escherichiacoli
RGGRLCYCRPRFCVCVGR,26,2,4758,Protegrin structure-activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity.,Escherichiacoli
FFHHIFRGIVHVGKTIHRLVTG,186,2,4867,Solution structure and cell selectivity of piscidin 1 and its analogues.,Escherichiacoli
RWKPFKKELKVGRNIRDGIIKAGPAVAVIGQATSIARPTGK,1344,2,4871,"Production, purification, and characterization of the cecropin from Plutella xylostella, pxCECA1, using an intein-induced self-cleavable system in Escherichia coli.",Escherichiacoli
LRVRRTLQCSCRRVCRNTCSCIRLSRSTYAS,1345,2,4888,"Rattusin, an intestinal ?-defensin-related peptide in rats with a unique cysteine spacing pattern and salt-insensitive antibacterial activities.",Escherichiacoli
GLFNVFKGALKTAGKHVAGSLLNQLKCKVSGGC,1346,2,4933,"Antimicrobial peptides from the skin of the Japanese mountain brown frog, Rana ornativentris.",Escherichiacoli
VGKTWIKVIRGIGKSKIKWQ,1347,197,4955,Bactrocerin-1: a novel inducible antimicrobial peptide from pupae of oriental fruit fly Bactrocera dorsalis Hendel.,Sarcinalutea
CIAKGNGCQPSGVQGNCCSGHCHKEPGWVAGYCK,1348,50,4997,"Isolation and characterization of Psacotheasin, a novel Knottin-type antimicrobial peptide, from Psacothea hilaris.",Enterococcusfaecium
LFCKGGSCHFGGCPSHLIKVGSCFGFRSCCKWPWNA,1349,8,5002,Primary structure and antibacterial activity of chicken bone marrow-derived beta-defensins.,Bacillussubtilis
GRLKKLGKKIEGAGKRVFKAAEKALPVVAGVKALG,1350,64,5077,"Cloning and analysis of a cecropin gene from the malaria vector mosquito, Anopheles gambiae.",Alcaligenesfaecalis
ELPKLPDDKVLIRSRSNCPKGKVWNGFDCKSPFAFS,1351,198,5086,"Scarabaecin, a novel cysteine-containing antifungal peptide from the rhinoceros beetle, Oryctes rhinoceros.",Pyriculariaoryzae
DHYLCVKNEGICLYSSCPSYTKIEGTCYGGKAKCCK,1352,4,5088,"A beta-defensin 1-like antimicrobial peptide from the tree shrew, Tupaia belangeri.",Staphylococcusaureus
GGYYCPFFQDKCHRHCRSFGRKAGYCGGFLKKTCICV,1353,8,5100,Functional characterization of two defensin isoforms of the hard tick Ixodes ricinus.,Bacillussubtilis
GGYYCPFRQDKCHRHCRSFGRKAGYCGGFLKKTCICV,1353,8,5102,Functional characterization of two defensin isoforms of the hard tick Ixodes ricinus.,Bacillussubtilis
QLGELIQQGGQKIVEKIQKIGQRIRDFFSNLRPRQEA,1354,2,5105,Expression and activity of a novel cathelicidin from domestic cats.,Escherichiacoli
FTCAISCDIKVNGKPCKGSGEKKCSGGWSCKFNVCVKV,1355,18,5106,"Juruin: an antifungal peptide from the venom of the Amazonian Pink Toe spider, Avicularia juruensis, which contains the inhibitory cystine knot motif.",Micrococcusluteus
AGCIKNGGRCNASAGPPYCCSSYCFQIAGQSYGVCKNR,1356,48,5107,"Purification, characterization, and molecular cloning of the gene of a seed-specific antimicrobial protein from pokeweed.",Bacillusmegaterium
ILENLLARSTNEDREGSIFDTGPIRRPKPRPRPRPEG,200,34,5109,Oyster hemocytes express a proline-rich peptide displaying synergistic antimicrobial activity with a defensin.,Micrococcuslysodeikticus
RWKVFKKIEKVGRNVRDGIIKAGPAIGVLGQAKALG,1357,2,5114,"Antibacterial properties and partial cDNA sequences of cecropin-like antibacterial peptides from the common cutworm, Spodoptera litura.",Escherichiacoli
RWKVFKKIEKMGRNIRDGIVKAGPAIEVLGSAKALGK,1357,2,5115,"Antibacterial properties and partial cDNA sequences of cecropin-like antibacterial peptides from the common cutworm, Spodoptera litura.",Escherichiacoli
VAKCTEESGGKYFVFCCYKPTRICYMNEQKCESTCIGK,1358,24,5116,Discovery of novel antimicrobial peptides with unusual cysteine motifs in dandelion Taraxacum officinale Wigg. flowers.,Fusariumoxysporum
GGKCTVDWGGQGGGRRLPSPLFCCYKPTRICYLNQETCETETCP,1358,24,5117,Discovery of novel antimicrobial peptides with unusual cysteine motifs in dandelion Taraxacum officinale Wigg. flowers.,Fusariumoxysporum
ANKCIIDCMKVKTTCGDECKGAGFKTGGCALPPDIMKCCHNC,1358,24,5118,Discovery of novel antimicrobial peptides with unusual cysteine motifs in dandelion Taraxacum officinale Wigg. flowers.,Fusariumoxysporum
GFGCPFNENECHAHCLSIGRKFGFCAGPLRATCTCGKQ,1359,48,5119,Dermatophytic defensin with antiinfective potential.,Bacillusmegaterium
FPWSCPTLSGVCRKVCLPTEMFFGPLGCGKEFQCCVSHFF,1360,18,5123,A novel beta-defensin antimicrobial peptide in Atlantic cod with stimulatory effect on phagocytic activity.,Micrococcusluteus
PICTRNGLPVCGETCFGGTCNTPGCTCTW,1361,1,5131,Cyclic peptides from Oldenlandia affinis DC. Molecular and biological properties.,None_target
PVCTRNGLPVCGETCVGGTCNTPGCTCSW,1361,1,5132,Cyclic peptides from Oldenlandia affinis DC. Molecular and biological properties.,None_target
PICKRNGLPVCGETCTLGTCYTQGCTCSW,1361,1,5133,Cyclic peptides from Oldenlandia affinis DC. Molecular and biological properties.,None_target
TTKNYGNGVCNSVNWCQCGNVWASCNLATGCAAWLCKLA,1362,55,5134,Diverse antimicrobial killing by Enterococcus faecium E 50-52 bacteriocin.,Campylobacterjejuni
QQCGRQAGNRRCPNNLCCSQFGYCGRTNEYCCTGFGCQSNCRRCG,1363,36,5144,Synergistic antifungal activity of two chitin-binding proteins from spindle tree (Euonymus europaeus L.).,Alternariabrassicicola
GWLKKIGKKIERVGQHTRDATIQGLGIAQQAANVAATARG,1104,4,5153,"Purification of three antibacterial proteins from the culture medium of NIH-Sape-4, an embryonic cell line of Sarcophaga peregrina.",Staphylococcusaureus
ATCDLLSGIGVQHSACALHCVFRGNRGGYCTGKGICVCRN,1364,2,5157,"Purification, sequence and antibacterial activity of two novel sapecin homologues from Sarcophaga embryonic cells: similarity of sapecin B to charybdotoxin.",Escherichiacoli
LTCEIDRSLCLLHCRLKGYLRAYCSQQKVCRCVQ,1364,2,5158,"Purification, sequence and antibacterial activity of two novel sapecin homologues from Sarcophaga embryonic cells: similarity of sapecin B to charybdotoxin.",Escherichiacoli
YDLSKNCRLRGGICYIGKCPRRFFRSGSCSRGNVCCLRFG,1365,2,5161,"Isolation, purification and de novo sequencing of TBD-1, the first beta-defensin from leukocytes of reptiles.",Escherichiacoli
AACSDRAHGHICESFKSFCKDSGRNGVKLRANCKKTCGLC,1366,2,5171,"Aurelin, a novel antimicrobial peptide from jellyfish Aurelia aurita with structural features of defensins and channel-blocking toxins.",Escherichiacoli
GFGCPGDAYQCSEHCRALGGGRTGGYCAGPWYLGHPTCTCSF,1367,4,5172,"Eurocin, a new fungal defensin: structure, lipid binding, and its mode of action.",Staphylococcusaureus
ADTLACRQSHQSCSFVACRAPSVDIGTCRGGKLKCCKWAPSS,1368,2,5173,"Two novel duck antibacterial peptides, avian beta-defensins 9 and 10, with antimicrobial activity.",Escherichiacoli
VLLFLFQAAPGSADAPFADTAACRSQGNFCRAGACPPTFAASGSCHGGLLNCCAK,1368,2,5174,"Two novel duck antibacterial peptides, avian beta-defensins 9 and 10, with antimicrobial activity.",Escherichiacoli
CLAGRLDKQCTCRRSQPSRRSGHEVGRPSPHCGPSRQCGCHMD,1369,6,5175,"Drosomycin-like defensin, a human homologue of Drosophila melanogaster drosomycin with antifungal activity.",Aspergillusfumigatus
YENPYGCPTDEGKCFDRCNDSEFEGGYCGGSYRATCVCYRT,1370,2,5176,"Two novel non-cationic defensin-like antimicrobial peptides from haemolymph of the female tick, Amblyomma hebraeum.",Escherichiacoli
GILDTIKSIASKVWNSKTVQDLKRKGINWVANKLGVSPQAA,1371,2,5177,"Hadrurin, a new antimicrobial peptide from the venom of the scorpion Hadrurus aztecus.",Escherichiacoli
DTLACRQSHGSCSFVACRAPSVDIGTCRGGKLKCCKWAPSS,207,55,5178,The beta-defensin gallinacin-6 is expressed in the chicken digestive tract and has antimicrobial activity against food-borne pathogens.,Campylobacterjejuni
DDTPSSRCGSGGWGPCLPIVDLLCIVHVTVGCSGGFGCCRIG,1372,3,5186,"Structure, self-assembly, and dual role of a beta-defensin-like peptide from the Chinese soft-shelled turtle eggshell matrix.",Pseudomonasaeruginosa
FSCDVLSFQSKWVSPNHSACAVRCLAQRRKGGKCKNGDCVCR,1373,18,5188,Identification and characterization of the parasitic wasp Nasonia defensins: positive selection targeting the functional region?,Micrococcusluteus
GTPCGESCVYIPCISGVIGCSCTDKVCYLN,1374,1,5235,Structural and biochemical characteristics of the cyclotide kalata B5 from Oldenlandia affinis.,None_target
GLPVCGETCFGGTCNTPGCSCTWPICTRD,1374,2,5236,Structural and biochemical characteristics of the cyclotide kalata B5 from Oldenlandia affinis.,Escherichiacoli
GLPTCGETCFGGTCNTPGCSCSSWPICTRN,1374,199,5237,Structural and biochemical characteristics of the cyclotide kalata B5 from Oldenlandia affinis.,Haemonchuscontortus
GLPVCGETCTLGTCYTQGCTCSWPICKRN,1374,2,5238,Structural and biochemical characteristics of the cyclotide kalata B5 from Oldenlandia affinis.,Escherichiacoli
GIPCAESCVYIPCTVTALLGCSCSNRVCYN,1374,199,5239,Structural and biochemical characteristics of the cyclotide kalata B5 from Oldenlandia affinis.,Haemonchuscontortus
GLPVCGETCFGGTCNTPGCICDPWPVCTRN,1374,199,5240,Structural and biochemical characteristics of the cyclotide kalata B5 from Oldenlandia affinis.,Haemonchuscontortus
RRIRPRPPRLPRPRPRPLPFPRPGPRPIPRPLPFPRPGPRPIPRPLPFPRPGPRPIPRPL,1375,2,5242,"Purification, composition, and activity of two bactenecins, antibacterial peptides of bovine neutrophils.",Escherichiacoli
AQRCGDQARGAKCPNCLCCGKYGFCGSGDAYCGAGSCQSQCRGC,1376,158,5256,A novel antifungal hevein-type peptide from Triticum kiharae seeds with a unique 10-cysteine motif.,Bipolarissorokiniana
KGAPCAKKPCCGPLGHYKVDCSTIPDYPCCSKYGFCGSGPQYCG,1377,12,5257,"Purification, characterization, and sequencing of antimicrobial peptides, Cy-AMP1, Cy-AMP2, and Cy-AMP3, from the Cycad (Cycas revoluta) seeds.",Clavibactermichiganensis
KGGPCAKKPCCGPLGHYKVDCSTIPDYPCCSKYGFCGSGPQYCG,1377,12,5258,"Purification, characterization, and sequencing of antimicrobial peptides, Cy-AMP1, Cy-AMP2, and Cy-AMP3, from the Cycad (Cycas revoluta) seeds.",Clavibactermichiganensis
TKYYGNGVYCNSKKCWVDWGTAQGCIDVVIGQLGGGIPGKGKC,1378,32,5260,"Purification, characterization and amino acid sequencing of divergicin M35: a novel class IIa bacteriocin produced by Carnobacterium divergens M35.",Lactococcuslactis
ATYYGNGVYCNKQKCWVDWSRARSEIIDRGVKAYVNGFTKVLGGIGGR,1379,8,5261,"Isolation and characterization of enterocin SE-K4 produced by thermophilic enterococci, Enterococcus faecalis K-4.",Bacillussubtilis
AQEPVKGPVSTKPGSCPIILIRCAMLNPPNRCLKDTDCPGIKKCCEGSCGMACFVPQ,1380,2,5269,Supernatants of Pseudomonas aeruginosa induce the Pseudomonas-specific antibiotic elafin in human keratinocytes.,Escherichiacoli
KYYGNGVSCNKKGCSVDWGKAIGIIGNNSAANLATGGAAGWKS,1381,2,5277,"Biochemical and genetic characterization of mundticin KS, an antilisterial peptide produced by Enterococcus mundtii NFRI 7393.",Escherichiacoli
MLAKIKAMIKKFPNPYTLAAKLTTYEINWYKQQYGRYPWERPVA,1382,200,5278,"Isolation and characterization of enterocin EJ97, a bacteriocin produced by Enterococcus faecalis EJ97.",Bacilluscirculans
GIFPKIIGKGIVNGIKSLAKGVGMKVFKAGLNNIGNTGCNNRDEC,1383,4,5281,"Antimicrobial peptides and protease inhibitors in the skin secretions of the crawfish frog, Rana areolata.",Staphylococcusaureus
GIFSKINKKKAKTGLFNIIKTVGKEAGMDVIRAGIDTISCKIKGEC,1383,4,5282,"Antimicrobial peptides and protease inhibitors in the skin secretions of the crawfish frog, Rana areolata.",Staphylococcusaureus
GLFPKFNKKKVKTGIFDIIKTVGKEAGMDVLRTGIDVIGCKIKGEC,1383,4,5283,"Antimicrobial peptides and protease inhibitors in the skin secretions of the crawfish frog, Rana areolata.",Staphylococcusaureus
GLMDTVKNAAKNLAGQLLDTIKCKMTGC,1383,4,5284,"Antimicrobial peptides and protease inhibitors in the skin secretions of the crawfish frog, Rana areolata.",Staphylococcusaureus
GILDTIKNAAKTVAVGLLEKIKCKMTGC,1383,4,5285,"Antimicrobial peptides and protease inhibitors in the skin secretions of the crawfish frog, Rana areolata.",Staphylococcusaureus
GFISTVKNLATNVAGTVIDTIKCKVTGGC,1383,4,5286,"Antimicrobial peptides and protease inhibitors in the skin secretions of the crawfish frog, Rana areolata.",Staphylococcusaureus
SIGSALKKALPVAKKIGKIALPIAKAALPVAAGLVG,215,2,5299,Antibacterial activity and pore-forming properties of ceratotoxins: a mechanism of action based on the barrel stave model.,Escherichiacoli
SIGTAVKKAVPIAKKVGKVAIPIAKAVLSVVGQLVG,215,2,5306,Antibacterial activity and pore-forming properties of ceratotoxins: a mechanism of action based on the barrel stave model.,Escherichiacoli
RIIDLLWRVRRPQKPKFVTVWVR,217,2,5317,Effects of tryptophan residues of porcine myeloid antibacterial peptide PMAP-23 on antibiotic activity.,Escherichiacoli
MGIIAGIIKVIKSLIEQFTGK,222,56,5352,Novel phenol-soluble modulin derivatives in community-associated methicillin-resistant Staphylococcus aureus identified through imaging mass spectrometry.,Staphylococcusepidermidis
MAIVGTIIKIIKAIIDIFAK,222,56,5354,Novel phenol-soluble modulin derivatives in community-associated methicillin-resistant Staphylococcus aureus identified through imaging mass spectrometry.,Staphylococcusepidermidis
FAVWGCADYRGYCRAACFAFEYSLGPKGCTEGYVCCVPNTF,1384,4,5356,The first salamander defensin antimicrobial peptide.,Staphylococcusaureus
FFRHLFRGAKAIFRGARQGWRAHKVVSRYRNRDVPETDNNQEEP,1385,201,5359,"Piscidin 4, a novel member of the piscidin family of antimicrobial peptides.",Streptococcusiniae
GLVGTLLGHIGKAILG,1386,4,5371,A family of antimicrobial and immunomodulatory peptides related to the frenatins from skin secretions of the Orinoco lime frog Sphaenorhynchus lacteus (Hylidae),Staphylococcusaureus
MVALLKSLERRRLMITISTMLQFGLFLIALIGLVIKLIELSNKK,1387,4,5372,Dual toxic-peptide-coding Staphylococcus aureus RNA under antisense regulation targets host cells and bacterial rivals unequally.,Staphylococcusaureus
MITISTMLQFGLFLIALIGLVIKLIELSNKK,1387,4,5373,Dual toxic-peptide-coding Staphylococcus aureus RNA under antisense regulation targets host cells and bacterial rivals unequally.,Staphylococcusaureus
KTKQQFLIKAQTQLFKVFGYTL,1388,18,5375,"Purification and Characterization of Plantaricin ZJ5, a New Bacteriocin Produced by Lactobacillus plantarum ZJ5.",Micrococcusluteus
KTCENLSDSFKGPCIPDGNCNKHCKEKEHLLSGRCRDDFRCWCTRNC,1389,103,5393,Heterologous expression and solution structure of defensin from lentil Lens culinaris.,Agrobacteriumtumefaciens
FCKSLPLPLSVK,1390,4,5394,Isolation and identification of a new intracellular antimicrobial peptide produced by Paenibacillus alvei AN5.,Staphylococcusaureus
KRFKKFFKKLKNSVKKRAKKFFKKPKVIGVTFPF,1392,202,5396,"Antimicrobial and antibiofilm activity of cathelicidins and short, synthetic peptides against Francisella.",Francisellanovicida
CYCRIPACIAGERRYGTCIYQGRLWAFCC,227,30,5401,Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides.,HIV-1IIIB
QWGYGGYGRGYGGYGGYGRGYGGYGGYGRGYGGYGRGMYGGYGRPYGGYGWGK,1393,18,5408,"TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM.",Micrococcusluteus
GIGAVLKVLTTGLPALISWIKRKRQQ,227,2,5417,Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides.,Escherichiacoli
AIFIFIRWLLKLGHHGRAPP,228,8,5418,"Salusin-beta, an antimicrobially active peptide against Gram-positive bacteria.",Bacillussubtilis
SDYLNNNPLFPRYDIGNVELSTAYRSFANQKAPGRLNQNWALTADYTYR,1394,2,5427,Cationic Bioactive Peptide from the Seeds of Benincasa hispida.,Escherichiacoli
DVNDLKNLCAKTHNLLPMCAMFGKK,1395,4,5440,"Cloning and expression of genes enocoding antimicrobial peptides and bradykinin from the skin and brain of Oki Tago's brown frog, Rana tagoi okiensis.",Staphylococcusaureus
GIGAVLKVLSTGLPALISWIKRKRQQ,1396,1,5455,Identification of a novel melittin isoform from Africanized Apis mellifera venom.,None_target
GLGSVFGRLARILGRVIPKVAKKLGPKVAKVLPKVMKEAIPMAVEMAKSQEEQQPQ,1397,1,5490,"Cytotoxicity of pilosulin 1, a peptide from the venom of the jumper ant Myrmecia pilosula.",None_target
GYGCPFNQYQCHSHCSGIRGYKGGYCKGTFKQTCKCY,1398,25,5515,Antibacterial activity and mechanism of action of tick defensin against Gram-positive bacteria.,Bacilluscereus
LTCDLLSFEAKGFAANHSLCAAHCLAIGRKGGACQNGVCVCRR,1398,18,5516,Antibacterial activity and mechanism of action of tick defensin against Gram-positive bacteria.,Micrococcusluteus
ALWFTMLKKLGTMALHAGKAALGAAANTISQGTQ,1399,203,5530,The vertebrate peptide antibiotics dermaseptins have overlapping structural features but target specific microorganisms.,Aeromonascaviae
ALWMTLLKKVLKAAAKALNAVLVGANA,1399,203,5531,The vertebrate peptide antibiotics dermaseptins have overlapping structural features but target specific microorganisms.,Aeromonascaviae
GLWSKIKTAGKSVAKAAAKAAVKAVTNAV,1399,203,5532,The vertebrate peptide antibiotics dermaseptins have overlapping structural features but target specific microorganisms.,Aeromonascaviae
KSTVGQKLKKKLNQAVDKVKEVLNKSEYMCPVVSSFCKQHCARLGKSGQCDLLECIC,1400,8,5540,Cytolytic and K+ channel blocking activities of beta-KTx and scorpine-like peptides purified from scorpion venoms.,Bacillussubtilis
KDRPKKPGLCPPRPQKPCVKECKNDDSCPGQQKCCNYGCKDECRDPIFVG,1401,48,5542,"Antimicrobial activity of omwaprin, a new member of the waprin family of snake venom proteins.",Bacillusmegaterium
GVVKVSRLKGESLRARL,239,8,5545,"Antimicrobial peptides derived from pepsinogens in the stomach of the bullfrog, Rana catesbeiana.",Bacillussubtilis
IIKVPLKKFKSMREVMRDHGIKAPVVDPATKY,239,8,5546,"Antimicrobial peptides derived from pepsinogens in the stomach of the bullfrog, Rana catesbeiana.",Bacillussubtilis
SGRGKQGGKVRAKAKTRSSRAGLQFPVGRVHRLLRKGNY,239,8,5547,"Antimicrobial peptides derived from pepsinogens in the stomach of the bullfrog, Rana catesbeiana.",Bacillussubtilis
SLFSLIKAGAKFLGKNLLKQGACYAACKASKQC,1019,18,5556,"Antimicrobial peptides from the skin of a Korean frog, Rana rugosa.",Micrococcusluteus
GIMSIVKDVAKNAAKEAAKGALSTLSCKLAKTC,1019,18,5557,"Antimicrobial peptides from the skin of a Korean frog, Rana rugosa.",Micrococcusluteus
GIMSIVKDVAKTAAKEAAKGALSTLSCKLAKTC,1019,18,5558,"Antimicrobial peptides from the skin of a Korean frog, Rana rugosa.",Micrococcusluteus
GILDTLKQFAKGVGKDLVKGAAQGVLSTVSCKLALTC,1019,18,5559,"Antimicrobial peptides from the skin of a Korean frog, Rana rugosa.",Micrococcusluteus
ATYYGNGLYCNKEKCWVDWNQAKGEIGKIIVNGWVNHGPWAPRR,1402,204,5568,"Bacteriocin T8, a novel class IIa sec-dependent bacteriocin produced by Enterococcus faecium T8, isolated from vaginal secretions of children infected with human immunodeficiency virus.",Lactobacillusacidophilus
FIHHIFRGIVHAGRSIGRFLTG,1403,201,5569,Peptide antibiotics in mast cells of fish.,Streptococcusiniae
ADDRCERMCQRYHDRREKKQCMKGCRYG,1404,89,5579,"Genes encoding 4-Cys antimicrobial peptides in wheat Triticum kiharae Dorof. et Migush.: multimodular structural organization, instraspecific variability, distribution and role in defence.",Fusariumgraminearum
TDDRCERMCQHYHDRREKKQCMKGCRYGESD,1404,89,5580,"Genes encoding 4-Cys antimicrobial peptides in wheat Triticum kiharae Dorof. et Migush.: multimodular structural organization, instraspecific variability, distribution and role in defence.",Fusariumgraminearum
IGGALGNALNGLGTWANMMNGGGFVNQWQVYANKGKINQYRPY,1405,196,5581,"Garvicin A, a novel class IId bacteriocin from Lactococcus garvieae that inhibits septum formation in L. garvieae strains.",Bordetellapertussis
NLKAIAALAKKLL,1160,4,5603,Antimicrobial peptides from the venom gland of the social wasp Vespa tropica.,Staphylococcusaureus
INLKAITALAKKLL,1160,4,5604,Antimicrobial peptides from the venom gland of the social wasp Vespa tropica.,Staphylococcusaureus
INLKAIAPLAKKLL,1160,4,5605,Antimicrobial peptides from the venom gland of the social wasp Vespa tropica.,Staphylococcusaureus
VIVKAIATLASKLL,1160,126,5606,Antimicrobial peptides from the venom gland of the social wasp Vespa tropica.,Enterobactercloacae
INLKAIAALVKKLL,1160,4,5607,Antimicrobial peptides from the venom gland of the social wasp Vespa tropica.,Staphylococcusaureus
INLKAIAALARNY,1160,4,5608,Antimicrobial peptides from the venom gland of the social wasp Vespa tropica.,Staphylococcusaureus
FLPIIGKLLSGLL,1160,4,5609,Antimicrobial peptides from the venom gland of the social wasp Vespa tropica.,Staphylococcusaureus
FLPIIGKLLSG,1160,4,5610,Antimicrobial peptides from the venom gland of the social wasp Vespa tropica.,Staphylococcusaureus
SPIHACRYQRGVCIPGPCRWPYYRVGSCGSGLKSCCVRNRWA,242,42,5620,Expression in Pichia Pastoris and biological activity of Avian ?-defensin 6 and its mutant peptide without cysteines.,Salmonellatyphimurium
FIHHIIGGLFSVGKHIHGLIHGH,1406,4,5622,Cloning and functional characterization of three novel antimicrobial peptides from tilapia (Oreochromis niloticus).,Staphylococcusaureus
FIHHIIGGLFSAGKAIHRLIRRRRR,1406,4,5623,Cloning and functional characterization of three novel antimicrobial peptides from tilapia (Oreochromis niloticus).,Staphylococcusaureus
IWDAIFHGAKHFLHRLVNPGGKDAVKDVQQKQ,1406,4,5624,Cloning and functional characterization of three novel antimicrobial peptides from tilapia (Oreochromis niloticus).,Staphylococcusaureus
NPVSCVRNKGICVPIRCPGNMKQIGTCVGRAVKCCRKK,1407,23,5626,Bactericidal activity of tracheal antimicrobial peptide against respiratory pathogens of cattle.,Mannheimiahaemolytica
GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,243,2,5627,"A class of highly potent antibacterial peptides derived from pardaxin, a pore-forming peptide isolated from Moses sole fish Pardachirus marmoratus.",Escherichiacoli
GCRFCCNCCPNMSGCGVCCRF,1408,52,5651,"Bass hepcidin synthesis, solution structure, antimicrobial activities and synergism, and in vivo hepatic response to bacterial infections.",Enterococcusfaecalis
GKFSVFGKILRSIAKVFKGVGKVRKQFKTASDLDKNQ,1008,4,5652,"Oxyopinins, large amphipathic peptides isolated from the venom of the wolf spider Oxyopes kitabensis with cytolytic properties and positive insecticidal cooperativity with spider neurotoxins.",Staphylococcusaureus
FLSLIPHIVSGVAALAKHLG,1409,2,5656,"Membrane association, electrostatic sequestration, and cytotoxicity of Gly-Leu-rich peptide orthologs with differing functions.",Escherichiacoli
RRSKARGGSRGSKMGRKDSKGGSRGRPGSGSRPGGGSSIAGASRGDRGGTRNA,1410,4,5668,"Structural and functional characterization of CATH_BRALE, the defense molecule in the ancient salmonoid, Brachymystax lenok.",Staphylococcusaureus
DRCTKRYGRCKRDCLESEKQIDICSLPRKICCTEKLYEEDDMF,1411,2,5669,The novel human ?-defensin 114 regulates lipopolysaccharide (LPS)-mediated inflammation and protects sperm from motility loss.,Escherichiacoli
YSKSLPLSVLNP,1412,4,5670,Detection of secreted antimicrobial peptides isolated from cell-free culture supernatant of Paenibacillus alvei AN5.,Staphylococcusaureus
NRWCFAGDD,1413,205,5672,Characterization of an antimicrobial peptide produced by Bacillus subtilis subsp. spizezinii showing inhibitory activity towards Haemophilus parasuis.,Haemophilusparasuis
GLLLDTVKGAAKNVAGILLNKLKCKMTGDC,1414,2,5683,Different expression profiles of bioactive peptides in Pelophylax nigromaculatus from distinct regions.,Escherichiacoli
AATAKKGAKKADAPAKPKKATKPKSPKKAAKKAGAKKGVKRAGKKGAKKTTKAKK,1416,8,5685,"cgMolluscidin, a novel dibasic residue repeat rich antimicrobial peptide, purified from the gill of the Pacific oyster, Crassostrea gigas.",Bacillussubtilis
GYGDGCYSEDDLSVCCKKKFKVIGKCFKSVRECQNSGCKYH,1417,194,5686,A novel cysteine-rich antifungal peptide ToAMP4 from Taraxacum officinale Wigg. flowers.,Alternariaalternata
AMPWRPATGLLPIKPTHIKPLCGDD,1418,4,5691,"Identification of multiple antimicrobial peptides from the skin of fine-spined frog, Hylarana spinulosa (Ranidae).",Staphylococcusaureus
GFLNTAMNTVTNLAGTLMDKAKCKIRGC,1418,4,5692,"Identification of multiple antimicrobial peptides from the skin of fine-spined frog, Hylarana spinulosa (Ranidae).",Staphylococcusaureus
GIFSLFKAGAKFFGKNLLKEAGKAGAEHLACKAANQC,1418,4,5693,"Identification of multiple antimicrobial peptides from the skin of fine-spined frog, Hylarana spinulosa (Ranidae).",Staphylococcusaureus
FLPAVLKVAAHILPTAICAISRRC,1418,4,5694,"Identification of multiple antimicrobial peptides from the skin of fine-spined frog, Hylarana spinulosa (Ranidae).",Staphylococcusaureus
FMGTALKIAANVLPAAFCKIFKKC,1418,4,5695,"Identification of multiple antimicrobial peptides from the skin of fine-spined frog, Hylarana spinulosa (Ranidae).",Staphylococcusaureus
GLRDKIKNVAIDVAKGAGTGVLKALLCQLDKSC,1418,4,5696,"Identification of multiple antimicrobial peptides from the skin of fine-spined frog, Hylarana spinulosa (Ranidae).",Staphylococcusaureus
GVLDTLKNVAIGVAKGAGTGVLKALLCQLDKSC,1418,4,5697,"Identification of multiple antimicrobial peptides from the skin of fine-spined frog, Hylarana spinulosa (Ranidae).",Staphylococcusaureus
GAFGNLLKGVAKKAGLKILSIAQCKLSGTC,1418,4,5698,"Identification of multiple antimicrobial peptides from the skin of fine-spined frog, Hylarana spinulosa (Ranidae).",Staphylococcusaureus
GAFGDLLKGVAKEAGLKLLNMAQCKLSGNC,1418,4,5699,"Identification of multiple antimicrobial peptides from the skin of fine-spined frog, Hylarana spinulosa (Ranidae).",Staphylococcusaureus
GLFGVLAKVAAHVVPAIAEHF,1419,25,5708,"Maculatin 1.1, an anti-microbial peptide from the Australian tree frog, Litoria genimaculata solution structure and biological activity.",Bacilluscereus
GWASSIGSILGKFAKGGAQAFLQPK,248,2,5714,Origin and functional diversification of an amphibian defense peptide arsenal.,Escherichiacoli
GLLSNVAGLLKQFAKGGVNAVLNPK,248,2,5717,Origin and functional diversification of an amphibian defense peptide arsenal.,Escherichiacoli
PPCRGIFCRRVGSSSAIARPGKTLSTFITV,1420,4,5729,"Identification and polymorphism discovery of the cathelicidins, Lf-CATHs in ranid amphibian (Limnonectes fragilis).",Staphylococcusaureus
GKCNVLCQLKQKLRSIGSGSHIGSVVLPRG,1420,4,5730,"Identification and polymorphism discovery of the cathelicidins, Lf-CATHs in ranid amphibian (Limnonectes fragilis).",Staphylococcusaureus
LLPIVGNLLKSLL,251,4,5732,"Design, structural and functional characterization of a Temporin-1b analog active against Gram-negative bacteria.",Staphylococcusaureus
EYHLMNGANGYLTRVNGKYVYRVTKDPVSAVFGVISNGWGSAGAGFGPQH,1422,206,5736,"Garvieacin Q, a novel class II bacteriocin from Lactococcus garvieae BCC 43578.",Bacilluscoagulans
ACQCPDAISGWTHTDYQCHGLENKMYRHVYAICMNGTQVYCRTEWGSSC,1423,8,5743,"Identification, purification and characterization of laterosporulin, a novel bacteriocin produced by Brevibacillus sp. strain GI-9.",Bacillussubtilis
DHYICAKKGGTCNFSPCPLFNRIEGTCYSGKAKCCIR,1426,2,5782,"Molecular cloning, expression and characterization of the porcine beta defensin 2 in E. coli.",Escherichiacoli
GFGCPNDYSCSNHCRDSIGCRGGYCKYQLICTCYGCKKRRSIQE,1429,8,5794,"Cloning and localization of MCdef, a defensin from Manila clams (Ruditapes philippinarum).",Bacillussubtilis
GAFGNFLKGVAKKAGLKILSIAQCKLSGTC,1431,4,5805,"Two novel antimicrobial peptides from skin secretions of the frog, Rana nigrovittata.",Staphylococcusaureus
GAFGNFLKGVAKKAGLKILSIAQCKLFGTC,1431,4,5806,"Two novel antimicrobial peptides from skin secretions of the frog, Rana nigrovittata.",Staphylococcusaureus
KFCEKPSGTWSGVCGNSGACKDQCIRLEGAKHGSCNYKPPAHRCICYYEC,1432,166,5807,Novel antifungal defensins from Nigella sativa L. seeds.,Aspergillusniger
KFCEKPSGTWSGVCGNSGACKDQCIRLEGAKHGSCNYKLPAHRCICYYEC,1432,166,5808,Novel antifungal defensins from Nigella sativa L. seeds.,Aspergillusniger
KICERASGTWKGICIHSNDCNNQCVKWENAGSGSCHYQFPNYMCFCYFDC,1436,158,5812,"Isolation, molecular cloning and antimicrobial activity of novel defensins from common chickweed (Stellaria media L.) seeds.",Bipolarissorokiniana
KICERASGTWKGICIHSNDCNNQCVKWENAGSGSCHYQFPNYMCFCYFNC,1436,158,5813,"Isolation, molecular cloning and antimicrobial activity of novel defensins from common chickweed (Stellaria media L.) seeds.",Bipolarissorokiniana
GLPVCGETCAGGTCNTPGCSCSWPICTRN,1437,127,5814,Cyclotides from an extreme habitat: characterization of cyclic peptides from Viola abyssinica of the Ethiopian highlands.,Humanhistiocytic
GLPVCGETCFGGTCNTPGCTCDPWPVCTRN,1437,127,5815,Cyclotides from an extreme habitat: characterization of cyclic peptides from Viola abyssinica of the Ethiopian highlands.,Humanhistiocytic
LMCTHPLDCSN,1438,156,5816,Identification of an antifungal peptide from Trapa natans fruits with inhibitory effects on Candida tropicalis biofilm formation.,Candidatropicalis
DFGCARGMIFVCMRRCARMYPGSTGYCQGFRCMCDTHIPIRRPPFIMG,1439,4,5817,Cloning and characterization of a male-specific defensin-like antimicrobial peptide from the tick Haemaphysalis longicornis.,Staphylococcusaureus
RRIRPRPPRLPRPRPRPLPFPRPGPRPIPRPLPFPRPGPRPIPRPLPFPRPGPRPIPRP,256,2,5818,Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7.,Escherichiacoli
RYCERSSGTWSGVCGNSGKCSNQCQRLEGAAHGSCNYVFPAHKCICYYPC,1440,65,5828,Four plant defensins from an indigenous South African Brassicaceae species display divergent activities against two test pathogens despite high sequence similarity in the encoding genes.,Botrytiscinerea
QKLCERPSGTWSGVCGNNNACRNQCINLEKARHGSCNYVFPAHKCICYFPC,1440,65,5832,Four plant defensins from an indigenous South African Brassicaceae species display divergent activities against two test pathogens despite high sequence similarity in the encoding genes.,Botrytiscinerea
RYCERSSGTWSGVCGNTDKCSSQCQRLEGAAHGSCNYVFPAHKCICYYPC,1440,65,5833,Four plant defensins from an indigenous South African Brassicaceae species display divergent activities against two test pathogens despite high sequence similarity in the encoding genes.,Botrytiscinerea
QKLCERPSGTWSGVCGNNGACRNQCIRLERARHGSCNYVFPAHKCICYFPC,1440,65,5834,Four plant defensins from an indigenous South African Brassicaceae species display divergent activities against two test pathogens despite high sequence similarity in the encoding genes.,Botrytiscinerea
RRSRRGRGGGRRGGSGGRGGRGGGGRSGAGSSIAGVGSRGGGGGRHYA,1441,4,5835,Amphibian cathelicidin fills the evolutionary gap of cathelicidin in vertebrate.,Staphylococcusaureus
MLCKLSMFGAVLGVPACAIDCLPMGKTGGSCEGGVCGCRKLTFKILWDKKFG,1442,4,5837,"A defensin-like antimicrobial peptide from the venoms of spider, Ornithoctonus hainana.",Staphylococcusaureus
RMCKTPSGKFKGYCVNNTNCKNVCRTEGFPTGSCDFHVAGRKCYCYKPCP,1443,104,5838,"Recombinant expression, affinity purification and functional characterization of Scots pine defensin 1.",Fusariumsolani
TNYGNGVGVPDAIMAGIIKLIFIFNIRQGYNFGKKAT,1444,35,5839,"Isolation of Lactobacillus salivarius 1077 (NRRL B-50053) and characterization of its bacteriocin, including the antimicrobial activity spectrum.",Salmonellaenteritidis
GFLDIIKDTGKEFAVKILNNLKCKLAGGCPP,1445,208,5841,Effects of Two Novel Peptides from Skin of Lithobates Catesbeianus on Tumor Cell Morphology and Proliferation,ListeriaATCC
RTCESQSHRFKGTCVRQSNCAAVCQTEGFHGGNCRGFRRRCFCTKHC,1446,24,5851,"v-AMP1, a ripening induced peptide from Vitis vinifera shows strong antifungal activity.",Fusariumoxysporum
GFGCPWNRYQCHSHCRSIGRLGGYCAGSLRLTCTCYRS,1447,32,5858,"Purification of a novel arthropod defensin from the American oyster, Crassostrea virginica.",Lactococcuslactis
IFGSIYHRKCVVKNRCETVSGHKTCKDLTCCRAVIFRHERPEVCRPQT,1448,21,5867,"Strongylocins, novel antimicrobial peptides from the green sea urchin, Strongylocentrotus droebachiensis.",Vibrioanguillarum
IFNSIYHRKCVVKNRCETVSGHKTCKDLTCCRAVIFRHERPEVCRPST,1449,21,5869,"Two recombinant peptides, SpStrongylocins 1 and 2, from Strongylocentrotus purpuratus, show antimicrobial activity against Gram-positive and Gram-negative bacteria.",Vibrioanguillarum
WNPFRKLYRKECNDVTSCDTVSGVKTCTKKNCCHRKFFGKTILKAPECTVIS,1449,21,5870,"Two recombinant peptides, SpStrongylocins 1 and 2, from Strongylocentrotus purpuratus, show antimicrobial activity against Gram-positive and Gram-negative bacteria.",Vibrioanguillarum
GKIPVKAIKKAGAAIGKGLRAINIASTAHDVYSFFKPKHKKK,1450,2,5874,"Isolation, gene expression and solution structure of a novel moricin analogue, antibacterial peptide from a lepidopteran insect, Spodoptera litura.",Escherichiacoli
KTCMTKKEGWGRCLIDTTCAHSCRKQGYKGGNCKGMRRTCYCLLDC,1451,24,5877,Cloning and characterization of a plant defensin VaD1 from azuki bean.,Fusariumoxysporum
RSMRLSFRARGYGFR,263,18,5882,New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A.,Micrococcusluteus
SWLSKTAKKLENSAKKRISEGIAIAIKGGSR,1306,4,5883,Cecropin P1 and novel nematode cecropins: a bacteria-inducible antimicrobial peptide family in the nematode Ascaris suum.,Staphylococcusaureus
SWLSKTYKKLENSAKKRISEGVAIAILGGLR,1306,4,5884,Cecropin P1 and novel nematode cecropins: a bacteria-inducible antimicrobial peptide family in the nematode Ascaris suum.,Staphylococcusaureus
MRKEFHNVLSSGQLLADKRPARDYNRK,267,62,5888,Functional and structural characteristics of anticancer peptide Pep27 analogues.,Acutemyeloid
SCTCRRAWICRWGERHSGKCIDQKGSTYRLCCRR,1452,2,5935,"A novel horse alpha-defensin: gene transcription, recombinant expression and characterization of the structure and function.",Escherichiacoli
LVQPRGPRSGPGPWQGGRRKFRRQRPRLSHKGPMPF,272,5,5979,Apelin peptides block the entry of human immunodeficiency virus (HIV).,HIV
QRPRLSHKGPMPF,272,5,5982,Apelin peptides block the entry of human immunodeficiency virus (HIV).,HIV
GLLNVIKDTAQNLFAAALDKLKCKVTKCN,1454,2,6008,Evidence from the primary structures of dermal antimicrobial peptides that Rana tagoi okiensis and Rana tagoi tagoi (Ranidae) are not conspecific subspecies.,Escherichiacoli
GLLNVIKDTAQNLFAAALEKLKCKVTKCN,1454,2,6009,Evidence from the primary structures of dermal antimicrobial peptides that Rana tagoi okiensis and Rana tagoi tagoi (Ranidae) are not conspecific subspecies.,Escherichiacoli
DDDKTEEEDDKENETTKVVE,1455,8,6075,Novel antimicrobial peptides isolated from skin secretions of the Mexican frog Hyla eximia.,Bacillussubtilis
KYYGNGVHCTKSGCSVNWGEAFSAGVHRLANGGNGFW,1456,50,6095,"Characterization of leucocin B-KM432Bz from Leuconostoc pseudomesenteroides isolated from boza, and comparison of its efficiency to pediocin PA-1.",Enterococcusfaecium
GIMDTIKGAAKDLAGQLLDKLKCKITKC,1457,2,6166,"Purification of peptides with differential cytolytic activities from the skin secretions of the Central American frog, Lithobates vaillanti (Ranidae).",Escherichiacoli
FLGAIAGVAAKFLPKVFCFITKKC,1457,2,6167,"Purification of peptides with differential cytolytic activities from the skin secretions of the Central American frog, Lithobates vaillanti (Ranidae).",Escherichiacoli
FLPLIAGVAANFLPKIFCLISKKC,1457,2,6168,"Purification of peptides with differential cytolytic activities from the skin secretions of the Central American frog, Lithobates vaillanti (Ranidae).",Escherichiacoli
FLPVIASVAAKVLPKVFCFITKKC,1457,2,6169,"Purification of peptides with differential cytolytic activities from the skin secretions of the Central American frog, Lithobates vaillanti (Ranidae).",Escherichiacoli
FLPLIAGVAASILPKIFCFITKKC,1457,2,6170,"Purification of peptides with differential cytolytic activities from the skin secretions of the Central American frog, Lithobates vaillanti (Ranidae).",Escherichiacoli
AISYGNGVYCNKEKCWVNKAENKQAITGIVIGGWASSLAGMGH,1458,209,6216,Interactions between two carnobacteriocins Cbn BM1 and Cbn B2 from Carnobacterium maltaromaticum CP5 on target bacteria and Caco-2 cells.,Carnobacteriumdivergens
VNYGNGVSCSKTKCSVNWGQAFQERYTAGINSFVSGVASGAGSIGRRP,1458,209,6227,Interactions between two carnobacteriocins Cbn BM1 and Cbn B2 from Carnobacterium maltaromaticum CP5 on target bacteria and Caco-2 cells.,Carnobacteriumdivergens
GWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,1459,2,6281,Bactericidal activity of Musca domestica cecropin (Mdc) on multidrug-resistant clinical isolate of Escherichia coli.,Escherichiacoli
TVSAEESCPPGAVWSTCSNCHAYCKNKDLMCITACQEGCKCTTQGYKIHNNECIPAEKCP,1461,8,6464,Proteomic analysis of skin defensive factors of tree frog Hyla simplex.,Bacillussubtilis
FSRYARMRDSRPWSDRKNNYSGPQFTYPPEKAPPEKLIKWNNEGSPIFEMPAEGGHIEP,1462,4,6587,"A novel antimicrobial peptide from skin secretions of the earthworm, Pheretima guillelmi (Michaelsen).",Staphylococcusaureus
RECKAQGRHGTCFRDANCVQVCEKQAGWSHGDCRAQFKCKCIFEC,1463,210,6593,"NmDef02, a novel antimicrobial gene isolated from Nicotiana megalosiphon confers high-level pathogen resistance under greenhouse and field conditions.",Phytophthorainfestans
PDPGQPWQVKAGRPPCYSIPCRKHDECRVGSCSRCNNGLWGDRTCR,1464,25,6594,"Purification and characterization of a novel salivary antimicrobial peptide from the tick, Ixodes scapularis.",Bacilluscereus
ATYDGKCYKKDNICKYKAQSGKTAICKCYVKVCPRDGAKCEFDSYKGKCYC,1465,4,6595,A highly thermostable antimicrobial peptide from Aspergillus clavatus ES1: biochemical and molecular characterization.,Staphylococcusaureus
RYCLSQSHRFKGLCMSSSNCANVCQTENFPGGECKADGATRKCFCKKIC,1466,211,6596,Evolutionary relationship between defensins in the Poaceae family strengthened by the characterization of new sugarcane defensins.,Kocuriarhizophila
RHRHCFSQSHKFVGACLRESNCENVCKTEGFPSGECKWHGIVSKCHCKRIC,1466,211,6598,Evolutionary relationship between defensins in the Poaceae family strengthened by the characterization of new sugarcane defensins.,Kocuriarhizophila
ENDHRMPNELNRPNNLSKGGAKCGAAIAGGLFGIPKGPLAWAAGLANVYSKCN,1467,14,6622,"Enterocin B, a new bacteriocin from Enterococcus faecium T136 which can act synergistically with enterocin A.",Lactobacillussakei
TTHSGKYYGNGVYCTKNKCTVDWAKATTCIAGMSIGGFLGGAIPGKC,1467,14,6623,"Enterocin B, a new bacteriocin from Enterococcus faecium T136 which can act synergistically with enterocin A.",Lactobacillussakei
VTCELLMFGGVVGDSACAANCLSMGKAGGSCNGGLCDCRKTTFKELWDKRFG,1468,4,6644,A defensin antimicrobial peptide from the venoms of Nasonia vitripennis.,Staphylococcusaureus
FNKLKQGSSKRTCAKCFRKIMPSVHELDERRRGANRWAAGFRKCVSSICRY,1469,2,6645,"Perinerin, a novel antimicrobial peptide purified from the clamworm Perinereis aibuhitensis grube and its partial characterization.",Escherichiacoli
LSKYGGECSVEHNTCTYLKGGKDHIVSCPSAANLRCKTERHHCEYDEHHKTVDCQTPV,1470,2,6646,Isolation and characterization of a novel antifungal peptide from Aspergillus niger.,Escherichiacoli
TPGGIDFISGGPHVAQDVLNAIKNFFK,1471,206,6692,Purification and characterization of multiple bacteriocins and an inducing peptide produced by Enterococcus faecium NKR-5-3 from Thai fermented fish.,Bacilluscoagulans
YSSKDCLKDIGKGIGAGTVAGAAGGGLAAGLGAIPGAFVGAHFGVIGGSAACIGGLLGN,1471,206,6693,Purification and characterization of multiple bacteriocins and an inducing peptide produced by Enterococcus faecium NKR-5-3 from Thai fermented fish.,Bacilluscoagulans
FLPFLLSALPKVFCFFSKKC,1472,4,6702,"Molecular cloning and functional characterization of novel antimicrobial peptides from the skin of brown frog, Rana zhenhaiensis.",Staphylococcusaureus
FLPLLLSALPSFLCLVFKKC,1472,4,6703,"Molecular cloning and functional characterization of novel antimicrobial peptides from the skin of brown frog, Rana zhenhaiensis.",Staphylococcusaureus
GIMRVFKGVLKTAGKSVAKNVAGSFLDRLKCKISGGC,1472,4,6704,"Molecular cloning and functional characterization of novel antimicrobial peptides from the skin of brown frog, Rana zhenhaiensis.",Staphylococcusaureus
GLADYWRTAFRANFANLGPGIRCKSARC,1472,4,6705,"Molecular cloning and functional characterization of novel antimicrobial peptides from the skin of brown frog, Rana zhenhaiensis.",Staphylococcusaureus
GADRCRERCERRHRGDWQGKQRCLMECRRREQEED,1473,33,6766,A novel hairpin-like antimicrobial peptide from barnyard grass (Echinochloa crusgalli L.) seeds: Structure-functional and molecular-genetics characterization.,Pseudomonassyringae
DCYCRIPACIAGERRYGTCIYQGRLWAFCC,1474,30,6785,Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro.,HIV-1IIIB
RWKIFKKIEKMGRNIRDGIVKAGPAIEVLGSAKAI,333,77,6851,Biological activities of cecropin B-thanatin hybrid peptides.,Klebsiellapneumoniae
SFLNFFKGAAKNLLAAGLDKLKCKISGTQC,1476,2,7008,A family of acyclic brevinin-1 peptides from the skin of the Ryukyu brown frog Rana okinavana.,Escherichiacoli
GGLRSLGRKILRAWKKYGPIIVPIIRIG,1477,2,7038,"Antimicrobial activity of cathelicidins BMAP28, SMAP28, SMAP29, and PMAP23 against Pasteurella multocida is more broad-spectrum than host species specific.",Escherichiacoli
RFGRFLRKIRRFRPKVTITIQGSARF,1478,2,7129,Chicken cathelicidins display antimicrobial activity against multiresistant bacteria without inducing strong resistance.,Escherichiacoli
RVKRFWPLVPVAINTVAAGINLYKAIRRK,1478,2,7130,Chicken cathelicidins display antimicrobial activity against multiresistant bacteria without inducing strong resistance.,Escherichiacoli
GRPNPVNNKPTPHPRL,356,2,7178,Hydroxyproline substitutions stabilize non-glycosylated drosocin against serum proteases without challenging its antibacterial activity.,Escherichiacoli
GFFLNALKNFAKTAGKRLKSLLNHASCKLSGQC,1479,2,7211,Purification and modeling amphipathic alpha helical antimicrobial peptides from skin secretions of Euphlyctis cyanophlyctis.,Escherichiacoli
VIPFVASVAAEMMQHIFCAASRKC,1479,2,7212,Purification and modeling amphipathic alpha helical antimicrobial peptides from skin secretions of Euphlyctis cyanophlyctis.,Escherichiacoli
FLPLIGRVLSGIL,363,8,7382,"Characterisation and evaluation of synthetic antimicrobial peptides against Bacillus globigii, Bacillus anthracis and Burkholderia thailandensis.",Bacillussubtilis
ILGPVLGLVSDTLDDVLGIL,363,8,7383,"Characterisation and evaluation of synthetic antimicrobial peptides against Bacillus globigii, Bacillus anthracis and Burkholderia thailandensis.",Bacillussubtilis
VAIALKAAHYHTHKE,363,8,7384,"Characterisation and evaluation of synthetic antimicrobial peptides against Bacillus globigii, Bacillus anthracis and Burkholderia thailandensis.",Bacillussubtilis
GLFDVIKKVASVIGGL,363,8,7386,"Characterisation and evaluation of synthetic antimicrobial peptides against Bacillus globigii, Bacillus anthracis and Burkholderia thailandensis.",Bacillussubtilis
GWFDVVKHIASAV,363,8,7387,"Characterisation and evaluation of synthetic antimicrobial peptides against Bacillus globigii, Bacillus anthracis and Burkholderia thailandensis.",Bacillussubtilis
SKGKKANKDVELARG,363,8,7388,"Characterisation and evaluation of synthetic antimicrobial peptides against Bacillus globigii, Bacillus anthracis and Burkholderia thailandensis.",Bacillussubtilis
RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFP,365,2,7468,Antimicrobial and immunomodulatory activities of PR-39 derived peptides.,Escherichiacoli
GFCWYVCVYRNGVRVCYRRCN,1480,2,7486,Polypeptides having antimicrobial activity and polynucleotides encoding same.,Escherichiacoli
LLFGKIISRLLGN,1481,182,7658,"Development of antimicrobial peptide defenses of southern leopard frogs, Rana sphenocephala, against the pathogenic chytrid fungus, Batrachochytrium dendrobatidis.",Batrachochytriumdendrobatidis
KFFKKLKNSVKKRAKKFFKKPRVIGVSIPF,381,2,7699,Efficacy of OH-CATH30 and its analogs against drug-resistant bacteria in vitro and in mouse models.,Escherichiacoli
LRDLVCYCRTRGCKRRERMNGTCRKGHLMYTLCCR,1482,42,7701,Cryptdins: antimicrobial defensins of the murine small intestine.,Salmonellatyphimurium
CVLIGQRCDNDRGPRCCSGQGNCVPLPFLGGVCAV,1483,4,7862,A Cactus-Derived Toxin-Like Cystine Knot Peptide with Selective Antimicrobial Activity.,Staphylococcusaureus
SLGNFFRKARKKIGEEFKRIVQRIKDFLQHLIPRTEA,1485,2,7987,Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity.,Escherichiacoli
DLRGACAAAHAL,395,180,7995,"Centrocins: isolation and characterization of novel dimeric antimicrobial peptides from the green sea urchin, Strongylocentrotus droebachiensis.",Listonellaanguillarum
DLRAICAGAHAL,395,1,7999,"Centrocins: isolation and characterization of novel dimeric antimicrobial peptides from the green sea urchin, Strongylocentrotus droebachiensis.",None_target
TLIWEFYHQILDEYNKENKG,1060,4,8032,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus
FLPGLIKVAVGVGSTILCKITKKC,1060,4,8033,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus
FLPGLIKAAVGIGSTIFCKISRKC,1060,4,8034,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus
SILSTLKDVGISAIKSAGSGVLSTLLCKLNKNC,1060,4,8035,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus
SILSTLKDVGISALKNAGSGVLKTLLCKLNKNCEK,1060,4,8036,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus
FLPMLAGLAANFLPKIICKITKKC,1060,4,8039,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus
FLPIVASLAANFLPKIICKITKKC,1060,4,8040,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus
FLPPSPWKETFRTT,1060,4,8041,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus
NILSSIANGINRALSFFG,1060,4,8042,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus
GFMDTAKNVAKNVAKNVAVTLLDKLRCKVTGGC,1060,4,8043,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus
SIMSTLKQFGISAIKGAAQNVLGVLSCKIAKTC,1060,4,8044,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus
GIFSLIKTAAKFVGKNLLKQAGKAGLEHLACKANNQC,1060,4,8045,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus
AVIPPLRCKAAFC,1060,4,8046,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus
FLPLFLPKIICEITKKC,1060,4,8047,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus
GLWNTIKEAGKKFALNLLDKIRCGIAGGCKG,1060,4,8048,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus
GFMDTAKNVFKNVAVTLLDKLKCKIAGGC,1060,4,8049,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus
GILDTLKQLGKAAAQSLLSKAACKLAKTC,1060,4,8050,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus
QINWGSVVGHCIGGAIIGGAFSGGAAAGVGCLVGSGKAIINGL,1486,1,8059,"Thermophilin 13, a nontypical antilisterial poration complex bacteriocin, that functions without a receptor.",None_target
LALERRSGWLRLFGLKPRRKH,1487,4,8062,"Molecular cloning of novel antimicrobial peptide genes from the skin of the Chinese brown frog, Rana chensinensis.",Staphylococcusaureus
NFAEIFAAVNKLIKQGVVKG,1487,4,8063,"Molecular cloning of novel antimicrobial peptide genes from the skin of the Chinese brown frog, Rana chensinensis.",Staphylococcusaureus
ILPIIGKILSTIFGK,1487,4,8064,"Molecular cloning of novel antimicrobial peptide genes from the skin of the Chinese brown frog, Rana chensinensis.",Staphylococcusaureus
GLLSVFKGVLKTAGKNVAKNVAGSLLDQLKCKISGGC,1487,4,8065,"Molecular cloning of novel antimicrobial peptide genes from the skin of the Chinese brown frog, Rana chensinensis.",Staphylococcusaureus
GLWDSIKNFGKTIALNVMDKIKCKIGGGCPP,1487,4,8066,"Molecular cloning of novel antimicrobial peptide genes from the skin of the Chinese brown frog, Rana chensinensis.",Staphylococcusaureus
KRRPAKAWSGRRTRLCCHRVPSPNSTNLKGHHVRLCKPCKLEPEPRLWVVPGALPQV,1488,4,8072,AP-57/C10orf99 is a new type of mutifunctional antimicrobial peptide.,Staphylococcusaureus
ATCDLLSGTGVGHSACAAHCLLRGNRGGYCNGKGVCVCRN,1489,4,8085,Molecular characterization and expression of the antimicrobial peptide defensin from the housefly (Musca domestica).,Staphylococcusaureus
VTCDLLSFEAKGFAANHSICAAHCLAIGRKGGSCQNGVCVCRN,1490,48,8086,"Two novel insect defensins from larvae of the cupreous chafer, Anomala cuprea: purification, amino acid sequences and antibacterial activity.",Bacillusmegaterium
VTCDLLSFEAKGFAANHSICAAHCLVIGRKGGACQNGVCVCRN,1490,48,8087,"Two novel insect defensins from larvae of the cupreous chafer, Anomala cuprea: purification, amino acid sequences and antibacterial activity.",Bacillusmegaterium
VTCDLLSLQIKGIAINDSACAAHCLAMRRKGGSCKQGVCVCRN,1491,8,8088,"A sapecin homologue of Holotrichia diomphalia: purification, sequencing and determination of disulfide pairs.",Bacillussubtilis
GFGCPFNQGACHRHCRSIGRRGGYCAGLFKQTCTCYSR,1492,4,8092,"Identification and characterization of antimicrobial peptide, defensin, in the taiga tick, Ixodes persulcatus.",Staphylococcusaureus
LTCDILGSTPACAAHCIARGYRGGWCDGQSVCNCRR,1493,2,8093,"Isolation, characterization and chemical synthesis of a new insect defensin from Chironomus plumosus (Diptera).",Escherichiacoli
LLSLALAALPKLFCLIFKKC,1494,4,8094,Identification and characterisation of a novel antimicrobial polypeptide from the skin secretion of a Chinese frog (Rana chensinensis).,Staphylococcusaureus
ATCDLLSGFGVGDSACAAHCIARRNRGGYCNAKKVCVCRN,1037,18,8104,Full sequence and characterization of two insect defensins: immune peptides from the mosquito Aedes aegypti.,Micrococcusluteus
APVPFSCTRGCLTHLV,1495,18,8106,A non-pediocin low molecular weight antimicrobial peptide produced by Pediococcus pentosaceus strain IE-3 shows increased activity under reducing environment.,Micrococcusluteus
LRLKSIVSYAKKVL,1496,2,8128,Identification and biochemical characterization of a new antibacterial and antifungal peptide derived from the insect Sphodromantis viridis.,Escherichiacoli
CWSCMGHSCWSCMGHSCWSCAGHSCWSCMGHSCWSCMGHSCWSCAGHCCGSCWHGGM,1497,17,8130,"Sonorensin: an antimicrobial peptide, belonging to the heterocycloanthracin subfamily of bacteriocins, from a new marine isolate, Bacillus sonorensis MT93.",Listeriamonocytogenes
GSCGASIAEFNSSQILAKRAPPCRRPRLQNSEDVTHTTLP,1498,36,8155,"ARACINs, Brassicaceae-specific peptides exhibiting antifungal activities against necrotrophic pathogens in Arabidopsis.",Alternariabrassicicola
GSCGAPISKYDFQVLAKRPPPCRRPRLENTEDVTHTTRP,1498,36,8156,"ARACINs, Brassicaceae-specific peptides exhibiting antifungal activities against necrotrophic pathogens in Arabidopsis.",Alternariabrassicicola
KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL,403,2,8157,"Identification and Characterization of the First Cathelicidin from Sea Snakes with Potent Antimicrobial and Anti-inflammatory Activity, and Special Mechanism.",Escherichiacoli
GFGCPEDEYECHNHCKNSVGCRGGYCDAGTLRQRCTCYGCNQKGRSIQE,1499,4,8161,"A defensin from clam Venerupis philippinarum: Molecular characterization, localization, antibacterial activity, and mechanism of action.",Staphylococcusaureus
FSTKTRNWFSEHFKKVKEKLKDTFA,404,2,8162,Bioprospecting the American alligator (Alligator mississippiensis) host defense peptidome.,Escherichiacoli
KTRNWFSEHFKKVKEKLKDTFA,404,2,8163,Bioprospecting the American alligator (Alligator mississippiensis) host defense peptidome.,Escherichiacoli
ATCDLLSPFKVGHAACAAHCIARGKRGGWCDKRAVCNCRK,1500,4,8170,Purification and characterization of a novel antibacterial peptide from black soldier fly (Hermetia illucens) larvae.,Staphylococcusaureus
GRRRRSVQWCAVSQPEATKCFQWQRNMRKVRGPPVSCIKRDSPIQCIQA,405,7,8171,Identification of multifunctional peptides from human milk.,Streptococcusmutans
GWLRDFGKRIERVGQHTRDATIQAIGVAQQAANVAATVRG,1501,2,8173,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli
GWLKKIGKKIERVGQHTRDATIQVLGVAQQAANVAATARG,1501,2,8174,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli
GWLKKIGKKIERVGQHTRDASIQAIGIAQQAANVAATARG,1501,2,8175,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli
GLVKKIGKKIERVGQHTRDASIQAIGIAQQAANVAATARG,1501,2,8176,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli
GWLKKFGKKIERVGQHTRDATIQAIGVAQQAANVAATLKG,1501,2,8177,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli
ATCDLLSATGFSGTACAAHCLLIGHRGGYCNTKSVCVCRD,1501,2,8178,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli
ATCDLLSGTGVKHSACAAHCLLRGNRGGYCNGRAICVCRN,1501,2,8179,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli
ATCDLLSGTGANHSACAAHCLLRGNRGGYCNSKAVCVCRN,1501,2,8180,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli
LTCNIDRSFCLAHCLLRGYKRGFCTVKKICVCRH,1501,2,8181,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli
GTCSFSSALCVVHCRVRGYPDGYCSRKGICTCRR,1501,2,8182,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli
FTCNSYACKAHCILQGHKSGSCARINLCKCQR,1501,2,8183,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli
HHHHRFGKIGHELHKGVKKVEKVTHDVNKVTSGVKKVASSIEKAKNV,1501,2,8184,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli
HHHFGRIGHELHKGVKKVEKVTSDVNKVTNGVKQVANGIAKAKTVIEAGSIAGAVAAAAA,1501,2,8185,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli
HHHLFGHVGHEVERSLHKVGHKLEHACHEVHKTAKKVQK,1501,2,8187,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli
AGFRKRFNKLVKKVKHTIKETANVSKDVAIVAGSGVAVGAAMG,1501,2,8188,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli
GFRKRFNKLVKKVKHTIKETANVSKDVAIVAGSGVAVGAAMG,1501,2,8189,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli
EWRPHGSNGGSSLRPGRPQTLPPQRPIQPDFNGPRQRF,1501,2,8191,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli
EWRPHGSIGGSGLRPGRPQTLPPQRPRRPDFNGPRHRF,1501,2,8192,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli
SPFVDRPRRPIQHNGPKPRIITNPPFNPNARPAW,1501,2,8193,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli
SWIKKDKFPSSTGPYNPNPPPPRF,1501,2,8194,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli
KACPRNCDTDIAYMVCPSSGERIIRKVCTNCCAAQKGCKLFRSNGSIKCTGT,1503,37,8196,"Characterization of Peptides from Capsicum annuum Hybrid Seeds with Inhibitory Activity Against ?-Amylase, Serine Proteinases and Fungi.",Saccharomycescerevisiae
FLPLILPSIVTALSSFLKQG,1504,4,8197,"Identification and characterization of an antimicrobial peptide of Hypsiboas semilineatus (Spix, 1824) (Amphibia, Hylidae). ",Staphylococcusaureus
GASPALWGCDSFLGYCRIACFAHEASVGQKDCAEGMICCLPNVF,1505,2,8198,The first anionic defensin from amphibians.,Escherichiacoli
GRADYNFGYGLGRGTRKFFNGIGRWVRKTF,1506,14,8200,"Purification and characterization of a novel plantaricin, KL-1Y, from Lactobacillus plantarum KL-1.",Lactobacillussakei
SSRRPCRGRSCGPRLRGGYTLIGRPVKNQNRPKYMWV,406,2,8201,A novel cathelicidin from Bufo bufo gargarizans Cantor showed specific activity to its habitat bacteria.,Escherichiacoli
FFPIVAGVAGQVLKKIYCTISKKC,1507,2,8204,"Peptides with antimicrobial activity of the brevinin-1 family isolated from skin secretions of the southern leopard frog, Rana sphenocephala.",Escherichiacoli
MTPLWRVMGNKPFGAYCQDHVECSTGICKGGHCIYSQPIKS,1508,212,8205,"Molecular characterization of the liver-expressed antimicrobial peptide 2 (LEAP-2) in a teleost fish, Plecoglossus altivelis: antimicrobial activity and molecular mechanism.",Vibriovulnificus
QSHISLCRWCCNCCKANKGCGFCCKF,1509,96,8206,Turbot (Scophthalmus maximus) hepcidin-1 and hepcidin-2 possess antimicrobial activity and promote resistance against bacterial and viral infection.,Edwardsiellatarda
GMKCKFCCNCCNLNGCGVCCRF,1509,96,8207,Turbot (Scophthalmus maximus) hepcidin-1 and hepcidin-2 possess antimicrobial activity and promote resistance against bacterial and viral infection.,Edwardsiellatarda
KSCCRNTTARNCYNVCRIPG,1512,1,8274,"Purification, characterization, and sequencing of novel antimicrobial peptides, Tu-AMP 1 and Tu-AMP 2, from bulbs of tulip (Tulipa gesneriana L.).",None_target
TPRPVCAATCDCKIITGTKCPPGYEK,1512,1,8275,"Purification, characterization, and sequencing of novel antimicrobial peptides, Tu-AMP 1 and Tu-AMP 2, from bulbs of tulip (Tulipa gesneriana L.).",None_target
DHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK,1513,2,8282,Human-?-defensins-1-3 and analogs do not require proton motive force for antibacterial activity against Escherichia coli.,Escherichiacoli
GYGCPFNQYQCHSHCKGIRGYKGGYCKGAFKQTCKCY,414,8,8285,Structural and functional characterization of peptides derived from the carboxy-terminal region of a defensin from the tick Ornithodoros savignyi.,Bacillussubtilis
GVFDIIKGAGKQLIAHAMEKIAEKVGLNKDGN,1514,2,8293,Characterization and Biological Activities of Ocellatin Peptides from the Skin Secretion of the Frog Leptodactylus pustulatus.,Escherichiacoli
GVFDIIKGAGKQLIAHAMGKIAEKVGLNKDGN,1514,2,8294,Characterization and Biological Activities of Ocellatin Peptides from the Skin Secretion of the Frog Leptodactylus pustulatus.,Escherichiacoli
GVFDIIKGAGKQLIARAMGKIAEKVGLNKDGN,1514,2,8295,Characterization and Biological Activities of Ocellatin Peptides from the Skin Secretion of the Frog Leptodactylus pustulatus.,Escherichiacoli
SGPNGQCGPGWGGCRGGLCCSQYGYCGSGPKYCAH,1515,65,8296,A novel antifungal peptide from leaves of the weed Stellaria media L.,Botrytiscinerea
VGPGGECGGRFGGCAGGQCCSRFGFCGSGPKYCAH,1515,166,8297,A novel antifungal peptide from leaves of the weed Stellaria media L.,Aspergillusniger
GYYCPFRQDKCHRHCRSFGRKAGYCGNFLKRTCICVKK,415,17,8298,Ixodes ricinus defensins attack distantly-related pathogens.,Listeriamonocytogenes
GYFCPYNGYCDHHCRKKLRWRGGYCGGRWKLTCICVRG,415,17,8300,Ixodes ricinus defensins attack distantly-related pathogens.,Listeriamonocytogenes
GFFCPYNGYCDRHCRKKLRRRGGYCGGRWKLTCICIMN,415,17,8301,Ixodes ricinus defensins attack distantly-related pathogens.,Listeriamonocytogenes
GFGCPLNQGACHNHCRSIKRRGGYCSGIIKQTCTCYRK,415,17,8302,Ixodes ricinus defensins attack distantly-related pathogens.,Listeriamonocytogenes
GFGCPKSALSCSQQCRENNTHSGGYCNGPFNIVCSCY,415,17,8304,Ixodes ricinus defensins attack distantly-related pathogens.,Listeriamonocytogenes
GFLSILKKVLPKVMAHMK,416,1,8307,Melectin MAPs: the influence of dendrimerization on antimicrobial and hemolytic activity.,None_target
VPAESEAAHLRVRRGFGCPLNQGACHNHCRSIRRRGGYCSGIIKQTCTCYRN,1516,101,8335,"Molecular characterization of a defensin gene from a hard tick, Dermacentor silvarum.",Bacilluspumilus
LKGASKLIPHLLPSRQQ,1517,2,8338,Identification of novel peptides from amphibian (Xenopus tropicalis) skin by direct tissue MALDI-MS analysis.,Escherichiacoli
IRPVPFFPPVHAKKVFPLH,1517,2,8340,Identification of novel peptides from amphibian (Xenopus tropicalis) skin by direct tissue MALDI-MS analysis.,Escherichiacoli
EWKLPDLIINHITLTRRNCFKYRCG,1518,213,8351,"Gene cloning, expression profiling and anti-microbial assay of Muscin, a new antimicrobial peptide in the housefly (Musca domestica)",Microbacteriumoxydans
FLPGLIKAAVGVGSTILCKITKKC,1060,4,8373,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus
FLPGLIKAAVGIGSTIFCKISKKC,1519,4,8374,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus",Staphylococcusaureus
PPIQNPSMAPPTQNPYGQPMTPPTQNPYGQPMAPP,1520,2,8416,Identification of a Novel Proline-Rich Antimicrobial Peptide from Brassica napus.,Escherichiacoli
GLLSGILGAGKRIVCGLSGLC,1521,4,8425,Novel peptides from skins of amphibians showed broad-spectrum antimicrobial activities.,Staphylococcusaureus
GIFSKFAGRGLKNLFMKGAKKIGKEVGMDVLRTGIDIAGCKIRGEC,1521,4,8426,Novel peptides from skins of amphibians showed broad-spectrum antimicrobial activities.,Staphylococcusaureus
FLPAVLRVAAKVGPAVFCAITQKC,1521,4,8427,Novel peptides from skins of amphibians showed broad-spectrum antimicrobial activities.,Staphylococcusaureus
RFCFKGTPCG,1521,4,8428,Novel peptides from skins of amphibians showed broad-spectrum antimicrobial activities.,Staphylococcusaureus
FFPLIAGLAARFLPKIFCSITKRC,1521,4,8429,Novel peptides from skins of amphibians showed broad-spectrum antimicrobial activities.,Staphylococcusaureus
GIFSKFAGKGLKNLFMKGAKTIGKEVGMDVLRTGIDIAGCKIKGEC,1521,4,8430,Novel peptides from skins of amphibians showed broad-spectrum antimicrobial activities.,Staphylococcusaureus
GLLSGILGAGKKIVCGLSGLC,1521,4,8431,Novel peptides from skins of amphibians showed broad-spectrum antimicrobial activities.,Staphylococcusaureus
FLPGLECVSGKIVPTVFCAITRIC,1521,4,8432,Novel peptides from skins of amphibians showed broad-spectrum antimicrobial activities.,Staphylococcusaureus
VIPFVASVAAEMMQHVYCAASKRC,1521,4,8433,Novel peptides from skins of amphibians showed broad-spectrum antimicrobial activities.,Staphylococcusaureus
SFLSTFKKLAIDAAKNAGQSVLHTLTCKLDNQC,1521,4,8434,Novel peptides from skins of amphibians showed broad-spectrum antimicrobial activities.,Staphylococcusaureus
GIFSKFVGKGLKNLFMKGAKTIGREVGMDVLRTGIDIAGCKIKGEC,1521,4,8435,Novel peptides from skins of amphibians showed broad-spectrum antimicrobial activities.,Staphylococcusaureus
FFPSIAGLAAKFLPKIFCSITKRC,1521,4,8436,Novel peptides from skins of amphibians showed broad-spectrum antimicrobial activities.,Staphylococcusaureus
SPAIWGCDSFLGYCRLACFAHEASVGQKECAEGMLCCIPNVF,1522,2,8441,"A novel defensin-like antimicrobial peptide from the skin secretions of the tree frog, Theloderma kwangsiensis.",Escherichiacoli
GLLSGLKKVGKHVAKNVAVSLMDSLKCKISGDC,1523,4,8579,"Ranatuerin 1T: an antimicrobial peptide isolated from the skin of the frog, Rana temporaria.",Staphylococcusaureus
NPFKKLERVGQHIRDGIIKAGPAVEVIGQANSIARPAGK,1524,4,8606,Cecropins from Plutella xylostella and Their Interaction with Metarhizium anisopliae.,Staphylococcusaureus
KGFKKIEKLGRHIRDGVVKAGPAVGVVGQASSIMG,1524,4,8607,Cecropins from Plutella xylostella and Their Interaction with Metarhizium anisopliae.,Staphylococcusaureus
LIQRGRFGRFLGRIRRFRPRINFDIRARGSIRLG,1525,2,8609,Novel Cathelicidins from Pigeon Highlights Evolutionary Convergence in Avain Cathelicidins and Functions in Modulation of Innate Immunity.,Escherichiacoli
KRFWQLVPLAIKIYRAWKRR,1526,2,8610,Identification of a novel cathelicidin antimicrobial peptide from ducks and determination of its functional activity and antibacterial mechanism.,Escherichiacoli
NLCASLRARHTIPQCKKFGRR,1527,2,8612,Identification of a novel antimicrobial peptide from amphioxus Branchiostoma japonicum by in silico and functional analyses.,Escherichiacoli
GLPWILLRWLFFRG,1528,4,8613,"Diversity, Antimicrobial Action and Structure-Activity Relationship of Buffalo Cathelicidins.",Staphylococcusaureus
AIPWIWIWRLLRKG,1528,4,8614,"Diversity, Antimicrobial Action and Structure-Activity Relationship of Buffalo Cathelicidins.",Staphylococcusaureus
RIRFPWPWRWPWWRRVRG,1528,4,8615,"Diversity, Antimicrobial Action and Structure-Activity Relationship of Buffalo Cathelicidins.",Staphylococcusaureus
RIRFPWPWRWPWWPRFRG,1528,4,8616,"Diversity, Antimicrobial Action and Structure-Activity Relationship of Buffalo Cathelicidins.",Staphylococcusaureus
AIPWIWIWWLLRKG,1528,4,8617,"Diversity, Antimicrobial Action and Structure-Activity Relationship of Buffalo Cathelicidins.",Staphylococcusaureus
AIPWSIWWRLLFKG,1528,4,8618,"Diversity, Antimicrobial Action and Structure-Activity Relationship of Buffalo Cathelicidins.",Staphylococcusaureus
AIPWSIWWHLLFKG,1528,4,8619,"Diversity, Antimicrobial Action and Structure-Activity Relationship of Buffalo Cathelicidins.",Staphylococcusaureus
GLRKKFRKTRKRIQKLGRKIGKTGRKVWKAWREYGQIPYPCRI,431,67,8645,Comparative Evaluation of the Antimicrobial Activity of Different Antimicrobial Peptides against a Range of Pathogenic Bacteria.,Yersiniaruckeri
ATCDLLSISTPWGSVNHAACAAHCLALNRGFRGGYCSSKAVCTCRK,1529,4,8704,"Purification and characterization of a novel defensin from the salivary glands of the black fly, Simulium bannaense.",Staphylococcusaureus
ATCDLFSFQSKWVTPNHAACAAHCTARGNRGGRCKKAVCHCRK,1530,214,8705,Characterization of Cimex lectularius (bedbug) defensin peptide and its antimicrobial activity against human skin microflora.,Corynebacteriumrenale
ACDFQQCWVTCQRQYSINFISARCNGDSCVCTFRT,1531,4,8706,Cloning and purification of the first termicin-like peptide from the cockroach Eupolyphaga sinensis.,Staphylococcusaureus
QSHLSMCRYCCNCCRNNKGCGFCCKF,1532,4,8707,Two hepcidins from spotted scat (Scatophagus argus) possess antibacterial and antiviral functions in vitro.,Staphylococcusaureus
NPAGCRFCCGCCPNMIGCGVCCRF,1532,4,8708,Two hepcidins from spotted scat (Scatophagus argus) possess antibacterial and antiviral functions in vitro.,Staphylococcusaureus
GLPLCGETCVGGTCNTPGCSCGWPVCVRN,1533,112,8715,Viola plant cyclotide vigno 5 induces mitochondria-mediated apoptosis via cytochrome C release and caspases activation in cervical cancer cells.,Humancervical
AVAGEKLWLLPHLLKMLLTPTP,1534,129,8764,Antimycobacterial Activity of a New Peptide Polydim-I Isolated from Neotropical Social Wasp Polybia dimorpha.,Mycobacteriumabscessus
GFGCPRDQYKCNSHCQSIGCRAGYCDAVTLWLRCTCTDCNGKK,1535,34,8789,Insight into invertebrate defensin mechanism of action: oyster defensins inhibit peptidoglycan biosynthesis by binding to lipid II.,Micrococcuslysodeikticus
GFGCPGDQYECNRHCRSIGCRAGYCDAVTLWLRCTCTGCSGKK,1535,34,8790,Insight into invertebrate defensin mechanism of action: oyster defensins inhibit peptidoglycan biosynthesis by binding to lipid II.,Micrococcuslysodeikticus
AGLQFPVGRIGRLLRK,1536,50,8808,"Scolopendin 2, a cationic antimicrobial peptide from centipede, and its membrane-active mechanism.",Enterococcusfaecium
FWQKMSFA,1537,25,8892,"Purification and Characterization of Plantaricin JLA-9: A Novel Bacteriocin against Bacillus spp. Produced by Lactobacillus plantarum JLA-9 from Suan-Tsai, a Traditional Chinese Fermented Cabbage.",Bacilluscereus
AATKPKKAGAEAAPKKPAKKQTKKKPAKKAGGKKKPKRAGAKKAKK,1538,8,8926,"Antimicrobial peptide, hdMolluscidin, purified from the gill of the abalone, Haliotis discus.",Bacillussubtilis
MPRRRRSSSRPVRRRRRPRVSRRRRRRGGRRR,449,2,8930,Rational design of artificial ?-strand-forming antimicrobial peptides with biocompatible properties.,Escherichiacoli
GMASLLAKVLPHVVKLIK,450,18,8943,Interaction of a novel antimicrobial peptide isolated from the venom of solitary bee Colletes daviesanus with phospholipid vesicles and Escherichia coli cells.,Micrococcusluteus
GGLKKLGKKLEGAGKRVFKASEKALPVVVGIKAIGK,453,2,8974,Aedesin: structure and antimicrobial activity against multidrug resistant bacterial strains.,Escherichiacoli
KYYGNGVHCTKSGCSVNWGEAFSAGVHRLA,1539,206,9000,Identification and characterization of novel multiple bacteriocins produced by Leuconostoc pseudomesenteroides QU 15.,Bacilluscoagulans
KGLGKLIGIDWLLGQAKDAVKQYKKDYKRWH,1539,206,9001,Identification and characterization of novel multiple bacteriocins produced by Leuconostoc pseudomesenteroides QU 15.,Bacilluscoagulans
FIGRAIGDFVYFGAKGLRESGKLLNYYYKHKH,1539,206,9002,Identification and characterization of novel multiple bacteriocins produced by Leuconostoc pseudomesenteroides QU 15.,Bacilluscoagulans
DTTPCGESCVWIPCVSSIVGCSCQNKVCYQN,1540,2,9050,Immunostimulating and Gram-negative-specific Antibacterial Cyclotides from the Butterfly Pea Clitoria ternatea.,Escherichiacoli
DTIPCGESCVWIPCISSILGCSCKDKVCYHN,1540,2,9051,Immunostimulating and Gram-negative-specific Antibacterial Cyclotides from the Butterfly Pea Clitoria ternatea.,Escherichiacoli
GLPICGETCFKTKCYTKGCSCSYPVCKRN,1540,2,9052,Immunostimulating and Gram-negative-specific Antibacterial Cyclotides from the Butterfly Pea Clitoria ternatea.,Escherichiacoli
GSVIGCGETCLRGRCYTPGCTCDHGICKKN,1540,2,9053,Immunostimulating and Gram-negative-specific Antibacterial Cyclotides from the Butterfly Pea Clitoria ternatea.,Escherichiacoli
GSVIKCGESCLLGKCYTPGCTCSRPICKKN,1540,2,9054,Immunostimulating and Gram-negative-specific Antibacterial Cyclotides from the Butterfly Pea Clitoria ternatea.,Escherichiacoli
GSAIRCGESCLLGKCYTPGCTCDRPICKKN,1540,2,9055,Immunostimulating and Gram-negative-specific Antibacterial Cyclotides from the Butterfly Pea Clitoria ternatea.,Escherichiacoli
DLQCAETCVHSPCIGPCYCKHGLICYRN,1540,2,9056,Immunostimulating and Gram-negative-specific Antibacterial Cyclotides from the Butterfly Pea Clitoria ternatea.,Escherichiacoli
FFVLKFLLKWAGKVGLEHLACKFKNWC,1541,2,9058,Two novel antimicrobial peptides from skin venoms of spadefoot toad Megophrys minor.,Escherichiacoli
YPCKLNLKLGKVPFH,460,2,9125,De Novo Transcriptome Analysis and Detection of Antimicrobial Peptides of the American Cockroach Periplaneta americana (Linnaeus).,Escherichiacoli
LRHKVYGYCVLGP,460,2,9130,De Novo Transcriptome Analysis and Detection of Antimicrobial Peptides of the American Cockroach Periplaneta americana (Linnaeus).,Escherichiacoli
RGSALTHLP,1542,215,9190,"Cationic Antimicrobial Peptides Derived from Crocodylus siamensis Leukocyte Extract, Revealing Anticancer Activity and Apoptotic Induction on Human Cervical Cancer Cells.",Vibriocholerae
KKKKQSWYAAAGDAIVSFGEGFLNAW,464,1,9194,Structure-activity relationships of an antimicrobial peptide plantaricin s from two-peptide class IIb bacteriocins.,None_target
RNKLAYNMGHYAGKATIFGLAAWALLA,464,1,9196,Structure-activity relationships of an antimicrobial peptide plantaricin s from two-peptide class IIb bacteriocins.,None_target
IEFEKSTESHDIQKRGVTITVKPPFPGCVFYECIANCRSRGYKNGGYCTINGCQCLR,1543,8,9206,"Cloning and expression of gallerimycin, an antifungal peptide expressed in immune response of greater wax moth larvae, Galleria mellonella.",Bacillussubtilis
MELRGCNNSGCDSVCRALGFNHGRCVSADTCRCYN,1544,2,9207,The potential of the Galleria mellonella innate immune system is maximized by the co-presentation of diverse antimicrobial peptides.,Escherichiacoli
KWKIFKKIEKAGRNIRDGIIKAGPAVSVVGEAATIYKTG,1544,2,9208,The potential of the Galleria mellonella innate immune system is maximized by the co-presentation of diverse antimicrobial peptides.,Escherichiacoli
RTCENLADKYRGPCFSGCDTHCTTKENAVSGRCRDDFRCWCTKRC,1545,89,9210,Differential antifungal and calcium channel-blocking activity among structurally related plant defensins.,Fusariumgraminearum
RTCESQSHKFKGPCASDHNCASVCQTERFSGGRCRGFRRRCFCTTHC,466,89,9212,Structure-activity determinants in antifungal plant defensins MsDef1 and MtDef4 with different modes of action against Fusarium graminearum.,Fusariumgraminearum
VSFPWSCAALSGVCRQGACLPSELYFGPLGCGKGSLCCVSYFL,1546,2,9235,"Identification and characterization of a ?-defensin gene involved in the immune defense response of channel catfish, Ictalurus punctatus.",Escherichiacoli
AAKIILNPKFRCKAAFC,474,2,9365,Kunitzins: Prototypes of a new class of protease inhibitor from the skin secretions of European and Asian frogs.,Escherichiacoli
MGAIIKAGAKIVGKGVLGGGASWLGWNVGEKIWK,1547,32,9410,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis
MGAIIKAGAKIIGKGLLGGAAGGATYGGLKKIFG,1547,32,9411,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis
MGAIIKAGAKIVGKGALTGGGVWLAEKLFGGK,1547,32,9412,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis
MGKLAIKAGKIIGGGIASALGWAAGEKAVGK,1547,32,9414,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis
MGAVAKFLGKAALGGAAGGATYAGLKKIFG,1547,32,9415,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis
MGALIKTGAKIIGSGAAGGLGTYIGHKILGK,1547,32,9416,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis
MGAVIKVGAKVIGWGAASGAGLYGLEKIFKK,1547,32,9417,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis
MGAVVKGGLKIIGGTAASWLGWEAGTRIWK,1547,32,9419,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis
MGAAVKMLGKAFAGGVAGGATYGGLKKIFG,1547,32,9420,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis
MGAVVKGALKIIGGGAASGGAVYGLERIFGR,1547,32,9421,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis
MGKKIGKWIITGAAGWAGWEIGEGIWK,1547,32,9423,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis
MKYLGTLIKGAAGGAGAYVGEKIYNWYKN,1547,32,9424,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis
MGALFKAALKAAGGGAAGGATYGGLKHFFG,1547,32,9425,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis
MAKIGKWVVKGAAGYLGWEIGEGIWK,1547,32,9428,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis
MGALVKGGLKLIGGTAASWLGWEAGERVWK,1547,32,9429,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis
MGAIIKGGLKLVGGGAAGGFTYGGLKKIFG,1547,32,9430,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis
MGAIIKGAAKVLGKGAATGGVIYGLEKLFR,1547,32,9431,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis
RYPAVGYT,1548,48,9491,Lacrain: the first antimicrobial peptide from the body extract of the Brazilian centipede Scolopendra viridicornis.,Bacillusmegaterium
ACVNQCPDAIDRFIVKDKGCHGVEKKYYKQVYVACMNGQHLYCRTEWGGPCQL,1549,41,9529,Laterosporulin10: a novel defensin like Class IId bacteriocin from Brevibacillus sp. strain SKDU10 with inhibitory activity against microbial pathogens.,Mycobacteriumtuberculosis
QSHLSLCRYCCNCCRNKGCGYCCKF,1550,44,9561,"Cloning and Characterization of Antimicrobial Peptide, Hepcidin in Medium Carp, Puntius sarana",Aeromonashydrophila
FFHHIFRGIVHVGKTIHKLVTG,1551,201,9562,A Diverse Family of Host-Defense Peptides (Piscidins) Exhibit Specialized Anti-Bacterial and Anti-Protozoal Activities in Fishes,Streptococcusiniae
LIGSLFRGAKAIFRGARQGWRSHKAVSRYRARYVRRPVIYYHRVYP,1551,201,9563,A Diverse Family of Host-Defense Peptides (Piscidins) Exhibit Specialized Anti-Bacterial and Anti-Protozoal Activities in Fishes,Streptococcusiniae
LFGSVKAWFKGAKKGFQDYRYQKDMAKMNKRYGPNWQQRGGQEPPADAQANDQPP,1551,201,9564,A Diverse Family of Host-Defense Peptides (Piscidins) Exhibit Specialized Anti-Bacterial and Anti-Protozoal Activities in Fishes,Streptococcusiniae
FFGRLKSMWRGARGGLKAYKYQKDMAKMNKRYGPNWQQGGGQEPPADAQANDQPP,1551,201,9565,A Diverse Family of Host-Defense Peptides (Piscidins) Exhibit Specialized Anti-Bacterial and Anti-Protozoal Activities in Fishes,Streptococcusiniae
IWSFLIKAATKLLPSLFGGGKKDS,488,90,9592,Characterisation of three alpha-helical antimicrobial peptides from the venom of Scorpio maurus palmatus.,Bacilussubtilis
GVWDWIKKTAGKIWNSEPVKALKSQALNAAKNFVAEKIGATPS,488,90,9595,Characterisation of three alpha-helical antimicrobial peptides from the venom of Scorpio maurus palmatus.,Bacilussubtilis
RTCESKSHRFKGPCVSTHNCANVCHNEGFGGGKCRGFRRRCYCTRHC,1552,65,9596,The antifungal plant defensin AtPDF2.3 from Arabidopsis thaliana blocks potassium channels.,Botrytiscinerea
GHLGRPYIGGGGGFNRGGGFHRGGGFHRGGGFHSGGGFHRGGGFHSGGSFGYR,1553,48,9673,"Armadillidin H, a Glycine-Rich Peptide from the Terrestrial Crustacean Armadillidium vulgare, Displays an Unexpected Wide Antimicrobial Spectrum with Membranolytic Activity.",Bacillusmegaterium
GHLGRPYIGGGGGFNRGGGFHRGGGFHRGGGFQSGGGFHRGGGFHSGGSFGYR,1553,48,9674,"Armadillidin H, a Glycine-Rich Peptide from the Terrestrial Crustacean Armadillidium vulgare, Displays an Unexpected Wide Antimicrobial Spectrum with Membranolytic Activity.",Bacillusmegaterium
KRMGIFHLFWAGLRKLGNLIKNKIQQGIENFLG,1554,2,9675,Cathelicidins in the Tasmanian devil (Sarcophilus harrisii).,Escherichiacoli
KRIGLIRLIGKILRGLRRLG,1554,2,9676,Cathelicidins in the Tasmanian devil (Sarcophilus harrisii).,Escherichiacoli
KRIRFFERIRDRLRDLGNRIKNRIRDFFS,1554,2,9677,Cathelicidins in the Tasmanian devil (Sarcophilus harrisii).,Escherichiacoli
TFKRKNGSRKNGHRPGGYSLIALGNKKVLKAPYMESI,1554,2,9678,Cathelicidins in the Tasmanian devil (Sarcophilus harrisii).,Escherichiacoli
KREDFLDQIIRDFRNFIYQKYRRLRDEFRKLRDILSG,1554,2,9679,Cathelicidins in the Tasmanian devil (Sarcophilus harrisii).,Escherichiacoli
GIKHILFMAKTKLPRATCTAEIKENCDRKK,1554,2,9680,Cathelicidins in the Tasmanian devil (Sarcophilus harrisii).,Escherichiacoli
GPDSCNHDRGLCRVGNCNPGEYLAKYCFEPVILCCKPLSPTPTKT,1555,2,9704,Structure-function analysis of Avian β-defensin-6 and β-defensin-12: role of charge and disulfide bridges.,Escherichiacoli
FIFHIIKGLFHAGKMIHGLVTRRRHGVEELQDLDQRAFEREKAFA,492,2,9705,"Two isoforms of piscidin from Malabar grouper, Epinephelus malabaricus: Expression and functional characterization.",Escherichiacoli
FIFHIIKGLFHAGKMIHGLVTRRRH,492,2,9706,"Two isoforms of piscidin from Malabar grouper, Epinephelus malabaricus: Expression and functional characterization.",Escherichiacoli
FFFHIIKGLFHAGRMIHGLVNRRRHRHGMEELDLDQRAFEREKAFA,492,2,9708,"Two isoforms of piscidin from Malabar grouper, Epinephelus malabaricus: Expression and functional characterization.",Escherichiacoli
LLGRCKVKSNRFNGPCLTDTHCSTVCRGEGYKGGDCHGLRRRCMCLC,493,92,9710,Comparative Analysis of the Antimicrobial Activities of Plant Defensin-Like and Ultrashort Peptides against Food-Spoiling Bacteria,Lactobacillusbrevis
KTCENLANTYRGPCFTTGSCDDHCKNKEHLRSGRCRDDFRCWCTRNC,493,92,9711,Comparative Analysis of the Antimicrobial Activities of Plant Defensin-Like and Ultrashort Peptides against Food-Spoiling Bacteria,Lactobacillusbrevis
IWGLIAHGVGHVGRLIHGLIRG,1556,8,9712,Characterization of a novel piscidin-like antimicrobial peptide from Pseudosciaena crocea and its immune response to Cryptocaryon irritans.,Bacillussubtilis
RDCESDSHKFHGACFSDTNCANVCQTEGFAGKCVGVQRHCHCTKDC,493,92,9718,Comparative Analysis of the Antimicrobial Activities of Plant Defensin-Like and Ultrashort Peptides against Food-Spoiling Bacteria,Lactobacillusbrevis
ACIKNGGRCVASGGPPYCCSNYCLQIAGQSYGVCKKH,493,92,9719,Comparative Analysis of the Antimicrobial Activities of Plant Defensin-Like and Ultrashort Peptides against Food-Spoiling Bacteria,Lactobacillusbrevis
KVCRQRSAGFKGPCVSDKNCAQVCLQEGWGGGNCDGPFRRCKCIRQC,493,92,9726,Comparative Analysis of the Antimicrobial Activities of Plant Defensin-Like and Ultrashort Peptides against Food-Spoiling Bacteria,Lactobacillusbrevis
RIPCQYEDATEDTICQQHCLPKGYSYGICVSYRCSCV,1557,4,9743,An anionic defensin from Plutella xylostella with potential activity against Bacillus thuringiensis.,Staphylococcusaureus
FFGRLKSVWSAVKHGWKAAKSR,1558,4,9755,Trichoplaxin - a new membrane-active antimicrobial peptide from placozoan cDNA.,Staphylococcusaureus
DLWNSIKDMAAAAGRAALNAVTGMVNQ,1559,18,9758,Schistosoma mansoni dermaseptin-like peptide: structural and functional characterization.,Micrococcusluteus
APRMEIGKRREKLGRNVFKAAKKALPVIAGYKALG,1560,2,9759,Mitochondrial inactivation by Anopheles albimanus cecropin 3: molecular mechanisms.,Escherichiacoli
GFGCPLNQGACHNHCRSIRRRGGYCSGIIKQTCTCYRN,1561,18,9760,Defensin from the ornate sheep tick Dermacentor marginatus and its effect on Lyme borreliosis spirochetes.,Micrococcusluteus
ECIPTKHDCTNDRKNCCPGHECKCYNTQIGGSKKEQCGCKKSLLAKAKNFGGKVITIFKA,499,95,9762,Cysteine-rich toxins from Lachesana tarabaevi spider venom with amphiphilic C-terminal segments.,Arthrobacterglobiformis
AFGCPFDQGTCHSHCRSIRRRGERCSGFAKRTCTCYQK,1562,88,9779,Defensins from the tick Ixodes scapularis are effective against phytopathogenic fungi and the human bacterial pathogen Listeria grayi.,Listeriafleischmannii
GFGCPFDQGACHRHCQSIGRRGGYCAGFIKQTCTCYHN,1562,88,9780,Defensins from the tick Ixodes scapularis are effective against phytopathogenic fungi and the human bacterial pathogen Listeria grayi.,Listeriafleischmannii
GLRKRLRKFRNKIKEKLKKIGQKIQGFVPKLAPRTDY,501,25,9792,Positive selection in cathelicidin host defense peptides: adaptation to exogenous pathogens or endogenous receptors?,Bacilluscereus
KKCKFFCKVKKKIKSIGFQIPIVSIPFK,1563,2,9847,Cathelicidins from the bullfrog Rana catesbeiana provides novel template for peptide antibiotic design.,Escherichiacoli
KKCGFFCKLKNKLKSTGSRSNIAAGTHGGTFRV,1563,2,9848,Cathelicidins from the bullfrog Rana catesbeiana provides novel template for peptide antibiotic design.,Escherichiacoli
SGYLPGKEYVYKYKGKVF,1564,4,9864,Longipin: An Amyloid Antimicrobial Peptide from the Harvestman Acutisoma longipes (Arachnida: Opiliones) with Preferential Affinity for Anionic Vesicles.,Staphylococcusaureus
NGNLLGGLLRPVLGVVKGLTGGLGKK,508,4,9916,Thaulin-1: The first antimicrobial peptide isolated from the skin of a Patagonian frog Pleurodema thaul (Anura: Leptodactylidae: Leiuperinae) with activity against Escherichia coli.,Staphylococcusaureus
IWQWIVGGLGFLAGDAWSHSDQISSGIKKRKKKGYGY,1566,18,9920,Expression of a novel bacteriocin-the plantaricin Pln1-in Escherichia coli and its functional analysis.,Micrococcusluteus
APKGVQGPNG,1567,64,9921,"Glycin-rich antimicrobial peptide YD1 from B. amyloliquefaciens, induced morphological alteration in and showed affinity for plasmid DNA of E. coli.",Alcaligenesfaecalis
GSQLVYREWVGHSNVIKP,1568,8,9949,"Lariatins, novel anti-mycobacterial peptides with a lasso structure, produced by Rhodococcus jostii K01-B0171.",Bacillussubtilis
GSQLVYREWVGHSNVIKGPP,1568,8,9950,"Lariatins, novel anti-mycobacterial peptides with a lasso structure, produced by Rhodococcus jostii K01-B0171.",Bacillussubtilis
GLFKKLRRKIKKGFKKIFKRLPPIGVGVSIPLAGKR,514,59,9972,Cathelicidin antimicrobial peptide from Alligator mississippiensis has antibacterial activity against multi-drug resistant Acinetobacter baumanii and Klebsiella pneumoniae.,Acinetobacterbaumannii
QPFSLERW,1569,18,9975,Evidence of an Antimicrobial Peptide Signature Encrypted in HECT E3 Ubiquitin Ligases,Micrococcusluteus
KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,1570,2,10049,Design of hybrid ?-hairpin peptides with enhanced cell specificity and potent anti-inflammatory activity.,Escherichiacoli
RNGCIVDPRCPYQQCRRPLYCRRR,1571,94,10066,Comparative Analysis of the Bacterial Membrane Disruption Effect of Two Natural Plant Antimicrobial Peptides.,Salmonellaenterica
GWLDVAKKIGKAAFNVAKNFL,525,2,10137,Effects of dimerization on the structure and biological activity of antimicrobial peptide Ctx-Ha.,Escherichiacoli
RWKIFKKIEKMGRNIRDGIVKAGPAIEVLGSAKAIGK,1572,2,10182,"A potential food biopreservative, CecXJ-37N, non-covalently intercalates into the nucleotides of bacterial genomic DNA beyond membrane attack.",Escherichiacoli
WGWKEVVQNGQTIFSAGQKLGNMVGKIVPLPFG,1573,209,10201,"Identification and three-dimensional structure of carnobacteriocin XY, a class IIb bacteriocin produced by Carnobacteria.",Carnobacteriumdivergens
SAILAITLGIFATGYGMGVQKAINDRRKK,1573,209,10202,"Identification and three-dimensional structure of carnobacteriocin XY, a class IIb bacteriocin produced by Carnobacteria.",Carnobacteriumdivergens
FLPLLAGLAANFLPTIICKIARKC,1574,4,10205,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus
GIMDTIKNAAKDVVQSLLNKASCKLAKTC,1574,4,10206,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus
CGYKYGCMVKVDR,1574,4,10207,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus
FFGTKGIFSKVEPIFCKISHSC,1574,4,10208,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus
IVRPPIRCKAAFC,1574,4,10209,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus
FLPAIIGMAAKVLPAFLCKITKKC,1574,4,10212,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus
GILMDTFKGAAKNVAGFLLDKLKCKISGGC,1574,4,10213,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus
GAPKGCWTKSYPPQPCFGKK,1574,4,10214,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus
GLWTTIKEGLKKFSLGVLDKIRCKIAGGC,1574,4,10215,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus
QYRPGSFGPLNQK,1574,4,10218,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus
DYSIRTRLHQESSRNVF,1574,4,10220,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus
DNVYSRPPQRFGQNVIS,1574,4,10221,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus
SFLDKFKDVAIGVAKGAGTGVLKALLCKLDNSC,1574,4,10222,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus
CVVSSGWKWNYKIRCKLTGNC,1574,4,10223,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus
FKTWKNRPILSSCSGIIKG,1574,4,10224,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus
CQWQFISPSRAGCIGP,1574,4,10225,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus
FFPLIPGVRCKILRTC,1574,4,10226,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus
FFLLPIPNDVKCKVLGICKS,1574,4,10227,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus
ILPSKLCRLLGNC,1574,4,10228,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus
ASVVNKLTGGVAGLLK,1575,2,10229,Isolation and characterisation of a novel antibacterial peptide from a native swine intestinal tract-derived bacterium.,Escherichiacoli
FFFHIVKGLFHAGRMIHGLVNRRRHRHGMEELDLDQRAFEREKAFA,529,2,10232,"Three new piscidins from orange-spotted grouper (Epinephelus coioides): Phylogeny, expression and functional characterization.",Escherichiacoli
IFGLLLHGAIHVGKLIHGLVRRHGEEQLDDLEQLDKRALDYNPGRPGFD,529,2,10234,"Three new piscidins from orange-spotted grouper (Epinephelus coioides): Phylogeny, expression and functional characterization.",Escherichiacoli
FFRHIKSFWKGAKAIFRGARQGWREHRALSKQRKMDQGGGGNEVDNGTPPYWQK,529,2,10236,"Three new piscidins from orange-spotted grouper (Epinephelus coioides): Phylogeny, expression and functional characterization.",Escherichiacoli
NILSSIVNGINRALSFFG,1576,4,10258,A novel family of antimicrobial peptides from the skin of Amolops loloensis,Staphylococcusaureus
NVLSSVANGINRALSFFG,1576,4,10259,A novel family of antimicrobial peptides from the skin of Amolops loloensis,Staphylococcusaureus
GWLKKIGKKIERVGQHTRGLGIAQIAANVAATAR,1577,2,10344,A Novel Antimicrobial Peptide Derived from the Insect Paederus dermatitis,Escherichiacoli
KWKFFKKIERVGQNIRDGIIKAGPAVAVVGQATNIAKG,1578,2,10351,"Characterization and functional study of a Cecropin-like peptide from the Chinese oak silkworm, Antheraea pernyi.",Escherichiacoli
KRRGSVTTRYQFLMIHLLRPKKLFA,1579,4,10356,Novel cathelicidin-derived antimicrobial peptides from Equus asinus.,Staphylococcusaureus
RILTMTKRVKMPQLYKQIVCRLFKTC,1580,2,10357,A novel antimicrobial peptide from skin secretions of the tree frog Theloderma kwangsiensis.,Escherichiacoli
GGLKKLGKKLEGAGKRVFNAAEKALPVVAGAKALRK,1581,3,10520,Synergistic Efficacy of Aedes aegypti Antimicrobial Peptide Cecropin A2 and Tetracycline against Pseudomonas aeruginosa,Pseudomonasaeruginosa
NLLNDALGTVNGLLGRS,552,2,10525,"Dendropsophin 1, a novel antimicrobial peptide from the skin secretion of the endemic Colombian frog Dendropsophus columbianus.",Escherichiacoli
GIPCGESCVWIPCLTSAIGCSCKSKVCYRN,553,2,10528,Bactericidal activity of cyclotides where phosphatidylethanolamine-lipid selectivity determines antimicrobial spectra.,Escherichiacoli
GTLPCGESCVWIPCISSVVGCSCKSKVCYKD,553,2,10529,Bactericidal activity of cyclotides where phosphatidylethanolamine-lipid selectivity determines antimicrobial spectra.,Escherichiacoli
GIPCAESCVWIPCTVTALLGCSCKDKVCYLD,553,2,10530,Bactericidal activity of cyclotides where phosphatidylethanolamine-lipid selectivity determines antimicrobial spectra.,Escherichiacoli
GLPCGESCVFIPCITTVVGCSCKNKVCYNN,553,2,10531,Bactericidal activity of cyclotides where phosphatidylethanolamine-lipid selectivity determines antimicrobial spectra.,Escherichiacoli
GGTIFDCGESCFLGTCYTKGCSCGEWKLCYGTN,553,2,10532,Bactericidal activity of cyclotides where phosphatidylethanolamine-lipid selectivity determines antimicrobial spectra.,Escherichiacoli
GLPVCGETCFGGTCNTPGCACDPWPVCTRD,553,2,10533,Bactericidal activity of cyclotides where phosphatidylethanolamine-lipid selectivity determines antimicrobial spectra.,Escherichiacoli
GGVCPKILQRCRRDSDCPGACICRGNGYCGSGSD,553,2,10535,Bactericidal activity of cyclotides where phosphatidylethanolamine-lipid selectivity determines antimicrobial spectra.,Escherichiacoli
GGVCPKILKKCRRDSDCPGACICRGNGYCGSGSD,553,2,10536,Bactericidal activity of cyclotides where phosphatidylethanolamine-lipid selectivity determines antimicrobial spectra.,Escherichiacoli
GLPTCGETCTLGKCNTPKCTCNWPICYKD,1582,111,10537,Lysine-rich Cyclotides: A New Subclass of Circular Knotted Proteins from Violaceae.,Humanskin
GVIPCGESCVFIPCINKKKCSCKNKVCYRD,1582,2,10538,Lysine-rich Cyclotides: A New Subclass of Circular Knotted Proteins from Violaceae.,Escherichiacoli
GLPTCGETCTLGKCNTPKCTCNWPICYKN,1582,111,10539,Lysine-rich Cyclotides: A New Subclass of Circular Knotted Proteins from Violaceae.,Humanskin
GKYTCGETCFKGKCYTPGCTCSYPICKKD,1582,2,10540,Lysine-rich Cyclotides: A New Subclass of Circular Knotted Proteins from Violaceae.,Escherichiacoli
GKPTCGETCFKGKCYTPGCTCSYPLCKKD,1582,2,10541,Lysine-rich Cyclotides: A New Subclass of Circular Knotted Proteins from Violaceae.,Escherichiacoli
GKPICGETCFKGKCYTPGCTCSYPICKKD,1582,2,10542,Lysine-rich Cyclotides: A New Subclass of Circular Knotted Proteins from Violaceae.,Escherichiacoli
GKPICGETCFKGKCYTPGCTCSYPICKKN,1582,2,10543,Lysine-rich Cyclotides: A New Subclass of Circular Knotted Proteins from Violaceae.,Escherichiacoli
GLPTCGETCFKGKCYTPGCSCSYPICKKD,1582,2,10544,Lysine-rich Cyclotides: A New Subclass of Circular Knotted Proteins from Violaceae.,Escherichiacoli
GLPTCGETCFKGKCYTPGCSCSYPICKKN,1582,2,10545,Lysine-rich Cyclotides: A New Subclass of Circular Knotted Proteins from Violaceae.,Escherichiacoli
IVPFLLGMVPKLVCLITKKC,1583,56,10585,Cytotoxic peptides with insulin-releasing activities from skin secretions of the Italian stream frog Rana italica (Ranidae).,Staphylococcusepidermidis
SMATPHVAGAAALILSKHPTWTNAQVRDRLESTATYLGNSFYYGK,1584,25,10587,"Novel antimicrobial activities of a peptide derived from a Japanese soybean fermented food, Natto, against Streptococcus pneumoniae and Bacillus subtilis group strains.",Bacilluscereus
RPKKVQGRKAEKDNGDGTTAANASGKKKSSNVFK,1585,2,10588,Identification of the first cathelicidin gene from skin of Chinese giant salamanders Andrias davidianus with its potent antimicrobial activity.,Escherichiacoli
RRGLFKKLRRKIKKGFKKIFKRLPPVGVGVSIPLAGRR,1586,2,10590,"As-CATH1-6, novel cathelicidins with potent antimicrobial and immunomodulatory properties from Alligator sinensis, play pivotal roles in host antimicrobial immune responses.",Escherichiacoli
TRRKFWKKVLNGALKIAPFLLG,1586,2,10591,"As-CATH1-6, novel cathelicidins with potent antimicrobial and immunomodulatory properties from Alligator sinensis, play pivotal roles in host antimicrobial immune responses.",Escherichiacoli
TRWLWLLRGGLKAAGWGIRAHLNRNQ,1586,2,10592,"As-CATH1-6, novel cathelicidins with potent antimicrobial and immunomodulatory properties from Alligator sinensis, play pivotal roles in host antimicrobial immune responses.",Escherichiacoli
ASENGKCNLLCLVKKKLRAVGNVIKTVVGKIA,1587,2,10613,The first identified cathelicidin from tree frogs possesses anti-inflammatory and partial LPS neutralization activities.,Escherichiacoli
RTCESQSHRFKGPCARDSNCATVCLTEGFSGGDCRGFRRRCFCTRPC,1588,24,10684,Inhibition of cereal rust fungi by both class I and II defensins derived from the flowers of Nicotiana alata.,Fusariumoxysporum
MWGRILGTVAKYGPKAVSWAWQHKWELINMGDLAFRYIQRIWG,1589,32,10691,"Lactolisterin BU, a novel Class II broad spectrum bacteriocin from Lactococcus lactis subsp. lactis bv. diacetylactis BGBU1-4.",Lactococcuslactis
MMRVMRRKTKVIWEKKDFIGLYSID,1590,4,10711,"Catesbeianin-1, a novel antimicrobial peptide isolated from the skin of Lithobates catesbeianus (American bullfrog).",Staphylococcusaureus
GLFDIVKKVVGAIGSL,1591,25,10737,The importance of bacterial membrane composition in the structure and function of aurein 2.2 and selected variants.,Bacilluscereus
FFGPLIKIATGVLPNLICKALGKC,1592,2,10742,Three novel antimicrobial peptides from the skin of the Indian bronzed frog Hylarana temporalis (Anura: Ranidae).,Escherichiacoli
GIGSMLLGLAKNVGMSLLNKAQCKISGKC,1592,2,10743,Three novel antimicrobial peptides from the skin of the Indian bronzed frog Hylarana temporalis (Anura: Ranidae).,Escherichiacoli
GFMGDTLKGIARNAALALMNAAQCKLSGKC,1592,2,10744,Three novel antimicrobial peptides from the skin of the Indian bronzed frog Hylarana temporalis (Anura: Ranidae).,Escherichiacoli
MKFKFNPTGTIVKKLTQYEIAWFKNKHGYYPWEIPRC,1593,4,10757,"The Leaderless Bacteriocin Enterocin K1 Is Highly Potent against Enterococcus faecium: A Study on Structure, Target Spectrum and Receptor.",Staphylococcusaureus
MKTILRFVAGYDIASHKKKTGGYPWERGKA,1593,4,10758,"The Leaderless Bacteriocin Enterocin K1 Is Highly Potent against Enterococcus faecium: A Study on Structure, Target Spectrum and Receptor.",Staphylococcusaureus
APKVNVNALRKGGRVIRKGLGVIGAAGTAHEVYNHVRNRNQG,1594,2,10759,"Cloning and functional identification of moricins from the diamondback moth, Plutella xylostella (L.).",Escherichiacoli
APKVNVNALKKGGHVIKKGLGVIGAAGTAHEVYNHVRNRNQG,1594,2,10760,"Cloning and functional identification of moricins from the diamondback moth, Plutella xylostella (L.).",Escherichiacoli
GLMDIFKVAVNKLLAAGMNKPRCKAAHC,571,4,10826,"Induction of antimicrobial peptides from Rana dybowskii under Rana grylio virus stress, and bioactivity analysis.",Staphylococcusaureus
IIPLPLGYFAKKP,571,4,10827,"Induction of antimicrobial peptides from Rana dybowskii under Rana grylio virus stress, and bioactivity analysis.",Staphylococcusaureus
VLPLVGNLLNDLLGK,571,4,10829,"Induction of antimicrobial peptides from Rana dybowskii under Rana grylio virus stress, and bioactivity analysis.",Staphylococcusaureus
AIGHCLGATL,1595,8,10838,Antimicrobial peptide from mucus of Andrias davidianus: screening and purification by magnetic cell membrane separation technique.,Bacillussubtilis
GLTRLFSVIK,1596,8,10839,"Purification, characterization and application of a novel antimicrobial peptide from Andrias davidianus blood.",Bacillussubtilis
GVIPGQKQCIALKGVCRDKLCSTLDDTIGICNEGKKCCRRWWILEPYPTPVPKGKSP,1597,43,10850,Involvement of ?-defensin 130 (DEFB130) in the macrophage microbicidal mechanisms for killing Plasmodium falciparum.,Plasmodiumfalciparum
GFGCPFNQYECHAHCSGVPGYKGGYCKGLFKQTCNCY,574,4,10868,Activity of tick antimicrobial peptide from Ixodes persulcatus (persulcatusin) against cell membranes of drug-resistant Staphylococcus aureus.,Staphylococcusaureus
GYPWWDYRDLFGGHTFISP,1598,85,10894,"Novel propeptin analog, propeptin-2, missing two amino acid residues from the propeptin C-terminus loses antibiotic potency.",Mycobacteriumsmegmatis
GYPWWDYRDLFGGHTFI,1598,216,10895,"Novel propeptin analog, propeptin-2, missing two amino acid residues from the propeptin C-terminus loses antibiotic potency.",Mycobacteriumphlei
LALRTAGWLRLLGFRDKKKN,1599,4,10911,Molecular Cloning and Functional Characterization of Antimicrobial Peptides Brevinin-1ULf and Ulmin-1ULa in the Skin of the Newly Classified Ryukyu Brown Frog Rana ulma.,Staphylococcusaureus
GFGSKPLDSFGLNFF,1600,4,10931,"Chaxapeptin, a Lasso Peptide from Extremotolerant Streptomyces leeuwenhoekii Strain C58 from the Hyperarid Atacama Desert.",Staphylococcusaureus
GFGSKPIDSFGLSWL,1601,31,10942,"Sungsanpin, a lasso peptide from a deep-sea streptomycete.",Humanlung
GILDTLKNLAKTAGKGILKSLVNTASCKLSGQC,1602,4,11021,Assessment of antimicrobial and wound healing effects of Brevinin-2Ta against the bacterium Klebsiella pneumoniae in dermally-wounded rats.,Staphylococcusaureus
WQQPSCSSICDYSCGKSACISYSGRCGCCASCRRGPIY,1603,2,11022,"Paralithocins, Antimicrobial Peptides with Unusual Disulfide Connectivity from the Red King Crab, Paralithodes camtschaticus.",Escherichiacoli
RSPPQCQYTNCAAVLCPAVYCANAYTPPCGCCDICPPQKYGGGYRPR,1603,2,11023,"Paralithocins, Antimicrobial Peptides with Unusual Disulfide Connectivity from the Red King Crab, Paralithodes camtschaticus.",Escherichiacoli
RSQPGPTCPSSVQAILCDNRCGRSACSYYIERCACCAKCNRIPYYGASNHP,1603,2,11024,"Paralithocins, Antimicrobial Peptides with Unusual Disulfide Connectivity from the Red King Crab, Paralithodes camtschaticus.",Escherichiacoli
FLPLLLAGLPSFLCLVFKKC,592,4,11075,"Identification of novel Amurin-2 variants from the skin secretion of Rana amurensis, and the design of cationicity-enhanced analogues.",Staphylococcusaureus
KRFKKFFRKLKKSVKKRAKEFFKKPRVIGVSIPF,593,4,11084,The antimicrobial potential of a new derivative of cathelicidin from Bungarus fasciatus against methicillin-resistant Staphylococcus aureus.,Staphylococcusaureus
KRFKKFFRKIKKGFRKIFKKTKIFIGGTIPI,1604,4,11165,Python Cathelicidin CATHPb1 Protects against Multidrug-Resistant Staphylococcal Infections by Antimicrobial-Immunomodulatory Duality.,Staphylococcusaureus
KRNGFRKFMRRLKKFFAGGGSSIAHIKLH,1604,4,11166,Python Cathelicidin CATHPb1 Protects against Multidrug-Resistant Staphylococcal Infections by Antimicrobial-Immunomodulatory Duality.,Staphylococcusaureus
KRFQNFFRELEKKFREFFRVYRITIGATIRF,1604,4,11167,Python Cathelicidin CATHPb1 Protects against Multidrug-Resistant Staphylococcal Infections by Antimicrobial-Immunomodulatory Duality.,Staphylococcusaureus
TRSRWRRFIRGAGRFARRYGWRIALGLVG,1604,4,11168,Python Cathelicidin CATHPb1 Protects against Multidrug-Resistant Staphylococcal Infections by Antimicrobial-Immunomodulatory Duality.,Staphylococcusaureus
SPPQAMGFPPQVNVEHYIPASYSVAALTVTEEE,1604,4,11169,Python Cathelicidin CATHPb1 Protects against Multidrug-Resistant Staphylococcal Infections by Antimicrobial-Immunomodulatory Duality.,Staphylococcusaureus
RAAPQRRLRAMARLKKFAEAGGADPDSGGLRARFPER,1604,4,11170,Python Cathelicidin CATHPb1 Protects against Multidrug-Resistant Staphylococcal Infections by Antimicrobial-Immunomodulatory Duality.,Staphylococcusaureus
FFGHLFKLATKIIPSLFQRKKE,1605,48,11208,Mesobuthus Venom-Derived Antimicrobial Peptides Possess Intrinsic Multifunctionality and Differential Potential as Drugs.,Bacillusmegaterium
FFGHLFKLATKIIPSFFRRKNQ,1605,48,11209,Mesobuthus Venom-Derived Antimicrobial Peptides Possess Intrinsic Multifunctionality and Differential Potential as Drugs.,Bacillusmegaterium
NLVSALIEGRKYLKNVLKKLNRLKEKNKAKNSKENN,597,4,11212,"Discovery of Distinctin-Like-Peptide-PH (DLP-PH) From the Skin Secretion of Phyllomedusa hypochondrialis, a Prototype of a Novel Family of Antimicrobial Peptide.",Staphylococcusaureus
GFLEKLKTGAKDFASAFVNSIKGT,598,4,11216,"A Combined Molecular Cloning and Mass Spectrometric Method to Identify, Characterize, and Design Frenatin Peptides from the Skin Secretion of Litoria infrafrenata.",Staphylococcusaureus
VSGPAGPPGTH,1606,25,11318,"Purification, Characterization, and Mode of Action of Plantaricin GZ1-27, a Novel Bacteriocin against Bacillus cereus.",Bacilluscereus
FKFGSFIKRMWRSKLAKKLRAKGKELLRDYANRVLSPEEEAAAPAPVPA,605,25,11319,"Meucin-49, a multifunctional scorpion venom peptide with bactericidal synergy with neurotoxins.",Bacilluscereus
MGAIAKLVAKFGWPIVKKYYKQIMQFIGEGWAINKIIDWIKKHI,1607,1,11332,The safe enterocin DD14 is a leaderless two-peptide bacteriocin with anti-Clostridium perfringens activity.,None_target
MGAIAKLVAKFGWPFIKKFYKQIMQFIGQGWTIDQIEKWLKRH,1607,1,11333,The safe enterocin DD14 is a leaderless two-peptide bacteriocin with anti-Clostridium perfringens activity.,None_target
RRCICTTRTCRFPYRRLGTCIFQNRVYTFCC,1608,4,11357,Synergistic actions of antibacterial neutrophil defensins and cathelicidins.,Staphylococcusaureus
ILPLLLGKVVCAITKKC,1609,4,11358,An atypical member of the brevinin-1 family of antimicrobial peptides isolated from the skin of the European frog Rana dalmatina.,Staphylococcusaureus
GSAQPYKQLHKVVNWDPYG,1610,2,11360,The first antimicrobial peptide from sea amphibian.,Escherichiacoli
TVKCGMNGKMPCKHGAFYTDTCDKNVFYRCVWGRPVKKHCGRGLVWNPRGFCDYA,1611,2,11401,Characterization of a novel antimicrobial peptide with chitin-biding domain from Mytilus coruscus.,Escherichiacoli
SCASRCKGHCRARRCGYYVSVLYRGRCYCKCLRC,1612,18,11402,Involvement of mytilins in mussel antimicrobial defense.,Micrococcusluteus
GCASRCKAKCAGRRCKGWASASFRRRCYCKCFRC,1612,18,11403,Involvement of mytilins in mussel antimicrobial defense.,Micrococcusluteus
KKIGKKIERVGQHTRDATIQTIAVAQQAANVAATLKG,1613,4,11404,"Expression and characterization of a housefly cecropin gene in the methylotrophic yeast, Pichia pastoris.",Staphylococcusaureus
FFQELKEGWKNIKKA,1614,16,11493,"Gene expressions and biological activities of two novel antimicrobial peptides (AMPs) isolated from leucocytes of the rock bream, Oplegnathus fasciatus",Aeromonassalmonicida
FFGRLKAVFRGARQGWKEHRY,1614,16,11494,"Gene expressions and biological activities of two novel antimicrobial peptides (AMPs) isolated from leucocytes of the rock bream, Oplegnathus fasciatus",Aeromonassalmonicida
FFSMIPKIATGIASLVKNL,1615,2,11523,Peptidomic analysis of the host-defense peptides in skin secretions of the Trinidadian leaf frog Phyllomedusa trinitatis (Phyllomedusidae),Escherichiacoli
GLVSGLLNSVTGLLGNLAGGGL,1615,2,11524,Peptidomic analysis of the host-defense peptides in skin secretions of the Trinidadian leaf frog Phyllomedusa trinitatis (Phyllomedusidae),Escherichiacoli
FFRNLWKGAKAAFRAGHAAWRA,620,2,11525,Identification and Characterization of Novel Antimicrobial Peptide from Hippocampus comes by In Silico and Experimental Studies.,Escherichiacoli
GLVGTLLGHIGKAILGG,1616,2,11538,Unveiling the Multifaceted Mechanisms of Antibacterial Activity of Buforin II and Frenatin 2.3S Peptides from Skin Micro-Organs of the Orinoco Lime Treefrog (Sphaenorhynchus lacteus).,Escherichiacoli
GFGCPLNERECHSHCQSIGRKFGYCGGTLRLTCICGKE,1617,4,11540,"Triintsin, a human pathogenic fungus-derived defensin with broad-spectrum antimicrobial activity.",Staphylococcusaureus
QSKKCCGRCSSRMCTKREKEEHTEDCRGSFCCLTHRKKK,1618,2,11543,Molecular characterization of a novel ovodefensin gene in chickens.,Escherichiacoli
GWLKKLGKKIERVGQHTRDATIQTIGVAQQAVNVAATLKG,1619,2,11570,"Identification, Characterization, Immunolocalization, and Biological Activity of Lucilin Peptide.",Escherichiacoli
KKCKGYRCRPVGFSSPISRRINDSENIYLPFGV,1620,2,11571,Identification and characterization of two novel cathelicidins from the frog Odorrana livida.,Escherichiacoli
RKCNFLCKVKNKLKSVGSKSLIGSATHHGIYRV,1620,2,11572,Identification and characterization of two novel cathelicidins from the frog Odorrana livida.,Escherichiacoli
AFKCKFCCGCCRAGVCGLCCRF,1621,212,11732,Molecular characterization of a hepcidin homologue in starry flounder (Platichthys stellatus) and its synergistic interaction with antibiotics,Vibriovulnificus
FFHHIFNGLVGVGKTIHRLI,1622,2,11762,"Expression analysis and biological activity of moronecidin from rock bream, Oplegnathus fasciatus.",Escherichiacoli
DSEGWKVQPNINRDQDGNTAGSVRVQKQLGNHEVHAGASRVFSGPNRGGPSYNVGATFNW,1623,2,11821,Biological Profiling of Coleoptericins and Coleoptericin-Like Antimicrobial Peptides from the Invasive Harlequin Ladybird Harmonia axyridis.,Escherichiacoli
FLGAVLKVAGKLVPAAICKISKKC,639,4,11867,Evaluating the Bioactivity of a Novel Broad-Spectrum Antimicrobial Peptide Brevinin-1GHa from the Frog Skin Secretion of Hylarana guentheri and Its Analogues.,Staphylococcusaureus
GVWGIAKIAGKVLGNILPHVFSSNQS,1624,2,11935,"Peptidoglycan potentiates the membrane disrupting effect of the carboxyamidated form of DMS-DA6, a Gram-positive selective antimicrobial peptide isolated from Pachymedusa dacnicolor skin.",Escherichiacoli
LSKYGGQCSLKHNTCTYLKGGRNVIVNCGSAANKRCKSDRHHCEYDEHHRRVDCQTPV,641,110,11936,Rational Design and Biotechnological Production of Novel AfpB-PAF26 Chimeric Antifungal Proteins.,Penicilliumdigitatum
RSICCSFPDPWGGLCCEDHCSYIGKPGGQCSDKGVCTCN,1625,8,11983,"Recombinant AfusinC, an anionic fungal CS?? defensin from Aspergillus fumigatus, exhibits antimicrobial activity against gram-positive bacteria",Bacillussubtilis
AKKPFVQRVKNAASKAYNKLKGLAMQSQYGCPIISNMCEDHCRRKKMEGQCDLLDCVCS,648,2,12100,Chemical synthesis of a two-domain scorpion toxin LaIT2 and its single-domain analogs to elucidate structural factors important for insecticidal and antimicrobial activities.,Escherichiacoli
ADSGEGDFLAEGGGVR,1626,18,12111,"Human Antimicrobial Peptide Isolated From Triatoma infestans Haemolymph, Trypanosoma cruzi-Transmitting Vector.",Micrococcusluteus
HGVSGHGQHGVHG,1627,79,12129,Further studies on the antiviral activity of alloferon and its analogues.,HSV-1
GVSGHGQHGVHG,1627,79,12130,Further studies on the antiviral activity of alloferon and its analogues.,HSV-1
GTLPCGESCVWIPCISSVVGCSCKSKVCYKN,1628,199,12162,The anthelmintic activity of the cyclotides: natural variants with enhanced activity,Haemonchuscontortus
GIPCGESCVWIPCISAAIGCSCKSKVCYRN,1628,199,12163,The anthelmintic activity of the cyclotides: natural variants with enhanced activity,Haemonchuscontortus
GSIPACGESCFKGKCYTPGCSCSKYPLCAKN,1628,199,12164,The anthelmintic activity of the cyclotides: natural variants with enhanced activity,Haemonchuscontortus
GLVPCGETCFTGKCYTPGCSCSYPICKKN,1628,199,12165,The anthelmintic activity of the cyclotides: natural variants with enhanced activity,Haemonchuscontortus
GLPCGETCFTGKCYTPGCSCSYPICKKIN,1628,199,12166,The anthelmintic activity of the cyclotides: natural variants with enhanced activity,Haemonchuscontortus
GLPTCGETCFGGTCNTPGCTCDPWPVCTHN,1628,199,12167,The anthelmintic activity of the cyclotides: natural variants with enhanced activity,Haemonchuscontortus
GVPCGESCVFIPCITGVIGCSCSSNVCYLN,1628,199,12168,The anthelmintic activity of the cyclotides: natural variants with enhanced activity,Haemonchuscontortus
GIPCAESCVWIPCTVTALVGCSCSDKVCYN,1628,199,12169,The anthelmintic activity of the cyclotides: natural variants with enhanced activity,Haemonchuscontortus
LNLKKILGKIGVMLSHLN,1629,2,12172,"Molecular cloning and antimicrobial activity of bombolitin, a component of bumblebee Bombus ignitus venom",Escherichiacoli
GIMDTVKNAAKNLAGQLLDKLKCKITAC,655,4,12184,"A novel antimicrobial peptide, Ranatuerin-2PLx, showing therapeutic potential in inhibiting proliferation of cancer cells",Staphylococcusaureus
GGTIFDCGETCFLGTCYTPGCSCGNYGFCYGTN,1630,5,12187,Anti-HIV cyclotides from the Chinese medicinal herb Viola yedoensis,HIV
GVIPCGESCVFIPCISAAIGCSCKNKVCYRN,1631,5,12196,Cyclotides as natural anti-HIV agents,HIV
GTACGESCYVLPCFTVGCTCTSSQCFKN,1631,5,12197,Cyclotides as natural anti-HIV agents,HIV
GIPCGESCVFIPCLTTVAGCSCKNKVCYRN,1631,5,12198,Cyclotides as natural anti-HIV agents,HIV
GFPCGESCVFIPCISAAIGCSCKNKVCYRN,1631,5,12199,Cyclotides as natural anti-HIV agents,HIV
VGTDFSGNDDISDVQK,1632,2,12216,Loxosceles gaucho Spider Venom: An Untapped Source of Antimicrobial Agents.,Escherichiacoli
RRWCFRVCYRGFCYRKCR,1633,2,12230,Cytotoxic Potential of the Novel Horseshoe Crab Peptide Polyphemusin III.,Escherichiacoli
RRWCFRVCYKGFCYRKCR,1634,2,12231,Cytotoxic Potential of the Novel Horseshoe Crab Peptide Polyphemusin III,Escherichiacoli
RRGCFRVCYRGFCFQRCR,1633,2,12233,Cytotoxic Potential of the Novel Horseshoe Crab Peptide Polyphemusin III.,Escherichiacoli
RWCFRVCYRGICYRKCR,1634,2,12234,Cytotoxic Potential of the Novel Horseshoe Crab Peptide Polyphemusin III,Escherichiacoli
KWCFRVCYRGICYRKCR,1634,2,12235,Cytotoxic Potential of the Novel Horseshoe Crab Peptide Polyphemusin III,Escherichiacoli
GFWSSVWDGAKNVGTAIIKNAKVCVYAVCVSHK,664,18,12236,Novel Antimicrobial Peptides from the Arctic Polychaeta Nicomache minor Provide New Molecular Insight into Biological Role of the BRICHOS Domain.,Micrococcusluteus
INLKAIAALVKKV,1635,2,12243,Antibacterial effects of gold nanoparticles functionalized with the extracted peptide from Vespa orientalis wasp venom.,Escherichiacoli
GRFKRFRKKLKRLWHKVGPFVGPILHY,669,18,12306,Combined Antibacterial Effects of Goat Cathelicidins With Different Mechanisms of Action.,Micrococcusluteus
RRLRPRRPRLPRPRPRPRPRPR,669,18,12307,Combined Antibacterial Effects of Goat Cathelicidins With Different Mechanisms of Action.,Micrococcusluteus
GGLRSLGRKILRAWKKYGPIIVPIIRI,673,59,12332,A bovine myeloid antimicrobial peptide (BMAP-28) and its analogs kill pan-drug-resistant Acinetobacter baumannii by interacting with outer membrane protein A (OmpA).,Acinetobacterbaumannii
GWGCNIFGGNDYRCHRHCKSISGYKGGYCKLGGICKCY,1636,4,12351,"Bldesin, the first functionally characterized pathogenic fungus defensin with Kv1.3 channel and chymotrypsin inhibitory activities.",Staphylococcusaureus
AQRCGDQARGAKCPNCLCCGKYGFCGSGDAYCGAGSCQSQCRGCR,1637,106,12392,Novel mode of action of plant defense peptides - hevein-like antimicrobial peptides from wheat inhibit fungal metalloproteases.,Fusariumverticillioides
AQRCGDQARGAKCPNCLCCGKYGFCGSGDAYCGKGSCQSQCRGCR,1637,106,12393,Novel mode of action of plant defense peptides - hevein-like antimicrobial peptides from wheat inhibit fungal metalloproteases.,Fusariumverticillioides
AQRCGDQARGAKCPNCLCCGKYGFCGSGDAYCGEGSCQSQCRGCR,1637,106,12394,Novel mode of action of plant defense peptides - hevein-like antimicrobial peptides from wheat inhibit fungal metalloproteases.,Fusariumverticillioides
AQRCGDQARGAKCPNCLCCGKYGFCGSGDAYCGNGSCQSQCRGCR,1637,106,12395,Novel mode of action of plant defense peptides - hevein-like antimicrobial peptides from wheat inhibit fungal metalloproteases.,Fusariumverticillioides
EQCGRQAGGKLCPNNLCCSQWGWCGSTDEYCSPDHNCQSNCKD,1638,65,12396,Hevein-Like Antimicrobial Peptides of Plants.,Botrytiscinerea
IFGAILPLALGALKNLIK,683,115,12404,Evaluation of cytotoxicity features of antimicrobial peptides with potential to control bacterial diseases of citrus.,Xanthomonascitri
GLFSKKGGKGGKSWIKGVFKGIKGIGKEVGGDVIRTGIEIAACKIKGEC,1640,2,12416,Functional Characterization of a Novel Lipopolysaccharide-Binding Antimicrobial and Anti-Inflammatory Peptide in Vitro and in Vivo.,Escherichiacoli
TRGRWGRFKRRAGRFIRRNRWQIISTGLKLIG,1641,2,12428,"Roles of polymorphic cathelicidins in innate immunity of soft-shell turtle, Pelodiscus sinensis.",Escherichiacoli
KKPSKKPKPQAMTFPKVTVEYFPASFSTAALTVPED,1641,2,12436,"Roles of polymorphic cathelicidins in innate immunity of soft-shell turtle, Pelodiscus sinensis.",Escherichiacoli
QSVACTSYYCSKFCGSAGCSLYGCYLLHPGKICYCLHCSR,685,2,12438,"Structural and Antimicrobial Features of Peptides Related to Myticin C, a Special Defense Molecule from the Mediterranean Mussel Mytilus galloprovincialis.",Escherichiacoli
RRSRSPRRKWTWKPRRRGSYTLISQGGNKGKH,1641,2,12448,"Roles of polymorphic cathelicidins in innate immunity of soft-shell turtle, Pelodiscus sinensis.",Escherichiacoli
TRSRWRRFTRRAGGFIRKNRWNIISTALKWIG,1641,2,12449,"Roles of polymorphic cathelicidins in innate immunity of soft-shell turtle, Pelodiscus sinensis.",Escherichiacoli
ASLLSLALMSQTTPIHPTPNYRTAWFLFSGLLGSAGVLFFLEAPTEVRSGG,1641,2,12450,"Roles of polymorphic cathelicidins in innate immunity of soft-shell turtle, Pelodiscus sinensis.",Escherichiacoli
RHCLSQSHRFKGMCVSSNNCANVCRTESFPDGECKSHGLERKCFCKKVC,1642,1,12481,Two novel antimicrobial defensins from rice identified by gene coexpression network analyses.,None_target
RTCESQSHRFKGPCARKANCASVCNTEGFPDGYCHGVRRRCMCTKPCP,1642,1,12484,Two novel antimicrobial defensins from rice identified by gene coexpression network analyses.,None_target
RQLKSSRRGALVCVRLKLCSAILSRGLSCGMFSCNARR,1643,166,12486,The attack of the phytopathogens and the trumpet solo: Identification of a novel plant antifungal peptide with distinct fold and disulfide bond pattern.,Aspergillusniger
FIHHIIGGLFHVGKSIHDLIR,1644,17,12525,Identification of a moronecidin-like antimicrobial peptide in the venomous fish Pterois volitans: Functional and structural study of pteroicidin-?.,Listeriamonocytogenes
FVPAILCSILKTC,1645,156,12532,Host defense peptides in skin secretions of Odorrana tiannanensis: Proof for other survival strategy of the frog than merely anti-microbial.,Candidatropicalis
CEKPSKFFSGPCIGSSGKTQCAYLCRRGEGLQDGNCKGLKCVCAC,1646,24,12554,"Astratides: Insulin-Modulating, Insecticidal, and Antifungal Cysteine-Rich Peptides from Astragalus membranaceus.",Fusariumoxysporum
VDCSGACSPFEVPPCGSRDCRCIPIGLVVGFCIYPTG,1646,218,12555,"Astratides: Insulin-Modulating, Insecticidal, and Antifungal Cysteine-Rich Peptides from Astragalus membranaceus.",Spodopterafrugiperda
EEESEVAHLRVRRGFGCPLNQGACHRHCRSIRRRGGYCSGIIKQTCTCYRN,1647,18,12614,Hemolymph defensin from the hard tick Haemaphysalis longicornis attacks Gram-positive bacteria.,Micrococcusluteus
RQCKAESNTFTGICIAKPPCRQACIREKFTDGHCSKVLRRCLCTKRC,702,112,12616,Structural and functional characterization of the membrane-permeabilizing activity of Nicotiana occidentalis defensin NoD173 and protein engineering to enhance oncolysis.,Humancervical
FIVPSIFLLKKAFCIALKKC,1649,4,12644,A novel membrane-disruptive antimicrobial peptide from frog skin secretion against cystic fibrosis isolates and evaluation of anti-MRSA effect using Galleria mellonella model.,Staphylococcusaureus
GGVGKIIEYFIGGGVGRYG,708,2,12667,Discovery and structure of the antimicrobial lasso peptide citrocin.,Escherichiacoli
ILELAGNAARDNKKTRIIPRHLQL,1650,2,12671,Acipensins - Novel Antimicrobial Peptides from Leukocytes of the Russian Sturgeon Acipenser gueldenstaedtii.,Escherichiacoli
FIHHIIGGLFSVGKHIHSLIHGH,1651,212,12673,Study of the Antimicrobial Activity of Tilapia Piscidin 3 (TP3) and TP4 and Their Effects on Immune Functions in Hybrid Tilapia (Oreochromis spp.).,Vibriovulnificus
QNCPTRRGLCVTSGLTACRNHCRSCHRGDVGCVRCSNAQCTGFLGTTCTCINPCPRC,712,8,12688,Induction of antibacterial proteins and peptides in the coprophilous mushroom Coprinopsis cinerea in response to bacteria.,Bacillussubtilis
VKVGINGFGRIGRLVTRAAFHGKKVEIVAIND,1652,8,12690,"Antimicrobial function of the GAPDH-related antimicrobial peptide in the skin of skipjack tuna, Katsuwonus pelamis.",Bacillussubtilis
RICTPIPFPMCY,1653,48,12692,"Purification, Conformational Analysis, and Properties of a Family of Tigerinin Peptides from Skin Secretions of the Crowned Bullfrog Hoplobatrachus occipitalis.",Bacillusmegaterium
RTCIPIPLVMC,1653,48,12693,"Purification, Conformational Analysis, and Properties of a Family of Tigerinin Peptides from Skin Secretions of the Crowned Bullfrog Hoplobatrachus occipitalis.",Bacillusmegaterium
RICTAIPLPMCL,1653,48,12694,"Purification, Conformational Analysis, and Properties of a Family of Tigerinin Peptides from Skin Secretions of the Crowned Bullfrog Hoplobatrachus occipitalis.",Bacillusmegaterium
RTCIPIPPVCF,1653,48,12695,"Purification, Conformational Analysis, and Properties of a Family of Tigerinin Peptides from Skin Secretions of the Crowned Bullfrog Hoplobatrachus occipitalis.",Bacillusmegaterium
KLKNFAKGVAQSLLNKASCKLSGQC,725,2,12878,Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentials.,Escherichiacoli
MADVIAKIVEIVKGLIDQFTQK,729,122,12951,Effect of amino acid substitution in the staphylococcal peptides warnericin RK and PSM? on their anti-Legionella and hemolytic activities.,Legionellapneumophila
VDFPNKGGKCDRKECRKTCKKLNYRGKCFPNYCRCFPG,733,4,13048,Loop Replacement Enhances the Ancestral Antibacterial Function of a Bifunctional Scorpion Toxin.,Staphylococcusaureus
GFGCNGPWDEDDMKCHNHCKSIKGYKGGYCAKAGFVCKCY,1654,4,13058,A recombinant fungal defensin-like peptide-P2 combats multidrug-resistant Staphylococcus aureus and biofilms.,Staphylococcusaureus
GFGCNGPWDEDDMKCHNHCKSIKGYKGGYCASAGFVCKCY,1654,4,13059,A recombinant fungal defensin-like peptide-P2 combats multidrug-resistant Staphylococcus aureus and biofilms.,Staphylococcusaureus
GFGCGGPWNEDDMQCHNHCKSIKGYKGGYCASAGFVCKCY,1654,4,13060,A recombinant fungal defensin-like peptide-P2 combats multidrug-resistant Staphylococcus aureus and biofilms.,Staphylococcusaureus
GFGCNGPWDEDDMKCHNHCKTIKGYKGGYCASAGFVCKCY,1654,4,13061,A recombinant fungal defensin-like peptide-P2 combats multidrug-resistant Staphylococcus aureus and biofilms.,Staphylococcusaureus
GFGCPGNEKKCHNHCKGIKGYKGGYCDGPYIPFVGRPRCKCY,1654,4,13062,A recombinant fungal defensin-like peptide-P2 combats multidrug-resistant Staphylococcus aureus and biofilms.,Staphylococcusaureus
GWGCNIFGGNDYRCHRHCKSIKGYKGGYCKLGGICKCY,1654,4,13063,A recombinant fungal defensin-like peptide-P2 combats multidrug-resistant Staphylococcus aureus and biofilms.,Staphylococcusaureus
GWGCTIFGGNDSRCHRHCKSIRGYRGGYCKLGGICKCY,1654,4,13064,A recombinant fungal defensin-like peptide-P2 combats multidrug-resistant Staphylococcus aureus and biofilms.,Staphylococcusaureus
QSHLSLCRWCCNCCHNKGCGFCCKF,1655,44,13120,"Cloning, characterization and tissue-specific expression of the antimicrobial peptide hepcidin from caspian trout (Salmo caspius) and the antibacterial activity of the synthetic peptide.",Aeromonashydrophila
HRRQGPIFDTRPSPFNPNQPRPGPIY,1656,43,13147,The Drosophila melanogaster antimicrobial peptides Mtk-1 and Mtk-2 are active against the malarial parasite Plasmodium falciparum.,Plasmodiumfalciparum
KWKFFKKIERVGQNIRDGIIKAGPAVQVVGQAATIYKGK,1656,43,13148,The Drosophila melanogaster antimicrobial peptides Mtk-1 and Mtk-2 are active against the malarial parasite Plasmodium falciparum.,Plasmodiumfalciparum
RWKVFKKIERMGQHIRDGIIKAGPAVAVVGQASTIISG,1656,43,13149,The Drosophila melanogaster antimicrobial peptides Mtk-1 and Mtk-2 are active against the malarial parasite Plasmodium falciparum.,Plasmodiumfalciparum
RRSRFGRFFKKVRKQLGRVLRHSRITVGGRMRF,1658,2,13254,"Diversity, immunoregulatory action and structure-activity relationship of green sea turtle cathelicidins.",Escherichiacoli
RRSIFRKLRRKIKKGLKKGIQHLLAGGRQGLPQGGRPGMI,1658,2,13255,"Diversity, immunoregulatory action and structure-activity relationship of green sea turtle cathelicidins.",Escherichiacoli
TRGRWKRFWRGAGRFFRRHKEKIIRAAVDIVLS,1658,2,13256,"Diversity, immunoregulatory action and structure-activity relationship of green sea turtle cathelicidins.",Escherichiacoli
MAFPFSTQRINPEIEEGNASLADLPVTHAGSLPGIKAQVRTALGIALLLVA,1658,2,13273,"Diversity, immunoregulatory action and structure-activity relationship of green sea turtle cathelicidins.",Escherichiacoli
GLLASLGKVFGGYLAEKLKPK,1659,182,13305,"Antimicrobial peptide defenses against chytridiomycosis, an emerging infectious disease of amphibian populations.",Batrachochytriumdendrobatidis
FLPILAGLAANLVPKLICSITKKC,1660,182,13306,Probiotics Modulate a Novel Amphibian Skin Defense Peptide That Is Antifungal and Facilitates Growth of Antifungal Bacteria.,Batrachochytriumdendrobatidis
VALTGLTVAEYFR,1662,2,13431,"Sarconesin II, a New Antimicrobial Peptide Isolated from Sarconesiopsis magellanica Excretions and Secretions.",Escherichiacoli
ATCDLLSPFKVGHAACALHCIAMGRRGGWCDGRAVCNCRR,1663,4,13462,Antibacterial and immunomodulatory activities of insect defensins-DLP2 and DLP4 against multidrug-resistant Staphylococcus aureus.,Staphylococcusaureus
VDKGSYLPRPTPPRPIYNRN,750,2,13548,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli
GLFSVVKGVLKGVGKNVSGSLLDQLKCKISGGC,1664,4,13623,"LFB: A Novel Antimicrobial Brevinin-Like Peptide from the Skin Secretion of the Fujian Large Headed Frog, Limnonectes fujianensi.",Staphylococcusaureus
SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGCRT,752,2,13624,Bioevaluation of Ranatuerin-2Pb from the Frog Skin Secretion of Rana pipiens and its Truncated Analogues.,Escherichiacoli
GLFDIIKKIAESF,1665,4,13669,AurH1: a new heptapeptide derived from Aurein1.2 antimicrobial peptide with specific and exclusive fungicidal activity.,Staphylococcusaureus
INWKALLDAAKKVL,1666,2,13694,The effects of the C-terminal amidation of mastoparans on their biological actions and interactions with membrane-mimetic systems.,Escherichiacoli
RECRIGNGQCKNQCHENEIRIAYCIRPGTHCCLQQ,760,41,13730,Antimicrobial activity and structure of a consensus human ?-defensin and its comparison to a novel putative hBD10.,Mycobacteriumtuberculosis
QSHLSLCRWCCNCCNRYKGCGFCCKF,1668,25,13803,Antimicrobial activity and mechanisms of multiple antimicrobial peptides isolated from rockfish Sebastiscus marmoratus.,Bacilluscereus
SLLWRWNSMKPVGASCRDHLECGTKYCRRSICTF,1668,25,13804,Antimicrobial activity and mechanisms of multiple antimicrobial peptides isolated from rockfish Sebastiscus marmoratus.,Bacilluscereus
KGARQAWKDYKYNRNMQKMNQGYGQQGG,1668,25,13805,Antimicrobial activity and mechanisms of multiple antimicrobial peptides isolated from rockfish Sebastiscus marmoratus.,Bacilluscereus
FFRHIVGAISRIFGQKQRDMAD,1668,25,13806,Antimicrobial activity and mechanisms of multiple antimicrobial peptides isolated from rockfish Sebastiscus marmoratus.,Bacilluscereus
GLLKSLCRKFVKVHLPELIEELTTTD,1668,25,13807,Antimicrobial activity and mechanisms of multiple antimicrobial peptides isolated from rockfish Sebastiscus marmoratus.,Bacilluscereus
GFGCPLNQRACHRHCRSIGRRGGFCAGLIKQTCTCYRK,1669,4,13808,"Antibacterial and antifungal activity of defensins from the Australian paralysis tick, Ixodes holocyclus.",Staphylococcusaureus
GFGCPNEWRCNAHCKRNRFRGGYCDSWFRRRCHCYG,1669,4,13809,"Antibacterial and antifungal activity of defensins from the Australian paralysis tick, Ixodes holocyclus.",Staphylococcusaureus
FIHHIIKGIFHIGKMIHSAINRRRH,1670,16,13810,"An insight into piscidins: The discovery, modulation and bioactivity of greater amberjack, Seriola dumerili, piscidin.",Aeromonassalmonicida
GFGGGRGGFGGGRGGFGGGGIGGGGFGGGYGGGKIKG,1671,18,13884,Serrulin: A Glycine-Rich Bioactive Peptide from the Hemolymph of the Yellow Tityus serrulatus Scorpion.,Micrococcusluteus
GWLKKIGKKIERVGQHTRDATIQAIGVAQQAANVAATLKG,772,59,13934,Antibacterial mechanism of peptide Cec4 against Acinetobacter baumannii.,Acinetobacterbaumannii
MGIIAGIIKFIKGLIEKFTGK,1672,2,13972,Phenol-Soluble-Modulin-Inspired Amphipathic Peptides Have Bactericidal Activity against Multidrug-Resistant Bacteria.,Escherichiacoli
RSGPPGLQGRLQRLLQASGNHAAGILTM,1673,2,13996,Additive effects of orexin B and vasoactive intestinal polypeptide on LL-37-mediated antimicrobial activities.,Escherichiacoli
RKRCRFCCNCCPGKQGCVFCCGF,1674,8,13997,Biochemical and molecular identification of a novel hepcidin type 2-like antimicrobial peptide in the skin mucus of the pufferfish Takifugu pardalis.,Bacillussubtilis
KPCTKLSKGWRGLCAPHKCSSYCIHHEGAYHGACLKNRHSKHYGCYCYYRHCY,774,89,14007,Antifungal potency and modes of action of a novel olive tree defensin against closely related ascomycete fungal pathogens.,Fusariumgraminearum
IKVPAIVKDTQKKVAKGVISTVADALSKS,1675,2,14147,Low structural variation in the host-defense peptide repertoire of the dwarf clawed frog Hymenochirus boettgeri (Pipidae).,Escherichiacoli
KIPPVVKDTLKKVAKGVLSAVAGALS,1675,2,14148,Low structural variation in the host-defense peptide repertoire of the dwarf clawed frog Hymenochirus boettgeri (Pipidae).,Escherichiacoli
IKIPPIVKDTLKKVAKGVLSTVADALSKS,1675,2,14149,Low structural variation in the host-defense peptide repertoire of the dwarf clawed frog Hymenochirus boettgeri (Pipidae).,Escherichiacoli
LKIPGFVRDTLKKVAKEIFSAVTGAVTQS,1675,2,14150,Low structural variation in the host-defense peptide repertoire of the dwarf clawed frog Hymenochirus boettgeri (Pipidae).,Escherichiacoli
GMASKAGAIAGKIAKVALKAL,796,2,14200,Influence of C-terminal amidation on the antimicrobial and hemolytic activities of cationic a-helical peptides,Escherichiacoli
FLGALLKIGAKVLPSVLCGIFKKC,1676,2,14203,"Functional characterization of two novel peptides and their analogs identifed from the skin secretion of Indosylvirana aurantiaca, an endemic frog species of Western Ghats, India",Escherichiacoli
GIKSALLGIAKNVGMSLLQKAQCKLSGSC,1676,2,14205,"Functional characterization of two novel peptides and their analogs identifed from the skin secretion of Indosylvirana aurantiaca, an endemic frog species of Western Ghats, India",Escherichiacoli
MSKVISALSKYGPKAVNWAKNHKGQIANWLLHGLSIPDIVQNVKNAVGIK,1677,32,14215,"Identification and characterisation of capidermicin, a novel bacteriocin produced by Staphylococcus capitis.",Lactococcuslactis
APKVNVNALKKGGRVIKKGLGVIGAAGTAHEVYNHVRNRNQG,1678,4,14238,Molecular Identification of a Moricin Family Antimicrobial Peptide (Px-Mor) From Plutella xylostella With Activities Against the Opportunistic Human Pathogen Aureobasidium pullulans.,Staphylococcusaureus
MTPLWRIMNSKPFGAYCQNNYECSTGLCRAGHCSTSHRAPSETVNY,1679,2,14244,Molecular Characterization and Gene Expression Data of Liver Expressed Antimicrobial Peptide-2 (LEAP-2) Isolated From Rock Bream ( Oplegnathus fasciatus),Escherichiacoli
GLKEIFKAGLGSLVKGIAAHVAS,798,4,14273,Increases in Hydrophilicity and Charge on the Polar Face of Alyteserin 1c Helix Change its Selectivity towards Gram-Positive Bacteria.,Staphylococcusaureus
GLVNGLLSSVLGGGQGGGGLLGGIL,1680,4,14617,A glycine-leucine-rich peptide structurally related to the plasticins from skin secretions of the frog Leptodactylus laticeps (Leptodactylidae).,Staphylococcusaureus
FFGHLFKLATKIIPSLFR,1681,4,14624,Therapeutic Potential of a Scorpion Venom-Derived Antimicrobial Peptide and Its Homologs Against Antibiotic-Resistant Gram-Positive Bacteria.,Staphylococcusaureus
FFGALFKLATKIIPSLFR,1681,4,14625,Therapeutic Potential of a Scorpion Venom-Derived Antimicrobial Peptide and Its Homologs Against Antibiotic-Resistant Gram-Positive Bacteria.,Staphylococcusaureus
GRFKRFRKKFKKLFKKLSPVIPLLHLG,813,2,14675,Anti-antimicrobial Peptides: Folding-Mediated Host Defense Antagonists,Escherichiacoli
KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL,813,2,14677,Anti-antimicrobial Peptides: Folding-Mediated Host Defense Antagonists,Escherichiacoli
FYPRPYRPPYLPDPRPFPRPLPAFGHEFRRH,1682,4,14831,"Identification and Functional Characterization of the Astacidin Family of Proline-Rich Host Defence Peptides (PcAst) From the Red Swamp Crayfish (Procambarus Clarkii, Girard 1852)",Staphylococcusaureus
VMWCYVFGYGFNCAVW,1683,85,14834,"Identification and Characterization of Pantocin wh-1, a Novel Cyclic Polypeptide Produced by Pantoea dispersa W18",Mycobacteriumsmegmatis
GFSSLFKAGAKYLLKQVGKAGAQQLACKAANNC,1684,4,14871,Brevinin-2GHk From Sylvirana guentheri and the Design of Truncated Analogs Exhibiting the Enhancement of Antimicrobial Activity,Staphylococcusaureus
SKTKRRSLLKRLGDGIRGFWNGFRGRK,1685,3,14968,"Marsupial and Monotreme Cathelicidins Display Antimicrobial Activity, Including Against Methicillin-Resistant Staphylococcus Aureus",Pseudomonasaeruginosa
KRGLWESLKRKVTKLGDDIRNTLRNFKIKFPVPRQG,1685,3,14969,"Marsupial and Monotreme Cathelicidins Display Antimicrobial Activity, Including Against Methicillin-Resistant Staphylococcus Aureus",Pseudomonasaeruginosa
PIRTKRRWKLIKKGGKIVKDLLTKNNIIILPGGNE,1685,3,14970,"Marsupial and Monotreme Cathelicidins Display Antimicrobial Activity, Including Against Methicillin-Resistant Staphylococcus Aureus",Pseudomonasaeruginosa
WYQLIRTFGNLIHQKYRKLLEAYRKLRD,827,2,14985,Opossum Cathelicidins Exhibit Antimicrobial Activity Against a Broad Spectrum of Pathogens Including West Nile Virus,Escherichiacoli
IINNPITCMTNGAICWGPCPTAFRQIGNCGHFKVRCCKIR,852,135,15215,A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses.,HumanInfluenza
IPLRGAFINGRWDSQCHRFSNGAIACA,1686,135,15501,An Amphibian Host Defense Peptide Is Virucidal for Human H1 Hemagglutinin-Bearing Influenza Viruses.,HumanInfluenza
GFGCPFNQGQCHKHCQSIRRRGGYCDGFLKTRCVCYR,1687,4,15563,Scorpion Potassium Channel-blocking Defensin Highlights a Functional Link with Neurotoxin.,Staphylococcusaureus
FLGALFKVASKLVPAAICSISKKC,1688,4,15602,Brevinin-1GHd: a novel Hylarana guentheri skin secretion-derived Brevinin-1 type peptide with antimicrobial and anticancer therapeutic potential.,Staphylococcusaureus
SSRRKPCKGWLCKLKLRGGYTLIGSATNLNRPTYVRA,886,149,15626,Cathelicidin-DM is an Antimicrobial Peptide from Duttaphrynus melanostictus and Has Wound-Healing Therapeutic Potential.,Staphylococcushaemolyticus
CRPYGYRCDGVINQCCDPYHCTPPLIGICL,1689,139,15662,Antiviral Cystine Knot ?-Amylase Inhibitors From Alstonia Scholaris,DENV-2
FLGAILKIGHALAKTVLPMVTNAFKPKQ,1690,2,15801,"Biological Properties of a Novel Multifunctional Host Defense Peptide from the Skin Secretion of the Chaco Tree Frog, Boana raniceps.",Escherichiacoli
RWKLFKKIEKVGRNVRDGLIKAGPAIAVIGQAKSLGK,896,4,15840,Antibacterial Activity of Rationally Designed Antimicrobial Peptides.,Staphylococcusaureus
KFFKKLKKSVKKHVKKFFKKPKVIGVSIPF,1692,2,15870,"Characterization of a Cathelicidin from the Colubrinae Snake, Sinonatrix annularis.",Escherichiacoli
FFGHLLRGIVSVGKHIHGLITG,1693,2,15906,"Trematocine, a Novel Antimicrobial Peptide from the Antarctic Fish Trematomus bernacchii: Identification and Biological Activity.",Escherichiacoli
SLFSLIKAGAKFLGKNMLKQGPQYPACKVSKDSENVNWKS,1694,2,16046,"Antimicrobial Property and Mode of Action of the Skin Peptides of the Sado Wrinkled Frog, Glandirana susurra, against Animal and Plant Pathogens.",Escherichiacoli
GLISTIWNTASNVAGTLTDSVKCKFKKC,1694,2,16047,"Antimicrobial Property and Mode of Action of the Skin Peptides of the Sado Wrinkled Frog, Glandirana susurra, against Animal and Plant Pathogens.",Escherichiacoli
GPSGFLGMR,1695,18,16099,Two Tachykinin-Related Peptides with Antimicrobial Activity Isolated from Triatoma infestans Hemolymph,Micrococcusluteus
APAAGFFGMR,1695,18,16100,Two Tachykinin-Related Peptides with Antimicrobial Activity Isolated from Triatoma infestans Hemolymph,Micrococcusluteus
FALGAVTKVLPKLFCLITRKC,914,4,16101,"Characterisation of a novel peptide, Brevinin-1H, from the skin secretion of Amolops hainanensis and rational design of several analogues.",Staphylococcusaureus
GWGCNIFGGNDYRCHRHCKSIRGYKGGYCKLGGICKCY,920,4,16163,"The second N-terminal aromatic residue of the fungal defensin, blapersin, of Blastomyces percursus is essential for its antibacterial activity.",Staphylococcusaureus
GTCIDLGSRLYCKLIRRRGMCRSRSHRARIAMMRCERSCGRCH,1696,2,16167,AmAMP1 from Acropora millepora and damicornin define a family of coral-specific antimicrobial peptides related to the Shk toxins of sea anemones.,Escherichiacoli
RGTCIDLGSRLYCKLIRRRGMCRSRSHRARIAMMRCERSCGRCH,1696,2,16169,AmAMP1 from Acropora millepora and damicornin define a family of coral-specific antimicrobial peptides related to the Shk toxins of sea anemones.,Escherichiacoli
YLPKVLHQTPGHLKP,1698,201,16334,Two short antimicrobial peptides derived from prosaposin-like proteins in the starry flounder (Platichthys stellatus),Streptococcusiniae
FTKIYGSRLQKVLGN,1698,201,16335,Two short antimicrobial peptides derived from prosaposin-like proteins in the starry flounder (Platichthys stellatus),Streptococcusiniae
FLPGILKVAANVVPGVICAITKKC,936,4,16462,Enhanced Antimicrobial Activity of N-Terminal Derivatives of a Novel Brevinin-1 Peptide from The Skin Secretion of Odorrana schmackeri.,Staphylococcusaureus
GLKDWWNKHKDKIVKVVKEMGKAGINAAGK,1701,53,16498,The dinoponeratoxin peptides from the giant ant Dinoponera quadriceps display in vitro antitrypanosomal activity.,Trypanosomacruzi
ARSYGNGVYCNNKKCWVNRGEATQSIIGGMISGWASGLAGM,1702,117,16519,Strong synergy between a eukaryotic antimicrobial peptide and bacteriocins from lactic acid bacteria.,Listeriaivanovii
LLKELWTKMKGAGKAVLGKIKGLL,944,2,16530,Investigation of the structure-activity relationship in ponericin L1 from Neoponera goeldii.,Escherichiacoli
RFRLPFRRPPIRIHPPPFYPPFRRFL,951,2,16644,Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor Drugs.,Escherichiacoli
FIGAIARLLSKIF,958,8,16936,Anticancer Activities of Antimicrobial BmKn2 Peptides Against Oral and Colon Cancer Cells,Bacillussubtilis
INLKAIAAMAKKLL,958,8,16938,Anticancer Activities of Antimicrobial BmKn2 Peptides Against Oral and Colon Cancer Cells,Bacillussubtilis
FLPIAGKLLSGLSGLL,958,8,16939,Anticancer Activities of Antimicrobial BmKn2 Peptides Against Oral and Colon Cancer Cells,Bacillussubtilis
KKCNFFCKLKKKVKSVGSRNLIGSATHHHRIYRV,1703,2,17030,Identification and characterization of novel bi-functional cathelicidins from the black-spotted frog (Pelophylax nigromaculata) with both anti-infective and antioxidant activities.,Escherichiacoli
EGCNILCLLKRKVKAVKNVVKNVVKSVVG,1703,2,17031,Identification and characterization of novel bi-functional cathelicidins from the black-spotted frog (Pelophylax nigromaculata) with both anti-infective and antioxidant activities.,Escherichiacoli
SPRVCIRVCRNGVCYRRCWG,1704,4,17237,Structure Elucidation and Functional Studies of a Novel β-hairpin Antimicrobial Peptide from the Marine Polychaeta Capitella teleta.,Staphylococcusaureus
KRFKKFWKKIKNSVKKRAKKFFRKPRVIAVSIPF,1705,2,17238,Identification of a Novel Cathelicidin from the Deinagkistrodon acutus Genome with Antibacterial Activity by Multiple Mechanisms.,Escherichiacoli
ACNDRDCSLDCIMKGYNTGSCVRGSCQCRRTSG,984,2,17337,Antimicrobial peptide-like genes in Nasonia vitripennis: a genomic perspective.,Escherichiacoli
KFGGECSLKHNTCTYLKGGKNHVVNCGSAANKKCKSDRHHCEYDEHHKRVDCQTPV,1706,6,17348,"New Antimicrobial Potential and Structural Properties of PAFB: A Cationic, Cysteine-Rich Protein from Penicillium chrysogenum Q176.",Aspergillusfumigatus
KRKFHEKHHSHRGY,19,11,495,Histatin 5-derived peptide with improved fungicidal properties enhances human immunodeficiency virus type 1 replication by promoting viral entry,Candidaalbicans
KRLFKELLFSLRKY,19,11,496,Histatin 5-derived peptide with improved fungicidal properties enhances human immunodeficiency virus type 1 replication by promoting viral entry,Candidaalbicans
KRLFKKLKFSLRKY,19,11,497,Histatin 5-derived peptide with improved fungicidal properties enhances human immunodeficiency virus type 1 replication by promoting viral entry,Candidaalbicans
LLLFLLKKRKKRKY,19,11,498,Histatin 5-derived peptide with improved fungicidal properties enhances human immunodeficiency virus type 1 replication by promoting viral entry,Candidaalbicans
AKRHHGYKRKFH,21,11,558,Energy depletion protects Candida albicans against antimicrobial peptides by rigidifying its cell membrane,Candidaalbicans
KRLFKKLLKFSLRKY,21,11,560,Energy depletion protects Candida albicans against antimicrobial peptides by rigidifying its cell membrane,Candidaalbicans
DLIWKLLSKAQEKFGKNKSR,21,11,562,Energy depletion protects Candida albicans against antimicrobial peptides by rigidifying its cell membrane,Candidaalbicans
FKCRRWQWRMKKLG,21,11,563,Energy depletion protects Candida albicans against antimicrobial peptides by rigidifying its cell membrane,Candidaalbicans
GKPRPYTPRPTSHPRPIRV,21,11,566,Energy depletion protects Candida albicans against antimicrobial peptides by rigidifying its cell membrane,Candidaalbicans
KRLFKELKFSLRKY,29,11,726,A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides,Candidaalbicans
WSPQEEDRIIEGGI,29,11,727,A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides,Candidaalbicans
DSHAKRHHGYKRKF,30,11,728,"Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5",Candidaalbicans
KRHHGYKRKFHEKHHSHR,30,11,729,"Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5",Candidaalbicans
DSHAKRHHGYKR,30,11,731,"Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5",Candidaalbicans
HHGYKRKFHEKH,30,11,735,"Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5",Candidaalbicans
YKRKFHEKHHSH,30,11,736,"Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5",Candidaalbicans
KFHEKHHSHRGY,30,11,737,"Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5",Candidaalbicans
KRHHGYKRKFH,30,11,738,"Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5",Candidaalbicans
AKRHHGYKRKF,30,11,739,"Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5",Candidaalbicans
AKRHHGYKRK,30,11,740,"Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5",Candidaalbicans
AKRHHGYKR,30,11,741,"Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5",Candidaalbicans
KCWNLRGSCREKCIKNEKLYIFCTSGKLCCLKPK,57,11,1251,Molecular cloning and characterization of three beta-defensins from canine testes.,Candidaalbicans
DKLIGSCVWGAVNYTSNCRAECKRRGYKGGHCGSFANVNCWCET,83,11,2076,Lead optimization of antifungal peptides with 3D NMR structures analysis.,Candidaalbicans
DKLIGSCVWGAVNYTSNCNAECKRRGYKGGHCGSFANVNCWCQT,83,11,2077,Lead optimization of antifungal peptides with 3D NMR structures analysis.,Candidaalbicans
DKLIGSCVWGAVNYTSNCNAECKRRGYKGGHCGSFANVNCWCER,83,11,2078,Lead optimization of antifungal peptides with 3D NMR structures analysis.,Candidaalbicans
NKLIGSCVWGAVNYTSNCNAECKRRGYKGGHCGSFANVNCWCET,83,11,2079,Lead optimization of antifungal peptides with 3D NMR structures analysis.,Candidaalbicans
DKLIGSCVWGAVNYTRNCNAECKRRGYKGGHCGSFANVNCWCET,83,11,2080,Lead optimization of antifungal peptides with 3D NMR structures analysis.,Candidaalbicans
DKLIGSCVWGAVNYTSRCNAECKRRGYKGGHCGSFANVNCWCET,83,11,2081,Lead optimization of antifungal peptides with 3D NMR structures analysis.,Candidaalbicans
DKLIGSCVWGAVNYTSNCNAECKRRGYKGGHCGSFLNVNCWCET,83,11,2082,Lead optimization of antifungal peptides with 3D NMR structures analysis.,Candidaalbicans
DKLIGSCVWGAVNYTSNCNAECKRRGYKGGHCGSFINVNCWCET,83,11,2083,Lead optimization of antifungal peptides with 3D NMR structures analysis.,Candidaalbicans
DKLIGSCVWGAVNYTSNCNAECKRRGYKGGHCGSFANINCWCET,83,11,2084,Lead optimization of antifungal peptides with 3D NMR structures analysis.,Candidaalbicans
DKLIGSCVWGAVNYTSNCNAECKRRGYKGGHCGSFLNINCWCET,83,11,2085,Lead optimization of antifungal peptides with 3D NMR structures analysis.,Candidaalbicans
DKLIGSCVWLAVNYTSNCNAECKRRGYKGGHCGSFLNVNCWCET,83,11,2086,Lead optimization of antifungal peptides with 3D NMR structures analysis.,Candidaalbicans
DKLIGSCVWLAVNYTSNCNAECKRRGYKGGHCGSFANVNCWCET,83,11,2087,Lead optimization of antifungal peptides with 3D NMR structures analysis.,Candidaalbicans
DKLIGSCVWGAVNYTSNCRAECKRRGYKGGHCGSFLNVNCWCET,83,11,2088,Lead optimization of antifungal peptides with 3D NMR structures analysis.,Candidaalbicans
WKLLSKAQEKFGKNKSR,115,11,3109,A one-enzyme strategy to release an antimicrobial peptide from the LFampin-domain of bovine lactoferrin.,Candidaalbicans
SVDGKEDLIWKLLSKAQEKFGKNKSR,115,11,3110,A one-enzyme strategy to release an antimicrobial peptide from the LFampin-domain of bovine lactoferrin.,Candidaalbicans
DLIWKLLSKAQEKFGKNKSRSFQLFGSPPGQR,115,11,3111,A one-enzyme strategy to release an antimicrobial peptide from the LFampin-domain of bovine lactoferrin.,Candidaalbicans
LAHQKPFIRKSYKCLHKRCR,140,11,4094,"MUC7 20-Mer: investigation of antimicrobial activity, secondary structure, and possible mechanism of antifungal action.",Candidaalbicans
DSHEERRQGRHGHHEYGRKFHEKH,149,11,4242,Histatins in non-human primates: gene variations and functional effects.,Candidaalbicans
DSHEKRHHEHRRKFHEKHHSHRGY,149,11,4243,Histatins in non-human primates: gene variations and functional effects.,Candidaalbicans
KVFKRLEKLFSKIQNDK,193,11,4956,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans
FKRLEKLFSKIQNDK,193,11,4957,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans
RLEKLFSKIQNDK,193,11,4958,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans
AKKVFKRLEKLFSKIQN,193,11,4959,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans
AKKVFKRLEKLFSKI,193,11,4960,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans
AKKVFKRLEKLFS,193,11,4961,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans
KVFKRLEKLFSKI,193,11,4962,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans
KVFKRLEKLFS,193,11,4963,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans
FKRLEKLF,193,11,4964,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans
WKKVFKRLEKLFSKIWNWK,193,11,4965,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans
FKRLEKLFSKIWNWK,193,11,4966,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans
FKRLKKLFSKIWNWK,193,11,4967,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans
FKRLEKLFKKIWNWK,193,11,4968,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans
FKRLKKLFKKIWNWK,193,11,4969,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans
AKKVFKRLRKLFKKI,193,11,4970,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans
DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA,202,11,5145,The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.,Candidaalbicans
DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV,202,11,5146,The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.,Candidaalbicans
DAEFRHDSGYEVRHQKLVFFAEDVGSNKGAIIGLMVGGVVIA,202,11,5148,The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.,Candidaalbicans
AIVVGGVMLGIIAGKNSGVDEAFFVLKQHHVEYGSDHRFEAD,202,11,5149,The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.,Candidaalbicans
DSHAKRHHGYKIKFHENHHSHRGY,203,11,5154,"In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1.",Candidaalbicans
DSHAKRHHGYKIKFHEKHHSLRGY,203,11,5155,"In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1.",Candidaalbicans
EGRERDHELRHRRHHHQSPKSHFELPHYPGLLAHQKPFIRKSYKCLHKRCR,203,11,5156,"In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1.",Candidaalbicans
DSHEKRHHGYKRKFHEKHHSHRGY,211,11,5199,Fungicidal effect of three new synthetic cationic peptides against Candida albicans.,Candidaalbicans
TKCFQWQRNMRKVRGPPVSCIKR,211,11,5200,Fungicidal effect of three new synthetic cationic peptides against Candida albicans.,Candidaalbicans
KRLFRRWQWRMKKY,211,11,5201,Fungicidal effect of three new synthetic cationic peptides against Candida albicans.,Candidaalbicans
KRLFRRLLFSMKKY,211,11,5202,Fungicidal effect of three new synthetic cationic peptides against Candida albicans.,Candidaalbicans
FKCKKVVISLRRY,211,11,5203,Fungicidal effect of three new synthetic cationic peptides against Candida albicans.,Candidaalbicans
RFRPPIRRPPIRPPFYPPFRPP,213,11,5253,Delineation of an active fragment and poly(L-proline) II conformation for candidacidal activity of bactenecin 5.,Candidaalbicans
RRPPIRPPFYPPFRPP,213,11,5254,Delineation of an active fragment and poly(L-proline) II conformation for candidacidal activity of bactenecin 5.,Candidaalbicans
RPPIRPPIFPPIRPPFRPPLGPFP,213,11,5255,Delineation of an active fragment and poly(L-proline) II conformation for candidacidal activity of bactenecin 5.,Candidaalbicans
WRKWRKRWWWRKWRKRWW,309,11,6461,Endocytosis-mediated vacuolar accumulation of the human ApoE apolipoprotein-derived ApoEdpL-W antimicrobial peptide contributes to its antifungal activity in Candida albicans.,Candidaalbicans
AKKVFKRLEKLFSKIQNDK,193,11,7551,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans
AKKVFKRLEKLFSKIQNWK,193,11,7552,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans
AKKVFKRLEKLFSKIWNDK,193,11,7553,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans
AKKVFKRLEKLFSKIWNWK,193,11,7554,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans
AKKVFKRLEKSFSKIQNDK,193,11,7555,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans
AKKVSKRLEKLFSKIQNDK,193,11,7556,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans
FLAKAVAKAAAKALAKAL,376,11,7647,Predicting antimicrobial peptides from eukaryotic genomes: in silico strategies to develop antibiotics.,Candidaalbicans
KAGLAFPVGRVHRLLRK,376,11,7648,Predicting antimicrobial peptides from eukaryotic genomes: in silico strategies to develop antibiotics.,Candidaalbicans
GLARGLREASKALDR,376,11,7649,Predicting antimicrobial peptides from eukaryotic genomes: in silico strategies to develop antibiotics.,Candidaalbicans
GLAKGIKEAAKALDKAL,376,11,7650,Predicting antimicrobial peptides from eukaryotic genomes: in silico strategies to develop antibiotics.,Candidaalbicans
CKYLLKWR,517,11,9994,"DS6: anticandidal, antibiofilm peptide against Candida tropicalis and exhibit synergy with commercial drug.",Candidaalbicans
CKYLLRWR,517,11,9999,"DS6: anticandidal, antibiofilm peptide against Candida tropicalis and exhibit synergy with commercial drug.",Candidaalbicans
ADMDFTGIAESIIKKIKETNAKPPA,538,11,10358,"Characterization of TistH, a multifunctional peptide from the scorpion Tityus stigmurus: Structure, cytotoxicity and antimicrobial activity",Candidaalbicans
KEFKRIVQRIKDFLRNLV,543,11,10405,"The Naturally Occurring Host Defense Peptide, LL-37, and Its Truncated Mimetics KE-18 and KR-12 Have Selected Biocidal and Antibiofilm Activities Against Candida albicans, Staphylococcus aureus, and Escherichia coli In vitro.",Candidaalbicans
KYHSGPSDKSKVISGKCEWQGGQLNCIAT,623,11,11559,Anti-Candidal Activity and Functional Mapping of Recombinant and Synthetic Neosartorya fischeri Antifungal Protein 2 (NFAP2).,Candidaalbicans
IATSPYYACNCPNNCKHKKGSGC,623,11,11560,Anti-Candidal Activity and Functional Mapping of Recombinant and Synthetic Neosartorya fischeri Antifungal Protein 2 (NFAP2).,Candidaalbicans
IAGAHKCKPCYGYKTNSCCNSPN,623,11,11561,Anti-Candidal Activity and Functional Mapping of Recombinant and Synthetic Neosartorya fischeri Antifungal Protein 2 (NFAP2).,Candidaalbicans
GKCEWQGGQLNCIAT,623,11,11562,Anti-Candidal Activity and Functional Mapping of Recombinant and Synthetic Neosartorya fischeri Antifungal Protein 2 (NFAP2).,Candidaalbicans
NNCKHKKGSGC,623,11,11563,Anti-Candidal Activity and Functional Mapping of Recombinant and Synthetic Neosartorya fischeri Antifungal Protein 2 (NFAP2).,Candidaalbicans
CCNKGKNKGSH,623,11,11564,Anti-Candidal Activity and Functional Mapping of Recombinant and Synthetic Neosartorya fischeri Antifungal Protein 2 (NFAP2).,Candidaalbicans
KYHSGPSDKSKVIS,623,11,11565,Anti-Candidal Activity and Functional Mapping of Recombinant and Synthetic Neosartorya fischeri Antifungal Protein 2 (NFAP2).,Candidaalbicans
IATSPYYACNCP,623,11,11566,Anti-Candidal Activity and Functional Mapping of Recombinant and Synthetic Neosartorya fischeri Antifungal Protein 2 (NFAP2).,Candidaalbicans
RSGRARDDFRAWATK,681,11,12386,Improved smallest peptides based on positive charge increase of the ?-core motif from P?D1 and their mechanism of action against Candida species.,Candidaalbicans
RSGRARRRFRAWATK,681,11,12387,Improved smallest peptides based on positive charge increase of the ?-core motif from P?D1 and their mechanism of action against Candida species.,Candidaalbicans
GRARDDFRA,681,11,12388,Improved smallest peptides based on positive charge increase of the ?-core motif from P?D1 and their mechanism of action against Candida species.,Candidaalbicans
GRARRRFRA,681,11,12389,Improved smallest peptides based on positive charge increase of the ?-core motif from P?D1 and their mechanism of action against Candida species.,Candidaalbicans
AKYTGKCYKKKNECKYKNDAGKDTFIKCPKFDNKKCTKDNNKCTVDTYNNAVDCD,689,11,12491,The Evolutionary Conserved ?-Core Motif Influences the Anti-Candida Activity of the Penicillium chrysogenum Antifungal Protein PAF.,Candidaalbicans
AKYTGKCKTKKNKCKYKNDAGKDTFIKCPKFDNKKCTKDNNKCTVDTYNNAVDCD,689,11,12492,The Evolutionary Conserved ?-Core Motif Influences the Anti-Candida Activity of the Penicillium chrysogenum Antifungal Protein PAF.,Candidaalbicans
KKIGQKIKNFFQKL,691,11,12498,Structure-activity relationship study of the antimicrobial CRAMP-derived peptide CRAMP20-33.,Candidaalbicans
KKIWQKIKNFFQKL,691,11,12499,Structure-activity relationship study of the antimicrobial CRAMP-derived peptide CRAMP20-33.,Candidaalbicans
KRIWQKIKNFFQKL,691,11,12500,Structure-activity relationship study of the antimicrobial CRAMP-derived peptide CRAMP20-33.,Candidaalbicans
KKIWQRIKNFFQKL,691,11,12501,Structure-activity relationship study of the antimicrobial CRAMP-derived peptide CRAMP20-33.,Candidaalbicans
KKIWQKIRNFFQKL,691,11,12502,Structure-activity relationship study of the antimicrobial CRAMP-derived peptide CRAMP20-33.,Candidaalbicans
KKIWQKIKRFFQKL,691,11,12503,Structure-activity relationship study of the antimicrobial CRAMP-derived peptide CRAMP20-33.,Candidaalbicans
KKIWQKIKNFFRKL,691,11,12504,Structure-activity relationship study of the antimicrobial CRAMP-derived peptide CRAMP20-33.,Candidaalbicans
HLNARVQRELIGWLDWLK,717,11,12777,"Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from ?-amylase of rice.",Candidaalbicans
HLNKAVQRELIGWLDWLK,717,11,12778,"Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from ?-amylase of rice.",Candidaalbicans
HLLKRVQRELIGWLDWLK,717,11,12779,"Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from ?-amylase of rice.",Candidaalbicans
HLNKRVQAELIGWLDWLK,717,11,12805,"Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from ?-amylase of rice.",Candidaalbicans
HLNKRVQRELIGWLDWLA,717,11,12806,"Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from ?-amylase of rice.",Candidaalbicans
HLNKRVQRELIRWLDWLK,717,11,12807,"Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from ?-amylase of rice.",Candidaalbicans
HLNKRVQRELRGWLDWLK,717,11,12808,"Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from ?-amylase of rice.",Candidaalbicans
HLNKRVQRELIGWLRWLK,717,11,12809,"Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from ?-amylase of rice.",Candidaalbicans
HLNKRVQRLLIGWLDWLK,717,11,12810,"Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from ?-amylase of rice.",Candidaalbicans
HLLKRVQREIGWLRWLK,717,11,12817,"Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from ?-amylase of rice.",Candidaalbicans
HLNKRVQRLLIRWLRWLK,717,11,12818,"Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from ?-amylase of rice.",Candidaalbicans
VAIALKAAAYHTHKE,781,11,14070,Bioinorganic chemistry of calcitermin - the picklock of its antimicrobial activity.,Candidaalbicans
VAIALKAAHYHTAKE,781,11,14072,Bioinorganic chemistry of calcitermin - the picklock of its antimicrobial activity.,Candidaalbicans
KPPQFTKAQWFAIQHISLNPPKSTIAMKAINNYKWKSKNQNTFLK,792,11,14152,Insight into the Antifungal Mechanism of Action of Human RNase N-terminus Derived Peptides.,Candidaalbicans
RPRGMTSSQWFRIQHMQPSPQASNSAMRNINRHTRRSRDLNTFLH,792,11,14153,Insight into the Antifungal Mechanism of Action of Human RNase N-terminus Derived Peptides.,Candidaalbicans
LRRHASEGGHGPHW,807,11,14432,Identification and characterization of multifunctional cationic peptides derived from peptic hydrolysates of rice bran protein,Candidaalbicans
EKLLGKQDKGVIIRA,807,11,14433,Identification and characterization of multifunctional cationic peptides derived from peptic hydrolysates of rice bran protein,Candidaalbicans
SSFSKGVQRAAF,807,11,14434,Identification and characterization of multifunctional cationic peptides derived from peptic hydrolysates of rice bran protein,Candidaalbicans
ATKAVCVLKGDGPVQGIINF,821,11,14832,In-depth Proteomics and Natural Peptidomics Analyses Reveal Antibacterial Peptides in Human Endometrial Fluid,Candidaalbicans
VKAQEPVKGPVSTKPGSCPIILIRCA,821,11,14833,In-depth Proteomics and Natural Peptidomics Analyses Reveal Antibacterial Peptides in Human Endometrial Fluid,Candidaalbicans
LLVLRSLGPWHPGHCLLR,907,11,16005,Fungicidal activity of peptides encoded by immunoglobulin genes.,Candidaalbicans
FRWKYPKPLKR,925,11,16323,A designed antifungal peptide with therapeutic potential for clinical drug-resistant Candida albicans.,Candidaalbicans
RWKYPKPLKR,925,11,16324,A designed antifungal peptide with therapeutic potential for clinical drug-resistant Candida albicans.,Candidaalbicans
RWKQVKVKR,925,11,16325,A designed antifungal peptide with therapeutic potential for clinical drug-resistant Candida albicans.,Candidaalbicans
RCVRWWKRVCK,925,11,16326,A designed antifungal peptide with therapeutic potential for clinical drug-resistant Candida albicans.,Candidaalbicans
RWRFKWKK,925,11,16327,A designed antifungal peptide with therapeutic potential for clinical drug-resistant Candida albicans.,Candidaalbicans
RWRFKWAKK,925,11,16328,A designed antifungal peptide with therapeutic potential for clinical drug-resistant Candida albicans.,Candidaalbicans
ARWRFKWAKK,925,11,16329,A designed antifungal peptide with therapeutic potential for clinical drug-resistant Candida albicans.,Candidaalbicans
RWRFKWWKK,925,11,16330,A designed antifungal peptide with therapeutic potential for clinical drug-resistant Candida albicans.,Candidaalbicans
GWLIRGAIHAGKAIHGLIHRRRH,927,11,16388,Octominin: A Novel Synthetic Anticandidal Peptide Derived from Defense Protein of Octopus minor.,Candidaalbicans
LLCLDGTRKPVTEAQSCHLAVAPNHAVVSR,945,11,16556,Lactoferrin-Derived Peptide Lactofungin Is Potently Synergistic with Amphotericin B.,Candidaalbicans
DSAAKRHHGYKRKFHEKHHSHRGY,966,11,17014,Specific Histidine Residues Confer Histatin Peptides with Copper-Dependent Activity against Candida albicans.,Candidaalbicans
DSHAKRAAGYKRKFHEKHHSHRGY,966,11,17015,Specific Histidine Residues Confer Histatin Peptides with Copper-Dependent Activity against Candida albicans.,Candidaalbicans
DSHAKRHHGYKRKFHEKAASHRGY,966,11,17016,Specific Histidine Residues Confer Histatin Peptides with Copper-Dependent Activity against Candida albicans.,Candidaalbicans
DSHAGYKRKFHEKHHSHRGY,985,11,17338,Metal-binding and nuclease activity of an antimicrobial peptide analogue of the salivary histatin 5.,Candidaalbicans
DSHAKRHHGYKRKFHEKHHSHRGY,19,11,15,Histatin 5-derived peptide with improved fungicidal properties enhances human immunodeficiency virus type 1 replication by promoting viral entry,Candidaalbicans
GKPRPYSPRPTSHPRPIRV,21,11,564,Energy depletion protects Candida albicans against antimicrobial peptides by rigidifying its cell membrane,Candidaalbicans
DSHAKRHHGYKRKFHEKHHSHRGYRSNYLYDN,995,11,625,"Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans.",Candidaalbicans
RKFHEKHHSHRGYR,30,11,730,"Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5",Candidaalbicans
RLKELITTGGQKIGEKIRRIGQRIKDFFKNLQPREEKS,1041,11,1156,"Canine cathelicidin (K9CATH): gene cloning, expression, and biochemical activity of a novel pro-myeloid antimicrobial peptide.",Candidaalbicans
DKLIGSCVWGAVNYTSNCNAECKRRGYKGGHCGSFANVNCWCET,83,11,2089,Lead optimization of antifungal peptides with 3D NMR structures analysis.,Candidaalbicans
FLPILASLAAKFGPKLFCLVTKKC,1240,11,3536,Isolation of peptides of the brevinin-1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii.,Candidaalbicans
FLPILASLAAKLGPKLFCLVTKKC,1240,11,3537,Isolation of peptides of the brevinin-1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii.,Candidaalbicans
FLPILASLAATLGPKLLCLITKKC,1240,11,3538,Isolation of peptides of the brevinin-1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii.,Candidaalbicans
GILSTFKGLAKGVAKDLAGNLLDKFKCKITGC,1240,11,3539,Isolation of peptides of the brevinin-1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii.,Candidaalbicans
GIMDSVKGLAKNLAGKLLDSLKCKITGC,1240,11,3540,Isolation of peptides of the brevinin-1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii.,Candidaalbicans
AALKGCWTKSIPPKPCSGKR,1255,11,3799,Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.,Candidaalbicans
AALRGCWTKSIPPKPCSGKR,1255,11,3800,Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.,Candidaalbicans
AALRGCWTKSIPPKPCPGKR,1255,11,3801,Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.,Candidaalbicans
SALVGCWTKSYPPNPCFGRG,1255,11,3804,Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.,Candidaalbicans
AAFRGCWTKNYSPKPCL,1255,11,3828,Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.,Candidaalbicans
GIVEQCCASVCSLYQLENYCN,140,11,4095,"MUC7 20-Mer: investigation of antimicrobial activity, secondary structure, and possible mechanism of antifungal action.",Candidaalbicans
KTCENLADTYKGPCFTTGSCDDHCKNKEHLRSGRCRDDFRCWCTKNC,1276,11,4120,"Isolation, characterization and cloning of a cDNA encoding a new antifungal defensin from Phaseolus vulgaris L. seeds.",Candidaalbicans
APPGARPPPGPPPPGPPPPGP,1277,11,4121,Structural and functional characterization of the porcine proline-rich antifungal peptide SP-B isolated from salivary gland granules.,Candidaalbicans
RPDFCLEPPYTGPCKARMIRYFYNAKAGLCQPFVYGGCRAKRNNFKSSEDCMRTCGGA,1391,11,5395,Bovine pancreatic trypsin inhibitor is a new antifungal peptide that inhibits cellular magnesium uptake.,Candidaalbicans
VVCACRRALCLPLERRAGFCRIRGRIHPLCCRR,227,11,5403,Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides.,Candidaalbicans
MLWSASMRIFASAFSTRGLGTRMLMYCSLPSRCWRK,1430,11,5803,Identification of a novel antifungal peptide with chitin-binding property from marine metagenome.,Candidaalbicans
RMKKLGNHKVSCERNTKRCRKAI,1475,11,7005,Antifungal effect and pore-forming action of lactoferricin B like peptide derived from centipede Scolopendra subspinipes mutilans.,Candidaalbicans
FFGTLFKLGSKLIPGVMKLFSKKKER,1565,11,9865,Activity of Scorpion Venom-Derived Antifungal Peptides against Planktonic Cells of Candida spp. and Cryptococcus neoformans and Candida albicans Biofilms.,Candidaalbicans
FWSFLVKAASKILPSLIGGGDDNKSSS,1565,11,9866,Activity of Scorpion Venom-Derived Antifungal Peptides against Planktonic Cells of Candida spp. and Cryptococcus neoformans and Candida albicans Biofilms.,Candidaalbicans
GILGKIWEGVKSLI,1565,11,9870,Activity of Scorpion Venom-Derived Antifungal Peptides against Planktonic Cells of Candida spp. and Cryptococcus neoformans and Candida albicans Biofilms.,Candidaalbicans
IATSPYYACNCPNNCKHKKGSGCKYHSGPSDKSKVISGKCEWQGGQLNCIAT,623,11,11558,Anti-Candidal Activity and Functional Mapping of Recombinant and Synthetic Neosartorya fischeri Antifungal Protein 2 (NFAP2).,Candidaalbicans
AKYTGKCTKSKNECKYKNDAGKDTFIKCPKFDNKKCTKDNNKCTVDTYNNAVDCD,689,11,12487,The Evolutionary Conserved ?-Core Motif Influences the Anti-Candida Activity of the Penicillium chrysogenum Antifungal Protein PAF.,Candidaalbicans
LSVKAFTGIQLRGVCGIEVKARG,1648,11,12615,"Isolation, functional characterization and biological properties of MCh-AMP1, a novel antifungal peptide from Matricaria chamomilla L.",Candidaalbicans
RTCQSQSHRFRGPCLRRSNCANVCRTEGFPGGRCRGFRRRCFCTTHC,1657,11,13150,Salt-Tolerant Antifungal and Antibacterial Activities of the Corn Defensin ZmD32.,Candidaalbicans
GRTSKQELCTWERGSVRQADKTIAG,1661,11,13424,"Isolation and functional characterization of an antifungal hydrophilic peptide, Skh-AMP1, derived from Satureja khuzistanica leaves.",Candidaalbicans
AAFRGCWTKSYSPKPCLGKR,925,11,16322,A designed antifungal peptide with therapeutic potential for clinical drug-resistant Candida albicans.,Candidaalbicans
FWGTLAKWALK,1700,11,16491,Antifungal In Vitro Activity of Pilosulin- and Ponericin-Like Peptides from the Giant Ant Dinoponera quadriceps and Synergistic Effects with Antimycotic Drugs.,Candidaalbicans
FWGTLAKWALKAI,1700,11,16492,Antifungal In Vitro Activity of Pilosulin- and Ponericin-Like Peptides from the Giant Ant Dinoponera quadriceps and Synergistic Effects with Antimycotic Drugs.,Candidaalbicans
FWGTLAKWALKAIPAAMGMKQNK,1700,11,16493,Antifungal In Vitro Activity of Pilosulin- and Ponericin-Like Peptides from the Giant Ant Dinoponera quadriceps and Synergistic Effects with Antimycotic Drugs.,Candidaalbicans
